Citrus Sinensis ID: 010131
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | yes | no | 0.988 | 0.550 | 0.725 | 0.0 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.932 | 0.521 | 0.402 | 6e-91 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.940 | 0.525 | 0.390 | 2e-88 | |
| C0LGV0 | 895 | Probable LRR receptor-lik | no | no | 0.835 | 0.482 | 0.396 | 1e-81 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.870 | 0.507 | 0.380 | 4e-80 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.856 | 0.497 | 0.376 | 1e-79 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.858 | 0.509 | 0.368 | 3e-79 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.794 | 0.468 | 0.382 | 3e-78 | |
| C0LGQ7 | 898 | Probable LRR receptor-lik | no | no | 0.878 | 0.505 | 0.361 | 4e-78 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.818 | 0.480 | 0.377 | 5e-78 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 731 bits (1887), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/520 (72%), Positives = 432/520 (83%), Gaps = 9/520 (1%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + ALS KNL+GEIPP + MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+G
Sbjct: 416 VTKIALSRKNLRGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSG 475
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
SLP Y+ LPNLQEL IENNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG
Sbjct: 476 SLPPYLAHLPNLQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILG 534
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
SI +AILL+L SL++L LR+ K +K DS T K AYS RGGH +D
Sbjct: 535 ISIAAVAILLLLVGGSLVLLCALRK----TKRADKGDSTETKKK-GLVAYSAVRGGHLLD 589
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EGVAYFI LP LEEAT+NF KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVT
Sbjct: 590 EGVAYFISLPVLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVT 649
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA
Sbjct: 650 EVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIA 709
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DAAKGLEYLHTGCNP IIHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+G
Sbjct: 710 QDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKG 769
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY +QQLTEKSDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KG
Sbjct: 770 TVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKG 829
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 480
DV I+DP + NVKIES+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE+G +
Sbjct: 830 DVCGIIDPCIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENG 889
Query: 481 F---SSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
SSSSSK QSSRKTLLTSFLE+ESPD+S LAPAAR
Sbjct: 890 LKSSSSSSSKAQSSRKTLLTSFLELESPDISRNSLAPAAR 929
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (859), Expect = 6e-91, Method: Compositional matrix adjust.
Identities = 203/504 (40%), Positives = 292/504 (57%), Gaps = 22/504 (4%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + LS NLKG IP + M L L L N G +P L V L N+LTG
Sbjct: 407 ITKLDLSSSNLKGTIPSSVTEMTKLQILNLSHNHFDGYIPSFPPSSLLISVDLSYNDLTG 466
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF-KLIL 119
LP + SLP+L L+ N + + A L +I N + + ++ +F ++ +
Sbjct: 467 QLPESIISLPHLNSLYFGCNQHMRDDDEAKLNSSLI-----NTDYGRCNAKKPKFGQVFM 521
Query: 120 GTSIGVLAILLVLFLCSLIVLRKLRRKISNQ----KSYEKADSLRTSTKPSNTAYSIARG 175
+I +IL+ L + L R + I+ + K+Y A +N +S+
Sbjct: 522 IGAITSGSILITLAVVILFFCRYRHKSITLEGFGGKTYPMA---------TNIIFSLPSK 572
Query: 176 GHFMDEGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR 234
F + V+ L +E AT + IG+G FGSVY G + DG+EVAVK+ + + +
Sbjct: 573 DDFFIKSVSVKPFTLEYIELATEKYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQG 632
Query: 235 TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDW 293
T++F E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G +K LDW
Sbjct: 633 TREFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEPAKRKILDW 692
Query: 294 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLT 352
TRL IA AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E +
Sbjct: 693 PTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDS 752
Query: 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 412
++S RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V W
Sbjct: 753 YVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEW 812
Query: 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
A+ I+ V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D++
Sbjct: 813 AKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALI 872
Query: 473 IEKGGDQKFSSSSSKGQSSRKTLL 496
IE + S S G S+R +++
Sbjct: 873 IENNASEYMKSIDSLGGSNRYSIV 896
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 195/499 (39%), Positives = 283/499 (56%), Gaps = 13/499 (2%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + LS NLKG IP + M L L L N P L + L N+L+G
Sbjct: 409 ITKLDLSSNNLKGAIPSIVTKMTNLQILNLSHNQFDMLFPSFPPSSLLISLDLSYNDLSG 468
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
LP + SLP+L+ L+ N + + L +I N + ++ +F +
Sbjct: 469 WLPESIISLPHLKSLYFGCNPSMSDEDTTKLNSSLI-----NTDYGRCKAKKPKFGQVFV 523
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
LL+ ++ + R K + + K + T N +S+ F
Sbjct: 524 IGAITSGSLLITLAVGILFFCRYRHKSITLEGFGKTYPMAT-----NIIFSLPSKDDFFI 578
Query: 181 EGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV 239
+ V+ L +E+AT + IG+G FGSVY G + DG+EVAVK+ + + + T++F
Sbjct: 579 KSVSVKPFTLEYIEQATEQYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFD 638
Query: 240 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQ 298
E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G ++ K LDW TRL
Sbjct: 639 NELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKILDWPTRLS 698
Query: 299 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 357
IA AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E +++S
Sbjct: 699 IALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLE 758
Query: 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417
RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V WA+ I
Sbjct: 759 VRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAKPYI 818
Query: 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 477
+ V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D++ IE
Sbjct: 819 RASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNA 878
Query: 478 DQKFSSSSSKGQSSRKTLL 496
+ S S G S+R +++
Sbjct: 879 SEYMKSIDSLGGSNRYSIV 897
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (778), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 190/479 (39%), Positives = 279/479 (58%), Gaps = 47/479 (9%)
Query: 21 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80
+++ L +L L N L ++ L++L ++ L+NN L GS+P +G L L+ L++ENN
Sbjct: 428 SLKDLQKLNLSFNQLESFGSELEDLVNLEVLDLQNNSLQGSVPETLGKLKKLRLLNLENN 487
Query: 81 SFVGEIPPALLTGKVIFKYDNNPKL-----------------------HKESRRRMRFKL 117
+ VG +P +L + + NP L +K+ R++ R +
Sbjct: 488 NLVGPLPQSLNITGLEVRITGNPCLSFSSISCNNVSSTIDTPQVTIPINKKQRKQNRIAI 547
Query: 118 ILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGH 177
+LG S G L ++F+ I R+ R K + D R K N ++ +R
Sbjct: 548 LLGVSGGALFATFLVFVFMSIFTRRQRNK--------ERDITRAQLKMQN--WNASR--- 594
Query: 178 FMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ 237
E++ AT NF + IG+GSFG+VY GK+ DGK+VAVK+ D
Sbjct: 595 --------IFSHKEIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADS 646
Query: 238 FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTR 296
F+ EV LLS+I H+NLV G+C E ++ILVYEY+ G+L D L+G +++ L+W++R
Sbjct: 647 FINEVHLLSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRSKRHSLNWVSR 706
Query: 297 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 355
L++A DAAKGL+YLH G P IIHRDVKSSNILLD +M AKVSDFGLS+Q + D +HI+
Sbjct: 707 LKVAVDAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHIT 766
Query: 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415
+V +GT GYLDPEYY QLTEKSDVYSFGVVLLELI G++P+S N+V WAR
Sbjct: 767 TVVKGTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARP 826
Query: 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474
++ G IVD +L S+ + A +AI+CV + RP + E++ ++++ ++
Sbjct: 827 NLQAG-AFEIVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAYSLQ 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (765), Expect = 4e-80, Method: Compositional matrix adjust.
Identities = 187/492 (38%), Positives = 279/492 (56%), Gaps = 42/492 (8%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
LS L G I P ++N+ L EL L N LTG +P + L LR + L NN LTG +P
Sbjct: 419 LSSSGLTGVITPSIQNLTMLRELDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPE 478
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP--KLHKESRRRMRFKLILGTS 122
++ ++ L +H+ N+ G +P AL +NN KL + + + + + S
Sbjct: 479 FLATIKPLLVIHLRGNNLRGSVPQALQ------DRENNDGLKLLRGKHQPKSWLVAIVAS 532
Query: 123 IGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEG 182
I +A+ +++ L + + R RRK S +K +R S + N + +
Sbjct: 533 ISCVAVTIIV-LVLIFIFR--RRKSSTRKV------IRPSLEMKNRRFKYS--------- 574
Query: 183 VAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEV 242
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV
Sbjct: 575 --------EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEV 625
Query: 243 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
LL R+HH NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA +
Sbjct: 626 ELLLRVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIE 685
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGT 361
+A G+EYLH GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT
Sbjct: 686 SALGIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGT 745
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421
+GYLDPEYY LTEKSDVYSFG+VLLE+I+G +PV +E + IV WA+SM+ GD
Sbjct: 746 LGYLDPEYYQKNWLTEKSDVYSFGIVLLEIITG-QPV-IEQSRDKSYIVEWAKSMLANGD 803
Query: 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI---EKGGD 478
+ SI+D L + S W+ E+A+ C+ RP M + + + ++I K
Sbjct: 804 IESIMDRNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEIYNLTKRRS 863
Query: 479 QKFSSSSSKGQS 490
Q +SS S G +
Sbjct: 864 QDQNSSKSSGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 297 bits (761), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 177/470 (37%), Positives = 277/470 (58%), Gaps = 27/470 (5%)
Query: 30 LDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EI 86
L+G+ LTG + D+S+L L ++ L NN+L+G +P++ + +L+ +++ N + I
Sbjct: 418 LNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAI 477
Query: 87 PPAL---LTGK--VIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 141
P +L + K + +N K+ +++ I + GV A+L++L + +I +
Sbjct: 478 PDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAASVAGVFALLVILAIFFVIKRK 537
Query: 142 KLR-RKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC 200
++ K +++ T+ SN + I R + + Y PE+ + TNNF
Sbjct: 538 NVKAHKSPGPPPLVTPGIVKSETRSSNPSI-ITR-----ERKITY----PEVLKMTNNFE 587
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
+ +GKG FG+VY+G + DG EVAVK+++ S + ++F EV LL R+HHR+LV L+GYC
Sbjct: 588 RVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYC 646
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320
++ L+YEYM NG LR+ + G L W R+QIA +AA+GLEYLH GC P ++H
Sbjct: 647 DDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVH 706
Query: 321 RDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKS 379
RDVK++NILL+ AK++DFGLSR D H+S+V GT GYLDPEYY L+EKS
Sbjct: 707 RDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKS 766
Query: 380 DVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESI 439
DVYSFGVVLLE+++ +PV ++ +I W M+ KGD+ SIVDP L+G+
Sbjct: 767 DVYSFGVVLLEIVT-NQPV-IDKTRERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGA 824
Query: 440 WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE----KGGDQKFSSSS 485
W+I E+A+ CV RP M +V+ + D + +E +G ++ +S S
Sbjct: 825 WKIVELALACVNPSSNRRPTMAHVVMELNDCVALENARRQGSEEMYSMGS 874
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 180/488 (36%), Positives = 279/488 (57%), Gaps = 44/488 (9%)
Query: 5 ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 63
L+ N PP +T L L + LTG + + L +L+ + L NN L+G +P
Sbjct: 392 GLNCNNSDDSTPP------IITSLNLSSSGLTGIIVLTIQNLANLQELDLSNNNLSGGVP 445
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTGKVI-FKYDNNPKLH----------KESRRR 112
++ + +L +++ N+ G +P L+ K++ + NPKL+ +E R+
Sbjct: 446 EFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNCTVESCVNKDEEGGRQ 505
Query: 113 MRFKLI-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS 171
++ I + SIG + V F +L++ +R+ N S ++A + + P+++ S
Sbjct: 506 IKSMTIPIVASIGSV----VAFTVALMIFCVVRK---NNPSNDEAPT--SCMLPADSRSS 556
Query: 172 ----IARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM 227
+ + F E+ TNNF K +GKG FG VYYG + ++VAVK++
Sbjct: 557 EPTIVTKNKKFT---------YAEVLTMTNNFQKILGKGGFGIVYYGSVNGTEQVAVKML 607
Query: 228 ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN 287
+ S + +QF EV LL R+HH+NLV L+GYCEE + L+YEYM NG L + + G
Sbjct: 608 SHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDLDEHMSGKRG 667
Query: 288 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347
L+W TRL+IA +AA+GLEYLH GC P ++HRDVK++NILL+ + K++DFGLSR
Sbjct: 668 GSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKLADFGLSRSF 727
Query: 348 E-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406
E TH+S+V GT+GYLDPEYY LTEKSDVYSFGVVLL +I+ +PV ++ +
Sbjct: 728 PIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVMIT-NQPV-IDQNREK 785
Query: 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466
+I W M+ KGD+ SI DP L+G+ S+W+ E+A+ C+ +RP M ++V
Sbjct: 786 RHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCMNPSSMTRPTMSQVVFE 845
Query: 467 IQDSIKIE 474
+++ + E
Sbjct: 846 LKECLASE 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 293 bits (749), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 175/458 (38%), Positives = 258/458 (56%), Gaps = 47/458 (10%)
Query: 35 LTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL-- 91
LTG + P L L+ + L NN LTG++P ++ +LP+L EL++E N G +P LL
Sbjct: 426 LTGQIDPVFITLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLER 485
Query: 92 --TGKVIFKYDNNPKL-------HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRK 142
G + + NP L +K++ R+ + + G+ +LL L
Sbjct: 486 SKDGSLSLRVGGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLAL---------- 535
Query: 143 LRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK 202
IS + ++ S++T + Y + E+ E TNNF +
Sbjct: 536 ----ISFWQFKKRQQSVKTGPLDTKRYYKYS-----------------EIVEITNNFERV 574
Query: 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 262
+G+G FG VYYG ++ G++VA+K+++ S + ++F EV LL R+HH+NL+ LIGYC E
Sbjct: 575 LGQGGFGKVYYGVLR-GEQVAIKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHE 633
Query: 263 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 322
Q L+YEY+ NGTL D L G N L W RLQI+ DAA+GLEYLH GC P I+HRD
Sbjct: 634 GDQMALIYEYIGNGTLGDYLSGK-NSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRD 692
Query: 323 VKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 381
VK +NIL++ ++AK++DFGLSR E + +S+ GT+GYLDPE+Y QQ +EKSDV
Sbjct: 693 VKPTNILINEKLQAKIADFGLSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDV 752
Query: 382 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 441
YSFGVVLLE+I+G+ +S +I M+ KGD+ SIVDP L W+
Sbjct: 753 YSFGVVLLEVITGQPVISRSRTEENRHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWK 812
Query: 442 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSI-KIEKGGD 478
I EVA+ C + +R M ++V +++S+ + GD
Sbjct: 813 ITEVALACASESTKTRLTMSQVVAELKESLCRARTSGD 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ7|Y4245_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20450 OS=Arabidopsis thaliana GN=At4g20450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 182/503 (36%), Positives = 275/503 (54%), Gaps = 49/503 (9%)
Query: 5 ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS 64
L+ N+ IPP + +++ + L+G + D+ L L+ + L NN LTG +P
Sbjct: 418 GLNCSNMFPSIPPRITSID-FSNFGLNGTITS----DIQYLNQLQKLDLSNNNLTGKVPE 472
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLT----GKVIFKYDNN-----PKLHKESRR-RMR 114
++ + L +++ N+ G IP +LL G + Y+ N P E+ +
Sbjct: 473 FLAKMKLLTFINLSGNNLSGSIPQSLLNMEKNGLITLLYNGNNLCLDPSCESETGPGNNK 532
Query: 115 FKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS--I 172
KL++ ++ +++ + L+ + LR+K KPS + S +
Sbjct: 533 KKLLVPILASAASVGIIIAVLLLVNILLLRKK-----------------KPSKASRSSMV 575
Query: 173 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 232
A + E VA TNNF + +G+G FG VY+G + D ++VAVK++++S +
Sbjct: 576 ANKRSYTYEEVAVI---------TNNFERPLGEGGFGVVYHGNVNDNEQVAVKVLSESSA 626
Query: 233 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 292
+QF EV LL R+HH NLV L+GYC+E +L+YEYM NG L+ L G ++ PL
Sbjct: 627 QGYKQFKAEVDLLLRVHHINLVTLVGYCDEGQHLVLIYEYMSNGNLKQHLSGENSRSPLS 686
Query: 293 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDL 351
W RL+IA + A+GLEYLH GC P +IHRD+KS NILLD N +AK+ DFGLSR
Sbjct: 687 WENRLRIAAETAQGLEYLHIGCKPPMIHRDIKSMNILLDNNFQAKLGDFGLSRSFPVGSE 746
Query: 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 411
TH+S+ G+ GYLDPEYY LTEKSDV+SFGVVLLE+I+ +PV ++ + +I
Sbjct: 747 THVSTNVAGSPGYLDPEYYRTNWLTEKSDVFSFGVVLLEIIT-SQPV-IDQTREKSHIGE 804
Query: 412 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471
W + GD+ +IVDP + G+ S+W+ E+A+ CV RP M ++ +Q+ +
Sbjct: 805 WVGFKLTNGDIKNIVDPSMNGDYDSSSLWKALELAMSCVSPSSSGRPNMSQVANELQECL 864
Query: 472 KIE---KGGDQKFSSSSSKGQSS 491
E KGG S SS QS+
Sbjct: 865 LTENSRKGGRHDVDSKSSLEQST 887
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 5e-78, Method: Compositional matrix adjust.
Identities = 176/466 (37%), Positives = 262/466 (56%), Gaps = 43/466 (9%)
Query: 35 LTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
LTG + S L L I+ L NN LTG +P ++G+L NL EL++E N G IP LL
Sbjct: 425 LTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLER 484
Query: 94 K----VIFKYDNNPKL---------HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVL 140
++ + D NP L +++++ + ++ + +GVL ++L + +L +L
Sbjct: 485 SNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAI---ALFLL 541
Query: 141 RKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC 200
K R + +A L T+ + + E+ + TNNF
Sbjct: 542 YKKRHRRGGSGGV-RAGPLDTTKR---------------------YYKYSEVVKVTNNFE 579
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
+ +G+G FG VY+G + D +VAVKI+++S + ++F EV LL R+HH+NL LIGYC
Sbjct: 580 RVLGQGGFGKVYHGVLND-DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYC 638
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320
E + L+YE+M NGTL D L G L W RLQI+ DAA+GLEYLH GC P I+
Sbjct: 639 HEGKKMALIYEFMANGTLGDYLSGE-KSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQ 697
Query: 321 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPEYYGNQQLTEKS 379
RDVK +NIL++ ++AK++DFGLSR D + + A GT+GYLDPEY+ Q+L+EKS
Sbjct: 698 RDVKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKS 757
Query: 380 DVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438
D+YSFGVVLLE++SG+ ++ AE ++I M+ GD+ IVDP L S
Sbjct: 758 DIYSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGS 817
Query: 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSS 484
W+I EVA+ C +RP M +V +++S+ + G +SS
Sbjct: 818 AWKITEVAMACASSSSKNRPTMSHVVAELKESVSRARAGGGSGASS 863
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | ||||||
| 224107699 | 934 | predicted protein [Populus trichocarpa] | 0.998 | 0.552 | 0.779 | 0.0 | |
| 224100089 | 932 | predicted protein [Populus trichocarpa] | 0.998 | 0.553 | 0.795 | 0.0 | |
| 225425928 | 930 | PREDICTED: probable LRR receptor-like se | 0.996 | 0.553 | 0.776 | 0.0 | |
| 297738322 | 926 | unnamed protein product [Vitis vinifera] | 0.988 | 0.551 | 0.772 | 0.0 | |
| 255547926 | 911 | protein with unknown function [Ricinus c | 0.953 | 0.541 | 0.761 | 0.0 | |
| 357463139 | 930 | Leucine-rich repeat family protein / pro | 0.982 | 0.546 | 0.745 | 0.0 | |
| 356567402 | 929 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.552 | 0.738 | 0.0 | |
| 356538111 | 930 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.551 | 0.729 | 0.0 | |
| 449512995 | 956 | PREDICTED: probable LRR receptor-like se | 0.980 | 0.530 | 0.741 | 0.0 | |
| 449435025 | 923 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.980 | 0.549 | 0.740 | 0.0 |
| >gi|224107699|ref|XP_002314568.1| predicted protein [Populus trichocarpa] gi|222863608|gb|EEF00739.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2174), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/521 (77%), Positives = 458/521 (87%), Gaps = 5/521 (0%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + ALSGKNLKGEIPPE+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L+G
Sbjct: 415 ITKIALSGKNLKGEIPPEINNMETLTELWLDGNFLTGPIPSISNLVNLKIVHLENNKLSG 474
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
LP Y+GSLP+LQEL+I+NN F GEIP LLTGKVI Y++NP LHKE+ ++ KLILG
Sbjct: 475 QLPKYLGSLPDLQELYIQNNYFSGEIPSGLLTGKVIINYEHNPGLHKEAGKKKHSKLILG 534
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
SIG+LA LLV+ + SL+ LR L+RK S+QK+ + SLR S KPS TAYS++RG H MD
Sbjct: 535 VSIGILAALLVVLIGSLLFLRNLQRKTSHQKTAVQGSSLRVSAKPS-TAYSVSRGWHMMD 593
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EGV+Y+IPL E+EEAT NF KKIG+GSFG+VYYG+MK+GKEVAVKIM DS +H TQQFVT
Sbjct: 594 EGVSYYIPLSEIEEATKNFSKKIGRGSFGTVYYGQMKEGKEVAVKIMGDSTTHMTQQFVT 653
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCEEE+QRILVYEYMHNGTLRD +HGSVNQK LDWL RLQIA
Sbjct: 654 EVALLSRIHHRNLVPLIGYCEEENQRILVYEYMHNGTLRDHIHGSVNQKRLDWLARLQIA 713
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
D+AKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARG
Sbjct: 714 EDSAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARG 773
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY NQQLTEKSDVYSFGVVLLEL+SGKKPVS EDFGAE+NIVHWAR++I+KG
Sbjct: 774 TVGYLDPEYYANQQLTEKSDVYSFGVVLLELLSGKKPVSTEDFGAEMNIVHWARALIRKG 833
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GD 478
D +SIVDPVLIGNVKIESIWRIAEVAIQCVEQR SRP+MQEI+LAIQ++ KIEKG G
Sbjct: 834 DAMSIVDPVLIGNVKIESIWRIAEVAIQCVEQRAVSRPRMQEIILAIQEANKIEKGTYGS 893
Query: 479 QKFSSSSSKGQSSRKTLLTSFLEIE--SPDLSNECLAPAAR 517
QK S SSK QSSRKTLLTSFLEIE SPDLSN CL PAAR
Sbjct: 894 QKLPSGSSKAQSSRKTLLTSFLEIESQSPDLSNGCLVPAAR 934
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100089|ref|XP_002311739.1| predicted protein [Populus trichocarpa] gi|222851559|gb|EEE89106.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 840 bits (2169), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/519 (79%), Positives = 461/519 (88%), Gaps = 3/519 (0%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + ALSGKNLKGEIPPE+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L G
Sbjct: 415 ITKIALSGKNLKGEIPPEINNMEQLTELWLDGNFLTGPIPGISNLVNLKIVHLENNKLNG 474
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
LP Y+GSLP LQ L+I+NNSF GEIP LTGKVIF Y++NP LHKE+R++M KLI+G
Sbjct: 475 PLPKYLGSLPKLQALYIQNNSFSGEIPSEFLTGKVIFNYEHNPGLHKEARKKMHLKLIVG 534
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
SIG+LA LLV+ + SL+ LR L+RK S++KS + +SLR STKPS TAYS+ARG H MD
Sbjct: 535 ISIGILAGLLVVVIGSLLFLRNLQRKTSHKKSEVQGNSLRASTKPS-TAYSVARGWHMMD 593
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EGV+Y+IPLPELEEAT NF KKIG+GSFG+VYYG+MKDGKEVAVKIMADS +H T QFVT
Sbjct: 594 EGVSYYIPLPELEEATKNFSKKIGRGSFGTVYYGQMKDGKEVAVKIMADSSTHLTLQFVT 653
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPL+GYCEEEHQRILVYEYMHNGTLRD +HG VNQK LDWL RLQIA
Sbjct: 654 EVALLSRIHHRNLVPLLGYCEEEHQRILVYEYMHNGTLRDHIHGPVNQKRLDWLARLQIA 713
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DAAKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARG
Sbjct: 714 EDAAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARG 773
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY NQQLTEKSDVYSFGVVLLEL+SGKKPVS EDFG+ELNIVHWARS+I+KG
Sbjct: 774 TVGYLDPEYYANQQLTEKSDVYSFGVVLLELVSGKKPVSTEDFGSELNIVHWARSLIRKG 833
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD-- 478
DV+SIVDPVLIGN KIESIWRIAEVAIQCVEQR FSRP+M EI+LAIQ++ KIEKG D
Sbjct: 834 DVMSIVDPVLIGNAKIESIWRIAEVAIQCVEQRAFSRPRMHEIILAIQEANKIEKGTDGS 893
Query: 479 QKFSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
QK S+SSK QSSRKTLLTSFLEIESPDLSN CL PAAR
Sbjct: 894 QKQQSASSKAQSSRKTLLTSFLEIESPDLSNGCLVPAAR 932
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425928|ref|XP_002267668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2085), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/519 (77%), Positives = 448/519 (86%), Gaps = 4/519 (0%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + LSGKNL G IP ELKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG
Sbjct: 414 ITKITLSGKNLNGVIPSELKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTG 473
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
LPSY+GSLP+LQELH++NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG
Sbjct: 474 PLPSYLGSLPSLQELHVQNNLLSGEIPPALLTGKVIFNYEGNSKLHKEAHK-THFKLILG 532
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
S+G+LA+LLVL + SL +L RRK S KS +K SLRTSTK S T+YSIARGG+ MD
Sbjct: 533 ASVGLLALLLVLCIGSLFLLCNTRRKESQSKSNDKGSSLRTSTKAS-TSYSIARGGNLMD 591
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EGVA +I L +LEEAT NF K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVT
Sbjct: 592 EGVACYISLSDLEEATKNFAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVT 651
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A
Sbjct: 652 EVALLSRIHHRNLVPLIGYCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVA 711
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DAAKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARG
Sbjct: 712 EDAAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARG 771
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY NQQLTEKSDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I G
Sbjct: 772 TVGYLDPEYYANQQLTEKSDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNG 831
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GD 478
DVISIVDP L+GNVKIESIWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD
Sbjct: 832 DVISIVDPFLLGNVKIESIWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGD 891
Query: 479 QKFSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
K S SSKGQSSRKTLLT+FL+IESPDLSN+CL P+AR
Sbjct: 892 HKACSGSSKGQSSRKTLLTNFLDIESPDLSNDCLVPSAR 930
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738322|emb|CBI27523.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2065), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/519 (77%), Positives = 446/519 (85%), Gaps = 8/519 (1%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + LSGKNL G IP ELKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG
Sbjct: 414 ITKITLSGKNLNGVIPSELKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTG 473
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
LPSY+GSLP+LQELH++NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG
Sbjct: 474 PLPSYLGSLPSLQELHVQNNLLSGEIPPALLTGKVIFNYEGNSKLHKEAHK-THFKLILG 532
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
S+G+LA+LLVL + SL +L RRK +S K SLRTSTK S T+YSIARGG+ MD
Sbjct: 533 ASVGLLALLLVLCIGSLFLLCNTRRK----ESQSKRSSLRTSTKAS-TSYSIARGGNLMD 587
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EGVA +I L +LEEAT NF K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVT
Sbjct: 588 EGVACYISLSDLEEATKNFAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVT 647
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A
Sbjct: 648 EVALLSRIHHRNLVPLIGYCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVA 707
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DAAKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARG
Sbjct: 708 EDAAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARG 767
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY NQQLTEKSDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I G
Sbjct: 768 TVGYLDPEYYANQQLTEKSDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNG 827
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GD 478
DVISIVDP L+GNVKIESIWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD
Sbjct: 828 DVISIVDPFLLGNVKIESIWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGD 887
Query: 479 QKFSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
K S SSKGQSSRKTLLT+FL+IESPDLSN+CL P+AR
Sbjct: 888 HKACSGSSKGQSSRKTLLTNFLDIESPDLSNDCLVPSAR 926
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547926|ref|XP_002515020.1| protein with unknown function [Ricinus communis] gi|223546071|gb|EEF47574.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/520 (76%), Positives = 443/520 (85%), Gaps = 27/520 (5%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + ALSGKNLKGE+PPE+ NM L+EL HLENN+L+G
Sbjct: 416 ITKIALSGKNLKGEVPPEINNMVELSEL-----------------------HLENNKLSG 452
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
SLP Y+GSLPNL+EL+I+NNSFVG++P ALLTGKV Y++NP LHKE ++M FKL LG
Sbjct: 453 SLPKYLGSLPNLRELYIQNNSFVGKVPAALLTGKVNLNYEDNPGLHKEVAKKMHFKLTLG 512
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
SIGVLAILLVL L +LI LR+L+RK S+QK+ +S+R STKPS TAYSI RG H MD
Sbjct: 513 ISIGVLAILLVLLLGTLIYLRRLQRKTSHQKTDNPGNSMRASTKPS-TAYSITRGWHLMD 571
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EG +Y+I ELEEAT NF KKIGKGSFGSVYYG+MKDGKEVAVKIMADSCSH TQQFVT
Sbjct: 572 EGGSYYISFAELEEATKNFFKKIGKGSFGSVYYGQMKDGKEVAVKIMADSCSHLTQQFVT 631
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIG+CEEEHQRILVYEYMHNGTLRD +HG N+K LDWLTRLQIA
Sbjct: 632 EVALLSRIHHRNLVPLIGFCEEEHQRILVYEYMHNGTLRDHIHGIDNRKSLDWLTRLQIA 691
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DAAKGLEYLHTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAE+DLTHISSVARG
Sbjct: 692 EDAAKGLEYLHTGCSPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEDDLTHISSVARG 751
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY NQQLTEKSDVYSFGVVLLELISGKKPVS EDFGAE+NIVHWAR++I+KG
Sbjct: 752 TVGYLDPEYYANQQLTEKSDVYSFGVVLLELISGKKPVSTEDFGAEMNIVHWARALIRKG 811
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GD 478
DV+SIVDPVLIGNVKIESIWR+AEVAIQCV+QR SRP+MQE++L+IQ++IKIEKG G
Sbjct: 812 DVVSIVDPVLIGNVKIESIWRVAEVAIQCVQQRAVSRPRMQEVILSIQEAIKIEKGTDGS 871
Query: 479 QKFSSS-SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
QK S+S SSK QSSRKTLLTSFLEIESPDLSN CL PAAR
Sbjct: 872 QKLSNSGSSKAQSSRKTLLTSFLEIESPDLSNGCLVPAAR 911
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463139|ref|XP_003601851.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] gi|355490899|gb|AES72102.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1972), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/515 (74%), Positives = 435/515 (84%), Gaps = 7/515 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
LSG+NL GEIP EL NMEALTELWLD N LTG LPDMS LI+L+I+HLENN+LTG LP+Y
Sbjct: 420 LSGRNLTGEIPRELNNMEALTELWLDRNLLTGQLPDMSNLINLKIMHLENNKLTGPLPTY 479
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 125
+GSLP LQ L+I+NNSF G+IP LL+ K+ F YD+NP LHK S++ F L++G SIGV
Sbjct: 480 LGSLPGLQALYIQNNSFTGDIPAGLLSTKITFIYDDNPGLHKRSKKH--FPLMIGISIGV 537
Query: 126 LAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 185
L IL+V+FL SL++LR LRRK S QKS E+A S RT TK T YS R G+ MDEG AY
Sbjct: 538 LVILMVMFLASLVLLRYLRRKASQQKSDERAISGRTGTK-HLTGYSFGRDGNLMDEGTAY 596
Query: 186 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 245
+I L +L+ ATNNF KKIGKGSFGSVYYGKMKDGKE+AVK M D SH QFVTEVALL
Sbjct: 597 YITLSDLKVATNNFSKKIGKGSFGSVYYGKMKDGKEIAVKTMTDPSSHGNHQFVTEVALL 656
Query: 246 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 305
SRIHHRNLVPLIGYCEEE+Q ILVYEYMHNGTLRD +H ++K LDWLTRL+IA DAAK
Sbjct: 657 SRIHHRNLVPLIGYCEEEYQHILVYEYMHNGTLRDHIHECSSEKRLDWLTRLRIAEDAAK 716
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 365
GLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVA+GTVGYL
Sbjct: 717 GLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVAKGTVGYL 776
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425
DPEYY NQQLTEKSDVYSFGVVLLELI GKKPVS ED+G E+NIVHWARS+I+KGD+ISI
Sbjct: 777 DPEYYANQQLTEKSDVYSFGVVLLELICGKKPVSPEDYGPEMNIVHWARSLIRKGDIISI 836
Query: 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---S 482
+DP+LIGNVK ESIWR+AE+A+QCVE G SRP+MQE++LAIQD+ KIEKG + + S
Sbjct: 837 MDPLLIGNVKTESIWRVAEIAMQCVEPHGASRPRMQEVILAIQDASKIEKGTESQLKVSS 896
Query: 483 SSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
SSSS QSSRKTLLTSFLEIESPDLSN CL P+AR
Sbjct: 897 SSSSIPQSSRKTLLTSFLEIESPDLSNGCL-PSAR 930
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567402|ref|XP_003551909.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1961), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/520 (73%), Positives = 436/520 (83%), Gaps = 7/520 (1%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + LS +N+KGEIP EL NMEALTELWLDGN LTG LPDM LI+L+IVHLENN+L+G
Sbjct: 414 ITKINLSRRNMKGEIPRELNNMEALTELWLDGNMLTGQLPDMRNLINLKIVHLENNKLSG 473
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
LPSY+GSLP+LQ L I+NNSF G IP LL+GK+IF +D+NP+LHK +++ F+L+LG
Sbjct: 474 PLPSYLGSLPSLQALFIQNNSFSGVIPSGLLSGKIIFNFDDNPELHKGNKKH--FQLMLG 531
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
SIGVLAILL+LFL SL++L LRRK S QK EK S R+STKP T YS R G+ MD
Sbjct: 532 ISIGVLAILLILFLTSLVLLLNLRRKTSRQKCDEKGISGRSSTKPL-TGYSFGRNGNIMD 590
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EG AY+I L EL+EATNNF K IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV
Sbjct: 591 EGTAYYITLSELKEATNNFSKNIGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVN 650
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCEEE+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA
Sbjct: 651 EVALLSRIHHRNLVPLIGYCEEEYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIA 710
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DA+KGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARG
Sbjct: 711 EDASKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARG 770
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY NQQLTEKSDVYSFGVVLLELISGKKPVS ED+G E+NIVHWARS+I+KG
Sbjct: 771 TVGYLDPEYYANQQLTEKSDVYSFGVVLLELISGKKPVSSEDYGPEMNIVHWARSLIRKG 830
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 480
DVISI+DP L+GNVK ES+WR+AE+AIQCVEQ G RP+MQE++LAIQD+ IEKG + +
Sbjct: 831 DVISIMDPSLVGNVKTESVWRVAEIAIQCVEQHGACRPRMQEVILAIQDASNIEKGSEIQ 890
Query: 481 F---SSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
SS SK QSSRKTLL SFLEIESPDLSN CL P+AR
Sbjct: 891 LKLSSSGGSKPQSSRKTLLASFLEIESPDLSNSCL-PSAR 929
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538111|ref|XP_003537548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/521 (72%), Positives = 435/521 (83%), Gaps = 8/521 (1%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + LS +NLKGEIP +L NMEALTELWLDGN LTG LPDMS LI+++I+HLENN+LTG
Sbjct: 414 ITKINLSRRNLKGEIPGKLNNMEALTELWLDGNMLTGQLPDMSNLINVKIMHLENNKLTG 473
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
LPSY+GSLP+LQ L I+NNSF G IP LL+GK+IF +D+NP+LHK +++ F+L+LG
Sbjct: 474 PLPSYLGSLPSLQALFIQNNSFSGVIPSGLLSGKIIFNFDDNPELHKGNKKH--FQLMLG 531
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
SIGVL ILL+LFL SL++L LRRK S QK EK S R+STKP T YS R G+ MD
Sbjct: 532 ISIGVLVILLILFLTSLVLLLILRRKTSQQKRDEKGVSGRSSTKPL-TGYSFGRDGNIMD 590
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EG AY+I L EL+EATNNF K IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV
Sbjct: 591 EGTAYYITLSELKEATNNFSKNIGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVN 650
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCEEE+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA
Sbjct: 651 EVALLSRIHHRNLVPLIGYCEEEYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIA 710
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DAAKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARG
Sbjct: 711 EDAAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARG 770
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY NQQLTEKSDVYSFGVVLLEL+SGKK VS ED+G E+NIVHWARS+I+KG
Sbjct: 771 TVGYLDPEYYANQQLTEKSDVYSFGVVLLELLSGKKAVSSEDYGPEMNIVHWARSLIRKG 830
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 480
DVISI+DP L+GN+K ES+WR+AE+A+QCVEQ G RP+MQE++LAIQD+ IEKG + +
Sbjct: 831 DVISIMDPSLVGNLKTESVWRVAEIAMQCVEQHGACRPRMQEVILAIQDASNIEKGTESQ 890
Query: 481 FSSSSSKG----QSSRKTLLTSFLEIESPDLSNECLAPAAR 517
SSS G QSSRKTLL SFLEIESPDLSN CL P+AR
Sbjct: 891 LKLSSSGGNSKPQSSRKTLLASFLEIESPDLSNSCL-PSAR 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449512995|ref|XP_004164199.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/519 (74%), Positives = 436/519 (84%), Gaps = 12/519 (2%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + LS KNLKGEIPPE+ M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG
Sbjct: 448 ITKIELSRKNLKGEIPPEINTMDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTG 507
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
+LPSY+ SLPNLQEL+I+NN+F GEIP LL K+IFKYD N LHK R ++ KLILG
Sbjct: 508 TLPSYLCSLPNLQELYIQNNTFSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILG 567
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
S+GVL +L++L L SL++LRKLRRK + + +K SL STK S +AYSI +G D
Sbjct: 568 VSLGVLVLLVILLLGSLLLLRKLRRKTAPYQ--KKGGSLNISTKRS-SAYSIGKG----D 620
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EG+AY++ L ELEEATNNF KKIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+T
Sbjct: 621 EGMAYYLSLSELEEATNNFSKKIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMT 680
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA
Sbjct: 681 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIA 740
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DAAKGLEYLHTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARG
Sbjct: 741 EDAAKGLEYLHTGCSPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARG 800
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY QQLTEKSDVYSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ KG
Sbjct: 801 TVGYLDPEYYACQQLTEKSDVYSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHKG 860
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GD 478
DV SIVDP L G VKIES+WRIAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G+
Sbjct: 861 DVTSIVDPFLEGKVKIESVWRIAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGN 920
Query: 479 QKFSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
QK SS + K QSSRKTLLT+FLEIESPD S L P+AR
Sbjct: 921 QKLSSENLKAQSSRKTLLTTFLEIESPDGS---LLPSAR 956
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435025|ref|XP_004135296.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1888), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/520 (74%), Positives = 436/520 (83%), Gaps = 13/520 (2%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + LS KNLKGEIPPE+ M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG
Sbjct: 414 ITKIELSRKNLKGEIPPEINTMDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTG 473
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
+LPSY+ SLPNLQEL+I+NN+F GEIP LL K+IFKYD N LHK R ++ KLILG
Sbjct: 474 TLPSYLCSLPNLQELYIQNNTFSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILG 533
Query: 121 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
S+GVL +L++L L SL++LRKLRRK + + +K SL STK S +AYSI +G D
Sbjct: 534 VSLGVLVLLVILLLGSLLLLRKLRRKTAPYQ--KKGGSLNISTKRS-SAYSIGKG----D 586
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EG+AY++ L ELEEATNNF KKIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+T
Sbjct: 587 EGMAYYLSLSELEEATNNFSKKIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMT 646
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA
Sbjct: 647 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIA 706
Query: 301 HDAAKGLEYLHTGCNPGII-HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 359
DAAKGLEYLHTGC+P II HRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVAR
Sbjct: 707 EDAAKGLEYLHTGCSPSIIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVAR 766
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419
GTVGYLDPEYY QQLTEKSDVYSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ K
Sbjct: 767 GTVGYLDPEYYACQQLTEKSDVYSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHK 826
Query: 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--G 477
GDV SIVDP L G VKIES+WRIAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G
Sbjct: 827 GDVTSIVDPFLEGKVKIESVWRIAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEG 886
Query: 478 DQKFSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 517
+QK SS + K QSSRKTLLT+FLEIESPD S L P+AR
Sbjct: 887 NQKLSSENLKAQSSRKTLLTTFLEIESPDGS---LLPSAR 923
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 517 | ||||||
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.988 | 0.550 | 0.688 | 4.4e-187 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.891 | 0.493 | 0.489 | 1.7e-114 | |
| TAIR|locus:2156549 | 895 | AT5G48740 [Arabidopsis thalian | 0.547 | 0.316 | 0.503 | 1.7e-82 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.545 | 0.317 | 0.491 | 2.2e-82 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.558 | 0.329 | 0.472 | 7.4e-80 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.541 | 0.316 | 0.461 | 2.2e-78 | |
| TAIR|locus:2066143 | 786 | AT2G28970 [Arabidopsis thalian | 0.835 | 0.549 | 0.386 | 6.2e-78 | |
| TAIR|locus:2148151 | 866 | AT5G16900 [Arabidopsis thalian | 0.553 | 0.330 | 0.467 | 9.5e-78 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.835 | 0.488 | 0.380 | 1.5e-77 | |
| TAIR|locus:2195825 | 865 | AT1G51850 [Arabidopsis thalian | 0.845 | 0.505 | 0.375 | 2e-77 |
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1814 (643.6 bits), Expect = 4.4e-187, P = 4.4e-187
Identities = 358/520 (68%), Positives = 407/520 (78%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ + ALS KNL+GEIPP + MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+G
Sbjct: 416 VTKIALSRKNLRGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSG 475
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILG 120
SLP Y+ LPNLQEL IENNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG
Sbjct: 476 SLPPYLAHLPNLQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILG 534
Query: 121 TSXXXXXXXXXXXXXXXXXXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMD 180
S LR+ K +K DS T K AYS RGGH +D
Sbjct: 535 ISIAAVAILLLLVGGSLVLLCALRKT----KRADKGDSTETKKK-GLVAYSAVRGGHLLD 589
Query: 181 EGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT 240
EGVAYFI LP LEEAT+NF KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVT
Sbjct: 590 EGVAYFISLPVLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVT 649
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
EVALLSRIHHRNLVPLIGYCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA
Sbjct: 650 EVALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIA 709
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
DAAKGLEYLHTGCNP IIHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+G
Sbjct: 710 QDAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKG 769
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
TVGYLDPEYY +QQLTEKSDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KG
Sbjct: 770 TVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKG 829
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEXXXXX- 479
DV I+DP + NVKIES+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE
Sbjct: 830 DVCGIIDPCIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENG 889
Query: 480 --XXXXXXXXXXXXRKTLLTSFLEIESPDLSNECLAPAAR 517
RKTLLTSFLE+ESPD+S LAPAAR
Sbjct: 890 LKSSSSSSSKAQSSRKTLLTSFLELESPDISRNSLAPAAR 929
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.7e-114, P = 1.7e-114
Identities = 231/472 (48%), Positives = 306/472 (64%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
LS NL G IP +L + L ELWLDGN TGP+PD SR +L I+HLENN LTG +PS
Sbjct: 421 LSSMNLTGNIPSDLVKLTGLVELWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSS 480
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXX 125
+ LPNL+EL+++NN G IP L VI + N L K + + +I+G S
Sbjct: 481 LTKLPNLKELYLQNNVLTGTIPSDLAKD-VISNFSGNLNLEKSGDKGKKLGVIIGASVGA 539
Query: 126 XXXXXXXXXXXXXXXRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAY 185
+ + + S E + + S+T S A G A+
Sbjct: 540 FVLLIATIISCIVMCKSKKNNKLGKTSAELTNRPLPIQRVSSTL-SEAHGD------AAH 592
Query: 186 FIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALL 245
L E+EEAT F K+IG G FG VYYGK ++GKE+AVK++A++ ++F EV LL
Sbjct: 593 CFTLYEIEEATKKFEKRIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLL 652
Query: 246 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAA 304
SRIHHRNLV +GYC+EE + +LVYE+MHNGTL++ L+G V + + W+ RL+IA DAA
Sbjct: 653 SRIHHRNLVQFLGYCQEEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAA 712
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
+G+EYLHTGC P IIHRD+K+SNILLD +MRAKVSDFGLS+ A + +H+SS+ RGTVGY
Sbjct: 713 RGIEYLHTGCVPAIIHRDLKTSNILLDKHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGY 772
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVI 423
LDPEYY +QQLTEKSDVYSFGV+LLEL+SG++ +S E FG NIV WA+ I GD+
Sbjct: 773 LDPEYYISQQLTEKSDVYSFGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIR 832
Query: 424 SIVDPVLI-GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474
I+DP L + ++S+W+IAE A+ CV+ G RP M E+ IQD+I+IE
Sbjct: 833 GIIDPALAEDDYSLQSMWKIAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIE 884
|
|
| TAIR|locus:2156549 AT5G48740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 1.7e-82, Sum P(2) = 1.7e-82
Identities = 144/286 (50%), Positives = 198/286 (69%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 250
E++ AT NF + IG+GSFG+VY GK+ DGK+VAVK+ D F+ EV LLS+I H
Sbjct: 600 EIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHLLSQIRH 659
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEY 309
+NLV G+C E ++ILVYEY+ G+L D L+G +++ L+W++RL++A DAAKGL+Y
Sbjct: 660 QNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRSKRHSLNWVSRLKVAVDAAKGLDY 719
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPE 368
LH G P IIHRDVKSSNILLD +M AKVSDFGLS+Q + D +HI++V +GT GYLDPE
Sbjct: 720 LHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKGTAGYLDPE 779
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428
YY QLTEKSDVYSFGVVLLELI G++P+S N+V WAR ++ G IVD
Sbjct: 780 YYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQAG-AFEIVDD 838
Query: 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474
+L S+ + A +AI+CV + RP + E++ ++++ ++
Sbjct: 839 ILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAYSLQ 884
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 2.2e-82, Sum P(2) = 2.2e-82
Identities = 140/285 (49%), Positives = 192/285 (67%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 250
E+ E TNNF +GKG FG VY+G + ++VAVK+++ + H +QF EV LL R+HH
Sbjct: 575 EVTEMTNNFRSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHH 634
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
+NLV L+GYCE+ + LVYEYM NG L++ G L W TRLQIA +AA+GLEYL
Sbjct: 635 KNLVSLVGYCEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEAAQGLEYL 694
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 369
H GC P I+HRDVK++NILLD + +AK++DFGLSR E +H+S+V GT+GYLDPEY
Sbjct: 695 HKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEY 754
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429
Y LTEKSDVYSFGVVLLE+I+ ++ + E + +I W MI KGD+ IVDP
Sbjct: 755 YRTNWLTEKSDVYSFGVVLLEIITNQRVI--ERTREKPHIAEWVNLMITKGDIRKIVDPN 812
Query: 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474
L G+ +S+W+ E+A+ CV +RP M ++V + + + +E
Sbjct: 813 LKGDYHSDSVWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLE 857
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 7.4e-80, Sum P(2) = 7.4e-80
Identities = 139/294 (47%), Positives = 191/294 (64%)
Query: 179 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF 238
+D YFI E+ TNNF + +GKG FG VY+G + +G +VAVKI+++ + ++F
Sbjct: 557 LDTAKRYFI-YSEVVNITNNFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEF 614
Query: 239 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 298
EV LL R+HH NL LIGYC E++ L+YEYM NG L D L G + L W RLQ
Sbjct: 615 RAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSGK-SSLILSWEERLQ 673
Query: 299 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSV 357
I+ DAA+GLEYLH GC P I+HRDVK +NILL+ N++AK++DFGLSR E + +S+V
Sbjct: 674 ISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTV 733
Query: 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417
GT+GYLDPEYY +Q+ EKSDVYSFGVVLLE+I+GK P +++ SM+
Sbjct: 734 VAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGK-PAIWHSRTESVHLSDQVGSML 792
Query: 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471
GD+ IVD L ++ S W+I E+A+ C + RP M ++V+ ++ SI
Sbjct: 793 ANGDIKGIVDQRLGDRFEVGSAWKITELALACASESSEQRPTMSQVVMELKQSI 846
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 2.2e-78, Sum P(2) = 2.2e-78
Identities = 131/284 (46%), Positives = 188/284 (66%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 250
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 575 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G+EYL
Sbjct: 634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYL 693
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 369
H GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYLDPEY
Sbjct: 694 HIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEY 753
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429
Y LTEKSDVYSFG+VLLE+I+G+ PV +E + IV WA+SM+ GD+ SI+D
Sbjct: 754 YQKNWLTEKSDVYSFGIVLLEIITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDRN 811
Query: 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 812 LHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEI 855
|
|
| TAIR|locus:2066143 AT2G28970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 784 (281.0 bits), Expect = 6.2e-78, P = 6.2e-78
Identities = 177/458 (38%), Positives = 263/458 (57%)
Query: 25 LTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 83
+ L L + LTG LP + L ++ + L NN LTG +PS++ ++ +L L + N+F
Sbjct: 310 IISLNLSASGLTGSLPSVFQNLTQIQELDLSNNSLTGLVPSFLANIKSLSLLDLSGNNFT 369
Query: 84 GEIPPALLTGK---VIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXXX 140
G +P LL + ++ K + NP+L K S + K L
Sbjct: 370 GSVPQTLLDREKEGLVLKLEGNPELCKFSSCNPKKKKGLLVPVIASISSVLIVIVVVALF 429
Query: 141 RKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGH----FMDEGV--AYFIPLPELEE 194
LR+K K A + PS + + H F+ + + AYF E++E
Sbjct: 430 FVLRKK----KMPSDAQA-----PPSLPVEDVGQAKHSESSFVSKKIRFAYF----EVQE 476
Query: 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 254
TNNF + +G+G FG VY+G + ++VAVK+++ S S + F EV LL R+HH+NLV
Sbjct: 477 MTNNFQRVLGEGGFGVVYHGCVNGTQQVAVKLLSQSSSQGYKHFKAEVELLMRVHHKNLV 536
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L+GYC+E L+YEYM NG L+ L G L W +RL++A DAA GLEYLHTGC
Sbjct: 537 SLVGYCDEGDHLALIYEYMPNGDLKQHLSGKRGGFVLSWESRLRVAVDAALGLEYLHTGC 596
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQ 373
P ++HRD+KS+NILLD +AK++DFGLSR E+ TH+S+V GT GYLDPEYY
Sbjct: 597 KPPMVHRDIKSTNILLDERFQAKLADFGLSRSFPTENETHVSTVVAGTPGYLDPEYYQTN 656
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433
LTEKSDVYSFG+VLLE+I+ + P+ ++ + ++V W +++ GD+ +IVDP L G
Sbjct: 657 WLTEKSDVYSFGIVLLEIITNR-PI-IQQSREKPHLVEWVGFIVRTGDIGNIVDPNLHGA 714
Query: 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471
+ S+W+ E+A+ CV RP M ++V +++ +
Sbjct: 715 YDVGSVWKAIELAMSCVNISSARRPSMSQVVSDLKECV 752
|
|
| TAIR|locus:2148151 AT5G16900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 9.5e-78, Sum P(2) = 9.5e-78
Identities = 135/289 (46%), Positives = 188/289 (65%)
Query: 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 246
I E+ TNNF + IG+G FG VY+G + D ++VAVK+++ S S ++F EV LL
Sbjct: 563 ITYSEILLMTNNFERVIGEGGFGVVYHGYLNDSEQVAVKVLSPSSSQGYKEFKAEVELLL 622
Query: 247 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
R+HH NLV L+GYC+E+ L+YEYM NG L+ L G L W RL IA + A G
Sbjct: 623 RVHHINLVSLVGYCDEQAHLALIYEYMANGDLKSHLSGKHGDCVLKWENRLSIAVETALG 682
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 365
LEYLH+GC P ++HRDVKS NILLD + +AK++DFGLSR + + +H+S+ GT GYL
Sbjct: 683 LEYLHSGCKPLMVHRDVKSMNILLDEHFQAKLADFGLSRSFSVGEESHVSTGVVGTPGYL 742
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425
DPEYY +LTEKSDVYSFG+VLLE+I+ + PV +E +I R+M+ + D+ +I
Sbjct: 743 DPEYYRTYRLTEKSDVYSFGIVLLEIITNQ-PV-LEQANENRHIAERVRTMLTRSDISTI 800
Query: 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474
VDP LIG S+ + ++A+ CV+ +RP M +V ++ IK E
Sbjct: 801 VDPNLIGEYDSGSVRKALKLAMSCVDPSPVARPDMSHVVQELKQCIKSE 849
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 1.5e-77, Sum P(2) = 1.5e-77
Identities = 174/457 (38%), Positives = 258/457 (56%)
Query: 30 LDGNFLTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 88
L + LTG + P + L L I+ L NN LTG +P ++ L ++ + + N+ G +P
Sbjct: 410 LSASGLTGIIAPAIQNLTHLEILALSNNNLTGEVPEFLADLKSIMVIDLRGNNLSGPVPA 469
Query: 89 ALLTGK-VIFKYDNNPKL--------HKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXX 139
+LL K ++ D+NP + HK + + + S
Sbjct: 470 SLLQKKGLMLHLDDNPHILCTTGSCMHKGEGEKKSIIVPVVASIVSLAVIIGALILFLVF 529
Query: 140 XRKLRRKISNQ-KSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN 198
+K K+ SY +A R S + S A + + F V TNN
Sbjct: 530 RKKKASKVEGTLPSYMQASDGR-SPRSSEPAI-VTKNKRFTYSQVVIM---------TNN 578
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
F + +GKG FG VY+G + ++VAVKI++ S S +QF EV LL R+HH+NLV L+G
Sbjct: 579 FQRILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVGLVG 638
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
YC+E L+YEYM NG L++ + G+ N+ L+W TRL+I D+A+GLEYLH GC P +
Sbjct: 639 YCDEGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIVIDSAQGLEYLHNGCKPLM 698
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTE 377
+HRDVK++NILL+ + AK++DFGLSR TH+S+V GT GYLDPEYY +LTE
Sbjct: 699 VHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGTPGYLDPEYYKTNRLTE 758
Query: 378 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437
KSDVYSFG+VLLE+I+ + PV ++ + I W M+ KGD+ISI+DP L G+
Sbjct: 759 KSDVYSFGIVLLEMITNR-PV-IDQSREKPYISEWVGIMLTKGDIISIMDPSLNGDYDSG 816
Query: 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474
S+W+ E+A+ C+ RP M ++++A+ + + E
Sbjct: 817 SVWKAVELAMSCLNPSSTRRPTMSQVLIALNECLVSE 853
|
|
| TAIR|locus:2195825 AT1G51850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 755 (270.8 bits), Expect = 2.0e-77, Sum P(2) = 2.0e-77
Identities = 174/464 (37%), Positives = 263/464 (56%)
Query: 25 LTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 83
+T L L + LTG + + L +L+ + L +N LTG +P ++G + +L +++ N+
Sbjct: 384 ITSLDLSSSGLTGSITQAIQNLTNLQELDLSDNNLTGEIPDFLGDIKSLLVINLSGNNLS 443
Query: 84 GEIPPALLTGKVI-FKYDNNPKL---------HKESRRRMRFKLILGTSXXXXXXXXXXX 133
G +PP+LL K + + NP L E + + ++ +
Sbjct: 444 GSVPPSLLQKKGMKLNVEGNPHLLCTADSCVKKGEDGHKKKSVIVPVVASIASIAVLIGA 503
Query: 134 XXXXXXXRKLRR-KISNQK-SYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPE 191
RK + K+ SY +A R S + S A + + F VA
Sbjct: 504 LVLFFILRKKKSPKVEGPPPSYMQASDGR-SPRSSEPAI-VTKNRRFTYSQVAIM----- 556
Query: 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 251
TNNF + +GKG FG VY+G + ++VAVKI++ S S ++F EV LL R+HH+
Sbjct: 557 ----TNNFQRILGKGGFGMVYHGFVNGTEQVAVKILSHSSSQGYKEFKAEVELLLRVHHK 612
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
NLV L+GYC+E L+YEYM NG L++ + G+ N+ L+W TRL+I ++A+GLEYLH
Sbjct: 613 NLVGLVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFTLNWGTRLKIVVESAQGLEYLH 672
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYY 370
GC P ++HRDVK++NILL+ + +AK++DFGLSR E TH+S+V GT GYLDPEYY
Sbjct: 673 NGCKPPMVHRDVKTTNILLNEHFQAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDPEYY 732
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430
LTEKSDVYSFG+VLLELI+ + PV ++ + +I W M+ KGD+ SI+DP L
Sbjct: 733 KTNWLTEKSDVYSFGIVLLELITNR-PV-IDKSREKPHIAEWVGVMLTKGDINSIMDPNL 790
Query: 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474
+ S+W+ E+A+ C+ RP M ++V+ + + I E
Sbjct: 791 NEDYDSGSVWKAVELAMSCLNPSSARRPTMSQVVIELNECIASE 834
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGI2 | Y1677_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.725 | 0.9883 | 0.5500 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 517 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-30 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-28 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-54
Identities = 73/207 (35%), Positives = 115/207 (55%), Gaps = 13/207 (6%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 252
KK+G+G+FG VY G +K E VAVK + + S ++ F+ E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
+V L+G C + +V EYM G L D L + + L LQ+A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYG 371
+ +HRD+ + N L+ N+ K+SDFGLSR ED + + + ++ PE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 372 NQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + T KSDV+SFGV+L E+ + G++P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-53
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 252
KK+G+G+FG VY G +K EVAVK + + S + + F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
+V L+G C EE ++V EYM G L D L + K L L A A+G+EYL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES 121
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 373 QQLTEKSDVYSFGVVLLELIS-GKKP 397
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-53
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 12/206 (5%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRN 252
KK+G+G+FG VY GK+K EVAVK + + S + ++F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
+V L+G C EE +V EYM G L L N+ L L A A+G+EYL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLES 120
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 373 QQLTEKSDVYSFGVVLLELIS-GKKP 397
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 9e-53
Identities = 77/193 (39%), Positives = 113/193 (58%), Gaps = 10/193 (5%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
+G+G FG+VY + K GK+VA+KI+ + S ++ + E+ +L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320
E+E+ LV EY G+L+D L N+ L L+I +GLEYLH + GIIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 321 RDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLTEK 378
RD+K NILLD N + K++DFGLS+ D + GT Y+ PE G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 379 SDVYSFGVVLLEL 391
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 6e-49
Identities = 75/210 (35%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 201 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 255
KK+G+G+FG VY GK+K EVAVK + + S + F+ E ++ ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDAAKGLEY 309
L+G C EE LV EYM G L D L S + L L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPE 368
L + +HRD+ + N L+ ++ K+SDFGLSR +D + + ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 369 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ T KSDV+SFGV+L E+ + G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+K+G+GSFG VY + K GK VA+K++ ++ + E+ +L ++ H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
E+E + LV EY G L D L + L LEYLH + GI
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGI 118
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
+HRD+K NILLD + K++DFGL+RQ + + V GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176
Query: 379 SDVYSFGVVLLELISGKKP 397
D++S GV+L EL++GK P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 82/203 (40%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 255
+K+G GSFG+VY K K GK VAVKI+ S + Q E+ +L R+ H N+V
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVR 62
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
LI E++ LV EY G L D L PL +IA +GLEYLH +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQ 374
GIIHRD+K NILLD N K++DFGL+++ + + +++ GT Y+ PE G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 375 LTEKSDVYSFGVVLLELISGKKP 397
K DV+S GV+L EL++GK P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 257
+ +G+GSFGSVY KD G+ +AVK + S + E+ +LS + H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 258 G-YCEEEHQRILVY-EYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
G +EE + ++ EY+ G+L L G + + + TR QI GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILE----GLAYLH-- 118
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGN 372
+ GI+HRD+K +NIL+D + K++DFG +++ + + + RGT ++ PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
++ +D++S G ++E+ +GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 8e-40
Identities = 74/201 (36%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+KIGKG FG VY + K GKEVA+K++ + ++ + E+ +L + H N+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 316
++ + +V E+ G+L+D L + NQ LT QIA + KGLEYLH +
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKST-NQT----LTESQIAYVCKELLKGLEYLH---SN 117
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
GIIHRD+K++NILL + K+ DFGLS Q + + V GT ++ PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175
Query: 377 EKSDVYSFGVVLLELISGKKP 397
K+D++S G+ +EL GK P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-35
Identities = 125/480 (26%), Positives = 207/480 (43%), Gaps = 45/480 (9%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
LS L GEIP EL + + L L L N L+G +P S + L + L N+L+G +P
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565
Query: 65 YMGSLPNLQELHIENNSFVGEIPP--ALL-------TGKVIFKYDNNPKLHKESRRRMRF 115
+G++ +L +++I +N G +P A L G + + +R +
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKT 625
Query: 116 KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARG 175
L LVL L + + R K E D
Sbjct: 626 PSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWEL------------- 672
Query: 176 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR 234
F D V+ I + ++ + I +G G+ Y GK +K+G + VK + D S
Sbjct: 673 -QFFDSKVSKSITINDILSSLKEE-NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730
Query: 235 TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 294
+ +E+A + ++ H N+V LIG C E L++EY+ L + L L W
Sbjct: 731 S----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWE 780
Query: 295 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354
R +IA AK L +LH C+P ++ ++ I++D + L D
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839
Query: 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414
S A Y+ PE + +TEKSD+Y FG++L+EL++GK P E FG +IV WAR
Sbjct: 840 ISSA-----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVEWAR 893
Query: 415 SMIKKGDVISIVDPVLIGNVKIES--IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
+ +DP + G+V + I + +A+ C +RP +++ ++ + +
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 69/196 (35%), Positives = 110/196 (56%), Gaps = 11/196 (5%)
Query: 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 262
IGKG FG V G + G++VAVK + D S Q F+ E ++++ + H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 263 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 322
+ +V EYM G+L D L S + + +L A D +G+EYL +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127
Query: 323 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 382
+ + N+L+ ++ AKVSDFGL+++A + + V + PE ++ + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 383 SFGVVLLELIS-GKKP 397
SFG++L E+ S G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 127 bits (323), Expect = 1e-33
Identities = 75/216 (34%), Positives = 105/216 (48%), Gaps = 38/216 (17%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI 257
K+IGKGSFG VY + K DGK +K + S + + EV +L +++H N+ I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---I 62
Query: 258 GYCE--EEHQRIL-VYEYMHNGTLRDRLHGSVNQKP----------LDWLTRLQIAHDAA 304
Y E EE ++ V EY G L ++ QK LDW Q+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIK---KQKKEGKPFPEEQILDWFV--QLC---- 113
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 363
L+YLH+ I+HRD+K NI L N K+ DFG+S+ L+ +A+ VG
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGT 166
Query: 364 --YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
YL PE N+ KSD++S G VL EL + K P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 71/201 (35%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVP 255
+KIGKG+FG VY G +K EVAVK +C ++F+ E +L + H N+V
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
LIG C ++ +V E + G+L L N+ + L LQ++ DAA G+EYL +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL--LQMSLDAAAGMEYLESKN- 113
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 373
IHRD+ + N L+ N K+SDFG+SR+ EE + S + + PE
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 374 QLTEKSDVYSFGVVLLELISG 394
+ T +SDV+S+G++L E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
K +G+GS G VY + K GK A+K I D +Q + E+ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 259 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+E + +V EYM G+L D L G + + L ++ R QI GL+YLHT +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILK----GLDYLHTKRH- 120
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQL 375
IIHRD+K SN+L++ K++DFG+S+ E L + V GTV Y+ PE +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESY 177
Query: 376 TEKSDVYSFGVVLLELISGKKP 397
+ +D++S G+ LLE GK P
Sbjct: 178 SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 199 FCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHR 251
F K++G+G FG V + G++VAVK + S HR+ F E+ +L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHE 66
Query: 252 NLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
N+V G CE+ R L+ EY+ +G+LRD L +Q ++ L + KG++Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDY 124
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDP 367
L + IHRD+ + NIL++ K+SDFGL++ ED + G + + P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELIS 393
E + + SDV+SFGV L EL +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 18/218 (8%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRI-HHRNL 253
+K+G+GSFG VY + D K VA+K++A +S S ++F+ E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
V L + ++E LV EY+ G+L D L + PL L I LEYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 314 CNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTH-----ISSVARGTVGYLDP 367
GIIHRD+K NILLD + K+ DFGL++ + + + S + GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 368 EYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
E + SD++S G+ L EL++G P E
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 4e-31
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 202 KIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
IG+G+FG VY G ++ G VA+K + + + E+ LL + H N+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 315
E ++ EY NG+LR + K +A + +GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH---E 117
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
G+IHRD+K++NIL + K++DFG++ + + +SV GT ++ PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGA 176
Query: 376 TEKSDVYSFGVVLLELISGKKP 397
+ SD++S G ++EL++G P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 7/200 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
F K++G G FG V+ GK + +VA+K++ + + F+ E ++ ++ H NLV L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
C ++ +V EYM NG L + L + +WL L + D + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD+ + N L+ + KVSDFGL+R +D S + V + PE + + + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 379 SDVYSFGVVLLELIS-GKKP 397
SDV+SFGV++ E+ S GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 6/202 (2%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 249
E+E K+G G +G VY G K VAVK + + + ++F+ E A++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
H NLV L+G C E ++ E+M G L D L N++ ++ + L +A + +EY
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 119
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
L IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 370 YGNQQLTEKSDVYSFGVVLLEL 391
+ + KSDV++FGV+L E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
+KIG+G+ G VY + GKEVA+K M + + E+ ++ H N+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 257 IG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 312
Y + +V EYM G+L D + Q + + QIA + +GLEYLH+
Sbjct: 81 YDSYLVGDEL-WVVMEYMDGGSLTD----IITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+IHRD+KS NILL + K++DFG + Q ++ + +SV GT ++ PE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ K D++S G++ +E+ G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 9/201 (4%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ ++ H LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
C ++ +V EYM NG L + L K L++ D +G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQF 121
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYGNQQLTE 377
IHRD+ + N L+D KVSDFGLSR +D + SSV ++ V + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 378 KSDVYSFGVVLLELIS-GKKP 397
KSDV++FGV++ E+ S GK P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 34/225 (15%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVT-EVALLSRI-HHRNL 253
F K IG+GSF +V K K KE A+KI+ + ++V E +L+R+ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ L ++E V EY NG L R +GS+++K TR A + LEYLH
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH 119
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFG---------LSRQAEEDLTHISSVAR--- 359
+ GIIHRD+K NILLD +M K++DFG + D T+I S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 360 -------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
GT Y+ PE + + SD+++ G ++ ++++GK P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 6/199 (3%)
Query: 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+K+G G FG V+ G K+ VA+KI+ + Q F EV L R+ H++L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
C ++ E M G+L L S + L + + +A A+G+ YL I
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+ + NIL+ ++ KV+DFGL+R +ED+ ++SS + + PE + + KS
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 380 DVYSFGVVLLELIS-GKKP 397
DV+SFG++L E+ + G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
+K+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 261 EEEHQRILVYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
EE +V EYM G+L D L G + L L + +A A+G+ YL + I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL--VDMAAQIAEGMAYLES---RNYI 125
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTE 377
HRD+ + NIL+ N+ K++DFGL+R E+D A+ + + PE YG T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTI 183
Query: 378 KSDVYSFGVVLLELIS-GKKP 397
KSDV+SFG++L E+++ G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 201 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 255
K IG G FG V G++ K +VA+K + S + + F+TE +++ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L G + +++ EYM NG+L L N + + A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQ 374
+HRD+ + NIL++ N+ KVSDFGLSR+ E+ + T+ + + + + PE ++
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 375 LTEKSDVYSFGVVLLELIS-GKKP 397
T SDV+SFG+V+ E++S G++P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 203 IGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFV-TEVALLSRIHHRNLVPLIG 258
+GKGSFG V + KD GK A+K++ + + TE +LSRI+H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 259 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ E + LV EY G L L G +++ R A + LEYLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAA-EIVLALEYLH---SL 112
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
GII+RD+K NILLD + K++DFGL+++ + + ++ GT YL PE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 377 EKSDVYSFGVVLLELISGKKPVSVED 402
+ D +S GV+L E+++GK P ED
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 70/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 251
+++G+G+FG V+ G+ + VAVK + ++ S+ ++ F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG------SVNQKPLDWLTR---LQIA 300
N+V G C E I+V+EYM +G L R HG P+ LT LQIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVAR 359
A G+ YL + +HRD+ + N L+ ++ K+ DFG+SR D +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ ++ PE ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 254
+ IGKGSFG+V + K DGK + K M QQ V+EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIV 62
Query: 255 PLIGYCEEEH----QRI-LVYEYMHNGTLRDRL-HGSVNQKPLD----WLTRLQIAHDAA 304
Y + Q + +V EY G L + +K ++ W Q+
Sbjct: 63 ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--- 116
Query: 305 KGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 362
L H +PG ++HRD+K +NI LD N K+ DFGL++ L H SS A+ V
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK----ILGHDSSFAKTYV 171
Query: 363 G---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
G Y+ PE + EKSD++S G ++ EL + P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
++IG G FG V+ G + ++VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLH---GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
C E LV+E+M +G L D L G +Q+ L L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + +
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 376 TEKSDVYSFGVVLLELIS-GKKP 397
+ KSDV+SFGV++ E+ S GK P
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
F K++G G FG V+ GK + +VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
C ++ +V E+M NG L + L + D L L + D +G+EYL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SF 121
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD+ + N L+ KVSDFG++R +D SS A+ V + PE + + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 379 SDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437
SDV+SFGV++ E+ + GK P + + +V MI +G + P L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK---SNYEVV----EMISRGF--RLYRPKLASMT--- 229
Query: 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467
+ EV C ++ RP E++ AI
Sbjct: 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 72/203 (35%), Positives = 115/203 (56%), Gaps = 23/203 (11%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
+ IG+G FG+V G+ G++VAVK + C Q F+ E A+++++HH+NLV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 261 EEEHQRI-LVYEYMHNGTL----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
H + +V E M G L R R V+ L LQ + D A+G+EYL +
Sbjct: 69 L--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--- 118
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
++HRD+ + NIL+ + AKVSDFGL+R + + ++ V + PE +++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN----SKLPVKWTAPEALKHKKF 174
Query: 376 TEKSDVYSFGVVLLELIS-GKKP 397
+ KSDV+S+GV+L E+ S G+ P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 30/233 (12%)
Query: 187 IPLPELEEATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQ-FV 239
IPL + F +++G+G+FG VY G+ VA+K + ++ + QQ F
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 240 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN------- 287
E L+S + H N+V L+G C +E +++EY+ +G L + L H V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 288 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346
+ LD L IA A G+EYL + +HRD+ + N L+ + K+SDFGLSR
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 347 A-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
D + S + V ++ PE + T +SD++SFGVVL E+ S G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 3e-27
Identities = 68/197 (34%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 262
IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 263 EHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 321
E + +V EYM G+L D L S + L L+ + D + +EYL +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 322 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 381
D+ + N+L+ + AKVSDFGL+++A + + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 382 YSFGVVLLELIS-GKKP 397
+SFG++L E+ S G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 64/220 (29%), Positives = 119/220 (54%), Gaps = 25/220 (11%)
Query: 203 IGKGSFGSVYY------GKMKDGKEVAV-KIMADSCSHRTQQFV----TEVALLSRIHHR 251
IGKG++G VY G+M K+V + +A R + V +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
N+V +G+ E + EY+ G++ R +G ++ + + T Q+ +GL Y
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVL----EGLAY 123
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPE 368
LH + GI+HRD+K+ N+L+D + K+SDFG+S+++++ + +++ +G+V ++ PE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 369 YYGNQQ--LTEKSDVYSFGVVLLELISGKKPVS-VEDFGA 405
+ + K D++S G V+LE+ +G++P S E A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
KIG G+FG VY + G+ +AVK + D+ ++ E+ +L + H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 258 GYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
G E +++ ++ EY GTL + L + LD +GL YLH+
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQ 373
GI+HRD+K +NI LD N K+ DFG + + + + T + + G Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 374 QLTEK---SDVYSFGVVLLELISGKKP 397
+ +D++S G V+LE+ +GK+P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 24/216 (11%)
Query: 201 KKIGKGSFGSVYYGKMK--DGK--EVAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 254
K +G+G FGSV G++ DG +VAVK M D ++ ++F++E A + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 255 PLIGYC--EEEHQRI----LVYEYMHNGTLRD-----RLHGSVNQKPLDWLTRLQIAHDA 303
LIG C Q+I ++ +M +G L RL G + PL L + + D
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 362
A G+EYL N IHRD+ + N +L +M V+DFGLS++ D +A+ V
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 363 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ E ++ T KSDV++FGV + E+ + G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 70/219 (31%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 190 PELEEATNNFCKKIGKGSFGSVYYGKM--KDGK----EVAVKIMADSCSHRTQQ-FVTEV 242
PE+ + + +G G+FG VY G +DG +VAVK + +SCS + + F+ E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 243 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 298
++S+ +H+N+V LIG E R ++ E M G L+ L + L L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 299 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLTHI 354
A D AKG +YL IHRD+ + N LL AK++DFG++R
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
A + ++ PE + + T K+DV+SFGV+L E+ S
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 201 KKIGKGSFGSVYYG--KMKDGKE--VAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 255
K++G G+FGSV G MK GKE VAVK + ++F+ E ++++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
LIG C+ E +LV E G L L + L ++AH A G+ YL
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE-S 113
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 369
+ +HRD+ + N+LL +AK+SDFG+SR A D ++ R + + PE
Sbjct: 114 KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 370 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
YG + + KSDV+S+GV L E S G KP
Sbjct: 172 YG--KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 75/218 (34%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 203 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLVPL 256
+G GSFGSVY G + DG AVK + Q+ V E+ALLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+G EE + E + G+L L +GS + + TR QI GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QIL----LGLEYLH--- 119
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
+ +HRD+K +NIL+D N K++DFG+++Q E + S +G+ ++ PE Q
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQG 177
Query: 375 L-TEKSDVYSFGVVLLELISGKKPVS-VEDFGAELNIV 410
+D++S G +LE+ +GK P S +E A I
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 201 KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
++G G+ G V K+ GK +AVK + + +Q + E+ +L + + +V
Sbjct: 7 GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
G + EYM G+L L + P L ++ +A KGL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHE--KH 120
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQ 373
IIHRDVK SNIL++ + K+ DFG+S Q ++S+A+ GT Y+ PE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGN 174
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406
+ KSD++S G+ L+EL +G+ P E+ +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 250
E++ + +K+G G FG V+ G + VAVK + + + F+ E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
L+ L C E +V E M G+L + L G + L + +A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYL 119
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
IHRD+ + N+L+ N KV+DFGL+R +ED+ A+ + + PE
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176
Query: 371 GNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + KSDV+SFG++L E+++ G+ P
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 193 EEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLSR 247
EE F +++GKG+FGSV Y ++D G+ VAVK + S + + F E+ +L
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 248 IHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 305
+ H N+V G C +R LV EY+ G+LRD L +++ LD L A K
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICK 119
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVG 363
G+EYL + +HRD+ + NIL++ R K+ DFGL++ +D + + +
Sbjct: 120 GMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
+ PE + + SDV+SFGVVL EL +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-25
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 201 KKIGKGSFGSVYYG--KMKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVP 255
K IG G FG V+ G KM KEVAV I + Q F++E +++ + H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L G + +++ EYM NG L L + + + A G++YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGNQ 373
+HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 374 QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432
+ T SDV+SFG+V+ E++S G++P +W S +V+ ++
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP-------------YWDMS---NHEVMKAINDGFRL 229
Query: 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
++ + ++ +QC +Q RP+ +IV
Sbjct: 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 255
+ IG G+ VY E VA+K + + C + EV +S+ +H N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
+ LV Y+ G+L D + S + LD + + KGLEYLH+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYG 371
G IHRD+K+ NILL + K++DFG+S + + R GT ++ PE
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG-GDRTRKVRKTFVGTPCWMAPEVME 179
Query: 372 NQQ-LTEKSDVYSFGVVLLELISGKKPVS 399
K+D++SFG+ +EL +G P S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 201 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 255
+ IG+G FG VY G + VAVK + S ++F+ E ++ + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
LIG E I V E G LR L VN+ LD + + ++ + L YL +
Sbjct: 72 LIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
+HRD+ + N+L+ K+ DFGLSR E++ + +S + + ++ PE ++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 376 TEKSDVYSFGVVLLELIS-GKKP 397
T SDV+ FGV + E++ G KP
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 201 KKIGKGSFGSVYYGKMKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 254
KKIG+GSFG +Y K K KE+ + M +++ EV LL+++ H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEY 309
+E + +V EY G L R+ G + + L W ++ + GL++
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKH 116
Query: 310 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
+H + I+HRD+KS NI L N M AK+ DFG++RQ D ++ GT YL PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPE 172
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
N+ K+D++S G VL EL + K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 72/213 (33%), Positives = 112/213 (52%), Gaps = 27/213 (12%)
Query: 203 IGKGSFGSVYYG-KMKDGKEVAVK------IMADSCSHRT---QQFVTEVALLSRIHHRN 252
IG GSFGSVY G G+ +AVK + A S + E+ALL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 253 LVPLIG-YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 309
+V +G + +H I + EY+ G++ L +G+ + + R QI KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVR-QIL----KGLNY 121
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----RGTVGY 364
LH N GIIHRD+K +NIL+D K+SDFG+S++ E + + +G+V +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ PE T K+D++S G +++E+++GK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 258
++IG+G+FG V+ G+++ D VAVK ++ + +F+ E +L + H N+V LIG
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 317
C ++ +V E + G L + P L +Q+ +AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQQL 375
IHRD+ + N L+ K+SDFG+SR+ EED + S+ + + V + PE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 376 TEKSDVYSFGVVLLELIS 393
+ +SDV+SFG++L E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 35/275 (12%)
Query: 201 KKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVP 255
K IG G FG V G++K +E+ V I + +Q F++E +++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 312
L G + ++V EYM NG+L L Q T +Q+ A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYL-- 122
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 370
+ G +HRD+ + NIL++ N+ KVSDFGLSR E+D + + + + + PE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 371 GNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429
++ T SDV+S+G+V+ E++S G++P +W S DVI ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMS---NQDVIKAIEEG 225
Query: 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
++ + ++ + C ++ RPK ++IV
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 21/262 (8%)
Query: 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCE 261
+GKG+FG V+ G +KD VAVK + + +F++E +L + H N+V LIG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 321
+ +V E + G L ++ L + + DAA G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES---KNCIHR 117
Query: 322 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 381
D+ + N L+ N K+SDFG+SRQ ++ + S + + + + PE + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 382 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 441
+S+G++L E S + V + N AR ++KG +S + +++
Sbjct: 178 WSYGILLWETFS----LGVCPYPGMTN--QQAREQVEKGYRMSCPQKC------PDDVYK 225
Query: 442 IAEVAIQCVEQRGFSRPKMQEI 463
+ + +C + + +RPK E+
Sbjct: 226 VMQ---RCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 201 KKIGKGSFGSVYYGKMKD--GK--EVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 255
KK+G GSFG V G+ GK VAVK + +D S F+ E A++ + H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEYLHTGC 314
L G H ++V E G+L DRL + ++ L A A G+ YL +
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV--GYLDPEYYGN 372
IHRD+ + NILL + + K+ DFGL R ++ H V + PE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 373 QQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + SDV+ FGV L E+ + G++P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 202 KIGKGSFGSVYYGKMKDGKEV-AVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
++G+G+ GSV ++K+ + A+K I D +Q + E+ + +V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 260 CEEEHQRIL--VYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYL 310
+E + EY G+L D ++ V +K L +IA KGL YL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLSYL 121
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDP 367
H+ IIHRD+K SNILL + K+ DFG+S + ++S+A GT Y+ P
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL------VNSLAGTFTGTSFYMAP 172
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E + + SDV+S G+ LLE+ + P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-23
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 254
K +G+G+FG VY D G+E+AVK + + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 255 PLIGYCEEEHQRILVY-EYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
G C + + + ++ EYM G+++D + +G++ + TR QI G+EYLH
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILE----GVEYLH 121
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPE 368
+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPE 177
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ K+DV+S G ++E+++ K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 202 KIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
K+G+GS+GSVY + G+ VA+K++ Q+ + E+++L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 317
+ +V EY G++ D + + K L T +IA + KGLEYLH +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM--KITNKTL---TEEEIAAILYQTLKGLEYLH---SNK 119
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
IHRD+K+ NILL+ +AK++DFG+S Q + + ++V GT ++ PE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178
Query: 378 KSDVYSFGVVLLELISGKKPVS 399
K+D++S G+ +E+ GK P S
Sbjct: 179 KADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEV 242
L L+E K +G G+FG+VY G E VA+K++ + S + + + E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 243 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
+++ + H ++V L+G C Q L+ + M G L D + ++ + L
Sbjct: 61 YVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQ 117
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGT 361
AKG+ YL ++HRD+ + N+L+ K++DFGL++ + D + +
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ ++ E ++ T KSDV+S+GV + EL++ G KP
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 202 KIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 258
KIGKGSFG V+ K K V A+K + S +R ++ + E +L+++ ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
++ + +V EY NG L L + P D + R I GL +LH+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK---K 121
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
I+HRD+KS N+ LD K+ D G+++ D T+ ++ GT YL PE ++ E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 378 KSDVYSFGVVLLELISGKKPVSVEDFGA 405
KSDV++ GVVL E +GK P + GA
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 199 FCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHR 251
+ + IG+G+FG V+ + + VAVK++ + S Q F E AL++ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------------HGSV-------NQKPLD 292
N+V L+G C L++EYM G L + L H + N PL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 293 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ------ 346
+L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 347 ---AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+E D I ++ PE + T +SDV+++GVVL E+ S G +P
Sbjct: 186 YKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 203 IGKGSFGSVYYGKMKDGKEV-AVKIMADS-C--SHRTQQFVTEVALLSRIHHRNLVPLIG 258
IGKG+FG V + +D K++ A+K M C + + E +L ++H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
++E LV + + G LR H S K + + I + LEYLH + GI
Sbjct: 68 SFQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGI 121
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD+K NILLD ++DF ++ + D T +S + GT GY+ PE Q +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 379 SDVYSFGVVLLELISGKKP 397
D +S GV E + GK+P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 257
IGKG FG VY+G + D + S + T +QF+ E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 258 GYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR--LQIAHDAAKGLEYLHTGC 314
G C E ++V YM +G LR+ + + + L LQ+A KG+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA----KGMEYL---A 115
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYYG 371
+ +HRD+ + N +LD + KV+DFGL+R E H + A+ V ++ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKP 397
Q+ T KSDV+SFGV+L EL++ P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-23
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 250
E+ + KK+G G FG V+ G + +VAVK + + Q F+ E L+ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 60
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEY 309
LV L +E ++ EYM G+L D L K L L +L + A+G+ Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 118
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
+ IHRD++++N+L+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 370 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
T KSDV+SFG++L E+++ GK P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 38/214 (17%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF-VT---EVALLSRIHHRNLVP 255
+IG+G++G VY + K G+ VA+K + + + F +T E+ LL ++ H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 256 LIGYCEEEHQR--ILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEY 309
L + + +V+EYM H+ T L S K T QI +GL+Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLT---GLLDSPEVK----FTESQIKCYMKQLLEGLQY 115
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG-------TV 362
LH + GI+HRD+K SNIL++ + K++DFGL+R + T+
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRNSADYTNRVITL 165
Query: 363 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
Y PE G + + D++S G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 6e-23
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 201 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 254
+++G+G+FG V+ + +D VAVK + D+ + + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKPLDWLTR---LQIAHDAA 304
G C E I+V+EYM +G L R HG LT+ L IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 363
G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ PE ++ T +SDV+S GVVL E+ + GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-23
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 250
E+ T KK+G G FG V+ G +VA+K + S + F+ E L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQH 60
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
LV L +E I + EYM NG+L D L K L + +A A+G+ ++
Sbjct: 61 PRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFI 118
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 371 GNQQLTEKSDVYSFGVVLLELIS-GKKP 397
T KSDV+SFG++L E+++ G+ P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 201 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
++IG G++G VY + G+ VA+K++ + E+++L H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 316
+ +V EY G+L+D V + PL + LQIA+ + KGL YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPL---SELQIAYVCRETLKGLAYLH---ET 120
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 371
G IHRD+K +NILL + K++DFG+S Q LT ++A+ GT ++ PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTA--TIAKRKSFIGTPYWMAPEVAA 174
Query: 372 NQQL---TEKSDVYSFGVVLLELISGKKPVS 399
++ K D+++ G+ +EL + P+
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 203 IGKGSFGSVYYGKMK-DGKEVAVKIM--AD-SCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
I KG++G V+ K K G A+K++ AD ++ Q +TE +LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+ + LV EY+ G L L +V D R+ IA + LEYLH + GI
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLH---SNGI 114
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQ--------AEEDLTHISSVARGTVGYLDPEYY 370
IHRD+K NIL+D N K++DFGLS+ +D + GT Y+ PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406
Q ++ D +S G +L E + G P F E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 203 IGKGSFGSVYYGKMK----DGKE--VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 255
+G+G FG V+ K K +G E V VK + + Q F E+ + ++ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS------VNQKPLDWLTRLQIAHDAAKGLEY 309
L+G C E ++ EY G L+ L + + PL ++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
L +HRD+ + N L+ KVS LS+ + A + +L PE
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 370 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ KSDV+SFGV++ E+ + G+ P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 256
++IG GSFG+VY+ + ++ + VA+K M+ S Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
G EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQ 373
IHRD+K+ NILL K++DFG + + + GT ++ PE
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 374 QLTEKSDVYSFGVVLLELISGKKP 397
Q K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG-- 258
IG+G++G VY + K G+ VA+KIM D ++ E +L + +H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 259 ----YCEEEHQRILVYEYMHNGTLRD---RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ Q LV E G++ D L + +W+ I + +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAYLH 130
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 366
+IHRD+K NILL N K+ DFG+S Q + S++ R GT ++
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYWMA 181
Query: 367 PE-----YYGNQQLTEKSDVYSFGVVLLELISGKKPVS 399
PE + +SDV+S G+ +EL GK P+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 65/205 (31%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 203 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 257
IG G FG V G++K GK VA+K + + + ++ F++E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G + +++ E+M NG L L + Q + L + + A G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--VGMLRGIAAGMKYL---SEMN 126
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVA-RGTVGYLDPEYYGNQ 373
+HRD+ + NIL++ N+ KVSDFGLSR E+ D T+ SS+ + + + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 374 QLTEKSDVYSFGVVLLELIS-GKKP 397
+ T SDV+S+G+V+ E++S G++P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 201 KKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 254
+++G+G+FG V+ + KD VAVK + D + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKP------LDWLTRLQIAH 301
G C + I+V+EYM +G L R HG V+ +P L L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 302 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARG 360
A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ ++ PE ++ T +SDV+SFGV+L E+ + GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 198 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
NF KIG+GS G V G++VAVK M R + EV ++ H N+V +
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 312
+ +V E++ G L D + H +N++ QIA K L +LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSFLHA 133
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
G+IHRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ D++S G++++E++ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 202 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 255
++G+G+FG V+ + +D VAVK + ++ Q F E LL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 303
G C E ++V+EYM +G L R HG V L L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 362
A G+ YL + +HRD+ + N L+ + K+ DFG+SR D + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 363 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ PE ++ T +SD++SFGVVL E+ + GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 8e-22
Identities = 77/235 (32%), Positives = 115/235 (48%), Gaps = 19/235 (8%)
Query: 171 SIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMAD 229
S +R G D +A + E+ + ++IG GSFG+VY+ + ++ + VA+K M+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSY 60
Query: 230 SCSHRT---QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV 286
S Q + EV L RI H N + G EH LV EY G+ D L V
Sbjct: 61 SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--V 117
Query: 287 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346
++KPL + I H A +GL YLH+ +IHRD+K+ NILL + K++DFG +
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 347 AEEDLTHISSVARGTVGYLDPEY---YGNQQLTEKSDVYSFGVVLLELISGKKPV 398
A + + GT ++ PE Q K DV+S G+ +EL K P+
Sbjct: 175 ASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 25/229 (10%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGK-----MKDGKEVAVKIMAD-SCSHRTQQFVTEVAL 244
EL + F +++G+ +FG +Y G M + VA+K + D + + +F E +L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 245 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN---------QKP 290
++ +HH N+V L+G +E +++EY++ G L + L H V +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 349
LD L IA A G+EYL + +H+D+ + NIL+ + K+SD GLSR+
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
D + + + ++ PE + + SD++SFGVVL E+ S G +P
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 200 CKKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
+ IGKGSFG VY K + VA+K++ + + E+ LS+ +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G + + ++ EY G+ D L LD I + GLEYLH G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEG 118
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQQ 374
IHRD+K++NILL K++DFG+S Q LT S VG ++ PE
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQ----LTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 375 LTEKSDVYSFGVVLLELISGKKPVS 399
EK+D++S G+ +EL G+ P+S
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-21
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 202 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 261
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 321
EE I V EYM G+L D L G + K L + +A A G+ Y+ +HR
Sbjct: 72 EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 322 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 381
D++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 382 YSFGVVLLELIS-GKKP 397
+SFG++L EL + G+ P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-21
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 202 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 261
K+G+G FG V+ G +VA+K + + + F+ E ++ ++ H LVPL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 321
EE I V E+M G+L D L + K L + +A A G+ Y+ IHR
Sbjct: 72 EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 322 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 381
D++++NIL+ N+ K++DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 382 YSFGVVLLELIS-GKKP 397
+SFG++L EL++ G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
KK+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320
EE I V EYM G+L D L + L + +A A G+ Y+ IH
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 321 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 380
RD++S+NIL+ + K++DFGL+R E++ A+ + + PE + T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 381 VYSFGVVLLELIS-GKKP 397
V+SFG++L EL++ G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 255
KK+GKGS+GSVY K + D + A+K + +Q+ V E+ +L+ ++H N+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNHPNI-- 61
Query: 256 LIGYCE---EEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAAKGL 307
I Y E + ++ +V EY G L + ++ L W +Q+ +GL
Sbjct: 62 -ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--THISSVARGTVGYL 365
+ LH I+HRD+KS+NILL N K+ D G+S+ ++++ T I GT Y+
Sbjct: 117 QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 408
PE + + + KSD++S G +L E+ + P +L
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLR 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 203 IGKGSFGS-VYYGKMKDGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGY 259
+GKG+FG Y + +D V K + S + ++ E+ +LS + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--DAAKGLEYLHTGCNPG 317
+++ ++ EY + GTL D++ V QK + + + + + Y+H G
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
I+HRD+K+ NI L K+ DFG+S+ + + +V GT Y+ PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 378 KSDVYSFGVVLLELISGKK 396
KSD+++ G VL EL++ K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 75/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 190 PELEEATNNFCKKIGKGSFGSVYYGKM-KDG--KEVAVKIMADSCS---HRTQQFVTEVA 243
P LE F IG+G+FG V ++ KDG + A+K M + S HR F E+
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 59
Query: 244 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 292
+L ++ HH N++ L+G CE L EY +G L D L S +
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 293 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349
L+ Q+ H D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
+ ++ R V ++ E T SDV+S+GV+L E++S
Sbjct: 177 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 202 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ-----QFVTEVALLSRIHHRNLVP 255
+IG+G+ G V+ K + G+ VA+K + R + Q + E+ L H +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYLHT 312
L+ +LV EYM L + L ++PL Q+ KG+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPL---PEAQVKSYMRMLLKGVAYMH- 116
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 371
GI+HRD+K +N+L+ + K++DFGL+R E+ + S T Y PE YG
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410
++ D+++ G + EL++G E+ +L IV
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 188 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGKEVAVKIM-ADSCSHRTQQFVT 240
P EL K +G+G+FG V + VAVK++ D+ V+
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64
Query: 241 EVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQK-------- 289
E+ ++ I H+N++ L+G C +E +V EY +G LRD R +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 290 PLDWLTR---LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346
P + LT+ + A+ A+G+E+L + IHRD+ + N+L+ + K++DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR- 180
Query: 347 AEEDLTHISSVARGTVGYLD-----PEYYGNQQLTEKSDVYSFGVVLLELIS 393
D+ HI + T G L PE ++ T +SDV+SFGV+L E+ +
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 27/211 (12%)
Query: 203 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 257
IG+G+FG V +K DG ++ A+K++ + S + F E+ +L ++ HH N++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 258 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 302
G CE + EY G L D + HG+ + L LQ A D
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQFASD 127
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 362
A G++YL IHRD+ + N+L+ N+ +K++DFGLSR E++ ++ R V
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPV 182
Query: 363 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
++ E T KSDV+SFGV+L E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 201 KKIGKGSFGSVYYGKMKDGK---EVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP 255
K +G+G FGSV G++ +VAVK M + R++ F++E + H N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 256 LIGYCEEEHQR------ILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRL--QIAHDAAKG 306
LIG C + + +++ +M +G L L+ + P T++ + D A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYL 365
+EYL + IHRD+ + N +L+ NM V+DFGLS++ D +A+ V ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
E ++ T KSDV+SFGV + E+ + G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 202 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
KIG+GS G V + K G++VAVK+M R + EV ++ H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320
+ ++ E++ G L D V+Q L+ + + L YLH+ G+IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD----IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 321 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 380
RD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 381 VYSFGVVLLELISGKKP 397
++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 203 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 257
IG+G+FG V ++K DG + A+K M + S + F E+ +L ++ HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 258 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 302
G CE L EY +G L D + + + L L A D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAAD 120
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 362
A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R V
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPV 175
Query: 363 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
++ E T SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 203 IGKGSFGSVYYGKMKDGKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHHRNLVPL 256
+GKG++G+VY G G+ +AVK + + ++ EV LL + H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+G C +++ + E++ G++ L+ G + + T+ QI G+ YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QIL----DGVAYLHNNC 122
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTH--ISSVARGTVGYLDPEY 369
++HRD+K +N++L N K+ DFG +R+ TH + GT ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
KSD++S G + E+ +GK P++ D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 256
++IG GSFG+VY+ + +++ + VA+K M+ S + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
G EH LV EY G+ D L V++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY---Y 370
+IHRDVK+ NILL K+ DFG + I + A VG ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANXFVGTPYWMAPEVILAM 186
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKPV 398
Q K DV+S G+ +EL K P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 202 KIGKGSFGSVYYGKMKDGKE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLI 257
+IG GSFG+VY+ E VAVK M+ S + + Q + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G +EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQQ 374
+IHRD+K+ NILL + K++DFG + ++ + + GT ++ PE Q
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 375 LTEKSDVYSFGVVLLELISGKKPV 398
K DV+S G+ +EL K P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 199 FCKKIGKGSFGSVY----YGKMKDGK--EVAVKIMADSCSHRT--QQFVTEVALLSRI-H 249
F K +G G+FG V YG K +VAVK M +H + + ++E+ ++S + +
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSELKIMSHLGN 97
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
H N+V L+G C +++ EY G L + L + L L ++ AKG+ +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 310 LHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDP 367
L + C IHRD+ + N+LL K+ DFGL+R D ++ AR V ++ P
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELIS 393
E N T +SDV+S+G++L E+ S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 201 KKIGKGSFGSVYYGKMK----DGKEVAVKIM-AD-SCSHRTQQFVTEVALLSRIHHRNLV 254
+ +GKG FGSV ++K ++VAVK++ AD S ++F+ E A + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 255 PLIGYC--EEEHQRI----LVYEYMHNGTLRDRLHGS-VNQKP--LDWLTRLQIAHDAAK 305
LIG R+ ++ +M +G L L S + ++P L T ++ D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGY 364
G+EYL + IHRD+ + N +L+ NM V+DFGLS++ D ++ V +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
L E + T SDV++FGV + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 31/276 (11%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ------FVTEVALLSRIHHRNL 253
+++G G+F S Y + +K G +AVK + + ++Q E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 254 VPLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
+ ++G CE+ H + V E+M G++ L + +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLH- 120
Query: 313 GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPE 368
IIHRDVK +N+L+D R +++DFG + + T GT+ ++ PE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428
+Q DV+S G V++E+ + K P + E L ++ S + + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
L +V ++C+E + RP +E++
Sbjct: 239 GL------------RDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 250
E+ + KK+G G FG V+ +VAVK M S + F+ E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEY 309
LV L +E I+ E+M G+L D L +++PL L + + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAF 117
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
+ IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 370 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
T KSDV+SFG++L+E+++ G+ P
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 202 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
KIG+GS G V K GK+VAVK M R + EV ++ HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 261 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ +V E++ G L D + H +N++ + + + L YLH N G+I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGVI 140
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 380 DVYSFGVVLLELISGKKP 397
D++S G++++E+I G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 201 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 253
+++G+GSFG VY G K VA+K + ++ S R + +F+ E +++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTR---LQIAHDAAKG 306
V L+G ++V E M G L+ L + N L T +Q+A + A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 365
+ YL +HRD+ + N ++ ++ K+ DFG++R E D V ++
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELIS 393
PE + T KSDV+SFGVVL E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 201 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 250
K +G+G FG V K K+ VAVK++ D + + V+E+ ++ I H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRL 297
+N++ L+G C ++ ++ EY G LR+ L V + + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 298 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 356
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
R V ++ PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-20
Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR-----NLV 254
K I KG+FGSVY K + G A+K++ S Q VT V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVA 60
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYL 310
L + + LV EY++ G S+ + P DW Q + G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDC-----ASLIKTLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
H GIIHRD+K N+L+D K++DFGLSR E+ + GT YL PE
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETI 165
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKPVSVE 401
+ SD +S G V+ E + G P E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 29/218 (13%)
Query: 201 KKIGKGSFGSVY----YGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRI-HH 250
K +G+G FG V YG K + VAVK++ D+ + + ++E+ L+ I H
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRL 297
+N++ L+G C +E ++ EY G LR+ L V ++ L + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 298 QIAHDAAKGLEYLHTG-CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHIS 355
A+ A+G+EYL + C IHRD+ + N+L+ + K++DFGL+R + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
S R V ++ PE ++ T +SDV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 200 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMA---------DSCSHRTQQFVTEVALLSRIH 249
+K+G+G++G VY + K G+ VA+K + + + E++LL +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-------LREISLLKELK 56
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
H N+V L+ E + LV+EY L+ L PL I + +GL Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 368
H+ I+HRD+K NIL++ + K++DFGL+R L T+ V T+ Y PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168
Query: 369 -YYGNQQLTEKSDVYSFGVVLLELISGK 395
G++ + D++S G + E+I+GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 200 CKKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRN 252
+++G+GSFG VY G +KD E VA+K + ++ S R + +F+ E +++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 253 LVPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAK 305
+V L+G + +++ E M G +LR + + Q P +Q+A + A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 364
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLEL 391
+ PE + T SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 33/227 (14%)
Query: 201 KKIGKGSFGSVYYGKMKDGK------EVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNL 253
K +G+G FG V K VAVK++ + + S + ++E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVN--------QKPLD 292
+ L G C ++ +L+ EY G+LR L G+ N ++ L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 293 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352
+ A ++G++YL ++HRD+ + N+L+ + K+SDFGLSR E+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 353 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ S R V ++ E + T +SDV+SFGV+L E+++ G P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 199 FCKKI---GKGSFGSVY---YGKMKD--GKEVAVKIMADSCSHR-TQQFVTEVALLSRIH 249
+ KKI G+G FG V Y D G+ VAVK + C + T + E+ +L ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 250 HRNLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKG 306
H N+V G C E+ + L+ EY+ G+LRD L +N L L A +G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGY 364
+ YLH+ IHRD+ + N+LLD + K+ DFGL++ E + + V +
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
E + + SDV+SFGV L EL++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 66/254 (25%), Positives = 105/254 (41%), Gaps = 41/254 (16%)
Query: 197 NNFC--KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHH 250
++F K IG+G+FG V+ + KD +V A+K++ S + Q E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
+V L ++E LV EYM G L L + P + R IA + L+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYIA-ELVLALDSV 117
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS-------------------------- 344
H G IHRD+K NIL+D + K++DFGL
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 345 --RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
R+ + ++ GT Y+ PE + D +S GV+L E++ G P +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 403 -FGAELNIVHWARS 415
I++W S
Sbjct: 235 LQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVP 255
KIG+G++G VY + K E VA+K + ++ + E+ LL ++H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L+ + LV+E+M L + Q+ L + +GL + H+
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPE-YYG 371
GI+HRD+K N+L++ K++DFGL+R TH T Y PE G
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLG 172
Query: 372 NQQLTEKSDVYSFGVVLLELISGK 395
++ + D++S G + EL+S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 254
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 255 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
G + +R L E+M G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QIL----EGVSYL 122
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 367
H+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSP 178
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E + K+D++S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 254
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 255 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----QGVSYL 122
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 367
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSP 178
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E + K+DV+S ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 198 NFCKKIGKGSFGSVYYGKM--------KDGKE---------VAVKIM-ADSCSHRTQQFV 239
NF +K+G+G FG V+ + K E VAVK++ D+ + + F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 240 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPL 291
EV +LSR+ N+ L+G C + ++ EYM NG L L V N K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 292 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EED 350
+ T L +A A G+ YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
+ A + ++ E + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 201 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 255
++G G+FG+V Y K K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+IG CE E +LV E G L L + V +K + ++ H + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE-- 112
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYG 371
+HRD+ + N+LL AK+SDFGLS+ D + + G V + PE
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 372 NQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + KSDV+SFGV++ E S G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 206 GSFGSVYYGKMKDGK-----EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGY 259
G+FG ++YG + D K EV VK + D S + + E LL + H+N++P++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 260 CEEEHQRILV-YEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDA---AKGLEYLH 311
C E+ + V Y YM+ G L+ L G N L+ Q+ H A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA--LSTQQLVHMAIQIACGMSYLH 134
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYY 370
G+IH+D+ + N ++D ++ K++D LSR H + V ++ E
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 371 GNQQLTEKSDVYSFGVVLLELIS-GKKP 397
N++ + SDV+SFGV+L EL++ G+ P
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ H N+V +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 380 DVYSFGVVLLELISGKKP 397
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
KIG+GS G V +K GK VAVK M R + EV ++ H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 261 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ +V E++ G L D + H +N++ + + K L LH G+I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 380 DVYSFGVVLLELISGKKP 397
D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 254
K +G+G+FG VY D G+E+A K + D S T + V+ E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 255 PLIGYCEEEHQRILV--YEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QIL----EGMSYL 122
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 367
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSP 178
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E + K+DV+S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 203 IGKGSFGSVYYGKMKD----GKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 254
+G G+FG VY G D G VAVK + + + + +F+ E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK---PLDWLTRL-QIAHDAAKGLEYL 310
L+G C + ++ E M G L L + ++ PL L L I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 311 HTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 364
IHRD+ + N L+ D + K+ DFGL+R + D V +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ PE + + T +SDV+SFGV++ E+++ G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 261
+GKG++G VY + + +A+K + + S Q E+AL S + HRN+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 262 EEHQRILVYEYMHNGTLRDRLHG-----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
E + E + G+L L N++ + + T+ QI +GL+YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH---DN 127
Query: 317 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--YGNQ 373
I+HRD+K N+L++ + K+SDFG S++ + + GT+ Y+ PE G +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 374 QLTEKSDVYSFGVVLLELISGKKP 397
+D++S G ++E+ +GK P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLI 257
KKIG+GSFG K K DGK+ +K + S ++ EVA+LS + H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHT 312
EE +V +Y G L +++ + LDW ++ +A L+++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH- 118
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 369
+ I+HRD+KS NI L + K+ DFG++R L +AR GT YL PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV----LNSTVELARTCIGTPYYLSPEI 172
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGK 395
N+ KSD+++ G VL E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY- 259
IG+G++G+VY GK + G+ VA+KI+ D+ EVALLS++ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 260 -CEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
+ R+ ++ EY G++R + P+ I + L+Y+H G
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---G 121
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLT 376
+IHRD+K++NIL+ K+ DFG++ ++ + S+ GT ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 377 EKSDVYSFGVVLLELISGKKPVSVED 402
K+D++S G+ + E+ +G P S D
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-18
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 21/194 (10%)
Query: 219 GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL-VYEYMH 274
G EVA+K++ H+ +F E AL +R++H N+V L+ E + V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---D 331
TLR+ L L ++ L H N GI+HRD+K NI++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 332 INMRAKVSDFGLS-------RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 384
+ AKV DFG+ LT + V GT Y PE + +T SD+Y++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 385 GVVLLELISGKKPV 398
G++ LE ++G++ V
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 188 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGK--EVAVKIMADSCSHRT-QQF 238
P EL K +G+G FG V K K K VAVK++ D + +
Sbjct: 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 239 VTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG------------- 284
V+E+ ++ I H+N++ L+G C ++ ++ EY G LR+ L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 285 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344
+ ++ L + + A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 345 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
R D ++ R V ++ PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 69/235 (29%), Positives = 119/235 (50%), Gaps = 39/235 (16%)
Query: 201 KKIGKGSFGSVYYG------KMKDGK--EVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 250
K +G+G FG V K K + +VAVK++ +D+ ++E+ ++ I H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 297
+N++ L+G C ++ ++ EY G LR+ L + Q P + L+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 298 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 357
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196
Query: 358 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 403
+ T G ++ PE ++ T +SDV+SFGV+L E+ + G P V VE+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 198 NFCKKIGKGSFGS--VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 255
N + +G+GSFG + D K +I S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEYL 310
E + +V EY G L ++ G + L W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDP 367
H ++HRD+KS NI L N + K+ DFG +R LT + A VG Y+ P
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPP 169
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E + N KSD++S G +L EL + K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 31/230 (13%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE---------------VAVKIM-ADSCSHRTQQFVTEV 242
+K+G+G FG V+ + + E VAVK++ AD F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 243 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL---------RDRLHGSVNQKPLDW 293
++SR+ + N++ L+G C + ++ EYM NG L + N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 294 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLT 352
L +A A G++YL + +HRD+ + N L+ + K++DFG+SR D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSV 400
I A + ++ E + T SDV++FGV L E+ + ++P S+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 13/220 (5%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVT--EVALLSRIHHRNLV 254
K +G+GSFG V+ + G + A+K++ + + T E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L + E + L+ +++ G L RL V D + +A + A L++LH+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELALALDHLHS-- 116
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
GII+RD+K NILLD K++DFGLS+++ + S GTV Y+ PE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRG 174
Query: 375 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414
T+ +D +SFGV++ E+++G P +D + ++ A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLI 257
+ +G+G+FG V+ + K D K V +K I + + + E +L + H N+ I
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62
Query: 258 GYCE---EEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEY 309
Y E E+ ++V EY GTL + + N L + ++ +A L +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHH 116
Query: 310 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
+HT I+HRD+K+ NILLD + M K+ DFG+S+ + V GT Y+ PE
Sbjct: 117 VHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPE 171
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405
+ +KSD+++ G VL EL S K+ + A
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 27/210 (12%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRT--QQFVTEVALLSRI-HHRNLVPL 256
+K+GKG++G V+ + KE VA+K + D+ + T Q+ E+ L + H N+V L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 257 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+ + E+ + LV+EYM D LH + L+ + + I + K L+Y+H+G
Sbjct: 73 LNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRYIMYQLLKALKYIHSG- 126
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLD 366
+IHRD+K SNILL+ + R K++DFGL+R LT VA T Y
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY--VA--TRWYRA 180
Query: 367 PE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
PE G+ + T+ D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVK-I------MADSCSHRTQQFVTEVALLSRIHHRN 252
KK+G+G++ VY + K G+ VA+K I A + T + E+ LL + H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA--LREIKLLQELKHPN 63
Query: 253 LVPLIG-YCEEEHQRI-LVYEYMHN---GTLRDRLHGSVNQKPLDWLTRLQIAHDAA--- 304
++ L+ + + I LV+E+M ++D+ L A +
Sbjct: 64 IIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKS------------IVLTPADIKSYML 109
Query: 305 ---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVA 358
+GLEYLH + I+HRD+K +N+L+ + K++DFGL+R +TH V
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVV 164
Query: 359 RGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
T Y PE +G + D++S G + EL+
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 202 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 257
++G G+FG V G KM+ + +VA+K++ + + + E ++ ++ + +V +I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G CE E +LV E G L L G ++ + + L H + G++YL
Sbjct: 62 GVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM--HQVSMGMKYLE---GKN 115
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQL 375
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 376 TEKSDVYSFGVVLLELIS-GKKP 397
+ +SDV+S+G+ + E S G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 3e-17
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+KIG+G+ G+VY + G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 380 DVYSFGVVLLELISGKKP 397
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+KIGKGSFG V+ G + K VA+KI+ + + E+ +LS+ + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
++ + ++ EY+ G+ D L PLD I + KGL+YLH+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKK--- 122
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTE 377
IHRD+K++N+LL + K++DFG++ Q + T I + GT ++ PE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 378 KSDVYSFGVVLLELISGKKPVS 399
K+D++S G+ +EL G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 3e-17
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ + N+V +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ +V EY+ G+L D V + +D + + + L++LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 380 DVYSFGVVLLELISGKKP 397
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+G G+ GSV K + G +A K + + S +Q + E+ ++ +V G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
E+ + E+M G+L DR++ P++ L + IA +GL YL+ I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--I 125
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQL 375
+HRD+K SNIL++ + K+ DFG+S + I+S+A GT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL------INSIADTFVGTSTYMSPERIQGGKY 179
Query: 376 TEKSDVYSFGVVLLELISGKKPVS 399
T KSDV+S G+ ++EL GK P +
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPL 256
+G+G++G V + K G+ VA+K +S +T + EV +L ++ H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ + LV+EY+ TL + L S P D R I + + Y H+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-AVRSYI-WQLLQAIAYCHSH--- 119
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ----AEEDLTHISSVARGTVGYLDPEYY-G 371
IIHRD+K NIL+ + K+ DFG +R LT VA T Y PE G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVA--TRWYRAPELLVG 175
Query: 372 NQQLTEKSDVYSFGVVLLELISG 394
+ + DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 52/198 (26%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+KIG+G+ G+V+ + G+EVA+K + + + + E+ ++ + + N+V +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ +V EY+ G+L D V + +D + + + LE+LH +I
Sbjct: 85 FLVGDELFVVMEYLAGGSLTD----VVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+KS N+LL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 380 DVYSFGVVLLELISGKKP 397
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVA---VKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
KKIGKG F VY DG+ VA V+I + Q + E+ LL ++ H N++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAAKGLEYLH 311
+ E ++ +V E G L + QK L W +Q+ LE++H
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMH 123
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ I+HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 124 S---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKP 397
KSD++S G +L E+ + + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE-----------------VAVKIM-ADSCSHRTQQFVT 240
F +K+G+G FG V+ ++ + ++ VAVKI+ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLD-- 292
EV +LSR+ N++ L+G C +E ++ EYM NG L N
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 293 --------WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344
+ + L +A A G++YL + +HRD+ + N L+ N+ K++DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 345 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
R D I A + ++ E + T SDV++FGV L E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
K IG G++G V K G++VA+K +++ ++ + E+ LL + H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 258 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEY 309
E+ + +V E M D LH V + P LT I + +GL+Y
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LH-KVIKSPQP-LTDDHIQYFLYQILRGLKY 118
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
LH+ +IHRD+K SNIL++ N K+ DFGL+R + D Y+ +
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE----KGFLTEYVVTRW 171
Query: 370 Y-------GNQQLTEKSDVYSFGVVLLELISGK 395
Y + + T+ D++S G + EL++ K
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 203 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 258
+GKG FG V ++K GK A K + + + + E +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
E + LV M+ G L+ ++ +V + + A GLE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
++RD+K N+LLD + ++SD GL+ + + GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFS 174
Query: 379 SDVYSFGVVLLELISGKKP 397
D ++ G L E+I+G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 256
+IG G FG V G+ G A VK + S + Q F+ EV ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+G C E +LV E+ G L++ L G V Q ++A + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQA 119
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGN 372
IH D+ N L ++ K+ D+GL+ Q ED + +L PE
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 373 QQ-------LTEKSDVYSFGVVLLEL 391
+ T+KS+++S GV + EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHH 250
+++G+GSFG VY G +D VAVK + +S S R + +F+ E +++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQ--KPLDWLTRL-QIAHDA 303
++V L+G + ++V E M +G L+ L + N +P L + Q+A +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 362
A G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 363 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
++ PE + T SD++SFGVVL E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALL 245
EL+ + + +G G FG + G +K K VA+ + CS + ++ F+ E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 246 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 305
+ H N+V L G + ++V EYM NG L L Q L + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLAS 118
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG--TVG 363
G++YL G +H+ + + +L++ ++ K+S F R E+ I + G V
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL 173
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ PE + SDV+SFG+V+ E++S G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
++IGKGSFG VY G KEV A+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+ + ++ EY+ G+ D L PL+ I + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 379 SDVYSFGVVLLELISGKKPVS 399
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY- 259
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 260 -----CEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+ Q LV E+ G++ D + + N DW+ I + +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 374 QLTE-----KSDVYSFGVVLLELISGKKPV 398
+ + +SD++S G+ +E+ G P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 199 FCKKI---GKGSFGSV---YYGKMKD--GKEVAVK-IMADSCSHRTQQFVTEVALLSRIH 249
F K+I G+G FG V Y D G++VAVK + +S + E+ +L ++
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 250 HRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 307
H N+V G C E+ L+ E++ +G+L++ L + N+ L +L+ A KG+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGM 122
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYL 365
+YL + +HRD+ + N+L++ + K+ DFGL++ E D + + V +
Sbjct: 123 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELIS 393
PE + SDV+SFGV L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYC 260
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 261 EEEH------QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+++ Q LV E+ G++ D + + N +W+ I + +GL +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 128
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 374 QLTE-----KSDVYSFGVVLLELISGKKPV 398
+ + KSD++S G+ +E+ G P+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 188 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEV 242
L ELE +IG G+ G+VY + G+ A+K++ D+ +Q E+
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR---RQICREI 123
Query: 243 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
+L ++H N+V + + ++ E+M G+L + + +A
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQ-------FLADV 173
Query: 303 AAK---GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 358
A + G+ YLH I+HRD+K SN+L++ K++DFG+SR + + SSV
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 359 RGTVGYLDPEYYGNQQLTE------KSDVYSFGVVLLELISGKKPVSV 400
GT+ Y+ PE N L D++S GV +LE G+ P V
Sbjct: 230 -GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 203 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GYC 260
+G G+FG VY + K+ G A KI+ + F+ E+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 317
E IL+ E+ G L S+ + LT QI + L +LH +
Sbjct: 73 YENKLWILI-EFCDGGAL-----DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEY-----YG 371
+IHRD+K+ NILL ++ K++DFG+S + + + GT ++ PE +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFK 181
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKP 397
+ K+D++S G+ L+EL + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 203 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
+G G+ G+VY + + +AVK I D +Q ++E+ +L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320
E++ + E+M G+L ++ + P L R+ +A KGL YL + I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKI---PEHVLGRIAVA--VVKGLTYLWS---LKILH 118
Query: 321 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTE 377
RDVK SN+L++ + K+ DFG+S Q ++S+A+ GT Y+ PE +Q
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 378 KSDVYSFGVVLLELISGKKP 397
SDV+S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 187 IPLPELEEATNNF--CKKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVA 243
+ L L + T+ + + IGKG++G VY KDG AVKI+ D S ++ E
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYN 70
Query: 244 LLSRI-HHRNLVPLIG-YCEEEH----QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTR 296
+L + +H N+V G + + + Q LV E + G++ + + G + + LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 297 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 355
I + A GL++LH N IIHRDVK +NILL K+ DFG+S Q L +
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 356 SVARGTVGYLDPEYYGNQQLTEKS-----DVYSFGVVLLELISGKKPV 398
SV GT ++ PE +Q + S DV+S G+ +EL G P+
Sbjct: 188 SV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+K+G+G++ +VY G+ + E VA+K I D+ + E++L+ + H N+V L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
E++ +LV+EYM + L+ + + LD T + KG+ + H +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTE 377
+HRD+K N+L++ K++DFGL+R + S+ T+ Y P+ G++ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 378 KSDVYSFGVVLLELISGK 395
D++S G ++ E+I+G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 22/218 (10%)
Query: 192 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRTQ-QFVTEVALL 245
L+E K +G G+FG+VY G + +G+ V A+KI+ ++ + +F+ E ++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 246 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 301
+ + H +LV L+G C + LV + M +G L D +H + Q L+W ++
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118
Query: 302 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 360
AKG+ YL ++HRD+ + N+L+ K++DFGL+R E D ++ +
Sbjct: 119 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 203 IGKGSFGSVYYGKMKDGKE-VAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNLVPL 256
+G G++G V VA+K ++ S H RT + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHMDHENVIGL 79
Query: 257 IG-YCEEEHQRIL--VYEYMHNGTLRDR-LHGSVNQKPL--DWLTRL--QIAHDAAKGLE 308
+ + VY H L L+ V + L D + L QI +GL+
Sbjct: 80 LDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLK 132
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
Y+H+ GIIHRD+K SNI ++ + K+ DFGL+R ++++T VA T Y PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPE 185
Query: 369 YYGN-QQLTEKSDVYSFGVVLLELISGK 395
N + D++S G ++ EL++GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
++IGKGSFG V+ G + + VA+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+ + ++ EY+ G+ D L P D + + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEKK--- 122
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181
Query: 379 SDVYSFGVVLLELISGKKPVS 399
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+G+GS+G V K K+ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+ + LV+E++ + T+ D L N LD + +G+E+ H + I
Sbjct: 68 VFRRKKRLYLVFEFVDH-TVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY-GNQQLT 376
IHRD+K NIL+ + K+ DFG +R A + VA T Y PE G+ +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYG 179
Query: 377 EKSDVYSFGVVLLELISG 394
D+++ G ++ E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 255
F + +GKGS+G V + + DGK+ +K + ++ + E LLS++ H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 256 LIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEY 309
E E+ +V + G L +L + + ++W ++ +A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
LH I+HRD+K+ N+ L KV D G++R E+ ++S GT Y+ PE
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPEL 173
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405
+ N+ KSDV++ G + E+ + K + +D +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 203 IGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 254
+G+G+F ++ G ++ EV +K++ S + ++ F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
G C + I+V EY+ G+L L + N + W +L++A A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 315 NPGIIHRDVKSSNILLDINMRA--------KVSDFGLS--RQAEEDLTHISSVARGTVGY 364
+ G+ H +V + N+LL K+SD G+S +E L + +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------RIPW 170
Query: 365 LDPEYYGN-QQLTEKSDVYSFGVVLLELISG-KKPVSVED 402
+ PE N Q L+ +D +SFG L E+ SG KP+S D
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 210 SVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEE 262
S+Y G + KEV ++ E+ L RI N++ + G+ ++
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 263 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN-PGIIHR 321
+ L+ EY G LR+ L +K L + T+L +A D KGL L+ N P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 322 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKS 379
++ S + L+ N + K+ GL E+ L+ + Y + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 380 DVYSFGVVLLELISGKKP 397
D+YS GVVL E+ +GK P
Sbjct: 204 DIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 53/220 (24%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF--------VTEVALLSRI-HH 250
K++G G+FGSVY + K+ E VA+K M ++F + EV L ++ H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPL------DWLTRLQIAH 301
N+V L E + V+EYM ++DR KP + QI
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-----KGKPFSESVIRSII--YQIL- 109
Query: 302 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 361
+GL ++H G HRD+K N+L+ K++DFGL+R+ + V T
Sbjct: 110 ---QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--ST 161
Query: 362 VGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGK 395
Y PE Y + + D+++ G ++ EL + +
Sbjct: 162 RWYRAPEILLRSTSY-SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 15/144 (10%)
Query: 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330
E+M G+L D++ + P + L ++ IA +GL YL I+HRDVK SNIL+
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 331 DINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVV 387
+ K+ DFG+S Q I S+A GT Y+ PE T +SD++S G+
Sbjct: 134 NSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 388 LLELISGKKPVSVEDFGAELNIVH 411
L+E+ G+ P+ D EL +
Sbjct: 188 LVEMAIGRYPIPPPD-AKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPL 256
K IG+G+FG V K+K+ +V A+KI+ T F E +L ++ + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKGLEYLHT 312
++E+ LV +Y G L L ++ P D +L + IA D+ L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-- 370
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 371 ---GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 408
G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMAD------SCSHRTQQFVTEVALLSRIHHRNL 253
+ IG G+FG V+ +DGK VA+K M + SC ++ E+ +L H N+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC----KRVFRELKMLCFFKHDNV 61
Query: 254 V--------PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLD----WLTRLQIA 300
+ P I EE + +V E M + LH V+ +PL + QI
Sbjct: 62 LSALDILQPPHIDPFEEIY---VVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
+GL+YLH+ GI+HRD+K N+L++ N K+ DFGL+R E D + +
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 361 TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
T Y PE G++ T D++S G + EL+ +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
++IG G++G VY + + G+ A+K++ E+ ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ + E+ G+L+D H + PL ++ + +GL YLH + G +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LT 376
HRD+K +NILL N K++DFG+S Q + S GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 377 EKSDVYSFGVVLLELISGKKPV 398
+ D+++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 203 IGKGSFGSVYYGKMKDG-------KEVAVKIMADSCSHRTQ-----QFVTEVALL-SRIH 249
+G G+FG VY + K+ KE+ V A R + V+EV ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDA 303
H N+V E + +V + + L + ++ + W +Q+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV--- 123
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 363
L YLH I+HRD+ +NI+L + + ++DFGL++Q + + + ++SV GT+
Sbjct: 124 -LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV-GTIL 178
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y PE N+ EK+DV++FG +L ++ + + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 202 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLI 257
++G+G +G V+ K KD E VA+K M S + + +TE +L+ LV L+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 258 GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYL 310
Y ++ + + L EY+ G R L N L ++ + A DA L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDA------L 117
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
H G IHRD+K N L+D + K++DFGLS+ +T+ +SV G+ Y+ PE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVL 170
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKPVS 399
+ D +S G +L E + G P S
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVA 243
E+ +T F +++G+ FG VY G + + + VA+K + D ++F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 244 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR-- 296
+ SR+ H N+V L+G +E +++ Y + L + L H V D +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 297 ------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 349
+ I A G+E+L + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
D + + + ++ PE + + SD++S+GVVL E+ S G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 194 EATNNFC--KKIGKGSFGSVYYGK-MKDGKEVAVK-IMAD-SCSHRTQQFVTEVALLSRI 248
E TN + + +G G+FG V + G+ VA+K IM S ++ E+ LL +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 249 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 307
H N++ L + I V E + GT LH + +PL+ + +GL
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGL 121
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 367
+Y+H+ G++HRD+K SNIL++ N K+ DFGL+R + +T GY+
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------GYVST 168
Query: 368 EYYGN-------QQLTEKSDVYSFGVVLLELISGK 395
YY Q+ + D++S G + E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 258
+GKG FG V +M+ GK A K + + + + + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 317
+ + LV M+ G LR ++ + P GLE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
II+RD+K N+LLD + ++SD GL+ + ++ + A GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 378 KSDVYSFGVVLLELISGKKP 397
D ++ GV L E+I+ + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 8e-15
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 203 IGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 258
+G G FG V K+K + A+K + QQ +E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+++ ++ EY G L L G + ++ R IA EYLH N
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARFYIAC-VVLAFEYLH---NR 112
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 371
GII+RD+K N+LLD N K+ DFG +++ + S + GT Y+ PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK-------LKSGQKTWTFCGTPEYVAPEIIL 165
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
N+ D +S G++L EL++G+ P +D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 202 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVP 255
IG+G++G VY K K DGKE A+K T Q E+ALL + H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 256 LIGYCEEEHQRI--LVYEY----------MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 303
L+ E + L+++Y H R + S+ K L W QI +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM-VKSLLW----QILN-- 119
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRA--KVSDFGLSRQAEEDLTHISSVAR 359
G+ YLH+ ++HRD+K +NIL+ + R K+ D GL+R L ++ +
Sbjct: 120 --GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 360 G--TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELIS 393
T+ Y PE G + T+ D+++ G + EL++
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 253
K +GKGSFG V ++K E A+K ++ D T V L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT--MVERRVLALAWEHPFL 58
Query: 254 VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
L +C + + V EY++ G D + + D A + GL++LH
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
GII+RD+K N+LLD + K++DFG+ ++ + +S GT Y+ PE
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILK 169
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
Q+ E D +SFGV+L E++ G+ P ED
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 203 IGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIG-Y 259
IGKG++G V+ K+G + AVKI+ D ++ E +L + H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 260 CEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 312
+++ Q LV E + G++ D + G + + + + IA H+A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLH- 141
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG- 371
IHRDVK +NILL K+ DFG+S Q + + GT ++ PE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 372 NQQL----TEKSDVYSFGVVLLELISGKKPVS 399
QQL + DV+S G+ +EL G P++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 248
NF +GKGSFG V + K E+ A+KI+ D ++ V +AL +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV--LALPGKP 60
Query: 249 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI--------- 299
L L + + V EY++ G D + +Q
Sbjct: 61 PF--LTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHIQQVGKFKEPHA 103
Query: 300 ---AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 354
A + A GL +LH+ GII+RD+K N++LD K++DFG+ ++ T
Sbjct: 104 VFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
Query: 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 258
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
E + LV M+ G L+ ++ + + + + A + GLE LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 181
Query: 379 SDVYSFGVVLLELISGKKP 397
D ++ G +L E+I+G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-VAVKIMA--DSCSHRTQQFV-TEVALLSRIHHRNLVPL 256
K +G G+FG V+ + + + A+K+MA + + +Q V E +L + H ++ L
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 257 IGYCEEEHQRIL--VYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
+ E QR L + EY+ G L R G + T L A + LEYLH+
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLFYASEIVCALEYLHS 119
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
I++RD+K NILLD K++DFG +++ + + GT YL PE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQS 172
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ + D ++ G+++ E++ G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 199 FCKKIGKGSFGSVYYGK---MKDGKE--------------VAVKIM-ADSCSHRTQQFVT 240
F +K+G+G FG V+ + M+ + VAVK++ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSV---NQKPLD 292
E+ ++SR+ N++ L+ C ++ EYM NG L R + + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 293 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DL 351
+ T + +A A G++YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
I A + ++ E + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
++GKG++GSVY + G +A+K I + + Q + E+ +L + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
G E + EYM G+L D+L+ + P D L R I + KGL++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE 121
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY- 369
N IIHRDVK +N+L++ N + K+ DFG+S +S+A+ +G Y+ PE
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERI 173
Query: 370 -----YGNQQLTEKSDVYSFGVVLLELISGKKP 397
N T +SDV+S G+ +LE+ G+ P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 254
K +G G FG+V+ G + +G VA+K + D +T Q +T+ L + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLH---GSVN-QKPLDWLTRLQIAHDAAKGLEYL 310
L+G C + LV + G+L D + S++ Q+ L+W ++ AKG+ YL
Sbjct: 73 RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEY 369
++HR++ + NILL + +++DFG++ +D + S + + ++ E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 370 YGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 399
+ T +SDV+S+GV + E++S G +P +
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 256
K +GKG+FG V + K GK A+KI+ +TE +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ + + V EY++ G L H S + + TR A + L+YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
I++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 377 EKSDVYSFGVVLLELISGKKPVSVED 402
D + GVV+ E++ G+ P +D
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 35/217 (16%)
Query: 203 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVPL- 256
IG+G++G VY + KD G+ VA+K + + + F + E+ +L +++HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 257 ---------IGYCEEEHQRILVYEYM-HN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAA 304
+ + +++ LV+EYM H+ G L L ++ +L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------L 126
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 362
+GL Y H +HRD+K SNILL+ + K++DFGL+R +EE + + V T+
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181
Query: 363 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 398
Y PE G ++ DV+S G +L EL + KKP+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 253
F K +G GSFG V + K + A+KI++ + + +Q + E +L I H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
V L G +++ LV EY+ G L L + P R A LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV-ARFYAA-QVVLALEYLH-- 118
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+ I++RD+K N+LLD + K++DFG +++ + + GT YL PE ++
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSK 173
Query: 374 QLTEKSDVYSFGVVLLELISGKKP 397
+ D ++ G+++ E+++G P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 258
+GKGSFG V ++K G+ AVK++ + +TE +LS + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 259 YCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
C + R+ V E+++ G L + S + D A + L +LH + G
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLH---DKG 116
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
II+RD+K N+LLD K++DFG+ ++ + S+ GT Y+ PE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175
Query: 378 KSDVYSFGVVLLELISGKKPVSVED----FGAELN 408
D ++ GV+L E++ G P E+ F A LN
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 44/214 (20%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVA---VKIM-----ADSCSHRTQQFVTEVALLSRIHHRN 252
+++GKGSFG+VY +KD K VA +K++ + + T Q E LLS++ H
Sbjct: 6 QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 253 LVP-------------LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 299
+V + YCE + E H G S NQ +W +L +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL-----SENQV-CEWFIQLLL 117
Query: 300 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSV 357
G+ Y+H I+HRD+K+ NI L N+ K+ DFG+SR DL ++
Sbjct: 118 ------GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATT 164
Query: 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLEL 391
GT Y+ PE +Q KSD++S G +L E+
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 252
K +GKG+FG V + K GK A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT----LTESRVLQNTRHPF 56
Query: 253 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
L L Y + H R+ V EY + G L H S + + R A + L YLH
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEY 369
+ +++RD+K N++LD + K++DFGL + E ++ +++ GT YL PE
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
+ D + GVV+ E++ G+ P +D
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 203 IGKGSFGSVYYGKM---KDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHR--NLV 254
IG G+ G VY KM K G +AVK M + + + + +V L S H +V
Sbjct: 23 IGSGTCGQVY--KMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIV 77
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTG 313
GY + + E M T D+L + P D L ++ +A K L YL
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKE- 132
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
G+IHRDVK SNILLD + K+ DFG+S + + S G Y+ PE
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPP 189
Query: 374 QLTEK----SDVYSFGVVLLELISGKKP 397
K +DV+S G+ L+EL +G+ P
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 13/217 (5%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 255
K IGKGSFG V K K DG AVK++ + ++ LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L + + V +Y++ G L H + L+ R A + A + YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARFYAA-EVASAIGYLHS--- 114
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
II+RD+K NILLD ++DFGL ++ E S+ GT YL PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPY 173
Query: 376 TEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVH 411
D + G VL E++ G P D NI+H
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIG 258
KIG+GS+G V+ + ++ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-GCNPG 317
+ + LV+EY + T+ + L N + + +I + + + H C
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYY-GNQ 373
IHRDVK NIL+ + K+ DFG +R +D T VA T Y PE G+
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVA--TRWYRAPELLVGDT 176
Query: 374 QLTEKSDVYSFGVVLLELISG 394
Q DV++ G V EL++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 200 CKKIGKGSFGSVYYGKM---KDGKEVAVK-IMADSCSHRTQQFVTEV-ALLSRIHHRNLV 254
+IG+G+FG+V KM G +AVK I + ++ + ++ ++ +V
Sbjct: 9 LGEIGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 255 PLIGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLH 311
G E + E M ++ + P + L + IA K L YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--IAVATVKALNYLK 124
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 367
IIHRDVK SNILLD N K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRDAGCRPYMAP 176
Query: 368 EY---YGNQQLTEKSDVYSFGVVLLELISGKKP 397
E +SDV+S G+ L E+ +GK P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVKIM---------ADSCSHRTQQFVTEVALLSRIHH 250
K IG+G+FG V KMK+ +V A+KI+ +C F E +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDVLVNGDR 60
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKG 306
R + L ++E+ LV +Y G L L ++ P D +L + +A D+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
L Y +HRD+K N+LLD N +++DFG + D T S+VA GT Y+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 367 PEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPV----SVEDFGAELN 408
PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+++G G++G VY + G+ AVKI+ E+ ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 316
+ + EY G+L+D H + PL + LQIA+ + +GL YLH+
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVT---GPL---SELQIAYVCRETLQGLAYLHS---K 125
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG---NQ 373
G +HRD+K +NILL N K++DFG++ + + S GT ++ PE N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184
Query: 374 QLTEKSDVYSFGVVLLELISGKKPV 398
+ D+++ G+ +EL + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 248
K IG+G+FG V KMK + + A+KI+ A++ R ++ V + ++ +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 249 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 304
H+ ++E+ LV +Y G L L ++ P D ++ + +A +
Sbjct: 67 HYA--------FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
L Y +HRD+K N+LLD+N +++DFG + +D T SSVA GT Y
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 365 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 408
+ PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 203 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
+GKG FG V GKM K++ K + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 65
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
E + LV M+ G L+ ++ ++ D + A + GLE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR---E 121
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
I++RD+K NILLD ++SD GL+ + E T V GTVGY+ PE N++ T
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERYT 179
Query: 377 EKSDVYSFGVVLLELISGKKP 397
D + G ++ E+I GK P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 198 NFCKKIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQF-VT---EVALLSRIHH 250
K+G+G+FG VY ++K G+ VA+K +M + F +T E+ +L ++ H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKH 66
Query: 251 RNLVPLIGYCEEEHQRI--------LVYEYM-H--NGTLRD-RLHGSVNQ-KPLDWLTRL 297
N+VPLI E + +V YM H +G L + + + +Q K L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK----CYML 122
Query: 298 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHI 354
Q+ G+ YLH N I+HRD+K++NIL+D K++DFGL+R +
Sbjct: 123 QLLE----GINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 355 SSVARG-------TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
T Y PE G ++ T D++ G V E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRI---HHRNLVPL 256
IG+G++G+VY + + G+ VA+K + S + E+ALL ++ H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 257 IGYC-----EEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLE 308
+ C + E + LV+E++ +D L + L T + +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
+LH+ I+HRD+K NIL+ + + K++DFGL+R ++ S V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 369 YYGNQQLTEKSDVYSFGVVLLEL 391
D++S G + EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 258
+K+G+GS+ +VY GK K +GK VA+K++ T + E +LL + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 259 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ LV+EY+H + D+ G ++ + + L Q+ +GL Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-LFLFQLL----RGLSYIH---QR 122
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 375
I+HRD+K N+L+ K++DFGL+R A+ +H S T+ Y P+ G+ +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 376 TEKSDVYSFGVVLLELISG 394
+ D++ G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNL 253
+ K IG+G+FG V + K K+V A+K+++ R+ F E +++ + +
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
V L +++ +V EYM G L + + S P W R A + L+ +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIH-- 159
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+ G IHRDVK N+LLD + K++DFG + + + A GT Y+ PE +Q
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 374 ----QLTEKSDVYSFGVVLLELISGKKP 397
+ D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 51/219 (23%)
Query: 202 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHRN 252
+IG+G++G VY + E VA+K + R + E+ LL + H N
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 253 LVPL---------------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 297
+V L + YCE++ +L D + ++ + L L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----------DNMPTPFSESQVKCLM-L 115
Query: 298 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 357
Q+ +GL+YLH IIHRD+K SN+LL K++DFGL+R ++
Sbjct: 116 QLL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 358 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
T+ Y PE G T D+++ G +L EL++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 199 FCKKIGKGSFG--SVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 253
IGK V+ K K VAVK + DSCS + + E+ ++ H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYL 310
+P + + + +V M G+ D L + L L IA D L+Y+
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYI 117
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--------RQAEEDLTHISSVARGTV 362
H + G IHR VK+S+ILL + + +S S RQ SSV +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK--NL 172
Query: 363 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVS 399
+L PE Q L EKSD+YS G+ EL +G P
Sbjct: 173 PWLSPEVL-QQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 201 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 256
K+IG G FG V G++ G +V VK + S S + Q +F+ E + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGC 314
+G C E +LV E+ G L+ L + + D T ++A + A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-----VARGTVGYLDPEY 369
IH D+ N LL ++ K+ D+GLS ++ +++ R L E
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 370 YGNQQL---TEKSDVYSFGVVLLELIS-GKKP 397
+GN + T++S+V+S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 248
+G+G FG V + K E+ A+K + + S ++ + E A +
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSE 59
Query: 249 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKG 306
H LV L C + + V EY G L +H V +P R A G
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG 113
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGY 364
L+YLH I++RD+K N+LLD K++DFGL + E + + GT +
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEF 167
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
L PE T D + GV++ E++ G+ P +D
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 61/257 (23%), Positives = 98/257 (38%), Gaps = 68/257 (26%)
Query: 179 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY-YGKMKDGKEVAVKIM------ADSC 231
+I +G+G++G V GK VA+K + D
Sbjct: 3 SFSISERYIQKG----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVT 52
Query: 232 SHRTQ------QFVT--EVALLSRIHHRNLVPLIG-YCEEEHQRILVYEYMHNGTLRDRL 282
R F T E+ +++ I H N++ L+ Y E + LV + M L+
Sbjct: 53 KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLK--- 107
Query: 283 HGSVNQKPLDWLTRLQIAH------DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 336
K +D RL + GL LH +HRD+ +NI ++
Sbjct: 108 ------KVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158
Query: 337 KVSDFGLSR-----------------QAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEK 378
K++DFGL+R Q E++T S V T+ Y PE G ++
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMT--SKVV--TLWYRAPELLMGAEKYHFA 214
Query: 379 SDVYSFGVVLLELISGK 395
D++S G + EL++GK
Sbjct: 215 VDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 203 IGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQ-QFVTEVALLSR-IHHRNLVPLI 257
+G+G++G V KM+ G +AVK + + + + Q + + ++ + R + V
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL----DWLTRLQIAHDAAKGLEYLHTG 313
G E + E M T D+ + V K L D L + IA K LEYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSK 122
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 369
+ +IHRDVK SN+L++ N + K+ DFG+S + SVA+ G Y+ PE
Sbjct: 123 LS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDAGCKPYMAPER 174
Query: 370 Y---GNQQLTE-KSDVYSFGVVLLELISGKKP 397
NQ+ + KSDV+S G+ ++EL +G+ P
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVT--EVALLSRIHHRNLVP 255
K IGKGSFG V K K DGK AVK++ + + Q+ + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L + + V ++++ G L H + + R A + A L YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 373
I++RD+K NILLD ++DFGL ++ A+ D T + GT YL PE Q
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 411
D + G VL E++ G P D AE+ NI+H
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 255
K +GKGSFG V+ ++K + A+K + + + E +LS H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L + + V EY++ G L H K D A + GL++LH+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHK-FDLPRATFYAAEIICGLQFLHS--- 114
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
GI++RD+K NILLD + K++DFG+ ++ + GT Y+ PE Q+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 376 TEKSDVYSFGVVLLELISGKKPVSVED 402
D +SFGV+L E++ G+ P D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---------SCS---HRTQQFVTEVAL 244
NF +GKGSFG V + K E+ A+KI+ C+ R +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 245 LSRIHHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH-- 301
L+++H C + R+ V EY++ G L ++ + R + H
Sbjct: 63 LTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQ---------VGRFKEPHAV 104
Query: 302 ----DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 357
+ A GL +LH+ GII+RD+K N++LD K++DFG+ ++ D +
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161
Query: 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 162 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 24/210 (11%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 254
K +G G+FG+VY G + +G++ VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAHDAAKGLEYL 310
L+G C + L+ + M G L D R H +Q L+W ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE 368
++HRD+ + N+L+ K++DFGL++ A+E H + + ++ E
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-GKVPIKWMALE 181
Query: 369 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ T +SDV+S+GV + EL++ G KP
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 198 NFCK--KIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRN 252
NF K KIG+G++G VY + K G+ VA+K I D+ + + E++LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 309
+V L+ E++ LV+E++H L ++ PL + I +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 368
H+ ++HRD+K N+L++ K++DFGL+R + T+ V T+ Y PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 170
Query: 369 -YYGNQQLTEKSDVYSFGVVLLELISGK 395
G + + D++S G + E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRN 252
K +GKG+FG V + K G+ A+KI+ D +H VTE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTRHPF 56
Query: 253 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
L L Y + H R+ V EY + G L H S + + R A + LEYLH
Sbjct: 57 LTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
+ D + GVV+ E++ G+ P +D
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 71/225 (31%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVA----LLSRIHHRNLVP 255
K IGKGSFG V K K DGK AVK++ + ++ +A LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
L + + V +Y++ G L R+R + A + A L YL
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAEIASALGYL 112
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPE 368
H+ II+RD+K NILLD ++DFGL ++ T S GT YL PE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPE 166
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 411
Q D + G VL E++ G P D AE+ NI++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 258
+GKG FG V +++ GK A K + + + + E +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
E + LV M+ G L+ ++ N + L A + GLE LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH---RENT 123
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
++RD+K NILLD ++SD GL+ + E + V GTVGY+ PE NQ+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRYTLS 181
Query: 379 SDVYSFGVVLLELISGKKP 397
D + G ++ E+I G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
KKIG+G F VY + DG VA+K I + + E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLH 311
E+++ +V E G L + QK L W +Q+ LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 409
KSD++S G +L E+ + + P +G ++N+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 202 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIG 258
KIG+G++G+V+ K ++ E VA+K + D + E+ LL + H+N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 259 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ + LV+EY + D +G ++ + + Q+ KGL + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-FQLL----KGLAFCHS---H 118
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 375
++HRD+K N+L++ N K++DFGL+R + S+ T+ Y P+ +G +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 376 TEKSDVYSFGVVLLELISGKKPV----SVED 402
+ D++S G + EL + +P+ V+D
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
++G G+FG VY K K+ G A K++ + ++ E+ +L+ +H +V L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320
+ + ++ E+ G + D + +++ LT QI + LE L + IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 321 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 377
RD+K+ N+LL ++ K++DFG+S + + L S GT ++ PE + + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPY 192
Query: 378 --KSDVYSFGVVLLELISGKKP 397
K+D++S G+ L+E+ + P
Sbjct: 193 DYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 201 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 252
K +G G++G V+ + GK A+K++ + + T+ TE +L I
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 253 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYL 310
+ + Y + ++ L+ +Y++ G L L K +QI + + LE+L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
H GII+RD+K NILLD N ++DFGLS++ ED + GT+ Y+ P+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 371 --GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419
G+ + D +S GV++ EL++G P +V+ G + + +R ++K
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD--GEKNSQAEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 252
K +GKG+FG V K K G+ A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRHPF 56
Query: 253 LVPLIGYCEEEHQRI-LVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
L L Y + H R+ V EY + G L R+R+ + +
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------FYGAEIVSA 107
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
L+YLH+ N +++RD+K N++LD + K++DFGL ++ +D + + GT YL
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLA 164
Query: 367 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
PE + D + GVV+ E++ G+ P +D
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 81/324 (25%), Positives = 145/324 (44%), Gaps = 48/324 (14%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVK-------IMAD--SCS---HRTQQFVTEVALLSR 247
K +GKGSFG V ++K G+ AVK ++ D C+ R E L+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 248 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 307
++ + +EH V E+++ G L + ++ D A + GL
Sbjct: 61 LY-------CTFQTKEHL-FFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGL 109
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 367
++LH+ GII+RD+K N++LD + K++DFG+ ++ S+ GT Y+ P
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAP 165
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGA-ELNIVHWARSMIKKG-D 421
E + T D +SFGV+L E++ G+ P +D F + ++ H+ R + K+ D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225
Query: 422 VISIV---DPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474
++ + DP ++GN++ ++ +E+R P + V + D
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA--LEKRELD-PPFKPKVKSPSDYSNF- 281
Query: 475 KGGDQKFSSSSSKGQSSRKTLLTS 498
D++F S + S K L+ S
Sbjct: 282 ---DREFLSEKPRLSYSDKNLIDS 302
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 28/221 (12%)
Query: 192 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALL 245
L+E K +G G+FG+VY G + DG+ VA+K++ ++ S + ++ + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 246 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPLDWLTRLQ 298
+ + + L+G C + LV + M G L +DR+ GS Q L+W ++
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GS--QDLLNWCVQI- 118
Query: 299 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 357
AKG+ YL ++HRD+ + N+L+ K++DFGL+R + D T +
Sbjct: 119 -----AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
Query: 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + ++ E +++ T +SDV+S+GV + EL++ G KP
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRNLV 254
KKIG+G F VY + D K VA+K M D+ + Q V E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDCVKEIDLLKQLNHPNVI 65
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 309
+ E+++ +V E G L + QK L W +Q+ +E+
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
+H+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 409
KSD++S G +L E+ + + P +G ++N+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 258
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
E + LV M+ G L+ ++ N D + A + GLE L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
++RD+K NILLD ++SD GL+ Q E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTFS 181
Query: 379 SDVYSFGVVLLELISGKKP 397
D + G ++ E+I G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPL 256
K I G++G+VY + K+ ++ KI + R Q Q E +L+ + +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 257 IGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+C E +R L V EY+ G L ++ P+D + R+ A + LEYLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVD-MARMYFA-ETVLALEYLH--- 118
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------HISSVAR--------G 360
N GI+HRD+K N+L+ K++DFGLS+ LT HI R G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
T Y+ PE Q + D ++ G++L E + G P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 202 KIGKGSFGSVYYGKMK-DGKEVAVK-IMAD-------SCSHRTQQFVTEVALLSRIHHRN 252
KIG+G++G VY + K G+ VA+K I + S + R E++LL ++H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR------EISLLKELNHPN 59
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 309
+V L+ E++ LV+E++ L ++ PL L I + +G+ Y
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL---THISSVARGTVGYLD 366
H+ ++HRD+K N+L+D K++DFGL+R + TH V T+ Y
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV--TLWYRA 167
Query: 367 PE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
PE G++Q + D++S G + E+++ ++P
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ--------QFVTEVALLSRIH--- 249
+IG G++G+VY + G VA+K S R Q V EVALL R+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK------SVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 250 HRNLVPLIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 304
H N+V L+ C + E + LV+E++ + LR L V L T +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFL 118
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
+GL++LH C I+HRD+K NIL+ + K++DFGL+R + V T+ Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWY 173
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 398
PE D++S G + E+ +KP+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 45/213 (21%)
Query: 202 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT---EVALLSRI-HHRNLVPL 256
KIG+G+F V + K GK A+K M Q V E+ L R+ H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRL 63
Query: 257 IGYC-EEEHQRI-LV--------YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
I + + R+ LV YE + + R ++ ++ +L K
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELI-----KGRKRPLPEKRVKSYMYQL------LKS 112
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
L+++H GI HRD+K NIL+ + K++DFG R + ++ T Y
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS--TRWYRA 166
Query: 367 PE------YYGNQQLTEKSDVYSFGVVLLELIS 393
PE YYG K D+++ G V E++S
Sbjct: 167 PECLLTDGYYG-----PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPLIG 258
+G GSFG V K K G+ A+K + + +Q E ++L + H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK--------GLEYL 310
++E++ + E++ G L L + P +D AK EYL
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAGRFP----------NDVAKFYHAELVLAFEYL 134
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
H + II+RD+K N+LLD KV+DFG +++ + + GT YL PE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVI 187
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKP 397
++ + D ++ GV+L E I+G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 202 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYC 260
++G G+FG VY + K+ +A + D+ S + ++ E+ +L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320
E+ ++ E+ G + D + + ++PL + + L YLH IIH
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 321 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-----GNQQL 375
RD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 185
Query: 376 TEKSDVYSFGVVLLELISGKKP 397
K+DV+S G+ L+E+ + P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 196 TNNFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHR 251
NF +GKGSFG V + K E+ A+KI+ + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 252 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLE 308
+ + C + R+ V EY++ G L + G + + A + + GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISVGLF 115
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
+LH GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPE 171
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
Q + D +++GV+L E+++G+ P ED
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 253
K +GKGSFG V ++K E+ AVK I+ D T +AL + H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
L + + + V EY++ G L + D A + GL++LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 371
GII+RD+K N+LLD K++DFG+ ++ T S GT Y+ PE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS 169
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGAELNI-VHWARSMIKK 419
Q D ++ GV+L E+++G+ P +D F + L V + R + K+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 237 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 296
Q + E+ +L + +V G + + + E+M G+L D++ + P + L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 107
Query: 297 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356
+ IA +GL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 357 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
+A GT Y+ PE + +SD++S G+ L+EL G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 41/111 (36%), Positives = 63/111 (56%), Gaps = 7/111 (6%)
Query: 290 PLDWLTRLQIAHDAAKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348
PLD L+ + A+G+++L + C IHRDV + N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 349 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
D + + AR V ++ PE + T +SDV+S+G++L E+ S GK P
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 257
+KIG+G++G VY G+ K G+ VA+K I +S + E++LL + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
+E + L++E++ + L+ L + +D + +G+ + H+
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RR 121
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE-YYGNQ 373
++HRD+K N+L+D K++DFGL+R TH V T+ Y PE G+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVV--TLWYRAPEVLLGSP 177
Query: 374 QLTEKSDVYSFGVVLLELISGKKPV 398
+ + D++S G + E+ + KKP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLI 257
K IG+G++G V K + ++VA+K +A++ +R T E+ LL + H N++ +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 258 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLD-----WLTRLQIAHDAAK 305
H+ +VYE M LH + +Q D +L +L +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQL------LR 119
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVG 363
GL+Y+H+ ++HRD+K SN+LL+ N K+ DFGL+R E ++ V R
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---W 173
Query: 364 YLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPV 398
Y PE N + T DV+S G + EL+ G+KP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 32/210 (15%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 254
K++G G++G+V + G +VA+K ++ + R + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMKHENVI 77
Query: 255 PLIGY------CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKG 306
L+ + H LV +M GT +L H +++ + +L + KG
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV-----YQMLKG 130
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
L+Y+H GIIHRD+K N+ ++ + K+ DFGL+RQ + ++T T Y
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRA 183
Query: 367 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 395
PE N T+ D++S G ++ E+++GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 203 IGKGSFGSVYYGKMKD---------GKEVAVKI-MADSCSHRTQQFVTEVALLSRIHHRN 252
+G+G+F ++Y G ++ G+EV+V + + S + F +L+S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 253 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
LV L G C +E+ I+V EY+ G L LH N L W L +A A L YL
Sbjct: 63 LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE 118
Query: 312 TGCNPGIIHRDVKSSNILL---DINMR----AKVSDFGLSRQAEEDLTHISSVARGTVGY 364
+ ++H +V NIL+ +N K+SD G+ L+ V R + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV---LSREERVER--IPW 170
Query: 365 LDPEYYGNQQ--LTEKSDVYSFGVVLLELIS-GKKPVS 399
+ PE N Q LT +D +SFG LLE+ S G++P+S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 202 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI- 257
IG+G++G V K G +VA+K ++ H+T Q+ + E+ +L R H N++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 258 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRL--QIAHDAAKGLEY 309
E + +V E M L+ + + L D + QI +GL+Y
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL----RGLKY 121
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS------VARGTVG 363
+H N ++HRD+K SN+LL+ N K+ DFGL+R A D H + VA T
Sbjct: 122 IH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA--TRW 174
Query: 364 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGK 395
Y PE N + K+ D++S G +L E++S +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLS-RIHHRNLVP 255
K +GKGSFG V ++K EV A+K++ + +TE +L+ H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L + + + V EY++ G L ++ S + D A + L +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 373
G+I+RD+K NILLD K++DFG+ ++ T + GT Y+ PE
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVED 402
+ D ++ GV++ E+++G+ P ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 34/81 (41%), Positives = 50/81 (61%), Gaps = 1/81 (1%)
Query: 11 LKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSL 69
L G IPP + +++ L L L N L+G +P++ +L +L I+HL +N TG +P + SL
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 70 PNLQELHIENNSFVGEIPPAL 90
P LQ L + +N F GEIP L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 237 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 296
Q + E+ +L + +V G + + + E+M G+L D++ + P L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 107
Query: 297 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356
+ IA KGL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 357 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
+A GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQFVT----EVALLSRIHHRN 252
K +GKG +G V+ + G + A+K++ + R Q+ E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEY 309
+V LI + + L+ EY+ G L L + +L+ + +A LE+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDP 367
LH GII+RD+K NILLD K++DFGL +++ E +TH GT+ Y+ P
Sbjct: 116 LHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--------FGAELNI----VHWARS 415
E + D +S G ++ ++++G P + E+ +LN+ AR
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 416 MIKK 419
++KK
Sbjct: 230 LLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
K IG G+ G V G VAVK ++ ++T ++ E+ LL ++H+N++ L+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 258 GY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
EE LV E M + L +H ++ + + +L + G+++LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ GIIHRD+K SNI++ + K+ DFGL+R A + V T Y PE
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195
Query: 372 NQQLTEKSDVYSFGVVLLELISG 394
E D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 75/268 (27%)
Query: 201 KKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 252
K +G G+FG V K VAVK++ + + + ++E+ +L I +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 253 LVPLIGYCEEEHQRILV-YEYMHNGTL---------------------RDRLHGSVNQKP 290
+V L+G C + + ++V E+ G L R R V Q
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 291 LD--------------------------------WLTRLQI------AHDAAKGLEYLHT 312
+D W + L + + A+G+E+L +
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 313 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYY 370
C IHRD+ + NILL N K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 193 RKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248
Query: 371 GNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ T +SDV+SFGV+L E+ S G P
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 203 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
+GKG FG V GKM K++ K + + + E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
E + LV M+ G L+ ++ +V ++ L+ + + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
I++RD+K N+LLD ++SD GL+ + ++ T I+ A GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA-GTNGYMAPEILKEEPYS 172
Query: 377 EKSDVYSFGVVLLELISGKKP 397
D ++ G + E+++G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 256
K +GKG G V+ ++K ++ A+K++ ++ ++ +TE +L+ + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK---GLEYLHTG 313
+ E LV +Y G L + ++P L+ AA+ LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGG----ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-- 120
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----------------------EEDL 351
GI++RD+K NILL + +SDF LS+Q+
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 352 THI-SSVAR-----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
T R GT Y+ PE D ++ G++L E++ G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 201 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 252
+ +G G++G V+ G GK A+K++ + +T + TE +L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 253 -LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
LV L + + + L+ +Y++ G L L+ + + R+ IA + L++LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYIA-EIVLALDHLH 122
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 368
GII+RD+K NILLD ++DFGLS++ EE+ + GT+ Y+ PE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPE 176
Query: 369 YY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
G+ + D +S GV+ EL++G P +V+
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 256
+ IGKG G VY + VA+K + + S ++F+ E + + + H +VP+
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTR----LQIAHDAAKGL 307
C + Y+ TL+ L SV Q K L T L I H +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG--LSRQAEEDLTHISSVAR------ 359
EY+H+ G++HRD+K NILL + + D+G + ++ EE+ V
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 360 ---------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 403
GT Y+ PE +E +D+Y+ GV+L ++++ P +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 203 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-----PL 256
IG+G FG VY + D GK A+K + D + +Q T +AL RI +LV P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERIM-LSLVSTGDCPF 58
Query: 257 I---GYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
I Y ++ + + M+ G L L HG ++ + + A + GLE++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHM 113
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ PE
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 371 GNQQLTEKS-DVYSFGVVLLELISGKKP 397
+ S D +S G +L +L+ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 53/237 (22%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR------TQQFVTEVALLSRIHHRNLV 254
KKIG G FG V+ K K +E + S+R Q V EV ++ + H+N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEF---FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 255 PLIG-YCEEEHQRI-LVYEYMHNGTLRD------RLHGSVNQKPLDWLTRLQIAHDAAKG 306
I + + +Q++ ++ E+ G L ++ G + + + +TR Q+ H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLLH----A 130
Query: 307 LEYLHT---GCN-PGIIHRDVKSSNILLDINMR-----------------AKVSDFGLSR 345
L Y H G N ++HRD+K NI L +R AK+ DFGLS+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 346 QAEEDLTHISSVARGTVG---YLDPEY--YGNQQLTEKSDVYSFGVVLLELISGKKP 397
I S+A VG Y PE + + +KSD+++ G ++ EL SGK P
Sbjct: 191 N-----IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 203 IGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPL 256
+G G++GSV Y +++ ++VAVK ++ S H + + E+ LL + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 257 IGY------CEEEHQRILVYEYMHNGTLRDRLHGSVN-QKPLDWLTRLQIAHDAAKGLEY 309
+ E ++ LV M L+ V QK D + I + +GL+Y
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGAD-----LNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
+H+ GIIHRD+K SN+ ++ + ++ DFGL+RQA++++T VA T Y PE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVA--TRWYRAPEI 186
Query: 370 YGN-QQLTEKSDVYSFGVVLLELISGK 395
N + D++S G ++ EL+ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 256
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+++ +V EYM G L + + S P W + A + L+ +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHS---M 161
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 368
G+IHRDVK N+LLD + K++DFG + +E A GT Y+ PE
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 369 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 203 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 257
+G G++GSV K G VAVK ++ S H + + E+ LL + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 258 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
EE + + ++ L + + QK D + I + +GL+Y+H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 372
IIHRD+K SN+ ++ + K+ DFGL+R ++++T VA T Y PE N
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 192
Query: 373 QQLTEKSDVYSFGVVLLELISGK 395
+ D++S G ++ EL++G+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVP 255
K IGKGSFG V + K + K AVK++ + ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L + + V +Y++ G L H + L+ R A + A L YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLHS--- 114
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
I++RD+K NILLD ++DFGL ++ E S+ GT YL PE Q
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 376 TEKSDVYSFGVVLLELISGKKP 397
D + G VL E++ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 202 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVT---EVALLSRIHHRNLVPL 256
+I +G++G VY + K G+ VA+K + + + +T E+ +L ++ H N+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHPNIVTV 69
Query: 257 --IGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
+ + +V EY+ + +L + + Q + L LQ+ G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM-LQLL----SGVAHLHD 124
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 371
I+HRD+K+SN+LL+ K+ DFGL+R+ L + + T+ Y PE G
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLG 180
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPV 398
++ + D++S G + EL++ KKP+
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIH------- 249
+G G+ G+V K + DG+ AVK+ M+++ +R Q EV L
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIVKC 96
Query: 250 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 308
H + E I LV +Y + G LR + R H+A GL
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEA--GLL 148
Query: 309 YL------HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 359
++ H + +IHRD+KS+NILL N K+ DFG S+ ++ V R
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS--DDVGRTFC 206
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
GT Y+ PE + + ++K+D++S GV+L EL++ K+P E+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 203 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRN---LVP 255
IGKG+FG VY + KD + + A+K+++ ++ + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
L + + LV +YM G L L G ++ + IA + LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR----AKFYIA-ELVLALEHLHKY 115
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYG 371
I++RD+K NILLD + DFGLS+ + T+ GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLL 169
Query: 372 NQQ-LTEKSDVYSFGVVLLELISGKKPVSVED 402
+++ T+ D +S GV++ E+ G P ED
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 203 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 253
IG+GS+ V ++K ++ A+K++ H +T++ V E A + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF----L 58
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
V L + + LV EY++ G L H +K + R A + L +LH
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPEEHARFYAA-EICIALNFLH-- 113
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
GII+RD+K N+LLD + K++D+G+ ++ S+ GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGE 171
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSV 400
+ D ++ GV++ E+++G+ P +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 201 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 255
K++G G++GSV + G++VA+K + S +++ F E+ LL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 256 LIGY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
L+ +E LV YM + H +++ + +L + GL+Y
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-PLSEDKVQYLV-----YQMLCGLKY 132
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
+H+ GIIHRD+K N+ ++ + K+ DFGL+R A+ ++T T Y PE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEV 185
Query: 370 YGN-QQLTEKSDVYSFGVVLLELISGK 395
N + D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 64/272 (23%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 256
K IG+G+FG V + KD G A+K + S +Q E +L+ + +V L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 257 IGYC--EEEHQRILVYEYMHNG---TL---RDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 308
Y ++E+ L+ EY+ G TL +D TR IA + ++
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--------TRFYIA-ETILAID 115
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------SRQAEEDLTHISS---- 356
+H G IHRD+K N+LLD K+SDFGL + L+H
Sbjct: 116 SIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 357 ----------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLEL 391
+A TVG Y+ PE + ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 392 ISGKKP-VSVEDFGAELNIVHWARSMIKKGDV 422
+ G P S I++W ++ +V
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 35/84 (41%), Positives = 50/84 (59%), Gaps = 4/84 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLP 63
LSGKN+ G+I + + + + L N L+GP+PD + LR ++L NN TGS+P
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135
Query: 64 SYMGSLPNLQELHIENNSFVGEIP 87
GS+PNL+ L + NN GEIP
Sbjct: 136 R--GSIPNLETLDLSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 256
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+++ +V EYM G L + + S P W R A + L+ +H+
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 161
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 368
G IHRDVK N+LLD + K++DFG + ++ A GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 369 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 203 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 258
IGKGSFG V + +D + + A+K + + + E +L++++ +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ + LV +++ G L L G + R A + LE LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTA-ELLCALENLHKF--- 112
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
+I+RD+K NILLD + DFGL + ++D T+ GT YL PE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHG 169
Query: 375 LTEKSDVYSFGVVLLELISGKKPVSVED 402
T+ D ++ GV+L E+++G P E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT-----EVALLSRIHHRNLV 254
+K+G+GS+ +VY G + +G+ VA+K++ S +T++ V E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP--LDWLTRLQIAHDAAKGLEYLHT 312
L + V+EYMH L + Q P L +GL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH- 120
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE-YY 370
I+HRD+K N+L+ K++DFGL+R ++ T+ S V T+ Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 371 GNQQLTEKSDVYSFGVVLLELISGK 395
G + D++ G + +E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 9/142 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
L + L+G IP ++ + L + L GN + G +P + + L ++ L N GS+P
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPKL-----HKESRRRMRFK 116
+G L +L+ L++ NS G +P AL L + F + +N L + +
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVG 544
Query: 117 LILGTSIGVLAILLVLFLCSLI 138
+G + GV L L +C++
Sbjct: 545 AKIGIAFGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 30/232 (12%)
Query: 203 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+G+G FG V + K ++ A+K+M S F E +LS + + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYLHT 312
+++ LV EY G L L + + D +L L +A +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA---------IHS 117
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--- 369
G +HRD+K N+L+D K++DFG + + + S + GT Y+ PE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 370 ---YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWARSM 416
G + D +S GV+ E+I G+ P E A+ NI+++ R +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 203 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI--GY 259
IG+G FG VY + D GK A+K + D + +Q T +AL RI ++ L+ G
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERI----MLSLVSTGD 55
Query: 260 C----------EEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 307
C + + + M+ G L L HG ++K + + A + GL
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGL 110
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 367
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 368 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 397
E + S D +S G +L +L+ G P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 240 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQ 298
+E+ L+ H +V + + + +L+ EY G L ++ + + P
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 299 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSV 357
+ + L+ +H+ ++HRD+KS+NI L K+ DFG S+Q + ++ ++S
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
GT YL PE + ++ ++K+D++S GV+L EL++ +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 190 PELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADS---CSHRTQQFVTEVALL 245
P +EE K I +G+FG VY G K + K AVK++ + + Q E L
Sbjct: 1 PSIEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL 58
Query: 246 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDA 303
+ +V L + + LV EY+ G ++ LH G +++ ++ +
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEV 113
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345
A L+YLH GIIHRD+K N+L+ K++DFGLS+
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 201 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRTQQFVT-------EVALLSRIHH 250
K IG G+ G V Y G+ VA+K ++ R Q VT E+ L+ ++H
Sbjct: 22 KPIGSGAQGIVCAAYD--TVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNH 74
Query: 251 RNLVPLIGYCE-----EEHQRI-LVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 303
+N++ L+ EE Q + LV E M N L V Q LD + +
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN------LC-QVIQMDLDHERMSYLLYQM 127
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 363
G+++LH + GIIHRD+K SNI++ + K+ DFGL+R A V T
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 182
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 395
Y PE E D++S G ++ E+I G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 304 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 361
A+G+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350
LD L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 351 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + AR V ++ PE N T +SDV+S+G++L E+ S G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 202 KIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
K+G+G++ +V+ G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KGLEYLHT 312
E LV+EY+ + ++ LD L H+ +GL Y H
Sbjct: 72 IHTERCLTLVFEYLDSDL----------KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 371
I+HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 372 NQQLTEKSDVYSFGVVLLELISGK 395
+ + + D++ G +L E+ +G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 203 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 253
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFL 58
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
V L + E + V EY++ G L H +K + R A + + L YLH
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNYLH-- 113
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
GII+RD+K N+LLD K++D+G+ ++ +S GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 171
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSV 400
D ++ GV++ E+++G+ P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 203 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP---- 255
IGKGS+G V G++VA+K + D H + + + E+ LL + H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 256 LIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 311
++ E + I +V+E M + LH + K D LT + + L+Y+H
Sbjct: 68 MLPPSRREFKDIYVVFELMESD-----LHQVI--KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI---SSVARGTVGYLDP 367
T + HRD+K NIL + + + K+ DFGL+R A D T I VA T Y P
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA--TRWYRAP 175
Query: 368 EYYGN--QQLTEKSDVYSFGVVLLELISGK 395
E G+ + T D++S G + E+++GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 304 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 361
AKG+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 189 AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 45/236 (19%)
Query: 199 FCKKIGKGSFG---SVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIH-HRN 252
K++G+G++G S + + + VA+K + + S + ++ + E+ LL H+N
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 253 LVPLI--------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--- 301
+ L + E + +YE + L + L AH
Sbjct: 64 ITCLYDMDIVFPGNFNE-----LYLYEELMEADLHQIIRSGQ---------PLTDAHFQS 109
Query: 302 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHI 354
GL+Y+H+ ++HRD+K N+L++ + K+ DFGL+R E+ +
Sbjct: 110 FIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 355 SS-VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 408
+ VA T Y PE Q T+ DV+S G +L EL+ K +D+ +LN
Sbjct: 167 TEYVA--TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 34/86 (39%), Positives = 51/86 (59%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
L+ L G+IP EL M++L ++L N L+G +P ++ L L + L N LTG +PS
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
+G+L NLQ L + N G IPP++
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 201 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 256
K IG G+ G V Y + D + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 257 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191
Query: 372 NQQLTEKSDVYSFGVVLLELISGK 395
E D++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 202 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 256
K+G+G++G VY K KDG KE A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQK 65
Query: 257 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 311
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 312 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 365
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 366 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 201 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 256
K IG G+ G V Y + + + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 257 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 372 NQQLTEKSDVYSFGVVLLELISGK 395
E D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHR 251
+KIG+G++G VY + + E +A+K + R +Q + E++LL + H
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA----HDAAKGL 307
N+V L E + LV+EY L L ++ P D+ ++ + +G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGI 115
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVG 363
Y H+ ++HRD+K N+L+D A K++DFGL+R TH V T+
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLW 168
Query: 364 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
Y PE G++ + D++S G + E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 53/241 (21%)
Query: 202 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF----VTEVALLSRIHHRNLVP 255
KIG+G+FG V+ + K K+ VA+K ++ + + + F + E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKILQLLKHENVVN 75
Query: 256 LIGYCEEEHQR--------ILVYEYM-HNGTLRDRLHGSVNQKPLDW-LTRLQ-IAHDAA 304
LI C + LV+E+ H+ L G ++ K + + L+ ++ +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHD------LAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGT 361
GL Y+H I+HRD+K++NIL+ + K++DFGL+R ++ + + T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 362 VGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
+ Y PE G + D++ G ++ E+ W RS I +G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEM--------------------WTRSPIMQG 226
Query: 421 D 421
+
Sbjct: 227 N 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 201 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 252
K +G G++G V+ GK A+K++ + +T + TE +L +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 253 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK------ 305
+ + Y + ++ L+ +Y+ G + L+ R + D +
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-----------QRDNFSEDEVRFYSGEI 114
Query: 306 --GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 363
LE+LH GI++RD+K NILLD ++DFGLS++ + + GT+
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 364 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVE 401
Y+ PE + K+ D +S G+++ EL++G P ++E
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 257
+ +G GS G V+ D K VAVK + + + + E+ ++ R+ H N+V +
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 258 ----GYCEEEHQRIL--------VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 305
G E L V EYM L + Q PL + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 363
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H ++ G V
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 364 -------YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 395
L P Y T+ D+++ G + E+++GK
Sbjct: 183 WYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 202 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 256
K+G+G++G VY K KDG ++ A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 257 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 311
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 312 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 365
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 366 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 202 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
K+G+G++ +VY G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 260 CEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
E LV+EY+ + D S+N + L Q+ +GL Y H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-LFLFQLL----RGLNYCH---RRK 124
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLT 376
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 377 EKSDVYSFGVVLLELISGK 395
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 202 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ-------FVTEVALLSRIHHRNL 253
K+G+GS+ +VY G+ K G+ VA+K + R + + E +LL + H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KG 306
V L + LV+EY+ D ++ +D H+ +G
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLD----TDL------KQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
L Y H ++HRD+K N+L+ K++DFGL+R A+ + S T+ Y
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRP 171
Query: 367 PE-YYGNQQLTEKSDVYSFGVVLLELISG 394
P+ G+ + + D++ G + E+ +G
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGK--EVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRN 252
NF + +G GSFG V K+ VA+K S + +Q +E +L+ I+H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
V L G ++E LV E++ G L + + P D A EYL +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPND--VGCFYAAQIVLIFEYLQS 149
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
I++RD+K N+LLD + K++DFG ++ + T ++ GT Y+ PE N
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYTLC-GTPEYIAPEILLN 202
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ +D ++ G+ + E++ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 203 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 253
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFL 58
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
V L + E + V E++ G L H +K + R A + + L +LH
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNFLHER 115
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 371
GII+RD+K N+LLD K++D+G+ ++ D T S GT Y+ PE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILR 169
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKP 397
+ D ++ GV++ E+++G+ P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 33/79 (41%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 10 NLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGS 68
NL GEIP E+ + +L L L N LTGP+P + L +L+ + L N+L+G +P + S
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 69 LPNLQELHIENNSFVGEIP 87
L L L + +NS GEIP
Sbjct: 283 LQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 210 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV--------PLIGYCE 261
S GK K + +A ++ A S Q E+ L R++H N++ Y
Sbjct: 184 STNQGKPKCERLIAKRVKAGS--RAAIQLENEILALGRLNHENILKIEEILRSEANTYMI 241
Query: 262 EEHQRILVYEYMHNGTL--RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ +Y +M++ +DR PL TR I +EY+H + +I
Sbjct: 242 TQKYDFDLYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIH---DKKLI 289
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+K NI L+ + + + DFG + E++ GTV PE E +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 380 DVYSFGVVLLELIS 393
D++S G++LL+++S
Sbjct: 350 DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 203 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGY 259
+G+G++G V + K+ KE VA+K DS + + T E+ +L + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 260 CEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ LV+EY+ L + +G +K ++ +L K + + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKN--- 119
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYYGNQQ 374
I+HRD+K N+L+ N K+ DFG +R E + + VA T Y PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--TRWYRSPELLLGAP 177
Query: 375 LTEKSDVYSFGVVLLELISGK 395
+ D++S G +L EL G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+K+G+G++ +V+ G+ K + VA+K I + + EV+LL + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ LV+EY+ + L+ + G++ + QI +GL Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL----RGLAYCH---RR 123
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 375
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 376 TEKSDVYSFGVVLLELISGK 395
+ + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 256
++IG G FG V ++ VA VK + + S + Q +F+ + + H N++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCN 315
+G C E +LV+EY G L+ L + L LQ +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
+H D+ N L ++ KV D+G+ + +ED + +L PE G
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 375 -------LTEKSDVYSFGVVLLELI-SGKKPVS 399
T+ S+V++ GV L EL + +P S
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 276 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 334
T RD L +N+ P L ++ + ++ A G+E+L + +HRD+ + N+L+
Sbjct: 223 RTRRDTL---INESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGK 276
Query: 335 RAKVSDFGLSRQAEEDLTHISSVARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLE 390
K+ DFGL+R D +IS +G+ + ++ PE N T SDV+SFG++L E
Sbjct: 277 LVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 391 LIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 449
+ + G P EL + + IK+G + P + I E+ +C
Sbjct: 334 IFTLGGTPYP------ELPMNEQFYNAIKRG--YRMAKPAHASD-------EIYEIMQKC 378
Query: 450 VEQRGFSRPKMQEIVLAIQD 469
E++ RP ++V + D
Sbjct: 379 WEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 202 KIGKGSFGSVYYG-KMKDGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVP 255
IG G++G V + GK+VA+K + + + RT + E+ +L H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIA 68
Query: 256 L--IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 308
+ I + +V + M + L +H +Q + R Q+ +GL+
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLL----RGLK 121
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----EEDLTHISS-VARGTVG 363
Y+H+ +IHRD+K SN+L++ + ++ DFG++R E ++ VA T
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRW 176
Query: 364 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 398
Y PE + T D++S G + E++ G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 12/108 (11%)
Query: 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350
L L L + A+G+E+L + +HRD+ + N+LL K+ DFGL+R D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----D 286
Query: 351 LTHISS-VARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
+ H S+ V++G+ V ++ PE + T SDV+S+G++L E+ S
Sbjct: 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 256
K + GS G V+ K G+ V +KI + + E LL ++H +++ +
Sbjct: 72 KTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRMKD 124
Query: 257 ------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
I H +Y Y+ T R R PL L I +GL YL
Sbjct: 125 TLVSGAITCMVLPHYSSDLYTYL---TKRSR--------PLPIDQALIIEKQILEGLRYL 173
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDP 367
H IIHRDVK+ NI ++ + + D G ++ A L +A GTV P
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA-GTVETNAP 225
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELIS 393
E + K+D++S G+VL E+++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
LS +L GEIP + ++ L L L N TG +P ++ L L+++ L +N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 98
+G NL L + N+ GEIP L + +FK
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
|
Length = 968 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 15/145 (10%)
Query: 267 ILVYEYMHNGTLRDRLHGSVNQKPLDW-LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 325
+L+ +Y+ +G L D L + L + I + L LH IIH D+K
Sbjct: 85 VLIMDYIKDGDLFDLLK---KEGKLSEAEVKK-IIRQLVEALNDLH---KHNIIHNDIKL 137
Query: 326 SNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 384
N+L D R + D+GL + + S GT+ Y PE D ++
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192
Query: 385 GVVLLELISGKKPVSVEDFGAELNI 409
GV+ EL++GK P ED EL++
Sbjct: 193 GVLTYELLTGKHPF-KEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 29/83 (34%), Positives = 48/83 (57%), Gaps = 1/83 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
LS L GEIP ++ + +L L L GN L G +P ++ L L + L +N+L G +P
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
Query: 65 YMGSLPNLQELHIENNSFVGEIP 87
+G + +L+ +++ N+ GEIP
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKI----MADSCSHRTQQFVTEVALLSRIHHRN-LV 254
+KIG+G++G VY + K+ GK VA+K M + T + E++LL + +V
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64
Query: 255 PLIG--YCEEEHQRI---LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 307
L+ + EE++ + LV+EY+ + L+ + +G +PL T + KG+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 308 EYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDL---THISSVARGTVG 363
+ H G++HRD+K N+L+D K++D GL R + TH T+
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLW 176
Query: 364 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISG 394
Y PE G+ + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 202 KIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRTQQFVT--EVALLSRIH---HRN 252
+IG+G++G V+ K +D G+ VA+K + T EVA+L + H N
Sbjct: 8 EIGEGAYGKVF--KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 253 LVPLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDA 303
+V L C + E + LV+E++ T D++ G + D + +L
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------ 119
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 363
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLW 174
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 398
Y PE D++S G + E+ +KP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 30/189 (15%)
Query: 218 DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275
+G+E+ V + SHR F +L+S++ H +L + G C + I+V E++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 276 GTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330
G L +++ P+ W ++ +A A L YL + ++H +V + NILL
Sbjct: 101 GPLDVCLRKEKGR-----VPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
Query: 331 DINMRA-------KVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVY 382
A K+SD G+S A L+ V R + ++ PE G L+ +D +
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTA---LSREERVER--IPWIAPECVPGGNSLSTAADKW 205
Query: 383 SFGVVLLEL 391
SFG LLE+
Sbjct: 206 SFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGY 259
K IG G FG VY + + + +A + + V E + + I+ + + L
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 260 CEEEHQRILVY---------EYMHNGTLRDRLHGSVNQ---------KPLDWLTRLQIAH 301
+H I Y + L ++L + + K L I
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIMK 133
Query: 302 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS------ 355
D LEY+H GI H D+K NI++D N R + D+G++ HI
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415
+ RGT+ Y + + +T + D+ S G +L+ + + FG N++H A
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHAA-- 246
Query: 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 450
K D I + G +KI++ + I+CV
Sbjct: 247 ---KCDFIKRLHE---GKIKIKNANKFIYDFIECV 275
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 6 LSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 63
LS N G IP + N+E L L N L+G +P D+ L+++ L N L G +P
Sbjct: 125 LSNNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPAL 90
+ + +L +L+ L + +N VG+IP L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 32/95 (33%), Positives = 46/95 (48%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+S NL+G I +M +L L L N G LPD L + L N+ +G++P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYD 100
+GSL L +L + N GEIP L + K + D
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
|
Length = 968 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 23/186 (12%)
Query: 240 TEVALLSRIHHRNLVPLI-GYCEEEHQRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRL 297
E+ +L I HR ++ LI Y + +++ +Y + T DR PL +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAI 188
Query: 298 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 357
I + L YLH GIIHRDVK+ NI LD A + DFG + + + H +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTP 242
Query: 358 A----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW 412
GT+ PE K+D++S G+VL E+ + FG ++
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL----FGKQVKSSSSQ 298
Query: 413 ARSMIK 418
RS+I+
Sbjct: 299 LRSIIR 304
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
N+V L Y E LV ++ G L + P + + R A + L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRW--AAEMVVALDALH 102
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 369
GI+ RD+ +NILLD +++ F + E+ D + ++ Y PE
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHW----ARSMIKK 419
G + TE D +S G +L EL++GK V G LNI W ARS++++
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 56/245 (22%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 256
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 257 IGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
+++ L+ E++ G + +D L Q ++ +A DA L
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF---YIAETVLAIDAIHQL--- 120
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------------------------- 343
G IHRD+K N+LLD K+SDFGL
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 344 ----SRQAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 396
R+AE + +A TVG Y+ PE + + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 397 PVSVE 401
P E
Sbjct: 235 PFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 203 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 261
IG GSFG VY D E VA+K + ++ + E+ ++ ++H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYY 129
Query: 262 EEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
E + +V E++ + H + N L ++ + L Y+H+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 314 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE- 368
I HRD+K N+L+D N K+ DFG ++ + +++I S Y PE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPEL 241
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISG 394
G T D++S G ++ E+I G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 47/166 (28%)
Query: 294 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL---------- 343
L R IA + +E +H G IHRD+K NIL+D + K++DFGL
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 344 --------SRQ---------AEEDLTHISSVAR---------------GTVGYLDPEYYG 371
RQ +E D + + R GT Y+ PE
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVED-FGAELNIVHWARSM 416
T+ D +S GV+L E++ G+ P + +L +++W ++
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 203 IGKGSFGSVYYGKMKD-----------GKEVAVKIMADSCSHR--TQQFVTEVALLSRIH 249
+G+G+ +Y G + KE+ V + SHR + F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
H+++V L G C + + I+V E++ G L +H + W + ++A A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 310 LHTGCNPGIIHRDVKSSNILL-------DINMRAKVSDFG-----LSRQAEEDLTHISSV 357
L + ++H +V + NILL + K+SD G LSRQ E + I +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIPWI 175
Query: 358 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLEL 391
A PE ++ L+ +D +SFG L E+
Sbjct: 176 A--------PECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 33/82 (40%), Positives = 42/82 (51%), Gaps = 1/82 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
LS NL GEIP L + L +L L N L G +P + LR V L++N +G LPS
Sbjct: 363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
Query: 65 YMGSLPNLQELHIENNSFVGEI 86
LP + L I NN+ G I
Sbjct: 423 EFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
LS G +P +L ++ L +L L N L+G +PD +S L + L +N+L+G +P+
Sbjct: 482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPA 541
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
+P L +L + N GEIP L
Sbjct: 542 SFSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 219 GKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276
G+ V V+ I ++C++ F+ E+ + +H N+VP +++ +V +M G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 277 TLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333
+ +D + +D ++ L IA+ K L+Y+H + G +HR VK+S+IL+ ++
Sbjct: 85 SAKDLICTHF----MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD 137
Query: 334 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN--QQLTEKSDVYSF 384
+ S+ + + L + + +V +L PE Q KSD+YS
Sbjct: 138 GKVYLSGLRSNLSMINHGQR-LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 385 GVVLLELISGKKP 397
G+ EL +G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 44/239 (18%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 256
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+++ L+ E++ G + L D LT + A+ + + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGL-------------------------------SR 345
G IHRD+K N+LLD K+SDFGL R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 346 QAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 401
+AE + +A TVG Y+ PE + + D +S GV++ E++ G P E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 68/258 (26%)
Query: 201 KKIGKGSFGSV-YYGKMKDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 256
K IGKG+FG V K GK A+K + S + Q E +L+ +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW------LTRLQIAHDAAKGLEYL 310
++ L+ E++ G L L + + +TR +A + +E +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECVLAIEAV 117
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---------------RQAEEDLTHIS 355
H G IHRD+K NIL+D K+SDFGLS Q + + I
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 356 S----------------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSF 384
+ +A TVG Y+ PE + Q ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 385 GVVLLELISGKKPVSVED 402
G ++ E + G P E+
Sbjct: 235 GAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
L N G+IP L ++ L L L N +G +P ++ + +L ++ L N LTG +P
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
+ S NL +L + +NS GEIP +L
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 13/85 (15%)
Query: 10 NLKGEIPPELKNMEALTELWLDGNFLTGPLPD-------MSRLIDLRIVHLENNELTGSL 62
GEIP L LT L L N LTG +P+ + +LI L +N L G +
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI------LFSNSLEGEI 396
Query: 63 PSYMGSLPNLQELHIENNSFVGEIP 87
P +G+ +L+ + +++NSF GE+P
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 53/150 (35%)
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGL--------------------------------- 343
G IHRD+K NIL+D++ K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 344 ----------------SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 387
++Q + L H S V GT Y+ PE + T+ D +S GV+
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAH-SLV--GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 388 LLELISGKKP-VSVEDFGAELNIVHWARSM 416
L E++ G+ P ++ +L +++W ++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 47/147 (31%)
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLS------------------RQAEEDLT------ 352
G IHRD+K NIL+D + K++DFGL RQ D +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 353 -------------------HISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLE 390
H +A VG Y+ PE T+ D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 391 LISGKKP-VSVEDFGAELNIVHWARSM 416
++ G+ P ++ ++ +++W S+
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 3/99 (3%)
Query: 297 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356
L I + ++YLH IIHRD+K+ NI ++ + DFG + + +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 395
GT+ PE D++S G+VL E+ +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 202 KIGKG--SFGSVYYGK-MKDGKEVAVKIM-ADSCS-HRTQQFVTEVALLSRIHHRNLVPL 256
+IG+G + SVY + G V V+I ++C+ + EV L H N++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
++ +M G+ L + + L I A +GL YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN--- 120
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLDPE 368
G IHR++K+S+IL I+ VS GLS Q + + + + +L PE
Sbjct: 121 GYIHRNIKASHIL--ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 369 YYGNQQL---TEKSDVYSFGVVLLELISGKKP 397
Q L KSD+YS G+ EL +G+ P
Sbjct: 179 LL-RQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 289 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348
+PL +A ++Y+H GIIHRD+K+ N+L++ + DFG + A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 349 EDLTHISSVARGTVGYLD---PEYYGNQQLTEKSDVYSFGVVLLE 390
+ + G G +D PE T D++S G+V+ E
Sbjct: 312 GSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 32/149 (21%), Positives = 54/149 (36%), Gaps = 17/149 (11%)
Query: 200 CKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VP-L 256
K + G VY + E +KI + EVA+L + + L VP +
Sbjct: 3 IKLLKGGLTNRVY--LLGTKDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKV 58
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ E + L+ E++ TL + + IA A+ L LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSR 345
+ H D+ NIL+D + D+ +
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 199 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-H 249
F K +G G+FG V GK + VAVK M + +H ++ ++E+ +LS +
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK-MLKASAHTDEREALMSELKILSHLGQ 100
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTL 278
H+N+V L+G C +++ EY G L
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 199 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 250
K +G+G+FG V K + VAVK++ + + + +TE+ +L I HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 251 RNLVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHG 284
N+V L+G C + ++V EY G L + L
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRS 105
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.003
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 3/60 (5%)
Query: 25 LTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 82
L L L N LT +PD + L +L+++ L N LT P LP+L+ L + N+
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.17 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.12 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.78 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.7 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.68 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.66 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.61 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.58 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.57 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.3 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.29 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.28 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.27 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.27 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.26 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.24 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.13 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.12 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.09 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.09 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.06 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.03 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.03 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.03 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.02 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.01 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-57 Score=507.94 Aligned_cols=439 Identities=27% Similarity=0.472 Sum_probs=310.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++.+|..+.++++|+.|+|++|.++|.+|. |..+++|+.|+|++|+++|.+|..+..+++|+.|++++
T Consensus 501 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~ 580 (968)
T PLN00113 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISH 580 (968)
T ss_pred cCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccC
Confidence 45677777777777777777777888888888888877776 77788888888888888878887777777888888888
Q ss_pred ccccCCCCccc-cccceeeeccCCCcccccc-------ccc----cceeeeeeehhhHHHHHHHHHHHHHhhhhhhhccc
Q 010131 80 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKES-------RRR----MRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKI 147 (517)
Q Consensus 80 N~l~~~~P~~~-~~~~~~~~~~~n~~~~~~~-------~~~----~~~~~i~~~~~~~~~~~lvl~l~~~~~~~~~~~~~ 147 (517)
|+++|.+|..- +.......+.+|+.+|+.. |.. ....+++++++++++ +++++++.++++++|++
T Consensus 581 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~- 657 (968)
T PLN00113 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFL--VLALVAFGFVFIRGRNN- 657 (968)
T ss_pred CcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHH--HHHHHHHHHHHHHhhhc-
Confidence 88887777542 1222334578899888532 211 111222222222222 22222222222222211
Q ss_pred ccchhhhhhccccccCCCCCCccccccCCccccCCcccccChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEE
Q 010131 148 SNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKI 226 (517)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~ 226 (517)
...+..+... ..+.. .+........+...++... +...+.||+|+||.||+|... +++.||||.
T Consensus 658 ~~~~~~~~~~----------~~~~~----~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~ 722 (968)
T PLN00113 658 LELKRVENED----------GTWEL----QFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKE 722 (968)
T ss_pred cccccccccc----------ccccc----cccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEE
Confidence 1111111000 00000 0001111122334444332 334578999999999999874 789999999
Q ss_pred ecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHH
Q 010131 227 MADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306 (517)
Q Consensus 227 ~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a 306 (517)
+...... ...|++.+++++|||||+++++|.+.+..++||||+++|+|.++++ .++|.++.+++.|+|+|
T Consensus 723 ~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~ 792 (968)
T PLN00113 723 INDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKA 792 (968)
T ss_pred ccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHH
Confidence 8654322 2346889999999999999999999999999999999999999996 27899999999999999
Q ss_pred HHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 307 L~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
|+|||..+.++|+||||||+||+++.++.+++. ||.+...... ....+++.|+|||++.+..++.++|||||||
T Consensus 793 L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gv 866 (968)
T PLN00113 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGL 866 (968)
T ss_pred HHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHH
Confidence 999996555899999999999999999888875 6554433211 1224788999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 464 (517)
++|||+||+.||. ..........+|++..........++|+.+... ...++..++.+++.+|++.||++||||+||+
T Consensus 867 vl~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl 945 (968)
T PLN00113 867 ILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945 (968)
T ss_pred HHHHHHhCCCCCC-cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHH
Confidence 9999999999996 344455667788876666666666777776443 3456777899999999999999999999999
Q ss_pred HHHHhhhhhh
Q 010131 465 LAIQDSIKIE 474 (517)
Q Consensus 465 ~~L~~~~~~~ 474 (517)
+.|+++....
T Consensus 946 ~~L~~~~~~~ 955 (968)
T PLN00113 946 KTLESASRSS 955 (968)
T ss_pred HHHHHhhccc
Confidence 9999887643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-56 Score=441.77 Aligned_cols=289 Identities=49% Similarity=0.835 Sum_probs=254.5
Q ss_pred cccccChhHHHHHHHhhh--cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceee
Q 010131 183 VAYFIPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260 (517)
Q Consensus 183 ~~~~~~~~~l~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 260 (517)
....|++.++..+|.+|. +.||+|+||.||+|.+.+|+.||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 445688999999999996 799999999999999999999999988765433145599999999999999999999999
Q ss_pred ecCC-eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc
Q 010131 261 EEEH-QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 261 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
.+.+ +.+||||||++|+|.++++..... .++|.++++||.++|+||+|||+.+.+.|+||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9988 599999999999999999975433 89999999999999999999999888899999999999999999999999
Q ss_pred cccCccccCC-CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 340 DFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 340 Dfg~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
|||+|+.... ........ .||.+|+|||++..+..+.|+||||||++++|++||+.|.+.........+.+|++..+.
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999976554 22211111 699999999999999999999999999999999999999875444456679999999999
Q ss_pred cCCcccccCcccc-CCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 419 KGDVISIVDPVLI-GNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 419 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
++.+.+++|+.+. ..+.. ++...+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999997 66664 6888999999999999999999999999999665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=383.69 Aligned_cols=262 Identities=37% Similarity=0.544 Sum_probs=215.4
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchh--HHHHHHHHHHHhcCCCCCccccceeeecCC-eeEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRIL 268 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~l 268 (517)
+......+.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 3333444556799999999999999944449999998654322 568999999999999999999999999887 7999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-cEecCCCCCCeEeCCCC-cEEEccccCccc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSNILLDINM-RAKVSDFGLSRQ 346 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~ 346 (517)
||||+++|+|.++++.. ....+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++.
T Consensus 118 VtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999999999864 36789999999999999999999999 77 99999999999999997 999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccC--CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
..... .......||+.|||||++. ...++.|+||||||+++|||+||+.||..... .+.+......+....
T Consensus 194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPP 266 (362)
T ss_pred ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCC
Confidence 65432 1223356999999999999 56999999999999999999999999973332 222333333332222
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
+ +...+..+..++.+||+.||..||++.+++..|+.+...
T Consensus 267 ~---------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 267 I---------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred C---------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 2 222455788999999999999999999999999988763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=366.27 Aligned_cols=250 Identities=27% Similarity=0.381 Sum_probs=210.0
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCCccccceeeecCC-eeEEEEEecCC
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYMHN 275 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 275 (517)
..+.||+|..|+||++.++ +++.+|+|.+... .....+++.+|++++++.+||+||.++|.|..+. ...++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4578999999999999988 6889999999544 3455688999999999999999999999999988 49999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|||.+++. ..+.+++..+-+|+.+|++||.|||+ .++|+||||||+|||++..|++||||||.+..+.+. ..
T Consensus 163 GSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 163 GSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 99999998 34789999999999999999999995 399999999999999999999999999999887655 44
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||..|||||.+.+..|+.++||||||++++|+++|+.||... .....+..+.+..... +.... +...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~-~ppP~-----lP~~-- 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVD-EPPPR-----LPEG-- 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhc-CCCCC-----CCcc--
Confidence 5677999999999999999999999999999999999999999743 2222333333333222 22211 1111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....++.+++..||++||.+|||++|+++.
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 244578899999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=385.46 Aligned_cols=264 Identities=28% Similarity=0.458 Sum_probs=225.4
Q ss_pred hhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 189 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..++......+.+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++..+|
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 346677778889999999999999999997779999999865 3445789999999999999999999999999889999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|||||+.|+|.++|+.. .+..+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+|+...
T Consensus 279 VtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999863 46789999999999999999999999 999999999999999999999999999999766
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
++.........-+..|.|||.+..+.++.|||||||||+||||+| |+.||...+.. + +...+..|..
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------e-v~~~le~GyR----- 422 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------E-VLELLERGYR----- 422 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------H-HHHHHhccCc-----
Confidence 655544555556779999999999999999999999999999999 99998743322 2 2233333322
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
-..+..++..+.+++..||+.+|++|||++.+...|+++...
T Consensus 423 ----lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 ----LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 122344667899999999999999999999999999887654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=363.65 Aligned_cols=256 Identities=28% Similarity=0.388 Sum_probs=208.3
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch-------hHHHHHHHHHHHhcCCCCCccccceeee
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCE 261 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 261 (517)
++.....|-+.+.||+|+||.|-+|..+ +|+.||||++++.... ....+.+|+++|++|+|||||+++++|.
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3445556667899999999999999755 7999999999753211 2234679999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEE
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKV 338 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl 338 (517)
..+..|+||||++||.|.+++- ..+.+.+..-..++.|++.|+.|||+ +||+||||||+|||+..+ ..+||
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred cCCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999999987 45667777788899999999999999 999999999999999766 77999
Q ss_pred ccccCccccCCCCcccccccccCCCCcCCCccCCCCC---CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 010131 339 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 415 (517)
+|||+|+..++ .....+.+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||.....+. . +..
T Consensus 321 tDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~e 392 (475)
T KOG0615|consen 321 TDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKE 392 (475)
T ss_pred cccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHH
Confidence 99999998874 345677889999999999976543 347899999999999999999998332211 1 233
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
++..|.+... .....+..++..++|.+||..||++|||+.|+++
T Consensus 393 QI~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 4444544221 1223345567889999999999999999999976
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=357.60 Aligned_cols=197 Identities=33% Similarity=0.564 Sum_probs=178.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||+||+|+++ ++..||||.+... .....+-+..|+.+|+.++|||||.++++++.++..++|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 445677999999999999987 5899999999765 4455677889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC------CcEEEccccCcccc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQA 347 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~Dfg~a~~~ 347 (517)
.||+|.++++ ..+.+++..+..++.|+|.||++||+ ++||||||||.|||++.. -.+||+|||+|+..
T Consensus 92 ~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999 45689999999999999999999999 999999999999999765 46899999999998
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
.+. ......+|++-|||||+++..+|+.|+|+||+|+++|++++|+.||...
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 754 3345678999999999999999999999999999999999999999833
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=373.20 Aligned_cols=247 Identities=27% Similarity=0.451 Sum_probs=210.8
Q ss_pred HHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.+|...+.||+|||+.||.++. ..|+.||+|++.+. .....+.+.+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4667789999999999999988 78999999999763 2445678899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+|++++|..+++ ..+.+++.+++.+++||+.||.|||+ .+|+|||||..|+|++++.++||+|||+|.....+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999988 46889999999999999999999999 99999999999999999999999999999988654
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. ...+.+|||.|+|||++.....+..+||||+||++|.|++|++||+..+..+ ....++..++ .-|.
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y---~~P~- 239 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY---SMPS- 239 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc---cccc-
Confidence 33 3456779999999999999999999999999999999999999998433222 1122222211 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+..+||.++|+.||.+|||+++|+.
T Consensus 240 ------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 ------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22235679999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=346.15 Aligned_cols=262 Identities=28% Similarity=0.368 Sum_probs=215.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccce-eeecCCe-e
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQ-R 266 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~ 266 (517)
...+.|.+.++||+|.||+||++.. .+|..||.|.+.-. .....++...|+.+|++|+|||||++++ .+.++.. .
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3445678889999999999999965 48999999988633 2345677899999999999999999998 4555444 8
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
++|||+|..|+|..+++... ..+.+++..+|+++.|++.||.++|+...+ -|.||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 89999999999999997654 456799999999999999999999984323 3889999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
+.+...... ....+|||.||+||.+.+..|+.||||||+||++|||+.-++||.+. ++.+ ....+.++++..
T Consensus 176 r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 176 RFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPP 247 (375)
T ss_pred hHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCC
Confidence 998765443 34567999999999999999999999999999999999999999854 2332 344566666544
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
+.|. -....+..+|..|+..||+.||+...+++.++.
T Consensus 248 ~p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 LPDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CcHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 4332 344578899999999999999997666665554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=378.74 Aligned_cols=265 Identities=31% Similarity=0.506 Sum_probs=224.0
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
++......+.++||+|+||.||+|... +...||||.+++.... ..++|.+|++++..++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 555566667899999999999999754 3467999999987766 678999999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccC-------C----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSV-------N----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
+..++|+|||..|+|.++|+... . ..+++..+.+.||.|||.|+.||-+ +.+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 99999999999999999997543 1 2348899999999999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCC-CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 010131 333 NMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 410 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 410 (517)
+..|||+|||+++..-. +.........-+.+|||||.+..+++|.+||||||||+|||+++ |+.||.+....+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 99999999999997543 33333323345779999999999999999999999999999998 999997444322
Q ss_pred HHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 411 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 411 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+...++.|++.. .+..++.++.+|+..||+.+|++||+++||-..|+...+..
T Consensus 714 --VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 --VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 444556665533 24456678999999999999999999999999999877653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.17 Aligned_cols=262 Identities=22% Similarity=0.281 Sum_probs=203.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|+-..++|+|+||.||+++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.++++|......++|+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 444578999999999999987 599999999975433 23355789999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+..-|.+.-+ ....++...+.+++.|++.|+.|+|+ ++++||||||+|||++.++.+||||||+|+..... ..
T Consensus 84 dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 84 DHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred chHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 8765555443 45678999999999999999999999 99999999999999999999999999999987642 22
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHHhcCCc--
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKGDV-- 422 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~-- 422 (517)
..+..+.|.+|.|||.+-+ .+|+...||||+||++.||++|.+.|.+.+.-+....+.... ..+....+
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 2344568999999999876 799999999999999999999999998665433322221111 11111111
Q ss_pred ----ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ----ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ----~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.-++.-....-+.....+++++..||+.||++|++.+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111111111223336889999999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=340.26 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=202.8
Q ss_pred HHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC--eeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 272 (517)
.+...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34457889999999999998874 8999999987654333677899999999999999999999754444 68899999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCC--
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE-- 349 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~-- 349 (517)
+++|+|.+++.... ..+++..+..+..||++||+|||+ +||+|+||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999998542 279999999999999999999999 99999999999999999 79999999999987763
Q ss_pred CCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
..........||+.|||||++.++ ....++||||+||++.||+||+.||... .....++..........
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-----
Confidence 222334456799999999999853 3446999999999999999999999732 11222222222222111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..+........+++.+|+..||++||||+++++..-
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 112223346779999999999999999999988644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=332.39 Aligned_cols=240 Identities=28% Similarity=0.400 Sum_probs=200.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.+++.++||+|+||.||.++.+ +++.+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+..|+|+|
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld 105 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD 105 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence 4456799999999999999766 58999999997642 2346778999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+.||.|..+|. .++.+++..+.-++..|+.||.|||+ ++|+||||||+|||+|.+|+++|+|||+++......
T Consensus 106 ~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 106 YLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred ccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999998 57789999999999999999999999 999999999999999999999999999999654432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. .+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||...+. ..+..... .++.. ..+
T Consensus 180 ~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~-~~k~~-~~p---- 246 (357)
T KOG0598|consen 180 D-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKIL-KGKLP-LPP---- 246 (357)
T ss_pred C-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHh-cCcCC-CCC----
Confidence 2 23457899999999999999999999999999999999999999984442 22222222 22210 000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRP 458 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RP 458 (517)
. -......+++.++|..||++|.
T Consensus 247 -~---~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 -G---YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -c---cCCHHHHHHHHHHhccCHHHhc
Confidence 0 0112567899999999999996
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.64 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=209.5
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCCccccceeeecCC-eeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH-QRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~l 268 (517)
...+|.+.++||.|.||.||+|+.. +|..||||.+++... .....=++|++.|++|+ |||||++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4568889999999999999999765 689999999986533 23334568999999998 999999999998888 8999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||| ..+|++.++++ +..+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+...
T Consensus 88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 99999 46999999875 7889999999999999999999999 999999999999999999999999999999886
Q ss_pred CCCcccccccccCCCCcCCCcc-CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 349 EDLTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.... .+..+.|..|+|||++ +.+.|+.+.|+||+||+++|+++-++.|.+.+..+.. ..+...+......++..
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi---~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI---YKICEVLGTPDKDSWPE 236 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH---HHHHHHhCCCccccchh
Confidence 6443 3445679999999986 6778999999999999999999999999865433221 11112221111111100
Q ss_pred ------------cccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 428 ------------PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 428 ------------~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
|... ...-.....+..+++.+|+++||.+|||++|.++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1110 11112355578899999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=346.06 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=206.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
+.+.|++.||+|+|++|++|+.. .++.+|||++.+.. ....+.+..|-.+|.+| .||.|++++..|.++...|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 34568899999999999999866 68999999997542 23345678899999999 899999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
+||+++|+|.++++ ..+.+++.....++.+|+.||+|||+ +|||||||||+|||+|.||+++|+|||.|+.+..
T Consensus 153 Le~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999998 46789999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCcc----------c--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 350 DLTH----------I--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 350 ~~~~----------~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
.... . ...++||..|.+||++.+...+..+|+|+|||+||+|+.|++||.+... ....+..+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliFqkI~ 300 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIFQKIQ 300 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHHHHHH
Confidence 2211 1 1347899999999999999999999999999999999999999973321 11122222
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.- .-+++...+..+.+|+.+.|..||.+|+|.+||.+.
T Consensus 301 ~l-----------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 AL-----------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred Hh-----------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 011122223467899999999999999999888764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=364.29 Aligned_cols=264 Identities=27% Similarity=0.460 Sum_probs=220.9
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
.||..+...+.++||.|-||.||+|+++- ...||||.++....+ ...+|+.|+.+|.+++||||+++.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 35555555667889999999999999872 357999999876544 4568999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++|+|||++|+|..+|+.+ .+.+++.++..++++||.|++||-+ +++|||||.++||||+.+..+|++|||++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999875 4669999999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCcccccccc--cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 345 RQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
+.+.++......... -+.+|.|||.+..++++.++|||||||++||.++ |..||...+..+ +...+.+|
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~g- 850 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQG- 850 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhc-
Confidence 988665533222222 2468999999999999999999999999999887 999997333221 22223222
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+-..+++++..|.+|++.||++|-.+||.+.||+..|++++...
T Consensus 851 --------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 851 --------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred --------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 222335667789999999999999999999999999999988643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=348.18 Aligned_cols=263 Identities=27% Similarity=0.440 Sum_probs=206.5
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+++.++||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34456778899999999999999742 356899999875432 3346789999999999 899999999988764
Q ss_pred -CeeEEEEEecCCCCHHhHhhccCC-------------------------------------------------------
Q 010131 264 -HQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 287 (517)
Q Consensus 264 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 287 (517)
+..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 457899999999999999874311
Q ss_pred ----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc-ccccccCC
Q 010131 288 ----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTV 362 (517)
Q Consensus 288 ----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~ 362 (517)
...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++......... .....++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2347888999999999999999999 999999999999999999999999999998654322211 22234567
Q ss_pred CCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHH
Q 010131 363 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 441 (517)
Q Consensus 363 ~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 441 (517)
.|+|||++.+..++.++|||||||++|||++ |..||....... .....+..+..... +......
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~ 305 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMRA---------PENATPE 305 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCCC---------CCCCCHH
Confidence 8999999999899999999999999999997 999997433211 11122222221111 1122346
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 442 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 442 l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=331.38 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=209.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecC-CCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|++.++||.|..++||+|+.. .++.||||++.- .+....+.+.+|+..++.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 45777899999999999999765 689999999964 3455578899999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
|.+||+.++++... ...+++..+..|++++++||.|||. +|.+|||||+.||||+.+|.+||+|||.+..+.....
T Consensus 106 Ma~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999998765 4459999999999999999999999 9999999999999999999999999998766543222
Q ss_pred cc---ccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 353 HI---SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 353 ~~---~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.. .....||+.|||||+++. ..|+.|+||||||++..||.+|..||..... .+.....+. +......-
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLq-n~pp~~~t 254 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQ-NDPPTLLT 254 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhc-CCCCCccc
Confidence 11 145679999999999643 4689999999999999999999999973321 111222222 22211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+..+........+.+++..||++||++|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11222223334457889999999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=372.80 Aligned_cols=270 Identities=31% Similarity=0.492 Sum_probs=223.6
Q ss_pred ChhHHHHHHHhhhcccCCCCceEEEEEEecC--Cc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceee
Q 010131 188 PLPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYC 260 (517)
Q Consensus 188 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 260 (517)
+++++......+.+.||+|+||.||.|...+ |. .||||.+++..+ +...+|++|..+|++++|||||+++|+|
T Consensus 685 ~lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 685 SLPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred ccccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 3666777777888999999999999998763 43 489999987644 4567899999999999999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccC----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcE
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 336 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 336 (517)
.+....++++|||++|+|..+|+..+ ....++..+++.++.|||+|+.||++ +++|||||.++|+|++....+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcE
Confidence 99999999999999999999999753 24578999999999999999999999 999999999999999999999
Q ss_pred EEccccCccccCC-CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 010131 337 KVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 337 kl~Dfg~a~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 414 (517)
||+|||+|+.+.. +.........-+..|||||.+..+.++.|+|||||||++||++| |..||...+.. +.+.
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~ 915 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLL 915 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHH
Confidence 9999999995433 33322222334578999999999999999999999999999999 99999743321 2222
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
...+.|++ +.+..++..+.+++..||+.+|++||++..+++.+..+......
T Consensus 916 ~~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 916 DVLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 23333321 23445667899999999999999999999999999988865443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=342.75 Aligned_cols=245 Identities=27% Similarity=0.452 Sum_probs=207.9
Q ss_pred hcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
-++||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..++|||||+||+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 46899999999999964 47899999999877777778899999999999999999999999888999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.|.+. ...+++.++..|++++++||+|||. ++|+|||||.+|||++.+|.+||+|||++..+...... ....
T Consensus 358 TDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~Tm 429 (550)
T KOG0578|consen 358 TDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RSTM 429 (550)
T ss_pred hhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cccc
Confidence 99986 4559999999999999999999999 99999999999999999999999999999988766543 3445
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.||+.|||||+.....|++|.||||||++++||+-|.+||-.++. .+ +...+......++-.+. ..
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lr-AlyLIa~ng~P~lk~~~-------kl 495 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LR-ALYLIATNGTPKLKNPE-------KL 495 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HH-HHHHHhhcCCCCcCCcc-------cc
Confidence 699999999999999999999999999999999999999973221 11 11222222222222221 22
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+.+++.+||+.||++||+++|+|+.
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3368899999999999999999999873
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.17 Aligned_cols=265 Identities=24% Similarity=0.288 Sum_probs=205.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC--Cee
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQR 266 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 266 (517)
.....|+-.++||+|.||.||+|+.. +|+.||+|+++-.. .....-..+|+.+|++|+||||+++.+...+. ...
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34456666789999999999999754 79999999987543 34445677999999999999999999988765 689
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
|||+|||+. +|.-++.. ..-.+++.++..++.|++.||+|||. +||+|||||.+|||||.+|.+||+|||+|++
T Consensus 194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 999999976 77777653 35579999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc--CCcc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--GDVI 423 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~ 423 (517)
+........+..+-|..|.|||++.| ..|+.+.|+||.|||+.||++|++.|.+...-+.... +...... ...+
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k---IfklcGSP~e~~W 344 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK---IFKLCGSPTEDYW 344 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH---HHHHhCCCChhcc
Confidence 87665554556667999999999876 4799999999999999999999999986543222111 1111110 0111
Q ss_pred cccC-c--cc---cCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVD-P--VL---IGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d-~--~l---~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+ | .. ...+. .......++|+..+|..||.+|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1000 0 00 00111 112235678999999999999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=341.89 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=210.6
Q ss_pred ccccChhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 184 AYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 184 ~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
.+.+++++|.+- +-||.|+.|.||+|+++ ++.||||+++... ..+++-|++|+||||+.|.|+|...
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 345666776554 34999999999999998 8999999876322 2478889999999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
..+|+|||||..|-|...|+ .+..+.......|..+||.|+.|||. +.|||||||.-||||..+..+||+|||-
T Consensus 185 PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999998 56788999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
++...+..+ .-.+.||..|||||++++.+.++|.||||||||||||+||..||..-+.... +.
T Consensus 259 S~e~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------Iw 321 (904)
T KOG4721|consen 259 SKELSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IW 321 (904)
T ss_pred hHhhhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EE
Confidence 987765422 2346799999999999999999999999999999999999999974332110 00
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.+=.-.+.-..+..+++.+.-|+++||+..|.+||++.+++..|+-..
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 111112222345567778999999999999999999999999987543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=341.71 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=204.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC----Cc-hhHHHHHHHHHHHhcCC-CCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS----CS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 266 (517)
...|.+.+.||+|.||+|+.|... +++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 345667889999999999999765 6899999977653 11 23456778999999998 99999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCcc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSR 345 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~ 345 (517)
++||||+.||+|.+++. ..+.+.+.....+++|++.|++|||+ +||+||||||+|||++.+ +++||+|||++.
T Consensus 96 ~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999998 46788999999999999999999999 999999999999999999 999999999999
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCC-CC-ccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc-
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQ-LT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV- 422 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 422 (517)
... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ..... ..+..+.+
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~-~ki~~~~~~ 241 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLY-RKIRKGEFK 241 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHH-HHHhcCCcc
Confidence 874 2233445677999999999999876 75 79999999999999999999998422 11111 22333321
Q ss_pred -ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 010131 423 -ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464 (517)
Q Consensus 423 -~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 464 (517)
...++ ...+..++.+|+..||.+|+|+.+|+
T Consensus 242 ~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 IPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11110 34678999999999999999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=346.83 Aligned_cols=266 Identities=32% Similarity=0.479 Sum_probs=215.1
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecC--C--cE-EEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeee
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKD--G--KE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 261 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 261 (517)
.++......+.++||+|+||.||+|++.. + .. ||||..+.. ......+|++|+++++.++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 35555566677999999999999998763 2 23 899998852 2456678999999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccc
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 341 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 341 (517)
.....++|||+|.||+|.++|+.. ...++..++..++.+.|.||+|||+ ++++||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999853 3369999999999999999999999 99999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH-hc
Q 010131 342 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI-KK 419 (517)
Q Consensus 342 g~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~-~~ 419 (517)
|+++.... .........-+..|+|||.+....++.++|||||||++||+++ |..||.+.... + ++..+ ..
T Consensus 307 GLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~-v~~kI~~~ 378 (474)
T KOG0194|consen 307 GLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------E-VKAKIVKN 378 (474)
T ss_pred ccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------H-HHHHHHhc
Confidence 99876541 1111111124679999999999999999999999999999999 88899743321 2 22333 32
Q ss_pred CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 010131 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 477 (517)
Q Consensus 420 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 477 (517)
+.... .+...+..+..++.+|+..+|++||+|.++.+.|+.+.......
T Consensus 379 ~~r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 379 GYRMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred CccCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 22111 12234556788889999999999999999999999988776643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=336.11 Aligned_cols=271 Identities=27% Similarity=0.438 Sum_probs=222.4
Q ss_pred cChhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCe
Q 010131 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 187 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 265 (517)
-.+.|+......|.++||+|-||.|.++....+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 34678888888899999999999999999987899999999876544 45899999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++|+|||++|+|.+++..+.. ..+.-....+|+.|||.|++||.+ .++||||+.++|+|+|.++++||+|||+++
T Consensus 610 icmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccc
Confidence 9999999999999999986532 224556677899999999999999 999999999999999999999999999999
Q ss_pred ccCC-CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 346 QAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 346 ~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
.+-. +..+......-+..|||||.+..++++.++|||+||+++||+++ ...||.... ..+.++........+..
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGR 762 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCc
Confidence 6543 33334444556789999999999999999999999999999875 788886221 12333334444433322
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..++ ..+..++..+.+++.+||..|-++||+++++...|++.
T Consensus 763 ~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2211 22345667899999999999999999999999988764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=306.65 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=204.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+|.-.++||+|.||.||+|+.. +|+.||||+++-... .-.....+|++.|+.++|+||+.++++|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4555689999999999999765 799999999875422 2235678999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
|+ .+|...+++ ....++..++..++.++++|++|||+ +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 95 599999986 35789999999999999999999999 9999999999999999999999999999999876544
Q ss_pred ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc------
Q 010131 353 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI------ 425 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 425 (517)
..... +.|..|.|||.+.| ..|+...|+||.||++.||+-|.+-|.+.+.-+.... +-+.+.......+
T Consensus 157 ~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~---If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK---IFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH---HHHHcCCCCcccCcccccc
Confidence 33322 57899999998866 5799999999999999999999888875443222111 1111111111111
Q ss_pred cC-------c-cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 426 VD-------P-VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 426 ~d-------~-~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.| | ......-........+++..|+..||.+|++++|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 0 00111222344456899999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=343.79 Aligned_cols=264 Identities=27% Similarity=0.485 Sum_probs=209.5
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
.|+......+.+.||+|.||+||+|.|.. .||||++.-.. ....+.|++|+.++++-+|.||+-+.|||..... .
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 34445555568899999999999999973 69999997543 3456789999999999999999999999998876 9
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+|+.+|+|.+|+.+++.. ...++..+.+.|++|||+|+.|||. ++|+|+|||..|||+.+++.|||+|||++..-
T Consensus 464 IiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999999864 4678999999999999999999999 99999999999999999999999999998753
Q ss_pred CCC-CcccccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 348 EED-LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 348 ~~~-~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
..- .........|...|||||+++. .+|++.+|||||||++|||+||..||.....+.. .-++..|..
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifmVGrG~l- 610 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFMVGRGYL- 610 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEEeccccc-
Confidence 221 1111122346788999999864 4789999999999999999999999972221110 001111111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
..|.. .....+++++.+|+..||..++++||.+.+|+..|+.++..
T Consensus 611 -~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 -MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 01110 11234666889999999999999999999999999988774
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=335.70 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=209.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+.. ..+.+.+.+|++++++++|||||.++++|+...+.++|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 3556788999999999999876 57899999987643 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+.| +|..++. ..+.++++.+..++.+++.||.|||+ .+|.|||+||.|||++.++.+|+||||+|+.+... +
T Consensus 83 a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 83 AVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 976 9999998 57889999999999999999999999 99999999999999999999999999999987664 3
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.......|||-|||||...+..|+..+|+||+||++||+++|++||.. ..+.+.++....+. ..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~--------v~-- 218 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDP--------VK-- 218 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCC--------CC--
Confidence 344556799999999999999999999999999999999999999962 23334444333321 11
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+......+.+++...|.+||.+|.|..+++..
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122344468899999999999999999999764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=330.93 Aligned_cols=257 Identities=22% Similarity=0.387 Sum_probs=206.4
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
....+++.+.||+|+||.||+|.++ .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4456778899999999999999764 356899999876543 33467899999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999998743 3578999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||...+.. + ....+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~-~~~~~~~~~~~~-- 228 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------D-VIKAVEDGFRLP-- 228 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------H-HHHHHHCCCCCC--
Confidence 3322221222335678999999999999999999999999999875 99999733221 1 111222221110
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.+...+..+.+++.+||+.+|++||+++||.+.|+++
T Consensus 229 -------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122345688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=327.93 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=199.4
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchh---HHHHHHHHHHHhcCCCCCccccceeeec----CCeeEEEEEec
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVYEYM 273 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 273 (517)
..||+|++|.||+|.+. |+.||||.++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 56999999999999985 8999999987543322 4678899999999999999999999876 34678999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++|+|.+++.. ...+++.....++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999973 4578999999999999999999997 2488899999999999999999999999988654321
Q ss_pred cccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 354 ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...+. .+........+....
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~------- 242 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNNSLK------- 242 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCC-------
Confidence 12347889999999976 6889999999999999999999999974321 111222222211111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.+...+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11123446889999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=331.76 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=203.5
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC-----------------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccc
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 255 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 255 (517)
...+.+.++||+|+||.||+|.+++ +..||+|.+..... .....|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456678899999999999997642 34699999876533 34567999999999999999999
Q ss_pred cceeeecCCeeEEEEEecCCCCHHhHhhccC----------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcE
Q 010131 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV----------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319 (517)
Q Consensus 256 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iv 319 (517)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999886421 11357888999999999999999999 9999
Q ss_pred ecCCCCCCeEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCC
Q 010131 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKK 396 (517)
Q Consensus 320 H~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~ 396 (517)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986543221 12223345778999999988899999999999999999987 556
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 397 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 397 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
||..... ......+............. ..+...+..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7753221 12222222222211110000 0111233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=345.37 Aligned_cols=261 Identities=29% Similarity=0.454 Sum_probs=205.6
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe------cCCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+.+.+.||+|+||.||+|++ .++..||||+++... ....+.+.+|+.+++.+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3455677889999999999999964 235689999987543 33456788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccC---------------------------------------------------------
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------- 286 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 286 (517)
+..++||||+++|+|.++++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999986421
Q ss_pred ---------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 287 ---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 287 ---------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
....+++..++.++.||+.||+|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 01257889999999999999999999 999999999999999999999999999998664332
Q ss_pred cc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 352 TH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 352 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.. ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .... ..+..+.... .+
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~~~~~--~~- 339 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFY----KMIKEGYRML--SP- 339 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHH----HHHHhCccCC--CC-
Confidence 21 1122334668999999999999999999999999999998 88898633221 1111 2222221110 01
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
...+..+.+++.+||+.||++|||++||++.|++.
T Consensus 340 ------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=338.82 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=206.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+++.||.|+.|.|-+|++. +|+.+|||++.+... .....+.+|+-+|+-+.|||++++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 456788999999999999876 799999999976522 2235578999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|-|.+++. ..+++++.+..+++.||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|....++.
T Consensus 94 v~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 94 VPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred cCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 99999999998 57889999999999999999999999 999999999999999999999999999998755432
Q ss_pred ccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.-.+.+|.+.|.|||++++.+| +.++||||+|||||.|+||+.||+++ ++.. +...++.|.+.
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~-LLlKV~~G~f~-------- 230 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRV-LLLKVQRGVFE-------- 230 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHH-HHHHHHcCccc--------
Confidence 3345679999999999999887 57999999999999999999999822 2222 22233344331
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+.....+..+|+.+|+..||++|.|++||++.
T Consensus 231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 122333467899999999999999999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=342.58 Aligned_cols=263 Identities=30% Similarity=0.463 Sum_probs=206.3
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeec
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 262 (517)
.+....+.+.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+++++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345567778999999999999999742 245799999975432 3346788999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccC--------------------------------------------------------
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 286 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 286 (517)
.+..++||||+++|+|.++++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999999885321
Q ss_pred -----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc-c
Q 010131 287 -----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 354 (517)
Q Consensus 287 -----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 354 (517)
....+++.++++++.||+.||+|||+ ++++||||||+||++++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 11347888999999999999999999 99999999999999999999999999999765433221 1
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . .......+.... .+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~~~~--~~----- 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGYQMS--RP----- 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcccCcc--CC-----
Confidence 122235668999999998899999999999999999997 999996332111 1 111122111000 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
...+..+.+++.+||+.||++|||+.+|+++|++++
T Consensus 338 --~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 --DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011346889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=324.29 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=207.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...+.+.+.||+|+||.||+|... .++.||+|.+... ......+.+|++++++++||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 344566789999999999999876 5889999998754 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998753 24568999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...+.. +. ...+..+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~-~~~~~~~~~~-------- 224 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QV-YELLEKGYRM-------- 224 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHCCCCC--------
Confidence 22222234568999999998899999999999999999998 99998643221 11 1122211110
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
......+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=323.30 Aligned_cols=257 Identities=26% Similarity=0.469 Sum_probs=208.1
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+...++++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4455677889999999999999998878899999987543 345678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997542 4568999999999999999999999 999999999999999999999999999998765332
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.........+..|+|||++.+..++.++||||||+++|||+| |+.||...... . ....+..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~----~~~~~~~~~~~------- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---E----VLQQVDQGYRM------- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCCCC-------
Confidence 211111223457999999999899999999999999999999 99998632211 1 11122211110
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.........+.+++.+|++.+|++||+++++++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111233578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=320.20 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=207.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
....+++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 34556678999999999999999888889999987653 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998753 34568899999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||++.+..++.++|||||||++|+|+| |+.||...... .. ...+..+... +.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~----~~~~~~~~~~----~~-- 225 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DV----MSALQRGYRM----PR-- 225 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCC----CC--
Confidence 22222335678999999988889999999999999999998 99999632211 11 1112222111 00
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
....+..+.+++.+|+..+|++||+++++.+.|++
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 ---MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=326.22 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=199.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|...+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 445688999999999999875 78999999986432 12334678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999887643 23468999999999999999999999 9999999999999999999999999999987543222
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ .+.+...+.....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~---------- 222 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQE---------- 222 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccc----------
Confidence 1234589999999999999999999999999999999999999974432211 1111111111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
.+.......+.+++.+||+.||++||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122346789999999999999997 788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.04 Aligned_cols=251 Identities=31% Similarity=0.502 Sum_probs=202.9
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+++.+.||+|+||.||+|.++++..+|+|.+... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 345667899999999999999988889999987643 2334678899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.++++.. ...+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998743 2468999999999999999999999 999999999999999999999999999988654332222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+. .+.... +..+.. ...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~-i~~~~~--~~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEM-ISRGFR--LYRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHCCCC--CCCCC----
Confidence 222235568999999998889999999999999999999 8999963321 111111 222211 11111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
.....+.+++.+||+.+|++||+++|+++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1224688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=325.38 Aligned_cols=263 Identities=19% Similarity=0.203 Sum_probs=200.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 556789999999999999886 57899999987542 233467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+++.+..+.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9887765543 24568999999999999999999999 99999999999999999999999999999876443322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHH---------HHHHHhcCCccc
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------ARSMIKKGDVIS 424 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 424 (517)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+....... ............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 23334588999999999988899999999999999999999999974432111000000 000000000000
Q ss_pred ccCccccCC------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGN------VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+..... ........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000111000 01113346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=331.17 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=196.3
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 9999987 35678999999999999999999999 9999999999999999999999999999875322211 123
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. ... ..+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~-~~~~~~~~------~~----p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLF-ELILMEEI------RF----PR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHH-HHHHcCCC------CC----CC
Confidence 345899999999999999999999999999999999999999733221 111 11111111 11 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2234678999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=331.18 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=202.9
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
...|++.+.||+|+||.||++... ++..||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 345667789999999999999876 688899999875432 334679999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999973 4568999999999999999999997 1469999999999999999999999999987654322
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC---cc-----
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VI----- 423 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~----- 423 (517)
.....|+..|+|||++.+..++.++|||||||++|||+||+.||...+..+ +..........+. ..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 223458999999999999999999999999999999999999996433211 1110000000000 00
Q ss_pred ----------------------cccC----ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 424 ----------------------SIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 424 ----------------------~~~d----~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+..+ ..............+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 000000011234468899999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=328.10 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=205.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|+-.+.||+|.||.||+|... .++.||+|++.-.. ....+.+.+|+.++..++++||.++|+.+..+...+++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 333478999999999999765 68899999997543 3456788999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
||++.+.++ .+..+.+..+.-+++++..||.|||. .+.+|||||+.|||+..+|.+||+|||.+..........
T Consensus 95 gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 95 GGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred Ccchhhhhc---cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999997 34555888888999999999999999 999999999999999999999999999998877655444
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
..+.||+.|||||++.+..|+.|+||||||++.+||++|.+|+....... ..-++-.......
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRL 231 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCcc
Confidence 66789999999999999999999999999999999999999997332211 1111111111112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++..||.+||+.||+|+++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2233446889999999999999999999876
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=319.49 Aligned_cols=252 Identities=29% Similarity=0.380 Sum_probs=197.3
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------------hhHHHHHHHHHHHhcCCCCCccccce
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------HRTQQFVTEVALLSRIHHRNLVPLIG 258 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~ 258 (517)
-..|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||+++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 346777899999999999999876 789999999964311 12357889999999999999999999
Q ss_pred eeec--CCeeEEEEEecCCCCHHhHhhccCCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 259 YCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 259 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
+..+ .+..|||+|||..|.+...- ..++ +++.+.+++++++..||+|||. +||+||||||+|+|++++|+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 9865 45789999999998875433 2344 9999999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCC----CcccccccccCCCCcCCCccCCC----CCCccceehhHHHHHHHHHhCCCCCCCCCccccc
Q 010131 336 AKVSDFGLSRQAEED----LTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 407 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~ 407 (517)
+||+|||.+...... ....-....|||.|+|||...++ ..+.+.||||+||+||.|+.|+.||.+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----- 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----- 323 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-----
Confidence 999999999866222 11122236799999999998763 24678999999999999999999997321
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
..+ ....+.+. .+.-....+....+.+||.+||++||++|.+..+|....
T Consensus 324 -~~~-l~~KIvn~--------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 -ELE-LFDKIVND--------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -HHH-HHHHHhcC--------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111 12222222 111111224455788999999999999999999986643
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=345.33 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=209.9
Q ss_pred HHhhhcccCCCCceEEEEEEecCC-cEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceee-ec------CCee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC-EE------EHQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~~------~~~~ 266 (517)
..++.++|.+|||+.||.|....+ ..||+|++-.......+.+.+|+++|++|+ |+|||.+++.. .. .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 345578999999999999988765 999999987777778889999999999996 99999999932 11 1356
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+|.||||+||+|-|++..+.. ..|++.++++|+.|+++|+++||. +..+|||||||.+||||+.+++.||||||.+..
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 899999999999999986653 349999999999999999999997 567899999999999999999999999999876
Q ss_pred cCCCCcccc--------cccccCCCCcCCCcc---CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 010131 347 AEEDLTHIS--------SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 347 ~~~~~~~~~--------~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 415 (517)
......... -....|+.|+|||.+ .+..+++|+|||||||+||-|+....||+...
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------- 262 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------- 262 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------
Confidence 433221110 112368999999975 67889999999999999999999999997321
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
...+++....-...+.....+.+||..||+.||.+||++.+|+..+.++.....
T Consensus 263 ------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 263 ------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 112222222111224566789999999999999999999999999998886644
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=321.82 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=210.4
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
...|.+.++||.|+||.||+|...+++.+++|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34577889999999999999999889999999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999754 24568999999999999999999999 99999999999999999999999999999876443222
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.. .... ... .+...
T Consensus 161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~-~~~~~--------- 223 (261)
T cd05148 161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYD---QIT-AGYRM--------- 223 (261)
T ss_pred c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH---HHH-hCCcC---------
Confidence 1 12335678999999988899999999999999999998 89999633211 1111 111 11100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
......+..+.+++.+|++.+|++|||++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11122334688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=313.11 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=211.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchh---HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
.-+|+|.+.||+|.||.|-+|.. ..|+.||||.+++....+ .-.+.+|+++|+.|+||||+.++.+|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45788999999999999999975 579999999998764433 34578999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||..+|.|+||+. ..+.+++.+...+++||..|+.|+|. ++++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998 46789999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCcccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
. ..-++++|++-|.+||++.+.+| ++..|-||+||+||.|+.|..||++.+.. . +-+++..|.+.+--
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~-lvrQIs~GaYrEP~-- 274 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------R-LVRQISRGAYREPE-- 274 (668)
T ss_pred c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------H-HHHHhhcccccCCC--
Confidence 3 23456789999999999999887 57899999999999999999999865542 1 22344445443322
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+....-||++||..+|++|-|+.+|...
T Consensus 275 ---------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 275 ---------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 22245689999999999999999998653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=320.14 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=207.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
..++.+.+.||+|+||.||+|...+ ++.||||.+...... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567788999999999999998643 478999998765444 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccC-----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
++||||+++++|.+++.... ....+++..+..++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999997532 23458899999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 010131 336 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 413 (517)
++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...+.. ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~--- 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVI--- 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH---
Confidence 99999999876433221 11223335678999999999999999999999999999999 99998633221 111
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
..+..+..... ....+..+.+++.+||+.||++||++.||++.|++
T Consensus 235 -~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 -ECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 12222222111 11223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.66 Aligned_cols=263 Identities=21% Similarity=0.321 Sum_probs=209.3
Q ss_pred HHHHHhhhcccCCCCceEEEEEE-ecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC-----ee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 266 (517)
...+|++.+.||+|||+-||++. ..+++.+|+|++.-...++.+..++|++..++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45678889999999999999997 4578999999987665677788999999999999999999999875433 48
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
|++++|+..|+|.+.+.... .+..+++.+++.|+.+|++||++||+. ..++.||||||.||++.+++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999998655 445899999999999999999999982 2349999999999999999999999999988
Q ss_pred ccCCCCccc--------ccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 010131 346 QAEEDLTHI--------SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 346 ~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 414 (517)
...-..... ......|..|.|||.+. +...++++|||||||+||+|+.|..||+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~-------------- 243 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER-------------- 243 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH--------------
Confidence 653221111 11123688999999884 56778999999999999999999999971
Q ss_pred HHHhcCCcc--cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 415 SMIKKGDVI--SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 415 ~~~~~~~~~--~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
....|.-. .+..+.+.-..+......+.+++..|++.||.+||++.+++..+++.+
T Consensus 244 -~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 244 -IYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -HhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11122211 111222221222235668999999999999999999999999988764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=333.96 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=201.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999886 58899999987532 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999997 34578999999999999999999999 9999999999999999999999999999986543
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+. .......... +......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~~~---~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWKET---LQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhcccc---ccCCCCC
Confidence 22334589999999999998999999999999999999999999974332111 1111110000 0000000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.........+.+++.+||..+|.+||+++|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011223467899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=333.17 Aligned_cols=262 Identities=30% Similarity=0.453 Sum_probs=222.6
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.|++.....+.++||-|.||.||.|.|+. .-.||||.++.+ ....++|+.|+.+|+.++|||+|+++|+|..+...|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 45666666678999999999999999984 567999999854 4567899999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+|||.+|+|.+||+.. +...++...++.++.||+.|++||.. +++|||||.++|+||.++..+|++|||+++.+.
T Consensus 341 iTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999876 46678888899999999999999998 999999999999999999999999999999987
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.+.........-...|.|||-+....++.|+|||+|||+|||+.| |-.||.+-+... +...+++|
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkg------- 482 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKG------- 482 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhcc-------
Confidence 655433333345678999999999999999999999999999998 889987544322 23333333
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+-+.+..++..+.+|++.||+++|.+||++.|+-+.++.+..
T Consensus 483 --yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 483 --YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 2223344567789999999999999999999999999998773
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=301.36 Aligned_cols=232 Identities=26% Similarity=0.375 Sum_probs=197.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+++.+.||.|+||+|.+++.+ +|..+|+|++.+..- ...+...+|..+|+.+.||.++++++.|.+.+..++||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 446789999999999999887 688999999976432 3346678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++||-|..+++ ..+.+++...+-++.||+.||+|||+ .+|++|||||+|||+|.+|.+||+|||.|+.....
T Consensus 126 v~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 126 VPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred cCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999998 46789999999999999999999999 99999999999999999999999999999987654
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC--cccccCccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--VISIVDPVL 430 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~d~~l 430 (517)
+.+.+|||.|+|||.+....+..++|-|||||++|||+.|.+||..... .+ +...+-+++ +...+.
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~-iY~KI~~~~v~fP~~fs--- 265 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQ-IYEKILEGKVKFPSYFS--- 265 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HH-HHHHHHhCcccCCcccC---
Confidence 4567899999999999999999999999999999999999999973332 11 112222222 222222
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCC
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSR 457 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~R 457 (517)
..+.+|+...++.|-.+|
T Consensus 266 ---------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 ---------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---------HHHHHHHHHHHhhhhHhh
Confidence 257799999999999999
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.35 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=200.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 35667889999999999999886 58999999986532 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999973 4578899999999999999999999 99999999999999999999999999999876443
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.. ..+..+... +
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~-~~i~~~~~~------~ 234 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIY-EKILAGRLK------F 234 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHH-HHHhcCCcC------C
Confidence 2 234589999999999999999999999999999999999999963321 1111 122222210 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 466 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~ 466 (517)
+......+.+++.+||+.||.+||+ +++++..
T Consensus 235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0011235789999999999999997 6777643
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=321.36 Aligned_cols=249 Identities=39% Similarity=0.607 Sum_probs=195.1
Q ss_pred hhcccCCCCceEEEEEEec-----CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 199 FCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999887 257899999965433 3468899999999999999999999999988889999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++|+|.+++... ....+++..++.|+.||+.||.|||+ .+++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 35679999999999999999999999 999999999999999999999999999998763221
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
............|+|||.+.+..++.++||||||+++||+++ |+.||...+ ..+.... +.++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~-~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEK-LKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHH-HHTTEETTS-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cccccccee-----
Confidence 122233346778999999988889999999999999999999 788886321 1222222 233322111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
+...+..+.+++.+||+.+|++|||++++++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111234688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=326.99 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=195.1
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|..++. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 9998887 34578999999999999999999999 9999999999999999999999999999875322211 122
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. ........ +.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~-~~~------~~----p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM-EEI------RF----PR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCC------CC----CC
Confidence 345899999999999999999999999999999999999999733221 11111111 111 01 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1234678999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=327.58 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=175.6
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
+....|++.++||+|+||.||+|.+. ++..+|+|++..... .....+.+|++++++++||||++++++|.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34567778899999999999999887 688899998875432 3446789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999973 4568899999999999999999997 24799999999999999999999999999876533
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 12345889999999999989999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.99 Aligned_cols=239 Identities=25% Similarity=0.335 Sum_probs=193.5
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5889999998643 223446688899999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 999973 4578999999999999999999999 9999999999999999999999999999876432221 22334
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +.. ..+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~~----------~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EPL----------RFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CCC----------CCCCcC
Confidence 589999999999999999999999999999999999999973321 222222221 111 011112
Q ss_pred HHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPK---MQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs---~~evl~ 465 (517)
...+.+++.+||+.||++||+ +.|++.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 346789999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=323.29 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=198.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+++.+.||+|+||.||+|+-+ +|..+|+|++++.. ....+.++.|-.+|...++|.||+++..|++.+..||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 345688999999999999765 69999999998753 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC---
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--- 349 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~--- 349 (517)
++||++..+|. ....+++.....++.+++.|+.-+|+ .|++||||||+|+|||..|++||+|||++.....
T Consensus 223 lPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 223 LPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred cCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999998 57889999999999999999999999 9999999999999999999999999999853211
Q ss_pred --------------------CCcc----c-------------------ccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 350 --------------------DLTH----I-------------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 350 --------------------~~~~----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
+... . ....+|||.|+|||++.+..|+..+|.||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 0 01235999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccc-cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 010131 387 VLLELISGKKPVSVEDFGA-ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
|+|||+.|.+||...+..+ ...++.|........ ......+..+||.+|+. ||++|-.
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999998555432 234444433222111 11111467799999999 9999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.12 Aligned_cols=243 Identities=23% Similarity=0.303 Sum_probs=198.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456789999999999999876 68999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 83 VPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999973 4578999999999999999999999 999999999999999999999999999988664321
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... +..+.. .
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~-i~~~~~------~--- 216 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEK-ILAGKL------E--- 216 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhCCc------C---
Confidence 234589999999999998899999999999999999999999974321 111111 111211 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~~ 466 (517)
.+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 217 -~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 -FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 01111336789999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=318.72 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=205.4
Q ss_pred HHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..+.+.+.||+|+||.||+|.+.. ...||||.+..... .....|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 446678899999999999998752 45799999875433 3456789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998753 3478999999999999999999999 9999999999999999999999999999987752
Q ss_pred CCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .. ...+..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DV----IKAVEDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCCC---
Confidence 211 11122234678999999998899999999999999999998 99998632211 11 12222211110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.....+..+.+++.+|++.+|++||+++||++.|++++
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 01123346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=325.08 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=197.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|.+.++||+|+||+||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3666789999999999999876 68899999986432 223456789999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++ +|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 86 DS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred Cc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 74 898888642 3457899999999999999999999 9999999999999999999999999999876533221
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------------C
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------G 420 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~ 420 (517)
......+++.|+|||.+.+ ..++.++||||+||++|+|+||+.||...+..+. .......... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhccccch
Confidence 1223457889999998865 5689999999999999999999999974432211 1111111110 0
Q ss_pred CcccccCccccCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISIVDPVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+...... .........+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00011111100000 0011235779999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=319.46 Aligned_cols=252 Identities=30% Similarity=0.489 Sum_probs=202.8
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3466788999999999999998877789999887442 335678999999999999999999999998888999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998743 3368999999999999999999999 999999999999999999999999999987654432222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... ..+..+..... +
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~-~~~~~~~~~~~--~----- 223 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETV-EKVSQGLRLYR--P----- 223 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHH-HHHhcCCCCCC--C-----
Confidence 222235678999999988889999999999999999999 99998632211 111 11222211100 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
......+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112347889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=321.44 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=201.4
Q ss_pred hhhcccCCCCceEEEEEEe-----cCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV 269 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 269 (517)
.+.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678999999999988653 3578899999876533 3456788999999999999999999988653 357899
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++.. ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999863 459999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.... ......++..|+|||.+.+..++.++||||||+++|||+||..||...... ..................+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence 3221 112223566799999998888999999999999999999999998633211 0000000000000001111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.......+...+..+.+++.+|++.+|++|||+++|++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112233457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.06 Aligned_cols=250 Identities=29% Similarity=0.489 Sum_probs=201.6
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+.+.+.||+|+||.||+|.++++..+|+|++.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 456788999999999999998877889999986432 2345788999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999998743 3468999999999999999999999 9999999999999999999999999999876543322222
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+ .. ..+..+.. . ..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~--~-------~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESVSAGYR--L-------YR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHHHcCCc--C-------CC
Confidence 22223457999999998899999999999999999999 899986332211 11 11211110 0 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
+...+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111344788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=316.40 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=204.6
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
....+++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 4456788899999999999999988888999999875433 34679999999999999999999998854 567899999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999998753 23468999999999999999999999 9999999999999999999999999999987544322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+. .+... .+..+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~-~~~~~~~~-------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLE-QVERGYRM-------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHH-HHHcCCCC--------
Confidence 22222234568999999988889999999999999999999 8899863221 11111 12111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
..+...+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=321.98 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=205.2
Q ss_pred HHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.+.+.+.||+|+||.||+|.... ...||+|.+..... .....|.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45678899999999999998653 25799999875433 334678999999999999999999999999889999
Q ss_pred EEEecCCCCHHhHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 269 VYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999875321 1568899999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 010131 336 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 413 (517)
++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~---- 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV---- 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----
Confidence 99999999876533221 12223346788999999988899999999999999999998 99999743321 11
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
...+..+.... .....+..+.+++.+||+.||.+||+++||++.|+.
T Consensus 236 ~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 12222222211 122344578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=317.09 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=207.7
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
++...++++.++||+|+||.||+|..++++.||+|.+.... ....++.+|+.++++++|+|++++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 35567888899999999999999998889999999987543 34567899999999999999999999874 45689999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999998753 24578999999999999999999999 99999999999999999999999999999776533
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.........++..|+|||++.+..++.++||||||+++||+++ |+.||...+.. .... .+..+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~----- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQ----NLERGYRMP----- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHH----HHHcCCCCC-----
Confidence 2222223335678999999998889999999999999999999 99999733221 1111 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.....+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=325.81 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=196.5
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999875 68999999997532 234467888999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 9999887 34578999999999999999999999 9999999999999999999999999999875432211 123
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. +...... .+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~-~~~~------~~----p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL-MEDI------KF----PR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc-cCCc------cC----CC
Confidence 345899999999999989999999999999999999999999743221 1111111 1110 11 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
.....+.+++.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1233678999999999999997 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.60 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=205.9
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCCccccceeeecCC
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 264 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 264 (517)
....+.+.+.||+|+||.||+|++. .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3446667899999999999999863 134799999975433 33467999999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccC----------------------------------------------------------
Q 010131 265 QRILVYEYMHNGTLRDRLHGSV---------------------------------------------------------- 286 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 286 (517)
..++||||+++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -----------------------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 287 -----------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 287 -----------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
....+++..+..++.|++.||+|||+ .+++|+||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 01347888899999999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccH
Q 010131 332 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 409 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 409 (517)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 9999999999999865432221 1222346778999999998899999999999999999997 999986322111
Q ss_pred HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 410 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.....+..+... ......+..+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 348 --~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 --TFYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111122222111 0112234578899999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=329.32 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=193.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+++.++||+|+||.||+|++. +++.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456789999999999999876 689999999865433 33467899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++|+|.+. ....+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 155 ~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGT-------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99998653 234667788999999999999999 99999999999999999999999999999876433221
Q ss_pred cccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 354 ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.....|+..|+|||++.. ...+.++|||||||++|||++|+.||......+ ......... .....
T Consensus 225 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~-~~~~~----- 294 (353)
T PLN00034 225 -CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAIC-MSQPP----- 294 (353)
T ss_pred -ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHh-ccCCC-----
Confidence 223458999999998743 234568999999999999999999997322221 111111111 11000
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.........+.+++.+||+.||++|||+.|+++.
T Consensus 295 ----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111223468899999999999999999999873
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=316.32 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=204.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
...|++.++||+|+||.||+|.+.++..||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45677889999999999999998877789999987532 234678999999999999999999998754 5579999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++|+|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999743 23467999999999999999999999 99999999999999999999999999999866443322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||+..+..++.++||||||+++|||+| |+.||...... + ....+..+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~-~~~~~~~~~~~--------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRM--------- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------H-HHHHHhcCCCC---------
Confidence 2223345678999999988899999999999999999999 88888632211 1 11111111100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
......+..+.+++.+|++.+|++||+++++++.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=327.20 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=211.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCe-eEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 270 (517)
..|...+.+|+|+||.++..+++ +++.+++|.+.-.. ....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 35667899999999999999876 67889999986432 3334578899999999999999999999998888 99999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
+|++||++.+.+.... +..+++++++.|+.|++.|+.|||+ .+|+|||||+.|||++.++.++|+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998653 6789999999999999999999998 99999999999999999999999999999998776
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. ......||+.|+.||.+.+.+|..|+||||+||++|||++-+++|...+... .+....+ +. ++
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~-~~----~~--- 224 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINR-GL----YS--- 224 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhh-cc----CC---
Confidence 42 3455679999999999999999999999999999999999999998554322 1111111 11 11
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+......+..++..||+.+|+.||++.+++..
T Consensus 225 --Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 --PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2233444578899999999999999999999886
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=325.58 Aligned_cols=262 Identities=28% Similarity=0.460 Sum_probs=205.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeec-C
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-E 263 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~ 263 (517)
...+|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++.++ +|+||++++++|.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3457888999999999999999643 247899999875432 3345688899999999 89999999998864 4
Q ss_pred CeeEEEEEecCCCCHHhHhhccCC--------------------------------------------------------
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 287 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 287 (517)
...++++||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999998864211
Q ss_pred --CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc-ccccccCCCC
Q 010131 288 --QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGY 364 (517)
Q Consensus 288 --~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~~y 364 (517)
...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++.......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 1368999999999999999999999 999999999999999999999999999998764332211 2223456789
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 443 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 443 (517)
+|||++.+..++.++|||||||++|||++ |..||......+ .....+..+..... +......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMRA---------PEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCCC---------CccCCHHHH
Confidence 99999999999999999999999999998 999996422211 11122222211110 112234688
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 444 EVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 444 ~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+++.+||+.+|++||++.||++.|+++++
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=322.15 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=209.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34556788999999999999753 355689999876655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 269 VYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999997532 12458999999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 010131 336 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 413 (517)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.||...+... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543221 12223346778999999999999999999999999999999 999986332211 1
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
...+..+..... ....+..+.+++.+||+.+|++||++++|+++|+++.+.
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 122222222111 112344688999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.80 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=208.7
Q ss_pred HHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
+..+.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 344566789999999999999742 34568999987665555678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccC----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 268 LVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
+||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999987432 12358999999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 415 (517)
|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|+| |..||...... . ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~-~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------E-VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHH
Confidence 999999986543221 11222335678999999998899999999999999999998 89998633221 1 112
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+..+...... . .....+.+++.+||+.+|.+|||++||.+.|+++...
T Consensus 234 ~i~~~~~~~~~-----~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQRP-----R----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCCCC-----C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22222221111 1 1223688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=325.27 Aligned_cols=262 Identities=29% Similarity=0.466 Sum_probs=221.2
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC---C--cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD---G--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
++..+...+.+.||+|.||.||+|.+.+ | -.||||..+.++ ..+.+.|+.|..+|+.++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 5566666678899999999999998653 3 358999988754 45678899999999999999999999999875
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++|||.++.|-|..+++. +...++......++.||+.||+|||+ ..+|||||..+||||.....+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 57999999999999999986 35678999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
+.+.++.....+...-+..|||||.+.-..++.++|||-|||.+||++. |..||.+-...+.. ..+++|.
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGe-- 609 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGE-- 609 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCC--
Confidence 9988776666665556779999999999999999999999999999987 99999854433211 1122222
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+-..++.++..|..|+.+||..||.+||.+.|+...|.++...+
T Consensus 610 -------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 610 -------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred -------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 22334556778999999999999999999999999999988643
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=314.24 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=197.4
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 689999998765432 3456799999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc-cc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SV 357 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~ 357 (517)
.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998642 3468999999999999999999999 9999999999999999999999999999876543211111 11
Q ss_pred cccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 358 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+..+... ....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~----~~~~~~~~~~~---------~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---Q----TREAIEQGVRL---------PCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---H----HHHHHHcCCCC---------CCcc
Confidence 123457999999998899999999999999999998 88888632211 1 11112111110 1111
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..+..+.+++.+|++.+|++|||+.||.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22347889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=325.35 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=197.2
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999876 68899999997532 22345688899999998 799999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++. ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99998886 34679999999999999999999999 999999999999999999999999999987532211 112
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHHhcCCcccccCccccCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .....++....+...... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--- 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I--- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C---
Confidence 33468999999999999999999999999999999999999996332221 122233333333332211 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~ 465 (517)
+......+.+++.+||+.||.+||+ ++++++
T Consensus 225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1112235789999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=325.20 Aligned_cols=260 Identities=24% Similarity=0.432 Sum_probs=205.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCe
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 265 (517)
+....++..+.||+|+||.||+|.+. ++. .||+|++.... ....+.+.+|+.+++.++||||++++++|... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34556777889999999999999864 333 48999987543 34456789999999999999999999999765 5
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++++||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 68999999999999999753 3468899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccc-cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 346 QAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 346 ~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
.......... ....++..|+|||++.+..++.++||||||+++|||++ |+.||...... + .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~-~~~~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E-ISSILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHhCCCCC
Confidence 7654322211 12224568999999999999999999999999999998 99999633211 1 11222222111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
. .+ ......+.+++.+||+.+|++||++.+++..|..+...
T Consensus 231 ~--~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 P--QP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred C--CC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0 01 11223678999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=321.00 Aligned_cols=241 Identities=26% Similarity=0.375 Sum_probs=194.7
Q ss_pred cccCCCCceEEEEEEec----CCcEEEEEEecCCC----chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999753 57899999987532 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ....+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987 34568888999999999999999999 9999999999999999999999999999875432221
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ........ .+.. . +
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~-~~~~-~-----~-- 219 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKIL-KGKL-N-----L-- 219 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHH-cCCC-C-----C--
Confidence 12234589999999999988899999999999999999999999974322 11122221 1211 0 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
+......+.+++.+||+.+|++|| +++++++
T Consensus 220 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 --PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111223678999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=330.84 Aligned_cols=258 Identities=19% Similarity=0.215 Sum_probs=196.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|.+.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 45777899999999999999875 68899999653 235678999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
. ++|..++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 4 788888863 4568999999999999999999999 99999999999999999999999999999754332222
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc-cccHHHHHHHHHhc-CCc---------
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIKK-GDV--------- 422 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~-~~~--------- 422 (517)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...+... .......+...+.. +..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 2334568999999999999899999999999999999999998875332111 00000001111100 000
Q ss_pred ---cccc---------CccccCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ---ISIV---------DPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ---~~~~---------d~~l~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... .+..... .....+..+.+++.+||+.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000000 00123457889999999999999999999985
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=340.48 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=202.6
Q ss_pred HhhhcccCCCCceEEEEEEec-C-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 566789999999999999765 3 67888888765544555678889999999999999999999999999999999999
Q ss_pred CCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-
Q 010131 275 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 352 (517)
Q Consensus 275 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 352 (517)
+|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886432 34568999999999999999999999 9999999999999999999999999999987644322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+...... .+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~-~~~~~~~------- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVL-YGKYDPF------- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCCCC-------
Confidence 123345689999999999999999999999999999999999999973321 11122221 1211110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.+|++||++.+++.
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112246889999999999999999999865
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=327.61 Aligned_cols=247 Identities=23% Similarity=0.285 Sum_probs=200.5
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC--CcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
....|.+.+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34467778999999999999998653 3689999986432 233467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999973 4578999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. . ....+..+... +
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~-~~~~i~~~~~~--~- 247 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------L-IYQKILEGIIY--F- 247 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------H-HHHHHhcCCCC--C-
Confidence 432 12345899999999999888999999999999999999999999743211 1 11122222110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
+......+.+++.+|++.||++|+ +++|+++.
T Consensus 248 -------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 -------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111123577999999999999995 88888764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=310.43 Aligned_cols=268 Identities=25% Similarity=0.380 Sum_probs=205.4
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC--CCCCccccceeeecCC----eeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~ 270 (517)
.++.+.+|+|+||.||+|.+. ++.||||++. ....+.|.+|-++++.. +|+||++++++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345688999999999999998 6999999986 44567899998888764 8999999999876544 789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC------CCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------CNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
||.+.|+|.++|. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||+|
T Consensus 288 ~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999997 56799999999999999999999974 3678999999999999999999999999999
Q ss_pred cccCCCCccc-ccccccCCCCcCCCccCCCC-C-----CccceehhHHHHHHHHHhCCCCCCCCCcc-----------cc
Q 010131 345 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQQ-L-----TEKSDVYSFGVVLLELISGKKPVSVEDFG-----------AE 406 (517)
Q Consensus 345 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~-~-----~~~~Dv~slG~~l~elltg~~p~~~~~~~-----------~~ 406 (517)
..+....... ....+||.+|||||++.+.. + -.+.||||+|.+||||++...-+.....+ ..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8876543222 22357999999999987642 1 23789999999999999866554311111 11
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
..+.+.-.-.+++.....+.|.... ...+..+.+.+..||+.||+.|.|+.=|-+.+.++....+.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1111111112222222222222111 14455788999999999999999999999999988877665
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=323.63 Aligned_cols=243 Identities=23% Similarity=0.355 Sum_probs=193.2
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999997542 23345677899988877 799999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99998886 34678999999999999999999999 9999999999999999999999999999875322211 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc--ccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......+....+......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---------- 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---------- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----------
Confidence 3346899999999999999999999999999999999999999632211 1122223333333322210
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
.+......+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111123357799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.38 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=206.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 3556789999999999999875 6899999987542 22334578899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999998886432 24558899999999999999999999 99999999999999999999999999998876443
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
... .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+.. .+.......
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~------ 227 (267)
T cd08228 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQ-KIEQCDYPP------ 227 (267)
T ss_pred hHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHH-HHhcCCCCC------
Confidence 221 1223478899999999888899999999999999999999999863221 1122221 122111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111223456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=325.67 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=197.4
Q ss_pred HhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 267 (517)
|++.+.||+|+||.||++... +++.||+|++.+.. ....+.+..|+.+++.+ +||||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456789999999999999753 57899999986432 22345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999987 34578999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
............||+.|+|||++.+. .++.++|||||||++|||+||+.||........ ... +...+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~-~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSE-VSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHH-HHHHHhcC------
Confidence 44333333345689999999998765 478899999999999999999999974332211 111 11111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
++.+. ......+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111 11233578999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=306.53 Aligned_cols=247 Identities=30% Similarity=0.480 Sum_probs=200.1
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
+.||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998765432 3456889999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccc
Q 010131 280 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 359 (517)
Q Consensus 280 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 359 (517)
+++... ...+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 998643 3468899999999999999999999 99999999999999999999999999998765433222222223
Q ss_pred cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 360 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
++..|+|||++.+..++.++||||||+++|++++ |..||...... . ....+..+.... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~-~~~~~~~~~~~~---------~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------Q-AREQVEKGYRMS---------CPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHHcCCCCC---------CCCCC
Confidence 4668999999998899999999999999999998 99999633211 1 111222221111 11123
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.03 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=200.9
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
....|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3456677899999999999999876 68899999986421 2234557889999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999863 357888899999999999999999 999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCcCCCccCCC----CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
...........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+.. ..............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLT 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCC
Confidence 4332223345689999999998653 4788999999999999999999999743321 11112221111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
..+ .......+.+++.+||+.+|.+ ||+++|+++.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111 1112346789999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.43 Aligned_cols=261 Identities=22% Similarity=0.292 Sum_probs=195.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4667789999999999999886 689999999875432 23346788999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 86 H-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred C-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 5 688887764 24568899999999999999999999 9999999999999999999999999999875432211
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--------c
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--------S 424 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 424 (517)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..... .......+.......... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhcc
Confidence 1223457899999998865 4578899999999999999999999974321 111111111111000000 0
Q ss_pred ccCcc-cc--CCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPV-LI--GNVKI-------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~-l~--~~~~~-------~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..++. .. ..... .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 00000 01235779999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=318.39 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=202.5
Q ss_pred HHHhhhcccCCCCceEEEEEEe-----cCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+++.+.||+|+||.||+|.+ .++..|++|.+..... .....+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4566788999999999999975 2467899999875433 334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccC--------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC
Q 010131 269 VYEYMHNGTLRDRLHGSV--------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 334 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~ 334 (517)
||||+++++|.+++.... ....+++.++..++.|++.||+|||+ ++++|+||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999985321 12357889999999999999999999 9999999999999999999
Q ss_pred cEEEccccCccccCCCC-cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 010131 335 RAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 412 (517)
Q Consensus 335 ~~kl~Dfg~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 412 (517)
.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++ |..||..... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~---- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QE---- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HH----
Confidence 99999999998654322 112223335678999999988889999999999999999998 9999863221 11
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
+...+..+.... .....+..+.+++.+|++.+|++||++.+|.+.|+.
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 112222222111 011123467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=320.22 Aligned_cols=261 Identities=29% Similarity=0.443 Sum_probs=201.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-----CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 268 (517)
.+++.+.||+|+||.||+|..+ +++.||+|.+........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4556789999999999999753 578999999876655566789999999999999999999998753 346789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 99999999999998642 3468999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCccc--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc------c---ccHHHHHHHHH
Q 010131 349 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA------E---LNIVHWARSMI 417 (517)
Q Consensus 349 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~------~---~~~~~~~~~~~ 417 (517)
...... .....++..|+|||++.+..++.++||||||+++|||++|..|+....... . ..........+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 332211 111223446999999998899999999999999999999887764221100 0 00000111111
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..+.. .......+..+.+++.+||+.+|++|||++||++.|+.+
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11110 001112334688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=319.35 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=207.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+++.+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344456678899999999999998642 3679999987543 23446688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhcc-------------CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 264 HQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
+..+++|||+++|+|.++++.. .....+++..++.++.|++.||+|||+ .+++||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 9999999999999999998642 124568999999999999999999999 999999999999999
Q ss_pred CCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcccccc
Q 010131 331 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 408 (517)
Q Consensus 331 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~ 408 (517)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 99999999999999876443211 1122234678999999988899999999999999999998 999986332211
Q ss_pred HHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 409 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
....+..+... ..+......+.+++.+|++.+|++|||++|+++.|++++
T Consensus 243 ----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ----LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11222222111 111122346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=313.85 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=204.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
..++++.++||+|+||.||+|...+ ++.||+|++...... ..+.+.+|+.++..++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3467788999999999999998642 578999999755433 346688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~ 333 (517)
++++||+++++|.+++.... ....+++..+..++.|++.||+|||+ ++++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 99999999999999985321 12358888999999999999999999 999999999999999999
Q ss_pred CcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 010131 334 MRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 411 (517)
Q Consensus 334 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 411 (517)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QD 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HH
Confidence 9999999999886533221 11223345778999999988889999999999999999998 8888863221 11
Q ss_pred HHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 412 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 412 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
+ ...+..+.... .....+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 235 ~-~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 V-IEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 12222222211 112234468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.61 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=202.9
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 265 (517)
....+++.+.||+|+||.||+|.+. .+..||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456777899999999999999754 246799999864332 344578899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccCC-------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 266 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
.++||||+++++|.+++..... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999875321 2346788999999999999999999 99999999999999999999999
Q ss_pred ccccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 010131 339 SDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
+|||++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .+.. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~-~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVL-RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHH-HH
Confidence 9999987654322211 112235678999999998899999999999999999999 7888863321 1111 11
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
...+..... ....+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 222221111 11223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=312.31 Aligned_cols=254 Identities=27% Similarity=0.443 Sum_probs=202.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..++.+.+.||+|++|.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|||++++++++.. +..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 34567788999999999999998877789999876432 334678899999999999999999998754 5678999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999753 23458999999999999999999999 99999999999999999999999999999765433222
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||...+..++.++||||||+++|||+| |+.||...... ... ..+..+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~--------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVL----EQVERGYRM--------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCC---------
Confidence 2222335678999999988899999999999999999999 89998632211 111 112111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=312.30 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=196.6
Q ss_pred ccCCCCceEEEEEEec---CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 202 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+||+|+||.||+|.++ ++..+|+|+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999753 578899999864432 235678999999999999999999998864 4678999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc--
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-- 354 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 354 (517)
+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999973 4568999999999999999999999 999999999999999999999999999998764433211
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... .. ...+..+.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~i~~~~~~~~-------- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV----TQMIESGERMEC-------- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCCCCC--------
Confidence 112224578999999988889999999999999999998 99999732211 11 122232222111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+...+..+.+++.+|++.||++||++.+|.+.|++.
T Consensus 220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=310.95 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=206.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +++.+|||.+.... ......+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4567789999999999999864 78999999876432 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886432 34568999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...... .+..... +..
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~-----~~~ 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEQCDY-----PPL 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh-hhhcCCC-----CCC
Confidence 221 12335788999999998888999999999999999999999999633221 111111 1111111 111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
. .......+.+++.+|++.+|++||||.+|++.++++
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 112344688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=322.16 Aligned_cols=240 Identities=28% Similarity=0.382 Sum_probs=190.9
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999987532 22344566677777654 899999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999999873 4578999999999999999999999 999999999999999999999999999997643322 222
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.... +.... +. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~-i~~~~------~~----~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDS-ILNDR------PH----FP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHcCC------CC----CC
Confidence 344689999999999998999999999999999999999999974332 111111 11110 00 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 464 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl 464 (517)
......+.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11233577999999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.09 Aligned_cols=264 Identities=30% Similarity=0.499 Sum_probs=206.0
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCc--EEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCe
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 265 (517)
.+....+.+.+.||+|+||.||+|.++ ++. .+++|.+.... ......+.+|++++.++ +||||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 345556778899999999999999875 454 45777776433 23456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 266 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
.++|+||+++++|.++++... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecC
Confidence 999999999999999987432 12368899999999999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 010131 333 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 411 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 411 (517)
++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |..||...+.. +
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~ 231 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E 231 (303)
T ss_pred CCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------H
Confidence 99999999999864321111 111223567999999988889999999999999999998 99999633221 1
Q ss_pred HHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 412 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 412 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.. .....+.... ........+.+++.+|++.+|++||+++++++.|+++...+.
T Consensus 232 ~~-~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 LY-EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HH-HHHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11 1111111000 111123367899999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=329.71 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=194.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 268 (517)
|++.++||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999875 68999999987432 23345688999999999999999999987543 24799
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+. ++|.+++. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999995 68998887 34568999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCc--ccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH--------
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------- 416 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 416 (517)
.... .......|++.|+|||++.+ ..++.++|||||||++|||+||+.||...+... ....+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHH
Confidence 2211 11233468999999999865 678999999999999999999999997433211 01111100
Q ss_pred ---HhcCCccccc---CccccC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 417 ---IKKGDVISIV---DPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 417 ---~~~~~~~~~~---d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+........+ .+.... .........+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 000000 0000122357899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=319.30 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=192.9
Q ss_pred HHhhhcccCCCCceEEEEEEec--CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCCccccceeee-----cC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 263 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~ 263 (517)
.|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3566789999999999999863 468899999864322 2234566787777766 6999999999885 24
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
...++||||++ ++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 46899999996 6899988643 24568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc---C
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---G 420 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 420 (517)
+...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+...... .
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 9765433 12233458999999999988899999999999999999999999997433211 11111111100 0
Q ss_pred Ccc---cccCcccc--C-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVI---SIVDPVLI--G-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~---~~~d~~l~--~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ......+. . .........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 0 000112345779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=328.29 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=201.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 556789999999999999876 68999999987532 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999974 3678999999999999999999999 999999999999999999999999999998754432
Q ss_pred ---------------------------cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc
Q 010131 352 ---------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 404 (517)
Q Consensus 352 ---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~ 404 (517)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11123345899999999999999999999999999999999999999743311
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVLA 466 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~ 466 (517)
............... +. .......+.+++.+|++ +|.+||+ ++|+++.
T Consensus 237 ------~~~~~i~~~~~~~~~--p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ------ETYNKIINWKESLRF--PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------HHHHHHhccCCcccC--CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111111110000000 00 00123467899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=309.08 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=206.1
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+...++.+.++||+|+||.||+|.+.++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 445567788999999999999999887888999988753 3345678999999999999999999999887 67899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999753 24568899999999999999999999 999999999999999999999999999987654332
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
........++..|+|||++.+..++.++|+||||+++|+++| |+.||...+.. ... ..+..+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~~~------ 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALERGYRMP------ 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHhCCCCCC------
Confidence 222222335678999999998889999999999999999999 99999633211 111 1222221111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=289.24 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=205.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
..++++.||+|-||.||.|+.+ ++..||+|++.+.. ..-..++.+|+++-+.|+||||++++++|.+....|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 3456889999999999999876 57789999997542 2334689999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|..+|.+...|.+.. ...+++.....++.|+|.||.|+|. ++|+||||||+|+|++..+..|++|||-+.....
T Consensus 103 ya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-- 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 176 (281)
T ss_pred ecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence 999999999998542 5568888899999999999999999 9999999999999999999999999999876542
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
......+||..|.+||...+...+.+.|+|++|++.||++.|.+||.....++ ....+.. .++.+|
T Consensus 177 -~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k---~~~~~p--- 242 (281)
T KOG0580|consen 177 -NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRK---VDLKFP--- 242 (281)
T ss_pred -CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHH---ccccCC---
Confidence 23345679999999999999999999999999999999999999997433211 1111111 122222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........++|.+|+..+|.+|.+..||++.
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1222357899999999999999999999763
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.87 Aligned_cols=243 Identities=24% Similarity=0.349 Sum_probs=195.1
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||++... +|+.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++. ....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9999886 34578999999999999999999995 26999999999999999999999999999875432211 122
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .... .+..+.. .+ +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~-~i~~~~~------~~----p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFE-LILMEEI------RF----PR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHH-HHhcCCC------CC----CC
Confidence 345899999999999999999999999999999999999999743221 1111 1111110 01 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
.....+.+++.+||+.||++|+ +++++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1223578999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.65 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=207.3
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+....+.+.+.||+|+||.||+|..++++.||||.+.... ...+.+.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3445667789999999999999998888899999987543 345678999999999999999999999998889999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++... ....+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999753 23568999999999999999999999 999999999999999999999999999988765432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.........+..|+|||.+.+..++.++||||+|+++|++++ |+.||...... ...+ .+..+...
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~~------- 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE----QVERGYRM------- 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-------
Confidence 222222234568999999998899999999999999999999 99999632211 1111 11111000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
..+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=316.88 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=203.2
Q ss_pred hhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
++.+.||+|+||.||+|... ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45688999999999999763 235789998875443 34567899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccC---------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeE
Q 010131 271 EYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 329 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nil 329 (517)
||+.+++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 9999999999986421 12358899999999999999999999 99999999999999
Q ss_pred eCCCCcEEEccccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccc
Q 010131 330 LDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 407 (517)
Q Consensus 330 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~ 407 (517)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--- 236 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--- 236 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 9999999999999997653322211 122235678999999988889999999999999999999 99998633211
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+ ......+... ..+......+.+++.+|++.+|++||+++|+++.|+++..
T Consensus 237 ~~----~~~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RL----FNLLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HH----HHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 1222221110 1111223468899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.68 Aligned_cols=267 Identities=24% Similarity=0.443 Sum_probs=211.1
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
++....+.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 344566677899999999999999742 24579999987543 33456789999999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
......++||||+++|+|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence 99999999999999999999987532 12457889999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 245 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 245 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence 99999999999999999876443221 1222335678999999998889999999999999999998 7888863321
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
.+.. ..+..+.... ........+.+++.+||+.+|++|||+.|+++.|+++......
T Consensus 246 ----~~~~-~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 246 ----EELF-KLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ----HHHH-HHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 1111 2222221111 1112334688999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=326.17 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=202.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
...+|.++||+|.||.|+++..+ +++.+|||++++.. ..+.+..+.|..++... +||.++.++.+|++.++.++|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 34567899999999999999887 58899999998763 35567788899998877 599999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+.||++..+.+ ...+++..+.-++..|+.||+|||+ ++||+||||.+|||+|.+|++||+|||+++..-.
T Consensus 448 mey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999655543 5779999999999999999999999 9999999999999999999999999999987532
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
. ...+.+.+||+.|+|||++.+..|+.+.|-|||||+||||+.|..||.+++.++. ....+...
T Consensus 521 ~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~--------- 584 (694)
T KOG0694|consen 521 Q-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDE--------- 584 (694)
T ss_pred C-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCC---------
Confidence 2 2246778899999999999999999999999999999999999999985554321 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
..|+.....+..++++++|..+|++|..+
T Consensus 585 --~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 --VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12233344567899999999999999976
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=319.53 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=194.1
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345677899998876 799999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 999998873 4578999999999999999999999 9999999999999999999999999999875432221 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+. ........ .+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~-~~~~---~~p------- 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESIL-HDDV---LYP------- 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHH-cCCC---CCC-------
Confidence 334589999999999998999999999999999999999999974332 11112212 1111 001
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRP-------KMQEIVLA 466 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RP-------s~~evl~~ 466 (517)
......+.+++.+||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11123678999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=316.10 Aligned_cols=266 Identities=24% Similarity=0.429 Sum_probs=209.5
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
++....|.+.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344456778899999999999999753 23569999987543 33456788899999999 799999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
...+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+ .+++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence 999999999999999999999975321 2358999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.+||+|||.+......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 99999999999999998765432111 1111224568999999998889999999999999999998 8888863221
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+ +...+..+...+ .+......+.+++.+|++.+|++|||+.+|++.|+++.....
T Consensus 249 ----~~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 ----EE-LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ----HH-HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11 112222222111 111223478899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.57 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=192.6
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHH---hcCCCCCccccceeeecCCeeEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALL---SRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|.+++ +.++||||+++++++.+.+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45688999999999999876 68999999997532 22345566676655 5668999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|..++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 82 E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998875 3568999999999999999999999 99999999999999999999999999998754322
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. +...... .+.. .
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~-~~~~------~- 219 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIV-NDEV------R- 219 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC------C-
Confidence 1 1223456899999999999999999999999999999999999999743321 1111111 1111 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.+......+.+++.+||+.||.+|| +++++++
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111234678999999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=316.69 Aligned_cols=259 Identities=30% Similarity=0.492 Sum_probs=202.9
Q ss_pred HHhhhcccCCCCceEEEEEEecC-C--cEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-G--KEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.+.+.+.||+|+||.||+|...+ + ..+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35567899999999999998763 3 347888887432 33456789999999999 7999999999999999999999
Q ss_pred EecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 271 EYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 9999999999996432 12358899999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
|+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||...... +... .
T Consensus 160 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~-~ 230 (297)
T cd05089 160 IADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYE-K 230 (297)
T ss_pred ECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHH-H
Confidence 999999864322111 111123457999999988889999999999999999998 99999633221 1111 1
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
+..+... ..+......+.+++.+|++.+|.+||++.++++.|+++.....
T Consensus 231 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 LPQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111110 0111123468899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=320.56 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=195.0
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999997542 22345688899999888 699999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++. ....+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 99998886 34579999999999999999999999 9999999999999999999999999999875322111 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............++....+...... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CC
Confidence 33568999999999999999999999999999999999999997433322223333333333322111 01
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
......+.+++.+||+.||++||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11123577999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.37 Aligned_cols=250 Identities=30% Similarity=0.505 Sum_probs=205.1
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45667889999999999999886 88999999976544 56789999999999999999999999998889999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999999743 23368999999999999999999999 9999999999999999999999999999987643222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....+..|+|||++.+..++.++||||||+++||+++ |..||...... . .......+....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~~~~--------- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---D----VVPHVEKGYRME--------- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHhcCCCCC---------
Confidence 2224568999999988889999999999999999997 99998633211 1 112222211111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.....+..+.+++.+||..+|++|||+.|++++|+++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1112235788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=309.71 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=200.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+++.+.||+|+||+||+|.+. +++ .|++|.+..... .....+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 34556789999999999999874 344 477887754332 234567888889999999999999998864 45789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999742 4568999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC--
Confidence 3222 11223446778999999998899999999999999999998 99999633211 1122233332211
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+.. ....+.+++.+|+..+|++|||+.|+++.|+.+..
T Consensus 232 ~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 12357789999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=315.31 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=207.8
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC-----CcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeec-CCe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQ 265 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 265 (517)
...++.+.+.||+|+||.||+|.+.+ +..|++|.+.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34566778899999999999998875 6889999987543 3345678899999999999999999998765 567
Q ss_pred eEEEEEecCCCCHHhHhhccCCC-----CccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 340 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 340 (517)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 568999999999999999999999 9999999999999999999999999
Q ss_pred ccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHh
Q 010131 341 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 341 fg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||...+. ..+.. .+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAA----YLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHH----HHH
Confidence 9999865432221 1222335678999999998889999999999999999999 9999963221 11111 222
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+.... .....+..+.+++.+|++.+|++|||+.|+++.|+++.+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 221100 011123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=324.22 Aligned_cols=250 Identities=21% Similarity=0.268 Sum_probs=199.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||+||+|... +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456789999999999999876 689999999875322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999743 3578999999999999999999999 9999999999999999999999999999987654433
Q ss_pred ccccccccCCCCcCCCccC------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 353 HISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .................
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRFLKFP 231 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCccCCC
Confidence 3333346899999999986 45678899999999999999999999973322 11122222211111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+ .......+.+++..|++ +|.+||+++++++
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1 11123457889999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=319.16 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=190.9
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999876 58899999987532 23445677888888876 699999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 999998873 4578999999999999999999999 9999999999999999999999999999875432211 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.... +..+... . +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~-i~~~~~~---~-------~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEA-ILNDEVV---Y-------P 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHH-HhcCCCC---C-------C
Confidence 334589999999999998999999999999999999999999974332 111111 2211110 0 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
......+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123367899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=312.37 Aligned_cols=246 Identities=23% Similarity=0.296 Sum_probs=194.9
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||+|+||+||++... +++.||+|.+..... ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 688999999864322 2235678899999999999999999999999999999999999999
Q ss_pred HhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccc
Q 010131 279 RDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 357 (517)
Q Consensus 279 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 357 (517)
.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98875322 34578999999999999999999999 99999999999999999999999999999765443221 223
Q ss_pred cccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHH
Q 010131 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437 (517)
Q Consensus 358 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 437 (517)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ....... ....+.. ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~-~~~~~~~----------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQ-RILNDSV----------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHH-hhcccCC----------CCccc
Confidence 458899999999999999999999999999999999999997432211 1111111 1111100 11122
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 438 SIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 438 ~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
....+.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 344688999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=314.37 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=202.1
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC---------------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCcccc
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD---------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPL 256 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~ 256 (517)
....|++.+.||+|+||.||++.... ...||+|.++.... .....|.+|++++++++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34567788999999999999987642 23589999876433 344679999999999999999999
Q ss_pred ceeeecCCeeEEEEEecCCCCHHhHhhccC---------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV---------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 257 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999986432 11247889999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCCCCCCCCcc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 404 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~ 404 (517)
|+++.++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876533221 11222335678999999988889999999999999999998 56677532211
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
................... ......+..+.+++.+|++.+|++|||+.+|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111111100000 0111123478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=308.95 Aligned_cols=261 Identities=24% Similarity=0.321 Sum_probs=197.5
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC-----eeEEEEEec
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYEYM 273 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~ 273 (517)
.+++|.|+||.||+|... +++.||||+.-.... .-.+|+++|++++|||||+++-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999876 578999998764432 2246999999999999999998885432 335899999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCCCC
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~ 351 (517)
+. +|.+.++... .+..++...+.-+..||++||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 65 8888887432 35678888889999999999999999 999999999999999977 999999999999886655
Q ss_pred cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH-------Hhc--CC
Q 010131 352 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------IKK--GD 421 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~--~~ 421 (517)
...+ ...+..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+++..+. +++.++-. +.. ..
T Consensus 181 pniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 181 PNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred Ccee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCcc
Confidence 4433 345889999998866 5799999999999999999999999986554322 22222111 110 11
Q ss_pred cccccCccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 010131 422 VISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 472 (517)
Q Consensus 422 ~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~ 472 (517)
..+...|.+... .......+..+++.++|+.+|.+|.++.|++.. ++.+..
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 112222222211 223345578899999999999999999999863 444443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=315.90 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=203.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+.+.++||+|+||.||++... ++..+++|.+..........+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34556789999999999999642 356899999876666666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCC------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcE
Q 010131 269 VYEYMHNGTLRDRLHGSVN------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 336 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~ 336 (517)
+|||+++++|.+++..... ...+++..++.++.|++.|++|||+ .+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875321 1358899999999999999999999 999999999999999999999
Q ss_pred EEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 010131 337 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 337 kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 414 (517)
||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... . ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---A---IE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---H---HH
Confidence 9999999876533221 11222335678999999998899999999999999999998 899986322111 1 11
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
....+..... +...+..+.+++.+||+.||++||++.||++.|+.
T Consensus 236 -~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 -CITQGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -HHHcCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1111111110 11123467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=324.09 Aligned_cols=263 Identities=26% Similarity=0.431 Sum_probs=206.7
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCCccccceeeec
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 262 (517)
++....+.+.++||+|+||.||+|++. .++.||+|++..... ...+.+.+|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 455556667899999999999999864 246899999975433 33457889999999997 9999999999999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccC--------------------------------------------------------
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 286 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 286 (517)
.+..++|+||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred ---------------------------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 287 ---------------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 287 ---------------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
....+++..+..++.|++.||+|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 11246778889999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~- 348 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN- 348 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-
Confidence 9999999999999999986533221 11122346788999999998889999999999999999998 88998632211
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
+.....+..+.... .+......+.+++.+||..+|++||+++||++.|++++
T Consensus 349 -----~~~~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 -----EQFYNAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -----HHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11112222221111 01112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.77 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=196.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 456789999999999999876 68999999997432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 83 LPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999873 4578999999999999999999999 9999999999999999999999999999875432110
Q ss_pred c-------------------------------------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCC
Q 010131 353 H-------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 395 (517)
Q Consensus 353 ~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~ 395 (517)
. ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235899999999999989999999999999999999999
Q ss_pred CCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 010131 396 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 465 (517)
Q Consensus 396 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 465 (517)
.||...+. .+...............+ .......+.+++.+|+. +|.+|++ ++|+++
T Consensus 237 ~Pf~~~~~------~~~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNP------QETYRKIINWKETLQFPD-------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCH------HHHHHHHHcCCCccCCCC-------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99974332 111111111111001000 00112356788999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.80 Aligned_cols=262 Identities=23% Similarity=0.403 Sum_probs=203.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-----CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC--Ce
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 265 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 265 (517)
..++.+.+.||+|+||.||++.+. ++..||+|.+.... ......+.+|++++++++|||++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345677889999999999999742 47889999987543 33346799999999999999999999998775 56
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 78999999999999998642 3468999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHH
Q 010131 346 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWAR 414 (517)
Q Consensus 346 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~---------~~~~~~~~~~ 414 (517)
........ ......++..|+|||.+.+..++.++||||||+++|||+|++.|....... ...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHH
Confidence 76433221 112334667899999998888999999999999999999988765321100 001111 111
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..+..+.... ........+.+++.+|++.+|++|||++++++.|+.+
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1222221111 1112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.73 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=200.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|+..++||+|+||.||++... +++.||+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 456788999999999999875 689999999865321 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999888643 23568999999999999999999999 9999999999999999999999999999887543222
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..+.+...+.... .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ----------E 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc----------c
Confidence 122357899999999998899999999999999999999999997433211 1111112221111 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
.+.......+.+++.+|++.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11222344678999999999999999 78887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=308.61 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=206.1
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
...++.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34456678899999999999998653 2468999887654 3445689999999999999999999999876 4578
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999743 3468999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
............++..|+|||.+....++.++||||||+++||+++ |..||......+ .. ..+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~----~~~~~~~~~~~- 229 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VI----GRIENGERLPM- 229 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HH----HHHHcCCcCCC-
Confidence 5433222223334568999999988889999999999999999986 999997433211 11 11222211111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
....+..+.+++.+|+..+|++|||+.++++.|+++...+
T Consensus 230 --------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 230 --------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1122346889999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=324.80 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=198.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
...|++.+.||+|+||.||+|... +++.||+|++.+. .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 345677889999999999999886 5889999998642 122345688999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999863 358889999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcccccccccCCCCcCCCccCCC----CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
..........||+.|+|||++.+. .++.++||||+||++|||++|+.||...+. ...............+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~ 268 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSLNF 268 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcccCC
Confidence 332223345689999999998653 378899999999999999999999974332 1112222221111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
.+ .......+.+++.+|+..++.+ ||++.|+++.
T Consensus 269 p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11 1112335778899999855543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=308.22 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=198.0
Q ss_pred hhcccCCCCceEEEEEEecC-Cc--EEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------CeeE
Q 010131 199 FCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 267 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 267 (517)
+.+.||+|+||.||+|.+.+ +. .||+|.++... ....+.+.+|+++++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 46789999999999998764 32 68999886542 33456789999999999999999999987432 2468
Q ss_pred EEEEecCCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 268 LVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
+++||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874321 23458999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 345 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 345 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
+......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .. ....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~----~~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SE----IYDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHHHHHcCCC
Confidence 8764332211 122235678999999999899999999999999999999 8889863221 11 1222333322
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
... ....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 233 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=312.65 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=203.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CC---cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..++..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+.+|++++++++|||++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 34556789999999999999875 33 379999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998742 3568999999999999999999999 9999999999999999999999999999876643
Q ss_pred CCcccc--cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 350 DLTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 350 ~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
...... .....+..|+|||++.+..++.++|||||||++|||++ |+.||..... .+... .+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~-~i~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMK-AINDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHH-HHhcCCCC---
Confidence 222111 11223457999999988889999999999999999998 9999963321 11111 22221110
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
......+..+.+++.+|++.+|++||++.+|++.|++++
T Consensus 230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 011123356889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=309.29 Aligned_cols=247 Identities=25% Similarity=0.446 Sum_probs=196.1
Q ss_pred ccCCCCceEEEEEEec---CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 202 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 355799999876533 234678999999999999999999998864 46899999999999
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc--
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-- 355 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-- 355 (517)
|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998742 4578999999999999999999999 9999999999999999999999999999976543322111
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... . +...+..+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~---------~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------E-VMSFIEQGKRLD---------C 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------H-HHHHHHCCCCCC---------C
Confidence 11223568999999988889999999999999999996 99999733211 1 112222222111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122345788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.14 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=203.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|++|.||+|... +++.|++|.+... .....+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345688999999999999876 6899999998643 2345677899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 82 ENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999999854 24678999999999999999999999 99999999999999999999999999998876543221
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||...+. .. .......+....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~~--------- 220 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GA-LILKIIRGVFPP--------- 220 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHHHcCCCCC---------
Confidence 2233578899999999998999999999999999999999999974331 11 111122222111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 11123346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=310.81 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=201.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 446778899999999999999874 6889999998765445556788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.++++. ...+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999999873 4578999999999999999999999 9999999999999999999999999999986643221
Q ss_pred ccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
......++..|+|||.+. ...++.++|||||||++|||++|+.||......... . .+.... ...+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~-----~~~~~~---~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F-----LMSKSN---FQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--e-----eeecCC---CCCCC
Confidence 112335788999999874 445788999999999999999999998632211100 0 000000 00011
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... .......+.+++.+||+.+|++|||++++++.
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Ccc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 100 11223468899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=311.07 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=194.4
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||+|+||.||++..+ +|+.||+|.+.... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 58999999986432 12234566799999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9888643 24468999999999999999999999 9999999999999999999999999999887654322 1234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...... ....+....... .... .. ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~-~~--------~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE-DEVK-FE--------HQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc-cccc-cc--------cccC
Confidence 5789999999999888999999999999999999999999632211 111111111111 1110 00 0112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
...+.+++.+||+.||++||+++|+++.+
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 33578999999999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.09 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=206.0
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+.+.+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34456677899999999999999742 35579999987543 33456789999999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
+..++||||+++|+|.++++... ...+++.++..++.|++.||+|||+ ++++|+||||+||+++.++.++++|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999997432 3348999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 344 SRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 344 a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
+......... ......++..|+|||.+.+..++.++||||+||++|||++ |+.||....... . .......+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~----~~~~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--K----FYKLIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--H----HHHHHHcCC
Confidence 9865433221 1122335678999999998899999999999999999998 999986332211 1 111222221
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
... ........+.+++.+|++.+|++|||+.|+++.|++.
T Consensus 262 ~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 100 0111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=295.33 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=201.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecC--CCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
...|.+.++||+|.|+.||+.... +|+.+|+|++.- -...+.+.+.+|+.+.+.|+||||+++.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 345677889999999999999765 689999998753 23446788999999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~ 347 (517)
|+|.|++|..-+-. ...+++..+-..++||++||.|+|. ++|||||+||+|+++.. ..-+||+|||+|...
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999999765542 3457788888999999999999999 99999999999999954 345999999999988
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
..+ .......|||+|||||+++..+++..+|||+.||+||-|+.|.+||.+++.. .+.+.+..+.+. ++
T Consensus 164 ~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd--~~ 232 (355)
T KOG0033|consen 164 NDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYD--YP 232 (355)
T ss_pred CCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccC--CC
Confidence 732 3344567999999999999999999999999999999999999999853321 122233333221 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.-... ......+|+++||..||.+|.|+.|.++
T Consensus 233 ~~~w~~----is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDT----VTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCc----CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111111 1224568999999999999999998764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=325.71 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=193.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 445788999999999999875 68899999996532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999873 4568899999999999999999999 9999999999999999999999999999754311000
Q ss_pred ----------------------------------------------ccccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 353 ----------------------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 353 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012246899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHH--hhccCCCCCCCHHHHH
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ--CVEQRGFSRPKMQEIV 464 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~~P~~RPs~~evl 464 (517)
++|||+||+.||...+... ................ .......+.+++.+ |+..+|..||+++|++
T Consensus 237 il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~~~-------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTE------TQLKVINWENTLHIPP-------QVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHH------HHHHHHccccccCCCC-------CCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999997433211 1111111111001000 00112356677777 4566666799999998
Q ss_pred HH
Q 010131 465 LA 466 (517)
Q Consensus 465 ~~ 466 (517)
+.
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=319.35 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=191.8
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +++.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987542 23345567788888764 899999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++.++..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999873 4568999999999999999999999 9999999999999999999999999999875322111 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +... .+..+. +.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~-~i~~~~------~~~----~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQ-SIRMDN------PCY----P 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHhCC------CCC----C
Confidence 2345899999999999989999999999999999999999999743321 1111 111111 111 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl~ 465 (517)
......+.+++.+||+.||++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11223578999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=306.33 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=208.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3566789999999999999887 78999999886321 2235678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+++++|.+++.... ....+++.+++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999886532 34568999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+... .+..+......
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~~---- 229 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEKCDYPPLP---- 229 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHh-hhhcCCCCCCC----
Confidence 211 1223478899999999988899999999999999999999999963321 1212111 11112111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.......+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 230 ----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1133447889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.59 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=200.1
Q ss_pred hhhcccCCCCceEEEEEEecC----CcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCe------
Q 010131 198 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 265 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 265 (517)
.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356889999999999998752 3679999987532 2334678999999999999999999998866544
Q ss_pred eEEEEEecCCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 266 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
.++++||+++|+|..++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 789999999999999885432 23468999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 343 LSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 343 ~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.. ..+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~-~~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIY-DYLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHHcC
Confidence 998754332211 112234678999999988899999999999999999999 8888863221 1111 122222
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..... .......+.+++.+||+.||++|||+.||++.|+++
T Consensus 232 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21111 112334788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=322.78 Aligned_cols=238 Identities=25% Similarity=0.350 Sum_probs=192.6
Q ss_pred cccCCCCceEEEEEEe----cCCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578999999875322 233557789999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~ 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence 9999999863 4578999999999999999999999 9999999999999999999999999999876543322 1
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+. .+...... .... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~-~~~~----------~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMIL-KAKL----------GM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHH-cCCC----------CC
Confidence 2234589999999999988899999999999999999999999974321 11111111 1111 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQE 462 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~e 462 (517)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112336789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=317.16 Aligned_cols=240 Identities=26% Similarity=0.371 Sum_probs=191.5
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +|+.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 58899999987532 23345567788888765 899999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ce
Confidence 999998873 4578999999999999999999999 9999999999999999999999999999875322111 22
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. +.. ..+..+. +.+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~-~~~~~~~------~~~~~--- 217 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELF-ESIRVDT------PHYPR--- 217 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCC------CCCCC---
Confidence 3355899999999999999999999999999999999999999743321 111 1111111 11111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 464 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl 464 (517)
.....+.+++.+||+.||++||++. +++
T Consensus 218 -~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 -WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1223578999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.97 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=200.1
Q ss_pred HHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..+.+.+.||+|++|.||+|.+.+ +..|++|.+..... .....|.+|+.++++++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 445667899999999999998753 56789998865433 33457899999999999999999999999888999
Q ss_pred EEEEecCCCCHHhHhhccCC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC---cEEEcc
Q 010131 268 LVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSD 340 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~D 340 (517)
+||||+++++|.+++..... ...+++..++.++.||+.||+|||+ ++++|+||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999875431 2358999999999999999999999 9999999999999998754 599999
Q ss_pred ccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHh
Q 010131 341 FGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 341 fg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||....... . . ..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~---~-~~~~ 235 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V---M-EFVT 235 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---H-HHHH
Confidence 99998763322111 112223568999999998899999999999999999997 999997433211 1 1 1111
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..... ..+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111 111122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=309.39 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=206.0
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
+....+.+.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 445567778999999999999998752 36899999865432 34567889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCC-------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 99999999999999999875321 2347889999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 415 (517)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |+.||...+.. ... .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~----~ 232 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVL----K 232 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHH----H
Confidence 999999876543221 11223346788999999988889999999999999999998 99998632221 111 1
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.+..+...... ...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 233 ~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVIDGGHLDLP---------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHhcCCCCCCC---------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 22222211111 1124578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=319.54 Aligned_cols=241 Identities=26% Similarity=0.352 Sum_probs=194.3
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||+||+|... +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999987532 23345677899999888 799999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999998873 4579999999999999999999999 9999999999999999999999999999875322211 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+. .+... .+..... . .+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~-~i~~~~~------~----~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQ-SILEDEV------R----YP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHH-HHHcCCC------C----CC
Confidence 234589999999999999999999999999999999999999974321 11111 1111111 0 01
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 465 (517)
......+.+++.+||+.||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1123467899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=310.50 Aligned_cols=255 Identities=28% Similarity=0.511 Sum_probs=203.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..+++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667889999999999999864 23479999886543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999743 3568999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCccccc--ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 350 DLTHISS--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 350 ~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
....... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||...+.. .... .+.++...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~~--- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIK----AIEEGYRL--- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHH----HHhCCCcC---
Confidence 3322111 1123467999999998899999999999999999887 99999633221 1111 12211100
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+ .....+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 229 -~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=320.39 Aligned_cols=240 Identities=25% Similarity=0.343 Sum_probs=191.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCC-CCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 271 (517)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..++| ++|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456789999999999999876 57899999987532 2345678889999999976 468889999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999873 4568999999999999999999999 999999999999999999999999999987532211
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+.. +.... +..... .
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~-i~~~~~------~-- 219 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQS-IMEHNV------S-- 219 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHH-HHcCCC------C--
Confidence 1 123345899999999999999999999999999999999999999743321 11111 111111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
.+......+.+++.+||+.||.+||+.
T Consensus 220 --~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 --YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011122357899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.10 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=196.0
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC-----eeEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILV 269 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 269 (517)
++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 34688999999999999875 78999999986532 234467889999999999999999999998766 78999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
+||+. ++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 83 TELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99996 67888776 35679999999999999999999999 9999999999999999999999999999986543
Q ss_pred CCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHH----------------H
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH----------------W 412 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~----------------~ 412 (517)
..........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+......... .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 332223334578899999998764 57899999999999999999999997443221100000 0
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....+.......-..+.+ ..........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000010000000000000 00011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=307.69 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=197.7
Q ss_pred cccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+++++.++||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999997642 26899999875543 345678999999999999999999998764 467999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 3478999999999999999999999 9999999999999999999999999999987644332211
Q ss_pred c--ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 356 S--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 356 ~--~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |..||...+. ..... .+..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~----~~~~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIA----MLESGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHH----HHHcCCcCC--------
Confidence 1 1223467999999998899999999999999999998 9999963321 11222 222221111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.....+..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11122346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.92 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=196.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 456788999999999999864 68899999986543 3345678999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|..+. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99996542 46788899999999999999999 999999999999999999999999999997654322
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||........ ......... +..... +.+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~-- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDEDP-----PVLP-- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccCC-----CCCC--
Confidence 2234588999999999988999999999999999999999999963222111 111111111 111110 1110
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01122357899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.64 Aligned_cols=264 Identities=27% Similarity=0.444 Sum_probs=204.4
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe------cCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+...++++.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4456788899999999999999974 2478899999975432 3346788999999999 689999999988654
Q ss_pred -CeeEEEEEecCCCCHHhHhhccCC-------------------------------------------------------
Q 010131 264 -HQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 287 (517)
Q Consensus 264 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 287 (517)
...++||||+++|+|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999864210
Q ss_pred ---------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc-cccc
Q 010131 288 ---------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSV 357 (517)
Q Consensus 288 ---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 357 (517)
...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1246888899999999999999999 99999999999999999999999999998765332211 1122
Q ss_pred cccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 358 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 358 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ....+..+..... +.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~--~~------- 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMRA--PD------- 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H----HHHHHhccCCCCC--CC-------
Confidence 335678999999988899999999999999999997 999986332211 1 1122222221111 10
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.....+.+++.+||+.+|++|||+.||++.|+.+.+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0123578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=309.17 Aligned_cols=250 Identities=30% Similarity=0.513 Sum_probs=196.7
Q ss_pred cccCCCCceEEEEEEecC-Cc--EEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|.+.+ +. .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998763 43 46888887533 33456788999999999 799999999999999999999999999
Q ss_pred CCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 276 GTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 276 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
|+|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987432 12357899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
++........ ......+..|+|||++.+..++.++||||||+++|||++ |..||...+.. ... ..+..+.
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~-~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY-EKLPQGY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHH-HHHhCCC
Confidence 9864321111 111223567999999988889999999999999999997 99999633221 111 1111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
..+ ........+.+++.+|++.+|.+|||+.|+++.|+++.
T Consensus 229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 11112346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=313.78 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=201.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+|.+.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 5566788999999999999864 688999999876655566788999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++. ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 101 ~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 101 GGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 999999986 3457899999999999999999999 99999999999999999999999999998765432211
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ........+ ... + ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~-~~~-----~--~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPE-----L--QN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC-CCC-----C--CC
Confidence 123357889999999998889999999999999999999999997332211 111111111 000 0 01
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||..+|++||++.|+++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1223346789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=322.40 Aligned_cols=199 Identities=25% Similarity=0.396 Sum_probs=172.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++.+++||||+++++++.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 456789999999999999876 58899999997532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 83 LPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999973 5679999999999999999999999 9999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCC
Q 010131 353 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 398 (517)
Q Consensus 353 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~ 398 (517)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346899999999999999999999999999999999999999
Q ss_pred CCC
Q 010131 399 SVE 401 (517)
Q Consensus 399 ~~~ 401 (517)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=308.76 Aligned_cols=251 Identities=29% Similarity=0.512 Sum_probs=202.1
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+++.+.||+|+||.||+|.+.+++.+|+|.+.... .....+.+|++++++++|||++++++++......++|+||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 456678999999999999988778899999886542 2346789999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++... ...+++..++.++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||.+...........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999998742 3468899999999999999999999 9999999999999999999999999999876543322212
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .+..+. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVE-TINAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHH-HHhCCC--CCCCCCC----
Confidence 22234578999999998899999999999999999998 9999863221 11111 122111 1111211
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2346889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=302.87 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=199.8
Q ss_pred cccCCCCceEEEEEEecC--C--cEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 3 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc--
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 353 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 353 (517)
++|.+++..... ..+++..++.++.|++.||+|||+ ++++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999975422 578999999999999999999999 99999999999999999999999999999876442211
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.............
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCcCC--------
Confidence 1112346778999999998899999999999999999999 9999963221 111111111111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.....+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=317.38 Aligned_cols=237 Identities=29% Similarity=0.388 Sum_probs=189.0
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||+||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999876 68999999986432 122344555555 56788999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99999887 35578999999999999999999999 999999999999999999999999999987542221 122
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +.. .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~-~~~------~~~~--- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILN-KPL------RLKP--- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHc-CCC------CCCC---
Confidence 334589999999999999999999999999999999999999974322 121222221 111 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
.....+.+++.+||+.||.+||++.
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=312.43 Aligned_cols=264 Identities=29% Similarity=0.445 Sum_probs=204.4
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC-----------------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccc
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 255 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 255 (517)
...+++.+.||+|+||.||+|...+ +..||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3456778999999999999997652 24689999875533 34567899999999999999999
Q ss_pred cceeeecCCeeEEEEEecCCCCHHhHhhccC--------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 256 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
+++++..++..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999987532 12368999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCCCCCCCCcc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 404 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~ 404 (517)
|+++.++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876533221 12223345778999999988889999999999999999998 6777753221
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
......+............. ......+..+.+++.+|++.||++|||+.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11122222111111111111 1111223478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.35 Aligned_cols=264 Identities=25% Similarity=0.438 Sum_probs=207.3
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeee
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCE 261 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 261 (517)
+....+.+.++||+|+||.||+|... ....||+|.+.... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34456667899999999999999752 24579999987543 23456788999999999 6999999999999
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCe
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 328 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Ni 328 (517)
..+..++||||+++|+|.+++.... ....+++.++..++.|++.||.|||+ ++++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence 9889999999999999999997532 12458999999999999999999999 9999999999999
Q ss_pred EeCCCCcEEEccccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcccc
Q 010131 329 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 406 (517)
Q Consensus 329 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 406 (517)
+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999998654322111 111224467999999998899999999999999999999 88888633211
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+ +...+..+..... ....+..+.+++.+|++.+|++|||+.|+++.|+++....
T Consensus 244 ----~-~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 ----E-LFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ----H-HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1 1122222221111 1122346789999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=305.28 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=198.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999876 4778899998765555667889999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|..++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~ 160 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 160 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-cc
Confidence 999988764 24578999999999999999999999 9999999999999999999999999999876543221 12
Q ss_pred cccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 356 SVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
....++..|+|||++. +..++.++|||||||++|||++|+.||...+. .+....... ........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~--- 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK-SEPPTLAQ--- 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhh-cCCCCCCC---
Confidence 2345788999999973 44577899999999999999999999963221 111111111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.+|.+||++.++++
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 ----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346889999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=310.87 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=202.4
Q ss_pred HHHhhhcccCCCCceEEEEEEecC-C---cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..+++.+.||+|+||.||+|.+.. + ..||||.+.... ......|..|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346678899999999999998753 3 369999987543 33456899999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998753 3568999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccc--ccccc--cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 350 DLTHI--SSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 350 ~~~~~--~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
..... ..... .+..|+|||++.+..++.++|||||||++||+++ |..||...+.. ....++ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~~~- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDYRL- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCcC-
Confidence 22111 11111 2347999999999999999999999999999887 99999633211 122211 111100
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
....+.+..+.+++.+|++.+|++||++.+|+..|+++
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=305.74 Aligned_cols=260 Identities=23% Similarity=0.350 Sum_probs=198.8
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeec-----CCeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e 271 (517)
.+.||+|+||.|+.|..+ +|+.||||++.+. .....++-.+|+++|+.++|+||+.+++.+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999876 7899999998743 23455778899999999999999999998755 346899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC-
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED- 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~- 350 (517)
+| +.+|...++ .+..++...+.-++.|+++||.|+|+ .+|+||||||+|++++.+...||+|||+|+.....
T Consensus 107 lM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 679999998 45569999999999999999999999 99999999999999999999999999999987543
Q ss_pred CcccccccccCCCCcCCCcc-CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHHhcCC
Q 010131 351 LTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKGD 421 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 421 (517)
.....+....|..|.|||++ ....|+.+.||||.||++.||++|++-|.+.+.-....++.... ..+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 11223445689999999986 45689999999999999999999999998665432222211110 0111000
Q ss_pred cccccCc--ccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 422 VISIVDP--VLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 422 ~~~~~d~--~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....+.. ... ...-+......++|+.+||..||.+|+|++|.++.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0001100 000 00001122246799999999999999999999874
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=313.98 Aligned_cols=266 Identities=26% Similarity=0.452 Sum_probs=210.1
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC--------CcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
++...++.+.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+++++++ +||||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 5566678889999999999999997531 2368999887543 23456889999999999 799999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
...+..++++||+++|+|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 99999999999999999999987532 23458889999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999998654322111 112224567999999999999999999999999999998 8888863321
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+.. ..+..+..... .......+.+++.+|++.+|++||++.|+++.|+++.....
T Consensus 243 ----~~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 ----EELF-KLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ----HHHH-HHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1111 12222211111 11223468899999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=324.21 Aligned_cols=250 Identities=25% Similarity=0.325 Sum_probs=194.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 456789999999999999875 68999999986432 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 83 LPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999987 34678899999999999999999999 9999999999999999999999999999864321000
Q ss_pred ------------c----------------------------------cccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 353 ------------H----------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 353 ------------~----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001235899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHH
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEI 463 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~ev 463 (517)
++|||+||+.||...+.. +.............+.+. ......+.+++.+|+. +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSH------ETYRKIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHH------HHHHHHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999743321 111111111111111110 0112357799999997 67665 599998
Q ss_pred HHH
Q 010131 464 VLA 466 (517)
Q Consensus 464 l~~ 466 (517)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.51 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=200.2
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeee-cCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 273 (517)
..+.+.+.||+|+||.||+|... |..||+|.+... ...+.+.+|+.++++++|+|++++++++. .++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 45667889999999999999876 888999998643 23467899999999999999999999754 556789999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998753 23458899999999999999999999 999999999999999999999999999987653322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.. ..+..+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~-~~~~~~~~~~-------- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVV-PRVEKGYKMD-------- 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHhcCCCCC--------
Confidence 12234568999999998899999999999999999998 9999863321 1111 1122221111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.....+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112344688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.41 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=204.4
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
+...+|.+.++||+|+||.||+|..++ +..||+|.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 344567788999999999999997542 45899998865432 23456889999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccC-------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 265 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
..++||||+++|+|.+++.... .....++..+..++.|++.||.|||+ ++++||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999997532 12345778889999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 415 (517)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+. .+...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~- 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLK- 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH-
Confidence 9999998765332211 1122234678999999998899999999999999999998 7888863221 11111
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.+..+..... .......+.+++.+|++.+|++|||+.++++.|++.+
T Consensus 233 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1212211111 1112347889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=303.59 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=199.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-----hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-----HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
+...+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 455789999999999999865 689999999864321 12356889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999873 4568899999999999999999999 99999999999999999999999999998765432
Q ss_pred Ccccc--cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 351 LTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 351 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
..... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...+.. ............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~------ 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN------ 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC------
Confidence 21111 2344778999999999988999999999999999999999999632211 111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+......+.+++.+||..+|.+|||+.|+++.
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112233467899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.20 Aligned_cols=264 Identities=24% Similarity=0.403 Sum_probs=202.3
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-----------------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccc
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-----------------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 255 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 255 (517)
...+.+.+.||+|+||.||++... ++..||+|++..... ....++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345677899999999999998543 234689999875433 34567999999999999999999
Q ss_pred cceeeecCCeeEEEEEecCCCCHHhHhhccC--------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 256 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
+++++...+..++||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999987532 12347888999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh--CCCCCCCCCcc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 404 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt--g~~p~~~~~~~ 404 (517)
|+++.++.++|+|||++......... ......++..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998865432211 1122234678999999888889999999999999999998 77888633221
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
................... + .....+..+.+++.+||+.||.+||++.||++.|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 ---QVIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111110000 0 011233578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=304.56 Aligned_cols=247 Identities=33% Similarity=0.497 Sum_probs=199.6
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
++||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4568999999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc-ccc
Q 010131 280 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVA 358 (517)
Q Consensus 280 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~ 358 (517)
+++... ...+++..+..++.+++.||+|||+ .+++||||+|+||+++.++.++|+|||.+........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998643 3468899999999999999999999 9999999999999999999999999999886543221111 112
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 437 (517)
..+..|+|||.+.+..++.++||||||+++|||+| |..||....... ....+..+... ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGYRM---------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCCCC---------CCCcc
Confidence 23567999999988899999999999999999999 888886332211 11112111100 01112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 438 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.+..+.+++.+|++.+|++|||+.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2347889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=318.84 Aligned_cols=240 Identities=26% Similarity=0.348 Sum_probs=192.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 271 (517)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456788999999999999876 57899999987542 22334567788888877 58999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 82 YVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998873 4568999999999999999999999 999999999999999999999999999987543221
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. ..... +.....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~-i~~~~~--------- 218 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQS-IMEHNV--------- 218 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCC---------
Confidence 1 123345899999999999999999999999999999999999999743221 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
..+......+.+++.+|++.+|++|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0111223467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.63 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=198.4
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
....|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3456777899999999999999886 58899999986421 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 121 VMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999863 357888899999999999999999 999999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCcCCCccCCC----CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||...+. ...............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~ 267 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSLT 267 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCccc
Confidence 4333233345689999999998653 378899999999999999999999974332 111222222111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
..+. ......+.+++.+|+..++.+ ||+++|+++.
T Consensus 268 ~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 268 FPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111 112335778999999844433 7789888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.92 Aligned_cols=249 Identities=33% Similarity=0.537 Sum_probs=203.1
Q ss_pred cccCCCCceEEEEEEecC----CcEEEEEEecCCCchh-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|.... +..|++|.+....... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 7889999997654433 67899999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCC------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 276 GTLRDRLHGSVN------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 276 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
++|.+++..... ...+++..++.++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999985421 3779999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+. ... ...+..+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEV----LEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHHcCCCCC---
Confidence 321 11223446789999999988889999999999999999999 6999974321 111 12222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=324.92 Aligned_cols=250 Identities=22% Similarity=0.280 Sum_probs=194.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456789999999999999875 58999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999973 4568899999999999999999999 999999999999999999999999999975321000
Q ss_pred -----------------------------------------cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHH
Q 010131 352 -----------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 390 (517)
Q Consensus 352 -----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 390 (517)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 010131 391 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP---KMQEIVLA 466 (517)
Q Consensus 391 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~evl~~ 466 (517)
|++|+.||...+..+ .............. +. .......+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~------~~~~i~~~~~~~~~--~~-----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE------TQLKVINWETTLHI--PS-----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH------HHHHHhccCccccC--CC-----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997433211 11111110000000 00 0111234667777876 5999999 88888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=289.84 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=205.2
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------hhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
.+.||+|..++|.++.++ +|+.+|+|++..... .-.+.-.+|+.+|+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 577999999999998766 688999999853211 1234566799999998 699999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
+|.|+.|.|.|++. ..-.++++...+|++|+.+|++|||. ++||||||||+|||+|++.++||+|||+++.+..
T Consensus 102 Fdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999998 46789999999999999999999999 9999999999999999999999999999998876
Q ss_pred CCcccccccccCCCCcCCCccC------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
+.. -...+|||+|+|||.+. ...|+...|+||+|+++|.|+.|.+||... ....+.+.+.+|++.
T Consensus 176 Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 176 GEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLMLRMIMEGKYQ 246 (411)
T ss_pred chh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHHHHHHHhcccc
Confidence 533 34567999999999874 346788999999999999999999999621 112233445555442
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 473 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~ 473 (517)
- ......+......+||.+||+.||.+|.|++|+++. +..+...
T Consensus 247 F------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 247 F------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred c------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 1 111223344467899999999999999999999874 4444433
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=318.47 Aligned_cols=241 Identities=28% Similarity=0.404 Sum_probs=190.6
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 68999999986532 223345556655 46778999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 99998887 35678999999999999999999999 9999999999999999999999999999875422211 12
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +.. .+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~-~~~--~~~~------- 217 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILH-KPL--VLRP------- 217 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHc-CCc--cCCC-------
Confidence 334589999999999999999999999999999999999999974322 111122221 111 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+|++.+|.+||++.+.++
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 12235779999999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=331.84 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=201.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC-------
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 264 (517)
..|.+.+.||+|+||+||+|... +|+.||||++.... ......+.+|+.++..++|+|+++++..+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 35677899999999999999765 68999999986532 334567889999999999999999988764332
Q ss_pred -eeEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 265 -QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 265 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3679999999999999987532 34578999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 343 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 343 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.+.... .+.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~-~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTL-AGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-cCC
Confidence 9987543221 122345689999999999999999999999999999999999999974322 22222222 121
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... .+......+.+++.+||+.||.+||++.++++.
T Consensus 262 ~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 111223468899999999999999999999763
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.80 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=201.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45666788999999999999865 57889999987443 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ...+++..+..++.|++.|+.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999886 3568999999999999999999999 9999999999999999999999999999876543321
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+..+. .+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~----~~~~~~~-----~~~--- 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVL----FLIPKNS-----PPT--- 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHH----hhhhcCC-----CCC---
Confidence 122234788999999999988999999999999999999999998632211 011 1111111 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........+.+++.+|++.+|++||++.+|++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 -LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 112234568899999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=323.31 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=191.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.++||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 445789999999999999875 68899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999873 4568899999999999999999999 999999999999999999999999999975321000
Q ss_pred ---------------------------------------------cccccccccCCCCcCCCccCCCCCCccceehhHHH
Q 010131 352 ---------------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 386 (517)
Q Consensus 352 ---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~ 386 (517)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHH
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEI 463 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~ev 463 (517)
++|||++|+.||...+.. +.............. +. .........+++.+|+ .+|++|++ +.|+
T Consensus 237 il~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~--p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPL------ETQMKVINWQTSLHI--PP-----QAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHH------HHHHHHHccCCCcCC--CC-----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 999999999999743321 111111111100000 00 0111234567777765 59999997 7777
Q ss_pred HH
Q 010131 464 VL 465 (517)
Q Consensus 464 l~ 465 (517)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=323.38 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=206.9
Q ss_pred HHhhhcccCCCCceEEEEEEec--CC--cEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK--DG--KEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
...+.++||+|.||.|++|.|+ .| ..||||.++..... ...+|++|+.+|-+|+|||++++||+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3446789999999999999987 34 35899999876544 56889999999999999999999999987 6788999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|.++.|+|.+.|+. .....+....+..++.|||.||.||.+ +++|||||..+|+++-....+||+|||+.+.+...
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999997 456788899999999999999999999 99999999999999999999999999999987654
Q ss_pred Ccc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... ......-...|+|||.++...++.++|||+|||++|||+| |..||.+.... +..+ .+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------qIL~----------~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------QILK----------NID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------HHHH----------hcc
Confidence 332 2222334678999999999999999999999999999999 88999744321 1111 122
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..-.-..+..+.+.+.+++..||..+|++|||+..|.+.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 111122344567789999999999999999999999744
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=303.42 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=203.0
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC--CCCCccccceeeecCC----eeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~ 270 (517)
..+.+.||+|.||.||+|.|+ |+.||||++. +.+.+.+.+|.++++.+ +|+||+.+++.-..+. +.+||+
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eEEEEEecCccccceeecccc-CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 345789999999999999999 9999999997 34557788999998875 9999999998754433 578999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhc-----CCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-----~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
+|.+.|||+|+|. ...++....++++..+|.||+|||. ..++.|.|||||++||||..++.+.|+|+|+|.
T Consensus 289 dYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 289 DYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred ecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999996 5789999999999999999999995 236889999999999999999999999999998
Q ss_pred ccCCCCc---ccccccccCCCCcCCCccCCCC------CCccceehhHHHHHHHHHhC----------CCCCCCCCcccc
Q 010131 346 QAEEDLT---HISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISG----------KKPVSVEDFGAE 406 (517)
Q Consensus 346 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~elltg----------~~p~~~~~~~~~ 406 (517)
....... -.....+||.+|||||++...- .-..+||||||.++||+.-. +.||.+- .+.+
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~-Vp~D 443 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV-VPSD 443 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC-CCCC
Confidence 7655432 2234567999999999986532 12378999999999999752 3555421 1112
Q ss_pred ccHHHHHHHHHhcCCcccccCccccC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIG-NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.++.+ ++..+- .+-+.|.+.. -.+.+....+.++++.||..+|.-|-|+=-+.+.|.++.+.+
T Consensus 444 Ps~ee-MrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 444 PSFEE-MRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred CCHHH-Hhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 22222 111111 1111122211 124567778999999999999999999999999999887643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=317.16 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=196.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4566789999999999999876 67889999987443 223356788999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++ +|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 87 DK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 75 888877642 3458899999999999999999999 99999999999999999999999999998764332211
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC-----------
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----------- 421 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 421 (517)
.....++..|+|||.+.+ ..++.++|||||||++|+|+||+.||...+..+.... +...+....
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSND 236 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcchh
Confidence 223347889999998864 5688999999999999999999999974433221111 111110000
Q ss_pred -cccccCccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 -VISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 -~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....-.+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 000112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=311.61 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=205.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-----CCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeec--CCee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 266 (517)
..+++.+.||+|+||.||+|.+. ++..||||++...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34566789999999999999864 3688999999765443 46789999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999743 3369999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccc--------cHHHHHHHH
Q 010131 347 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARSM 416 (517)
Q Consensus 347 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 416 (517)
....... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 111223456799999998889999999999999999999999998633221100 011111112
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+..+.. .......+..+.+++.+|++.+|++||||.||+++|+.+
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 221111 011122335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=296.68 Aligned_cols=264 Identities=20% Similarity=0.283 Sum_probs=200.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCC-ccccceeeecCC------
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEH------ 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------ 264 (517)
..+...++||+|+||+||+|+.+ +|+.||+|+++-... ..-....+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34556678999999999999876 789999999975433 22345678999999999999 999999998877
Q ss_pred eeEEEEEecCCCCHHhHhhccCCC-CccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
..++|+||+ .-+|..++...... ..++...+..++.||+.||+|||+ ++|+||||||.||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 788999999 45999998764321 467778999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
|+...-.... .....+|..|.|||++.+. .|+...||||+||++.||++++.-|.+....+ ....+...+.....
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCc
Confidence 9976533222 2334578999999998876 79999999999999999999999997544311 11111111111100
Q ss_pred cc------ccCc--cccC-----CCCHHHH---HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 423 IS------IVDP--VLIG-----NVKIESI---WRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 423 ~~------~~d~--~l~~-----~~~~~~~---~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.. ..+- .... ......+ ....+++.+|++.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 0000 0000 0001111 257799999999999999999999875
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=310.38 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=203.0
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
....+++.++||+|+||+||+|++. +|+ .||+|++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 3445667789999999999999864 444 489999875433 3456788999999999999999999998754 47
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++++||+++|+|.++++.. ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.
T Consensus 84 ~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 8999999999999998742 3568999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 347 AEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 347 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
........ .....++..|+|||...+..++.++|||||||++|||++ |..||..... ..+. ..+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIP----DLLEKGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCCcCC
Confidence 64332211 111234668999999988899999999999999999998 8999863221 1111 1222221111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
. .......+.+++.+||+.||++||++.++++.|+.+...
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 232 Q---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred C---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1 112234688999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.88 Aligned_cols=242 Identities=26% Similarity=0.349 Sum_probs=189.9
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||+||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999986432 122234444444 56788999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999999873 4568888899999999999999999 9999999999999999999999999999875432211 22
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... .... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~-~~~~--~~-------- 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN-KPLQ--LK-------- 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHh-CCcC--CC--------
Confidence 344689999999999999999999999999999999999999973322 111111111 1110 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......+.+++.+|++.+|.+||++.+.+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1123367899999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.10 Aligned_cols=263 Identities=23% Similarity=0.363 Sum_probs=204.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.++||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 3556789999999999999876 589999999875422 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCC--------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 272 YMHNGTLRDRLHGSVN--------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
|++||+|.+++..... ....++..++.++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999998864221 2345677889999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCc-----------------ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccc
Q 010131 344 SRQAEEDLT-----------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406 (517)
Q Consensus 344 a~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 406 (517)
+........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k- 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK- 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence 986521100 01122458999999999999999999999999999999999999997422111
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhhhc
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~~ 475 (517)
... .... .++.-. ......+..+.+++.+|++.||++|| +++++++.|+..+....
T Consensus 239 --i~~--~~~i--------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 239 --ISY--RDVI--------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred --hhh--hhhc--------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 000 0000 000000 00112334678999999999999995 67888888888776533
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.84 Aligned_cols=250 Identities=28% Similarity=0.390 Sum_probs=209.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCch---hHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 268 (517)
...|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3456778999999999999998874 999999999765432 3468999999999998 9999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC----CcEEEccccCc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLS 344 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a 344 (517)
|||++.||.|.+.+... .+++.....++.|++.+++|||+ .||+||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999854 39999999999999999999999 999999999999999643 57999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
..... .......+||+.|+|||++....++..+||||+|+++|.|++|..||......... ..+..+++
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF-- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC--
Confidence 98876 33455677999999999999999999999999999999999999999854432211 12333333
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...............+++..|+..||.+|+|+.++++
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1112222333456789999999999999999999998
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.05 Aligned_cols=239 Identities=23% Similarity=0.416 Sum_probs=189.5
Q ss_pred cccCCCCceEEEEEEecC-------------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 201 KKIGKGSFGSVYYGKMKD-------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
+.||+|+||.||+|++.+ ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998642 2358999887655555567889999999999999999999999988999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc-------EEEcc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------AKVSD 340 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~kl~D 340 (517)
+||||+++|+|..++... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888642 3568999999999999999999999 99999999999999987664 89999
Q ss_pred ccCccccCCCCcccccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHH-hCCCCCCCCCccccccHHHHHHHHHh
Q 010131 341 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 341 fg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+. ....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH-
Confidence 9998765322 1234678899999886 567899999999999999997 58888763221110 1111
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
.+.. .... .....+.+++.+||+.||.+||++.+|++.|
T Consensus 223 ~~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 0111 1134678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.59 Aligned_cols=257 Identities=29% Similarity=0.459 Sum_probs=203.3
Q ss_pred HHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
...+++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 345666789999999999999864 467899999875433 3356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccC-------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
++|+||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999987421 12357889999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
|+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876433211 11122234567999999988899999999999999999998 8888863221
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.+.. ..+..+..... ....+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 239 ----~~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----EEVI-YYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHH-HHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1212 22223322111 11123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=303.26 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=200.7
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346778899999999999999875 6889999998765555556788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ..+.+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999987 34578999999999999999999999 9999999999999999999999999999876543222
Q ss_pred ccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
......|+..|+|||++. ...++.++|||||||++|+|++|+.||....... . ...... .... .+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~----~~~~~~-~~~~---~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--A----LFLMTK-SNFQ---PPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--h----HHhhhc-cCCC---CCc
Confidence 122345889999999874 4568899999999999999999999986322111 0 011111 1110 011
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... .......+.+++.+|++.+|++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 100 0012235789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.10 Aligned_cols=250 Identities=24% Similarity=0.301 Sum_probs=198.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
++..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345678999999999999876 688999999865322 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988643 23468999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
. ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ........... ..
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~------~~--- 223 (285)
T cd05630 158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQ------EE--- 223 (285)
T ss_pred c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhh------hh---
Confidence 1 2235899999999999989999999999999999999999999743221110 01111111000 00
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
........+.+++.+||+.||++||| ++|+++
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 -YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11112235789999999999999999 888877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=306.12 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=206.7
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
+....+++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 34456788899999999999999876 58899999886543 33457889999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++.. .+.+++..+..++.+++.||.|||+ ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998873 4578999999999999999999996 25899999999999999999999999999865432
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-----ccccHHHHHHHHHhcCCccc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 424 (517)
.. .....|+..|+|||++.+..++.++|||||||++|+++||+.||...... ....+..+........ .
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 230 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-P-- 230 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-C--
Confidence 21 12345789999999998889999999999999999999999999743321 1111222222222211 0
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
+.+. ....+..+.+++.+|++.||++|||++|+++..
T Consensus 231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1110 112345688999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.07 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=195.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 556789999999999999876 5899999998642 122345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999642 4568999999999999999999999 9999999999999999999999999999876544333
Q ss_pred ccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 353 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...+. .+.............+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQFPP 231 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccCCC
Confidence 22333458999999999863 4578899999999999999999999974322 122222222111111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRG--FSRPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P--~~RPs~~evl~~ 466 (517)
. .......+.+++.+|+..++ ..||+++++++.
T Consensus 232 ~------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 D------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 01123456788888776533 347899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=304.52 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=200.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|++.++||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778899999999999999876 58899999998665566778999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998887642 3568999999999999999999999 9999999999999999999999999998875433221
Q ss_pred cccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 354 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
......++..|+|||++. ...++.++|||||||++|||++|+.||...+. ........ .........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~- 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSEPPTLSQ- 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHh-cCCCccCCC-
Confidence 112334788999999884 34567899999999999999999999963221 11111111 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.+|++||++.|+++
T Consensus 238 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 ------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1122336789999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=309.54 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=202.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 45667889999999999999864 78999999997655555677899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++. ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999986 3457899999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....+++.|+|||.+.+..++.++||||||+++|++++|+.||...+..... ......+ . +.+ .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~~~-~-----~~~--~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-T-----PEL--Q 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeeccCC-C-----CCC--C
Confidence 22335788999999999888999999999999999999999999743321110 0000000 0 000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223345789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=308.27 Aligned_cols=252 Identities=32% Similarity=0.529 Sum_probs=199.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHH--HHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|+||+||++... +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 356789999999999999887 4678999999876443322 3456999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++. ....+++..++.++.|+++||++||+ .+++|+||||+||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cc
Confidence 9999999997 35678999999999999999999999 99999999999999999999999999998764221 22
Q ss_pred cccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||.+. +..++.++||||+|+++|+|++|..||........ ........... .. ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~-~~---~~~--- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKRP-LP---SSS--- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHTH-HH---HHT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccccc-cc---ccc---
Confidence 233455788999999998 88999999999999999999999999974411111 11111111100 00 000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001257899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=300.90 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=192.4
Q ss_pred cccCCCCceEEEEEEecC---CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45799998875433 33457889999999999999999999999988999999999999
Q ss_pred CHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 277 TLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 277 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|.+++.... .....++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 22356777888999999999999999 999999999999999999999999999987543322211
Q ss_pred -ccccccCCCCcCCCccCCC-------CCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 355 -SSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 355 -~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .... ... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence 1223467889999988542 35789999999999999996 999996332211 1111 111 111222
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.++.+.. .....+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 12235778999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.38 Aligned_cols=238 Identities=24% Similarity=0.386 Sum_probs=187.3
Q ss_pred ccCCCCceEEEEEEecC-------------------------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCcccc
Q 010131 202 KIGKGSFGSVYYGKMKD-------------------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 256 (517)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13589998875544445678899999999999999999
Q ss_pred ceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC--
Q 010131 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-- 334 (517)
Q Consensus 257 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-- 334 (517)
+++|.+....++||||+++|+|..++.. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999864 24568899999999999999999999 9999999999999997643
Q ss_pred -----cEEEccccCccccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHH-hCCCCCCCCCccccc
Q 010131 335 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAEL 407 (517)
Q Consensus 335 -----~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~ 407 (517)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3899999987654322 11236788999998865 56899999999999999985 6999986332211
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
... ...... . ... .....+.+++.+||+.+|++|||+++|++.|
T Consensus 230 -~~~----~~~~~~--~-----~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 -KER----FYEKKH--R-----LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHH----HHHhcc--C-----CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 111110 0 000 1123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=315.83 Aligned_cols=240 Identities=25% Similarity=0.349 Sum_probs=192.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
+++.+.||+|+||.||+|... +|+.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456789999999999999876 68899999987532 233456778999998885 5778889999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++. ....+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 82 y~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999987 34579999999999999999999999 999999999999999999999999999987543221
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......... ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~-~~~--------- 218 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIME-HNV--------- 218 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC---------
Confidence 1 12334589999999999998999999999999999999999999974321 111112111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
..+......+.+++.+||+.+|.+|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111122367899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=329.57 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=192.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecC--------Cee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--------HQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~ 266 (517)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4667889999999999999875 68899999885432 2345799999999999999999876432 246
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLS 344 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a 344 (517)
++||||+++ +|.+++.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999974 7777665322 45678999999999999999999999 9999999999999999665 6999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc----
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---- 419 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 419 (517)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+ .+...+ ..+..
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~-~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRII-QVLGTPTED 293 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCCHH
Confidence 87643322 123457899999998765 468999999999999999999999997443221 111111 11100
Q ss_pred ------CCcccccCc-----cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 010131 420 ------GDVISIVDP-----VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 471 (517)
Q Consensus 420 ------~~~~~~~d~-----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~ 471 (517)
.....+.-+ .+....+...+..+.+++.+||+.||.+|||+.|+++. ++.+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000000000 00001111233468899999999999999999999853 55443
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.86 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=201.9
Q ss_pred HHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..+...+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34455788999999999999864 2467999988654433 4567999999999999999999999999989999
Q ss_pred EEEEecCCCCHHhHhhccCCC------CccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQ------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 341 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 341 (517)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754322 268999999999999999999999 99999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 342 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 342 g~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
|++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||..... ..... ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLN----RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHH----HHHcC
Confidence 9987543322222223345678999999988888999999999999999999 7888853221 11111 12212
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..... .....+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 01122347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=303.57 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=203.1
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|...+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34566788999999999999876 58899999987543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999986 3468899999999999999999999 9999999999999999999999999999976544321
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||++.+..++.++|+||||+++|||+||+.||....... . . .....+. ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~---~-~~~~~~~---------~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---V---L-FLIPKNN---------PP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---H---h-hhhhcCC---------CC
Confidence 1223347889999999988889999999999999999999999997332111 0 0 0111111 11
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233456678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=312.73 Aligned_cols=237 Identities=27% Similarity=0.379 Sum_probs=188.0
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 68899999986432 122344555554 67889999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|..++. ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99998886 34678899999999999999999999 999999999999999999999999999987532221 122
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+. .+...... .+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~-~~~~----------~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNIL-HKPL----------QLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHh-cCCC----------CCC
Confidence 334589999999999998999999999999999999999999974321 11111111 1111 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12233678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=292.88 Aligned_cols=259 Identities=20% Similarity=0.216 Sum_probs=197.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 271 (517)
|+..++|++|.||.||+|+.+ +++.||+|+++..... .--.-++|+.+|.+++|||||.+-.+... -+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 445688999999999999876 6889999999754322 11345789999999999999999887643 456899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
||+. +|...+... ..++...++..+..|+++|++|||. ..|+|||||++|+|+...|.+||+|||+|+.++...
T Consensus 158 ~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 158 YVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9965 888888754 3678999999999999999999999 999999999999999999999999999999988764
Q ss_pred cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc---CCcccccC
Q 010131 352 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD 427 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d 427 (517)
.. ....+-|..|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+....+..+. +-..+.. .....+.+
T Consensus 232 k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 232 KP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHhCCCccccCCCccc
Confidence 33 334457899999998866 4789999999999999999999999986543322211 1111111 00011111
Q ss_pred cc--------------ccCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PV--------------LIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~--------------l~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. +...+... -.+.=++|+..+|..||.+|.|++|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 00111101 1234568999999999999999999876
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=304.31 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=194.9
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
...||+|+||.||+|.+. ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 457999999999999865 5788999998766666667899999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCCCcccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 357 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 357 (517)
.+++.........++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||.+........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999753211122788889999999999999999 99999999999999976 67999999999876543221 1222
Q ss_pred cccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 358 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 358 ~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
..++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ...+....... . ...+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-------~----~~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI-------H----PEIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc-------C----CCCC
Confidence 3478899999998654 37889999999999999999999996322111 01111100000 0 1112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
......+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 223346889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=309.63 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=199.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+++.+.||+|+||.||++... ++..+|+|.+..... ....++.+|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456788999999999999876 578899998865433 334668899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.. ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 83 GGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999973 4668999999999999999999997 2589999999999999999999999999987653321
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc-----------
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI----------- 423 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 423 (517)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... ...+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCC
Confidence 223457889999999988889999999999999999999999986333111 111110000000000
Q ss_pred ---------cccCcccc---CCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 424 ---------SIVDPVLI---GNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 424 ---------~~~d~~l~---~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+..+.... ... .......+.+++.+||+.+|++|||++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 000 00123458899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=300.36 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=201.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999876 6889999998643 23345678899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++++|||.+........ .
T Consensus 82 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 82 GGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999988643 24568899999999999999999999 9999999999999999999999999999876543222 1
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....++..|+|||++.+..++.++|+||||+++|+|++|+.||...+. ..... .+..+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~-~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLIL-KVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHH-HHhcCCCCCC---------
Confidence 2234578899999999988899999999999999999999999973321 11111 1222222111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+......+.+++.+||+.||++||++.|++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11123357899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=306.71 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=197.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
++..+.||+|+||+||+|.+. +++.||+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 344578999999999999875 688999999865322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999888643 23469999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....|+..|+|||++.+..++.++|+||||+++|+|++|+.||........ .+.+.........
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~---------- 222 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEE---------- 222 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcccc----------
Confidence 1234589999999999988999999999999999999999999974322111 1111111111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
.+.......+.+++.+|++.||++||+ +.++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 011122335789999999999999999 566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.92 Aligned_cols=253 Identities=24% Similarity=0.306 Sum_probs=196.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||+||+++.. +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 57889999986421 22345588899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999742 3568899999999999999999999 9999999999999999999999999999987654433
Q ss_pred ccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 353 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+. .+.............. .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQF-P 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCcccC-C
Confidence 33334568999999999865 4678899999999999999999999974322 1111222211111000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
+.. ......+.+++.+|+..++++ |++++++++.
T Consensus 231 ~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 112346778999999866544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=321.17 Aligned_cols=216 Identities=27% Similarity=0.361 Sum_probs=182.9
Q ss_pred cccCCcccccChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-C-----
Q 010131 178 FMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H----- 250 (517)
Q Consensus 178 ~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h----- 250 (517)
+.+++..+.+-..|....+|.+.+.||+|.||.|-+|... +++.||||++++. .....+-..|+.+|..|+ |
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~ 247 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDK 247 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCC
Confidence 3444454555555655568888999999999999999765 6999999999865 334566778999999996 4
Q ss_pred CCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 251 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
-|+|+++++|...++.|+|+|.+ .-+|+++++.+. ..+++...+..++.||+.||.+||+ .+|||+||||+||||
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL 322 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILL 322 (586)
T ss_pred eeEEEeeeccccccceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheee
Confidence 38999999999999999999998 569999998764 5669999999999999999999999 999999999999999
Q ss_pred CCC--CcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCc
Q 010131 331 DIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 403 (517)
Q Consensus 331 ~~~--~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 403 (517)
.+. ..+||+|||.|+....... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+.
T Consensus 323 ~~~~r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ccCCcCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 754 4699999999988654322 34567899999999999999999999999999999999988876543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=303.51 Aligned_cols=251 Identities=29% Similarity=0.445 Sum_probs=193.5
Q ss_pred cccCCCCceEEEEEEec----CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeee-cCCeeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 274 (517)
+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 24579999885432 344578889999999999999999999775 4556789999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc-
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 353 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 353 (517)
+|+|.+++... ....++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999999743 3446778889999999999999999 99999999999999999999999999998765332111
Q ss_pred --cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 354 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 354 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
......++..|+|||.+.+..++.++|||||||++|||++| .+||...+ ..+.... +..+.....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~----- 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVY-LLQGRRLLQ----- 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH-HhcCCCCCC-----
Confidence 11122356789999999888999999999999999999995 55554221 1111111 111111100
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 01123468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=306.00 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=201.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+|.+.+.||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 3556788999999999999864 689999999876555556788999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++. ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 100 GGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 999999886 3468999999999999999999999 99999999999999999999999999998765433221
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+... ....... ....... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~-~~~~~~~-------~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIAT-NGTPELQ-------N 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCCcccC-------C
Confidence 223357889999999998889999999999999999999999997433211 1111111 1111100 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1122336789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=311.12 Aligned_cols=196 Identities=24% Similarity=0.383 Sum_probs=160.6
Q ss_pred hcccCCCCceEEEEEEec---CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEEEecC
Q 010131 200 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 274 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 274 (517)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999986532 23457789999999999999999998854 456789999985
Q ss_pred CCCHHhHhhccC------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe----CCCCcEEEccccCc
Q 010131 275 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 344 (517)
Q Consensus 275 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a 344 (517)
++|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58887765321 12358999999999999999999999 999999999999999 45678999999999
Q ss_pred cccCCCCcc--cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 345 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 345 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
+........ ......+|+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876443221 1233468999999999876 46899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=304.62 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=200.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667889999999999999886 68999999886542 334567899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|..++........+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 999999988754334578999999999999999999996 25999999999999999999999999999876533221
Q ss_pred cccccccCCCCcCCCccCCCC------CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...... ....... .+..+...
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~-~~~~~~~~---- 228 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLS-AIVDGDPP---- 228 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHH-HHhhcCCC----
Confidence 2234778999999985543 478999999999999999999999633221 1111111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+|++.+|++||+++++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 -----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112224456789999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=318.63 Aligned_cols=264 Identities=22% Similarity=0.249 Sum_probs=200.3
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec---CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
.+....|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......+
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 334456788899999999999999754 3578999987643 23568999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+|||++. ++|.+++. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 163 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999995 68888884 35679999999999999999999999 99999999999999999999999999999765
Q ss_pred CCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--c
Q 010131 348 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--S 424 (517)
Q Consensus 348 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 424 (517)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...+...... .
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 443221 2233568999999999999999999999999999999999999997544322111111111111100000 0
Q ss_pred -----------ccCccccCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 425 -----------IVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 425 -----------~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.........+. ......+.+++.+||..||++|||+.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0123457789999999999999999999874
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.64 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=196.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4566789999999999999876 58899999986432 233456788999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 87 D-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred c-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 6 5898888643 4568899999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc---CCcccccC--
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD-- 427 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-- 427 (517)
.....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...+..+ ....+...+.. .....+.+
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccc
Confidence 122346889999998765 457889999999999999999999997443211 11111111100 00000000
Q ss_pred -------ccccCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 -------PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 -------~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+....+ ........+.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00112335789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=300.86 Aligned_cols=249 Identities=28% Similarity=0.409 Sum_probs=202.1
Q ss_pred HHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|.+.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 346677899999999999999874 78999999875432 678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999864 24678999999999999999999999 9999999999999999999999999999887654322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ .. ....... +.+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~~-----~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IF-MIPNKPP-----PTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hh-hhccCCC-----CCC--C
Confidence 12233478899999999988999999999999999999999999973322110 00 0000000 000 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+......+.+++.+|++.+|++|||++||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11223346889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.49 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=202.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|++.+.||.|+||.||+|.+. ++..||+|.+........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 35778899999999999999875 68899999987665556678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999998742 3568999999999999999999999 99999999999999999999999999988765432221
Q ss_pred cccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 354 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.....++..|+|||.+. +..++.++||||||+++|+|++|+.||...+. ...... +..+.......
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~- 230 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLLK-ILKSEPPTLDQ- 230 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHHH-HhcCCCCCcCC-
Confidence 12334788999999874 34567899999999999999999999973321 111111 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+......+.+++.+||+.+|.+||++.++++.
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 ------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11123467899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=315.51 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=194.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------e
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 265 (517)
..|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45677899999999999999875 58999999986532 234567889999999999999999999886443 4
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 6899999965 5666654 247888999999999999999999 999999999999999999999999999997
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccc------------cHH---
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL------------NIV--- 410 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~------------~~~--- 410 (517)
...... ......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..... ...
T Consensus 172 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 643322 123345789999999999999999999999999999999999999754321100 000
Q ss_pred -HHHHHHHhcCC-c-----ccccCcccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 411 -HWARSMIKKGD-V-----ISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 411 -~~~~~~~~~~~-~-----~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+........ . .+....... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00011111000 0 000000000 00011123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=302.96 Aligned_cols=247 Identities=28% Similarity=0.419 Sum_probs=197.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch---------hHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
+.+...||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345678999999999999875 5889999988643221 125688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999973 4568899999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCcc-----cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 347 AEEDLTH-----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 347 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ..+.. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFK-IGEN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHH-Hhcc-
Confidence 6532111 112234788999999999888999999999999999999999999733211 11111 1111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+. .+......+.+++.+||+.||.+||++.||++
T Consensus 228 ----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 11223346889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=307.04 Aligned_cols=261 Identities=20% Similarity=0.250 Sum_probs=195.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345688999999999999876 68999999986432 223467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++........+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 6898888754445679999999999999999999999 9999999999999999999999999999876543221
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-----------C-
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-----------G- 420 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~- 420 (517)
......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||....... ............ .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHH
Confidence 1122346889999998765 457889999999999999999999997432211 000000000000 0
Q ss_pred ---CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 ---DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ---~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+ .........++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0000112346779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=310.13 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=193.5
Q ss_pred hhcccCCC--CceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 199 FCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 199 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+.++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 68899999875 68999999987542 233456778999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~- 352 (517)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986432 3458999999999999999999999 9999999999999999999999999986543321110
Q ss_pred -----ccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 353 -----HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 353 -----~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .... .. .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~----~~-~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLE----KL-NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHH----Hh-cCCcccc
Confidence 01112245678999999875 468899999999999999999999996322110 0000 00 0111000
Q ss_pred cC-------------------ccc-----------------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 VD-------------------PVL-----------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 ~d-------------------~~l-----------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+ ... ...........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000 00011123446889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=299.87 Aligned_cols=238 Identities=26% Similarity=0.442 Sum_probs=189.5
Q ss_pred cccCCCCceEEEEEEecCCc-----------EEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 201 KKIGKGSFGSVYYGKMKDGK-----------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999886432 5788877644333 6788999999999999999999999988 778999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-------cEEEcccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-------RAKVSDFG 342 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl~Dfg 342 (517)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++|+||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999753 2278999999999999999999999 9999999999999999887 79999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhc
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
++...... ....++..|+|||++.+. .++.++||||||+++|||++ |..||...+... ...+ ...
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~----~~~ 221 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERF----YQD 221 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHH----Hhc
Confidence 98875431 223356789999999876 78999999999999999999 577775332111 1111 111
Q ss_pred CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 420 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
..... .+ ....+.+++.+||..+|++|||+.||++.|+
T Consensus 222 ~~~~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHRLP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11000 00 0147889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.31 Aligned_cols=247 Identities=28% Similarity=0.386 Sum_probs=201.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 3567789999999999999876 68899999987543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.. ..+++..++.++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 99999999873 378999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
......++..|+|||++.+..++.++||||||+++|+|+||+.||...+.. ... ..+..+......+ .
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~-~~~~~~~~~~~~~-----~ 221 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVL-FLIPKNNPPSLEG-----N 221 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHH-HHhhhcCCCCCcc-----c
Confidence 122335788999999999888999999999999999999999999733211 111 1111111111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+||..+|++|||++++++
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02346789999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.44 Aligned_cols=259 Identities=25% Similarity=0.304 Sum_probs=191.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCCccccceeeec-----CCe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----EHQ 265 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~ 265 (517)
|++.+.||+|+||+||+|... +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456788999999999999876 688999999865322 2234566777777665 69999999998764 245
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||++ ++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 789999997 5888888643 23568999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---Cc
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DV 422 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~ 422 (517)
....... .....++..|+|||++.+..++.++||||+||++|+|++|++||........ + ..+....... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~-~~~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--L-GKIFDLIGLPPEDDW 231 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--H-HHHHHHhCCCChhhC
Confidence 6643221 2234578899999999988999999999999999999999999964322111 1 1111111000 00
Q ss_pred c-------cccCcccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 I-------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~-------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ....+... ..........+.+++.+||+.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 0011123346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=303.74 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=195.8
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecC------Cee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE------HQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~ 266 (517)
..|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++... ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34566788999999999999876 58899999986543 3456788999999998 799999999998653 457
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||||+||++++++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 8999999999999998753 24568999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCcccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
...... ......|+..|+|||++. +..++.++|||||||++|||++|+.||...... ... .......
T Consensus 161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~--~~~~~~~ 232 (272)
T cd06637 161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL--FLIPRNP 232 (272)
T ss_pred cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHH--HHHhcCC
Confidence 543222 223345888999999985 345788999999999999999999999632211 000 0111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... .......+.+++.+||..+|.+|||+.|+++
T Consensus 233 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111 1122346889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=313.73 Aligned_cols=191 Identities=25% Similarity=0.340 Sum_probs=163.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++...+..++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 335677899999999999999876 5678999975432 235699999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+ .++|.+++.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 139 ~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 139 Y-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred c-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 9 4688888864 34578999999999999999999999 9999999999999999999999999999875432211
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 398 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~ 398 (517)
.....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22345899999999999999999999999999999999865554
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.87 Aligned_cols=240 Identities=25% Similarity=0.428 Sum_probs=189.3
Q ss_pred cccCCCCceEEEEEEecC--------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 234888887655445567889999999999999999999999998899999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc--------EEEccccCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKVSDFGLS 344 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~Dfg~a 344 (517)
+++|+|.++++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999753 3468999999999999999999999 99999999999999987765 699999988
Q ss_pred cccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCC-CCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||...+... .. ......
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~~~-- 221 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYEDR-- 221 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHHcc--
Confidence 755332 22346789999999976 45789999999999999999985 5554221111 00 111110
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.. .+......+.+++.+||+.+|++|||++++++.|+
T Consensus 222 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 11111236889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.73 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=197.6
Q ss_pred cccCCCCceEEEEEEecC-------CcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998653 2579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccC----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-----cEEEccccC
Q 010131 273 MHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----RAKVSDFGL 343 (517)
Q Consensus 273 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~Dfg~ 343 (517)
+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 23457899999999999999999999 9999999999999999877 899999999
Q ss_pred ccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 344 SRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 344 a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
+........ .......++..|+|||++.+..++.++|||||||++|||+| |+.||..... .... ..+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~----~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVL----QHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHH----HHHhcCC
Confidence 876533211 11122235678999999999999999999999999999998 9999863221 1111 1111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.. ......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1112234578899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.41 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=204.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC-Cc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD-GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
....+++.+.||+|+||.||+|.+.+ |. .||+|.+..... .....+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 34566778999999999999998752 33 589998875543 345678899999999999999999999987 788
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999998753 3458999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccc-cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 347 AEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 347 ~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
......... ....++..|+|||.+....++.++||||||+++||+++ |+.||..... .+. ...+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~-~~~~~~~~~~~ 231 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEI-PDLLEKGERLP 231 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHH-HHHHhCCCCCC
Confidence 653322211 11223568999999988889999999999999999999 9999974322 111 12222221110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+ ......+.+++.+||..+|.+||++.++++.|+++..
T Consensus 232 --~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 --QP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --CC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01 1122357899999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=319.84 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=193.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
|.+.+.||+|+||.||+|.+. .++.||||... ...+.+|++++++++|+||+++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 555788999999999999876 57889999643 2345689999999999999999999999999999999994
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-cc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HI 354 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~ 354 (517)
++|.+++... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 244 ~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 244 SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 7888888642 3469999999999999999999999 9999999999999999999999999999986543221 11
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-ccccHHHHHHHHHhcCCc-----ccccCc
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDV-----ISIVDP 428 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~d~ 428 (517)
.....||..|+|||++.+..++.++|||||||++|||++|..|+...... ........+...+..... ......
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 22345899999999999999999999999999999999988765422211 111111111112211111 000000
Q ss_pred cc------------cCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VL------------IGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l------------~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+ ..... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00000 0112257799999999999999999999873
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=317.15 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=203.5
Q ss_pred ccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHh
Q 010131 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 280 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 280 (517)
+||+|.||+||.|++.+ ...+|||.+....+...+.+..|+.+.++|+|.|||+++|.|.+++..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999998764 56799999987777778889999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC-CCCcEEEccccCccccCCCCcccccccc
Q 010131 281 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVAR 359 (517)
Q Consensus 281 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 359 (517)
.++.....-.-.+.++--+.+||++||.|||+ ..|||||||.+||||+ -.|.+||+|||-++.... ....+..+.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccccc
Confidence 99875433333778888899999999999999 9999999999999996 478999999999987643 334456677
Q ss_pred cCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHH
Q 010131 360 GTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437 (517)
Q Consensus 360 g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 437 (517)
||..|||||++..+ .|+.++|||||||++.||.||++||..-..+.. .+.+-|.+ ......+.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy------KvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY------KVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce------ecCCCCcHH
Confidence 99999999999654 588999999999999999999999962221110 01111111 112344566
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 438 ~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+...+|.+|+.+||.+||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6778889999999999999999999986
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.95 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=198.0
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|...+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 345678999999999999888899999998864321 12356889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999973 3568899999999999999999999 99999999999999999999999999998764321
Q ss_pred C-----cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-CCccc
Q 010131 351 L-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-GDVIS 424 (517)
Q Consensus 351 ~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 424 (517)
. ........++..|+|||++.+..++.++||||||+++|+|++|+.||...+... . ....... +..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~~~-- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRGLM-- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccCCC--
Confidence 1 111223457889999999999889999999999999999999999996332111 0 0000000 111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.+. ......+.+++.+||+.+|++||++.|+++
T Consensus 228 ---~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ---PRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 122346789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=298.12 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=190.8
Q ss_pred cccCCCCceEEEEEEecCC---cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976543 346677665443 234578999999999999999999999999999999999999999
Q ss_pred CHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC-Cccc
Q 010131 277 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHI 354 (517)
Q Consensus 277 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~ 354 (517)
+|.++++... .....++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 23456777888999999999999999 99999999999999999999999999997643221 1111
Q ss_pred ccccccCCCCcCCCccCC-------CCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 355 SSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... .+.....+. +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccC
Confidence 223457889999998743 245789999999999999997 5667752221 122222222 2223334
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
++.+...+ ...+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44443222 235678888999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=310.28 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=195.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.++||+|+||.||++..+ +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 456789999999999999876 47889999986421 22334588899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999742 3568999999999999999999999 9999999999999999999999999999876543333
Q ss_pred ccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 353 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+. .+..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-- 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQF-- 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccccC--
Confidence 2333456899999999985 34678899999999999999999999974322 2222222221111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
+. ........+.+++.+|+..++.+ |++++|+++.
T Consensus 230 p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 01112345778888988654444 7899998776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=316.55 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=193.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 445688999999999999876 58999999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 83 ~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999987 35678999999999999999999999 9999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCC
Q 010131 353 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 398 (517)
Q Consensus 353 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~ 398 (517)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011345899999999999999999999999999999999999999
Q ss_pred CCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 010131 399 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 465 (517)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 465 (517)
...... .............. +.+. ......+.+++.+|+ .+|.+|++ +.|+++
T Consensus 237 ~~~~~~------~~~~~i~~~~~~~~-~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQ------ETYRKVMNWKETLV-FPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHH------HHHHHHHcCCCcee-cCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 743321 11111111110000 0110 011235677888876 49999996 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.83 Aligned_cols=249 Identities=33% Similarity=0.546 Sum_probs=200.7
Q ss_pred hhcccCCCCceEEEEEEecC-----CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 199 FCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.||.|+||.||++...+ +..||+|.+...... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56789999999999998764 388999999765443 567899999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999987432 1228999999999999999999999 9999999999999999999999999999987655422
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+. .... .....+.....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~-~~~~~~~~~~~------ 225 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVL-EYLKKGYRLPK------ 225 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHH-HHHhcCCCCCC------
Confidence 22222336789999999988889999999999999999998 7888863211 1111 11222221111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
....+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111344688999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=297.98 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=202.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++.+.||.|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4566789999999999999875 578899999976655566789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 84 ~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 84 GGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 99999988742 3578999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred ccccccCCCCcCCCccCCC---CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 355 SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.....++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+.... ... ...... ..+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~-~~~~~~---~~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFL-ISKSNF---PPPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhccC---CCccc-
Confidence 2234578899999998776 889999999999999999999999973321110 111 111100 00111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+|++.+|.+|||+++|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112234457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=297.36 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=190.0
Q ss_pred cccCCCCceEEEEEEecC---CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
++||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 35688887764432 33467889999999999999999999999999999999999999
Q ss_pred CHHhHhhccCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-c
Q 010131 277 TLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H 353 (517)
Q Consensus 277 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~ 353 (517)
+|.+++..... ....++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999975432 2345678889999999999999999 9999999999999999999999999999875432211 1
Q ss_pred cccccccCCCCcCCCccC-------CCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 354 ISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
......++..|+|||++. ...++.++|||||||++|||++ |..||...... +........+ ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-CccC
Confidence 112233567899999864 3456889999999999999999 78888632211 1112222221 1222
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.++.+. ......+.+++..|+ .||++|||++||++.|.
T Consensus 231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222 122345667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.05 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=198.1
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999875 6899999998755445566788999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++. ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......... ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 177 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL 177 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccce
Confidence 98875 3568999999999999999999999 99999999999999999999999999998765433221 2234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||++.+..++.++|||||||++|||++|+.||...+.. +... .+......... .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~-~~~~~~~~~~~-------~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMK-RLRDSPPPKLK-------NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhccCCCCcc-------ccCCC
Confidence 5788999999999888999999999999999999999999733211 1111 11111110000 01112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+.+++.+|++.+|++||+++++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2357899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=299.41 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=198.9
Q ss_pred hhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
...+.||+|++|.||+|.. .+++.||+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 4457899999999999986 4689999999864321 13467889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 349 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 349 (517)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 83 EWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred eccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999873 4578899999999999999999999 9999999999999998776 599999999877654
Q ss_pred CCcc---cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 350 DLTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 350 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~----- 228 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATT----- 228 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCC-----
Confidence 3211 12234578899999999888899999999999999999999999964332211 111111111000
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+......+.+++.+|++.+|++||++.|+++
T Consensus 229 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11122233457889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=295.00 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=202.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||.|+||.||.++.. +++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 456789999999999999765 5889999987643 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999997542 4568999999999999999999999 9999999999999999999999999999887644332
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
......+++.|+|||.+.+..++.++||||||+++|||++|..||..... .+...... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCCC--------
Confidence 22334578999999999888899999999999999999999999963221 12222222 2222111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=297.73 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=200.6
Q ss_pred HhhhcccCCCCceEEEEEEecC--CcEEEEEEecCCC----------chhHHHHHHHHHHHhc-CCCCCccccceeeecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC----------SHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEE 263 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~ 263 (517)
|.+.+.||+|+||.||+|.+.. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567889999999999999875 6889999875321 2233557788888875 6999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
+..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999999875422 34568999999999999999999995 2689999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ...... +..+..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~-~~~~~~ 230 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATK-IVEAVY 230 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHH-HhhccC
Confidence 998755432 22334578899999999988899999999999999999999999963221 111111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
....+ ......+.+++.+|++.||++||++.||.+++++
T Consensus 231 ~~~~~--------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLPE--------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCCc--------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11110 1123468899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=309.08 Aligned_cols=240 Identities=32% Similarity=0.458 Sum_probs=197.5
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+.||+|+||.||.|+.. +.+.||||++.-... ..-.++..|+..|++++|||++.+-|+|..+...++||||| -
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 478999999999999865 678899999975432 33467899999999999999999999999999999999999 5
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+-.|++.- ..+++.+..+..|+.+.+.||+|||+ .+.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 110 GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 110 GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 677777754 35789999999999999999999999 99999999999999999999999999999876543
Q ss_pred cccccCCCCcCCCcc---CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 356 SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
..++|||.|||||++ ..+.|+-|.||||+|++..||...++|+..... .. +...+..++ .|.+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MS-ALYHIAQNe-----sPtLq- 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MS-ALYHIAQNE-----SPTLQ- 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HH-HHHHHHhcC-----CCCCC-
Confidence 446799999999986 457899999999999999999999999862221 11 111222221 12222
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+....+.+++..||++-|.+|||..+++.
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3455667899999999999999999988753
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=299.18 Aligned_cols=247 Identities=30% Similarity=0.486 Sum_probs=198.5
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+++.+.||+|+||.||++.. +++.||+|...... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4567789999999999999976 47889999986432 346788999999999999999999998765 4799999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999999753 23468999999999999999999999 9999999999999999999999999999876433211
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...+.. +. ...+..+....
T Consensus 156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~~--------- 217 (254)
T cd05083 156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EV-KECVEKGYRME--------- 217 (254)
T ss_pred --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HH-HHHHhCCCCCC---------
Confidence 1223568999999988899999999999999999998 99998633221 11 12222221111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
.....+..+.+++.+|++.+|++||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011223467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=335.25 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=197.9
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeec--CCe
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQ 265 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 265 (517)
+.....|.+.+.||+|+||+||+|... ++..||+|++... .......+..|+.++++++|||||+++++|.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 334456778899999999999999876 5778999988643 22345678999999999999999999998854 456
Q ss_pred eEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCC----CCCcEecCCCCCCeEeCC--------
Q 010131 266 RILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC----NPGIIHRDVKSSNILLDI-------- 332 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~----~~~ivH~dlk~~Nill~~-------- 332 (517)
.++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999987532 2357999999999999999999999821 145999999999999964
Q ss_pred ---------CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 333 ---------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 333 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999987643221 233468999999999854 45889999999999999999999999632
Q ss_pred CccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 402 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+. ....+ ..+..+... .+ ......+.+||..||+.+|.+||++.|++.
T Consensus 247 ~~-----~~qli-~~lk~~p~l-----pi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQLI-SELKRGPDL-----PI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHHHH-HHHhcCCCC-----Cc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 11211 222221110 00 011346889999999999999999999984
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=314.04 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=195.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Ce
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 265 (517)
..|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 45667889999999999999865 58899999987542 23346788899999999999999999987543 34
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 97 ~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 6899999965 6766664 247888999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc-HH--------------
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV-------------- 410 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~-~~-------------- 410 (517)
....... .....+|..|+|||++.+..++.++|||||||++|+|++|+.||...+...... ..
T Consensus 168 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6543321 233458999999999999899999999999999999999999997543211100 00
Q ss_pred -HHHHHHHhcC-CcccccCcccc--------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 411 -HWARSMIKKG-DVISIVDPVLI--------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 411 -~~~~~~~~~~-~~~~~~d~~l~--------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+....... .......+... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000111100 00000000000 00111123467899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.80 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=198.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|...+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345678999999999999887 78999999986432 224467899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999973 4568899999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccccCCCCcCCCccCCCC-CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ...............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~----- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP----- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC-----
Confidence 2 123345788999999987766 89999999999999999999999963221 111111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11112346789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=294.64 Aligned_cols=248 Identities=26% Similarity=0.395 Sum_probs=199.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 272 (517)
|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 566789999999999999876 57899999986432 2345678899999999999999999998764 4467899999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999753 24568999999999999999999999 9999999999999999999999999999876643222
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+. ....... ..+....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~-------- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRI-IEGKLPP-------- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHH-HhcCCCC--------
Confidence 22334578899999999999999999999999999999999999963321 1111221 1222111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+|++.+|++||++.++++
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11223346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.17 Aligned_cols=256 Identities=25% Similarity=0.295 Sum_probs=205.2
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
.+.-...++.+.||.|.-|+||++.+++ +..+|+|++.+..- ....+...|-+||+.++||.++.+|..|+.++..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3444455678899999999999999884 58899999976532 3345677899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
|+|||||+||+|....+.. .++.+++..+.-++..|+.||+|||. .|||+|||||+||||.++|++-|+||.++..
T Consensus 153 cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999887644 57789999999999999999999999 9999999999999999999999999988643
Q ss_pred cCC---------------------------------CCc----------------------ccccccccCCCCcCCCccC
Q 010131 347 AEE---------------------------------DLT----------------------HISSVARGTVGYLDPEYYG 371 (517)
Q Consensus 347 ~~~---------------------------------~~~----------------------~~~~~~~g~~~y~aPE~~~ 371 (517)
... ... ..+..++||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 000 0112245899999999999
Q ss_pred CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhc
Q 010131 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE 451 (517)
Q Consensus 372 ~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 451 (517)
+...+.+.|-|+|||++|||+.|..||.+....+. ....+. +.+.-...+.....+.+||++.|.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l~NIv~---------~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET------LRNIVG---------QPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh------HHHHhc---------CCCcCCCCCcchhHHHHHHHHHhc
Confidence 99999999999999999999999999986554322 111221 111111112344578899999999
Q ss_pred cCCCCCCC----HHHHHH
Q 010131 452 QRGFSRPK----MQEIVL 465 (517)
Q Consensus 452 ~~P~~RPs----~~evl~ 465 (517)
+||.+|.. +.||.+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999998 777754
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=301.54 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=198.0
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
...||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 367999999999999875 6889999998765555567789999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++. ...+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++......... ....
T Consensus 107 ~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 178 (292)
T cd06658 107 TDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence 99885 3458899999999999999999999 99999999999999999999999999998765432221 2234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...+... . .. .+... +.+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~-~~~~~-----~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---A---MR-RIRDN-----LPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HH-HHHhc-----CCCcccc--cccc
Confidence 57889999999988889999999999999999999999997332211 1 11 11111 1111111 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+.+++.+|+..||.+|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3357799999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=311.65 Aligned_cols=240 Identities=26% Similarity=0.308 Sum_probs=186.7
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcC---CCCCccccceeeecCCeeEEEEEecCC
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
||+|+||+||+|+.. +++.||||++..... .....+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 589999999864321 2233455677777665 699999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.++|+|||++........ ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99999887 35678999999999999999999999 9999999999999999999999999999875432211 12
Q ss_pred cccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....||..|+|||++.+. .++.++|||||||++|+|+||+.||...+. .+. ...+..+.. .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~-~~~i~~~~~-~~~~~------ 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQM-YRNIAFGKV-RFPKN------ 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHH-HHHHHcCCC-CCCCc------
Confidence 334589999999998654 478999999999999999999999974322 111 112222211 01000
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~ 465 (517)
.....+.+++.+||+.||.+||+ +.++++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11235779999999999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=302.94 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=201.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
...++..+.||+|+||.||+|.+. +|. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 344455688999999999999864 343 578898865433 2344688999999999999999999998754 467
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998742 3468899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCccc-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ...+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EI----PDLLEKGERLP- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCCCC-
Confidence 4322211 122335678999999999899999999999999999997 99998633211 11 12222221111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+ ......+.+++.+|+..+|++||+++++++.|+.+...
T Consensus 232 -~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 -QP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01 11234678999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=306.77 Aligned_cols=196 Identities=26% Similarity=0.388 Sum_probs=159.8
Q ss_pred hcccCCCCceEEEEEEec---CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEEEecC
Q 010131 200 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 274 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 274 (517)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999875 35789999886532 23467889999999999999999998843 557789999986
Q ss_pred CCCHHhHhhccC------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe----CCCCcEEEccccCc
Q 010131 275 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 344 (517)
Q Consensus 275 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a 344 (517)
++|.+++.... ....+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764221 22358899999999999999999999 999999999999999 56678999999999
Q ss_pred cccCCCCcc--cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCC
Q 010131 345 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 345 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
+........ ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876443221 1223457899999999876 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.02 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=194.9
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Ce
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 265 (517)
..|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45677889999999999999865 58899999987532 23446788999999999999999999987543 35
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 7999999964 7777664 247888999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHH------------H--
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV------------H-- 411 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~------------~-- 411 (517)
....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+..... .
T Consensus 175 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 6543221 22345889999999999999999999999999999999999999744321110000 0
Q ss_pred --HHHHHHhcCC-cccc----cCcccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 412 --WARSMIKKGD-VISI----VDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 412 --~~~~~~~~~~-~~~~----~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+........ .... +.+... ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0000 000000 00111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=304.41 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=200.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|++|.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 556789999999999999876 58899999886532 233467899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+++.+..+.. ....+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 83 ERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9877766654 34568999999999999999999999 99999999999999999999999999999876554332
Q ss_pred cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh------------cC
Q 010131 354 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK------------KG 420 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~ 420 (517)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. ......... ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCc
Confidence 33334578899999999887 889999999999999999999999974322111 110111000 00
Q ss_pred Cc-----ccccCccc-cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DV-----ISIVDPVL-IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~-----~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ....++.. ...+.......+.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 00011122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=298.44 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=191.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 268 (517)
|...+.||+|+||.||+|... +++.|++|++.... ......+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 345688999999999999875 58899999886432 1234568899999999999999999998865 356789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
++||+++++|.+++.. ...+++...+.++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 84 ~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 84 FMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999973 4568899999999999999999998 999999999999999999999999999987653
Q ss_pred CCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... .......++..|+|||++.+..++.++|||||||++|||++|+.||...+. ...+........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----
Confidence 3111 111223478899999999988899999999999999999999999973221 111111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+. .+......+.+++ +|+..+|++||+++||++
T Consensus 227 ~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 1122233455666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=304.15 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=197.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.++||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 556789999999999999986 589999998764322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|..+... ...+++.++..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 83 DHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred CccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999887652 3458999999999999999999999 9999999999999999999999999999887544322
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCcccc-ccHHHHH-------HHHHhcCCc-c
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWA-------RSMIKKGDV-I 423 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~-------~~~~~~~~~-~ 423 (517)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ..+..+. ......... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 1223447889999998865 4578899999999999999999999864332110 0000000 000000000 0
Q ss_pred cccCccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+..... ........+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 01123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=318.93 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=210.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-C----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-D----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
...-.++||.|+||+||+|.|- . .-+||+|++..... ....++++|+.+|.+++|||+++++|+|..+. ..||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3344688999999999999764 3 34789999876543 45678999999999999999999999998776 7899
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
++||+.|+|.++++. .+..+-....+.|..|||+||.|||. ++++||||.++||||..-..+|+.|||+++....
T Consensus 776 tq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999987 45778889999999999999999998 9999999999999999999999999999998765
Q ss_pred CCcccc-cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
+..... ....-.+.|||=|.++...++.++|||||||++||++| |..|+++....+ +...++.|+. +
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR--L-- 919 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER--L-- 919 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc--C--
Confidence 543322 22234568999999999999999999999999999998 999998554332 3334444432 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
..++-....+..++.+||..|+..||+++++...+.++.
T Consensus 920 -----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 920 -----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 223344557889999999999999999999999988765
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.49 Aligned_cols=259 Identities=23% Similarity=0.283 Sum_probs=198.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|++|.||+|..+ +|+.||+|++.... ....+.+.+|++++++++|||++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 556788999999999999887 58999999886432 223456889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+++.|..++. ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 83 DHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred CccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9998888765 34568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh-----------cCC
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------KGD 421 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~~ 421 (517)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ......... ...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhccccc
Confidence 1122346789999999865 5678999999999999999999999974332211 111111100 000
Q ss_pred c-ccccCccccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 V-ISIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 ~-~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .....+......+ ......+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000011000001 112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=298.98 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=200.8
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..+.+.+.||+|+||.||+|... +++.||+|...... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45667789999999999999865 68899999886433 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999986 3468999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||.+.+..++.++|||||||++|+|++|..||..... ..... .+..+.. +.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~~~~-----~~--- 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLF-LIPKNNP-----PT--- 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHH-HHhcCCC-----CC---
Confidence 12233578899999999888899999999999999999999999963221 11111 1111111 11
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.....+..+.+++.+|++.+|.+||++.++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 -LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112233467899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=291.94 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=207.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.-+.+.++||+|+||.||+|.++ .|+.||+|.+.- ..+.+++..|+.++++++.|++|++||.+......++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34566789999999999999887 699999998753 456788999999999999999999999888888899999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
..|+..+.++.. .+++++.++..+++..+.||+|||. ..-+|||||+.|||++.+|.+||+|||.+..+.+....
T Consensus 111 GAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999999999863 6889999999999999999999999 88999999999999999999999999999887665443
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
. ..+.||+.|||||++..-.|..++||||+|++..||..|++||..-..-. +.-.+... |...-.
T Consensus 186 R-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------AIFMIPT~-------PPPTF~ 250 (502)
T KOG0574|consen 186 R-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-------AIFMIPTK-------PPPTFK 250 (502)
T ss_pred h-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-------eeEeccCC-------CCCCCC
Confidence 3 34569999999999999999999999999999999999999997211100 00001101 111112
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.+....+-++++.||-+.|++|-|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 24456668899999999999999999988865
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=307.39 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=192.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecC------Ce
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 265 (517)
.+|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 45677889999999999999865 688999999875322 2345677899999999999999999987543 34
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++++|++ +++|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999987 789988875 3569999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC----
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---- 420 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 420 (517)
...... ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+... ............
T Consensus 167 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 167 QADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPSPEV 239 (343)
T ss_pred ecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 754422 23457899999999876 578899999999999999999999997433211 001000000000
Q ss_pred -------CcccccC--ccccCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 421 -------DVISIVD--PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 421 -------~~~~~~d--~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....... +..... ........+.+++.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000 000112246799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=300.21 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=199.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999875 68999999987543 233567899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+++|.+++... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 -~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 -PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred -CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999998743 3669999999999999999999999 99999999999999999999999999998876543322
Q ss_pred cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc----------
Q 010131 354 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV---------- 422 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 422 (517)
......++..|+|||.+.+. .++.++||||+|+++|||+||.+||...... ...............
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 22334578899999998654 4689999999999999999998887633211 111111111110000
Q ss_pred --ccccCcccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 --ISIVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 --~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+..+... .....+....+.+++.+|++.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 0001122367889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=293.18 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=201.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||++... +|+.||+|.+... .....+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456789999999999999865 6899999998643 2334467899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 82 EGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999988743 23457899999999999999999999 99999999999999999999999999999866443221
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||++.+...+.++|+|||||++|+|++|+.||...+ ..+.+..... +....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~-~~~~~--------- 220 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIR-GSYPP--------- 220 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhc-CCCCC---------
Confidence 223347889999999998889999999999999999999999996322 1122222221 21111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+|++.+|.+||++.||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11123446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=293.61 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=199.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|...+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 455688999999999999875 689999999876543 35678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999973 4568899999999999999999999 99999999999999999999999999998876543332
Q ss_pred ccc---ccccCCCCcCCCccCCCC---CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 354 ISS---VARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 354 ~~~---~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... ...++..|+|||++.+.. .+.++||||||+++|++++|+.||...+.. ...... ...+..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~~~----- 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFH-VGAGHK----- 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHH-HhcCCC-----
Confidence 221 245788999999998766 889999999999999999999999633211 111111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.+.. .......+.+++.+|++.+|++||++.|++.
T Consensus 225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100 1112346779999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=295.17 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=203.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 566789999999999999865 68899999986532 3356789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc-
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 353 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 353 (517)
+++|.+++........+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999754334578999999999999999999999 99999999999999999999999999998776543222
Q ss_pred --cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 354 --ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 354 --~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
......++..|+|||++... .++.++|+||||+++|+|++|+.||....... . ........ .+.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~----~~~~~~~~------~~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--V----LMLTLQND------PPSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--h----HHHHhcCC------CCCc
Confidence 22334578899999998776 78999999999999999999999997332211 1 11111111 0111
Q ss_pred cCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... .......+.+++.+|++.||++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1110 1123456789999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.26 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=194.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456788999999999999876 689999999864322 22356778999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++... ...+++..++.++.||++||.|||+ ++++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 82 D-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 6 5788877642 4568999999999999999999999 99999999999999999999999999998865432221
Q ss_pred cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC------ccccc
Q 010131 354 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD------VISIV 426 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 426 (517)
.....++..|+|||.+.+. .++.++|||||||++|+|+||+.|+....... .............. .....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1223468899999988664 46899999999999999999999865222111 11111111110000 00000
Q ss_pred Ccc----cc-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPV----LI-----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~----l~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.. .. ..........+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00 0011122346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=296.67 Aligned_cols=253 Identities=28% Similarity=0.390 Sum_probs=201.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 271 (517)
|++.+.||.|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 455688999999999999765 68899999986432 3345678899999999999999999997754 456789999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCC--CCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+++++|.+++.... ....+++..++.++.|++.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 999999999987532 2467899999999999999999999211 2899999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. . . ....+..+...
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~---~-~~~~~~~~~~~----- 228 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---L---Q-LASKIKEGKFR----- 228 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---H---H-HHHHHhcCCCC-----
Confidence 43321 2233578899999999988899999999999999999999999974331 1 1 11222222221
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.........+.+++.+|++.+|++||++++|++.
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=297.93 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=194.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeee-----cCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~l 268 (517)
+|++.+.||+|+||.||+|... +++.+|+|++... ......+.+|+.+++++ +||||+++++++. .++..++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 4566789999999999999875 5789999987643 22346688899999999 6999999999874 3456899
Q ss_pred EEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 269 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 999999999999876432 34568899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
..... ......|+..|+|||++.. ..++.++||||+||++|||++|+.||....... . ... ......
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~-~~~-~~~~~~ 246 (286)
T cd06638 175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----A-LFK-IPRNPP 246 (286)
T ss_pred ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----H-Hhh-ccccCC
Confidence 43221 1223458899999998753 457889999999999999999999996332111 0 111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....++. .....+.+++.+||+.+|++|||+.|+++.
T Consensus 247 ~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 247 PTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111111 112358899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=294.58 Aligned_cols=252 Identities=27% Similarity=0.373 Sum_probs=202.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+++.+.||+|++|.||+|..+ +++.||+|.+.... ....+++.+|++++++++||||+++++++......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456788999999999999887 68999999987653 3445678999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.... ..+++..+..++.|++.||+|||+ ..+++|+||||+||+++.++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 83 GGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999999997532 678999999999999999999997 379999999999999999999999999998765432221
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ......+.+...... .. +.+.
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~-----~~~~--- 225 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIVNE-PP-----PRLP--- 225 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHhcC-CC-----CCCC---
Confidence 14578899999999998999999999999999999999999973322 112222323222221 11 1110
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||..+|++|||+.|++.
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0113446889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.79 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=199.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456788999999999999875 68899999986532 234567899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999997532 4468999999999999999999999 999999999999999865 4689999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ..+..... +......+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~-~~~~~~~~----- 223 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMS-GTFAPISD----- 223 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHh-cCCCCCCC-----
Confidence 12245788999999999888999999999999999999999999743321 11111111 11111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+||+.+|++|||+.|+++
T Consensus 224 ----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 ----RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12336889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=300.43 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=198.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||.||++... +++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 455688999999999999876 578999999875432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999973 4568999999999999999999999 999999999999999999999999999886421100
Q ss_pred -------------cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 352 -------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 352 -------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
........++..|+|||.+.+..++.++|+||||+++|||++|..||.+... .+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~~~ 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQVIS 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 0011123467889999999888899999999999999999999999963321 111111111
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
+... .+.. ....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 231 -~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 -DDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -cccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1110 1110 01223467899999999999999998777776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=296.40 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=195.5
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc----------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..+.||.|+||.||+|... +|+.||+|.++.... ...+.+.+|+.+++.++|||++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 4578999999999999765 689999998753211 11246788999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 85 IFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999974 3578999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcc-cccccccCCCCcCCCccCCCC--CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 348 EEDLTH-ISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 348 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
...... ......++..|+|||.+.... ++.++|+||||+++|++++|..||...+. ........... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc-cCC
Confidence 432211 122345788999999987654 78999999999999999999999962221 11111111111 111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.. .........+.+++.+|+..+|++||++.+|++
T Consensus 232 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 111223457889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=295.73 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=193.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 268 (517)
+.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 345688999999999999875 58999999875321 12345788899999999999999999988663 46789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
+|||+++++|.+++.. ...+++.....++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 84 FMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999873 3568889999999999999999999 999999999999999999999999999987653
Q ss_pred CCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...+.. .. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCCC-----
Confidence 3211 1122245788999999998888999999999999999999999999632111 11 111111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ...+......+.+++.+|+. +|++||+++||++
T Consensus 227 ~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 11223334567889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=298.43 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=201.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+|.+.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 45667789999999999999764 68899999986554455677899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 9999999986 3457899999999999999999999 99999999999999999999999999988765433221
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....+++.|+|||.+.+..++.++||||||+++|++++|+.||...+..... ......+. +.. .
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~~~~~------~~~--~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGT------PEL--Q 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehhcCCC------CCC--C
Confidence 22235788999999998888999999999999999999999999743221110 00000000 000 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233468899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=294.58 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=198.4
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
.+.||+|++|.||+|... +++.+++|++........+.+.+|+.+++.++|||++++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 478999999999999864 6889999998755445556788999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+........ .....
T Consensus 104 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 175 (285)
T cd06648 104 TDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSL 175 (285)
T ss_pred HHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccc
Confidence 999873 568999999999999999999999 9999999999999999999999999998876543322 12234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ...... +..+......+ ....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~-------~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKR-IRDNLPPKLKN-------LHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHH-HHhcCCCCCcc-------cccC
Confidence 578899999999888899999999999999999999999963221 111211 11111111100 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.+++.+||+.+|++||++.++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=304.98 Aligned_cols=250 Identities=26% Similarity=0.310 Sum_probs=198.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch---hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|++|+||+|... +++.||+|.+...... ..+.+..|+++++.++||||+++++.+.+....++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 455688999999999999876 4899999998754322 446788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+.+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999998743 34678999999999999999999999 9999999999999999999999999999875432111
Q ss_pred c----------------------------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc
Q 010131 353 H----------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 404 (517)
Q Consensus 353 ~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~ 404 (517)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788999999999888999999999999999999999999743321
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 465 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~ 465 (517)
. ....... ... ...........+.+++.+|++.+|++||+ ++|+++
T Consensus 239 ~------~~~~~~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 E------TFSNILK-KEV--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H------HHHHHhc-CCc--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 1111111 110 00001113457899999999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=293.33 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=197.0
Q ss_pred hhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------e
Q 010131 198 NFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 265 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~ 265 (517)
.+.+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999764 36889999987543 334567889999999999999999999875432 2
Q ss_pred eEEEEEecCCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 266 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
.++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 478899999999998875322 22357899999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 343 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 343 ~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
.++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||...+. ..... .+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYN----YLIKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHH----HHHcC
Confidence 98865432211 1122334678999999988889999999999999999999 8888863321 11111 11111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.... ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 0112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=297.50 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=198.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456789999999999999876 58999999986532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999874 4678999999999999999999999 99999999999999999999999999998876543
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+. .. ....+..+.. .+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~------~~-- 217 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQ-IYEKILEGKV------RF-- 217 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHHhcCCc------cC--
Confidence 2234578899999999888889999999999999999999999974331 11 1111111111 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
+......+.+++.+||+.+|.+|| +++|+++
T Consensus 218 --~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 --PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111234678999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=297.69 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=194.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeec------CCee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~ 266 (517)
..|++.+.||.|+||.||+|... +++.||+|++... ......+..|+.+++++ +||||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 45667789999999999999875 6889999998644 23446688899999998 79999999998853 4578
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 99999999999999987532 3458888899999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
...... ......|+..|+|||.+. +..++.++|||||||++|||++|+.||........ ... .....
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------~~~-~~~~~ 242 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------LFL-IPRNP 242 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------hhh-HhhCC
Confidence 543221 122345788999999875 34678899999999999999999999963221110 000 11110
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. +... .......+.+++.+||+.||.+||++.|+++
T Consensus 243 ~-----~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 P-----PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C-----CCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 1110 1123346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=301.39 Aligned_cols=259 Identities=20% Similarity=0.230 Sum_probs=196.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch-----hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|++.+.||+|++|.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 455678999999999999875 6899999999754322 2345778999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+ +++|.+++... ...+++..++.++.||++||.|||+ ++++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 99999999742 2379999999999999999999999 99999999999999999999999999999876543
Q ss_pred CcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------
Q 010131 351 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--------- 420 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 420 (517)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+ ............
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcc
Confidence 221 122335778999998854 467899999999999999999988876433211 111111110000
Q ss_pred CcccccCccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
............. ........+.+++.+||+.+|++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000000 11123457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=293.46 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=199.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 272 (517)
+++.++||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||++++++|.+. +..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 345688999999999999885 588999999875433 3456789999999999999999999988653 468999999
Q ss_pred cCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 273 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+++++|.+++.... ....++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999998875422 34568899999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .....+... .+.........+. .
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~-~- 232 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLS-YIVNMPNPELKDE-P- 232 (287)
T ss_pred c---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHH-HHhcCCchhhccC-C-
Confidence 1 1234678999999999889999999999999999999999999744321 111112111 1111111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+||+.+|++|||+.|+++
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=294.69 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=197.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCC---CCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 271 (517)
|++.+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 455688999999999999874 68999999986542 344567889999999996 9999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999999863 378999999999999999999999 999999999999999999999999999998765433
Q ss_pred cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ... ...... .+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~~-----~~~~ 222 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKSK-----PPRL 222 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccCC-----CCCC
Confidence 21 223457889999998865 456889999999999999999999997332211 110 111111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... .....+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 13346889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=299.54 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=194.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4556789999999999999876 689999999865432 22345778999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ ++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 86 D-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred C-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 7 4999988643 3478999999999999999999999 99999999999999999999999999998754322111
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---C--------
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---D-------- 421 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~-------- 421 (517)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... .........+... .
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 122235788999998865 457899999999999999999999996433110 1111111111000 0
Q ss_pred -cccc----c-CccccCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 -VISI----V-DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 -~~~~----~-d~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... . ...+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0 00000000 0011246789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.68 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=188.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC------CCccccceeeecC-Cee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH------RNLVPLIGYCEEE-HQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~~-~~~ 266 (517)
..|.+.++||+|+||+||+|... .++.||||+++... .....+..|+++++.++| .+++++++++... .+.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 45667889999999999999875 57889999986432 223455667777777654 4588888888654 467
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC------------
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------------ 334 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~------------ 334 (517)
++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 8999988 7789888863 4579999999999999999999996 15999999999999998765
Q ss_pred ----cEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHH
Q 010131 335 ----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410 (517)
Q Consensus 335 ----~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 410 (517)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.....
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4999999987643221 23456899999999999999999999999999999999999999754322111111
Q ss_pred HHH---------H--------HHHh-cCCcccccCcccc----CCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 411 HWA---------R--------SMIK-KGDVISIVDPVLI----GNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 411 ~~~---------~--------~~~~-~~~~~~~~d~~l~----~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... . .... .+......++... ... .......+.+|+.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000 0 0000 0000000010000 000 0011245779999999999999999999987
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=293.42 Aligned_cols=246 Identities=25% Similarity=0.324 Sum_probs=200.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999876 58999999987532 23457889999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 82 LLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 999999999873 3578999999999999999999999 9999999999999999999999999999887644321
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+... ........... . .
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~-~---------~ 219 (258)
T cd05578 156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQETA-D---------V 219 (258)
T ss_pred --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhccc-c---------c
Confidence 223447889999999988889999999999999999999999997443321 11111111110 0 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKM--QEIV 464 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~--~evl 464 (517)
..+...+..+.+++.+||+.||.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112233578899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=308.10 Aligned_cols=268 Identities=28% Similarity=0.408 Sum_probs=209.4
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC------CeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e 271 (517)
.+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++++|+|||+++++-++. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 467999999999999965 79999999997643 34567889999999999999999999876543 35689999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC--CCC--cEEEccccCcccc
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INM--RAKVSDFGLSRQA 347 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~kl~Dfg~a~~~ 347 (517)
||.+|||...+....+...+++.+++.++.+++.||.|||+ ++|+||||||.||++- .+| ..||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999988888999999999999999999999999 9999999999999983 333 4899999999998
Q ss_pred CCCCcccccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC--Cccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DVIS 424 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 424 (517)
.++. ......||..|.+||.+. ...|+...|.|||||++|+.+||..||...... .+..+.++....+. ....
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p--k~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP--KNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc--cccchhhhhhhccCCCceeE
Confidence 7765 345567999999999998 588999999999999999999999999632222 22222222222211 1111
Q ss_pred ccCccc------------cCCCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHhhhhhh
Q 010131 425 IVDPVL------------IGNVKIESIWRIAEVAIQCVEQRGFSRP--KMQEIVLAIQDSIKIE 474 (517)
Q Consensus 425 ~~d~~l------------~~~~~~~~~~~l~~li~~cl~~~P~~RP--s~~evl~~L~~~~~~~ 474 (517)
..++.. ...........+-..+..+|..+|++|. ...+.-..+.+|+...
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 111111 1112334455677888899999999999 7777777777777543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=309.02 Aligned_cols=241 Identities=27% Similarity=0.461 Sum_probs=194.6
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEe--cC--CCchhHHHHHHHHHHHhcCCCCCccccceeeecCCe--eEEEEE
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--AD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--RILVYE 271 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~--~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e 271 (517)
|..+||+|+|-+||+|.+. +|..||=-.+ .+ ......++|..|+.+|+.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4578999999999999876 5777763221 11 123445889999999999999999999999877655 679999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~ 350 (517)
.+..|+|..|.+. .+.++...+.+|++||++||.|||+ ..++|+|||||.+||||+.+ |.|||+|+|+|......
T Consensus 124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999984 5678889999999999999999998 45899999999999999865 89999999999987654
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh---cCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d 427 (517)
.. ....|||.|||||... ..|.+..||||||++++||+|+..||.... +..+..+.... ...+..+-|
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHhhccCC
Confidence 32 2367999999999987 689999999999999999999999997332 23332232222 222333334
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
| ++.++|.+|+.. .++|||+.|+++
T Consensus 271 P------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 P------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred H------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 4 577999999999 999999999986
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=296.26 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=194.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|+..+.||.|++|.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 345678999999999999876 689999998864332 23357889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
. ++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.........
T Consensus 82 ~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 82 H-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred c-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 5 6898888643 24578999999999999999999999 99999999999999999999999999998765432211
Q ss_pred cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC------------
Q 010131 354 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------ 420 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 420 (517)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.||...+... ...+... .....
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFR-TLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HhCCCChhhhhhhhHHH
Confidence 1223367889999988664 46889999999999999999999997433211 1111110 00000
Q ss_pred ----CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 ----DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+. .........+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000112235679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=294.47 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=204.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
-|.+.+.||+|.|..|-+|++- +|..||||++.+..- -....+.+|+..|+.++|||||++|.+.......|+|+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556688999999999999765 799999999976533 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe-CCCCcEEEccccCccccCCCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
-.+|+|++|+-.+ ...+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+.++.
T Consensus 99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999763 5679999999999999999999999 999999999999866 556889999999998776653
Q ss_pred cccccccccCCCCcCCCccCCCCCC-ccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. -...+|...|.|||++.+..|+ ++.||||+||+||-|++|+.||+.....+. +..++|-.
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK- 235 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK- 235 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc-
Confidence 3 3456799999999999988776 689999999999999999999984433221 12222321
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
-..+.....++.+||..||..||.+|-+.+||+.
T Consensus 236 -YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 -YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1234455668899999999999999999998864
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.77 Aligned_cols=261 Identities=20% Similarity=0.314 Sum_probs=197.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|++.++||.|++|.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 445789999999999999986 688999999875432 334667889999999999999999999999999999999997
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+ +|.+++........+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++........ .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 5 888888754444578999999999999999999999 9999999999999999999999999999876543221 1
Q ss_pred ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------Cccc
Q 010131 355 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DVIS 424 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 424 (517)
.....++..|++||.+.+ ..++.++||||||+++|+|++|+.||...+..+. ... ........ ....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLK-IFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH-HHHHhCCCChhhHHHHhcCch
Confidence 122346788999998865 4568899999999999999999999975443211 000 00000000 0000
Q ss_pred ccC--ccc----cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVD--PVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d--~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... +.. ...........+.+++.+|++.||.+||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000 00011123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=289.49 Aligned_cols=251 Identities=29% Similarity=0.400 Sum_probs=204.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+.+++|+|++++++++...+..++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 455689999999999999887 589999999876543 446789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.. ...+++..++.++.|+++|++|||+. .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999974 36789999999999999999999962 799999999999999999999999999988765433221
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++..|+|||.+.+..++.++||||||+++|+|+||+.||....... ..+...... ...... .
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~-~~~~~~---------~ 223 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAIC-DGPPPS---------L 223 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHh-cCCCCC---------C
Confidence 23347889999999999899999999999999999999999997443211 112122211 111111 1
Q ss_pred CHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 435 KIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 435 ~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... .+..+.+++.+|+..+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34578899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.94 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=203.3
Q ss_pred HHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
-++++..||.|+||.||+|..++ +-..|.|++........++|+-|+++|..++||+||++++.|...+..++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35667889999999999998875 34456788776667778899999999999999999999999888889999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
||-...++-. -+..+.+.++.-+++|++.||.|||+ ++|+|||||+.|||++-+|.++|+|||.+........ .
T Consensus 113 GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-k 186 (1187)
T KOG0579|consen 113 GGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-K 186 (1187)
T ss_pred CchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHHh-h
Confidence 9999888764 36789999999999999999999999 9999999999999999999999999998865433222 2
Q ss_pred ccccccCCCCcCCCcc-----CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 355 SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
...+.|||.|||||+. ...+|+.++||||||++|.||.-+.+|-.. .+....+. .+.......++.|.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVll-KiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLL-KIAKSEPPTLLQPS 259 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHH-HHhhcCCCcccCcc
Confidence 3456799999999986 456899999999999999999999999752 22222221 22223333333332
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+||.+||..||++.++++
T Consensus 260 -------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 -------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 33446889999999999999999999875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=289.37 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=195.6
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||.|++|.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999886 489999999865432 3446789999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999973 4568999999999999999999999 999999999999999999999999999998765432 12233
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .............. ...+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~---------~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNGK---------LEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCCC---------CCCCccc
Confidence 5788999999998888999999999999999999999999744321 11222222210110 1111112
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=296.35 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=196.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 270 (517)
.|.+.+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 5667789999999999999886 588999999864332 2234577899999999999999999998777 7899999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||++ ++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 86 e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 86 EYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9997 5998888643 3468999999999999999999999 99999999999999999999999999998876543
Q ss_pred CcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh-----------
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK----------- 418 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 418 (517)
... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||........ ...+.....
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHhh
Confidence 221 1223467899999988654 468999999999999999999999974332111 000000000
Q ss_pred c------CCcccccCccccCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 K------GDVISIVDPVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 ~------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ..........+....... ....+.+++.+||+.+|++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000111111111 2456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.78 Aligned_cols=265 Identities=21% Similarity=0.270 Sum_probs=195.1
Q ss_pred HhhhcccCCCCceEEEEEEecC---CcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 268 (517)
|++.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4567889999999999998753 7899999997633 33346778899999999999999999999887 78999
Q ss_pred EEEecCCCCHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC----CCcEEEcccc
Q 010131 269 VYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG 342 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg 342 (517)
||||+++ ++.+.+.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999965 6766664332 22478999999999999999999999 99999999999999999 8999999999
Q ss_pred CccccCCCCc--ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc------HHHHH
Q 010131 343 LSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------IVHWA 413 (517)
Q Consensus 343 ~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~------~~~~~ 413 (517)
++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987644322 11223457889999998766 457899999999999999999999997543322000 00000
Q ss_pred HHHHhc------------CCcccccCccccCCCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 414 RSMIKK------------GDVISIVDPVLIGNVK---------I--ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 414 ~~~~~~------------~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.. .......+........ . .....+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 0000000000000000 0 22346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=291.45 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=201.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|.+.+.||+|++|.||+|.++ +++.|++|++..... ..+.+.+|+++++.++|+|++++++++...+..++|+||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3455678999999999999887 688999999875543 56778899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 99 GGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 999999998532 379999999999999999999999 9999999999999999999999999998876543221 1
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ....... ........+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~------- 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLIT-TKGIPPLKN------- 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hcCCCCCcc-------
Confidence 12234678999999998888999999999999999999999999632211 1111111 111111111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+..+.+++.+|++.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=292.99 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=194.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecC-----CeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-----HQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~~l 268 (517)
.|.+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++... +..++
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 3556788999999999999875 68899999986432 2346678899999999 799999999998653 35799
Q ss_pred EEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 269 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
|+||+++++|.++++... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 999999999999886432 34578999999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCcccccccccCCCCcCCCccCCC-----CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
...... .....++..|+|||.+... .++.++|||||||++|||++|+.||...... ..... +..+..
T Consensus 179 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~~-~~~~~~ 250 (291)
T cd06639 179 TSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLFK-IPRNPP 250 (291)
T ss_pred cccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHHH-HhcCCC
Confidence 432211 1233578899999987543 3688999999999999999999999732211 11111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 251 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 251 PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 1122346889999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=291.85 Aligned_cols=244 Identities=26% Similarity=0.376 Sum_probs=197.2
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
..+||+|+||.||+|... +++.||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 467999999999999875 6899999998655555567799999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++........ .....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 99875 3458999999999999999999999 9999999999999999999999999998876543321 12234
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.. .... .+.... .+.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~----~~~~~~-----~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMK----MIRDNL-----PPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhhC-----CcccCC--cccC
Confidence 5788999999998888899999999999999999999999733221 1111 111110 001000 0112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 335779999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=292.59 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=192.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHH-HhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+++.+.||+|+||.||+|... +|+.||+|.+.... ......+..|+.. ++.++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456788999999999999876 68999999987543 2334556667665 56668999999999999999999999999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+ |+|.+++.... ....+++..++.++.|++.||+|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 68888776432 34578999999999999999999998 6 99999999999999999999999999988654322
Q ss_pred cccccccccCCCCcCCCccCC----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 352 THISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... .+....... +.......
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~~~~ 230 (283)
T cd06617 159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVE-EPSPQLPA 230 (283)
T ss_pred c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHh-cCCCCCCc
Confidence 1 122347889999998865 45688999999999999999999999632111 111111111 11111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+..+.+++.+||..+|++||++.++++
T Consensus 231 --------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 --------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112346889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=288.21 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=199.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 445688999999999999876 58899999986432 234467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999998743 23457999999999999999999999 9999999999999999885 469999999887654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...+ ..++...... +.....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~~------- 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFAPI------- 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCCCC-------
Confidence 1223457889999999988889999999999999999999999996322 2222222221 111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+|++.+|++|||+.|+++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.25 Aligned_cols=259 Identities=23% Similarity=0.265 Sum_probs=196.7
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEEEe
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 272 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 272 (517)
++.+.||+|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|||++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45678999999999999876 58899999997653 33346788999999999999999999999887 789999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++ ++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 82 MD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 97 4888888642 2578999999999999999999999 9999999999999999999999999999987655432
Q ss_pred ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---Ccccc---
Q 010131 353 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISI--- 425 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 425 (517)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||....... ....+....... .....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccc
Confidence 22223346788999997754 467899999999999999999999997433211 111111111000 00000
Q ss_pred -----------cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 -----------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 -----------~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+...........+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000112557889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=293.00 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=197.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCC------ee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~ 266 (517)
..|++.+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+.+++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45667899999999999999886 57899999987543 3456789999999999 7999999999986544 48
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
++||||+++++|.+++.... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999886432 24678999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
........ .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ..... +..+
T Consensus 162 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~ 233 (275)
T cd06608 162 QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFK-IPRN 233 (275)
T ss_pred ecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHH-hhcc
Confidence 65433221 223457889999998753 34678999999999999999999999632111 11111 1111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+ .........+.+++.+||..||++|||+.|+++
T Consensus 234 ~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 111223457889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=284.61 Aligned_cols=247 Identities=29% Similarity=0.485 Sum_probs=202.6
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
...+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++++..+...++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 45678999999999999886 68899999997765556678999999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 83 ~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 83 SLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred cHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 999998743 2578999999999999999999999 9999999999999999999999999999887655432 23
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. +...... ........++ .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~~-------~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIA-TNGPPGLRNP-------E 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHH-hcCCCCcCcc-------c
Confidence 345788999999998888999999999999999999999999733211 1111111 1111111111 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11346889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=294.51 Aligned_cols=254 Identities=28% Similarity=0.367 Sum_probs=194.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 345678999999999999876 58999999986533 234567889999999996 999999999999888999999998
Q ss_pred CCCCHHhHhhcc--CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 274 HNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 274 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
. +++.++.... .....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 5 4555443211 124678999999999999999999997 2599999999999999999999999999987654332
Q ss_pred cccccccccCCCCcCCCccCCC---CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 352 THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.. ....++..|+|||.+.+. .++.++|||||||++|+|++|+.||.... ...+....... +. .+
T Consensus 163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~-----~~ 229 (288)
T cd06616 163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GD-----PP 229 (288)
T ss_pred cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CC-----CC
Confidence 21 223478899999998766 68899999999999999999999996322 11111221111 11 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+...........+.+++.+|++.+|++|||+++|++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12122222344578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=296.32 Aligned_cols=246 Identities=30% Similarity=0.418 Sum_probs=195.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++|||+++++++|.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34677889999999999999875 689999999864322 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||++ |++.+.+... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5777766532 3468999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
....++..|+|||.+. ...++.++||||||+++|||+||+.||...+.. ..... +.....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~-~~~~~~----- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNDS----- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHH-HhcCCC-----
Confidence 2234788999999874 456888999999999999999999999633211 11111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+.+ ........+.+++.+||+.+|++||++.+|+..
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 112234578899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=293.64 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=194.4
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
++.+.||.|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++.+.+..+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45678999999999999875 79999999986443 2233568889999999999999999999999999999999994
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
++|.+++.... ...+++..++.++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 -LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68999887432 2468999999999999999999999 99999999999999999999999999998765432211
Q ss_pred ccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC-------------
Q 010131 355 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------- 420 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 420 (517)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||...+... .............
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1222357889999987654 57889999999999999999999997432211 1111110000000
Q ss_pred --CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 --DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 --~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.. ..........+.+++.+|++.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0001112246789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=317.91 Aligned_cols=270 Identities=19% Similarity=0.238 Sum_probs=188.6
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC--CcEEEEEE--------------ec---CCCchhHHHHHHHHHHHhcCCCCCc
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKI--------------MA---DSCSHRTQQFVTEVALLSRIHHRNL 253 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni 253 (517)
....|++.++||+|+||+||++.++. +..+++|. +. .........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34567888999999999999987642 22222221 10 0112234568899999999999999
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
+++++++...+..++|+|++. ++|.+++.... .........+..++.|++.||+|||+ ++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 999999999999999999984 57777765322 12223456678899999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-ccccHH
Q 010131 332 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIV 410 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~ 410 (517)
.++.+||+|||++...............||..|+|||++.+..++.++|||||||++|||++|..++...... ....+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999999876554333333456899999999999999999999999999999999987654322211 111111
Q ss_pred HHHHHHH-hcCCc-------ccccCccccC---CC------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 411 HWARSMI-KKGDV-------ISIVDPVLIG---NV------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 411 ~~~~~~~-~~~~~-------~~~~d~~l~~---~~------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+.+.... ....+ .+.++..... .. .......+.+++.+||+.||.+|||+.|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000 00000 0000000000 00 00112356788999999999999999999863
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=291.04 Aligned_cols=242 Identities=22% Similarity=0.278 Sum_probs=186.9
Q ss_pred ccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhc---CCCCCccccceeeecCCeeEEEEEecC
Q 010131 202 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSR---IHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 589999999865322 122334455444433 479999999999999899999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++. ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 999999887 34579999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....|+..|+|||.+. +..++.++||||+||++|+|++|..||......... ........ ... .
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~----~ 217 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNV----E 217 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCc----C
Confidence 2235889999999886 456889999999999999999999999743322111 11111100 011 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
.+......+.+++.+||+.||++|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1222344688999999999999999 59888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=290.07 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=191.9
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||+|+||+||+|... +|+.||+|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 68999999986432 22345677899999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence 99987432 2468999999999999999999999 9999999999999999999999999999876543211 2233
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ... +....... . .......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~------~----~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEE-LKRRTLEM------A----VEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHH-HHhccccc------c----ccCCccC
Confidence 467899999999888899999999999999999999999974332111 111 11110000 0 0111122
Q ss_pred HHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 44678999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=295.51 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=198.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCC--CchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
....|++.+.||+||.+.||++...+.+.+|+|++... ......-|.+|+..|.+| .|.+||++++|-..++..|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34557778999999999999999988888998876533 234457799999999999 599999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||- ..+|..+|.... ...+.-.+..+..|++.|+.+.|+ .||||.||||.|+|+- .|.+||+|||.|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9975 569999998542 223322778899999999999999 9999999999999986 57999999999998877
Q ss_pred CCcccc-cccccCCCCcCCCccCCC-----------CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 350 DLTHIS-SVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 350 ~~~~~~-~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
+.+... ...+||+.||+||.+... +.++++||||+||+||+|+.|+.||.. ..+...
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~-----~~n~~a------ 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ-----IINQIA------ 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH-----HHHHHH------
Confidence 665543 346799999999987432 356899999999999999999999961 111111
Q ss_pred hcCCcccccCccccCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 418 KKGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
++..+.||.-.-+++ .....+++++++.||+.||.+||+..|+++.
T Consensus 581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 122334442211111 1122248999999999999999999999873
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=287.77 Aligned_cols=245 Identities=28% Similarity=0.365 Sum_probs=196.1
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||.|+||.||++... +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999865433 3456788999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc------
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------ 352 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~------ 352 (517)
.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999974 3478999999999999999999999 9999999999999999999999999999876433211
Q ss_pred -ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......++..|+|||...+...+.++||||||+++|++++|+.||..... ...... ...+.... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~---~--- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQN-ILNGKIEW---P--- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HhcCCcCC---C---
Confidence 112234477899999999888899999999999999999999999973331 111111 11111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
........+.+++.+|++.+|++|||+.++.+.|+
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 --EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00002456889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=295.88 Aligned_cols=248 Identities=30% Similarity=0.408 Sum_probs=196.1
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..+...+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34566788999999999999875 68899999986432 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||++ |++.+.+.. ....+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9996 577777653 24568999999999999999999999 99999999999999999999999999988754432
Q ss_pred CcccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
....++..|+|||++. +..++.++|||||||++|||++|+.||...+.. .........+. ..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~--- 243 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-PT--- 243 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC-CC---
Confidence 2234788999999873 457889999999999999999999998632211 11111111111 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
.........+.+++.+|++.+|.+||++.+|++..-
T Consensus 244 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 244 -----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 011123346889999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=284.51 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=202.5
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEEEe
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 272 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 272 (517)
...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999887 689999999875542 4567899999999999999999999999888 889999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 83 VSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999874 3489999999999999999999999 9999999999999999999999999999887655432
Q ss_pred c-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 H-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......++..|+|||.+.+...+.++||||||+++|+|++|..||...+ +..............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~--------- 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP--------- 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC---------
Confidence 1 1223457889999999988889999999999999999999999997433 111111111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112222457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=297.62 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=195.3
Q ss_pred cccCCC--CceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
..||+| +||+||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999875 79999999986432 23346788999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc-
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 354 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 354 (517)
++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999987542 3458999999999999999999999 999999999999999999999999998654322111000
Q ss_pred -----ccccccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH------------
Q 010131 355 -----SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS------------ 415 (517)
Q Consensus 355 -----~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~------------ 415 (517)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 1112245679999998763 47899999999999999999999997432110 00000000
Q ss_pred ----HH----------------hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 010131 416 ----MI----------------KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 472 (517)
Q Consensus 416 ----~~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~ 472 (517)
.. ..+......+..+...........+.+++.+||+.||++|||+.|+++. ++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00 0000001111111112223455678999999999999999999999753 454444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=295.61 Aligned_cols=265 Identities=22% Similarity=0.251 Sum_probs=196.5
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC----
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH---- 264 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 264 (517)
.....|.+.+.||+|+||.||+|..+ +|+.||+|.++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34456777899999999999999986 58899999986542 223356778999999999999999999887654
Q ss_pred ------eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 265 ------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 265 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
..++|+||+++ ++.+.+... ...+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 777766532 3468999999999999999999999 99999999999999999999999
Q ss_pred ccccCccccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 339 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998765433222222345778999998754 45788999999999999999999999733211 1111111111
Q ss_pred hcCC---cccc--------cCcccc--C---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 418 KKGD---VISI--------VDPVLI--G---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 418 ~~~~---~~~~--------~d~~l~--~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... ...+ .++... . ......+..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 0000 000000 0 000012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=291.61 Aligned_cols=256 Identities=23% Similarity=0.266 Sum_probs=192.7
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCCccccceeeecC--CeeEEEEEe
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILVYEY 272 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~ 272 (517)
++.++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999865 68999999987542 222334567899999885 99999999999887 889999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++ ++|.+.+... ...+++.+++.++.|++.||+|||+ .+++||||+|+||+++. +.+||+|||++........
T Consensus 82 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 82 MD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred CC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 96 5888887642 3578999999999999999999999 99999999999999999 9999999999987643322
Q ss_pred ccccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH-----------hcC
Q 010131 353 HISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-----------KKG 420 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 420 (517)
. ....++..|+|||++. +..++.++|||||||++|||++|+.||...+..+ ...+..... ...
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccc
Confidence 1 2234688999999764 4567889999999999999999999997443211 111111111 111
Q ss_pred CcccccCccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.... .........+.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 111111110000 001123567899999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=288.62 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=202.1
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.++||+|++|.||++... +++.+++|.+.... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 445688999999999999765 68899999987532 234567888999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999986532 24578999999999999999999999 999999999999999999999999999998765542
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.. . .......+...
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~--------- 219 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------D-LRYKVQRGKYP--------- 219 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCCCC---------
Confidence 22234788999999999989999999999999999999999999743321 1 11112222211
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112234457899999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.25 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=192.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 456788999999999999865 688999999865432 223467789999999999999999999999999999999995
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++........
T Consensus 87 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 87 -TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred -CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 6777776532 3467888899999999999999999 99999999999999999999999999998764332211
Q ss_pred ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------Cccc
Q 010131 355 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DVIS 424 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 424 (517)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+... .....+...+... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhccc
Confidence 122346889999999865 357889999999999999999999997433211 0100011000000 0000
Q ss_pred ccCccc----cCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVL----IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l----~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...... .... .......+.+++.+|++.||.+|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 0000 0011346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=299.62 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=195.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Ce
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 265 (517)
..|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45666789999999999999875 68999999986432 23345677899999999999999999987543 35
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+. ++|.+.+.. .++...+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 699999995 588887752 28889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccc------------cHHHH-
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL------------NIVHW- 412 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~------------~~~~~- 412 (517)
....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... .+...
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 7644322 22334788999999999999999999999999999999999999744321100 00000
Q ss_pred ---HHHHHhcCC------cccccCccc----cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 413 ---ARSMIKKGD------VISIVDPVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 413 ---~~~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......... +........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000000000 001112345567899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=283.11 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=201.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999876 578999999976543 45578999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999874 3678999999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||...+. . ....... ......
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~-~~~~~~--------- 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----M-AALFRIV-QDDHPP--------- 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----H-HHHHHHh-ccCCCC---------
Confidence 2234578899999999888889999999999999999999999963321 1 1111111 111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+......+.+++.+||..+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11112346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.82 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=192.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCC-CCCccccceeeecCCe-----eE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ-----RI 267 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~ 267 (517)
|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 455688999999999999876 689999998765422 23457888999999995 6999999999877665 79
Q ss_pred EEEEecCCCCHHhHhhccCC--CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCc
Q 010131 268 LVYEYMHNGTLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 344 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a 344 (517)
+||||+++ +|.+++..... ...+++..++.++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 88888765332 3568999999999999999999999 99999999999999998 899999999998
Q ss_pred cccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+... .... +...+......
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTPTEQ 234 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCCChh
Confidence 765332111 112235788999998765 467899999999999999999999997432211 0111 00111000000
Q ss_pred ---ccc---C----cccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 ---SIV---D----PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ---~~~---d----~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... + +... ..........+.+++.+||+.||.+||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0 0000 0001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.23 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=193.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 268 (517)
.|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4566789999999999999865 68999999986432 23446688899999999999999999987543 35789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+||++ ++|.+.+. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999996 58887775 4568999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcc--cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC---c
Q 010131 349 EDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---V 422 (517)
Q Consensus 349 ~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 422 (517)
..... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+... ....+...+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 32211 1123457889999998654 568899999999999999999999996433211 1111111111000 0
Q ss_pred ccccCcc-------c--cCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 423 ISIVDPV-------L--IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 423 ~~~~d~~-------l--~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+.+.. . .... .......+.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0 0000 01123468899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=290.83 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=199.9
Q ss_pred HhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 267 (517)
|.+.+.||+|++|.||++... +++.||||.++... ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 345688999999999999753 57889999986432 12345688999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++.. ...+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999873 4568899999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcccccccccCCCCcCCCccCCCC--CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
............++..|+|||.+.+.. .+.++||||||+++|||++|..||...... ....+.........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~----- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK----- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC-----
Confidence 443322223345788999999987654 788999999999999999999999632211 11122222222111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
+. ........+.+++.+||+.+|++|||++++.+.|+..
T Consensus 229 --~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --PP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --CC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11 1111223678999999999999999999988877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=285.33 Aligned_cols=239 Identities=23% Similarity=0.318 Sum_probs=185.5
Q ss_pred hhhcc--cCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 198 NFCKK--IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 198 ~~~~~--lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+.+. ||+|+||.||++..+ ++..+|+|.......... |+.....+ +|||++++++++...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 599999999999875 688899999865322111 22222222 7999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++.. ...+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++.......
T Consensus 92 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 92 KDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 99999999974 3489999999999999999999999 9999999999999999998 99999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.... ........+.... . ... ..
T Consensus 165 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~-~~~-~~------- 229 (267)
T PHA03390 165 ----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE-DEELDLESLLKRQ-Q-KKL-PF------- 229 (267)
T ss_pred ----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-cchhhHHHHHHhh-c-ccC-Cc-------
Confidence 2347889999999998899999999999999999999999997332 2222222222211 1 000 00
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~ 465 (517)
.......+.+++.+||+.+|.+||+ ++|+++
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 --IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1123346889999999999999996 688874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=287.49 Aligned_cols=244 Identities=27% Similarity=0.294 Sum_probs=189.7
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHH-hcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALL-SRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.||+|+||.||+|... +|+.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999875 589999999865322 1223345555554 445899999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999873 4568999999999999999999999 9999999999999999999999999998876433 1
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.. .... .+..+... .. ....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~--~~----~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFD-NILSRRIN--WP----EEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHH-HHHhcccC--CC----Cccc
Confidence 2334788999999998888899999999999999999999999733221 1111 11111110 00 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
......+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123456889999999999999998876655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=296.18 Aligned_cols=260 Identities=23% Similarity=0.228 Sum_probs=193.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 270 (517)
.|++.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++++++|+|++++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4566788999999999999876 5899999998643222 223567899999999999999999998654 4689999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+. ++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+......
T Consensus 88 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 88 EYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred ecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9996 5888887643 3568999999999999999999999 99999999999999999999999999999876543
Q ss_pred CcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC--Ccc----
Q 010131 351 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DVI---- 423 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~---- 423 (517)
... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+... ....+....... ...
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhh
Confidence 211 122235778999999865 567899999999999999999999997433211 111111111000 000
Q ss_pred -----ccc--CccccCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 -----SIV--DPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 -----~~~--d~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ....... ........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0000000 00112446779999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=295.71 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=191.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCC--------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 264 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 264 (517)
.|.+.++||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4667889999999999999876 689999998864322 22345678999999999999999999986644
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++||||+. ++|.+.+... ...+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3599999996 5888877632 3468999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcc---cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 345 RQAEEDLTH---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 345 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
......... ......++..|+|||.+.+. .++.++||||||+++|||+||+.||...+..........+...+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 865432211 11223467889999988654 46889999999999999999999997443221111111111000000
Q ss_pred Ccccc-----cCc-cccCCC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DVISI-----VDP-VLIGNV---------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~~~~-----~d~-~l~~~~---------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... .+. ...... .......+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000 000000 0001235679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=290.11 Aligned_cols=261 Identities=21% Similarity=0.245 Sum_probs=193.1
Q ss_pred hhcccCCCCceEEEEEEecCCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345566666666666655 5899999998754 3345578999999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc----
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---- 352 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~---- 352 (517)
+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999997542 3468899999999999999999999 9999999999999999999999999998875432111
Q ss_pred --ccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH----hc-----
Q 010131 353 --HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI----KK----- 419 (517)
Q Consensus 353 --~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~----- 419 (517)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+.. ....+...... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 11122346778999999865 35788999999999999999999999733211 11111110000 00
Q ss_pred --CCccc----ccCcccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 420 --GDVIS----IVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 420 --~~~~~----~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..... ..++... ..........+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 0001000 01122334568899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=300.91 Aligned_cols=261 Identities=19% Similarity=0.311 Sum_probs=195.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec----CCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 268 (517)
.|.+.+.||+|++|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 4556788999999999999876 68999999987542 2344667889999999999999999998753 346799
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+||+. ++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 86 VMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 999995 68988886 34569999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcc---cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh------
Q 010131 349 EDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK------ 418 (517)
Q Consensus 349 ~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 418 (517)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... ...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHh
Confidence 32211 1123357889999998765 5688999999999999999999999974432111 000000000
Q ss_pred -----cCCcccccCcc-ccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 419 -----KGDVISIVDPV-LIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 419 -----~~~~~~~~d~~-l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........+.. .... ........+.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 0000 011234578999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=300.98 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=196.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 267 (517)
.|.+.+.||+|+||+||+|... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3555788999999999999865 6899999998653 223345677899999999999999999988654 3479
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 86 IVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999995 78988886 34679999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-------
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------- 419 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 419 (517)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... ..........
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 159 SEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDLG 234 (337)
T ss_pred CCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHhh
Confidence 43321 1223347889999998764 5688999999999999999999999974432110 1101110000
Q ss_pred ----CCcccc-------cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhh
Q 010131 420 ----GDVISI-------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 470 (517)
Q Consensus 420 ----~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~ 470 (517)
...... .++... .........+.+++.+||+.+|++|||++|+++. ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000 000000 0011234567899999999999999999999886 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=284.90 Aligned_cols=249 Identities=30% Similarity=0.463 Sum_probs=203.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||.||++... +++.|++|++..... ...+.+.+|+++++.++|||++++++.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345678999999999999876 688999999875433 45567889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++++|.+++.... ....+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999987532 24679999999999999999999999 899999999999999999999999999998765443
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.......+++.|+|||...+..++.++||||+|+++|+|++|+.||...+. .+...... ......+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~------- 223 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-KGQYPPI------- 223 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-cCCCCCC-------
Confidence 122334578899999999888899999999999999999999999963321 11122221 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||..+|++|||+.|+++
T Consensus 224 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 --PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=291.14 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=198.2
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.+.+.||+|++|.||+|... +++.+++|.+..... .....+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34578999999999999875 688999999875433 245678899999999999999999999999999999999997
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+ ++.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+........ .
T Consensus 82 ~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~ 154 (283)
T cd05118 82 T-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-P 154 (283)
T ss_pred C-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-c
Confidence 5 888887642 3578999999999999999999999 9999999999999999999999999999887655431 1
Q ss_pred ccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---CcccccC---
Q 010131 355 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIVD--- 427 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d--- 427 (517)
.....++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...+..+ ........+... ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhh
Confidence 2223477889999998776 78999999999999999999999996433211 111111111000 0000000
Q ss_pred --------ccc--cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 --------PVL--IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 --------~~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ...........+.+++.+||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00111234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=291.56 Aligned_cols=257 Identities=20% Similarity=0.246 Sum_probs=184.6
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCchh-H----------HHHHHHHHHHhcCCCCCccc
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-T----------QQFVTEVALLSRIHHRNLVP 255 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~niv~ 255 (517)
++....|.+.+.||+|+||+||+|.+.+ +..+|+|+........ . .....+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4445567788999999999999998764 3456666543221110 0 11223344566678999999
Q ss_pred cceeeecCC----eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 256 LIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 256 ~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
+++++.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ .+++||||||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVD 160 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEc
Confidence 998765443 3467777763 466666652 2345788889999999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc
Q 010131 332 INMRAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 405 (517)
.++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999865332111 1122458999999999999999999999999999999999999997442211
Q ss_pred cccHHHHHH----HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 406 ELNIVHWAR----SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 406 ~~~~~~~~~----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
....... ..+..+... ....+..+.+++..|++.+|++||+++++++.|
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 --NLIHAAKCDFIKRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred --HHHHHhHHHHHHHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111111 111111110 011235688999999999999999999999876
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=282.04 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=194.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 268 (517)
|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999875 5899999987532 123446788999999999999999999998664 45789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
++||+++++|.+++.. ...+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999873 3568899999999999999999999 999999999999999999999999999998653
Q ss_pred CCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||..... ...+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTK---- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCC----
Confidence 3111 111234578899999999988899999999999999999999999963211 1111111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+......+.+++.+|++ +|..||++.+++.
T Consensus 228 -----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 -----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11122233468899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.66 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=202.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC-----eeEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRIL 268 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 268 (517)
|.+.+.||.|++|.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999876 48999999987643 334567899999999999999999999987765 7899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||++ ++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+....
T Consensus 82 v~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999997 589888873 4489999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCc--ccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------
Q 010131 349 EDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 419 (517)
Q Consensus 349 ~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 419 (517)
.... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHh
Confidence 4321 112233478899999999887 889999999999999999999999974432110 0101100000
Q ss_pred -----CCcccccCc---c---ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhh
Q 010131 420 -----GDVISIVDP---V---LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 472 (517)
Q Consensus 420 -----~~~~~~~d~---~---l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~ 472 (517)
......+.. . -...........+.+++.+||+.+|++||+++++++. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 0 0000011134568899999999999999999999984 665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=287.55 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=195.7
Q ss_pred HhhhcccCCCCceEEEEEEe----cCCcEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeE
Q 010131 197 NNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 267 (517)
|++.+.||.|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 34568899999999999976 368999999987532 22346688899999999 5999999999999998999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999873 4568899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ................
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~---- 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSEP---- 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccCC----
Confidence 44322222334578899999998653 467899999999999999999999963222 1122222222221111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
..+......+.+++.+|++.+|++|| ++++++.
T Consensus 230 -------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 -------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01112234678999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=288.27 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=195.2
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
...++...+.||+|+||.||+|... +++.||+|.+... ......++.+|+++++.++|+|++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3445666788999999999999875 5788999988642 22334578899999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+. |++.+.+... ...+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999996 6887776532 3568999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.. ....++..|+|||.+. ...++.++|||||||++|+|++|+.||...+.. ..... ...+.....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~ 234 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNESPAL 234 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHH-HhhcCCCCc
Confidence 32 2234788999999874 356788999999999999999999998632211 11111 111111110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
. .......+.+++.+||+.+|++||+++++++.
T Consensus 235 ~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 Q--------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred C--------cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0 11233467899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=297.78 Aligned_cols=262 Identities=25% Similarity=0.331 Sum_probs=195.5
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcC-CCCCccccceeeecC--CeeE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE--HQRI 267 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~ 267 (517)
...|.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 346777899999999999999876 5889999988542 223345677899999999 999999999998653 3679
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999996 599888863 378899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCc----ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH-----
Q 010131 348 EEDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI----- 417 (517)
Q Consensus 348 ~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 417 (517)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||........ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSA 234 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 43321 12223457889999998754 5678899999999999999999999964332111 00000000
Q ss_pred ------hcCCcccccCcccc------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 418 ------KKGDVISIVDPVLI------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 418 ------~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+++.... ..........+.+++.+|++.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 00011134578899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=297.23 Aligned_cols=243 Identities=28% Similarity=0.410 Sum_probs=202.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|.|+.|.+|++. ++..||+|.+.+..-. ..+.+.+|+++|..++|||||+++.+.......|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 445689999999999999876 6899999999875432 3355889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
.+|.+++++. +.+...+.....++.|+.+|++|||+ +.|+|||||++|||++.+..+||+|||++..+... .
T Consensus 138 ~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~ 209 (596)
T KOG0586|consen 138 SGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--L 209 (596)
T ss_pred cCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--c
Confidence 9999999998 45566668889999999999999999 99999999999999999999999999999988643 3
Q ss_pred cccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....+|++.|.|||++.+..+ ++.+|+||+|+++|-|+.|..||++.....- -++.+.+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------------r~rvl~g 270 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------------RPRVLRG 270 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------------cchheee
Confidence 4556779999999999988765 5799999999999999999999985443211 1111111
Q ss_pred CC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~--~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+ +.....++.+++++++-.+|.+|++++++.+.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11 11122257799999999999999999999764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.32 Aligned_cols=264 Identities=26% Similarity=0.421 Sum_probs=212.8
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC--------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
|+......+.+.||+|.||.||+|.... ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 5555555677799999999999997541 45799999986543 4567899999999999 699999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccC-----CC--------CccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSV-----NQ--------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
...+..++|+||+..|+|.++++... .. ..++..+++.++.|||.|++||++ .+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999998654 01 248999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcccccccc--cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 404 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~ 404 (517)
||+..+..+||+|||+++.............. -+..|||||.+....++.|+|||||||+|||++| |..||.+-.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999976554333322222 2456999999999999999999999999999999 889986311
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
...++ ...+++|...+ .+..+..++.++++.||+.+|++||++.|+++.|+..+.
T Consensus 527 ~~~~l----~~~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEEL----LEFLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHH----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11112 22455554322 222334578899999999999999999999999999543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=284.93 Aligned_cols=241 Identities=22% Similarity=0.279 Sum_probs=186.7
Q ss_pred ccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHH---HhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 202 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL---LSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999865321 112234444443 444579999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 999999886 34579999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.......... ....... .++.+..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~~~- 220 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVELPD- 220 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCCCC-
Confidence 233588999999998754 68899999999999999999999997432221111 1111110 0111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.....+.+++.+|+..+|.+|| ++.++++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1234688999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=284.56 Aligned_cols=259 Identities=22% Similarity=0.272 Sum_probs=193.1
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCCccccceeeecCCe-----e
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQ-----R 266 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~ 266 (517)
++.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.+++++ +|||++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999987 489999999874322 2234566788777666 59999999999987776 8
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999996 58988886432 3468999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc---
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--- 423 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 423 (517)
....... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||......+ ............+...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCC
Confidence 6443221 22336788999999999899999999999999999999999987433211 1111111000000000
Q ss_pred ------cccCcccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 ------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........ ..........+.+++.+||+.||.+||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111233456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=286.04 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=194.9
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.+.+.||+|++|+||+|... +++.|++|.+..... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45688999999999999986 478899999865432 23334567999999998 999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++.... ...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 889999887432 3578999999999999999999999 99999999999999999999999999999876443221
Q ss_pred ccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc-HH---------HHHHHHHhcCCcc
Q 010131 355 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV---------HWARSMIKKGDVI 423 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~-~~---------~~~~~~~~~~~~~ 423 (517)
....++..|+|||.+. +..++.++|+||||+++|||++|+.||......+... .. .|...........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 2234788999999874 4567899999999999999999999996443211100 00 0000000000000
Q ss_pred cccCccc---cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+.... ...........+.+++.+|++.+|++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 00000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=291.26 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=192.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|++|+||+|... +|+.||+|.+..... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 556788999999999999876 688999999864322 23456889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+ ++|.+++... ....+++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++........
T Consensus 84 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 84 D-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred c-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 5 5788877543 23346888889999999999999999 99999999999999985 56799999999976543221
Q ss_pred ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc-----
Q 010131 353 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV----- 426 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 426 (517)
. .....++..|+|||++.+ ..++.++||||+|+++|+|+||+.||...+..+ .+.. ........ .....
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~-~~~~~~~~-~~~~~~~~~~ 233 (294)
T PLN00009 159 T-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFK-IFRILGTP-NEETWPGVTS 233 (294)
T ss_pred c-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCC-Chhhcccccc
Confidence 1 122346789999998865 457899999999999999999999997432211 0110 00000000 00000
Q ss_pred --C-----ccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 --D-----PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 --d-----~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 001112345789999999999999999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.40 Aligned_cols=257 Identities=20% Similarity=0.209 Sum_probs=192.4
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchh--------------HHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--------------TQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
+.+.||+|+||+||+|... +++.||||++....... ...+.+|++++++++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3567999999999999865 68999999986432211 12477899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 68999886 34568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC-------------cccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccH
Q 010131 344 SRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 409 (517)
Q Consensus 344 a~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~ 409 (517)
+....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 87654110 0111122357789999998764 46899999999999999999999997443211 1
Q ss_pred HHHHHHHHhcCCcc---ccc--------Ccccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 410 VHWARSMIKKGDVI---SIV--------DPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 410 ~~~~~~~~~~~~~~---~~~--------d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.......... ... ..... ..........+.+++.+||+.+|++|||++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111110000 000 00000 0000112346889999999999999999999986
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=268.67 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=193.8
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+...||.|..|.||+++.+ .|...|||.+.+.. .+..++++..+.++..- +.|.||+.+|||..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 5677999999999999887 58999999997653 34567788888887766 48999999999999988899999883
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
.-+...++. -.+++++.-+-++...++.||.||.+ +++|+|||+||+|||+|+.|++|+||||.+-.+-+...+
T Consensus 175 ~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 175 TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 344444443 24668888888999999999999998 589999999999999999999999999999887665443
Q ss_pred cccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 356 SVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....|.+.|||||.+. ...|+.++||||||+.++||.||+.||.+.+.+- +.+...+.+ .. |.+..
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~--eP----P~L~~ 317 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNE--EP----PLLPG 317 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhc--CC----CCCCc
Confidence 3345889999999985 4578889999999999999999999998543321 111122221 11 22222
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. .....+.+++..||++|+.+||...++++
T Consensus 318 ~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 13346889999999999999999998875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=285.67 Aligned_cols=246 Identities=27% Similarity=0.392 Sum_probs=198.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++ ||||+++++++..++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456788999999999999876 68999999986532 233467889999999998 9999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999973 4579999999999999999999999 999999999999999999999999999988654432
Q ss_pred c-------------------ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 010131 352 T-------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 412 (517)
Q Consensus 352 ~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 412 (517)
. .......++..|+|||...+..++.++||||||++++++++|+.||..... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~ 230 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------YLT 230 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------HHH
Confidence 1 112233467899999999888899999999999999999999999974331 111
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM----QEIVL 465 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~evl~ 465 (517)
...... .. ...+......+.+++.+||+.+|.+||++ +++++
T Consensus 231 ~~~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILK-LE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHh-cC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 00 01111224468899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=283.89 Aligned_cols=244 Identities=30% Similarity=0.423 Sum_probs=192.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+...++||+|+||+||+|... +++.|++|++..... .....+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 333577999999999999875 688999999864322 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+. |++.+++.. ....+++.+++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 577777753 24568999999999999999999999 99999999999999999999999999988653321
Q ss_pred ccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
....|+..|+|||++. ...++.++||||||+++|+|++|..||...+. ......... .......
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~--- 241 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NDSPTLQ--- 241 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh-cCCCCCC---
Confidence 2345788999999974 45688899999999999999999999863321 111111111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122357899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=284.32 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=192.7
Q ss_pred HHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.+.+.+.||+|+||.||+|.+++ ++.||||.+.... ......+..|+.++.+. .||||+++++++.+....++||||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 45678899999999999999874 8999999987543 23345667788777777 499999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++ +++.++.... ...+++..+..++.|++.||+|||+ ..+++||||+|+||+++.++.+||+|||++........
T Consensus 96 ~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 96 MS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred cC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 85 5777766542 3478999999999999999999996 25999999999999999999999999999876543322
Q ss_pred ccccccccCCCCcCCCccCCCC----CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
. ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... .......
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~~ 242 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPSLPPN 242 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCCCCCC
Confidence 1 2234678999999987553 788999999999999999999999632111 11111222111 1111000
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......+.+++.+||+.||++||++.++++.
T Consensus 243 -------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 243 -------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0123468899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=269.12 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=199.1
Q ss_pred hcccCCCCceEEEEEE-ecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 200 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
.+.||+|+|+.|--+. ..+|.++|||++.+...+...++.+|++++... .|+||++++++|+++...|+|||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4679999999999885 558999999999988888888999999999999 59999999999999999999999999999
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEEccccCccccCC--CCc
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEE--DLT 352 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~--~~~ 352 (517)
|..+++ ...-+++.+..++..+|+.||.|||. +||.|||+||+|||-..... +|||||.+...+.. +..
T Consensus 163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999998 46789999999999999999999999 99999999999999976544 89999988765322 111
Q ss_pred cc----ccccccCCCCcCCCcc-----CCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-----ccc---cHHHHHHH
Q 010131 353 HI----SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AEL---NIVHWARS 415 (517)
Q Consensus 353 ~~----~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-----~~~---~~~~~~~~ 415 (517)
.. -...+|+..|||||+. ....|+.++|.||+|+++|-|++|.+||.+.-.. .+. .-.+..-.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 11 1234578899999975 2346888999999999999999999999753321 111 11112223
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+++|.+ ++.|.. ......+-.+++...+..++.+|-++.++++
T Consensus 317 sIQEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3334432 111111 1123335568888899999999999999987
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=280.52 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=194.1
Q ss_pred HhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|.+.++||+|+||.||++.... +..+++|+++... .....++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567899999999999998763 4556666654321 223345778999999999999999999999888999999
Q ss_pred EecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 271 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
||+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999886432 34679999999999999999999999 99999999999999975 5699999999876543
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ......... .+.. +
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~-~~~~-----~- 223 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIV-EGPT-----P- 223 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHH-cCCC-----C-
Confidence 322 1223447889999999988888999999999999999999999996322 111111111 1111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+......+.+++.+|++.+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112233457889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=290.95 Aligned_cols=262 Identities=22% Similarity=0.275 Sum_probs=190.8
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeecCC-------
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 264 (517)
..|.+.++||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34566789999999999999876 6899999998643222 2346778999999999999999999875433
Q ss_pred -eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 265 -QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 265 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
..++|+||+.+ ++...+.. ....+++.++..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||+
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46899999964 67776653 24579999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCccc----------ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 010131 344 SRQAEEDLTHI----------SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 412 (517)
Q Consensus 344 a~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 412 (517)
+.......... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~~ 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LHL 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 97654322111 122346788999998765 4578999999999999999999999974332211 111
Q ss_pred HHHHHhc---------CCcccccCccccCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 413 ARSMIKK---------GDVISIVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 413 ~~~~~~~---------~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....... .......+.......+ ......+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111000 0000000000000000 112246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=281.75 Aligned_cols=257 Identities=24% Similarity=0.302 Sum_probs=196.2
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.+.||+|++|.||+|... +++.||+|++.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4578999999999999877 48999999987653 2334678889999999999999999999999999999999997
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+......... .
T Consensus 82 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 82 MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 5899999743 2479999999999999999999999 99999999999999999999999999998876443221 1
Q ss_pred cccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------Ccc--
Q 010131 356 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DVI-- 423 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~-- 423 (517)
....++..|+|||.+.+. .++.++||||||+++||+++|+.||....... ....+....... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccccc
Confidence 223356789999998766 88999999999999999999999997433211 111111111000 000
Q ss_pred cccCccccC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...-+.... .........+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 001112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=274.91 Aligned_cols=236 Identities=30% Similarity=0.386 Sum_probs=192.5
Q ss_pred cCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 203 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
||.|+||.||++... +++.+++|.+..... ...+.+..|++++++++|||++++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 589999999875432 2446788999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999973 3468999999999999999999999 9999999999999999999999999999887644321 12334
Q ss_pred ccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
.++..|+|||...+...+.++|+||||+++|++++|+.||...+. ......... +.. ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~----------~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-DPL----------RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-CCC----------CCCCCC
Confidence 578899999999888889999999999999999999999963332 111111111 110 011111
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQE 462 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~e 462 (517)
...+.+++.+||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 346789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=292.69 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=190.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecC-----------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE----------- 263 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----------- 263 (517)
+|.+.+.||.|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4566789999999999999875 6889999998766555667789999999999999999999876543
Q ss_pred ---CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEc
Q 010131 264 ---HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVS 339 (517)
Q Consensus 264 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~ 339 (517)
...++|+||++ ++|.+++. ...+++..++.++.|++.||.|||+ .+++||||||+||+++. ++.++|+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 58888875 3468999999999999999999999 99999999999999974 5678999
Q ss_pred cccCccccCCCCccc--ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 010131 340 DFGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 340 Dfg~a~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
|||.+.......... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~------~~~~ 231 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ------MQLI 231 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 999987654322111 122346889999997654 5678899999999999999999999964322110 0000
Q ss_pred HhcCC---------cccccCc-----cccCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 417 IKKGD---------VISIVDP-----VLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 417 ~~~~~---------~~~~~d~-----~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... ....... ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 0000000 000000 0112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=274.56 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=208.2
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeec-CC
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE-EH 264 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 264 (517)
.+.+.+....+-+|.||.||.|.|.+ .+.|.||.++...+. ....++.|.-.+..+.|||+.++.+++.+ ..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 34444556779999999999997653 456778877765443 45678899999999999999999998755 55
Q ss_pred eeEEEEEecCCCCHHhHhh-----ccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc
Q 010131 265 QRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
..+++|.++.-|+|..++. +......++..+...++.|++.|++|||+ ++++|.||.++|.++|+..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEec
Confidence 7789999999999999998 33345678888999999999999999999 999999999999999999999999
Q ss_pred cccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH
Q 010131 340 DFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 340 Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
|-.+++...+...+ .......+..||+||.+.+..++.++||||||+++|||+| |+.|+..-+.-+ +...+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~yl 511 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHYL 511 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHHH
Confidence 99999976554333 3334456779999999999999999999999999999998 999986322211 22333
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
++|.. -..+..++++++.++.-||...|++||+.+|++.-|.+.
T Consensus 512 kdGyR---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 KDGYR---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred hccce---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 33321 123445777899999999999999999999999988764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=291.55 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=194.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------ee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 266 (517)
.|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 3445688999999999999865 68999999986532 223356889999999999999999999886542 46
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+||+. .+|..+. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 96 ~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 96 YLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 89999996 4776654 2358899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH--------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-------- 417 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 417 (517)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... ........
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 167 ADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHH
Confidence 53321 22346788999999866 4688999999999999999999999974332110 00000000
Q ss_pred ---hcCCcccccC--ccc-cCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhhhhhc
Q 010131 418 ---KKGDVISIVD--PVL-IGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKIEK 475 (517)
Q Consensus 418 ---~~~~~~~~~d--~~l-~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~~~ 475 (517)
.......... +.. .... .......+.+++.+||+.||++||+++|++.. ++.....+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 0000000000 000 0000 00123357899999999999999999999954 777765443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.94 Aligned_cols=245 Identities=28% Similarity=0.386 Sum_probs=195.2
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+.+||.|.||.||-|... +|.-.|+|-++-.. ......+.+|..++..++|||+|+++|+-.+.+..++.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 457999999999999754 68889999876432 233466889999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc--
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-- 354 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-- 354 (517)
+|.+.+. .+...++.....+..|++.|++|||+ +|||||||||.||+++.+|.+|++|||.|..+.......
T Consensus 1320 sLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999987 35556777777789999999999999 999999999999999999999999999999876553221
Q ss_pred -ccccccCCCCcCCCccCCCC---CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 355 -SSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 355 -~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
-....||+.|||||++.+.. ...++||||+|||+.||+||+.||...+. ...+.. .+.-|....+.
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy----~V~~gh~Pq~P---- 1463 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMY----HVAAGHKPQIP---- 1463 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHh----HHhccCCCCCc----
Confidence 23456999999999996543 45689999999999999999999973322 211111 22223332222
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+=.+++.+||+.||+.|+++.|+++
T Consensus 1464 -----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1464 -----ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -----hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 222334568999999999999999987765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=290.60 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=189.6
Q ss_pred HhhhcccCCCCceEEEEEEec-C--CcEEEEEEecCCCc--hhHHHHHHHHHHHhcC-CCCCccccceeeecC----Cee
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-D--GKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE----HQR 266 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~ 266 (517)
|.+.+.||+|+||.||++... . +..||+|++..... ...+.+.+|+.+++++ +||||+++++++... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456788999999999999876 3 77899999865322 2345688899999999 599999999875332 356
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++++||+. ++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 78888885 68998886 35678999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCcc---cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh----
Q 010131 347 AEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---- 418 (517)
Q Consensus 347 ~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 418 (517)
....... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 5432211 1123457889999998765 568899999999999999999999997433211 0000000000
Q ss_pred -------cCCcccc---cC--c-cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 -------KGDVISI---VD--P-VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 -------~~~~~~~---~d--~-~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....... .. + .............+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00 0 0000000112346889999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=306.48 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=182.8
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeec---------------
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------------- 262 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------------- 262 (517)
.+.||+||||.||+++.+ ||+.||||++.-.. ......+.+|+.+|++|+|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 468999999999999988 89999999987543 2334668899999999999999987421100
Q ss_pred --------------------------------------------------------------------------------
Q 010131 263 -------------------------------------------------------------------------------- 262 (517)
Q Consensus 263 -------------------------------------------------------------------------------- 262 (517)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------C--------CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 010131 263 ----------------E--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318 (517)
Q Consensus 263 ----------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 318 (517)
. ...|+-||||+...+.++++.+... -.....|+++++|++||+|+|+ +||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~---~gi 718 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHD---QGI 718 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHh---Cce
Confidence 0 1247889999988888888743211 1467789999999999999999 999
Q ss_pred EecCCCCCCeEeCCCCcEEEccccCccccC------C-----------CCcccccccccCCCCcCCCccCCC---CCCcc
Q 010131 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAE------E-----------DLTHISSVARGTVGYLDPEYYGNQ---QLTEK 378 (517)
Q Consensus 319 vH~dlk~~Nill~~~~~~kl~Dfg~a~~~~------~-----------~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~ 378 (517)
|||||||.|||+|++..+||+|||+|+... . ......+...||.-|+|||++.+. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998721 0 001122345699999999999765 49999
Q ss_pred ceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 010131 379 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 458 (517)
Q Consensus 379 ~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 458 (517)
+|+||+||+++||+. ||... . ....+...++.+.+..- ..+.......=..+|++|++.||.+||
T Consensus 799 iDmYSLGIVlFEM~y---PF~Ts-M-----ERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTS-M-----ERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCch-H-----HHHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCC
Confidence 999999999999984 45411 1 11112233444444332 111222233446899999999999999
Q ss_pred CHHHHHH
Q 010131 459 KMQEIVL 465 (517)
Q Consensus 459 s~~evl~ 465 (517)
|+.|+++
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=265.81 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=194.3
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeec----CCeeEEEEEec
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYM 273 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~ 273 (517)
.++||-|-.|.|-.+..+ +++.+|+|++.+. ...++|++..-.. .|||||.+++++.. .....+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 378999999999999876 6899999998753 3455788775555 69999999998754 44678999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~ 350 (517)
+||.|.+.+.+. ....+++.++..|+.||+.|+.|||+ .+|.||||||+|+|... |..+||+|||+|+.....
T Consensus 142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999865 46679999999999999999999999 99999999999999964 456999999999986643
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. ....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.. ..+ ..+..-++..+..|.+. +.+
T Consensus 218 ~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS-~hg--~aispgMk~rI~~gqy~-FP~--- 288 (400)
T KOG0604|consen 218 GD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHG--LAISPGMKRRIRTGQYE-FPE--- 288 (400)
T ss_pred cc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc-cCC--ccCChhHHhHhhccCcc-CCC---
Confidence 22 2334469999999999999999999999999999999999999962 221 22222234444444321 111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+...++|+.+|..+|.+|.|+.|++.
T Consensus 289 --pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 289 --PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred --hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 112234456779999999999999999999876
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=285.04 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=192.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 271 (517)
.|.+.+.||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 4556789999999999999866 78999999886432 2234678899999999999999999998865 557889999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+ +++|.+++. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 91 ~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 91 LL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred hh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 98 568988875 3457888889999999999999999 999999999999999999999999999987653321
Q ss_pred cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc-HH--------HHHHHHHhcCC
Q 010131 352 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV--------HWARSMIKKGD 421 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~-~~--------~~~~~~~~~~~ 421 (517)
....++..|+|||.+.+ ..++.++||||||+++|+|+||+.||.......... +. ++..... .+.
T Consensus 163 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 237 (328)
T cd07856 163 ----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC-SEN 237 (328)
T ss_pred ----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc-chh
Confidence 22346788999998765 578999999999999999999999997433211000 00 0000000 000
Q ss_pred cccccCc-cccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 422 VISIVDP-VLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 422 ~~~~~d~-~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+++.. ......+ ......+.+++.+|++.+|++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000011 1123578899999999999999999998664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=285.64 Aligned_cols=263 Identities=23% Similarity=0.327 Sum_probs=194.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------ee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 266 (517)
+|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++..+. ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 4556789999999999999765 68999999986432 223456889999999999999999999886543 35
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+ +++|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 8999998 779988875 3568999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH----------H
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR----------S 415 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~----------~ 415 (517)
..... ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...+... ....... .
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHH
Confidence 54322 22346889999998865 468899999999999999999999997433210 0000000 0
Q ss_pred HHhcCCcccccC--cccc----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhhhh
Q 010131 416 MIKKGDVISIVD--PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 472 (517)
Q Consensus 416 ~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~~ 472 (517)
.+.......... +... ..........+.+++.+|++.||++|||+.++++ .++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000000000000 0000 0000112335789999999999999999999984 4554433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=277.84 Aligned_cols=270 Identities=19% Similarity=0.256 Sum_probs=208.9
Q ss_pred cccChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC--CC----Cccccc
Q 010131 185 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--HR----NLVPLI 257 (517)
Q Consensus 185 ~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~~~ 257 (517)
+.+...+....+|.+...+|+|.||.|-.+... .+..||||+++.. ....++.+-|+++|+++. .| -+|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 445566777889999999999999999999765 4789999998753 344566778999999993 23 378888
Q ss_pred eeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-----
Q 010131 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----- 332 (517)
Q Consensus 258 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~----- 332 (517)
++|.-.++.|+|+|.+ |-|+.+++..+ +..+++...+..++.|++++++|||+ .+++|-||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEE
Confidence 8999999999999988 77999999865 46789999999999999999999999 99999999999999832
Q ss_pred ---------------CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCC
Q 010131 333 ---------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397 (517)
Q Consensus 333 ---------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 397 (517)
+..++++|||.|+...+.. ...+.|..|.|||++.+-.++.++||||+||+|+|++||...
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 2358999999998765443 345679999999999999999999999999999999999999
Q ss_pred CCCCCccccccHHHHHH--------------HHHhcCCcccccCcccc----------------CCCCHHHHHHHHHHHH
Q 010131 398 VSVEDFGAELNIVHWAR--------------SMIKKGDVISIVDPVLI----------------GNVKIESIWRIAEVAI 447 (517)
Q Consensus 398 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~d~~l~----------------~~~~~~~~~~l~~li~ 447 (517)
|+.-+..+.....+.+. .....+ -.++-+.... -.....+...|++|+.
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 98544222111111111 011111 0110000000 0123456678999999
Q ss_pred HhhccCCCCCCCHHHHHH
Q 010131 448 QCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 448 ~cl~~~P~~RPs~~evl~ 465 (517)
+||..||.+|+|+.|+++
T Consensus 388 ~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALS 405 (415)
T ss_pred HHHccCccccccHHHHhc
Confidence 999999999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.10 Aligned_cols=243 Identities=25% Similarity=0.305 Sum_probs=196.7
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
-++||+|+||.||-++.+ +|+-+|.|.+.+.. .......++|-.+|.+++.+.||.+-..|++.+..++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 578999999999999766 69999999886542 22334578899999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.-+|... ..+.+++..+.-++.+|+.||++||+ .+||.||+||+|||+|+.|+++|+|+|+|..+.+.....
T Consensus 270 GDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~- 344 (591)
T KOG0986|consen 270 GDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR- 344 (591)
T ss_pred CceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCccc-
Confidence 9999888754 34689999999999999999999999 999999999999999999999999999999987765433
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
..+||.+|||||++.+..|+...|-||+||+||||+.|+.||......... +-+.+.... |+ ..++
T Consensus 345 -~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~-------~~---~ey~ 410 (591)
T KOG0986|consen 345 -GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLE-------DP---EEYS 410 (591)
T ss_pred -cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhc-------ch---hhcc
Confidence 236999999999999999999999999999999999999999732221110 011111111 11 1223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
.....+..++....|+.||++|....
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCC
Confidence 33344667888899999999987543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=266.38 Aligned_cols=203 Identities=26% Similarity=0.388 Sum_probs=169.3
Q ss_pred HHhhhcccCCCCceEEEEEEecC-----CcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 267 (517)
.|+.+.+||+|.||.||+|.-.+ .+.+|+|+++.... .-.....+|+.+++.++|||++.+..+|.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46668899999999999995442 23789999875432 223567889999999999999999999877 77889
Q ss_pred EEEEecCCCCHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC----CcEEEccc
Q 010131 268 LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDF 341 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Df 341 (517)
+++||.+. +|..+++-.. ....++...+.+|+.||+.|+.|||+ .=|+||||||.||||..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999975 8888876443 34679999999999999999999999 889999999999999887 89999999
Q ss_pred cCccccCCCCccc--ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCC
Q 010131 342 GLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVED 402 (517)
Q Consensus 342 g~a~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 402 (517)
|+++.+.+..... ...++.|..|.|||.+.+ ..|+.+.||||.||++.||+|-++.|.+..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999887654333 234567899999999876 478999999999999999999998887543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=287.93 Aligned_cols=255 Identities=21% Similarity=0.304 Sum_probs=192.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCe------e
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~ 266 (517)
.|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|||++++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 3556788999999999999886 57899999986532 2234567889999999999999999998766554 8
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 96 YLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999998 679999886 3568999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 419 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 419 (517)
.... .....++..|+|||.+.+ ..++.++||||||+++|++++|+.||....... ...........
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHH
Confidence 6433 123346888999998765 467899999999999999999999996432211 11111110000
Q ss_pred -----CCcccccCcccc---CCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 420 -----GDVISIVDPVLI---GNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 420 -----~~~~~~~d~~l~---~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....++..... ... .......+.+++.+||+.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000 000 0012457889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=289.38 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=189.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Cee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 266 (517)
+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 3445788999999999999764 68999999987532 22346688899999999999999999987543 346
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+++++++ +++|.+++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 98 ~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 98 YLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 7788876 789988875 3468999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH---------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------- 416 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 416 (517)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+... .+.......
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHh
Confidence 5332 123357889999998866 567889999999999999999999996332211 000000000
Q ss_pred -HhcCC---cccccCcccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 417 -IKKGD---VISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 417 -~~~~~---~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+.... ....++.... .+........+.+++.+|++.||.+||++.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000000000 00000123357899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=302.78 Aligned_cols=253 Identities=26% Similarity=0.316 Sum_probs=206.2
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
....+.+.++||+|+||.|..++++ +++.||+|++.+. ......-|..|-.+|..-+.+-|+.+.-.|.++.+.|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3456677899999999999999987 5888999999863 23445678999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|||||+||+|...+.. ...+++..+.-++..|+.||.-+|+ .|+|||||||+|||+|..|++||+|||.+-.+.
T Consensus 153 VMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999999999999984 3479999999999999999999999 999999999999999999999999999999888
Q ss_pred CCCcccccccccCCCCcCCCccC----C-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYG----N-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
.+..-.+...+|||.|++||++. + +.|++.+|-||+||++|||+.|..||..++ +++.....+...+..
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHKESL 300 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchhhhc
Confidence 77777778888999999999984 3 678999999999999999999999997332 333333333322222
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 465 (517)
.+.+. ........+||.+.+. +|+.|.. ++++..
T Consensus 301 ~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 301 SFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred CCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 22211 1123355677777665 6788887 777644
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=265.69 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=194.4
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
..||.|+||+|++-.++ .|+..|||+++.... ...++++.|.+...+- +.||||+++|.+..++..++.||.|. -|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 56999999999999887 699999999987654 5567888898876554 79999999999999999999999994 46
Q ss_pred HHhHhhcc--CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 278 LRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 278 L~~~l~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|..+-... .....+++.-+-.|....+.||.||-+ +..|+|||+||+|||++..|.+||||||.+-.+.+....
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk-- 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK-- 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh--
Confidence 64433211 135678888888899999999999998 589999999999999999999999999998876554332
Q ss_pred cccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 356 SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
+.-.|...|||||.+.. ..|+.+|||||+|++|||+.||+.|+...+. ..+.+..... |+...+..+ .
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~-gdpp~l~~~----~ 294 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI-GDPPILLFD----K 294 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-CCCCeecCc----c
Confidence 23347889999999853 3588999999999999999999999973322 2222322222 332222111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+....+..++.-|+.+|-.+||...++.+.
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 123455578899999999999999999998764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=264.92 Aligned_cols=240 Identities=24% Similarity=0.349 Sum_probs=196.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch---hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
....|.++||+|.||.|.+++-+ .++.+|+|++++...- ....-+.|-++|+..+||.+..+-..|+..++.|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 34567899999999999999876 6899999999876432 3345567999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||..||.|.-++. ....+++....-+-..|+.||.|||+ ++||.||+|.+|.|+|.+|++||+|||+++.--..
T Consensus 248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999988887 35678888888899999999999999 99999999999999999999999999999864322
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.......+|||.|+|||++....|+.+.|-|.+||++|||++|+.||...+...-..++ ...+-++...+
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-----l~ed~kFPr~l---- 391 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-----LMEDLKFPRTL---- 391 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-----HhhhccCCccC----
Confidence 23356788999999999999999999999999999999999999999754433211111 01111111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRP 458 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RP 458 (517)
..+...|+...|.+||.+|.
T Consensus 392 --------s~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 392 --------SPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --------CHHHHHHHHHHhhcChHhhc
Confidence 12456788899999999996
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=268.85 Aligned_cols=221 Identities=22% Similarity=0.216 Sum_probs=176.1
Q ss_pred CCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhc
Q 010131 206 GSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 284 (517)
Q Consensus 206 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 284 (517)
|.+|.||++... +++.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 68999999987542 233455555566799999999999999999999999999999999873
Q ss_pred cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCC
Q 010131 285 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364 (517)
Q Consensus 285 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y 364 (517)
...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3468999999999999999999999 999999999999999999999999999876654321 123356789
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 444 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 444 (517)
+|||...+..++.++||||+|+++|||++|+.|+....... .... .. ..+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~--~~-------~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT--TL-------NIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc--cc-------CCcccCCHHHHH
Confidence 99999988889999999999999999999998875221100 0000 00 011112346789
Q ss_pred HHHHhhccCCCCCCCHHH
Q 010131 445 VAIQCVEQRGFSRPKMQE 462 (517)
Q Consensus 445 li~~cl~~~P~~RPs~~e 462 (517)
++.+|++.||++||++.+
T Consensus 208 li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 208 LLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHccCCHHHhcCCCc
Confidence 999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=285.71 Aligned_cols=238 Identities=25% Similarity=0.364 Sum_probs=192.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|.+...+|.|+|+.|-.+... +++..+||++.+.. .+-.+|+.++... +||||+++.+.+.+..+.++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 34667778999999999998765 68899999997652 2234577676666 799999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe-CCCCcEEEccccCccccCCCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+.|+-+.+.+.. ..... ..+..|+.+|+.|+.|||+ +|+|||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 999988887763 22233 7778899999999999999 999999999999999 68999999999999987665
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+ ..+...+..+...+
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s~------- 533 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFSE------- 533 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcccc-------
Confidence 11223478999999999999999999999999999999999999744332 12333344343332
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+|+.+||+.||.+||+|.++..
T Consensus 534 -----~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 -----CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22235679999999999999999999865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.46 Aligned_cols=144 Identities=32% Similarity=0.459 Sum_probs=128.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.++||+|+||.||+|.+. +++.||||++.... ......+..|+.++..++||||+++++++...+..++|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 3456789999999999999877 68999999987532 2234678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
|+.+++|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 85 y~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999973 4568889999999999999999999 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.53 Aligned_cols=269 Identities=26% Similarity=0.378 Sum_probs=207.9
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
.++||.|.||+||-|.++ +|+.||||++.+.. .....++++|+.+|+.++||.||.+-..|+..+..++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 578999999999999876 79999999997642 3445789999999999999999999999999999999999995 5
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEEccccCccccCCCCcc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++.+++-.. ..+.+++..-.-++.||+.||.|||- ++|+|+||||+|||+... -++||||||+|+.+++..-
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 555555433 46778888888899999999999999 999999999999999643 5799999999999876433
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....||+.|+|||++++..|...-|+||.|+++|--++|..||. ++. ++- .++++.. -.+.+....
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN-EdE----dIn----dQIQNAa--FMyPp~PW~- 789 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN-EDE----DIN----DQIQNAA--FMYPPNPWS- 789 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC-Ccc----chh----HHhhccc--cccCCCchh-
Confidence 345679999999999999999999999999999999999999997 221 111 1222111 111222222
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--------HHhhhhhhcCCCCCcccCCCCCCC
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--------IQDSIKIEKGGDQKFSSSSSKGQS 490 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--------L~~~~~~~~~~~~~~~~~~~~~~~ 490 (517)
+.....+++|...|+..-++|-|.+.-+.. -.++.++|..--+++-...++...
T Consensus 790 ---eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThesDD~~ 851 (888)
T KOG4236|consen 790 ---EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHESDDAR 851 (888)
T ss_pred ---hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcchhhh
Confidence 222345688889999999999998876432 233455555555666555554433
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=266.09 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=195.8
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCC--Cch-----hHHHHHHHHHHHhcCCCCCccccceeee-c
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCE-E 262 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~-~ 262 (517)
....+|-+.+.||+|||+.||+|.+ ...+.||||+-.-. ... ..+...+|..+.+.|+||.||++|+||. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3455666678999999999999964 46789999985322 111 1245678999999999999999999985 5
Q ss_pred CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEc
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVS 339 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~ 339 (517)
.+..|-|+|||+|.+|.-+|+ ..+.+++.++..|+.||+.||.||.+. +.+|+|-||||.|||+-. .|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 567889999999999999998 467899999999999999999999973 589999999999999954 4789999
Q ss_pred cccCccccCCCCcc------cccccccCCCCcCCCccC----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccH
Q 010131 340 DFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 409 (517)
Q Consensus 340 Dfg~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~ 409 (517)
|||+++.+..+... .+....||.+|++||.+- ...++.|.||||.||++|+.+.|+.||...... .++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHH
Confidence 99999987654332 234567999999999873 346788999999999999999999999732211 111
Q ss_pred HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 410 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+....+...-+-.+. ..+....+...+|++||++.-++|....++..
T Consensus 694 -------LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 -------LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111110000 01111224568999999999999988877654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=258.17 Aligned_cols=238 Identities=32% Similarity=0.440 Sum_probs=193.1
Q ss_pred CceEEEEEEec-CCcEEEEEEecCCCchh-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhc
Q 010131 207 SFGSVYYGKMK-DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 284 (517)
Q Consensus 207 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 284 (517)
+||.||+|... +|+.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997654444 67899999999999999999999999998999999999999999999874
Q ss_pred cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCC
Q 010131 285 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364 (517)
Q Consensus 285 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y 364 (517)
...+++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2338999999999999999999999 899999999999999999999999999998765432 22334578899
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 444 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 444 (517)
++||.+.+..++.++||||||++++++++|..||..... .... ......+....... .......+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~----~~~~~~~~~~~~~~-------~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLEL----FKKIGKPKPPFPPP-------EWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHH----HHHHhccCCCCccc-------cccCCHHHHH
Confidence 999999888889999999999999999999999963211 1111 11222111110000 0003347889
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 010131 445 VAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 445 li~~cl~~~P~~RPs~~evl~ 465 (517)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=289.26 Aligned_cols=258 Identities=20% Similarity=0.255 Sum_probs=167.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-C----CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCcccccee------eecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-D----GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY------CEEEH 264 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~~~ 264 (517)
.|.+.+.||+|+||.||+|++. + +..||+|++..... .+.+..| .+....+.++..++.. +....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 4566789999999999999886 4 68999998764321 1111111 1222222333322221 24566
Q ss_pred eeEEEEEecCCCCHHhHhhccCC-----------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVN-----------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
..++||||+++++|.+++..... ........+..++.|++.||+|||+ ++|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHH
Confidence 78999999999999998874310 0011233456799999999999999 999999999999
Q ss_pred eEeCC-CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCC----------------------CCCccceehhH
Q 010131 328 ILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ----------------------QLTEKSDVYSF 384 (517)
Q Consensus 328 ill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Dv~sl 384 (517)
||++. ++.+||+|||+++..............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 58999999999987654444444556689999999965321 23456799999
Q ss_pred HHHHHHHHhCCCCCCCCCcc-------ccccHHHHHHHHHhcCCcccccCccccCCC--CHHHHHHHHHHHHHhhccCCC
Q 010131 385 GVVLLELISGKKPVSVEDFG-------AELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWRIAEVAIQCVEQRGF 455 (517)
Q Consensus 385 G~~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~li~~cl~~~P~ 455 (517)
||++|||+++..++...... .......|....... ..+.+...+ .........+|+.+||+.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999977665411000 001111111110000 000000000 000112345899999999999
Q ss_pred CCCCHHHHHHH
Q 010131 456 SRPKMQEIVLA 466 (517)
Q Consensus 456 ~RPs~~evl~~ 466 (517)
+|||++|+++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999873
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=282.22 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=201.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeee-----cCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~l 268 (517)
+.+|.++||.|.+|.||+++.. +++.+|+|++.... ...+++..|.++++.. +|||++.++|++. .++..+|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3456789999999999999765 68999999987653 3446678899999988 6999999999884 3568999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|||||.+||..|+++... +..+.|..+..|++.++.|+.|||. ..++|||||-.|||++.++.+||+|||.+....
T Consensus 99 VMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999998765 7889999999999999999999999 999999999999999999999999999998876
Q ss_pred CCCcccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
..... .....||+.|||||++.. ..|+..+|+||+|++..||..|.+|+.+... .. +.-.+...
T Consensus 175 sT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mr-aLF~IpRN--- 243 (953)
T KOG0587|consen 175 STVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MR-ALFLIPRN--- 243 (953)
T ss_pred ccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hh-hhccCCCC---
Confidence 54332 344569999999999843 3567799999999999999999999862211 00 00011111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
|...-..+....+++.++|..||.+|-++||++.++++
T Consensus 244 ----PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 244 ----PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111223455668999999999999999999998864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=262.35 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=197.0
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcC-CCCCccccceeeecCC
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 264 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 264 (517)
+.+.....+|..+||+|+||.|-+|..+ +.+.+|||++++... .+.+--+.|-++|... +-|.++++..+|+.-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3566677889999999999999999776 467799999987643 2233345577777766 5788999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
+.|+||||+.||+|--.++ .-+.+.+..+.-++..||-||-+||+ +||+.||||.+||++|.+|++||+|||++
T Consensus 424 RLyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred heeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999988887 45678888888999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
+.---+ ...+...+||+.|+|||++...+|+...|-|||||+||||+.|++||++++..+- . +.+.+.+
T Consensus 498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F-~aI~ehn--- 566 (683)
T KOG0696|consen 498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------F-QAIMEHN--- 566 (683)
T ss_pred cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------H-HHHHHcc---
Confidence 863222 2234567899999999999999999999999999999999999999986654321 1 1111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
-.++.....+...+....+.+.|.+|..
T Consensus 567 -------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 -------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1223333445668888899999999853
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=273.35 Aligned_cols=237 Identities=24% Similarity=0.319 Sum_probs=196.4
Q ss_pred hcccCCCCceEEEEEEecCCc-EEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKMKDGK-EVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
...||-|+||.|=++..+... .+|+|++++. .....+.+..|-.+|...+.|.||++|..|.++...|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 346999999999999877433 3888888764 234456788999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|.|...++ ..+.++..+..-++..+.+|++|||+ ++||.|||||+|.++|.+|-+||.|||+|+.+..+. .+
T Consensus 505 GElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KT 576 (732)
T KOG0614|consen 505 GELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KT 576 (732)
T ss_pred chhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC--ce
Confidence 99999998 56788889999999999999999999 999999999999999999999999999999887643 35
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
.+++||+.|.|||++.+...+.+.|.||+|+++|||+||.+||.+.+.-...+++ ++.-+.. +.+
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkGid~i---------~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKGIDKI---------EFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhhhhhh---------hcc
Confidence 6688999999999999999999999999999999999999999865543222211 1111111 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
........+++++.+..+|.+|..
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 222335678999999999999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=231.18 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=194.3
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
.++||+|.||+||+|+.. +++.||+|.++-.. ..--....+|+-+++.++|.|||+++++...+....+|+|||. .
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 478999999999999866 57889999986432 2233567899999999999999999999999999999999994 5
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|..+... -.+.++......++.|+++||.++|+ +++.|||+||.|.+++.+|+.|++|||+++.++-.... .+
T Consensus 86 dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc-ys 159 (292)
T KOG0662|consen 86 DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YS 159 (292)
T ss_pred HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-ee
Confidence 78777764 35678899999999999999999999 99999999999999999999999999999987654332 23
Q ss_pred ccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC---cccccCcccc
Q 010131 357 VARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD---VISIVDPVLI 431 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~l~ 431 (517)
....|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+..+...-+-|......+.. +..+.|-...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 34468999999998775 57889999999999999987 6666765444332222222211111111 1112221111
Q ss_pred CCCCH-----HHHH----HHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKI-----ESIW----RIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~-----~~~~----~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..++. +... .=.+++++.+.-+|.+|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11111 1111 2357888888899999999998775
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=275.31 Aligned_cols=257 Identities=22% Similarity=0.321 Sum_probs=177.4
Q ss_pred HHhhhcccCCCCceEEEEEEe-----------------cCCcEEEEEEecCCCchhHHH--------------HHHHHHH
Q 010131 196 TNNFCKKIGKGSFGSVYYGKM-----------------KDGKEVAVKIMADSCSHRTQQ--------------FVTEVAL 244 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~ 244 (517)
.+.+.++||+|+||+||+|.+ .+++.||||++........++ +..|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 455678999999999999964 235689999986543322233 3346777
Q ss_pred HhcCCCCCc-----cccceeeec--------CCeeEEEEEecCCCCHHhHhhccC---------------------CCCc
Q 010131 245 LSRIHHRNL-----VPLIGYCEE--------EHQRILVYEYMHNGTLRDRLHGSV---------------------NQKP 290 (517)
Q Consensus 245 l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~ 290 (517)
+.+++|.++ ++++++|.. .+..++||||+++++|.++++... ....
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777766544 677787753 346799999999999999987421 1123
Q ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCcc
Q 010131 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370 (517)
Q Consensus 291 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~ 370 (517)
+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 5677889999999999999999 9999999999999999999999999999976543322222223357899999987
Q ss_pred CCCCC----------------------CccceehhHHHHHHHHHhCCC-CCCCCCc-cc-----cccHHHHHHHHHhcCC
Q 010131 371 GNQQL----------------------TEKSDVYSFGVVLLELISGKK-PVSVEDF-GA-----ELNIVHWARSMIKKGD 421 (517)
Q Consensus 371 ~~~~~----------------------~~~~Dv~slG~~l~elltg~~-p~~~~~~-~~-----~~~~~~~~~~~~~~~~ 421 (517)
..... ..+.||||+||++|+|++|.. ||..... .. ......|. ......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhcccC
Confidence 54321 124799999999999999875 6642111 00 01111111 111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG---FSRPKMQEIVL 465 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~evl~ 465 (517)
. +-.. .........+++.+||..+| .+|+|++|+++
T Consensus 461 ~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 1000 11123357789999999766 68999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-34 Score=250.75 Aligned_cols=265 Identities=21% Similarity=0.313 Sum_probs=191.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecC--CCchhHHHHHHHHHHHhcCCCCCccccceeeec--------C
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 263 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 263 (517)
.+|.-..+||+|.||.||+|+.+ .|+.||+|+.-- ..........+|+++|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34444578999999999999876 577889886532 222233556789999999999999999998743 2
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
...++||.+|+. +|...+... ...++..++.+++.++..||.|+|. ..|+|||+|+.|+|++.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999965 777777632 3578999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCc---ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 010131 344 SRQAEEDLT---HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 344 a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
++.+..... ......+.|..|.+||.+.+ ..++++.|||+.||++.||+|+.+-+++........++...-..+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 976533221 12233456899999998754 68999999999999999999999998754432222222111111111
Q ss_pred CC--------ccccc--CccccCCCC--HHHH------HHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 420 GD--------VISIV--DPVLIGNVK--IESI------WRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 420 ~~--------~~~~~--d~~l~~~~~--~~~~------~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.- +..-+ +|...+.+. .+.. +...+|+..++..||.+|+++++++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 10 00001 111111110 0111 14668999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=282.58 Aligned_cols=240 Identities=25% Similarity=0.430 Sum_probs=184.9
Q ss_pred cccCCCCceE-EEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 201 KKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 201 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
+.+|.|+.|+ ||+|... |+.||||.+-.. ..+-..+|+..|+.- .|||||++++.-.+++..|+..|.| ..+|
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL 589 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL 589 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence 5689999985 8999997 899999988643 234567899999988 6999999999999999999999999 5799
Q ss_pred HhHhhcc-CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---C--CcEEEccccCccccCCCCc
Q 010131 279 RDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---N--MRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 279 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~Dfg~a~~~~~~~~ 352 (517)
.+++... ...........+.+..|++.||+|||+ .+||||||||.||||+. + .+++|+|||+++....+..
T Consensus 590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999863 111112224567889999999999999 99999999999999975 2 5699999999998765543
Q ss_pred cc--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 HI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.. .....||-+|+|||++....-+.+.||||+||++|+.++| .+||.. ....+.++ +....-...+.+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd-~~~R~~NI-------l~~~~~L~~L~~- 737 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD-SLERQANI-------LTGNYTLVHLEP- 737 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc-hHHhhhhh-------hcCccceeeecc-
Confidence 33 3345699999999999998888999999999999999885 999972 22111111 111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 464 (517)
..++ ...+||.+|+.++|..||++.+|+
T Consensus 738 -----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 -----LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111 567999999999999999999996
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=232.65 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=165.0
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecC
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.-...||+|++|.|=+-++. +|+..|+|.+.... .+..++.++|+.+..+. .+|.+|.++|........++.||.|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M- 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM- 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-
Confidence 34578999999999888765 69999999997643 34566788899987665 7999999999988888999999999
Q ss_pred CCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 275 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 275 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
..||..+-+... .+..+++.-+-+|+..+..||.|||+ +..++|||+||+|||++.+|++|+||||.+-.+.+....
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 457766554322 56789999999999999999999999 589999999999999999999999999999877654332
Q ss_pred cccccccCCCCcCCCccC----CCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 354 ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
+...|...|||||.+. ...|+.|+||||+|+++.||.+++.||+
T Consensus 206 --t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 206 --TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred --HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 2234788999999874 3478999999999999999999999996
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=262.15 Aligned_cols=281 Identities=22% Similarity=0.261 Sum_probs=218.5
Q ss_pred ccccCCcccccChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC------
Q 010131 177 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH------ 249 (517)
Q Consensus 177 ~~~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------ 249 (517)
.|.+....|.+.+.|+...+|.+....|+|-|++|.+|... .|..||||++.++.. -.+.=+.|+++|++|+
T Consensus 414 NWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 414 NWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred CcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchh
Confidence 34555677888999999999999999999999999999765 488999999986532 2344467999999995
Q ss_pred CCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeE
Q 010131 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 329 (517)
Q Consensus 250 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nil 329 (517)
--|+++++..|...+++|||+|-+ ..+|.+.|+.......+....+..++.|+.-||..|-. .+|+|.||||+|||
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNIL 568 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceE
Confidence 348999999999999999999987 57999999887777789999999999999999999998 89999999999999
Q ss_pred eCCC-CcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccccc
Q 010131 330 LDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 408 (517)
Q Consensus 330 l~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~ 408 (517)
|++. ..+||||||.|....+... ..+..+..|.|||++.|..|+...|+||.||+||||+||+..|.+.....-..
T Consensus 569 VNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred eccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 9875 5689999999988765432 22234567999999999999999999999999999999999998554322111
Q ss_pred HHHHHH-----HHHhcCCccc---------------------------ccCc------ccc-----CCCCHHHHHHHHHH
Q 010131 409 IVHWAR-----SMIKKGDVIS---------------------------IVDP------VLI-----GNVKIESIWRIAEV 445 (517)
Q Consensus 409 ~~~~~~-----~~~~~~~~~~---------------------------~~d~------~l~-----~~~~~~~~~~l~~l 445 (517)
+..-++ .+++.|.+.+ .+.| .+. .+........|.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 111111 1112211100 0111 111 11223456678899
Q ss_pred HHHhhccCCCCCCCHHHHHH
Q 010131 446 AIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 446 i~~cl~~~P~~RPs~~evl~ 465 (517)
+..||..||++|.|..+.++
T Consensus 726 Ldkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHhccChhhcCCHHHHhc
Confidence 99999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=242.33 Aligned_cols=245 Identities=22% Similarity=0.358 Sum_probs=197.0
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEe
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
++.++||+|+|..|..++++ +.+.+|+|++++. ..++.+....|-.+...- +||.+|-+..+|......++|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 34688999999999999886 5788999998764 234456677788887776 799999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++||+|--+++ .+..++++.+.-+...|..||.|||+ +||+.||||.+|||+|..|++||+|+|+++.--.. .
T Consensus 333 v~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~-g 405 (593)
T KOG0695|consen 333 VNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-G 405 (593)
T ss_pred ecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC-C
Confidence 99999977666 56789999999999999999999999 99999999999999999999999999999864332 2
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc-ccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
..++.++||+.|+|||++++..|....|-|++|++++||+.|+.||+.-... ...+-.++.-+.+-+..+.
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-------- 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-------- 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------
Confidence 2356678999999999999999999999999999999999999999743332 2334444444444332210
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
.+.....+...+++.-|.+||.+|..
T Consensus 478 --iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 --IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 01111224457888899999999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=243.36 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=192.1
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e 271 (517)
.+.||.|+||.||.+++. +|+.||+|++..... ...+.+.+|+++|..++|.|++..++...-. +..|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 367999999999999875 799999999865322 2456788999999999999999998875432 24578888
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
.| ..+|..++- ....++...+.-++.||++||+|||+ .+|.||||||.|.|++.+...||||||+++....+.
T Consensus 138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 457877776 56778888999999999999999999 999999999999999999999999999999876555
Q ss_pred cccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh-----------c
Q 010131 352 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------K 419 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 419 (517)
.........|..|.|||.+++. .|+.+.||||.||++.|++..+..|+....-...+ .+...+. +
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~---lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ---MIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH---HHHHHhCCCcHHHHHHHhh
Confidence 4444555578899999999874 78999999999999999999998887433221111 1111111 0
Q ss_pred CCcccccC-----ccccCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 420 GDVISIVD-----PVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 420 ~~~~~~~d-----~~l~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
|...-++. |.+..-+ ....-.+-..+...++..||++|.+..+.+..+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11001110 1110000 0111123457778899999999999999887653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=247.02 Aligned_cols=141 Identities=26% Similarity=0.424 Sum_probs=119.1
Q ss_pred cccChhHHHH-HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-----C---CCcc
Q 010131 185 YFIPLPELEE-ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----H---RNLV 254 (517)
Q Consensus 185 ~~~~~~~l~~-~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv 254 (517)
..+...|... .+|.+.++||-|.|++||++.+. +.+.||+|+.+.. .+..+....|+++|++++ | .+||
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 3444556555 88888999999999999999765 6789999998743 455677889999999984 3 3699
Q ss_pred ccceeeec----CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 255 PLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 255 ~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
++++.|.. +.+.|+|+|++ |.+|..++... +.+.++...+.+|++||+.||.|||.. .||+|-||||+|||+
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 99999865 45889999999 77898888765 577899999999999999999999994 699999999999998
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=256.81 Aligned_cols=199 Identities=26% Similarity=0.387 Sum_probs=168.0
Q ss_pred hcccCCCCceEEEEEEe-cCCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
++.||-|+||.|.++.- ++...+|.|.+++..- .....+..|-.||..-+.+-||++|..|.+.+.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 45699999999999964 4466789999876432 3345678899999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC-------
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE------- 348 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~------- 348 (517)
|++-.+|- .-+.+.+..+.-++..+..|+++.|. .|+|||||||+|||||.+|++||+|||++.-+.
T Consensus 714 GDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 714 GDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99999887 35678888888899999999999999 999999999999999999999999999986431
Q ss_pred --CCCcc--------------------------------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC
Q 010131 349 --EDLTH--------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG 394 (517)
Q Consensus 349 --~~~~~--------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg 394 (517)
++... .....+||+.|+|||++....++..+|-||.||+||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 10000 00123599999999999999999999999999999999999
Q ss_pred CCCCCCCCcc
Q 010131 395 KKPVSVEDFG 404 (517)
Q Consensus 395 ~~p~~~~~~~ 404 (517)
+.||......
T Consensus 868 ~~pf~~~tp~ 877 (1034)
T KOG0608|consen 868 QPPFLADTPG 877 (1034)
T ss_pred CCCccCCCCC
Confidence 9999855444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=232.88 Aligned_cols=210 Identities=38% Similarity=0.618 Sum_probs=183.0
Q ss_pred cCCCCceEEEEEEecC-CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHh
Q 010131 203 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 280 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 280 (517)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 899999998765332 35679999999999999999999999999899999999999999999
Q ss_pred HhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCCCcccccccc
Q 010131 281 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVAR 359 (517)
Q Consensus 281 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 359 (517)
++... ...+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 98742 1468999999999999999999999 89999999999999999 89999999999987654321 122234
Q ss_pred cCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 360 GTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 360 g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
+...|++||..... ..+.++|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67899999999887 888999999999999999
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=225.26 Aligned_cols=256 Identities=20% Similarity=0.321 Sum_probs=194.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecC--CeeEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILV 269 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 269 (517)
...|++.+++|+|-++.||.|.. .+.+.++||++++. ..+.+.+|+.+|+.|+ ||||+++++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 34678899999999999999974 46889999999843 4567889999999996 99999999998664 456799
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAE 348 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~ 348 (517)
+||+.+.+..... +.++...+...+.+++.||.|+|+ +||.|||+||.|+++|.. ..++|+|+|+|.+..
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988776653 467888899999999999999999 999999999999999965 569999999999876
Q ss_pred CCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH--------Hhc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------IKK 419 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~ 419 (517)
..... .....+..|.-||.+-. ..++..-|+|||||++..|+..+.||.. ..+...+++..++-. +..
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh-G~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC-CCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 65443 23345778899998754 5678899999999999999999999962 222333333333211 111
Q ss_pred CCcccccCccccC----------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 420 GDVISIVDPVLIG----------------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 420 ~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
- .--+||...+ +...-...+.++++.+.|..|-++|||++|.+..
T Consensus 262 Y--~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 Y--QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred H--ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 0012222211 0001112457799999999999999999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=226.29 Aligned_cols=252 Identities=18% Similarity=0.300 Sum_probs=187.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCcccccee-eecCCeeEEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY-CEEEHQRILVYE 271 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e 271 (517)
..|++.+.||+|.||.+-++.++ ..+.+++|.+... ....++|.+|..---.| .|.||+..|++ |+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 35778899999999999999987 4678999988654 34467899998776666 58999998874 677788899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC--CCCcEEEccccCccccCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~ 349 (517)
|++.|+|.+.+. ...+.+.....++.|+++|+.|+|+ +++||||||.+||||- +..++||||||.++..+.
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998875 4567888889999999999999999 9999999999999993 345799999999887544
Q ss_pred CCcccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
.-.. ..-+..|.+||.... -...+.+|||.||+++|.++||+.||+ ........+.+|.. +..+....
T Consensus 176 tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~--w~~rk~~~ 248 (378)
T KOG1345|consen 176 TVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQ--WLKRKNPA 248 (378)
T ss_pred eehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHH--HhcccCcc
Confidence 2221 123567999997632 245678999999999999999999998 44444444444432 22222221
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
.. ..... ....+..+.++-+..+|++|--..++.++-
T Consensus 249 ~P--~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 249 LP--KKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred Cc--hhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11 11111 122466778889999999995555555443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=253.66 Aligned_cols=194 Identities=25% Similarity=0.432 Sum_probs=166.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------hhHHHHHHHHHHHhcCC---CCCccccceeeecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEH 264 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 264 (517)
|...+.+|+|+||.|++|.++ +...|+||.+.+..- .+.-.+-.|+++|..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 444678999999999999987 466799998865321 11123557999999996 999999999999999
Q ss_pred eeEEEEEec-CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 265 QRILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 265 ~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
.+|++||-. ++-+|.+++. -.+.+++.+..-|++||+.|+++||+ .+|||||||-+||.++.+|-+||+|||.
T Consensus 643 ~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 999999976 4558999998 46789999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCC
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
+.....+. ...++||.+|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 717 aa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98765543 345679999999999999877 567899999999999999988874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=229.36 Aligned_cols=196 Identities=37% Similarity=0.618 Sum_probs=171.3
Q ss_pred hhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999998875 899999999866554 567899999999999999999999999998999999999999
Q ss_pred CCHHhHhhccCCCCc-cCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 276 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 276 gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
++|.+++... .. +++..+..++.+++.++.+||+ .+++|+|++|+||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999998743 23 8899999999999999999999 899999999999999999999999999988765442112
Q ss_pred ccccccCCCCcCCCcc-CCCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 355 SSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
.....++..|++||.+ ....++.++|||+||+++++|++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2234467789999998 66778889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=252.13 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=202.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++...+|.|.||.||+|+.. .++..|+|+++-....+..-..+|+-+++..+|||||.++|.+...+..++.||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4556789999999999999876 689999999987777777888899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+.-+ -.+++++.++..+++...+||+|||+ ++-+|||||-.||++++.|.+|++|||.+..+......
T Consensus 96 ggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 96 GGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred CCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 999999877 46789999999999999999999999 99999999999999999999999999998876543322
Q ss_pred ccccccCCCCcCCCcc---CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 355 SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
...+.||+.|||||+. +.+.|..++|||+.|+...|+---++|..... ...+...+.. ...+|.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pmr~l~LmTk----S~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PMRALFLMTK----SGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hHHHHHHhhc----cCCCCCcc
Confidence 3446699999999986 56678999999999999999988777754110 0111111111 11122111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+ .......+.++++.|+.++|.+||+++-+++
T Consensus 238 kD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 1122336789999999999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=225.52 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=188.6
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------CeeEEEEE
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILVYE 271 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e 271 (517)
..+|.|.- .|..|.+. .+++||+|++.... ....++..+|..++..+.|+||++++.+|.-. ...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 56788887 56566443 58899999886432 23345677899999999999999999988543 35789999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+| ..+|...+. -.++..++..|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+.....
T Consensus 102 ~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 102 LM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred hh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 99 568888776 357788899999999999999999 99999999999999999999999999999876554
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH---------------
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM--------------- 416 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------------- 416 (517)
...+....|..|.|||++-+..+.+..||||.||++.||++|+.-|.+.+. +-+|.+..
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhcCCCHHHHHHhh
Confidence 345566789999999999888899999999999999999999999975442 22222111
Q ss_pred ------HhcC------Ccccc-cCccccC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 417 ------IKKG------DVISI-VDPVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 417 ------~~~~------~~~~~-~d~~l~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+.. ...+. .|..... +.+.-......+++.+||..+|++|.+++++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1100 00000 0111111 1111233457799999999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=222.59 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=191.0
Q ss_pred HhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+...++||+|.|++||+|++. ..+.||+|.+.... .-..+.+|+++|..+ .+.||+++.+++..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 445789999999999999754 36789999986543 335688999999999 59999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~ 350 (517)
|++.....++.. .++...+..+++.+..||+++|. .|||||||||.|++.+. .+.-.|.|||+|......
T Consensus 116 ~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 116 YFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999888875 36688899999999999999999 99999999999999975 467899999998721100
Q ss_pred C-------------cc------------------------------cccccccCCCCcCCCccCC-CCCCccceehhHHH
Q 010131 351 L-------------TH------------------------------ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGV 386 (517)
Q Consensus 351 ~-------------~~------------------------------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~ 386 (517)
. .. ......||++|.|||++.. +.-+++.||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 00 0112359999999999754 56688999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHH---------HHhcCC--ccc------c---------cC-ccccC-CC----
Q 010131 387 VLLELISGKKPVSVEDFGAELNIVHWARS---------MIKKGD--VIS------I---------VD-PVLIG-NV---- 434 (517)
Q Consensus 387 ~l~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~~~--~~~------~---------~d-~~l~~-~~---- 434 (517)
+++.+++++.||.... .+...+.+.+.- ....|. +.+ + ++ ..+.. +.
T Consensus 267 I~Lslls~~~PFf~a~-dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAK-DDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred eeehhhccccccccCc-cccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999997332 222233332210 111122 111 0 00 00000 00
Q ss_pred ----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 435 ----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 435 ----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....+..+.+++.+|+..||.+|.|++|.++.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11122367899999999999999999998763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=262.27 Aligned_cols=195 Identities=19% Similarity=0.282 Sum_probs=139.0
Q ss_pred cCCC-CCccccceee-------ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 010131 247 RIHH-RNLVPLIGYC-------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318 (517)
Q Consensus 247 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 318 (517)
.++| +||++++++| ...+..+.++|++ +++|.+++.. ....+++.+++.++.||++||+|||+ ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 3455 5888888887 2334567788887 6699999974 24569999999999999999999999 999
Q ss_pred EecCCCCCCeEeCC-------------------CCcEEEccccCccccCCCC---------------cccccccccCCCC
Q 010131 319 IHRDVKSSNILLDI-------------------NMRAKVSDFGLSRQAEEDL---------------THISSVARGTVGY 364 (517)
Q Consensus 319 vH~dlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~g~~~y 364 (517)
+||||||+||||+. ++.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666666665321100 0001113478889
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 444 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 444 (517)
+|||++.+..++.++|||||||++|||++|..|+.... ..... +... ...+.. ........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~-~~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSS-LRHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHH-HHHh----hcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999988875111 00111 1100 011110 111224568
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 010131 445 VAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 445 li~~cl~~~P~~RPs~~evl~ 465 (517)
++.+||+++|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=204.63 Aligned_cols=169 Identities=21% Similarity=0.207 Sum_probs=126.7
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.++++.. +..+++.+++.++.|++.||+|||+ .+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899999742 4569999999999999999999998 55 999999999999999 99988754422
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
..|++.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+. ...... ++.- ....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~-~~~~~~------~~~~-~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILL-NGMPAD------DPRD-RSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHH-HHhccC------Cccc-cccH
Confidence 2478999999999999999999999999999999999999963221 111111111 111100 0000 0011
Q ss_pred HHHH--HHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 436 IESI--WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 436 ~~~~--~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.... ..+.+++.+||+.+|++||++.|+++.+..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1122 258999999999999999999999998876644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=205.89 Aligned_cols=254 Identities=21% Similarity=0.355 Sum_probs=192.3
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecC--CCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
+.-...++..+|.+...|..|+|+|+ |..+++|++.- ......++|..|.-.|+-+.||||++++|.|....+..++
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 33445567788999999999999998 66777787753 2233346799999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc--cccCcccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQA 347 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~--Dfg~a~~~ 347 (517)
..||+.|+|+..+++. ..-..+..+..+++.++|+|++|||+- ++-|.---|.++.+++|++.+++|+ |--++...
T Consensus 266 sq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred eeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999965 244577889999999999999999983 2334455689999999999988875 32222211
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCC---ccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLT---EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
....-.+.|++||.++..+-+ .++|+|||++++||+.|...||..-+.-+.. ...--+
T Consensus 344 --------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkiale----- 404 (448)
T KOG0195|consen 344 --------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIALE----- 404 (448)
T ss_pred --------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhhhc-----
Confidence 111236789999999765443 5899999999999999999999733322111 000011
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.++...++.....+.+++.-|+..||.+||.+..|+-.|++++
T Consensus 405 ----glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 ----GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1122233334456789999999999999999999999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-24 Score=208.82 Aligned_cols=262 Identities=24% Similarity=0.293 Sum_probs=196.5
Q ss_pred HHhhhcccCCCCceEEEEEEecCC--cEEEEEEecCCCchhHHHHHHHHHHHhcCCC----CCccccceee-ecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDG--KEVAVKIMADSCSHRTQQFVTEVALLSRIHH----RNLVPLIGYC-EEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l 268 (517)
.|.+.++||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566789999999999999987653 4788888765433322367889999988863 5888888888 47778899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-----CcEEEccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGL 343 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~ 343 (517)
||+.+ |.+|.++..... .+.++..+...|+.|++.+|+++|+ .|++||||||.|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999776543 6789999999999999999999999 999999999999999865 4699999999
Q ss_pred cc--ccCCCCc----c--c-ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 010131 344 SR--QAEEDLT----H--I-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 344 a~--~~~~~~~----~--~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 414 (517)
++ ....... . . .....||..|+++....+...+.+.|+||++.++.|++.|..||........ ...+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 3211111 1 1 2235599999999999999999999999999999999999999964333221 11111
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
........ +. ..... +..+.++...+-..+..++|....+...|++.....
T Consensus 251 ~~~~~~~~----~~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLT----DR--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcc----cc--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111111 10 11112 224555555566689999999999999998887765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=211.86 Aligned_cols=172 Identities=19% Similarity=0.164 Sum_probs=130.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec--CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..|.+.+.||+|+||+||+|.++ +++.||||++.... ....+.|.+|+++|++++|+|+++.+.. .+..+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 34667889999999999999875 57788999875331 1234568999999999999999864322 24579
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCC-CCCCeEeCCCCcEEEccccCccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+||||++|++|... . ... ...++.|+++||.|||+ +||+|||| ||+|||++.++.+||+|||+++.
T Consensus 95 LVmE~~~G~~L~~~-~---~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 95 LVRGWTEGVPLHLA-R---PHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEccCCCCHHHh-C---ccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 99999999999632 1 111 14678899999999999 99999999 99999999999999999999997
Q ss_pred cCCCCcccc-------cccccCCCCcCCCccCCCC------CCccceeh
Q 010131 347 AEEDLTHIS-------SVARGTVGYLDPEYYGNQQ------LTEKSDVY 382 (517)
Q Consensus 347 ~~~~~~~~~-------~~~~g~~~y~aPE~~~~~~------~~~~~Dv~ 382 (517)
......... ....+++.|+|||.+...+ .+..+|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 654321111 2345788899999985432 23446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-22 Score=194.41 Aligned_cols=260 Identities=29% Similarity=0.432 Sum_probs=197.2
Q ss_pred hhhcccCCCCceEEEEEEecCCcEEEEEEecCCCch---hHHHHHHHHHHHhcCCCC-CccccceeeecCCeeEEEEEec
Q 010131 198 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45678999999999999887 78999998765433 367899999999999988 7999999997777789999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 352 (517)
.++++.+++........+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999777632111378999999999999999999999 8999999999999999988 799999999986544332
Q ss_pred c-----cccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 353 H-----ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 353 ~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
. ......|+..|+|||.+.+ ...+...|+||+|++++++++|..||...... .........+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 2 2345668999999999987 67889999999999999999999997633321 0011111222211111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467799999999999999999988775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=185.81 Aligned_cols=263 Identities=19% Similarity=0.251 Sum_probs=200.6
Q ss_pred HHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
-|+++++||+|.||.++.|+. -++++||||.-... .+.-++..|....+.| ..+.|..++-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 356789999999999999964 47999999975432 3346788899999988 5789999988888888889999988
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-----CcEEEccccCccccC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGLSRQAE 348 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~Dfg~a~~~~ 348 (517)
|-||.|.+.- .+..++.+++..+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+|+.+.
T Consensus 107 -GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 7899887753 46789999999999999999999999 999999999999999654 348999999999876
Q ss_pred CCCccc------ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 349 EDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 349 ~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
+..+.. .....||..||+-....+.+-+.+.|+-|+|-+++..+-|..||++-..+......+ .+.+...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe----KIGe~Kr 256 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE----KIGETKR 256 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH----Hhccccc
Confidence 654432 234569999999999999999999999999999999999999998655432211111 1111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
..-++. +.. ..+.++..-+.-.-..+=.+-|..+-+...+.+++....
T Consensus 257 ~T~i~~-Lc~----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 257 STPIEV-LCE----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred cCCHHH-HHh----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 111111 111 123345555555556677888999999999988886544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=219.84 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=185.7
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEec----CCCc-hh-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA----DSCS-HR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
..+.+|.|++|.|+..... .....+.|... .... .. ...+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3567999999988777543 33334444332 1111 11 1225667777888999999998888777666666699
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
||++ +|...+.. ...+...++..++.|+..|++|+|+ .|+.|||+|++|++++.++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999873 3578888999999999999999999 999999999999999999999999999988765443
Q ss_pred c---ccccccccCCCCcCCCccCCCCCCc-cceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 352 T---HISSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 352 ~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
. .......|...|+|||.+.+..|.+ ..||||.|+++..|.+|+.||......+... ......++......
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEG 549 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccC
Confidence 3 4455677999999999999988876 6899999999999999999997444332211 00000000000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+ .......+.....++.+||+.+|.+|.|+++|++
T Consensus 550 ~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 P---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred h---HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 0112234556789999999999999999999976
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-24 Score=220.58 Aligned_cols=281 Identities=22% Similarity=0.287 Sum_probs=198.2
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC-chhHHHHHH---HHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SHRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.+.||.+.|=.|.+|+++.|. |+||++-+.. .-..+.|.+ |++ ...++|||++++.-+...+...|+|-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 445688999999999999999887 9999986543 333344444 444 4556899999998887777788888888
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc--CCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EED 350 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~--~~~ 350 (517)
+. -+|+|.+. .++.+...+...|+.|++.||..+|. .||+|||||.+||||+.-+-+.|+||..-+.. .++
T Consensus 103 vk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 84 58999987 56778888999999999999999999 99999999999999999999999999876542 221
Q ss_pred C----cccccccccCCCCcCCCccCC-----------CCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 010131 351 L----THISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 351 ~----~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 414 (517)
. .....+...-..|+|||.+-. ...+++.||||+||++.||++ |++||.. .+...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHh
Confidence 1 111222223457999998733 126789999999999999998 6888862 11111
Q ss_pred HHHhcCC-------cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh------hcCCCCCc
Q 010131 415 SMIKKGD-------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI------EKGGDQKF 481 (517)
Q Consensus 415 ~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~------~~~~~~~~ 481 (517)
. +.+. +..+-|+ .+.+++..|++.||++|-++++.++.-.+..=- .-+=-..|
T Consensus 247 Y--r~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy~FL~~Y~~~~ 312 (1431)
T KOG1240|consen 247 Y--RSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFYSFLYDYLDRF 312 (1431)
T ss_pred H--hccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHHHHHHHHHHhc
Confidence 1 1110 1111122 477999999999999999999998874433200 00001122
Q ss_pred ccCCCCCCCcchhcccccccccCcCCCc
Q 010131 482 SSSSSKGQSSRKTLLTSFLEIESPDLSN 509 (517)
Q Consensus 482 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 509 (517)
...+.+..-+-++...+.+++.-+...+
T Consensus 313 ~~~~~~~p~~~~~~~gs~i~d~~~~~~~ 340 (1431)
T KOG1240|consen 313 VPLTTSTPISDNTCTGSTIEDNVKLLDG 340 (1431)
T ss_pred CCccccCccccccccCcccccccccccC
Confidence 3333444455567777777776555444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=177.89 Aligned_cols=264 Identities=21% Similarity=0.300 Sum_probs=197.8
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC-CCccccceeeecCCeeEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv 269 (517)
+....|.+.++||.|+||.+|.|.. .+|..||||+-+.... ..++..|.++...|++ ..|..+..|..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 4455677889999999999999964 5799999998765433 3467789999999964 6777777888888889999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEEccccCccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQ 346 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~ 346 (517)
|+.. |.+|.+.+.- ....++..+++-++-|++.-++|+|. ++++||||||+|+|..-+ ..+.++|||+|+.
T Consensus 90 MdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhh
Confidence 9988 8899988764 35678999999999999999999999 999999999999999644 5689999999998
Q ss_pred cCCCCccc------ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 347 AEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 347 ~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
+.+..+.. .....||..|.+-....+...+.+.|+-|+|.+|..+--|..||++-......+..+ .+.+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----kI~Ek 239 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----KISEK 239 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH----HHHHh
Confidence 65433221 234568999999888888888999999999999999999999998554432222221 12222
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.....++ .+...+ +.++.-.+.-|-..-=++-|...-+-+.+.-+..
T Consensus 240 K~s~~ie-~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 240 KMSTPIE-VLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred hcCCCHH-HHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 2111111 122222 2345666777777777888888777776665443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=184.62 Aligned_cols=175 Identities=15% Similarity=0.187 Sum_probs=135.8
Q ss_pred hhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHH---------HHHHHHHHHhcCCCCCcccccee
Q 010131 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ---------QFVTEVALLSRIHHRNLVPLIGY 259 (517)
Q Consensus 189 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~ 259 (517)
++++...+|+..+.+|.|+||.||++.. ++..+|||++.+....... .+.+|+..+.++.|++|..+..+
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4566777888899999999999999766 5778999999765433222 26789999999999999999888
Q ss_pred eecC--------CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 260 CEEE--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 260 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
+... ...++||||++|.+|.++.. ++. ....+++.++..+|+ .|++|||+||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 6533 35789999999999988742 222 245699999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHH
Q 010131 332 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 392 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ell 392 (517)
.++ ++|+|||........... ..+.....+..++|+|+||+++....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987655322111 01334445667999999999876553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=180.79 Aligned_cols=140 Identities=18% Similarity=0.187 Sum_probs=109.9
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch--h-------H-----------------HHHHHHHHHHhcCCCCCc
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R-------T-----------------QQFVTEVALLSRIHHRNL 253 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 253 (517)
...||+|++|.||+|...+|+.||||+++..... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754211 1 0 122359999999988877
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHH-hcCCCCCcEecCCCCCCeEeCC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~dlk~~Nill~~ 332 (517)
.....+.. ...++||||++++++..... ....++...+..++.|++.+|.|+ |+ .||+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 44433322 22489999999887765432 245788999999999999999999 67 8999999999999998
Q ss_pred CCcEEEccccCccccC
Q 010131 333 NMRAKVSDFGLSRQAE 348 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~ 348 (517)
++.++|+|||++....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5789999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=191.05 Aligned_cols=217 Identities=28% Similarity=0.415 Sum_probs=164.8
Q ss_pred HhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCc-EecCC
Q 010131 245 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI-IHRDV 323 (517)
Q Consensus 245 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i-vH~dl 323 (517)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.-...++++++.||+|||+ ..| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeee
Confidence 4568899999999999999999999999999999999985 35678999999999999999999998 444 99999
Q ss_pred CCCCeEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCC-------CCCccceehhHHHHHHHHHhCC
Q 010131 324 KSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELISGK 395 (517)
Q Consensus 324 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~elltg~ 395 (517)
++.|+++|....+||+|||+......... .......-..-|.|||.+++. ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999877643110 111111234579999998763 2467899999999999999999
Q ss_pred CCCCCCCcccc-ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 396 KPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 396 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.||........ ..++.++. . .....+-|.+.... +....+..++.+||..+|++||++++|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~----~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVK----K-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHH----h-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99984333322 22333222 2 11112222222111 3344788999999999999999999999888876654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=170.48 Aligned_cols=141 Identities=21% Similarity=0.257 Sum_probs=111.9
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch--h------------------------HHHHHHHHHHHhcCCCCCc
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R------------------------TQQFVTEVALLSRIHHRNL 253 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 253 (517)
...||+|++|.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999878999999998754211 0 1224578999999999987
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhH-hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
.....+... ..++||||++++++... +. ...++......++.|++.++.++|+ ..||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 554444332 24899999998855433 32 3457788899999999999999997 37999999999999999
Q ss_pred CCcEEEccccCccccCC
Q 010131 333 NMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~ 349 (517)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=177.29 Aligned_cols=229 Identities=21% Similarity=0.302 Sum_probs=149.1
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCC----------CCccccceee-----
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH----------RNLVPLIGYC----- 260 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~----- 260 (517)
.+.||.|+++.||.+++. +|+++|||++.-.. ....+++.+|.-....+.+ -.++-.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 578999999999999987 58999999975322 2345677777666555432 1222222221
Q ss_pred ----ecC---C-----eeEEEEEecCCCCHHhHhhc---cC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCC
Q 010131 261 ----EEE---H-----QRILVYEYMHNGTLRDRLHG---SV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 324 (517)
Q Consensus 261 ----~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk 324 (517)
... . ..+++|+-+ .++|.+++.. .. ....+....++.+..|+++.+++||. .|++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 111 1 236778777 5688777542 11 12345556677888999999999999 999999999
Q ss_pred CCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCC--------CCCCccceehhHHHHHHHHHhCCC
Q 010131 325 SSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKK 396 (517)
Q Consensus 325 ~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~elltg~~ 396 (517)
|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.|++|..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999987766543322 224578999997633 357889999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCC
Q 010131 397 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 457 (517)
Q Consensus 397 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 457 (517)
||........... ...... +.++.+..||..+|+.+|++|
T Consensus 249 Pf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9984432211100 112333 667789999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=165.14 Aligned_cols=184 Identities=15% Similarity=0.143 Sum_probs=138.7
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch----hHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecC
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
...|++|+||+||.+.. ++.+++.+.+...... ....+.+|+++|++|. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999998876 5788887777654321 1235789999999995 5889999886 34699999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCC-CCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
|.+|..... .. ...++.|++.+|.++|+ .||+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~----~~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPP----RG------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhh----hh------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999875432 11 13577899999999999 99999999 799999999999999999999865443210
Q ss_pred ----c--------ccccccCCCCcCCCccCCC-CCC-ccceehhHHHHHHHHHhCCCCCCCC
Q 010131 354 ----I--------SSVARGTVGYLDPEYYGNQ-QLT-EKSDVYSFGVVLLELISGKKPVSVE 401 (517)
Q Consensus 354 ----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~Dv~slG~~l~elltg~~p~~~~ 401 (517)
. ......++.|++|+...-. ..+ ...+-++-|+-+|.++|+..+...+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0112257778888754321 223 5678889999999999999887633
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=193.25 Aligned_cols=250 Identities=22% Similarity=0.246 Sum_probs=178.4
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCCccccceeeecCCeeEEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 269 (517)
....+.+.+.||+|+||.||.|...+|+.||+|+-+..+... |.--.+++.+|+ -+.|..+...+.-.+..++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 334455678899999999999999889999999987655432 111223334443 34455555555667778999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-------CCcEEEcccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NMRAKVSDFG 342 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl~Dfg 342 (517)
+||.+.|+|.+++. ..+.++|.-.+.++.|++.-+++||. .+||||||||+|+||.. ...++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999998 57789999999999999999999999 99999999999999942 3459999999
Q ss_pred CccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 010131 343 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421 (517)
Q Consensus 343 ~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 421 (517)
.+-.+.--.. .......+|-.+-.+|...|+.++..+|.|.++-+++-|+.|+.-- ..+|.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g~ 908 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNGS 908 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCCc
Confidence 9876432111 1223445788999999999999999999999999999999987431 11111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 422 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
. ..+++.+......+. .-++...+|..|-..=|...++...|++....
T Consensus 909 ~-~~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 909 S-WMVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred c-eeccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 1 111111111111122 23555566665555557777777777766543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=161.81 Aligned_cols=133 Identities=16% Similarity=0.173 Sum_probs=104.5
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-----CCCCccccceeeecCC---e-eEEEEE
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLVPLIGYCEEEH---Q-RILVYE 271 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e 271 (517)
+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 6799999999996 443333479988765444567899999999999 5799999999998864 3 337899
Q ss_pred e--cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHH-HHHhcCCCCCcEecCCCCCCeEeCC----CCcEEEccccCc
Q 010131 272 Y--MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL-EYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLS 344 (517)
Q Consensus 272 ~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a 344 (517)
| +.+|+|.+++.. ..+++. ..++.+++.++ +|||+ .+|+||||||+||+++. +..++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 557999999963 235554 35678888787 99999 99999999999999974 347999995433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-20 Score=185.97 Aligned_cols=225 Identities=26% Similarity=0.344 Sum_probs=179.1
Q ss_pred ccCCCCceEEEEEE----ecCCcEEEEEEecCCCch--hHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecC
Q 010131 202 KIGKGSFGSVYYGK----MKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.+|+|+||.|++++ .+.|+.+|.|++++.... .......|..++...+ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999873 234778899888654321 1124556888888886 9999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|.|...+. ....+...........++-+++++|+ .+++|+|+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988877 45667777888889999999999999 99999999999999999999999999999876443222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
+||..|||||++. ....+.|-||||++.+||+||..||.. +.+...++. .-..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 6899999999998 557799999999999999999999983 112222221 1122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
+.+......+++..++..+|.+|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33444456788889999999999755
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=163.07 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=110.1
Q ss_pred HhhhcccCCCCceEEEEEE--ecCCcEEEEEEecCCCch------------------------hHHHHHHHHHHHhcCCC
Q 010131 197 NNFCKKIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 250 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 250 (517)
+.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 458999999998743210 01235689999999975
Q ss_pred CC--ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-cEecCCCCCC
Q 010131 251 RN--LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN 327 (517)
Q Consensus 251 ~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~dlk~~N 327 (517)
.. +.+++++ ...++||||+++++|..... ........+...++.|++.++++||+ .+ ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 32 3334432 23589999999988876543 23445666778999999999999999 89 9999999999
Q ss_pred eEeCCCCcEEEccccCccccCC
Q 010131 328 ILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999998875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=157.61 Aligned_cols=134 Identities=25% Similarity=0.414 Sum_probs=113.6
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCch--------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.||+|++|.||+|.+ +|..|++|+....... ....+.+|+.++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 5788999986543211 124578899999999999998888787777788999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|++|.+++... . . .+..++.+++.+|.++|+ .+++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988632 1 1 788999999999999999 9999999999999999 78999999998764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-18 Score=160.05 Aligned_cols=197 Identities=20% Similarity=0.224 Sum_probs=137.4
Q ss_pred CCCCccccceeeec---------------------------CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHH
Q 010131 249 HHRNLVPLIGYCEE---------------------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 301 (517)
Q Consensus 249 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 301 (517)
+|||||++.++|.+ ....|+||..+ ..+|..++- ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh----cCCCchHHHHHHHH
Confidence 49999999887643 23568888877 458888885 34456666777899
Q ss_pred HHHHHHHHHhcCCCCCcEecCCCCCCeEe--CCCC--cEEEccccCccccCC-----CCcccccccccCCCCcCCCccCC
Q 010131 302 DAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINM--RAKVSDFGLSRQAEE-----DLTHISSVARGTVGYLDPEYYGN 372 (517)
Q Consensus 302 ~ia~aL~~LH~~~~~~ivH~dlk~~Nill--~~~~--~~kl~Dfg~a~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~ 372 (517)
|+++|+.|||. +||.|||+|++|||+ |+|+ ...++|||++---.. ......-...|...-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999 999999999999999 4444 478899998653222 11111122346778999998754
Q ss_pred CC------CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHH
Q 010131 373 QQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVA 446 (517)
Q Consensus 373 ~~------~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 446 (517)
.+ .-.|+|.|+.|.+.||+++...||..... ...+... .++..+. ..+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~-----Yqe~qLP---------alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT-----YQESQLP---------ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh-----hhhhhCC---------CCcccCChHHHHHH
Confidence 32 23589999999999999999999973111 0011111 1111221 12223444678999
Q ss_pred HHhhccCCCCCCCHHHHHHHHH
Q 010131 447 IQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 447 ~~cl~~~P~~RPs~~evl~~L~ 468 (517)
...|+.||.+|++..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999877666654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.3e-18 Score=153.82 Aligned_cols=130 Identities=25% Similarity=0.447 Sum_probs=107.2
Q ss_pred ccCCCCceEEEEEEecCCcEEEEEEecCCCc-h-------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 202 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-H-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.||+|+||.||+|.+. |..|++|....... . ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999964 78899998654321 1 1256778999999999887666666666666779999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+|++|.+.+... .. .++.+++.+|.+||+ .+++|||++|+||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887531 11 789999999999999 9999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=152.87 Aligned_cols=137 Identities=20% Similarity=0.218 Sum_probs=108.3
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCch----------------------hHHHHHHHHHHHhcCCCCC--
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----------------------RTQQFVTEVALLSRIHHRN-- 252 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n-- 252 (517)
+.+.+.||+|+||.||++...+|+.||||++...... ....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5567889999999999999888999999987542210 1123667888999887774
Q ss_pred ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 253 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
+...++ ....++||||+++++|...... .....++.+++.++.++|+ .+++||||||+||+++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 444443 2345899999999998765420 2356788999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCC
Q 010131 333 NMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~ 349 (517)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999866544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-18 Score=171.48 Aligned_cols=173 Identities=27% Similarity=0.371 Sum_probs=132.9
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++.|++|...+|.+|+.........++.....++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999877777788999999999999999999 68999999999999999999999999998
Q ss_pred cccCCCC-----cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHh
Q 010131 345 RQAEEDL-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 345 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
....... ........||..||+||.+.+..|+.|+||||||++|+|+++ =..++.- .-...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence 8765544 122334569999999999999999999999999999999987 3333320 00111122
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE 462 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 462 (517)
.+.+ +|....+++.+ ..++.+++...|.+||++.+
T Consensus 474 ~g~i----p~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGII----PPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCC----ChHHhhcCcHH-----HHHHHHhcCCCcccCchHHH
Confidence 2222 22222233322 37888999999999994443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=172.66 Aligned_cols=133 Identities=24% Similarity=0.368 Sum_probs=109.3
Q ss_pred hhcccCCCCceEEEEEEecCCcEEEEEEe-cCCCc-------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIM-ADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..+.||+|+||+||+|.+.+. .+++|+. .+... ...+.+.+|+++++.++|++++....++.+....++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 367899999999999988744 4444443 21111 12356889999999999999998888877777789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
||+++++|.+++. ....++.+++.+|.|||+ .+++||||||+||++ .++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998875 346789999999999999 999999999999999 5789999999998753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.6e-17 Score=171.47 Aligned_cols=137 Identities=26% Similarity=0.546 Sum_probs=111.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
++.|+|++|+++|.+|..|+.|++|+.|+|++|.|+|.+|. ++.+++|+.|+|++|+|+|.+|..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 35799999999999999999999999999999999999997 99999999999999999999999999999999999999
Q ss_pred ccccCCCCccccc---cceeeeccCCCccccc----ccc-ccceeeeeeehhhHHHHHHHHHHHHH
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNNPKLHKE----SRR-RMRFKLILGTSIGVLAILLVLFLCSL 137 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n~~~~~~----~~~-~~~~~~i~~~~~~~~~~~lvl~l~~~ 137 (517)
|+++|.+|..+.. ....+.+.+|+.+|+. .|. ......++++++++++++++++++.+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~ 565 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAM 565 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCCCCCCcccCCCceEEEEEhHHHHHHHHHHHHHh
Confidence 9999999988654 3346778999999963 232 12334455555555444444333333
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.1e-17 Score=169.00 Aligned_cols=208 Identities=25% Similarity=0.325 Sum_probs=139.9
Q ss_pred hhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
-++.+..|+||.||..+++. .+.+|.|+=+.+ -+.+- ++.....|.+ | |+
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfv---------------v------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFV---------------V------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCcce---------------e------ch
Confidence 36889999999999998873 667888542211 11110 1222222222 2 33
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC------
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL------ 351 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~------ 351 (517)
-...++ +-+.++... +.+++|||+ .+|+|||+||+|.+|+.-|++|++|||+++......
T Consensus 138 c~tllk---~~g~lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 138 CATLLK---NIGPLPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhhcc---cCCCCcchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 333343 333444433 789999999 999999999999999999999999999987532111
Q ss_pred --------cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 352 --------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 352 --------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
.......+||+.|+|||++....|....|-|++|+++||.+.|+.||.++...+ .+...+...-
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd~i-- 275 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISDDI-- 275 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhhhc--
Confidence 112234579999999999999999999999999999999999999998543321 1222222110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 463 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev 463 (517)
...+.+...+.+..+++.+.|+.+|..|--....
T Consensus 276 ------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 276 ------EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred ------cccccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 1111122333467899999999999999644333
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=133.29 Aligned_cols=135 Identities=22% Similarity=0.207 Sum_probs=114.0
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC--CCccccceeeecCCeeEEEEEecCCCC
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 3679999999999999864 7899999865433 5678899999999976 588999988888788999999998877
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+... +......++.+++++++++|.....+++|+|++|+||+++.++.+++.|||.+...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 6543 55667788999999999999844457999999999999999899999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.2e-16 Score=139.42 Aligned_cols=138 Identities=22% Similarity=0.319 Sum_probs=98.1
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch--hHHHH----------------------HHHHHHHhcCCCCC--c
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQF----------------------VTEVALLSRIHHRN--L 253 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 253 (517)
.+.||+|+||+||+|...+|+.||||++...... ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753221 11111 34555555554332 3
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhH-hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
.+.+++ ...++||||++++.+... +... ... .....++.+++.++.++|. ..+++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 333332 245899999998543221 1110 011 5678899999999999997 37999999999999999
Q ss_pred CCcEEEccccCccccCC
Q 010131 333 NMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~ 349 (517)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-15 Score=141.37 Aligned_cols=135 Identities=19% Similarity=0.243 Sum_probs=105.4
Q ss_pred cccC-CCCceEEEEEEecCCcEEEEEEecCCC-------------chhHHHHHHHHHHHhcCCCCCc--cccceeeecCC
Q 010131 201 KKIG-KGSFGSVYYGKMKDGKEVAVKIMADSC-------------SHRTQQFVTEVALLSRIHHRNL--VPLIGYCEEEH 264 (517)
Q Consensus 201 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~ 264 (517)
..|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999886 7789999875311 1223567889999999988775 66776644322
Q ss_pred ----eeEEEEEecCC-CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc
Q 010131 265 ----QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 265 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
..++|+|+++| .+|.+++.. ..++.. .+.+++.+|.+||+ .||+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 689888753 334443 35789999999999 999999999999999999999999
Q ss_pred cccCcccc
Q 010131 340 DFGLSRQA 347 (517)
Q Consensus 340 Dfg~a~~~ 347 (517)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.3e-17 Score=168.77 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=185.2
Q ss_pred HhhhcccCCCCceEEEEEEecC--CcEEEEEEecCCC--chhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
+++.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4455679999999998886643 4456666665432 223344555777777776 9999999999999999999999
Q ss_pred ecCCCCHHhHh-hccCCCCccCHHHHHHHHHHHHHHHHHHh-cCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccC
Q 010131 272 YMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 348 (517)
Q Consensus 272 ~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~ 348 (517)
|..++++.+.+ +. .....+....-..+.|+..++.|+| . .++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 102 ~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccC--CccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999998887 42 1225566667778999999999999 7 9999999999999999999 99999999998875
Q ss_pred C--CCccccccccc-CCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 349 E--DLTHISSVARG-TVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 349 ~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
. +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|.... +...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~~~- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GRFT- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---cccc-
Confidence 5 33333444567 9999999998874 55778999999999999999999998444332 1222222111 0000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ..........++..+++..+|..|.+.+++..
T Consensus 252 ---~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 ---QL----PWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cC----ccccCChhhhhcccccccCCchhccccccccc
Confidence 00 01111224567888899999999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.8e-14 Score=145.26 Aligned_cols=141 Identities=24% Similarity=0.301 Sum_probs=100.3
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhH----------------------------------------HHHHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT 240 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 240 (517)
+.||.|++|.||+|++++|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999999999999999865421110 02445
Q ss_pred HHHHHhcCC----CCCccccceee-ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHH-HHHHHhcCC
Q 010131 241 EVALLSRIH----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-GLEYLHTGC 314 (517)
Q Consensus 241 E~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-aL~~LH~~~ 314 (517)
|+..+.+++ |.+-+.+-.++ ......++||||++|++|.++..... ... ....++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHh--
Confidence 555555552 22223322222 22445799999999999988765321 112 23456666666 4678898
Q ss_pred CCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 315 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
.|++|+|+||.||+++.+++++++|||++.....
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999877654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.4e-14 Score=132.42 Aligned_cols=200 Identities=27% Similarity=0.373 Sum_probs=141.4
Q ss_pred HHhcCCCCCccccceeeecCC-----eeEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 010131 244 LLSRIHHRNLVPLIGYCEEEH-----QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317 (517)
Q Consensus 244 ~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ 317 (517)
-+-.+.|.|+|+++.|+.+.. ...+++|||..|++..+|++.. ++..+......+|+.||..||.|||+ |.+.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 344557999999999986543 4689999999999999998654 56678888999999999999999998 6799
Q ss_pred cEecCCCCCCeEeCCCCcEEEccccCcccc---CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC
Q 010131 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG 394 (517)
Q Consensus 318 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~---~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg 394 (517)
|+|+++..+-|++..++-+|+.--.-.... ............+-++|.|||+=.....+.++|||+||+..+||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999998888532211110 00111112223367899999998777788899999999999999887
Q ss_pred CCCCC-CCCcc-ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 395 KKPVS-VEDFG-AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 395 ~~p~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..--. ..+.- .+.++.. ....+...+ =..++..|++.+|..||+|.+++.
T Consensus 279 Eiq~tnseS~~~~ee~ia~----------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN----------VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceeehhhhhhh----------heeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 64422 11110 0011100 000011111 126778999999999999998854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-13 Score=138.34 Aligned_cols=252 Identities=23% Similarity=0.218 Sum_probs=183.2
Q ss_pred HHHHHHHhhhcccCC--CCceEEEEEEe--c-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC-CCCCccccceeeec
Q 010131 191 ELEEATNNFCKKIGK--GSFGSVYYGKM--K-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 262 (517)
+....+..+.+.+|. |.+|.||.+.. . ++..+|+|.-+.... .....=.+|+....++ .|+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 455556667788999 99999999977 3 688899998443322 2223334566666667 49999998888999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHH----HHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEE
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAK 337 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~k 337 (517)
.+..++-+|++ +.+|.++.+.. ...++...++....+..+ ||.++|+ .+++|-|+||.||+...+ ...+
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceee
Confidence 99999999988 57888877642 334677778888888888 9999999 999999999999999999 8899
Q ss_pred EccccCccccCCCCcc----cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 010131 338 VSDFGLSRQAEEDLTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 413 (517)
++|||+...+...... ......|...|++||...+ .++.++|+|++|.++.+..++..+.........
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W------- 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSW------- 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCc-------
Confidence 9999999887654321 1122247788999998766 678899999999999999988777653211110
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..++.+. +..++.......+...+..|++.+|..|++.+.+..
T Consensus 336 -~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 -SQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0111110 001111111124556889999999999999888765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=7.2e-12 Score=127.10 Aligned_cols=167 Identities=20% Similarity=0.222 Sum_probs=127.7
Q ss_pred ecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHH
Q 010131 216 MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 295 (517)
Q Consensus 216 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 295 (517)
..++.+|.|...+...........+-++.|+.++||||++++..+..++..|+|+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34688999998876655445667788899999999999999999999999999999885 56666652 23556
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCC
Q 010131 296 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375 (517)
Q Consensus 296 ~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 375 (517)
+...+.||+.||.|||+ +.+++|++|....|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 67789999999999997 48999999999999999999999999988765432211 011111223466666543322
Q ss_pred CccceehhHHHHHHHHHhCC
Q 010131 376 TEKSDVYSFGVVLLELISGK 395 (517)
Q Consensus 376 ~~~~Dv~slG~~l~elltg~ 395 (517)
...|.|.|||+++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 4579999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.3e-12 Score=116.37 Aligned_cols=127 Identities=18% Similarity=0.181 Sum_probs=95.7
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCcc-ccceeeecCCeeEEEEEecCCCCHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
+.++.|.++.||+++.. +..|++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56899999999999876 78899998765432 223467899999988655544 444433 23458999999998875
Q ss_pred hHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-----cEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 280 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 280 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+.. .....++.+++++|+.||+ .+ ++|||++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 0113456799999999998 55 59999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.8e-13 Score=136.65 Aligned_cols=139 Identities=20% Similarity=0.267 Sum_probs=91.5
Q ss_pred cccCCCCceEEEEEEecC-CcEEEEEEecCCCchh----------------------------------HH------HHH
Q 010131 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR----------------------------------TQ------QFV 239 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~------~~~ 239 (517)
+.||.|++|.||+|++++ |+.||||+.++..... .+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542110 01 133
Q ss_pred HHHHHHhcCC----CCCccccceeeec-CCeeEEEEEecCCCCHHhHhhccCCC---CccCHHHHHHHHHHHHHHHHHHh
Q 010131 240 TEVALLSRIH----HRNLVPLIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQ---KPLDWLTRLQIAHDAAKGLEYLH 311 (517)
Q Consensus 240 ~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~aL~~LH 311 (517)
+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+.+.++..-...+ ..+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4444444442 3333333333322 34578999999999998742211011 123233333333333 3
Q ss_pred cCCCCCcEecCCCCCCeEeCCCC----cEEEccccCccccCC
Q 010131 312 TGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLSRQAEE 349 (517)
Q Consensus 312 ~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a~~~~~ 349 (517)
. .|++|+|+||.||+++.++ ++++.|||++.....
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 8999999999999999988 999999999887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.6e-11 Score=108.65 Aligned_cols=137 Identities=15% Similarity=0.173 Sum_probs=99.9
Q ss_pred cccCCCCceEEEEEEecC-------CcEEEEEEecCCC----------------------chhHHHHH----HHHHHHhc
Q 010131 201 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC----------------------SHRTQQFV----TEVALLSR 247 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 247 (517)
..||.|--+.||.|...+ +..+|||+.+-.. ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 4799999874210 01122333 79999999
Q ss_pred CCC--CCccccceeeecCCeeEEEEEecCCCCHHh-HhhccCCCCccCHHHHHHHHHHHHHHHHHH-hcCCCCCcEecCC
Q 010131 248 IHH--RNLVPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDV 323 (517)
Q Consensus 248 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~dl 323 (517)
+.. -++..++++ ...++||||+.+..+.. .+. ...++..+...+..+++.+|..| |. .+++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 853 456666654 45689999997654422 222 22345556677889999999999 88 89999999
Q ss_pred CCCCeEeCCCCcEEEccccCccccCC
Q 010131 324 KSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 324 k~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
++.||+++ ++.++|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6e-13 Score=112.08 Aligned_cols=87 Identities=30% Similarity=0.479 Sum_probs=79.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++.|.||+|+++ .+|+.+.+|.+|+.|++++|+++..+++++.+++|+.|+++.|++. .+|..|+.+|.|+.||+++|
T Consensus 35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltyn 112 (264)
T KOG0617|consen 35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYN 112 (264)
T ss_pred hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccc
Confidence 367899999999 8999999999999999999999999999999999999999999999 99999999999999999999
Q ss_pred cccC-CCCcc
Q 010131 81 SFVG-EIPPA 89 (517)
Q Consensus 81 ~l~~-~~P~~ 89 (517)
+++. .+|..
T Consensus 113 nl~e~~lpgn 122 (264)
T KOG0617|consen 113 NLNENSLPGN 122 (264)
T ss_pred ccccccCCcc
Confidence 9873 34443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.5e-11 Score=110.27 Aligned_cols=142 Identities=21% Similarity=0.314 Sum_probs=110.5
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCC--CCccccceeeecC---CeeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH--RNLVPLIGYCEEE---HQRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~ 274 (517)
+.|+.|.++.||++...+|+.+++|+...... .....+..|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999765332 134578899999999965 3456777776654 25689999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC---------------------------------------- 314 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~---------------------------------------- 314 (517)
|.++.+.+. ...++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988876543 135677778888888888888888521
Q ss_pred -------------CCCcEecCCCCCCeEeCC--CCcEEEccccCccc
Q 010131 315 -------------NPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQ 346 (517)
Q Consensus 315 -------------~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~ 346 (517)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256799999999999998 66789999997764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-10 Score=100.74 Aligned_cols=132 Identities=25% Similarity=0.382 Sum_probs=101.5
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCC-ch-------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..+++|+-+.+|.+.+. |.++++|.-.+.. .. ....-.+|+.++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999886 5557777543221 11 124466899999998755555555566667778899999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
++|-.|.+.+... ...++..+-.-+.-||. .||+||||.++||++..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888742 25677888888899999 9999999999999998665 999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-11 Score=123.22 Aligned_cols=241 Identities=22% Similarity=0.234 Sum_probs=171.9
Q ss_pred hhcccCCCCceEEEEEEec--CCcEEEEEEecCCCchhHHH--HHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 199 FCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
++..||.|.|+.|+....+ ++..+++|.+.+.......+ -..|+.+...+ .|.+++.....+......++--|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 4578999999999998643 57889999887654433322 34577776666 5889998888777777788999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++..... ....++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.+..+.-.
T Consensus 349 ~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 349 EGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred cCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 9998876653 34567778889999999999999999 999999999999999886 78899999988652211
Q ss_pred cccccccc-CCCC-cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 353 HISSVARG-TVGY-LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 353 ~~~~~~~g-~~~y-~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
...... +..| .+|+......+-.+.|+||||..+.+.+++...-.... +|. .+..+.... +
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~--~i~~~~~p~-----~ 483 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL--TIRSGDTPN-----L 483 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--eeecccccC-----C
Confidence 111112 3334 35666677788899999999999999999875533110 110 111111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 469 (517)
... ...+..+...+...++..||.+.+.....+.
T Consensus 484 ----~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 484 ----PGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----Cch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111 1356677888999999999999887665443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=7.8e-10 Score=109.08 Aligned_cols=170 Identities=21% Similarity=0.292 Sum_probs=131.1
Q ss_pred CceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeee----cCCeeEEEEEecCC-CCHHh
Q 010131 207 SFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILVYEYMHN-GTLRD 280 (517)
Q Consensus 207 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-gsL~~ 280 (517)
...+.|++... ||..|++|+++............-+++++++.|+|+|++..+|. .+...++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44688999766 89999999995443333333345688899999999999999876 34568999999987 46766
Q ss_pred HhhccC------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 281 RLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 281 ~l~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
.-.... .+...++..+|.++.|+..||.++|+ .|+.-+-|.+.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543221 23457889999999999999999999 999999999999999999999999888776654
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 397 (517)
.+.. |.+. --.+-|.-.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 4321 1111 12367999999999999999654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.7e-11 Score=127.37 Aligned_cols=87 Identities=31% Similarity=0.594 Sum_probs=78.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCc-ccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSL-PNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l-~~L~~l~l~ 78 (517)
|+.|+|++|+++|.+|..++.+++|+.|+|++|+|+|.+|+ ++.|++|+.|+|++|+|+|.+|..++.+ .++..++++
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~ 523 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT 523 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence 67899999999999999999999999999999999999998 9999999999999999999999998764 467889999
Q ss_pred cccccCCCC
Q 010131 79 NNSFVGEIP 87 (517)
Q Consensus 79 ~N~l~~~~P 87 (517)
+|......|
T Consensus 524 ~N~~lc~~p 532 (623)
T PLN03150 524 DNAGLCGIP 532 (623)
T ss_pred CCccccCCC
Confidence 998653344
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.2e-12 Score=110.25 Aligned_cols=105 Identities=32% Similarity=0.566 Sum_probs=90.6
Q ss_pred CceecCCCCccccc-CCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGE-IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|||++|+++.. +|..|+.++.|+.|+|++|.+.-.+|+++.|++|+.|.+..|.+- ++|.+++.+..|+.|++++
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 46788888888744 688888888888899999999888889999999999999999999 9999999999999999999
Q ss_pred ccccCCCCccccc-----cceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALLT-----GKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~~-----~~~~~~~~~n~~~~~ 107 (517)
|+++ .+|+++.. ....+.+..|||...
T Consensus 183 nrl~-vlppel~~l~l~~~k~v~r~E~NPwv~p 214 (264)
T KOG0617|consen 183 NRLT-VLPPELANLDLVGNKQVMRMEENPWVNP 214 (264)
T ss_pred ceee-ecChhhhhhhhhhhHHHHhhhhCCCCCh
Confidence 9999 89998754 345566788888743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.4e-10 Score=96.08 Aligned_cols=141 Identities=21% Similarity=0.257 Sum_probs=104.7
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEec-CCCch-------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..+-+|+-+.|+++.+. |+..+||.-. +...+ ...+..+|++.|.+++--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56889999999999997 7887777532 22111 234577899999998654554444456666677899999
Q ss_pred cCC-CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEEccccCccc
Q 010131 273 MHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQ 346 (517)
Q Consensus 273 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~ 346 (517)
++| .++.+++...... .........++.+|-+.+.-||. .+|+||||..+||++..++. +.+.|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 977 4778887654322 22333346789999999999999 99999999999999966543 58999999764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.7e-11 Score=136.48 Aligned_cols=106 Identities=29% Similarity=0.495 Sum_probs=95.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|. +.++++|+.|+|++|.++|.+|..+..+++|+.|++++
T Consensus 477 L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 556 (968)
T PLN00113 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556 (968)
T ss_pred ceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCC
Confidence 57899999999999999999999999999999999999997 99999999999999999999999999999999999999
Q ss_pred ccccCCCCccccc--cceeeeccCCCccc
Q 010131 80 NSFVGEIPPALLT--GKVIFKYDNNPKLH 106 (517)
Q Consensus 80 N~l~~~~P~~~~~--~~~~~~~~~n~~~~ 106 (517)
|+++|.+|..+.. .+..+.+.+|+..+
T Consensus 557 N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 557 NQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred CcccccCChhHhcCcccCEEeccCCccee
Confidence 9999999987643 45667778887553
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-08 Score=98.69 Aligned_cols=263 Identities=16% Similarity=0.145 Sum_probs=161.9
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCcccccee----e--ec-CCeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY----C--EE-EHQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~----~--~~-~~~~~lv~e 271 (517)
++.||+|+.+.+|..--- ...+.|+..........+. +..|... .||-+-.-+.+ . .+ +....+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 567999999999965321 1234577765544333332 3334443 45543321111 1 11 223567888
Q ss_pred ecCCC-CHHhHhhc---cCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 272 YMHNG-TLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 272 ~~~~g-sL~~~l~~---~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
.+.+. ...++... ........|.-.++.++.+|.+.+-||+ .|.+-||+.++|+||++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 77664 23333322 2234568899999999999999999999 99999999999999999999999985543333
Q ss_pred CCCCcccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhC-CCCCCCCCcc-ccccHHHHHHHHHhcC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFG-AELNIVHWARSMIKKG 420 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~-~~~~~~~~~~~~~~~~ 420 (517)
.++..+ ....|...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+-... ....-.+ ..+..|
T Consensus 168 ~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g 242 (637)
T COG4248 168 ANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG 242 (637)
T ss_pred cCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence 222222 2234788999999753 44556789999999999999886 9999754322 1111100 011112
Q ss_pred CcccccCcccc-----CCC-CHHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHhhhhhhc
Q 010131 421 DVISIVDPVLI-----GNV-KIESIWRIAEVAIQCVEQ--RGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 421 ~~~~~~d~~l~-----~~~-~~~~~~~l~~li~~cl~~--~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+....|.... ... -.--+..+.-+..+|+.. ++.-|||++..+..|..+.+...
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 22221111110 011 112233566777888865 36789999999999887765433
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-09 Score=96.12 Aligned_cols=126 Identities=25% Similarity=0.318 Sum_probs=83.4
Q ss_pred EEEEEEecCCcEEEEEEecCCCc----------------------h----hHHHHHHHHHHHhcCCCC--Cccccceeee
Q 010131 210 SVYYGKMKDGKEVAVKIMADSCS----------------------H----RTQQFVTEVALLSRIHHR--NLVPLIGYCE 261 (517)
Q Consensus 210 ~Vy~~~~~~~~~vavK~~~~~~~----------------------~----~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 261 (517)
.||.|...+|..+|||+.+.... . ......+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999999742100 0 113467899999999755 456665442
Q ss_pred cCCeeEEEEEecC--CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHH-HhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 262 EEHQRILVYEYMH--NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY-LHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 262 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~-LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
..++||||++ |..+..+... .++......++.+++..+.. +|. .|++|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 3579999998 5555443321 11233456677788886666 567 999999999999999987 9999
Q ss_pred ccccCccccC
Q 010131 339 SDFGLSRQAE 348 (517)
Q Consensus 339 ~Dfg~a~~~~ 348 (517)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.9e-09 Score=98.90 Aligned_cols=139 Identities=17% Similarity=0.166 Sum_probs=99.7
Q ss_pred cCCCCceEEEEEEecCCcEEEEEEecCCCch-----------hHHHHHHHHHHHhcCCCCC--ccccceeeec-----CC
Q 010131 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRN--LVPLIGYCEE-----EH 264 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~-----~~ 264 (517)
+-.-....|++..+. |+.|.||........ ....+.+|...+.++...+ ....+++... ..
T Consensus 30 v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 333333456777764 789999977433211 1124778999998885333 3444555533 23
Q ss_pred eeEEEEEecCCC-CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-------CCcE
Q 010131 265 QRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NMRA 336 (517)
Q Consensus 265 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~ 336 (517)
..++|+|++++. +|.+++.... ....+......++.+++..+..||. .||+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceE
Confidence 578999999886 8998885322 2345566777899999999999999 99999999999999975 4679
Q ss_pred EEccccCccc
Q 010131 337 KVSDFGLSRQ 346 (517)
Q Consensus 337 kl~Dfg~a~~ 346 (517)
.++||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.8e-09 Score=94.56 Aligned_cols=137 Identities=23% Similarity=0.217 Sum_probs=99.2
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc----------------------hhHHHHHHHHHHHhcCCCC--C
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------------------HRTQQFVTEVALLSRIHHR--N 252 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 252 (517)
+.++..||-|--+.||.|....|.++|||.=+-... -......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 346789999999999999999999999997431100 0123466899999999644 6
Q ss_pred ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 253 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
+.+.++ .+...+|||+++|-.|...- ++....-.++..|++-+..+-. .|+||||+++-||++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 776665 35678999999886664321 1233334445555555555445 89999999999999999
Q ss_pred CCcEEEccccCccccC
Q 010131 333 NMRAKVSDFGLSRQAE 348 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~ 348 (517)
+|.++++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998765543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.6e-10 Score=79.93 Aligned_cols=60 Identities=40% Similarity=0.527 Sum_probs=46.2
Q ss_pred CCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccccc
Q 010131 23 EALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 82 (517)
Q Consensus 23 ~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l 82 (517)
++|+.|+|++|+|+..+++ |.++++|+.|++++|.++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677888888888877766 77788888888888888755556677888888888888765
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-09 Score=116.34 Aligned_cols=242 Identities=19% Similarity=0.210 Sum_probs=161.9
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+.+-+|.++.++.+.-. .|...+.|+.... ...+.+....+-.++-..++|-++.....+.-....+++++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 356788999988877533 2433344333211 111222233333333334556666665555566778999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC------
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE------ 349 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~------ 349 (517)
++|...++. .+..+..........+..+++|||. ..+.|+|++|.|.+...+++.+++|||.......
T Consensus 889 ~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 889 GDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CCchhhhhc---CCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999883 4456666666777888999999998 7799999999999999999999999984322100
Q ss_pred C------------------------CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc
Q 010131 350 D------------------------LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405 (517)
Q Consensus 350 ~------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 405 (517)
. .........+|+.|.+||...+......+|.|+.|++++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 0011223458999999999999999999999999999999999999998433221
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 461 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 461 (517)
. + +.+..+.. .+ .....+......+++.+.+..+|.+|-.|.
T Consensus 1043 ~------f-~ni~~~~~-~~------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 I------F-ENILNRDI-PW------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h------h-hccccCCC-CC------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1 1 11111111 00 111223333566888888999999998776
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.8e-10 Score=113.45 Aligned_cols=151 Identities=18% Similarity=0.253 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc--------ccccccCCCCcCCCccC
Q 010131 300 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--------SSVARGTVGYLDPEYYG 371 (517)
Q Consensus 300 ~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~g~~~y~aPE~~~ 371 (517)
+.+++.|+.|+|. ..++||++|.|++|.++.++.+||+.|+.+.......... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999998 4899999999999999999999999999876544321111 11122456799999999
Q ss_pred CCCCCccceehhHHHHHHHHH-hCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhh
Q 010131 372 NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 450 (517)
Q Consensus 372 ~~~~~~~~Dv~slG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl 450 (517)
+...+.++|+||+|+++|.+. .|+.-+............ ...+..-...+....+.++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence 988899999999999999999 455555422221111110 001111111223445567888889999
Q ss_pred ccCCCCCCCHHHHHH
Q 010131 451 EQRGFSRPKMQEIVL 465 (517)
Q Consensus 451 ~~~P~~RPs~~evl~ 465 (517)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998887643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-07 Score=85.34 Aligned_cols=138 Identities=20% Similarity=0.226 Sum_probs=103.9
Q ss_pred cCCCCceEEEEEEecCCcEEEEEEecCCC------chhHHHHHHHHHHHhcCCC--CCccccceeeec-----CCeeEEE
Q 010131 203 IGKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEE-----EHQRILV 269 (517)
Q Consensus 203 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~-----~~~~~lv 269 (517)
-|+||-+.|++..+. |+.+-+|.-.... ......|.+|...+.++.. -.+.+++ ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 366999999998876 5578888865211 2345789999999999852 2345554 3321 2246799
Q ss_pred EEecCC-CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc--EEEccccCccc
Q 010131 270 YEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 346 (517)
Q Consensus 270 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~ 346 (517)
+|-+++ -+|.+++... .-.+.+......+..+++..++-||+ .|+.|+|+.++||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998864 5898888643 23356777788999999999999999 99999999999999986667 99999986654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.1e-09 Score=77.63 Aligned_cols=58 Identities=36% Similarity=0.456 Sum_probs=52.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCcee
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 58 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l 58 (517)
|+.|+|++|+|+...+..|.++++|++|++++|.++...|. |.++++|+.|++++|+|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 57899999999955556788999999999999999999887 99999999999999985
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.3e-08 Score=102.68 Aligned_cols=141 Identities=23% Similarity=0.307 Sum_probs=91.6
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHH----------------------------------------HHHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ----------------------------------------QFVT 240 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 240 (517)
+.|+.++-|.||+|++++|+.||||+.++......+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 568999999999999999999999998654322110 1233
Q ss_pred HHHHHhcCC-----CCCccccceee-ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHH-HHHHhcC
Q 010131 241 EVALLSRIH-----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG-LEYLHTG 313 (517)
Q Consensus 241 E~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a-L~~LH~~ 313 (517)
|...+.+++ .+++ ++=.++ +-.....++|||++|-.+.+...-. ....+...+ +..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~i---a~~~~~~f~~q~~~- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKEL---AELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHH---HHHHHHHHHHHHHh-
Confidence 444444431 2221 111222 2245678999999999888874321 233443333 2222222 122222
Q ss_pred CCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 314 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
.|++|+|.+|.||+++.++++.+.|||+.....+.
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 78999999999999999999999999998876543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.8e-09 Score=93.71 Aligned_cols=100 Identities=28% Similarity=0.441 Sum_probs=38.9
Q ss_pred CceecCCCCcccccCCcccc-CCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCC-CCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~-~~l~~L~~l~l~ 78 (517)
+++|+|++|+|+ .+. .++ .+++|+.|||++|.|+. ++.+..+++|+.|++++|+++ .++..+ ..+++|+.|+++
T Consensus 21 ~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 21 LRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp -----------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-T
T ss_pred cccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECc
Confidence 468999999999 453 576 58999999999999996 567889999999999999999 776555 368999999999
Q ss_pred cccccCCCCc----cccccceeeeccCCCcc
Q 010131 79 NNSFVGEIPP----ALLTGKVIFKYDNNPKL 105 (517)
Q Consensus 79 ~N~l~~~~P~----~~~~~~~~~~~~~n~~~ 105 (517)
+|++. .+-. .-...+..+++.+||..
T Consensus 97 ~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 97 NNKIS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp TS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 99998 4432 11335567889999853
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.8e-09 Score=108.24 Aligned_cols=79 Identities=30% Similarity=0.372 Sum_probs=37.4
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.||||+|++. ..|..+-.-+++..|+||+|+|..++-+ |.+|+.|-.||||+|+|. .+|+.+..|.+|+.|.|++|
T Consensus 106 t~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~N 183 (1255)
T KOG0444|consen 106 TILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNN 183 (1255)
T ss_pred eeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCC
Confidence 44444444444 4444444444444444444444443333 444444444445544444 44444444444444444444
Q ss_pred cc
Q 010131 81 SF 82 (517)
Q Consensus 81 ~l 82 (517)
.+
T Consensus 184 PL 185 (1255)
T KOG0444|consen 184 PL 185 (1255)
T ss_pred hh
Confidence 43
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=9.5e-08 Score=87.66 Aligned_cols=107 Identities=27% Similarity=0.299 Sum_probs=83.6
Q ss_pred HHHHHHHHHHHhcCCC--CCccccceeeecC----CeeEEEEEecCCC-CHHhHhhccCCCCccCHHHHHHHHHHHHHHH
Q 010131 235 TQQFVTEVALLSRIHH--RNLVPLIGYCEEE----HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 307 (517)
Q Consensus 235 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 307 (517)
.....+|...+.++.. =.+.+.+++.... ...++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 3457788888887743 3355566665442 2458999999884 799988742 2266667788999999999
Q ss_pred HHHhcCCCCCcEecCCCCCCeEeCCCC---cEEEccccCcccc
Q 010131 308 EYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQA 347 (517)
Q Consensus 308 ~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~ 347 (517)
+-||. .||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 9999999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-09 Score=103.73 Aligned_cols=99 Identities=22% Similarity=0.340 Sum_probs=74.2
Q ss_pred eecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 3 RCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
.|+|.+|+|. .+| +|..++.|.+|+++.|+|.-.+.+ ...|.+|.+|||.+|++. ..|+++.-+.+|..||+|+|.
T Consensus 210 ~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~ 286 (565)
T KOG0472|consen 210 LLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNND 286 (565)
T ss_pred HHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCc
Confidence 3555556655 455 555566666666666666554445 457889999999999999 999999999999999999999
Q ss_pred ccCCCCccccc-cceeeeccCCCcc
Q 010131 82 FVGEIPPALLT-GKVIFKYDNNPKL 105 (517)
Q Consensus 82 l~~~~P~~~~~-~~~~~~~~~n~~~ 105 (517)
++ .+|.++.+ +...+.+.|||-.
T Consensus 287 is-~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 287 IS-SLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred cc-cCCcccccceeeehhhcCCchH
Confidence 99 79988876 5555667888843
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.2e-09 Score=100.54 Aligned_cols=101 Identities=30% Similarity=0.442 Sum_probs=76.9
Q ss_pred eecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceee----------------------e
Q 010131 3 RCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT----------------------G 60 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~----------------------~ 60 (517)
.+++++|.++ -+|..++.+++|+.|+|++|-+...+-+++.+..|+.||++.|+|. |
T Consensus 416 ~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~ 494 (565)
T KOG0472|consen 416 DLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIG 494 (565)
T ss_pred HHHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhcccccc
Confidence 4556666666 5666777788888888888888876666888888888888877774 2
Q ss_pred cCCCC-CCCcccccccccccccccCCCCccccc--cceeeeccCCCcc
Q 010131 61 SLPSY-MGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 105 (517)
Q Consensus 61 ~~p~~-~~~l~~L~~l~l~~N~l~~~~P~~~~~--~~~~~~~~~n~~~ 105 (517)
.++.+ +.+|.+|+.||+.+|.+. .+|+.+.. ....+.++|||..
T Consensus 495 ~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 495 SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 33333 778899999999999999 89998865 5567788999865
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.5e-09 Score=106.23 Aligned_cols=89 Identities=24% Similarity=0.369 Sum_probs=74.9
Q ss_pred CceecCCCCccccc-CCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCC-CCCcccccccccc
Q 010131 1 MARCALSGKNLKGE-IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
|+.+++-+|++... ||.+++.|.-|+.||||+|+|+..+-.+...+++-+|+||+|+|. +||.. +-+|..|-.||||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS 158 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLS 158 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccc
Confidence 35567778887543 899999999999999999999987777888899999999999999 88887 4588888999999
Q ss_pred cccccCCCCcccc
Q 010131 79 NNSFVGEIPPALL 91 (517)
Q Consensus 79 ~N~l~~~~P~~~~ 91 (517)
+|++. .+|+.+.
T Consensus 159 ~NrLe-~LPPQ~R 170 (1255)
T KOG0444|consen 159 NNRLE-MLPPQIR 170 (1255)
T ss_pred cchhh-hcCHHHH
Confidence 99999 8998763
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.5e-09 Score=104.78 Aligned_cols=85 Identities=21% Similarity=0.196 Sum_probs=46.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCC-CCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~ 78 (517)
|+.|+||.|.|...-++.+....+|.+|+|++|+|+...+. |..|..|+.|+|++|+++ .+.+ .|..+++|+.|||+
T Consensus 295 L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCc
Confidence 35566777777666666666666777777777777666654 555555555555555444 2222 13334444444444
Q ss_pred cccccCCC
Q 010131 79 NNSFVGEI 86 (517)
Q Consensus 79 ~N~l~~~~ 86 (517)
+|.+++.|
T Consensus 374 ~N~ls~~I 381 (873)
T KOG4194|consen 374 SNELSWCI 381 (873)
T ss_pred CCeEEEEE
Confidence 44444333
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.6e-07 Score=81.58 Aligned_cols=138 Identities=24% Similarity=0.305 Sum_probs=95.4
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhH------------------------HHHHHHHHHHhcCC--CCCcc
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT------------------------QQFVTEVALLSRIH--HRNLV 254 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~E~~~l~~l~--h~niv 254 (517)
..|+.|--+.||+|...++..+|||+++....... ....+|+.-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 35788888999999988899999999864322111 11346777777773 44455
Q ss_pred ccceeeecCCeeEEEEEecCCCC-HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC
Q 010131 255 PLIGYCEEEHQRILVYEYMHNGT-LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333 (517)
Q Consensus 255 ~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~ 333 (517)
+.+++. .-.|||||+.... -.-.| ...++.......+..++++.+.-|-. ..++||+||+.-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence 555543 3479999996531 11111 12223333566677778888877765 37999999999999999 8
Q ss_pred CcEEEccccCccccCC
Q 010131 334 MRAKVSDFGLSRQAEE 349 (517)
Q Consensus 334 ~~~kl~Dfg~a~~~~~ 349 (517)
+.+.++|||.|....+
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 8999999998876653
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.7e-09 Score=109.98 Aligned_cols=102 Identities=29% Similarity=0.417 Sum_probs=86.5
Q ss_pred CceecCCCCcccccCCc-cccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|.+. ++|. .+.++..|+.|+||+|+|+.++-.+.+++.|++|...+|++. .+| ++..++.|+.+|++.
T Consensus 385 LKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~ 461 (1081)
T KOG0618|consen 385 LKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSC 461 (1081)
T ss_pred eeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEeccc
Confidence 678999999999 7886 467899999999999999986655999999999999999999 889 799999999999999
Q ss_pred cccc-CCCCcccc-ccceeeeccCCCcc
Q 010131 80 NSFV-GEIPPALL-TGKVIFKYDNNPKL 105 (517)
Q Consensus 80 N~l~-~~~P~~~~-~~~~~~~~~~n~~~ 105 (517)
|+|+ +.+|.... ..+..+.+.||++.
T Consensus 462 N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 462 NNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred chhhhhhhhhhCCCcccceeeccCCccc
Confidence 9987 34555554 45677888899864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.1e-07 Score=82.24 Aligned_cols=138 Identities=14% Similarity=0.170 Sum_probs=85.0
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC--ccccceeeecCCeeEEEEEecCCCC-
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGT- 277 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs- 277 (517)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 25567889876533 3345688999999885433 4677778777777889999998863
Q ss_pred HHhH---------------------hhccCCCCccCHHHHHH-HHH----------HHHH-HHHHHhc-CCCCCcEecCC
Q 010131 278 LRDR---------------------LHGSVNQKPLDWLTRLQ-IAH----------DAAK-GLEYLHT-GCNPGIIHRDV 323 (517)
Q Consensus 278 L~~~---------------------l~~~~~~~~l~~~~~~~-i~~----------~ia~-aL~~LH~-~~~~~ivH~dl 323 (517)
+... +|... ........... +-. .+.. ...+|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 11100 00111110000 000 0001 1122221 11356789999
Q ss_pred CCCCeEeCCCCcEEEccccCcc
Q 010131 324 KSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 324 k~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.5e-08 Score=87.70 Aligned_cols=80 Identities=25% Similarity=0.375 Sum_probs=40.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcc-cCccccceeEecCceeeecCCC--CCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~l~~L~~l~l~~n~l~~~~p~--~~~~l~~L~~l~l 77 (517)
|+.|+||+|+|+ .++ .+..+++|++|+|++|+|+...+.+ ..+++|+.|+|++|++. .+-+ .+..+++|+.|++
T Consensus 44 L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L 120 (175)
T PF14580_consen 44 LEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVLSL 120 (175)
T ss_dssp --EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-
T ss_pred CCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcceeec
Confidence 578999999999 555 5888999999999999999865555 46999999999999998 4433 4678899999999
Q ss_pred cccccc
Q 010131 78 ENNSFV 83 (517)
Q Consensus 78 ~~N~l~ 83 (517)
.+|+++
T Consensus 121 ~~NPv~ 126 (175)
T PF14580_consen 121 EGNPVC 126 (175)
T ss_dssp TT-GGG
T ss_pred cCCccc
Confidence 999998
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.6e-09 Score=103.21 Aligned_cols=104 Identities=21% Similarity=0.294 Sum_probs=79.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCC---CCCcccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY---MGSLPNLQELH 76 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~---~~~l~~L~~l~ 76 (517)
|.+|+||+|+|+..-+..|..|.+|++|+|++|++...-.. |..+++|+.|||++|.|++.|-+. |..|++|+.|.
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 57888888888865566788888888888888888876665 888888888888888888766553 66788888888
Q ss_pred cccccccCCCCcccccc---ceeeeccCCCcc
Q 010131 77 IENNSFVGEIPPALLTG---KVIFKYDNNPKL 105 (517)
Q Consensus 77 l~~N~l~~~~P~~~~~~---~~~~~~~~n~~~ 105 (517)
+.+|++. .||...+.+ +..+.+.+|+-.
T Consensus 399 l~gNqlk-~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 399 LTGNQLK-SIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred ecCceee-ecchhhhccCcccceecCCCCcce
Confidence 8888888 788766553 344556666543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.1e-09 Score=84.92 Aligned_cols=87 Identities=24% Similarity=0.332 Sum_probs=62.5
Q ss_pred ceecCCCCcccccCCccccC-CCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKN-MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.++|++|.|. .+|+.|.. ++.++.|+|++|.|+..+.++..++.|+.|+++.|.|. ..|..+..|.+|-.|+..+|
T Consensus 56 ~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~n 133 (177)
T KOG4579|consen 56 TKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPEN 133 (177)
T ss_pred EEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCC
Confidence 45677777777 67776653 45777777777777766556777777777777777777 66777777777777777777
Q ss_pred cccCCCCcccc
Q 010131 81 SFVGEIPPALL 91 (517)
Q Consensus 81 ~l~~~~P~~~~ 91 (517)
.+. ++|-.++
T Consensus 134 a~~-eid~dl~ 143 (177)
T KOG4579|consen 134 ARA-EIDVDLF 143 (177)
T ss_pred ccc-cCcHHHh
Confidence 777 6775543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-06 Score=79.08 Aligned_cols=140 Identities=18% Similarity=0.214 Sum_probs=88.7
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHH---------HHHHHHHhcCCC---CCccccce
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF---------VTEVALLSRIHH---RNLVPLIG 258 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~~~~ 258 (517)
++....+...+.+-......|.+-..+ |+.+++|..+.......+.| .+++..+.+++. .....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 344444445566666666666665554 78899998765443322222 234444444432 22333232
Q ss_pred eee-----cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC
Q 010131 259 YCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333 (517)
Q Consensus 259 ~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~ 333 (517)
+.. -....+++|||++|..|.+... ++. .++..+++++.-+|+ .|++|||.+|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence 222 2234578999999988876532 221 245677888999999 999999999999999955
Q ss_pred CcEEEccccCccc
Q 010131 334 MRAKVSDFGLSRQ 346 (517)
Q Consensus 334 ~~~kl~Dfg~a~~ 346 (517)
.+++.||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 499999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-06 Score=89.48 Aligned_cols=141 Identities=19% Similarity=0.231 Sum_probs=90.8
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhH-------------------------------------HHHHHHHH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-------------------------------------QQFVTEVA 243 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~E~~ 243 (517)
+.||.-+.|.||+|++++|+.||||+-++...... -+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999999999999999999765322210 01344555
Q ss_pred HHhcC----CCCC------ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC
Q 010131 244 LLSRI----HHRN------LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313 (517)
Q Consensus 244 ~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~ 313 (517)
-..+. .|-+ |.+++- .-.....|+||||+|..+.|.-.- ....++...+..- +.++... .-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~---l~~~~~~--qI 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNK---LVEAYLE--QI 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHH---HHHHHHH--HH
Confidence 44433 3444 222222 223467999999999877654221 2334555544333 3332222 11
Q ss_pred CCCCcEecCCCCCCeEeCC----CCcEEEccccCccccCCC
Q 010131 314 CNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 314 ~~~~ivH~dlk~~Nill~~----~~~~kl~Dfg~a~~~~~~ 350 (517)
...|++|+|-+|.||+++. ++.+.+.|||+.......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 1268999999999999984 678999999998876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.2e-06 Score=78.39 Aligned_cols=143 Identities=20% Similarity=0.258 Sum_probs=84.8
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCC--Cccccceeee---cCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGYCE---EEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~~ 275 (517)
+.++.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.++. .....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568899999999999986 69999987643 4556788899998888432 3556666442 23356899999999
Q ss_pred CCHHh----------------Hh---hcc-CCCCccCHHH---------HHHH------------HHHHHH-HHHHHhc-
Q 010131 276 GTLRD----------------RL---HGS-VNQKPLDWLT---------RLQI------------AHDAAK-GLEYLHT- 312 (517)
Q Consensus 276 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-aL~~LH~- 312 (517)
..+.. .+ +.. .......... .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 11 111 0111111100 0000 111222 2333332
Q ss_pred ---CCCCCcEecCCCCCCeEeC-CCCcEEEccccCccc
Q 010131 313 ---GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQ 346 (517)
Q Consensus 313 ---~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~ 346 (517)
.....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1347799999999999999 666678999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.3e-07 Score=97.35 Aligned_cols=93 Identities=23% Similarity=0.335 Sum_probs=49.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..+..+. .+|+.|+|++|+++ .+|..+. .+|+.|++++|
T Consensus 201 L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N 272 (754)
T PRK15370 201 ITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHN 272 (754)
T ss_pred CcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCC
Confidence 345666666666 4554443 356666666666664332232 24555666666655 5555443 25666666666
Q ss_pred cccCCCCccccccceeeeccCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNN 102 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n 102 (517)
+|+ .+|..+...+..+.+.+|
T Consensus 273 ~L~-~LP~~l~~sL~~L~Ls~N 293 (754)
T PRK15370 273 KIS-CLPENLPEELRYLSVYDN 293 (754)
T ss_pred ccC-ccccccCCCCcEEECCCC
Confidence 666 455555444444445444
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.7e-06 Score=78.22 Aligned_cols=140 Identities=19% Similarity=0.173 Sum_probs=85.7
Q ss_pred ccCCCCc-eEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecCCCCHH
Q 010131 202 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 202 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
.|..|.+ ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3555555 789999775 5788889876432 345677999988883 444667777777666789999999998776
Q ss_pred hHh-------------------hccCC-CCccCH--HHHHHHHH--------------------HHHHHHHHHhc----C
Q 010131 280 DRL-------------------HGSVN-QKPLDW--LTRLQIAH--------------------DAAKGLEYLHT----G 313 (517)
Q Consensus 280 ~~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~ia~aL~~LH~----~ 313 (517)
... +.... ..++.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11100 001110 00000000 01111222211 1
Q ss_pred CCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 314 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
....++|+|+.|.||+++++....|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13568999999999999998778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.1e-07 Score=99.99 Aligned_cols=96 Identities=25% Similarity=0.358 Sum_probs=68.4
Q ss_pred CceecCCCCcccccCCccccC-----------------CCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCC
Q 010131 1 MARCALSGKNLKGEIPPELKN-----------------MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP 63 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~-----------------l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p 63 (517)
|+.|+|++|+|+ .+|....+ +++|+.|+|++|.|++.++.. ++|+.|++++|+|+ .+|
T Consensus 344 Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l~---s~L~~LdLS~N~Ls-sIP 418 (788)
T PRK15387 344 LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLP---SELKELMVSGNRLT-SLP 418 (788)
T ss_pred cceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccCCCCcc---cCCCEEEccCCcCC-CCC
Confidence 567777777777 34432221 246788888888888644322 57888999999998 678
Q ss_pred CCCCCcccccccccccccccCCCCccccc--cceeeeccCCCcc
Q 010131 64 SYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 105 (517)
Q Consensus 64 ~~~~~l~~L~~l~l~~N~l~~~~P~~~~~--~~~~~~~~~n~~~ 105 (517)
... .+|+.|++++|+|+ .+|..+.. ....+.+.+|+..
T Consensus 419 ~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 419 MLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred cch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 643 46788999999999 89987643 4566778888755
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.1e-06 Score=71.24 Aligned_cols=129 Identities=22% Similarity=0.273 Sum_probs=90.5
Q ss_pred hhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCcccc-ceeeecCCeeEEEEEecCCC
Q 010131 198 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e~~~~g 276 (517)
+..+.|++|.+|.||++.+. |..+|+|+-+.+. ....+..|+++|..+.-.++.+= +.|-. -++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 34678999999999999998 6689999876543 35678899999999876665543 33322 23559999988
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCC-CCCeEeCCCCcEEEccccCccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK-SSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk-~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
.|.++-... +.. -...++++---|.. .||-|+.|. |...++..++.+.|+||..|+.
T Consensus 98 ~L~~~~~~~------~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887765411 222 23445555444555 899999997 4444444555999999998874
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.6e-08 Score=96.46 Aligned_cols=103 Identities=22% Similarity=0.320 Sum_probs=80.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|-+++|+++ .+|++++.+.+|..||.+.|++-..++.++.+.+|+.|++..|++. .+|.++..| .|..||++.|
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScN 221 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCN 221 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccC
Confidence 566778888888 7888888778888888888888877777888888888888888888 777777755 4778888888
Q ss_pred cccCCCCccccc--cceeeeccCCCcccc
Q 010131 81 SFVGEIPPALLT--GKVIFKYDNNPKLHK 107 (517)
Q Consensus 81 ~l~~~~P~~~~~--~~~~~~~~~n~~~~~ 107 (517)
+++ .||-.+.. .+..+.+++||-+..
T Consensus 222 kis-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred cee-ecchhhhhhhhheeeeeccCCCCCC
Confidence 888 78877654 566777888987643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.8e-07 Score=93.66 Aligned_cols=184 Identities=20% Similarity=0.230 Sum_probs=134.3
Q ss_pred hhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC-ccccceeeecCCeeEEEEEecCCC-
Q 010131 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYEYMHNG- 276 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g- 276 (517)
+-+-+++|+++.+||.+-.-.+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34567899999999987553344445554422 34456899999999999 777777777778889999999776
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+-..-.. .....+...+...+.+.-+++++++|+ ..=+|+| ||+..+ +..+..||+....+.... ...
T Consensus 321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 2221111 022334455566677788889999998 4457888 777654 789999999887776544 234
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
...+++.++|||+.....+..+-|+|+.|.-..++.-|-+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999988778877777754
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.2e-07 Score=99.74 Aligned_cols=87 Identities=29% Similarity=0.458 Sum_probs=82.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+||+|.++ .+|..+..+.+|+.|+++.|.+...+-+..++.+|++|+|.+|++. .+|.++..+++|+.|+++.|
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N 124 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFN 124 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchh
Confidence 678999999999 8999999999999999999999988877999999999999999999 99999999999999999999
Q ss_pred cccCCCCccc
Q 010131 81 SFVGEIPPAL 90 (517)
Q Consensus 81 ~l~~~~P~~~ 90 (517)
++. .+|.-+
T Consensus 125 ~f~-~~Pl~i 133 (1081)
T KOG0618|consen 125 HFG-PIPLVI 133 (1081)
T ss_pred ccC-CCchhH
Confidence 999 888765
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.8e-07 Score=95.65 Aligned_cols=75 Identities=23% Similarity=0.317 Sum_probs=37.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++..++.+. .+|+.|+|++|+|+ .+|..+. ++|+.|++++|
T Consensus 222 L~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N 293 (754)
T PRK15370 222 IKTLYANSNQLT-SIPATLP--DTIQEMELSINRITELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDN 293 (754)
T ss_pred CCEEECCCCccc-cCChhhh--ccccEEECcCCccCcCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCC
Confidence 456666766666 4555432 345555555555553222232 24555555555555 4444332 24455555555
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
+|+
T Consensus 294 ~Lt 296 (754)
T PRK15370 294 SIR 296 (754)
T ss_pred ccc
Confidence 554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-06 Score=94.64 Aligned_cols=96 Identities=27% Similarity=0.348 Sum_probs=61.1
Q ss_pred CceecCCCCcccccCCc---cccC--------------CCCCcEEEcCCCCCCCCCCcccCc-----------------c
Q 010131 1 MARCALSGKNLKGEIPP---ELKN--------------MEALTELWLDGNFLTGPLPDMSRL-----------------I 46 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~---~~~~--------------l~~L~~L~l~~N~l~~~~p~~~~l-----------------~ 46 (517)
|+.|+|++|+|++ +|. .+.. ..+|+.|+|++|+|++.++...++ .
T Consensus 304 L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~lp~~L~~L~Ls~N~L~~LP~l~~ 382 (788)
T PRK15387 304 LQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPTLPSELYKLWAYNNRLTSLPALPS 382 (788)
T ss_pred cceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCCCCCCCcccceehhhccccccCccccc
Confidence 5677777777774 333 2111 159999999999999854312111 2
Q ss_pred ccceeEecCceeeecCCCCCCCcccccccccccccccCCCCccccccceeeeccCCC
Q 010131 47 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 47 ~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
+|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|... ..+..+.+.+|.
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~-~~L~~L~Ls~Nq 433 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP-SGLLSLSVYRNQ 433 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch-hhhhhhhhccCc
Confidence 5677778888777 566532 46888899999988 587532 233444555553
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.6e-08 Score=91.60 Aligned_cols=88 Identities=27% Similarity=0.329 Sum_probs=61.7
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecC-ceeeecCCCC-CCCcccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN-NELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~-n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
++|+|+.|+|+..-|..|+.+.+|+.||||+|+|+.+-|+ |.+|++|..|-+-+ |+|+ .+|.. |+.|.+|+.|.+.
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllN 148 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLN 148 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcC
Confidence 4677778888733334677778888888888888877776 77777777766655 7777 66654 6677777777777
Q ss_pred cccccCCCCcccc
Q 010131 79 NNSFVGEIPPALL 91 (517)
Q Consensus 79 ~N~l~~~~P~~~~ 91 (517)
.|++. +++...+
T Consensus 149 an~i~-Cir~~al 160 (498)
T KOG4237|consen 149 ANHIN-CIRQDAL 160 (498)
T ss_pred hhhhc-chhHHHH
Confidence 77777 6665443
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.17 E-value=9.1e-07 Score=58.57 Aligned_cols=36 Identities=36% Similarity=0.506 Sum_probs=19.4
Q ss_pred CCcEEEcCCCCCCCCCCcccCccccceeEecCceee
Q 010131 24 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 59 (517)
Q Consensus 24 ~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~ 59 (517)
+|+.|+|++|+|+..+|.+.+|++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 455666666666643333556666666666666555
|
... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.16 E-value=9.4e-06 Score=72.92 Aligned_cols=105 Identities=25% Similarity=0.231 Sum_probs=83.4
Q ss_pred HHHHHHHhcCCC-CCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 010131 239 VTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317 (517)
Q Consensus 239 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ 317 (517)
..|.-+++.+.+ +++.+++|+|. .++|.||...+++...-.....-...+|..+.+||.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888865 69999999994 4789999987766432110001234789999999999999999999866566
Q ss_pred cEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 318 ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+.-.|++++|+-+++++++|+.|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.4e-05 Score=85.71 Aligned_cols=79 Identities=13% Similarity=0.304 Sum_probs=57.6
Q ss_pred hcccCCCCceEEEEEEecCC---cEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCCc--cccceeeecC---CeeEEE
Q 010131 200 CKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNL--VPLIGYCEEE---HQRILV 269 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 269 (517)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35689999999999887654 467778754322 123457889999999995 6654 7777887664 467899
Q ss_pred EEecCCCCH
Q 010131 270 YEYMHNGTL 278 (517)
Q Consensus 270 ~e~~~~gsL 278 (517)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.8e-06 Score=95.77 Aligned_cols=102 Identities=18% Similarity=0.299 Sum_probs=83.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|++. .+|..+..+++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|..++++++|+.|++++|
T Consensus 613 L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 613 LVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred CcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence 578899999988 6888888999999999998887778888999999999999998766699999999999999999987
Q ss_pred cccCCCCccc-cccceeeeccCCC
Q 010131 81 SFVGEIPPAL-LTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~-~~~~~~~~~~~n~ 103 (517)
.....+|... ...+..+.+.+|.
T Consensus 692 ~~L~~Lp~~i~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 692 ENLEILPTGINLKSLYRLNLSGCS 715 (1153)
T ss_pred CCcCccCCcCCCCCCCEEeCCCCC
Confidence 5444888764 2344455566654
|
syringae 6; Provisional |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.09 E-value=9.4e-07 Score=58.50 Aligned_cols=40 Identities=38% Similarity=0.675 Sum_probs=34.8
Q ss_pred cccceeEecCceeeecCCCCCCCcccccccccccccccCCCC
Q 010131 46 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 87 (517)
Q Consensus 46 ~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~P 87 (517)
++|+.|++++|+|+ .+|..+++|++|+.|++++|+++ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence 57999999999999 88888999999999999999999 554
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.1e-07 Score=82.43 Aligned_cols=80 Identities=23% Similarity=0.339 Sum_probs=56.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++||||+|.|+ .|-++..-++.++.|+||.|.|+. +.++..|++|+.||||+|.++ .+-.+=..+-+++.|.+++|
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEeccccceee-ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 567888888888 677777777888888888888875 334777888888888888877 55444344555555666666
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
.+.
T Consensus 363 ~iE 365 (490)
T KOG1259|consen 363 KIE 365 (490)
T ss_pred hHh
Confidence 554
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.5e-05 Score=69.90 Aligned_cols=125 Identities=28% Similarity=0.431 Sum_probs=90.4
Q ss_pred HHHhhhcccCCCCc-eEEEEEEecCCcEEEEEEecCC-----------Cc----------hhHHHHHHHHHHHhcCC---
Q 010131 195 ATNNFCKKIGKGSF-GSVYYGKMKDGKEVAVKIMADS-----------CS----------HRTQQFVTEVALLSRIH--- 249 (517)
Q Consensus 195 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~-----------~~----------~~~~~~~~E~~~l~~l~--- 249 (517)
...+|.+.||.|.. |.||++... |+.+|+|+++.. .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45667899999999 999999997 889999994210 00 11245889999988884
Q ss_pred CCCc--cccceeeecC------------------CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHH
Q 010131 250 HRNL--VPLIGYCEEE------------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309 (517)
Q Consensus 250 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~ 309 (517)
+.++ |+.+||..-. ....+|.||++... .+. .+-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4455 8999986211 12357788775432 122 2335677778889
Q ss_pred HhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 310 LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
+|. .||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 999 99999999999987 4589999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.06 E-value=9.8e-05 Score=66.66 Aligned_cols=130 Identities=23% Similarity=0.285 Sum_probs=92.1
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCC----------------chhHHHHHHHHHHHhcCC------CCCccccce
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----------------SHRTQQFVTEVALLSRIH------HRNLVPLIG 258 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~~ 258 (517)
..||+|+.=.||.- .+....+||+..... ....++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 46999999888864 445668889887654 123456677777666665 789999999
Q ss_pred eeecCCeeEEEEEecCC------CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 259 YCEEEHQRILVYEYMHN------GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 259 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
+.+++....+|+|.+.+ -+|.+++. ...++. ...+.+. +-..||-+ .+|+.+|++|+||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEEEe
Confidence 99999999999998754 25777774 344555 4444443 34456666 88999999999999954
Q ss_pred C---C-cEEEcc-ccC
Q 010131 333 N---M-RAKVSD-FGL 343 (517)
Q Consensus 333 ~---~-~~kl~D-fg~ 343 (517)
. . .+.|+| ||.
T Consensus 154 ~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCceEEEEEeCCCC
Confidence 3 2 467776 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.1e-07 Score=82.07 Aligned_cols=79 Identities=24% Similarity=0.341 Sum_probs=52.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++.|++|+|.|. .+-. +..|++|+.||||+|.|+....=-..|-+++.|.|+.|.+. .+ +.+..+-+|..||+++|
T Consensus 309 ir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N 384 (490)
T KOG1259|consen 309 LRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSN 384 (490)
T ss_pred eeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHh-hh-hhhHhhhhheecccccc
Confidence 467999999999 4443 88999999999999999864331223445555566666555 33 23555555556666666
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
++.
T Consensus 385 ~Ie 387 (490)
T KOG1259|consen 385 QIE 387 (490)
T ss_pred chh
Confidence 554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.03 E-value=7.6e-07 Score=89.10 Aligned_cols=84 Identities=35% Similarity=0.504 Sum_probs=52.6
Q ss_pred eecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccccc
Q 010131 3 RCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 82 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l 82 (517)
.|.|.+|-|. .+|..+.+|..|+.|||+.|+++-.++.+..| .|+.|-+++|+++ .+|..++.+..|..||.+.|++
T Consensus 102 ~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei 178 (722)
T KOG0532|consen 102 SLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDL-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI 178 (722)
T ss_pred HHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcC-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence 4555566665 56666666666666666666666655555554 4666666666666 6666666666666666666666
Q ss_pred cCCCCccc
Q 010131 83 VGEIPPAL 90 (517)
Q Consensus 83 ~~~~P~~~ 90 (517)
. ++|+.+
T Consensus 179 ~-slpsql 185 (722)
T KOG0532|consen 179 Q-SLPSQL 185 (722)
T ss_pred h-hchHHh
Confidence 6 566554
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00012 Score=71.21 Aligned_cols=76 Identities=11% Similarity=0.096 Sum_probs=56.9
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC---CCccccceeeec---CCeeEEEEEec
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH---RNLVPLIGYCEE---EHQRILVYEYM 273 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~~ 273 (517)
.+.||.|..+.||+....++ .+++|..+. ......+..|.+.|+.+.- -.+.+++++|.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 35799999999999987655 467777543 1133578899999998842 367888887754 35689999999
Q ss_pred CCCCH
Q 010131 274 HNGTL 278 (517)
Q Consensus 274 ~~gsL 278 (517)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.4e-07 Score=75.71 Aligned_cols=87 Identities=21% Similarity=0.242 Sum_probs=73.1
Q ss_pred eecCCCCcccccCCccccC---CCCCcEEEcCCCCCCCCCCcccC-ccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 3 RCALSGKNLKGEIPPELKN---MEALTELWLDGNFLTGPLPDMSR-LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~---l~~L~~L~l~~N~l~~~~p~~~~-l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
.|+||++.+. -+++.... ...|+..+|++|.|..-++.|.. .+.+++|+|++|.|+ .+|.++..++.|+.|+++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~ 108 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLR 108 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccc
Confidence 4788888877 67765544 45677789999999998888655 568999999999999 999999999999999999
Q ss_pred cccccCCCCccccc
Q 010131 79 NNSFVGEIPPALLT 92 (517)
Q Consensus 79 ~N~l~~~~P~~~~~ 92 (517)
.|.|. ..|.-+..
T Consensus 109 ~N~l~-~~p~vi~~ 121 (177)
T KOG4579|consen 109 FNPLN-AEPRVIAP 121 (177)
T ss_pred cCccc-cchHHHHH
Confidence 99999 77876655
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.9e-06 Score=82.69 Aligned_cols=95 Identities=21% Similarity=0.193 Sum_probs=76.7
Q ss_pred cCC-ccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccccccCCCCcccc
Q 010131 14 EIP-PELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 91 (517)
Q Consensus 14 ~~p-~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~P~~~~ 91 (517)
.-| ..|..|++|+.|+|++|+|++.-+. |.++..|+.|.|..|+|.-.--..|.++..|+.|+|.+|+|+-..|..+.
T Consensus 264 ~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~ 343 (498)
T KOG4237|consen 264 ICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQ 343 (498)
T ss_pred cChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEeccccc
Confidence 444 3588999999999999999998887 99999999999999999833334578899999999999999944444433
Q ss_pred c--cceeeeccCCCccccc
Q 010131 92 T--GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 92 ~--~~~~~~~~~n~~~~~~ 108 (517)
. .+..+.+-+||+.|+.
T Consensus 344 ~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 344 TLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred ccceeeeeehccCcccCcc
Confidence 2 3456678899999983
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 517 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-59 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-58 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-56 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-34 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-24 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-23 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-22 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-22 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-22 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-20 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-20 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-20 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-19 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-19 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 9e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 452 bits (1166), Expect = e-158
Identities = 127/319 (39%), Positives = 193/319 (60%), Gaps = 7/319 (2%)
Query: 161 TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKD 218
+ + + + A ++ +Y +PL +LEEATNNF K IG G FG VY G ++D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 219 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278
G +VA+K S ++F TE+ LS H +LV LIG+C+E ++ IL+Y+YM NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 279 RDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337
+ L+GS + W RL+I AA+GL YLHT IIHRDVKS NILLD N K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 338 VSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 396
++DFG+S++ E D TH+S+V +GT+GY+DPEY+ +LTEKSDVYSFGVVL E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 397 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS 456
+ +N+ WA G + IVDP L ++ ES+ + + A++C+
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 457 RPKMQEIVLAIQDSIKIEK 475
RP M +++ ++ ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 380 bits (977), Expect = e-130
Identities = 112/282 (39%), Positives = 173/282 (61%), Gaps = 6/282 (2%)
Query: 191 ELEEATNNFCK--KIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSR 247
EL+ A++NF +G+G FG VY G++ DG VAVK + + QF TEV ++S
Sbjct: 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83
Query: 248 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKG 306
HRNL+ L G+C +R+LVY YM NG++ L +P LDW R +IA +A+G
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
L YLH C+P IIHRDVK++NILLD A V DFGL++ + TH+++ RGT+G++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 367 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVIS 424
PEY + +EK+DV+ +GV+LLELI+G++ + + + ++ W + ++K+ + +
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466
+VD L GN K E + ++ +VA+ C + RPKM E+V
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-124
Identities = 102/292 (34%), Positives = 153/292 (52%), Gaps = 26/292 (8%)
Query: 191 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ----F 238
EL+ TNNF K+G+G FG VY G + + VAVK +A T++ F
Sbjct: 19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 239 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 298
E+ ++++ H NLV L+G+ + LVY YM NG+L DRL PL W R +
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 299 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 357
IA AA G+ +LH IHRD+KS+NILLD AK+SDFGL+R + + T ++S
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 358 ARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARS 415
GT Y+ PE G ++T KSD+YSFGVVLLE+I+G V D ++
Sbjct: 195 IVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV---DEHREPQLLLDIKEE 249
Query: 416 MIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466
+ + + +D + + S+ + VA QC+ ++ RP ++++
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 6e-89
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 31/308 (10%)
Query: 187 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 244
+ L + + +G FG V+ ++ + VAVKI ++ Q EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 245 LSRIHHRNLVPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
L + H N++ IG + + L+ + G+L D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIA 127
Query: 301 HDAAKGLEYLHT-------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353
A+GL YLH G P I HRD+KS N+LL N+ A ++DFGL+ + E +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 354 ISSVAR-GTVGYLDPEY-----YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 407
+ + GT Y+ PE + + D+Y+ G+VL EL S L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 408 NIVHWARSMIKKGDVISIV-----DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQ 461
D+ +V PVL K + + E +C + +R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 462 EIVLAIQD 469
+ I
Sbjct: 308 CVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 9e-76
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 10/213 (4%)
Query: 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 244
IP +L +KIG GSFG+V+ + G +VAVKI+ + H R +F+ EVA+
Sbjct: 34 IPWCDLN-----IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 245 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 304
+ R+ H N+V +G + +V EY+ G+L LH S ++ LD RL +A+D A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
KG+ YLH NP I+HR++KS N+L+D KV DFGLSR S A GT +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEW 205
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ PE ++ EKSDVYSFGV+L EL + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-74
Identities = 84/328 (25%), Positives = 144/328 (43%), Gaps = 39/328 (11%)
Query: 185 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 244
+ I E+E + +G+G+FG V K + K+VA+K + + F+ E+
Sbjct: 3 HMIDYKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQ 54
Query: 245 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 304
LSR++H N+V L G C LV EY G+L + LHG+ + +
Sbjct: 55 LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHISSVARGTVG 363
+G+ YLH+ +IHRD+K N+LL K+ DFG + + +T+ +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAA 168
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 420
++ PE + +EK DV+S+G++L E+I+ +KP ++ G + WA + G
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA---VHNGTRP 223
Query: 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 480
+I + I + +C + RP M+EIV + ++ G D+
Sbjct: 224 PLIKNLPK------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
Query: 481 F----SSSSSKGQSSRKTLLTSFLEIES 504
S G+ R F E
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDFAEFYR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 7e-71
Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 173 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC 231
A GG + + E+E + K+IGKG FG V+ G++ D VA+K +
Sbjct: 2 AMGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 232 SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 284
S + Q+F EV ++S ++H N+V L G +V E++ G L RL
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD 114
Query: 285 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVS 339
P+ W +L++ D A G+EY+ NP I+HRD++S NI L + AKV+
Sbjct: 115 --KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 340 DFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
DFGLS+Q+ ++ G ++ PE + TEK+D YSF ++L +++G+ P
Sbjct: 172 DFGLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 5e-68
Identities = 75/223 (33%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEV 242
I EL + IG G FG VY G EVAVK + S + E
Sbjct: 4 IDFAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 243 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
L + + H N++ L G C +E LV E+ G L L G K + + A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQ 113
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLD--------INMRAKVSDFGLSRQAEEDLTHI 354
A+G+ YLH IIHRD+KSSNIL+ N K++DFGL+R E T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTK 171
Query: 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
S A G ++ PE ++ SDV+S+GV+L EL++G+ P
Sbjct: 172 MSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 8e-68
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 244
I +L F K+ + G ++ G+ + G ++ VK++ +++ F E
Sbjct: 7 IDFKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 245 LSRIHHRNLVPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
L H N++P++G C+ + +M G+L + LH +D ++ A D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALD 119
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 362
A+G+ +LHT P I + S ++++D +M A++S + + S
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAP 172
Query: 363 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKP 397
++ PE + +D++SF V+L EL++ + P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-67
Identities = 72/339 (21%), Positives = 128/339 (37%), Gaps = 48/339 (14%)
Query: 187 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE--V 242
E +N + IG+G +G+VY G + D + VAVK+ + Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 243 ALLSRIHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 297
+ + H N+ I E + +LV EY NG+L L DW++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSC 114
Query: 298 QIAHDAAKGLEYLHT------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR------ 345
++AH +GL YLHT P I HRD+ S N+L+ + +SDFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 346 -QAEEDLTHISSVARGTVGYLDPEY-------YGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ + + GT+ Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 398 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR--------IAEVAI 447
+ + E + + + + V K W+ + E
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 448 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSS 486
C +Q +R Q + + + I + ++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-65
Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 244
IP ++ ++IG GSFG+VY GK +VAVK++ + + Q F EV +
Sbjct: 21 IPDGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 245 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 304
L + H N++ +GY I V ++ +L LH ++ + + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVG 363
+G++YLH IIHRD+KS+NI L + K+ DFGL+ ++ +H G++
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 364 YLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
++ PE + + +SDVY+FG+VL EL++G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 4e-65
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM--ADSCSHRTQQFVTEVAL 244
IP +LE + IGKG FG VY+G+ EVA++++ + + F EV
Sbjct: 30 IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 245 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 304
+ H N+V +G C ++ TL + + LD QIA +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIV 140
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHISSVARG 360
KG+ YLH GI+H+D+KS N+ D N + ++DFGL + G
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 361 TVGYLDPEYYGNQQL---------TEKSDVYSFGVVLLELISGKKP 397
+ +L PE ++ SDV++ G + EL + + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-63
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
+ +GKG FG ++ G+ + +K + + F+ EV ++ + H N++ I
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G ++ + + EY+ GTLR + W R+ A D A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-------------GTVGY 364
IIHRD+ S N L+ N V+DFGL+R ++ T + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ PE + EK DV+SFG+VL E+I
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-62
Identities = 77/324 (23%), Positives = 130/324 (40%), Gaps = 44/324 (13%)
Query: 189 LPELEEATNN----FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 244
LP L + T K+IGKG +G V+ GK + G++VAVK+ + + TE+
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQ 84
Query: 245 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
+ H N++ I + L+ +Y NG+L D L LD + L++A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLA 140
Query: 301 HDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355
+ + GL +LHT P I HRD+KS NIL+ N ++D GL+ + D +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 356 SVARGTVG---YLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406
VG Y+ PE + Q +D+YSFG++L E+ E
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVE 256
Query: 407 LNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR-------IAEVAIQCVEQRGFSR 457
+ + + + + V I + + W + ++ +C SR
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 458 PKMQEIVLAIQDSIKIEKGGDQKF 481
+ + K+ + D K
Sbjct: 317 LTALRVKKTLA---KMSESQDIKL 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-59
Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 40/318 (12%)
Query: 189 LPELEEATN----NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 244
LP L + T + IGKG FG V+ GK + G+EVAVKI S R+ E+
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQ 89
Query: 245 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
+ H N++ I +++ LV +Y +G+L D L+ + + +++A
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145
Query: 301 HDAAKGLEYLH-----TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLT 352
A GL +LH T P I HRD+KS NIL+ N ++D GL+ A + +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 353 HISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406
+ GT Y+ PE + + +++D+Y+ G+V E+ + + +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQ 264
Query: 407 LNIVHWARSMIKKGDVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 460
L S ++ +V + E++ +A++ +C G +R
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 461 QEIV-----LAIQDSIKI 473
I L+ Q+ IK+
Sbjct: 325 LRIKKTLSQLSQQEGIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-59
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV--TEVALLSRIHHRNLVPL 256
+ +GKG +G V+ G + G+ VAVKI + S + + TE+ + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 257 IGYC----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
I Q L+ Y G+L D L LD ++ L+I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 313 -----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGY 364
P I HRD+KS NIL+ N + ++D GL+ Q+ L ++ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 365 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
+ PE ++ D+++FG+VL E+ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-44
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
+IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 258 GY----CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ + +LV E M +GTL+ L + K L R QI KGL++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QIL----KGLQFLH 146
Query: 312 TGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
T P IIHRD+K NI + K+ D GL+ + +V GT ++ PE Y
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAV-IGTPEFMAPEMY 202
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKP 397
++ E DVY+FG+ +LE+ + + P
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 256
++IG+G+FG V+ G+++ VAVK ++ + F+ E +L + H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
IG C ++ +V E + G L L T LQ+ DAA G+EYL +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL-----DPEYYG 371
IHRD+ + N L+ K+SDFG+SR+ + A G + + PE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALN 288
Query: 372 NQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + +SDV+SFG++L E S G P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-43
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
K++G G FG V GK K +VAVK++ + +F E + ++ H LV G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
C +E+ +V EY+ NG L + L + K L+ L++ +D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE---SHQF 125
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD+ + N L+D ++ KVSDFG++R +D S + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 379 SDVYSFGVVLLELIS-GKKP 397
SDV++FG+++ E+ S GK P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-43
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
C E+ LV E+M +G L D L + L L + D +G+ YL +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYL---EEACV 125
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 379 SDVYSFGVVLLELIS-GKKP 397
SDV+SFGV++ E+ S GK P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 8e-43
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
IHR++ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 378 KSDVYSFGVVLLELIS-GKKP 397
KSDV++FGV+L E+ + G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-43
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 379 SDVYSFGVVLLELIS-GKKP 397
SDV+SFG++L EL + G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 379 SDVYSFGVVLLELIS-GKKP 397
SDV+SFG++L EL + G+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
F K++G G FG V YGK + +VA+K++ + +F+ E ++ + H LV L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 379 SDVYSFGVVLLELIS-GKKP 397
SD+++FGV++ E+ S GK P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+++G G FG V+ G +VAVK + F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+E I + EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 379 SDVYSFGVVLLELIS-GKKP 397
SDV+SFG++L E+++ G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
KK+G G FG V+ +VAVK M + F+ E ++ + H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+E I + E+M G+L D L + + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 379 SDVYSFGVVLLELIS-GKKP 397
SDV+SFG++L+E+++ G+ P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-42
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 378 KSDVYSFGVVLLELIS-GKKP 397
KSDV++FGV+L E+ + G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 259 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 309
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
+HRD+ + N+L+ + AKVSDFGL++ + + + V + PE ++ +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 378 KSDVYSFGVVLLELIS-GKKP 397
KSDV+SFG++L E+ S G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 180 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 234
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 235 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 293
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 294 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 352
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+ IG G FG V+ K + DGK +K + + ++ EV L+++ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 260 CEEEHQRI----------------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 303
+ + E+ GTL + + LD + L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQI 131
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 363
KG++Y+H + +I+RD+K SNI L + K+ DFGL + D S GT+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y+ PE +Q ++ D+Y+ G++L EL+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 202 KIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 257
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V LI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 376 TEKSDVYSFGVVLLELIS-GKKP 397
+ +SDV+S+GV + E +S G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 255
+ IG+G FG V+ G + VA+K + S ++ F+ E + + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
LIG E I + E G LR L + LD + + A+ + L YL +
Sbjct: 81 LIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
+HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE ++
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 376 TEKSDVYSFGVVLLELIS-GKKP 397
T SDV+ FGV + E++ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 253
K IG G G V YG+++ + VA+K + + R ++ F++E +++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+ L G ++V EYM NG+L L + + + + G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD- 169
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 369
G +HRD+ + N+L+D N+ KVSDFGLSR + + D + ++ + + + PE
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 370 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + SDV+SFGVV+ E+++ G++P
Sbjct: 228 FR--TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALL 245
+ + +G+G FG VY G + K VAVK C+ ++ F++E ++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 246 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 305
+ H ++V LIG EEE I + E G L L N+ L LT + + K
Sbjct: 68 KNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICK 124
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 365
+ YL + +HRD+ NIL+ K+ DFGLSR E++ + +SV R + ++
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
PE ++ T SDV+ F V + E++S GK+P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-39
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 24/296 (8%)
Query: 120 GTSIGVLAILLVLFLC--------SLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS 171
+I L+ C S I+ + + + + A++ + + + S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 172 IARG-GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VA 223
+DE Y +P E++ + IG+G FG V+ G + VA
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 224 VKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL 282
+K + S ++ F+ E + + H ++V LIG E ++ E G LR L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL 481
Query: 283 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342
+ LD + + A+ + L YL + +HRD+ + N+L+ N K+ DFG
Sbjct: 482 QV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
LSR E+ + +S + + ++ PE ++ T SDV+ FGV + E++ G KP
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVA 243
+ +F + IG+G FG VY+G + D AVK + F+TE
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 244 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 136
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVAR 359
AKG++YL + +HRD+ + N +LD KV+DFGL+R + H + A+
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 21/228 (9%)
Query: 180 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYG--KMKDGKE--VAVKIM-ADSCSHR 234
+ + I +L +K+G GSFG V G GK VAVK + D S
Sbjct: 8 LQSLTCLIGEKDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 235 TQQ--FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 292
F+ EV + + HRNL+ L G ++ V E G+L DRL L
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG 121
Query: 293 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEED 350
L + A A+G+ YL + IHRD+ + N+LL K+ DFGL R +D
Sbjct: 122 TL--SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
Query: 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + + PE + + SD + FGV L E+ + G++P
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+ +G+G FG V+ K K D A+K + + ++ + EV L+++ H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 259 YCEEEH---------QRILVY---EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
E++ ++ +Y + L+D ++G + + L I A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------- 359
+E+LH + G++HRD+K SNI ++ KV DFGL ++D + +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 360 ----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 392
GT Y+ PE + K D++S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 259 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 137
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST 193
Query: 378 KSDVYSFGVVLLELIS-GKKP 397
KSDV+SFG++L E+ S G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 20/214 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+K+G+G F V + + DG A+K + ++ E + +H N++ L+ Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 260 CEEEHQR----ILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
C E L+ + GTL + + L L + +GLE +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--------GTVGYLD 366
G HRD+K +NILL + + D G QA + T+ Y
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 367 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
PE + + E++DV+S G VL ++ G+ P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 201 KKIGKGSFGSVYYGKMKDGK---EVAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLVP 255
K++G G+FG+V G + K VAVKI+ ++ + + E ++ ++ + +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
+IG CE E + V E G L L + + +++ H + G++YL
Sbjct: 83 MIGICEAESWML-VMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+HRD+ + N+LL AK+SDFGLS+ +A+E+ + + V + PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 374 QLTEKSDVYSFGVVLLELIS-GKKP 397
+ + KSDV+SFGV++ E S G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-39
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 180 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 234
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 235 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 293
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 294 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 352
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-39
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALL 245
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 246 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 303
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 361
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
+ + PE + + SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-39
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 252
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
++ L G + +++ EYM NG L L L + + A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYY 370
N +HRD+ + NIL++ N+ KVSDFGLSR + + + T+ +S + + + PE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 371 GNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ T SDV+SFG+V+ E+++ G++P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-39
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 256
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
IG C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
+HR++ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 375 LTEKSDVYSFGVVLLELIS-GKKP 397
+ +SDV+S+GV + E +S G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-39
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 16/220 (7%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQ-FVTEVAL 244
E+ + +G+G FG V + G++VAVK + E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 245 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
L ++H N+V G C E+ L+ E++ +G+L++ L N+ ++ +L+ A
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQ 134
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 360
KG++YL + +HRD+ + N+L++ + K+ DFGL++ + +++ +
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 399
V + PE + SDV+SFGV L EL++ S
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 253
K +G G FG V G++K + VA+K + + + ++ F+ E +++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+ L G + ++V EYM NG+L L + + + + A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD- 165
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYG 371
G +HRD+ + NIL++ N+ KVSDFGL R + + + + + + + + PE
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 372 NQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ T SDV+S+G+VL E++S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVA 243
+ +F + IG+G FG VY+G + D AVK + QF+TE
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 244 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 200
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVAR 359
AKG+++L + +HRD+ + N +LD KV+DFGL+R E D H + A+
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVT 240
++ F + +G+G+F ++ G ++ EV +K++ + + ++ F
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 241 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
+++S++ H++LV G C + ILV E++ G+L L + N + W L++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------NMRAKVSDFGLSRQAEEDLT 352
A + +L +IH +V + NILL K+SD G+S
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174
Query: 353 HISSVARGTVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + + ++ PE N L +D +SFG L E+ S G KP
Sbjct: 175 ---DILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICSGGDKP 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 15/217 (6%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALL 245
EE + ++GKG+FGSV + G VAVK + S + + F E+ +L
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 246 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 303
+H +V G ++ LV EY+ +G LRD L ++ LD L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 136
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 361
KG+EYL + +HRD+ + NIL++ K++DFGL++ ++D + +
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ + PE + + +SDV+SFGVVL EL + K
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 245
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 246 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 303
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 154
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 361
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 155 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 393
+ + PE + + SDV+SFGVVL EL +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 254
K +G G FG+V+ G E V +K++ D ++ Q + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L+G C ++ V +Y+ G+L D + ++ L L AKG+ YL
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQ 373
G++HR++ + N+LL + +V+DFG++ +D + S A+ + ++ E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 374 QLTEKSDVYSFGVVLLELIS-GKKP 397
+ T +SDV+S+GV + EL++ G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLVP 255
+ IGKG FG VY+G+ D + A+K ++ + + F+ E L+ ++H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 256 LIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
LIG E ++ YM +G L + Q+ + A+G+EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT---VGYLDPEYYG 371
+HRD+ + N +LD + KV+DFGL+R + + R V + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 372 NQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ T KSDV+SFGV+L EL++ G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 255
K+G G +VY + +VA+K + ++ + EV S++ H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
+I EE+ LV EY+ TL + + + PL T + + G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
I+HRD+K NIL+D N K+ DFG+++ +E LT + V GTV Y PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188
Query: 375 LTEKSDVYSFGVVLLELISGKKP 397
E +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
+KIG+GSFG K DG++ +K + + S ++ EVA+L+ + H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHT 312
EE +V +Y G L R++ + LDW QI L+++H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICL----ALKHVH- 142
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+ I+HRD+KS NI L + ++ DFG++R + + GT YL PE N
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ KSD+++ G VL EL + K
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-38
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRT-QQFVTEVALLSRIHHRNLVPL 256
KKIG+G F VY DG VA+K + D + + E+ LL +++H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-------LDWLTRLQIAHDAAKGLEY 309
E+++ +V E G L + QK + Q+ LE+
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCS----ALEH 151
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 366
+H + ++HRD+K +N+ + K+ D GL R + ++ A VG Y+
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMS 204
Query: 367 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421
PE KSD++S G +L E+ + + P F + ++ I++ D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEQCD 254
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 257
IG GS+G + K DGK + K + S + Q V+EV LL + H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 258 GYCEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 315 NPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+ G ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
EKSD++S G +L EL + P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 259
+G G+ G++ Y M D ++VAVK + C + EV LL H N++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT 86
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
++ + + E TL++ + L + + GL +LH + I+
Sbjct: 87 EKDRQFQYIAIELC-AATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 320 HRDVKSSNILL-----DINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPEYY- 370
HRD+K NIL+ ++A +SDFGL ++ + S V GT G++ PE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLS 199
Query: 371 --GNQQLTEKSDVYSFGVVLLELISGKKP 397
+ T D++S G V +IS
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 19/237 (8%)
Query: 177 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADS 230
+ + L E+ + +G G+FG VY G++ +VAVK + +
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 231 CSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGS 285
CS + + F+ E ++S+ +H+N+V IG + R ++ E M G LR+
Sbjct: 72 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 286 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 342
L L L +A D A G +YL IHRD+ + N LL AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 343 LSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++R A V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 251
+++G+GSFG VY G K + VA+K + ++ S R + F+ E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTR---LQIAHDAA 304
++V L+G + +++ E M G LR N L + +Q+A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVG 363
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ PE + T SDV+SFGVVL E+ + ++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
+G+G+FG V + D + A+K + + ++EV LL+ ++H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 258 G-YCEEEHQRI------------LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 302
+ E + + EY NGTL D + Q+ W QI
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 359
+ L Y+H + GIIHRD+K NI +D + K+ DFGL++ L + ++
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 360 ----------GTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 394
GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMIYP 227
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNL 253
F IG+G+FG V ++K A+K M + S + F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIA 300
+ L+G CE L EY +G L D L S L L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 360
D A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
V ++ E T SDV+S+GV+L E++S G P
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 19/279 (6%)
Query: 135 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 194
I + S ++ + S ++T + + + L E+
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 195 ATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQQ-FVTEVALLSR 247
+ +G G+FG VY G++ +VAVK + + CS + + F+ E ++S+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 248 IHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTRLQIAHDA 303
+H+N+V IG + R ++ E M G LR+ L L L +A D
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ-AEEDLTHISSVAR 359
A G +YL IHRD+ + N LL AK+ DFG++R A
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVAL 244
+ + +G+G FG V + VAVK + + + + E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 245 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 302
L ++H +++ G CE+ LV EY+ G+LRD L + + L A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQ 142
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 360
+G+ YLH IHRD+ + N+LLD + K+ DFGL++ + +
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 399
V + PE + SDV+SFGV L EL++ S
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLV 254
K +G+G FGSV G +K VAVK M D+ S R + F++E A + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 255 PLIGYCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKG 306
L+G C E + ++ +M G L L S + + L+ D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 365
+EYL +HRD+ + N +L +M V+DFGLS++ D +A+ V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
E ++ T KSDV++FGV + E+ + G P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 255
+ +G+G G VY + + VA+K+M+++ S F T E R+ ++VP
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
+ + E + Q + ++ L L Q PL + I L+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
G HRDVK NIL+ + A + DFG++ +E LT + + GT+ Y+ PE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 375 LTEKSDVYSFGVVLLELISGKKP 397
T ++D+Y+ VL E ++G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-37
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 254
+ +GKG FGSV ++K VAVK++ AD + ++F+ E A + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 255 PLIGYCEEEHQRI------LVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAK 305
L+G + ++ +M +G L L S N L T ++ D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGY 364
G+EYL + IHRD+ + N +L +M V+DFGLSR+ D ++ V +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
L E + T SDV++FGV + E+++ G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 46/251 (18%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIM-----------------ADSCSHRTQQFVTEVA 243
+ + +G F + + KD K A+K S + F E+
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 244 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQ--- 298
+++ I + + G + ++YEYM N ++ +++ ++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 299 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358
I Y+H I HRDVK SNIL+D N R K+SDFG S + S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 359 RGTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 411
RGT ++ PE Y G K D++S G+ L + P F ++++V
Sbjct: 211 RGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVP-----FSLKISLVE 260
Query: 412 WARSMIKKGDV 422
+ I+ ++
Sbjct: 261 -LFNNIRTKNI 270
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPL 256
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185
Query: 377 EKSDVYSFGVVLLELISGKKP 397
EK D++S GV+ E + GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 258
+ + +G F VY + + G+E A+K + + + + + EV + ++ H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 259 YCEEEHQR-------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ L+ + G L + L ++ PL T L+I + + ++++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----------RG 360
P IIHRD+K N+LL K+ DFG + + S
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 361 TVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
T Y PE Y N + EK D+++ G +L L + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEV 242
+ ++ ++G+G+FG V+ + + VAVK + ++ Q F E
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 243 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKP 290
LL+ + H+++V G C E ++V+EYM +G L R HG V P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEE 349
L L +A A G+ YL +HRD+ + N L+ + K+ DFG+SR
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 350 DLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
D + + ++ PE Y + T +SDV+SFGVVL E+ + GK+P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 255
+ +G G V+ + ++D ++VAVK++ + R F E + ++H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 256 LIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ E E +V EY+ TLRD +H + P+ +++ DA + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH 133
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPE 368
GIIHRDVK +NI++ KV DFG++R + +T ++V GT YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE 189
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ +SDVYS G VL E+++G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEVALLSRIHHRN 252
+++G+G+FG V+ + + VAVK + D + F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQKPLDWLTRLQI 299
+V G C + I+V+EYM +G L R HG + L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 300 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVA 358
A A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 359 RGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ ++ PE Y + T +SDV+SFGV+L E+ + GK+P
Sbjct: 196 MLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTE 241
L E+ + F +++G+ FG VY G + VA+K + D ++ F E
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 242 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQ 288
L +R+ H N+V L+G ++ +++ Y +G L + + +
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 289 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-A 347
L+ + + A G+EYL + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 348 EEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
D + + + ++ PE YG + + SD++S+GVVL E+ S G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 256
+ +GKG FG+VY + K +A+K++ S Q E+ + S + H N++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGLEYLHTGCN 315
Y + + L+ E+ G L L D + + A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHYCH---E 132
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
+IHRD+K N+L+ K++DFG S A GT+ YL PE +
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 376 TEKSDVYSFGVVLLELISGKKP 397
EK D++ GV+ E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 250
F K +G G+FG V + VAVK++ S ++ ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------HGSVNQKPLDWLT 295
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 296 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHI 354
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
AR V ++ PE N T +SDV+S+G+ L EL S G P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 35/238 (14%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 259
K +G GS G+V + G+ VAVK M E+ LL+ H N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 260 CEEEHQRILVYEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
+ + E N L+D + N K + + A G+ +LH +
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---S 133
Query: 316 PGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSRQAEEDLTHISSVAR--- 359
IIHRD+K NIL+ N+R +SDFGL ++ + + +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 360 GTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410
GT G+ PE ++LT D++S G V ++S K + + E NI+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+GKG++G VY G+ +A+K + + S +Q E+AL + H+N+V +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLHTGC 314
E + E + G+L L + + T+ QI GL+YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLH--- 139
Query: 315 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYG 371
+ I+HRD+K N+L++ + K+SDFG S++ + GT+ Y+ PE G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKG 198
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKP 397
+ + +D++S G ++E+ +GK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 144 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN--FCK 201
R+ + +S +S + + S A P+ E + K
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 202 KIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHR 251
+G+G FG V K K+ VAVK++ D + + V+E+ ++ I H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRLQ 298
N++ L+G C ++ ++ EY G LR+ L V ++ + + +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 299 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 208 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK 260
Query: 359 RGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
++G+GSFG V+ K K G + AVK + E+ + + +VPL G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118
Query: 260 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
E + E + G+L + G + + + Q +GLEYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QAL----EGLEYLH---TRR 170
Query: 318 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 372
I+H DVK+ N+LL + RA + DFG + + D S + GT ++ PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ K D++S ++L +++G P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 36/228 (15%)
Query: 199 FCKKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI- 248
K +G+G+FG V K K+ VAVK++ D + + V+E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 249 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLT 295
H+N++ L+G C ++ ++ EY G LR+ L V ++ + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 296 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355
+ + A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 356 SVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 256
+GKGSF VY + + G EVA+K++ + Q+ EV + ++ H +++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 312
Y E+ + LV E HNG + L KP R QI G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQII----TGMLYLH- 129
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 369
+ GI+HRD+ SN+LL NM K++DFGL+ Q + GT Y+ PE
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP----HEKHYTLCGTPNYISPEI 183
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKP 397
+SDV+S G + L+ G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-35
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 33/243 (13%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 256
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
Y + +V E N L L +K +D R + + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 146
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 368
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 203
Query: 369 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 258
Query: 423 ISI 425
I
Sbjct: 259 IEF 261
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 39/278 (14%)
Query: 150 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 209
Q YE + T S+ Y ++D + E F K +G G+FG
Sbjct: 6 QFRYESQLQMVQVTGSSDNEY------FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFG 59
Query: 210 SVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLIGYCE 261
V + VAVK++ + ++ ++E+ +++++ H N+V L+G C
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 262 EEHQRILVYEYMHNGTLRDRL-----------------HGSVNQKPLDWLTR---LQIAH 301
L++EY G L + L ++ L+ LT L A+
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 302 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARG 360
AKG+E+L +HRD+ + N+L+ K+ DFGL+R + + AR
Sbjct: 180 QVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
V ++ PE T KSDV+S+G++L E+ S G P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 250
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 251 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTR 296
N+V L+G C + +++ E+ G L L + + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 297 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R D+
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 203
Query: 357 VARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
R L PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 8e-35
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 251
K +G+G FG V K VAVK++ ++ S + ++E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 290
+++ L G C ++ +L+ EY G+LR L +++
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350
L + A ++G++YL ++HRD+ + NIL+ + K+SDFGLSR D
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 351 LTHISSVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ S + + G + E + T +SDV+SFGV+L E+++ G P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 256
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 312
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 158
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 215
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ + + DV+S G ++ L+ GK P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 256
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 312
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 132
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 189
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ + + DV+S G ++ L+ GK P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 316
+ +V EY+ G+L D + + + QIA + + LE+LH+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN--- 135
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
+IHRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 377 EKSDVYSFGVVLLELISGKKP 397
K D++S G++ +E+I G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 250
F K +G G+FG V + VAVK++ + ++ ++E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ---------KPLDWLTRLQI 299
N+V L+G C +++ EY G L + R V + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 300 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 358
+ A+G+ +L + IHRDV + N+LL AK+ DFGL+R + + A
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
R V ++ PE + T +SDV+S+G++L E+ S G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 255
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 256 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 314 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 370 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 397
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRI--HHRNLVPL 256
K+IG G V+ + + A+K + + ++T + E+A L+++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
Y + +V E N L L +K +D R + + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 368
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184
Query: 369 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 239
Query: 423 ISI 425
I
Sbjct: 240 IEF 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 67/246 (27%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 251
+ + IG+G+FG V+ + VAVK++ + S Q F E AL++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 290
N+V L+G C L++EYM G L + L S P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350
L +L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 351 LTHISSVARGTVGYLDPEYY---GNQQL---------------TEKSDVYSFGVVLLELI 392
+YY GN + T +SDV+++GVVL E+
Sbjct: 228 -----------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 393 S-GKKP 397
S G +P
Sbjct: 271 SYGLQP 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-34
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT-EVALLSRIHHRNLVPL 256
+++G G FG V +D G++VA+K S + ++ E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 257 IGYCEEE------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
+ +L EY G LR L+ N L + D + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 311 HTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 367
H IIHRD+K NI+L + K+ D G +++ ++ V GT+ YL P
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAP 192
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427
E ++ T D +SFG + E I+G +P F V W + +K + +V
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 428 PVLIGNVKIESI 439
L G VK S+
Sbjct: 248 DDLTGAVKFSSV 259
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 256
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
Y + +V E N L L +K +D R + + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 174
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 368
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V G V Y+ PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231
Query: 369 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 286
Query: 423 ISI 425
I
Sbjct: 287 IEF 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 255
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 256 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 314 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 370 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 397
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 256
++G GS+G V+ + K DG+ AVK + + EV ++ H V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
EE L E +L+ L D L +LH +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
G++H DVK +NI L R K+ DFGL + G Y+ PE
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL-QGSYG 233
Query: 377 EKSDVYSFGVVLLELISGKKP 397
+DV+S G+ +LE+ +
Sbjct: 234 TAADVFSLGLTILEVACNMEL 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 201 KKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 250
K +G+G+FG V + +VAVK++ + + ++E+ ++ I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRL 297
+N++ L+G C ++ ++ EY G LR+ L ++ L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 298 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 357
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 358 ARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
+ T G L PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
KIG+GS G V + K G++VAVK+M R + EV ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 316
+ ++ E++ G L D + L QIA + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---AQ 160
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
G+IHRD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 377 EKSDVYSFGVVLLELISGKKP 397
+ D++S G++++E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-33
Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 23/204 (11%)
Query: 202 KIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIG 258
I G G +Y +G+ V +K + S Q + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 259 YCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+ E + +V EY+ +L+ L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+ G+++ D+K NI+L + K+ D G + + + GT G+ PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPEIVRTG 252
Query: 374 QLTEKSDVYSFGVVLLELISGKKP 397
T +D+Y+ G L L
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPT 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 1e-32
Identities = 40/263 (15%), Positives = 82/263 (31%), Gaps = 28/263 (10%)
Query: 157 DSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC--KKIGKGSFGSVYYG 214
L + ++Y + P E + + +G+G+F VY
Sbjct: 28 FKLLSGLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA 84
Query: 215 KMKD------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268
D ++ +K+ + + L + ++ +L
Sbjct: 85 TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144
Query: 269 VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 326
V E GTL + + + + +K + + A +E +H IIH D+K
Sbjct: 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPD 201
Query: 327 NILL-----------DINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDPEYYGNQQ 374
N +L D++ + D G S + A+ T G+ E N+
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261
Query: 375 LTEKSDVYSFGVVLLELISGKKP 397
+ D + + ++ G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYM 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+KIGKGSFG V+ G K VA+KI+ + + E+ +LS+ + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 315
++ + ++ EY+ G+ D L L QIA + KGL+YLH +
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 137
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN 372
IHRD+K++N+LL + K++DFG++ Q LT VG ++ PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ----LTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
K+D++S G+ +EL G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+ IG G+ V ++VA+K + + C + + E+ +S+ HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW--LTRLQIA---HDAAKGLEYLHTG 313
+ + LV + + G++ D + V + L IA + +GLEYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VG---YLDPE- 368
G IHRDVK+ NILL + +++DFG+S + R T VG ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 369 -----YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y K+D++SFG+ +EL +G P
Sbjct: 198 MEQVRGYD-----FKADIWSFGITAIELATGAAP 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
++G G+FG VY K K+ G A K++ + ++ E+ +L+ H +V L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 316
+ + ++ E+ G + + LT QI + L +LH+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
IIHRD+K+ N+L+ + +++DFG+S + + L S GT ++ PE + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 377 E-----KSDVYSFGVVLLELISGKKP 397
+ K+D++S G+ L+E+ + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 24/232 (10%), Positives = 59/232 (25%), Gaps = 42/232 (18%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
+ + G V+ + + ++ A+K+ A++ ++ +R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 257 IGYC--------------------------EEEHQRILVYEYMH--NGTLRDRLH-GSVN 287
+L+ L L V
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 288 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347
+ L + + L + G++H N+ + + R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 348 EEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKP 397
S V Y E+ T + + G+ + + P
Sbjct: 245 GTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+K+G+GS+GSVY K+ G+ VA+K + Q+ + E++++ + ++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 316
+ +V EY G++ D + + K L +IA KGLEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLT---EDEIATILQSTLKGLEYLHFM--- 144
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
IHRD+K+ NILL+ AK++DFG++ Q + + ++V GT ++ PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203
Query: 377 EKSDVYSFGVVLLELISGKKP 397
+D++S G+ +E+ GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 199 FCKKIGKG--SFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 253
IGKG +V + K G+ V V+ + ++CS+ F+ E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 310
VP +++ +V +M G+ +D + + L IA K L+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGY 364
H + G +HR VK+S+IL+ ++ + +S + V + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 365 LDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
L PE Y KSD+YS G+ EL +G P
Sbjct: 202 LSPEVLQQNLQGYD-----AKSDIYSVGITACELANGHVP 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 23/232 (9%)
Query: 180 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRT 235
+ + + E+ ++G G+ G V+ K+ G +A K++ +
Sbjct: 23 QKQKVGELKDDDFEK-----ISELGAGNGGVVF--KVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 236 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 295
Q + E+ +L + +V G + + + E+M G+L D++ + P L
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG 134
Query: 296 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--TH 353
+ ++ KGL YL I+HRDVK SNIL++ K+ DFG+S Q + + +
Sbjct: 135 K--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405
+ GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 191 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 33/222 (14%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 256
+KIG G FGSV+ + DG A+K + S Q + EV + + H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
E+ ++ EY + G+L D + + +GL Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 316 PGIIHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDLTHISS 356
++H D+K SNI + + K+ D G +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 357 VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
G +L E N K+D+++ + ++ +
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNL 253
+ +GKGSFG V K K G+E AVK+++ + + EV LL ++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ L + E++ LV E G L D + ++ + R Q+ G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QV----LSGITYMH 143
Query: 312 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
I+HRD+K N+LL + ++ DFGLS E + GT Y+ PE
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ EK DV+S GV+L L+SG P
Sbjct: 199 VL-HGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 258
+ +G G++G VY G+ G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 259 ------YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 309
+ Q LV E+ G++ D + + L IA + +GL +
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILRGLSH 144
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 366
LH +IHRD+K N+LL N K+ DFG+S Q L +G ++
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRTVGRRNTFIGTPYWMA 197
Query: 367 PEYYGNQQLTE-----KSDVYSFGVVLLELISGKKP 397
PE + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 201 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 255
++G+G++G V KM+ G+ +AVK + A S ++ + ++ + + V
Sbjct: 13 MELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 311
G E + E M + +L D+ + V K P D L + IA K LE+LH
Sbjct: 71 FYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH 126
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 367
+ +IHRDVK SN+L++ + K+ DFG+S + VA+ G Y+ P
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAP 178
Query: 368 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E + + KSD++S G+ ++EL + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 41/272 (15%), Positives = 88/272 (32%), Gaps = 61/272 (22%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH--- 250
+G+ + + G+ V + + + ++ V + LL I +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 251 -----RNLVPLIGYCEEEHQRI----------------LVYEYMH--NGTLRDRL-HGSV 286
R + P + + +++ +Y M T + L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 287 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 347 AEEDLTHISSVARGTVGYLDPEY-----------YGNQQLTEKSDVYSFGVVLLELISGK 395
+ + + G+ PE +T D ++ G+V+ +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 396 KP--------VSVEDFGAELNIVHWARSMIKK 419
P S F + NI R++++
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVP 255
KK+G G++G V + K E A+KI+ + + + + EVA+L + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
L + E++ LV E G L D + N+ + + Q+ G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-QV----LSGVTYLH-- 153
Query: 314 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
I+HRD+K N+LL + + K+ DFGLS E + GT Y+ PE
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL 210
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKP 397
++ EK DV+S GV+L L++G P
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
F + +G G+F V+ K + GK A+K + S + R E+A+L +I H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
E LV + + G L DR+ G +K + + Q+ ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QV----LSAVKYLH--- 123
Query: 315 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
GI+HRD+K N+L + N + ++DFGLS+ + + +S+ GT GY+ PE
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLA 180
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKP 397
+ ++ D +S GV+ L+ G P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 60/249 (24%), Positives = 90/249 (36%), Gaps = 53/249 (21%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 252
IG+GS+G V A+KI + ++ TEV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----------- 301
+ L E+E LV E H G L D+L+ ++ +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 302 -------------------DAAK-------GLEYLHTGCNPGIIHRDVKSSNILL--DIN 333
+ L YLH N GI HRD+K N L + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 334 MRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE--YYGNQQLTEKSDVYSFGVVL 388
K+ DFGLS++ + GT ++ PE N+ K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 389 LELISGKKP 397
L+ G P
Sbjct: 267 HLLLMGAVP 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 251
K +G G+ G V + K+VA++I++ + TE+ +L +++H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 309
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLL----AVQY 254
Query: 310 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309
Query: 367 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421
PE G D +S GV+L +SG P S L + I G
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 361
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 28/236 (11%), Positives = 66/236 (27%), Gaps = 42/236 (17%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHHRNL 253
+G+ + + G+ V + + + ++ V + LL I ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 254 ------------------VPLIGYCEEEHQRILVYEY--------MHNGTLRDRLHGSV- 286
+ + + + V + T + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 287 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 347 AEEDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ +T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---------ADSCSHRTQQFVTEVALLSRI-H 249
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 307
H N++ L E LV++ M G L D L ++++K + R + + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-ALL----EVI 137
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 367
LH I+HRD+K NILLD +M K++DFG S Q + GT YL P
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 368 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E + ++ D++S GV++ L++G P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
++IG GSFG+VY+ + + VA+K M + + Q + EV L ++ H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 313
G EH LV EY G+ D L V++KPL ++IA H A +GL YLH+
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQ---EVEIAAVTHGALQGLAYLHSH 173
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225
Query: 374 QLTE---KSDVYSFGVVLLELISGKKP 397
+ K DV+S G+ +EL K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-29
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKI-------------MADSCSHRTQQFVTEVAL 244
+K+G G++G V K K E A+K+ + ++ E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 245 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 302
L + H N++ L E++ LV E+ G L +++ ++ + + QI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QI--- 155
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR 359
G+ YLH I+HRD+K NILL + + K+ DFGLS +D +
Sbjct: 156 -LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-- 209
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
GT Y+ PE ++ EK DV+S GV++ L+ G P
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 201 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 255
+IG+G++GSV KM G+ +AVK + + +Q + ++ ++ +V
Sbjct: 28 GEIGRGAYGSVN--KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 311
G E + E M + + + P + L + I K L +L
Sbjct: 86 FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLK 142
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 367
N IIHRD+K SNILLD + K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAP 194
Query: 368 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E Q +SDV+S G+ L EL +G+ P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
IG+GS+G V K A K + +F E+ ++ + H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
E+ LV E G L +R+ + + + + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DV----LSAVAYCH--- 123
Query: 315 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--- 368
+ HRD+K N L + K+ DFGL+ + + + V GT Y+ P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLE 181
Query: 369 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
YG + D +S GV++ L+ G P
Sbjct: 182 GLYG-----PECDEWSAGVMMYVLLCGYPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 176 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSC 231
G+ G Y + +LE ++G G+ G V+ KM+ G +AVK M
Sbjct: 11 GYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVW--KMRFRKTGHVIAVKQMRRSGN 63
Query: 232 SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ 288
++ + ++ +L +V G + E M + R+ G + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123
Query: 289 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348
+ L ++ K L YL G+IHRDVK SNILLD + K+ DFG+S +
Sbjct: 124 RILG-----KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 349 EDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+D S G Y+ PE ++DV+S G+ L+EL +G+ P
Sbjct: 177 DDKAKDRSA--GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 254
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 313 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKP 397
EK DV+S GV+L L+SG P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 255
F +K+G G+FG V+ + + G E +K + D +Q E+ +L + H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLE 308
+ E+ H +V E G L +R+ + + L+ A+ L
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSE----GYVAELMKQMMNALA 138
Query: 309 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 365
Y H + ++H+D+K NIL + K+ DFGL+ + D ++ GT Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYM 193
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
PE + + +T K D++S GVV+ L++G P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 254
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 313 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE- 368
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 369 ---YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y EK DV+S GV+L L+SG P
Sbjct: 195 LRGTYD-----EKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 252
C+ IGKG F V ++ G++ AVKI S T+ E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK----- 305
+V L+ + +V+E+M L + + A+
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV----YSE----AVASHYMRQI 139
Query: 306 --GLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARG 360
L Y H + IIHRDVK +LL + + K+ FG++ Q E G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-G 195
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
T ++ PE + + DV+ GV+L L+SG P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 258
K +G+GSF K + AVKI++ TQ+ E+ L H N+V L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73
Query: 259 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
++ LV E ++ G L +R+ ++ ++ R ++ + ++H +
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-KL----VSAVSHMH---DV 125
Query: 317 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
G++HRD+K N+L + N+ K+ DFG +R D + + T+ Y PE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421
E D++S GV+L ++SG+ P D IKKGD
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 54/265 (20%), Positives = 106/265 (40%), Gaps = 21/265 (7%)
Query: 144 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN-----N 198
+K D + +++ + + P P + + +
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
E++++ +++YE+M G L +++ H +++ R Q+ KGL ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-QV----CKGLCHMH--- 272
Query: 315 NPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+H D+K NI+ K+ DFGL+ + V GT + PE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG 330
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ + +D++S GV+ L+SG P
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLV 254
+ +++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH- 122
Query: 313 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 178
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKP 397
++ D+++ GV+L L+ G P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-H 250
IG+G V + G E AVKIM + + E +L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 308
+++ LI E LV++ M G L D L ++++K + R + + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-SLL----EAVS 214
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
+LH I+HRD+K NILLD NM+ ++SDFG S E GT GYL PE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 369 ------YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ ++ D+++ GV+L L++G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
+ +++G G+FG V+ K G+ K + E+++++++HH L+ L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTG 313
E++++ +L+ E++ G L DR+ + ++ ++ + A +GL+++H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI---AAED--YKMSEAEVINYMRQACEGLKHMH-- 166
Query: 314 CNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
I+H D+K NI+ K+ DFGL+ + D I V T + PE
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 223
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKP 397
+ + +D+++ GV+ L+SG P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 250
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 308
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 309 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 258
+G+G+ V +E AVKI+ H + EV +L + HRN++ LI
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ EEE + LV+E M G++ +H N+ + + + A L++LH N
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALDFLH---NK 130
Query: 317 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGYLDP 367
GI HRD+K NIL + K+ DF L + + G+ Y+ P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 368 E-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E ++ D++S GV+L L+SG P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 255
+++GKG+F V G+E A I+ + Q+ E + + H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
L EE L+++ + G L + + ++ + QI + + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI----LEAVLHCH-- 127
Query: 314 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
G++HR++K N+LL K++DFGL+ + E + A GT GYL PE
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL 185
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKP 397
+ D+++ GV+L L+ G P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-27
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 250
+++G G F V + K GKE A K + ++ EV +L I H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 308
N++ L E + +L+ E + G L D L S+ + + QI G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QI----LDGVH 122
Query: 309 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
YLH + I H D+K NI+L N R K+ DFG++ + E + GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEF 177
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ PE + L ++D++S GV+ L+SG P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 251
K +G G+ G V + K+VA+KI++ + TE+ +L +++H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 309
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QML----LAVQY 129
Query: 310 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184
Query: 367 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421
PE G D +S GV+L +SG P S L + I G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 236
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLVP 255
+++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH-- 145
Query: 314 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVL 202
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKP 397
++ D+++ GV+L L+ G P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 50/234 (21%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVT----------- 240
+IGKGS+G V D A+K++ A +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 241 -------EVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPL 291
E+A+L ++ H N+V L+ ++ ++ +V+E ++ G + + KPL
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPL 134
Query: 292 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351
D KG+EYLH IIHRD+K SN+L+ + K++DFG+S + +
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 352 THISSVARGTVGYLDPE--------YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+S+ GT ++ PE + G + DV++ GV L + G+ P
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCP 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 250
+ +++G G F V + K G + A K + + EV++L I H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 308
N++ L E + IL+ E + G L D L S+ ++ + QI G+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QI----LNGVY 128
Query: 309 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
YLH + I H D+K NI+L R K+ DFGL+ + + + GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ PE + L ++D++S GV+ L+SG P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 39/214 (18%), Positives = 77/214 (35%), Gaps = 17/214 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLV 254
+ + + + D S ++ + +N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+ + + + L+D ++ + + + L I A+ +E+LH
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--- 181
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----------GTVG 363
+ G++HRD+K SNI ++ KV DFGL ++D + + GT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y+ PE + K D++S G++L EL+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 18/77 (23%), Positives = 31/77 (40%), Gaps = 2/77 (2%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+ +G+G FG V+ K K D A+K I + ++ + EV L+++ H +V
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 259 YCEEEHQRILVYEYMHN 275
E E
Sbjct: 72 AWLETPPEKWQEEMDEI 88
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 250
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 308
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 309 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV-TEVALLSRIHHRNLVP 255
+ +G+G FG V+ K K + Q V E+++L+ HRN++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILH 65
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
L E + ++++E++ + +R+ +N++ + Q+ + L++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QV----CEALQFLH- 119
Query: 313 GCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
+ I H D++ NI+ + K+ +FG +RQ + + Y PE +
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVH 175
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKP 397
+ ++ +D++S G ++ L+SG P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA----DSCSHRTQQFVTEVALLSRIHHRNLVP 255
+G+GS+G V + AVKI+ + E+ LL R+ H+N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 256 L--IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------G 306
L + Y EE+ + +V EY G + SV +K R + A G
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK------RFPV-CQAHGYFCQLIDG 121
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTV 362
LEYLH + GI+H+D+K N+LL K+S G++ A +D S G+
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSP 175
Query: 363 GYLDPEYYGNQQLTE--KSDVYSFGVVLLELISGKKP 397
+ PE K D++S GV L + +G P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 39/218 (17%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 251
+G G+FG V+ + KEV VK + + + E+A+LSR+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 305
N++ ++ E + LV E +G L + H +++ L Q+
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIFRQLVS---- 141
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 365
+ YL IIHRD+K NI++ + K+ DFG + E + GT+ Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYC 196
Query: 366 DPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
PE Y G + +++S GV L L+ + P
Sbjct: 197 APEVLMGNPYRG-----PELEMWSLGVTLYTLVFEENP 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ----QFVTEVALLSRI-HHRNLV 254
K++G+G F V K G+E A K + R Q + + E+A+L ++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GL 307
L E + IL+ EY G + + + ++ +D + G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSL----CLPELAEMVSE----NDVIRLIKQILEGV 144
Query: 308 EYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
YLH I+H D+K NILL K+ DFG+SR+ GT Y
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199
Query: 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406
L PE +T +D+++ G++ L++ P F E
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-----FVGE 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 311
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 367
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 368 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 24/216 (11%), Positives = 59/216 (27%), Gaps = 44/216 (20%)
Query: 202 KIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVP 255
G + D ++VA+ + Q+ ++ LSRI +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
++ ++V E++ G+L++ + ++ A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
G+ S + + I+ ++ +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------- 179
Query: 376 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 411
+ D+ G L L+ + P+ + L
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+ +G G FG V+ + G ++A KI+ ++ E+++++++ H NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 316
E ++ +LV EY+ G L DR+ +++ LT L +G+ ++H
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRI---IDES--YNLTELDTILFMKQICEGIRHMH---QM 206
Query: 317 GIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
I+H D+K NIL + K+ DFGL+R+ + V GT +L PE
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDF 264
Query: 375 LTEKSDVYSFGVVLLELISGKKP 397
++ +D++S GV+ L+SG P
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLI 257
K IGKG+F V + + G+EVA+KI+ + Q+ EV ++ ++H N+V L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
E E L+ EY G + D L HG + +K R QI ++Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVS----AVQYCH---Q 132
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 369
I+HRD+K+ N+LLD +M K++DFG S + G Y PE Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKP 397
G + DV+S GV+L L+SG P
Sbjct: 191 DG-----PEVDVWSLGVILYTLVSGSLP 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 258
+ +G G G V + G++ A+K++ DS R EV + ++V ++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILD 89
Query: 259 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 311
E H ++ E M G L R+ ++ T + I D +++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 312 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
+ I HRDVK N+L + + K++DFG +++ ++ + + T Y+ PE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPE 199
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
G ++ + D++S GV++ L+ G P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-CSHRTQQFVTEVALLSR-IHHRNLV 254
+ IG GS+ K E AVKI+ S E+ +L R H N++
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNII 79
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L ++ +V E M G L D++ + QK + K +EYLH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFSEREASAVLFTITKTVEYLH--- 133
Query: 315 NPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
G++HRD+K SNIL ++ DFG ++Q + + + T ++ PE
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVL 192
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKP 397
Q D++S GV+L +++G P
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
++G+G+ VY K K K A+K++ + + TE+ +L R+ H N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK-------GLE 308
E + LV E + G L DR+ G +++ DAA +
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSER------------DAADAVKQILEAVA 162
Query: 309 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 365
YLH GI+HRD+K N+L + K++DFGLS+ E + + GT GY
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422
PE + D++S G++ L+ G +P E + I +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------RRILNCEY 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 311
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 367
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 368 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIHHR-- 251
+G G FGSVY G + D VA+K + D V EV LL ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 252 NLVPLIGYCEEEHQRILVYEYMHN-GTLRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 305
++ L+ + E +L+ E L D + G++ ++ L R Q+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFFWQVLE---- 160
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
+ + H N G++HRD+K NIL+D+N K+ DFG ++ + GT Y
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214
Query: 365 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
PE Y+G + V+S G++L +++ G P
Sbjct: 215 SPPEWIRYHRYHG-----RSAAVWSLGILLYDMVCGDIP 248
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 256
+G G+FG V G+ G +VAVKI+ + E+ L H +++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+V EY+ G L D + HG V + L + QI ++Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILS----AVDYCH--- 128
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 368
++HRD+K N+LLD +M AK++DFGLS + + G+ Y PE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 186
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y G + D++S GV+L L+ G P
Sbjct: 187 YAG-----PEVDIWSCGVILYALLCGTLP 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 253
F K +G+GSF +V + +E A+KI+ + + E ++SR+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAK------- 305
V L +++ + Y NG L L ++ ++ +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIV 140
Query: 306 -GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----- 359
LEYLH GIIHRD+K NILL+ +M +++DFG ++ + S AR
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFV 193
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
GT Y+ PE + + SD+++ G ++ +L++G P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 52/258 (20%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIH---- 249
+GKG FG+V+ G + D +VA+K++ EVALL ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDA 303
H ++ L+ + E + +LV E L D + G + + +R Q+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVA-- 150
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTV 362
+++ H + G++HRD+K NIL+D+ AK+ DFG ++ GT
Sbjct: 151 --AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTR 202
Query: 363 GYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHW-- 412
Y PE Y+ + V+S G++L +++ G P + AEL+
Sbjct: 203 VYSPPEWISRHQYHA-----LPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257
Query: 413 --ARSMIKKGDVISIVDP 428
++I++ P
Sbjct: 258 PDCCALIRR---CLAPKP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 258
+ +G G G V K ++ A+K++ D R EV L R ++V ++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122
Query: 259 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 311
E + +V E + G L R+ + T + I + ++YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 312 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 233
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
G ++ + D++S GV++ L+ G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 200 CKKIGKGSFGSVYYGKMKDGKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPLI 257
CK IG GSFG V+ K+ + EVA+K ++ D +R E+ ++ + H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLK 98
Query: 258 ------GYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAKG 306
G ++E LV EY+ T+ R + + Q L +L Q+ +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQL----LRS 153
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYL 365
L Y+H+ GI HRD+K N+LLD K+ DFG ++ ++S + + Y
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYR 208
Query: 366 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 395
PE +G T D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQ--QFVTEVALLSRIHHRNL 253
K IG+G+F V KMK +V A+KIM R + F E +L R +
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 254 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
L + ++ + LV EY G L L + P + R +A + ++ +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVH- 179
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
G +HRD+K NILLD +++DFG + D T S VA GT YL PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 373 QQLTEKSDVY-------SFGVVLLELISGKKP 397
+ Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 253
+ +GKG FG V +++ ++ A K + R + + E +L +++ R +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 254 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
V L Y E + LV M+ G L+ ++ + A GLE LH
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH- 303
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
I++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 359
Query: 373 QQLTEKSDVYSFGVVLLELISGKKPVSVED 402
++ T D ++ G +L E+I+G+ P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 253
+ IGKGSFG V + D K++ A+K M C R + E+ ++ + H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 254 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
V L Y ++ + + +V + + G LR L N + +L I + L+YL
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC-ELVMALDYLQ- 132
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
N IIHRD+K NILLD + ++DF ++ + +++A GT Y+ PE + +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMA-GTKPYMAPEMFSS 188
Query: 373 QQLTEKS---DVYSFGVVLLELISGKKP 397
++ S D +S GV EL+ G++P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 29/239 (12%)
Query: 175 GGHFMDEGVAYFIPLPELEEATN-NFCKKIGKGSFGSVYYGKMKD-GKEVAVK-IMAD-S 230
G M A +E + G+G+FG+V GK K G VA+K ++ D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 231 CSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEEEHQRI---LVYEYMHNGTLRD--R 281
+R Q + L+ +HH N+V L Y E + + I +V EY+ TL R
Sbjct: 62 FRNRELQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCR 117
Query: 282 LHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 337
+ P L ++ Q+ + + LH + HRD+K N+L++ + K
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK 172
Query: 338 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
+ DFG +++ +++ + + Y PE +GNQ T D++S G + E++ G+
Sbjct: 173 LCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 253
+ +G+G FG V+ +MK ++ A K + R E +L+++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 254 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYLH 311
V L Y E + LV M+ G +R ++ P R GLE+LH
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
II+RD+K N+LLD + ++SD GL+ + + T A GT G++ PE
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKP 397
++ D ++ GV L E+I+ + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
K IG G+FG + + VAVK + + + + E+ + H N+V
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 260 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
++ EY G L +R+ G ++ + + Q+ G+ Y H +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLS----GVSYCH---SMQ 136
Query: 318 IIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 369
I HRD+K N LLD + R K+ DFG S+ + S+V GT Y+ PE Y
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEY 194
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKP 397
G + +DV+S GV L ++ G P
Sbjct: 195 DG-----KIADVWSCGVTLYVMLVGAYP 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 200 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 256
K IG GSFG VY K+ D G+ VA+K ++ D +R E+ ++ ++ H N+V L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112
Query: 257 IGYCEEEHQRI------LVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAK 305
+ ++ LV +Y+ T+ R + Q +L Q+ +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF----R 167
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 364
L Y+H+ GI HRD+K N+LLD + K+ DFG ++Q ++S + + Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 365 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
PE +G T DV+S G VL EL+ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 256
+G G+FG V GK G +VAVKI+ + E+ L H +++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+V EY+ G L D + +G +++K L + QI G++Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ-QILS----GVDYCH--- 133
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 368
++HRD+K N+LLD +M AK++DFGLS + + G+ Y PE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 191
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y G + D++S GV+L L+ G P
Sbjct: 192 YAG-----PEVDIWSSGVILYALLCGTLP 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 256
+ +G+GSFG V K ++VA+K ++ S + E++ L + H +++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
++V EY G L D + + + + QI +EY H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ-QIIC----AIEYCH--- 125
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 368
I+HRD+K N+LLD N+ K++DFGLS + + + G+ Y PE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKL 183
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y G + DV+S G+VL ++ G+ P
Sbjct: 184 YAG-----PEVDVWSCGIVLYVMLVGRLP 207
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIM--ADSCSHR-TQQFVTEVALLSRIHHRNL 253
K IG+G+FG V K+K+ +V A+KI+ + T F E +L + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 254 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
L Y ++ + LV +Y G L L ++ P + R +A + ++ +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVH- 192
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 373 QQLTEKS-----DVYSFGVVLLELISGKKP 397
+ + D +S GV + E++ G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 37/268 (13%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 258 ------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
EE LV E M + L V Q LD + + G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431
E D++S G ++ E++ K D+ + N +++ +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---------------VIE--QL 279
Query: 432 GNVKIESIWRIAEVAIQCVEQRGFSRPK 459
G E + ++ VE R
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGL 307
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
+G G++GSV + G++VA+K ++ ++ E+ LL + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 258 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 308
LV +M D L + K + + Q+ KGL+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEEKIQYLVYQML----KGLK 140
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 368
Y+H+ G++HRD+K N+ ++ + K+ DFGL+R A+ ++T V T Y PE
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--YVV--TRWYRAPE 193
Query: 369 -YYGNQQLTEKSDVYSFGVVLLELISGK 395
+ D++S G ++ E+++GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 6 LSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 63
+ G N L G IPP + + L L++ ++G +PD +S++ L + N L+G+LP
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPAL 90
+ SLPNL + + N G IP +
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 8e-21
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 1/101 (0%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
LS L+G+ + + ++ L N L L + +L + L NN + G+LP
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG 263
Query: 66 MGSLPNLQELHIENNSFVGEIPPAL-LTGKVIFKYDNNPKL 105
+ L L L++ N+ GEIP L + Y NN L
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 5e-19
Identities = 26/89 (29%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 6 LSGKNLKGE--IPPELKNMEALTELWL-DGNFLTGPLPD-MSRLIDLRIVHLENNELTGS 61
LSG NL IP L N+ L L++ N L GP+P +++L L +++ + ++G+
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 62 LPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+P ++ + L L N+ G +PP++
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 7e-19
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 2/87 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
++ N+ G IP L ++ L L N L+G LP +S L +L + + N ++G++P
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 65 YMGSLPNL-QELHIENNSFVGEIPPAL 90
GS L + I N G+IPP
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTF 194
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 24/83 (28%), Positives = 36/83 (43%), Gaps = 1/83 (1%)
Query: 6 LSGKNLKGEIPPELKNMEAL-TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS 64
G + G IP + L T + + N LTG +P ++L V L N L G
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215
Query: 65 YMGSLPNLQELHIENNSFVGEIP 87
GS N Q++H+ NS ++
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNELTGS 61
S L G +PP + ++ L + DGN ++G +PD S+L + + N LTG
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--FTSMTISRNRLTGK 189
Query: 62 LPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+P +L NL + + N G+
Sbjct: 190 IPPTFANL-NLAFVDLSRNMLEGDASVLF 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 4/89 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL---PDMSRLIDLRIVHLEN-NELTGS 61
+ G + + L L G L P ++ L L +++ N L G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 62 LPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+P + L L L+I + + G IP L
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 4e-11
Identities = 20/83 (24%), Positives = 37/83 (44%), Gaps = 3/83 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
L+ +L ++ ++ + L L L N + G LP +++L L +++ N L G +P
Sbjct: 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 65 YMGSLPNLQELHIENNSFVGEIP 87
G+L NN + P
Sbjct: 287 -GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 17/61 (27%), Positives = 25/61 (40%), Gaps = 2/61 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE-NNELTGS-LP 63
L + G +P L ++ L L + N L G +P L + N L GS LP
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310
Query: 64 S 64
+
Sbjct: 311 A 311
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-21
Identities = 39/86 (45%), Positives = 50/86 (58%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
L L+GEIP EL ++ L L LD N LTG +P +S +L + L NN LTG +P
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
++G L NL L + NNSF G IP L
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-20
Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 14/143 (9%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
L +L GEIP L N L + L N LTG +P + RL +L I+ L NN +G++P+
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL-----------LTGKVIFKYDNNPKLHK--ESRR 111
+G +L L + N F G IP A+ + GK N+ + +
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGN 592
Query: 112 RMRFKLILGTSIGVLAILLVLFL 134
+ F+ I + L+ +
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-20
Identities = 30/86 (34%), Positives = 42/86 (48%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
L G+IPP L N L L L N+L+G +P + L LR + L N L G +P
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
+ + L+ L ++ N GEIP L
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-19
Identities = 23/98 (23%), Positives = 45/98 (45%), Gaps = 3/98 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+SG + G++ + L L + N + +P + L+ + + N+L+G
Sbjct: 185 ISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRA 242
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTG-KVIFKYDNN 102
+ + L+ L+I +N FVG IPP L + + +N
Sbjct: 243 ISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENK 280
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-18
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 3/88 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLP 63
LSG + G +PP + L L L N +G LP + ++ L+++ L NE +G LP
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 64 SYMGSL-PNLQELHIENNSFVGEIPPAL 90
+ +L +L L + +N+F G I P L
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNL 388
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLP 63
+S G IPP +++L L L N TG +PD L + L N G++P
Sbjct: 254 ISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALL 91
+ GS L+ L + +N+F GE+P L
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDTL 339
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-17
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 6 LSGKNLKGEIPPELKNMEA-LTELWLDGNFLTGPLPD---MSRLIDLRIVHLENNELTGS 61
LS GE+P L N+ A L L L N +GP+ + L+ ++L+NN TG
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 62 LPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+P + + L LH+ N G IP +L
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-16
Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 6 LSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 63
L+ GEIP L + LT L L GN G +P L + L +N +G LP
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335
Query: 64 -SYMGSLPNLQELHIENNSFVGEIPPAL 90
+ + L+ L + N F GE+P +L
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 5e-16
Identities = 31/126 (24%), Positives = 56/126 (44%), Gaps = 26/126 (20%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
++ + G P N ++ L + N L+G +P + + L I++L +N+++GS+P
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL---------------LTGKV----IFK------Y 99
+G L L L + +N G IP A+ L+G + F+ +
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 734
Query: 100 DNNPKL 105
NNP L
Sbjct: 735 LNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-15
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 7/94 (7%)
Query: 6 LSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLENNELTGS 61
LS +L G + L + L L + N L + +L L ++ L N ++G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 62 LPS---YMGSLPNLQELHIENNSFVGEIPPALLT 92
L+ L I N G++ +
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV 200
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 19/91 (20%), Positives = 36/91 (39%), Gaps = 5/91 (5%)
Query: 6 LSGKNLK---GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 62
LS K L + L ++ L L+L + + G + L + L N L+G +
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPV 116
Query: 63 PSYM--GSLPNLQELHIENNSFVGEIPPALL 91
+ GS L+ L++ +N+ +
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 6e-13
Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 5 ALSGKNLKGEIPPELKNMEALTELWLDGNF--LTGPLP-DMSRLIDLRIVHLENNELTGS 61
++ + G+ +KN E GN G ++RL ++ + G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 62 LPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+ ++ L + N G IP +
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 8/48 (16%), Positives = 19/48 (39%)
Query: 41 DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 88
++ + + N ++ S + SL L+ L + N+ G +
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG 95
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 37/268 (13%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 258 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
EE Q + +V E M + L V Q LD + + G+++LH
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431
E D++S G ++ E+I G D + N +++ +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---------------VIE--QL 242
Query: 432 GNVKIESIWRIAEVAIQCVEQRGFSRPK 459
G E + ++ VE R
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGY 270
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 4e-21
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIH---H 250
+ + IG+G FG VY + D ++ A+K + + + + E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 251 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 307
+V + Y ++ + + M+ G L L HG ++ R A + GL
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA-EIILGL 305
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 367
E++H N +++RD+K +NILLD + ++SD GL+ + H +SV GT GY+ P
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASV--GTHGYMAP 359
Query: 368 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 397
E + S D +S G +L +L+ G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 258 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
EE + LV M G D L+ V + L + + +GL+Y+H
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM--GA--D-LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY- 370
+ IIHRD+K SN+ ++ + K+ DFGL+R +++T GY+ +Y
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRWYR 196
Query: 371 ------GNQQLTEKSDVYSFGVVLLELISGK 395
+ D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 253
K IG+G+FG V + K ++V A+K+++ + F E +++ + +
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------- 305
V L +++ +V EYM G L ++ ++ + A+
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVL 179
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 365
L+ +H + G IHRDVK N+LLD + K++DFG + ++ A GT Y+
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 366 DPE---YYGNQQLTEKS-DVYSFGVVLLELISGKKP 397
PE G + D +S GV L E++ G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 258 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
++ LV +M D L + + L + + KGL Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-Y 370
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T V T Y PE
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVV--TRWYRAPEVIL 198
Query: 371 GNQQLTEKSDVYSFGVVLLELISGK 395
+ T+ D++S G ++ E+I+GK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT-----------EVALLSRIH 249
+ I GS+G+V G +G VA+K + ++ S + E+ LL+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 250 HRNLVPL----IGYCEEEHQRI-LVYEYMHNGTLRDRLHG--SVNQKPLDWLTRLQ-IAH 301
H N++ L + + E ++ LV E M D L + + +Q +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRIVIS-PQHIQYFMY 141
Query: 302 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 361
GL LH G++HRD+ NILL N + DF L+R+ D V
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--H 196
Query: 362 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
Y PE + T+ D++S G V+ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHR--TQQFVTEVALLSRIHHRNL 253
+ K +GKG+FG V K K A+KI+ + + +TE +L H L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 254 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
L Y + H R+ V EY + G L H S + + R A + L+YLH+
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+++RD+K N++LD + K++DFGL ++ +D + + GT YL PE +
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 323
Query: 373 QQLTEKSDVYSFGVVLLELISGKKPVSVED 402
D + GVV+ E++ G+ P +D
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL-- 256
+K+G+G + V+ + + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 98
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 313
I LV+E+++N + + LT I ++ K L+Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK---------QLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 314 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
GI+HRDVK N+++D R ++ D+GL+ + VA + + PE +
Sbjct: 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVD 204
Query: 373 QQLTEKS-DVYSFGVVLLELISGKKP 397
Q+ + S D++S G +L +I K+P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRNL 253
K+G G++ +VY G K G VA+K + S + R E++L+ + H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKELKHENI 65
Query: 254 VPLIGYCEEEHQRILVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
V L E++ LV+E+M N D + L+ +GL + H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 368
I+HRD+K N+L++ + K+ DFGL+R + V T+ Y P+
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VV--TLWYRAPD 178
Query: 369 Y-YGNQQLTEKSDVYSFGVVLLELISGK 395
G++ + D++S G +L E+I+GK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 71/270 (26%)
Query: 199 FCKKIGKGSFGSVYYG------KMKDGKEVAVKIMADSCSHR-TQQFVTEVALLSRI-HH 250
K +G+G+FG V K + VAVK++ + +H + ++E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 251 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQ--------------------- 288
N+V L+G C + +++ E+ G L L N+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 289 -----KPLDWLTRLQIAHDAA----KGLEYLHTGCNPGIIHRDVKSSNILLDI------- 332
+ LD +T Q + + K L + P +++D + L+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 333 -----------------------NMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPE 368
K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 369 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 397
++ T +SDV+SFGV+L E+ S G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 252
+K+G+G++G VY K G+ VA+K + R T E++LL +HH N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 306
+V LI E LV+E+M D L +++ Q+ +G
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK----D-LKKVLDENKTGLQDSQIKIYLYQLL----RG 131
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 363
+ + H I+HRD+K N+L++ + K++DFGL+R TH V T+
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VV--TLW 184
Query: 364 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
Y P+ G+++ + D++S G + E+I+GK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 47/211 (22%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 256
+ +G G G V K ++ A+K++ D R EV L R ++V +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRI 76
Query: 257 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEY 309
+ E + +V E + G L R+ + T + I + ++Y
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQY 132
Query: 310 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 366
LH + I HRDVK N+L N K++DFG +++
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------TT 171
Query: 367 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
E Y + D++S GV++ L+ G P
Sbjct: 172 GEKYD-----KSCDMWSLGVIMYILLCGYPP 197
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 251
KIG+GS+G V+ + +D G+ VA+K + R E+ +L ++ H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR------EIRMLKQLKHP 62
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
NLV L+ + + LV+EY + T+ L Q+ + I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 368
IHRDVK NIL+ + K+ DFG +R + VA T Y PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--EVA--TRWYRSPE 172
Query: 369 Y-YGNQQLTEKSDVYSFGVVLLELISGK 395
G+ Q DV++ G V EL+SG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 62/243 (25%)
Query: 200 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL- 256
K +G GSFG V + GK A+K ++ D + E+ ++ + H N++ L
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNR---ELDIMKVLDHVNIIKLV 66
Query: 257 -IGYCEEEHQRI------------------------------------LVYEYMHNGTLR 279
Y + + ++ EY+ TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 280 D--RLHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 334
+ + L + Q+ + + ++H+ GI HRD+K N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLVNSKD 178
Query: 335 -RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELI 392
K+ DFG +++ ++ + + Y PE G + T D++S G V ELI
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 393 SGK 395
GK
Sbjct: 237 LGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 257
K +G G G V+ K VA+K + + + + E+ ++ R+ H N+V +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 258 ------------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 305
G E + +V EYM T D L + Q PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM--ET--D-LANVLEQGPLLEEHARLFMYQLLR 131
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISS----VARG 360
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H +
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-- 186
Query: 361 TVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK 395
T Y P + T+ D+++ G + E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 3e-18
Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 202 KIGKGSFGSVYYGKMKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRNL 253
KIG+G++G VY + G+ A+K + S + R E+++L + H N+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKELKHSNI 62
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 311
V L + + +LV+E++ D L ++ + G+ Y H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ----D-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 368
++HRD+K N+L++ K++DFGL+R TH + T+ Y P+
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV--TLWYRAPD 170
Query: 369 Y-YGNQQLTEKSDVYSFGVVLLELISGK 395
G+++ + D++S G + E+++G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 251
+G+GS+G V + KD G+ VA+K + R E+ LL ++ H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR------EIKLLKQLRHE 84
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
NLV L+ C+++ + LV+E++ + T+ D L + LD+ + G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 368
+ IIHRD+K NIL+ + K+ DFG +R E VA T Y PE
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VA--TRWYRAPE 194
Query: 369 Y-YGNQQLTEKSDVYSFGVVLLELISGK 395
G+ + + DV++ G ++ E+ G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 4e-18
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 252
KIG+G++G+V+ K ++ + VA+K + R + E+ LL + H+N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 306
+V L + + LV+E+ D L + D Q+ KG
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----D-LKKYFDSCNGDLDPEIVKSFLFQLL----KG 113
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 363
L + H+ ++HRD+K N+L++ N K+++FGL+R + V T+
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVV--TLW 166
Query: 364 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y P+ +G + + D++S G + EL + +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI- 257
+G+G++G V G+ VA+K I + + E+ +L H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 258 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLE 308
E ++ ++ E M T D LH ++ + L + Q + ++
Sbjct: 77 IQRPDSFENFNEVYIIQELM--QT--D-LHRVISTQMLSDDHIQYFIY-QTL----RAVK 126
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV---GYL 365
LH +IHRD+K SN+L++ N KV DFGL+R +E S ++
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 366 DPEYY-------GNQQLTEKSDVYSFGVVLLELISGK 395
+Y + + + DV+S G +L EL +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIH-HRNLVPL 256
KK+GKG++G V+ + G+ VAVK + D+ + T Q+ E+ +L+ + H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 257 --IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 309
+ + + LV++YM T D LH + L+ ++ Q+ K ++Y
Sbjct: 75 LNVLRADNDRDVYLVFDYM--ET--D-LHAVIRANILEPVHKQYVVY-QLI----KVIKY 124
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
LH+G G++HRD+K SNILL+ KV+DFGLSR +++ +
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 370 YGNQQLTE---------------------KSDVYSFGVVLLELISGK 395
LT+ D++S G +L E++ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMA-DSCSH--RTQQFVTEVALLSRIHHRNLVP 255
IG+G++G V + VA+K I + ++ RT + E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRFRHENIIG 89
Query: 256 LI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
+ E+ +V + M T D L+ + + L + +GL+Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLM--ET--D-LYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS----VARGTVGYLD 366
H+ ++HRD+K SN+LL+ K+ DFGL+R A+ D H VA T Y
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRA 199
Query: 367 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 395
PE N + T+ D++S G +L E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 253
++ K +GKG+FG V + K A+KI+ + + + VTE +L H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 254 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK--- 305
L Y + H R+ V EY + G L L + A+
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGEL---------------FFHLSRERVFTEERARFYG 111
Query: 306 -----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR- 359
LEYLH + +++RD+K N++LD + K++DFGL + E ++ + +
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKT 164
Query: 360 --GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
GT YL PE + D + GVV+ E++ G+ P +D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 253
+ +G GSFG V+ + + A+K++ R +Q E +LS + H +
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 305
+ + G ++ Q ++ +Y+ G L + L+ + AK
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPNPVAKFYAA 113
Query: 306 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 361
LEYLH + II+RD+K NILLD N K++DFG ++ D+T+ GT
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVTY---TLCGT 166
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y+ PE + + D +SFG+++ E+++G P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 253
+ K +G GSFG V K K+ A+KI+ + +Q + E +L ++ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 305
V L ++ +V EY+ G + + L+ A+
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM---------------FSHLRRIGRFSEPHARFYAA 148
Query: 306 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 361
EYLH + +I+RD+K N+L+D +V+DFG +++ + T GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTW---TLCGT 201
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
L PE ++ + D ++ GV++ E+ +G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 202 KIGKGSFGSVYYGKMKD---GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
K+G+G++G VY K KD K+ A+K I S E+ALL + H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 84
Query: 258 GYCEEEHQRI--LVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYL 310
R L+++Y + + S K L R + + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 311 HTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 363
H ++HRD+K +NIL+ R K++D G +R + L + V T
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 364 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
Y PE G + T+ D+++ G + EL++ +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 258
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 259 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
E ++V E + G L + + K T L +A +EY+H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK-----TVLLLADQMISRIEYIH--- 122
Query: 315 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQ--AEEDLTHISSVA----RGTVGYL 365
+ IHRDVK N L+ + + + DFGL+++ HI GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ + + + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 55/226 (24%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVK------------IMADSCSHRTQQFVTEVALLSRI 248
KIG+G+FG V+ + + G++VA+K I A + E+ +L +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----------LREIKILQLL 73
Query: 249 HHRNLVPLIGYCEEEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
H N+V LI C + LV+++ + D L G ++ + T +I
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLLSNVLVK-FTLSEIK 127
Query: 301 HDAA---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-------QAEED 350
GL Y+H I+HRD+K++N+L+ + K++DFGL+R
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 351 LTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
T+ V T+ Y PE G + D++ G ++ E+ +
Sbjct: 185 YTNR--VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIM--ADSCSHRTQQFVTEVALLSRIHHR 251
K +G+GSFG V+ K G + A+K++ A + E +L ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 252 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK- 305
+V L Y + ++ L+ +++ G L TRL + K
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDL---------------FTRLSKEVMFTEEDVKF 130
Query: 306 -------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358
L++LH + GII+RD+K NILLD K++DFGLS+++ + S
Sbjct: 131 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187
Query: 359 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
GTV Y+ PE + T+ +D +SFGV++ E+++G P +D
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIHHRNLV 254
+G+G F +VY + + VA+K I S T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 255 PLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPLD------WLTRLQIAHDAAK 305
L+ + LV+++M ++D N L ++ L +
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYM--LMTL----Q 123
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTV 362
GLEYLH I+HRD+K +N+LLD N K++DFGL++ TH V T
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VV--TR 176
Query: 363 GYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
Y PE +G + D+++ G +L EL+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 55/243 (22%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
IG+GS+G VY K VA+K + ++ + E+ +L+R+ ++ L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 258 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRL-------QIAHDA 303
+ +V E + D L LT +
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA--DS--D-LKKLFKTPIF----LTEEHIKTILYNLL--- 139
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTV 362
G ++H GIIHRD+K +N LL+ + KV DFGL+R + T+I +
Sbjct: 140 -LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 363 GYLDPEYYGNQQLTE--------------------KS-DVYSFGVVLLELISGKKPVSVE 401
+QLT KS D++S G + EL++ + +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 402 DFG 404
Sbjct: 256 PTN 258
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 33/197 (16%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
IG GS+G V + + VA+K + ++ + E+A+L+R++H ++V ++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 258 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH------DAAKG 306
E+ + +V E D K L H + G
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD----SD-FK-----KLFRTPVYLTELHIKTLLYNLLVG 168
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG------ 360
++Y+H+ GI+HRD+K +N L++ + KV DFGL+R + S +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 361 TVGYLDPEYYGNQQLTE 377
+ +QLT
Sbjct: 226 NLVTFPHTKNLKRQLTG 242
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 198 NFCKKIGKGSFGSVY---YGKMKDGKEV-AVKIMA-DSCSHRTQQFV---TEVALLSRIH 249
+ +GKG +G V+ + ++ A+K++ + E +L +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 250 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAA 304
H +V LI Y + ++ L+ EY+ G L +L+ D A
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGEL---------------FMQLEREGIFMEDTA 123
Query: 305 K--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356
L +LH GII+RD+K NI+L+ K++DFGL +++ D T +
Sbjct: 124 CFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
Query: 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
GT+ Y+ PE D +S G ++ ++++G P + E+
Sbjct: 181 FC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 252
+F K IGKGSFG V + K + AVK++ + + ++ LL + H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 253 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK-- 305
LV L + + ++ V +Y++ G L LQ A+
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGEL---------------FYHLQRERCFLEPRARFY 144
Query: 306 ------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 359
L YLH + I++RD+K NILLD ++DFGL + E++ H +S
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEH-NSTTS 197
Query: 360 ---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
GT YL PE Q D + G VL E++ G P +
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 197 NNFCK--KIGKGSFGSVYYGK-MKDGKEVAVKIM-------ADSCSHRTQQFVTEVALLS 246
+ K K+G+G++ +VY GK VA+K + A + R EV+LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLK 55
Query: 247 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIA 300
+ H N+V L E LV+EY+ +D L ++ Q+
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLD----KD-LKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSV 357
+GL Y H ++HRD+K N+L++ K++DFGL+R + + V
Sbjct: 111 ----RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--V 161
Query: 358 ARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
T+ Y P+ G+ + + D++ G + E+ +G+
Sbjct: 162 V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 258
KKIG G+FG + GK + + VA+K+ Q E ++ + +P +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 259 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+ +V E + G L D + + K T L IA +EY+H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK-----TVLMIAIQLISRMEYVH--- 122
Query: 315 NPGIIHRDVKSSNILLDINMRAKVS-----DFGLSRQ 346
+ +I+RDVK N L+ DF L+++
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 202 KIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRN 252
K+G+G++G VY + VA+K + + R EV+LL + HRN
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR------EVSLLKELQHRN 94
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
++ L H+ L++EY N L+ + + + G+ + H+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 313 GCNPGIIHRDVKSSNILLDINMRA-----KVSDFGLSRQ---AEEDLTHISSVARGTVGY 364
+HRD+K N+LL ++ + K+ DFGL+R TH + T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE--II--TLWY 203
Query: 365 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
PE G++ + D++S + E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 29/214 (13%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 258
++IG+GSFG ++ G + + ++VA+K Q E + +P +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 259 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+ +E +LV + + G L D + K T A ++ +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSIH--- 123
Query: 315 NPGIIHRDVKSSNILLDINMRAK-----VSDFGLSRQAEEDLT--HISSVA----RGTVG 363
+++RD+K N L+ V DFG+ + + +T HI GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
Y+ + ++ + + D+ + G V + + G P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 249
+ + IG+GS+ V ++K + A+K + D Q TE + + +
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASN 68
Query: 250 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 307
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 123
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 365
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 177
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
PE + D ++ GV++ E+++G+ P
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 252
NF +GKGSFG V + K E+ AVKI+ D T V L
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 253 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
L L C + R+ V EY++ G L H + + A + A GL +L
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ 459
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA 515
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
Q + D ++FGV+L E+++G+ P ED
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 258
+KIG GSFG +Y G ++ +EVA+K+ H Q + E + + +P +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70
Query: 259 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
+ E +LV + + G L + ++ K T L +A +E++H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK-----TVLMLADQMINRVEFVH--- 120
Query: 315 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLT--HISSVA----RGTVGYL 365
+ +HRD+K N L+ + RA + DFGL+++ + T HI GT Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ + + + D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 249
F + +GKGSFG V ++K+ ++ AVK I+ D T TE +LS +
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARN 82
Query: 250 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 308
H L L C + R+ V E+++ G L H +++ + R A + L
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALM 138
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLD 366
+LH GII+RD+K N+LLD K++DFG+ ++ T ++ GT Y+
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIA 192
Query: 367 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
PE D ++ GV+L E++ G P E+
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 9e-16
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 202 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIH---HRN 252
+IG G++G+VY + G VA+K + + ++ EVALL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 253 LVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAA 304
+V L+ + E + LV+E++ +D L +++ P L I
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD----QD-LRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
+GL++LH I+HRD+K NIL+ K++DFGL+R + V T+ Y
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWY 185
Query: 365 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
PE + T D++S G + E+ K
Sbjct: 186 RAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 49/232 (21%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMA-DSCSHRTQQFV---TEVALLSRI- 248
K +G G++G V+ + G + A+K++ + + + TE +L I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 249 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DA 303
LV L Y + ++ L+ +Y++ G L T L
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL---------------FTHLSQRERFTEHE 160
Query: 304 AK--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355
+ LE+LH GII+RD+K NILLD N ++DFGLS+ E + +
Sbjct: 161 VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADET 214
Query: 356 SVAR---GTVGYLDPE-YYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVED 402
A GT+ Y+ P+ G +K+ D +S GV++ EL++G P +V+
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 249
+ + IG+GS+ V ++K + A++ + D Q TE + + +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEKHVFEQASN 111
Query: 250 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 307
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 166
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 365
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 220
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
PE + D ++ GV++ E+++G+ P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---------- 249
+K+G G F +V+ K M + VA+KI+ + + E+ LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 83
Query: 250 -HRNLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHD 302
+++ L+ + H ++V+E + L + ++ PL + QI+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHV-VMVFEVLGE-NLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 303 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA------KVSDFGLSRQAEEDLT-HIS 355
GL+Y+H C IIH D+K N+L++I K++D G + +E T I
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 395
+ Y PE +D++S ++ ELI+G
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 252
K +GKGSFG V+ + K + A+K + D T V L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 253 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
L + + + + V EY++ G L + K A + GL++LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAA-EIILGLQFLH 135
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 368
+ GI++RD+K NILLD + K++DFG+ + E++ + GT Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLG-DAKTNTFCGTPDYIAPE 188
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
Q+ D +SFGV+L E++ G+ P +D
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 249
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 79
Query: 250 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 308
L L C + R+ V EY++ G L + V + A + A GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPH-AVFYAA-EIAIGLF 135
Query: 309 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYL 365
+L + GII+RD+K N++LD K++DFG+ + E++ + GT Y+
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWD-GVTTKTFCGTPDYI 188
Query: 366 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 40/231 (17%), Positives = 80/231 (34%), Gaps = 45/231 (19%)
Query: 201 KKIGKGSFGSVYYGK---------MKDGKEVAVKI-MADSCSHRTQQF------VTEVAL 244
+ + G +Y ++ ++K+ D Q F +V
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 245 LSRIHHRNL--VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
+++ L +P ++ R LV + G + L + LQ+A
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 301 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV--SDFGLSRQAEEDLTHI---- 354
LE+LH +H +V + NI +D +++V + +G + + H+
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 355 --SSVARGTVGYLDPEY------YGNQQLTEKSDVYSFGVVLLELISGKKP 397
S G + E+ G + +SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGDL-----EFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 60/254 (23%)
Query: 187 IPLPELEEATNNFC------KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFV 239
+P PE + + KKIG G FG +Y ++ A ++
Sbjct: 23 MPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE-YQENGPLF 81
Query: 240 TEVALLSRIHHRNL--------------VPLIGYC-----EEEHQRILVYEYMHNGT-LR 279
+E+ R+ ++ +PL + R +V E + G L+
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ 139
Query: 280 D--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337
+G+ + T LQ+ LEY+H +H D+K++N+LL +
Sbjct: 140 KISGQNGTFKKS-----TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191
Query: 338 V--SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYS 383
V +D+GLS + + H GT+ E+ G + +SDV
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVAL-SRRSDVEI 245
Query: 384 FGVVLLELISGKKP 397
G +L + GK P
Sbjct: 246 LGYCMLRWLCGKLP 259
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 202 KIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQF-----VT---EVALL---S 246
+IG+G++G V+ K +D K VA+K + R Q ++ EVA+L
Sbjct: 18 EIGEGAYGKVF--KARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 247 RIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-- 299
H N+V L + E + LV+E++ +D L +++ P + I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKD 124
Query: 300 -AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 358
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + S V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 359 RGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 395
T+ Y PE + T D++S G + E+ K
Sbjct: 182 --TLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 22/90 (24%), Positives = 35/90 (38%), Gaps = 2/90 (2%)
Query: 6 LSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS 64
+ NLK + L+ M+ L L N L G LP I L ++L N++T +
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPAN 371
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTGK 94
+ G ++ L +N IP
Sbjct: 372 FCGFTEQVENLSFAHNKL-KYIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 14/104 (13%), Positives = 34/104 (32%), Gaps = 19/104 (18%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG----- 60
++ + I + T++ N +T + RL LR ++ N+
Sbjct: 166 INSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICE 225
Query: 61 --------------SLPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+ +L +L ++ + N + ++P L
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 14/122 (11%), Positives = 35/122 (28%), Gaps = 22/122 (18%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------------------DMSRL 45
N+ + + + L + ++ + L
Sbjct: 190 QLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL 248
Query: 46 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 105
DL V + N LP+++ +LP +Q +++ N + + + K+
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPVGEKI 307
Query: 106 HK 107
Sbjct: 308 QI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 12/96 (12%)
Query: 6 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH---LENN 56
L L + + + + L + L N + P S L I + + N
Sbjct: 495 LRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGN 552
Query: 57 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 92
P + P+L +L I +N + +
Sbjct: 553 RTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 20/94 (21%), Positives = 30/94 (31%), Gaps = 10/94 (10%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG--------PLPDMSRLIDLRIVHLENNE 57
LS + L+ + L GN LT + L + L N+
Sbjct: 440 LSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499
Query: 58 LTGSLPS-YMGSLPNLQELHIENNSFVGEIPPAL 90
LT +LP L + + NSF + P
Sbjct: 500 LTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 11/89 (12%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 6 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSL 62
+ + + L + ++ + + SR+ + + +N +T +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPPALL 91
+ L L++ ++ N+ FV E
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAW 227
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 16/90 (17%), Positives = 35/90 (38%), Gaps = 11/90 (12%)
Query: 14 EIPP--ELKNMEALTELWLDGNFLTG-------PLP-DMSRLIDLRIVHLENNELTGSLP 63
IP + K++ ++ + N + PL + I++ ++L NN+++
Sbjct: 391 YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG 93
+ L +++ N EIP L
Sbjct: 451 ELFSTGSPLSSINLMGNML-TEIPKNSLKD 479
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 11/95 (11%), Positives = 32/95 (33%), Gaps = 10/95 (10%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT----- 59
+ N++ LT++ + LP + L +++++++ N
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 60 ---GSLPSYMGSLPNLQELHIENNSF-VGEIPPAL 90
+ +Q ++I N+ + +L
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 15/92 (16%), Positives = 31/92 (33%), Gaps = 11/92 (11%)
Query: 6 LSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 58
LS + P + N L GN P+ ++ L + + +N++
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578
Query: 59 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+ PN+ L I++N + +
Sbjct: 579 R-KVNE--KITPNISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 10/75 (13%), Positives = 27/75 (36%), Gaps = 2/75 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
G E P + +LT+L + N + + + ++ ++ +++N SY
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE-KITPNISVLDIKDNPNISIDLSY 606
Query: 66 MGSLPNLQELHIENN 80
+ + +
Sbjct: 607 VCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 5/89 (5%)
Query: 5 ALSGKN--LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 62
AL+GKN +G N EL + G L R+ L LE +G +
Sbjct: 41 ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGL---SLEGFGASGRV 97
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPPALL 91
P +G L L+ L + ++
Sbjct: 98 PDAIGQLTELEVLALGSHGEKVNERLFGP 126
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 57/253 (22%)
Query: 188 PLPELEEATNNFC------KKIGKGSFGSVYYGKMKDGKEVAVKI--MADSCSHRTQQFV 239
E T+ IG+G FG +Y M + V +
Sbjct: 22 QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF 81
Query: 240 TEVALLSRIHHRNL--------------VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 285
TE+ R VP + Y +M + DR
Sbjct: 82 TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSD 137
Query: 286 VNQKPLDWLTR-------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338
+ QK + + LQ++ LEY+H +H D+K+SN+LL+ +V
Sbjct: 138 L-QKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV 193
Query: 339 --SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYSF 384
D+GL+ + + H + A GT+ E+ G + + D+
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI-----EFTSIDAHNGVAP-SRRGDLEIL 247
Query: 385 GVVLLELISGKKP 397
G +++ ++G P
Sbjct: 248 GYCMIQWLTGHLP 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NL 253
K IGKGSFG V K + VA+K++ + Q E+ +L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161
Query: 254 VPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 305
+ ++ C + +E + L + + + + L ++ AH +
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELIKKN-KFQGFS-LPLVRKFAHSILQ 211
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDL-THISSVARGTV 362
L+ LH IIH D+K NILL R+ KV DFG S + + T+I S R
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS--R--- 263
Query: 363 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 395
Y PE + D++S G +L EL++G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 73/258 (28%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HR 251
+K+G G F +V+ ++ K VA+K++ S H T+ + E+ LL +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 252 NLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
+V L+ H +V+E + + L + S N + L +I +G
Sbjct: 102 MVVQLLDDFKISGVNGTHI-CMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQG 158
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDIN--------------------------------- 333
L+YLHT C IIH D+K NILL +N
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 334 ----------------MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
++ K++D G + + T T Y E
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 378 KSDVYSFGVVLLELISGK 395
+D++S + EL +G
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPAL 90
L +LQ L N + L
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 1/89 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
LS ++ +++ L+ L L GN + S L L+ + L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTG 93
+G L L+EL++ +N P +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 17/87 (19%), Positives = 33/87 (37%), Gaps = 2/87 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTG-SLP 63
L+G ++ + +L +L L L L+ +++ +N + LP
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPAL 90
Y +L NL+ L + +N L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 14/81 (17%), Positives = 26/81 (32%), Gaps = 2/81 (2%)
Query: 15 IPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGSLPNL 72
+ +E L L + L L +L + + + + L +L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 73 QELHIENNSFVGEIPPALLTG 93
+ L + NSF P + T
Sbjct: 448 EVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 2/84 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
LS L+ P ++ +L L + N L L+++ N + S
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
Query: 65 YMGSLP-NLQELHIENNSFVGEIP 87
+ P +L L++ N F
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 16/82 (19%), Positives = 25/82 (30%), Gaps = 1/82 (1%)
Query: 10 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-SYMGS 68
+ KG +L L L N + + L L + +++ L S S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 69 LPNLQELHIENNSFVGEIPPAL 90
L NL L I +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIF 441
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 17/86 (19%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
SL +L L + N A
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 6/91 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENNELTGSLP 63
NL + +++ L EL + N + LP+ S L +L + L +N++
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 64 SYMGSLPNLQ----ELHIENNSFVGEIPPAL 90
+ + L + L + N P A
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 12/89 (13%), Positives = 28/89 (31%), Gaps = 4/89 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENNELTGSLP 63
+S N K + +L L N + + L ++L N+ +
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
Query: 64 S--YMGSLPNLQELHIENNSFVGEIPPAL 90
++ + + ++L +E P
Sbjct: 561 HQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 16/87 (18%), Positives = 31/87 (35%), Gaps = 5/87 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALT----ELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 61
LS ++ +L+ + + L L N + P + I L + L NN + +
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLN 215
Query: 62 LPSY-MGSLPNLQELHIENNSFVGEIP 87
+ + L L+ + F E
Sbjct: 216 VMKTCIQGLAGLEVHRLVLGEFRNEGN 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 13/108 (12%), Positives = 26/108 (24%), Gaps = 11/108 (10%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG----PLPDMSRLIDLRIVHLENNELT- 59
L + ++ + L L D S L L + +E L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 60 -----GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 102
+ L N+ + + + + G + N
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 2e-12
Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-- 249
C+KIG+G FG V+ D VA+KI+A S ++ + E+ + +
Sbjct: 25 CEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83
Query: 250 -------HRNLVPLIGYC------------------------------EEEHQRILVYEY 272
+ L ++ Q +V E+
Sbjct: 84 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143
Query: 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332
G +++ K T I H L + HRD+ N+LL
Sbjct: 144 EFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKK 197
Query: 333 NMRAKVSDFGLSR 345
K+ +
Sbjct: 198 TSLKKLHYTLNGK 210
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 10 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 69
N I ++ + L ++ + T +D + + + + +L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNL 490
Query: 70 PNLQELHIENNSFVGEIPPAL 90
+L ++ + N + ++P L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 16/96 (16%), Positives = 28/96 (29%), Gaps = 13/96 (13%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDM-SRLIDLRIVHLEN 55
L ++P L ++ L L + N L D ++I ++
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 56 NELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPAL 90
N L S + + L L +N A
Sbjct: 558 NNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 19/102 (18%), Positives = 39/102 (38%), Gaps = 11/102 (10%)
Query: 14 EIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH---LENNELTGSLPS 64
+ + + + L+ + + N + P S+L I H E N + P+
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 106
+ + P+L +L I +N ++ L I +NP +
Sbjct: 801 GITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 11/91 (12%)
Query: 9 KNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENNELTGSLPSY 65
+N KN LT + L N LT L D + L L + + N + S P+
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQ 771
Query: 66 MGSLPNLQELHIE------NNSFVGEIPPAL 90
+ L+ I N + + P +
Sbjct: 772 PLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 16/89 (17%), Positives = 30/89 (33%), Gaps = 9/89 (10%)
Query: 14 EIPP--ELKNMEALTELWLDGNFLTGPLPDMS------RLIDLRIVHLENNELTGSLPSY 65
IP K++ + + N + ++S + I+ V L NE+
Sbjct: 633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTGK 94
+ + + + NN IP L K
Sbjct: 693 FATGSPISTIILSNNLM-TSIPENSLKPK 720
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 18/92 (19%), Positives = 32/92 (34%), Gaps = 7/92 (7%)
Query: 6 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP 63
+ NL+ E P L+ M L L N + L + L + L+ N++ +P
Sbjct: 555 MGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQIE-EIP 611
Query: 64 SYMGS-LPNLQELHIENNSFVGEIPPALLTGK 94
+ ++ L +N IP
Sbjct: 612 EDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 19/111 (17%), Positives = 37/111 (33%), Gaps = 15/111 (13%)
Query: 6 LSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 58
+S P + N L +GN + P ++ L + + +N++
Sbjct: 760 VSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818
Query: 59 TGSLPSYMGSLPNLQELHIENNSF----VGEIPPALLTGKVIFKYDNNPKL 105
+ + P L L I +N V + P + G + YD +
Sbjct: 819 R-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 9/79 (11%), Positives = 23/79 (29%), Gaps = 2/79 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSLPS 64
L+G KG +P + + L L + T + + + +
Sbjct: 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
Query: 65 -YMGSLPNLQELHIENNSF 82
++ L + ++
Sbjct: 390 MFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 11/94 (11%), Positives = 29/94 (30%), Gaps = 8/94 (8%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG---- 60
++ L + L L + + P+M + + L++ ++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 61 --SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 92
+ + L LQ ++ N+ F +
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 24/146 (16%), Positives = 43/146 (29%), Gaps = 8/146 (5%)
Query: 5 ALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 59
AL GKN + N EL + G+ L + R+ L L
Sbjct: 280 ALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL---SLAGFGAK 336
Query: 60 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLIL 119
G +P +G L L+ L +S + + ++M
Sbjct: 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQ 396
Query: 120 GTSIGVLAILLVLFLCSLIVLRKLRR 145
++ L + + ++K R
Sbjct: 397 RLNLSDLLQDAINRNPEMKPIKKDSR 422
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 25/86 (29%), Positives = 38/86 (44%), Gaps = 4/86 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
L L + P + + L + +D L LPD M + L + L N L +LP+
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPA 144
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
+ SL L+EL I + E+P L
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 6 LSGKNLKGEIPPELKNMEA---------LTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 55
+ E+P L + +A L L L+ + LP ++ L +L+ + + N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215
Query: 56 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+ L+ +L + LP L+EL + + + PP
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 19/102 (18%), Positives = 38/102 (37%), Gaps = 3/102 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L ++ +P + N++ L L + + L+ P + L L + L + P
Sbjct: 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPI 248
Query: 66 MGSLPNLQELHIENNSFVGEIPPAL--LTGKVIFKYDNNPKL 105
G L+ L +++ S + +P + LT L
Sbjct: 249 FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 4/89 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWL-DGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 63
L G PP L L L D + L LP + RL L + L LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLT 92
S + LP + + + ++
Sbjct: 295 SLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 26/96 (27%), Positives = 39/96 (40%), Gaps = 15/96 (15%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHL-ENNELTGSLP 63
+ L E+P ++ L L L N L LP ++ L LR + + ELT LP
Sbjct: 111 IDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT-ELP 167
Query: 64 SYMGS---------LPNLQELHIENNSFVGEIPPAL 90
+ S L NLQ L +E +P ++
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN---ELTGS 61
L + +P ++ + L +L L G LP +++L I+ + + +L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
Query: 62 LPSYMGSLP 70
P + P
Sbjct: 320 RPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 11/107 (10%), Positives = 23/107 (21%), Gaps = 24/107 (22%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-------------------- 45
G L + + + +
Sbjct: 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDA 78
Query: 46 --IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+ L + L P L +LQ + I+ + E+P +
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 18/104 (17%), Positives = 31/104 (29%), Gaps = 9/104 (8%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELTGSL 62
LS L +E L EL L N + + L+ + L +N++
Sbjct: 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 106
P ++ L L + N + L N +
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKL------CLELANTSIR 225
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 16/91 (17%), Positives = 31/91 (34%), Gaps = 6/91 (6%)
Query: 6 LSGKNLKGEIPPELK---NMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELT 59
L+ L + +L ++ L L + L+ + +L ++ L N L
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261
Query: 60 GSLPSYMGSLPNLQELHIENNSFVGEIPPAL 90
LP L+ +E N+ +L
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 21/86 (24%), Positives = 30/86 (34%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
L L LTEL L N + + + +L + L +N L+ +
Sbjct: 80 LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
L NLQEL + NN L
Sbjct: 140 TQVQLENLQELLLSNNKIQALKSEEL 165
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
L G LK + L L L+ N ++ L +L+I+ L N L S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTG 93
+ +L+ L+++ N
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 14/86 (16%), Positives = 27/86 (31%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
+ + P + + L L L N L+ + +L +HL +N + +
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
NL L + +N
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 20/86 (23%), Positives = 37/86 (43%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
L+ L+ LT L + N ++ P++ +L L++++L++NEL+
Sbjct: 32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK 91
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
NL ELH+ +NS
Sbjct: 92 TFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 4/89 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLP 63
L+ + + L L L N + L L ++ ++L N+
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 64 SYMGSLPNLQELHIENNSF--VGEIPPAL 90
+ +P+LQ L + + V P
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPF 476
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 25/132 (18%), Positives = 41/132 (31%), Gaps = 4/132 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHLENNELTGSL 62
LS + +L L L L L +L I+ L NN +
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN 496
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTS 122
+ L L+ L +++N+ + G I+ LH + F I
Sbjct: 497 DDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
Query: 123 IGVLAILLVLFL 134
L L ++ L
Sbjct: 556 FKDLFELKIIDL 567
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 9/94 (9%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLT---------GPLPDMSRLIDLRIVHLENN 56
LS N+ L+ +E L L L N L GP+ + L L I++LE+N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 57 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 90
L L+ + + N+
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 6 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 63
S L ++P +L N +T L L N L + +R L + + N ++ P
Sbjct: 11 CSHLKLT-QVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG 93
LP L+ L++++N +
Sbjct: 67 ELCQKLPMLKVLNLQHNELSQ-LSDKTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 5/93 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS-----RLIDLRIVHLENNELTG 60
+ ++ G + L L L +F + L I++L N+++
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
L +L+ L + N E+ G
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 2/84 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
L K++ L + L N L + + + L+ ++L+ N +T
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
Query: 65 YMG-SLPNLQELHIENNSFVGEIP 87
G + NL EL + N F
Sbjct: 603 VFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 25/139 (17%), Positives = 46/139 (33%), Gaps = 15/139 (10%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----------MSRLIDLRIVHLEN 55
L N++ L + + L L +F + L L +++E+
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 56 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF 115
N++ G + L NL+ L + N+ F + LH + + +
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE-----TFVSLAHSPLHILNLTKNKI 393
Query: 116 KLILGTSIGVLAILLVLFL 134
I + L L VL L
Sbjct: 394 SKIESDAFSWLGHLEVLDL 412
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 6/91 (6%)
Query: 6 LSGKNLKGEIPPELKNME--ALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSL 62
LS ++ EL +L +L L N + P + L + L N +L SL
Sbjct: 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSL 211
Query: 63 PSYMG---SLPNLQELHIENNSFVGEIPPAL 90
+ + +++ L + N+
Sbjct: 212 TEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 25/247 (10%)
Query: 160 RTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKD 218
+S K Y+ + D+ Y + E IGKGSFG V +
Sbjct: 23 MSSHKKERKVYN----DGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVE 78
Query: 219 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQRILVYEY 272
+ VA+KI+ + + Q EV LL ++ +V L + + LV+E
Sbjct: 79 QEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137
Query: 273 MHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331
+ L D L + N + + L + A L +L T IIH D+K NILL
Sbjct: 138 LSY-NLYDLLRNT-NFRGVS-LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 332 INMRA--KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 388
R+ K+ DFG S Q + + +I S R Y PE D++S G +L
Sbjct: 194 NPKRSAIKIVDFGSSCQLGQRIYQYIQS--R---FYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 389 LELISGK 395
+E+ +G+
Sbjct: 249 VEMHTGE 255
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 14/90 (15%), Positives = 22/90 (24%), Gaps = 3/90 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLENNELTGSLP 63
LS + +E L L + L L L + +
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG 93
L +L L + NSF +
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 3/90 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTG-SLP 63
L+G ++ P + +L L L +LI L+ +++ +N + LP
Sbjct: 87 LTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLP 146
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG 93
+Y +L NL + + N I L
Sbjct: 147 AYFSNLTNLVHVDLSYNYIQT-ITVNDLQF 175
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
++G + K N LT L L L + L L+++++ +N L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALL 91
S+ L +L L N L
Sbjct: 515 SHYNQLYSLSTLDCSFNRIET-SKGILQ 541
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
+ L ++P ++ + + L N L S +L+ + L E+
Sbjct: 18 CMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTG 93
L +L L + N P +G
Sbjct: 75 AWHGLHHLSNLILTGNPIQS-FSPGSFSG 102
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 1/89 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
LS ++ + L+ L L GN + P S L L + +L
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESF 122
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTG 93
+G L L++L++ +N PA +
Sbjct: 123 PIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 15/78 (19%), Positives = 25/78 (32%), Gaps = 1/78 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
LS L+ + L L + N L ++L L + N + S
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539
Query: 65 YMGSLPNLQELHIENNSF 82
+L ++ NNS
Sbjct: 540 LQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 18/94 (19%), Positives = 28/94 (29%), Gaps = 7/94 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPD-MSRLIDLRIVHLENNELTGSLP 63
L + + L +L + NF+ LP S L +L V L N +
Sbjct: 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170
Query: 64 SYMGSLPNL----QELHIENNSFVGEIPPALLTG 93
+ + L L + N I G
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQG 203
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 4/85 (4%)
Query: 12 KGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENNELTGSLPSYMGS 68
KG I + + +L+ L L N L+ LR + L N + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 69 LPNLQELHIENNSFVGEIPPALLTG 93
L LQ L ++++ +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 4/77 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L+ N + + + ++ + L G + L D+ + + + + +L P+
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLK-QFPT- 324
Query: 66 MGSLPNLQELHIENNSF 82
LP L+ L + N
Sbjct: 325 -LDLPFLKSLTLTMNKG 340
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 17/88 (19%), Positives = 27/88 (30%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L L EL L L+ + L L+ + L N+
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTG 93
+ P+L L I+ N+ E+ L
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 19/84 (22%), Positives = 28/84 (33%), Gaps = 2/84 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLP 63
LS K L L L L L L++++L ++ L S
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 64 SYMGSLPNLQELHIENNSFVGEIP 87
LP LQ L+++ N F
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 4/92 (4%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLENNELTGS 61
+ G + E+ L+N+E L EL L + + ++ L L+ ++L NE
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 62 LPSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
P L+ L + + +
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 13/89 (14%), Positives = 29/89 (32%), Gaps = 2/89 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
L+ L L +AL L+ ++ L ++L +N ++
Sbjct: 88 LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTG 93
L+ L +NN+ + ++
Sbjct: 148 KGFPTEKLKVLDFQNNAIH-YLSKEDMSS 175
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 14/77 (18%), Positives = 32/77 (41%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
LS +L +++ + + L N LT + + ++L +N ++ LPS
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSL 542
Query: 66 MGSLPNLQELHIENNSF 82
+ L + +++ N
Sbjct: 543 LPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 12/86 (13%), Positives = 26/86 (30%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
L+ + ++ L L L N L S L+ + ++
Sbjct: 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI 123
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
+ + L+ L++ +N P
Sbjct: 124 PLHNQKTLESLYLGSNHISSIKLPKG 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 14/86 (16%), Positives = 20/86 (23%), Gaps = 1/86 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
S L + LT L L + D L + L N L +
Sbjct: 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET 99
Query: 65 YMGSLPNLQELHIENNSFVGEIPPAL 90
+ L+ L L
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPL 125
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 64
L EIP L + L N L SRLI+L + L ++
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTG 93
S L L + N + + L+G
Sbjct: 76 TFQSQHRLDTLVLTANPLIF-MAETALSG 103
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 16/91 (17%), Positives = 28/91 (30%), Gaps = 4/91 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
+ L N + L L+L N ++ L+++ +NN +
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171
Query: 65 YMGSLPNLQ--ELHIENNSFVGEIPPALLTG 93
M SL L++ N I P
Sbjct: 172 DMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 18/89 (20%), Positives = 28/89 (31%), Gaps = 4/89 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHLENNELTGS 61
LS L + AL L L GN + + L I+ L +L+
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 62 LPSYMGSLPNLQELHIENNSFVGEIPPAL 90
SL + + + +N AL
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 15/90 (16%), Positives = 29/90 (32%), Gaps = 6/90 (6%)
Query: 6 LSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELTG 60
G I LKN +++L + P + + + ++L+ +
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPAL 90
+ LQEL + E+P L
Sbjct: 269 ISSNTFHCFSGLQELDLTATHL-SELPSGL 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 21/139 (15%), Positives = 42/139 (30%), Gaps = 5/139 (3%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
++ ++ L L L N L P+ + + L NN+L + + NL+
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 74 ELHIENNSFVGEIPPALLTGKVIFKY---DNNPKLHKESRRRMRFKLILGTSIGVLAILL 130
+ N F + + KL ++ + L
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300
Query: 131 VLFLCSLIVLRKLRRKISN 149
F LI L++ + +
Sbjct: 301 APFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 24/88 (27%), Positives = 34/88 (38%), Gaps = 7/88 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
LSG L +L L L L N L D+ L LR + L NN + L
Sbjct: 41 LSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-ELL-- 96
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTG 93
P+++ LH NN+ + + G
Sbjct: 97 --VGPSIETLHAANNNI-SRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
++ +LK + ++ + EL L GN L+ + L +++L +N L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD 75
Query: 65 YMGSLPNLQELHIENNSFVGEIPP 88
+ SL L+ L + NN E+
Sbjct: 76 -LESLSTLRTLDLNNNYV-QELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 18 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 78 ENNSFVGEIPPALLTG 93
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 11/87 (12%), Positives = 29/87 (33%), Gaps = 5/87 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENNELTGSLP 63
L+ + + + L L N + ++ + L ++L+ N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPAL 90
+ L+ L + +N + P
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 21 NMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79
N + + L L + +++ + L N L+ + + L+ L++ +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 80 NSFVGEIPP 88
N E
Sbjct: 68 NVLY-ETLD 75
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 16/65 (24%), Positives = 29/65 (44%), Gaps = 1/65 (1%)
Query: 16 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 75
+K++ L L + N ++ + ++ L L + L NN+L +G L NL L
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 76 HIENN 80
+ N
Sbjct: 317 FLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 16/66 (24%), Positives = 26/66 (39%), Gaps = 3/66 (4%)
Query: 16 PPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 74
L N+ L L+L+ N L ++ L +L + L N +T P + SL +
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337
Query: 75 LHIENN 80
N
Sbjct: 338 ADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 5e-08
Identities = 14/64 (21%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
L ++ +L N +T + ++ + L + + NN++T P + +L L L
Sbjct: 193 SPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 77 IENN 80
I N
Sbjct: 250 IGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 16/74 (21%), Positives = 35/74 (47%), Gaps = 3/74 (4%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
L N+ LT L + N ++ + + L L+++++ +N+++ S + +L L L
Sbjct: 237 SPLANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLF 293
Query: 77 IENNSFVGEIPPAL 90
+ NN E +
Sbjct: 294 LNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 13/67 (19%), Positives = 31/67 (46%), Gaps = 2/67 (2%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
L+N+ L EL+L+ + ++ + ++ L + ++L N S S + ++ L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLN 158
Query: 74 ELHIENN 80
L + +
Sbjct: 159 YLTVTES 165
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
+ N+ L L L+ N + + ++ L L N++T P + ++ L L
Sbjct: 171 TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 77 IENNSFVGEIPPALLT 92
I NN P A L+
Sbjct: 228 IGNNKITDLSPLANLS 243
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 4e-07
Identities = 17/76 (22%), Positives = 30/76 (39%), Gaps = 2/76 (2%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
L N+ + L L N L +S + L + + +++ P + +L +L L
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 77 IENNSFVGEIPPALLT 92
+ N P A LT
Sbjct: 184 LNYNQIEDISPLASLT 199
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 4e-07
Identities = 18/75 (24%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
++G+ + ++ + L L L+GN +T + +S L+ L +++ N++T S
Sbjct: 51 VAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKITD--ISA 105
Query: 66 MGSLPNLQELHIENN 80
+ +L NL+EL++ +
Sbjct: 106 LQNLTNLRELYLNED 120
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 6e-06
Identities = 13/80 (16%), Positives = 29/80 (36%), Gaps = 4/80 (5%)
Query: 13 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 72
+I P ++ L +T + L + + + ++ S+ + L NL
Sbjct: 13 NQIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVA-SIQG-IEYLTNL 68
Query: 73 QELHIENNSFVGEIPPALLT 92
+ L++ N P + L
Sbjct: 69 EYLNLNGNQITDISPLSNLV 88
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 8e-05
Identities = 11/54 (20%), Positives = 21/54 (38%), Gaps = 1/54 (1%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 59
L+ L E + + LT L+L N +T + ++ L + N +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVIK 346
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 15/84 (17%), Positives = 30/84 (35%), Gaps = 6/84 (7%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDLRIVHLENNELTGSLPSYM-GSL 69
+ +E L L + L + + S L +L + + + + + L
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGL 149
Query: 70 PNLQELHIENNSFVGEIPPALLTG 93
+L+ L + NSF P + T
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 14/79 (17%), Positives = 30/79 (37%), Gaps = 6/79 (7%)
Query: 14 EIPP-ELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 69
+P + LT+L L N L+ L+ + L N + ++ S L
Sbjct: 42 SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 100
Query: 70 PNLQELHIENNSFVGEIPP 88
L+ L ++++ ++
Sbjct: 101 EQLEHLDFQHSNLK-QMSE 118
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 10/85 (11%), Positives = 25/85 (29%), Gaps = 7/85 (8%)
Query: 14 EIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GS 68
++ ++ L L + + + L L ++ + N + +
Sbjct: 115 QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
Query: 69 LPNLQELHIENNSFVGEIPPALLTG 93
L NL L + ++ P
Sbjct: 174 LRNLTFLDLSQCQLE-QLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 14/80 (17%), Positives = 25/80 (31%), Gaps = 4/80 (5%)
Query: 16 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQ 73
+L L L N + + L L + +++ L + + SL NL
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 74 ELHIENNSFVGEIPPALLTG 93
L I + + G
Sbjct: 130 YLDISHTHTR-VAFNGIFNG 148
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 17/81 (20%), Positives = 32/81 (39%), Gaps = 6/81 (7%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSL 62
LS L+ ++ P ++ +L L + N L L L+++ N + S
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSLNHIMTSK 239
Query: 63 PSYMGSLP-NLQELHIENNSF 82
+ P +L L++ N F
Sbjct: 240 KQELQHFPSSLAFLNLTQNDF 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 14/97 (14%), Positives = 39/97 (40%), Gaps = 6/97 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L N+ P + ++ L L+ N ++ + ++ L ++ + +N+++ P
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISDLTP-- 370
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 102
+ +L + +L + + ++ P I N
Sbjct: 371 LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L+G LK L ++ LT+L L N ++ L +S L L + L N+++ P
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISP-- 282
Query: 66 MGSLPNLQELHIENNSFVGEIP 87
+ L L L + N P
Sbjct: 283 LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 23/75 (30%), Positives = 33/75 (44%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L + P L + ALT L L+ N L + +S L +L + L N ++ P
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDISP-- 326
Query: 66 MGSLPNLQELHIENN 80
+ SL LQ L NN
Sbjct: 327 VSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 5/87 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L+ + P L + LTEL L N ++ + ++ L L + L N+L S
Sbjct: 250 LANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLED--ISP 304
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLT 92
+ +L NL L + N+ P + LT
Sbjct: 305 ISNLKNLTYLTLYFNNISDISPVSSLT 331
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 20/87 (22%), Positives = 34/87 (39%), Gaps = 5/87 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+S + L + L L N ++ + + L +L + L N+L
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQLKD--IGT 238
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLT 92
+ SL NL +L + NN P + LT
Sbjct: 239 LASLTNLTDLDLANNQISNLAPLSGLT 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L L + ++ + LT++ N LT + + L L + + NN++ +
Sbjct: 51 LQADRLGIKSIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIAD--ITP 107
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLT 92
+ +L NL L + NN P LT
Sbjct: 108 LANLTNLTGLTLFNNQITDIDPLKNLT 134
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 21/82 (25%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+ + P L + L EL L+GN L + ++ L +L + L NN+++ P
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP-- 260
Query: 66 MGSLPNLQELHIENNSFVGEIP 87
+ L L EL + N P
Sbjct: 261 LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 19/87 (21%), Positives = 34/87 (39%), Gaps = 6/87 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
LS + L + +L +L L ++ L L + + +N+++ S
Sbjct: 141 LSSNTISD--ISALSGLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKVSD--ISV 194
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLT 92
+ L NL+ L NN P +LT
Sbjct: 195 LAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 17/65 (26%), Positives = 35/65 (53%), Gaps = 3/65 (4%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
LKN+ L ++ ++ N + + ++ L +L + L NN++T P + +L NL L
Sbjct: 84 TPLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140
Query: 77 IENNS 81
+ +N+
Sbjct: 141 LSSNT 145
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 12/79 (15%), Positives = 26/79 (32%), Gaps = 4/79 (5%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
+I + + L +T + + L + + + + + L NL
Sbjct: 16 QIFT-DTALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIKS--IDGVEYLNNLT 71
Query: 74 ELHIENNSFVGEIPPALLT 92
+++ NN P LT
Sbjct: 72 QINFSNNQLTDITPLKNLT 90
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 21/75 (28%), Positives = 34/75 (45%), Gaps = 6/75 (8%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L + I P LKN+ L L L N ++ + +S L L+ + N +T P
Sbjct: 119 LFNNQITD-IDP-LKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQ-VTDLKP-- 172
Query: 66 MGSLPNLQELHIENN 80
+ +L L+ L I +N
Sbjct: 173 LANLTTLERLDISSN 187
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 12/89 (13%), Positives = 26/89 (29%), Gaps = 8/89 (8%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
L N+ +T+L L+ T + + + P+ + + E
Sbjct: 369 TPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPD 427
Query: 77 IENNSFVGEIPPALLTGKVIFKYDNNPKL 105
I N T +V + + +
Sbjct: 428 ITWNL-------PSYTNEVSYTFSQPVTI 449
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 14/71 (19%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 19 LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
+ + L L + G +T +P++S L L ++ + ++ S+ + + +LP + + +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 78 ENNSFVGEIPP 88
N + +I P
Sbjct: 144 SYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 9/75 (12%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+S I ++ + + + L N + + L +L+ ++++ + +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY--RG 176
Query: 66 MGSLPNLQELHIENN 80
+ P L +L+ +
Sbjct: 177 IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 13/85 (15%), Positives = 35/85 (41%), Gaps = 3/85 (3%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L+ N+ ++ ++ + +L ++ T +S L +L + + ++T
Sbjct: 51 LANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPN 107
Query: 66 MGSLPNLQELHIENNSFVGEIPPAL 90
+ L +L L I +++ I +
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKI 132
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 5/91 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDLRIVHLENNELTGSL 62
LS + + +E L L + L + + S L +L + + + +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
L +L+ L + NSF P + T
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 7/92 (7%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELT-GS 61
L+G ++ + + +L +L L L + + L L+ +++ +N +
Sbjct: 83 LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 62 LPSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
LP Y +L NL+ L + +N I L
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 18/80 (22%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
++G + + P+ + LT L L L P + L L+++++ +N+L S+P
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVP 510
Query: 64 SYM-GSLPNLQELHIENNSF 82
+ L +LQ++ + N +
Sbjct: 511 DGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 64
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTG 93
SL +L L + N + +G
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSG 98
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 18/94 (19%), Positives = 34/94 (36%), Gaps = 7/94 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENNELTGSLP 63
NL + +++ L EL + N + LP+ S L +L + L +N++
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
Query: 64 SYMGSLPNLQ----ELHIENNSFVGEIPPALLTG 93
+ + L + L + N I P
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE 199
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 3/90 (3%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
LS ++ I +++ L+ L L GN + S L L+ + L
Sbjct: 59 LSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG 93
+G L L+EL++ +N P +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 6/83 (7%)
Query: 10 NLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLENNELTGSLPSYM 66
N G E+ ++ +L L L N L+ S L+ + L N + ++ S
Sbjct: 335 NKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 392
Query: 67 GSLPNLQELHIENNSFVGEIPPA 89
L L+ L ++++ ++
Sbjct: 393 LGLEQLEHLDFQHSNLK-QMSEF 414
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 17/86 (19%), Positives = 28/86 (32%), Gaps = 4/86 (4%)
Query: 10 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMG 67
+ KG +L L L N + + L L + +++ L + S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 418
Query: 68 SLPNLQELHIENNSFVGEIPPALLTG 93
SL NL L I + + G
Sbjct: 419 SLRNLIYLDISHTHTR-VAFNGIFNG 443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 2/80 (2%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
++ ++ L L L N L P+ + + L NN+L + + NL+
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 74 ELHIENNSFVGEIPPALLTG 93
+ N F +
Sbjct: 241 HFDLRGNGFHCGTLRDFFSK 260
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 20/84 (23%), Positives = 38/84 (45%), Gaps = 4/84 (4%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 64
++ +LK + ++ + EL L GN L+ D++ L +++L +N L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD 75
Query: 65 YMGSLPNLQELHIENNSFVGEIPP 88
+ SL L+ L + NN E+
Sbjct: 76 -LESLSTLRTLDLNNNYV-QELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 13/86 (15%), Positives = 32/86 (37%), Gaps = 8/86 (9%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTG-SL 62
+ N+ + + ++L N +T L D ++ + L+ NE+ +
Sbjct: 106 AANNNIS-RVSCS--RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNF 161
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPP 88
S L+ L+++ N ++
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 11/75 (14%), Positives = 26/75 (34%), Gaps = 2/75 (2%)
Query: 15 IPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
I +N + + L L + +++ + L N L+ + + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 74 ELHIENNSFVGEIPP 88
L++ +N E
Sbjct: 62 LLNLSSNVLY-ETLD 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 3/77 (3%)
Query: 18 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 78 ENNSFVGEIPPALLTGK 94
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAAS 167
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 24/74 (32%), Positives = 37/74 (50%), Gaps = 6/74 (8%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
PEL+N L + +D N L LPD+ L + NN+L LP + +LP L ++
Sbjct: 147 PELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIY 201
Query: 77 IENNSFVGEIPPAL 90
+NNS ++P
Sbjct: 202 ADNNSLK-KLPDLP 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 6/89 (6%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
E PEL+N+ LT ++ D N L LPD+ + L + NN L LP + +LP L
Sbjct: 186 EELPELQNLPFLTAIYADNNSLKK-LPDL--PLSLESIVAGNNILE-ELPE-LQNLPFLT 240
Query: 74 ELHIENNSFVGEIPPALLTGKVIFKYDNN 102
++ +NN +P + + + DN
Sbjct: 241 TIYADNNLLK-TLPDLPPSLEALNVRDNY 268
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 24/100 (24%)
Query: 6 LSGKNLKGEIPPELKNM-----------------EALTELWLDGNFLTGPLPDMSRLIDL 48
S +L E+P +++ L L + N L LP++ L
Sbjct: 98 ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LPELQNSSFL 155
Query: 49 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 88
+I+ ++NN L LP P+L+ + NN E+P
Sbjct: 156 KIIDVDNNSLK-KLPD---LPPSLEFIAAGNNQLE-ELPE 190
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 26/77 (33%), Positives = 37/77 (48%), Gaps = 5/77 (6%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
E PEL+N+ LT ++ D N L LPD+ L +++ +N LT LP SL L
Sbjct: 228 EELPELQNLPFLTTIYADNNLLKT-LPDL--PPSLEALNVRDNYLT-DLPELPQSLTFLD 283
Query: 74 ELHIENNSFVGEIPPAL 90
+ E+PP L
Sbjct: 284 VSENIFSGLS-ELPPNL 299
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 20/99 (20%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP---------DMSRLID-----LRIV 51
NL E+P E +N+++ TE + + P +SRL D +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 52 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 90
L N L+ SLP P+L+ L NS E+P
Sbjct: 77 ELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 19/77 (24%), Positives = 28/77 (36%), Gaps = 11/77 (14%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
+ + L EL + N L LP + L + N L +P NL+
Sbjct: 311 SLCDLPPS---LEELNVSNNKLIE-LPAL--PPRLERLIASFNHLA-EVPE---LPQNLK 360
Query: 74 ELHIENNSFVGEIPPAL 90
+LH+E N E P
Sbjct: 361 QLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 24/101 (23%), Positives = 37/101 (36%), Gaps = 25/101 (24%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+S L E+P L L N L +P++ +L+ +H+E N L P
Sbjct: 324 VSNNKLI-ELPALPPR---LERLIASFNHLAE-VPEL--PQNLKQLHVEYNPLR-EFPDI 375
Query: 66 MGSL----------------PNLQELHIENNSFVGEIPPAL 90
S+ NL++LH+E N E P
Sbjct: 376 PESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 13/75 (17%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L + E+P +N L +L ++ N L + DLR + + +
Sbjct: 382 LRMNSHLAEVPELPQN---LKQLHVETNPLREFPDIPESVEDLR---MNSERVVDPYEFA 435
Query: 66 MGSLPNLQELHIENN 80
+ L++ E++
Sbjct: 436 HETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 17/77 (22%), Positives = 26/77 (33%), Gaps = 11/77 (14%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
+ N L L N + L +L ++ NN+L LP+ P L+
Sbjct: 291 GLSELPPN---LYYLNASSNEIRSLCDLPPSLEEL---NVSNNKLI-ELPA---LPPRLE 340
Query: 74 ELHIENNSFVGEIPPAL 90
L N E+P
Sbjct: 341 RLIASFNHLA-EVPELP 356
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 16/90 (17%), Positives = 32/90 (35%), Gaps = 5/90 (5%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS 64
L I + + L L L + +P+++ L+ L + + N +
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFP-EIRP 235
Query: 65 YM-GSLPNLQELHIENNSFVGEIPPALLTG 93
L +L++L + N+ V I G
Sbjct: 236 GSFHGLSSLKKLWVMNSQ-VSLIERNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 23/91 (25%), Positives = 37/91 (40%), Gaps = 5/91 (5%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
L +++ +I + +L L L N+LT L LR + L NN + S+P
Sbjct: 106 LGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIP 163
Query: 64 SYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
SY +P+L L + + I G
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 6/91 (6%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
L N++ I + +++ L L L N + + L L + L +N LT +P
Sbjct: 82 LMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIP 139
Query: 64 SYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
S L L+EL + NN IP
Sbjct: 140 SGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 19/76 (25%), Positives = 36/76 (47%), Gaps = 10/76 (13%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTGSLPSYM-G 67
EI P + +L +LW+ + ++ ++ L ++L +N L+ SLP +
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL---VELNLAHNNLS-SLPHDLFT 287
Query: 68 SLPNLQELHIENNSFV 83
L L ELH+ +N +
Sbjct: 288 PLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 7/90 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
+ + L E+P + L L N + D L L ++ L N + +
Sbjct: 61 CTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV 116
Query: 65 YM-GSLPNLQELHIENNSFVGEIPPALLTG 93
L +L L + +N + IP
Sbjct: 117 GAFNGLASLNTLELFDNW-LTVIPSGAFEY 145
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 74
P L + L EL + GN P L L+ + + N++++ + L +L E
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 75 LHIENNSFVGEIPPALLTG 93
L++ +N+ +P L T
Sbjct: 271 LNLAHNNLS-SLPHDLFTP 288
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 20/103 (19%), Positives = 40/103 (38%), Gaps = 9/103 (8%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSL 62
L G + ++ LK + L +L L N ++ + + ++ LR +HL NN+L +
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KV 255
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 105
P + +Q +++ NN+ I
Sbjct: 256 PGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN--TKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 16/84 (19%), Positives = 35/84 (41%), Gaps = 8/84 (9%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLT-GPLPDM--SRLIDLRIVHLENNELTGSLPSYMGSL 69
++ + + + L N L + + + L + + + +T ++P G
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLP 191
Query: 70 PNLQELHIENNSFVGEIPPALLTG 93
P+L ELH++ N ++ A L G
Sbjct: 192 PSLTELHLDGNKI-TKVDAASLKG 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 7/90 (7%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
L + EI KN++ L L L N ++ P + L+ L ++L N+L LP
Sbjct: 59 LQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELP 116
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG 93
LQEL + N ++ ++ G
Sbjct: 117 E--KMPKTLQELRVHENEIT-KVRKSVFNG 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 11/84 (13%), Positives = 29/84 (34%), Gaps = 10/84 (11%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIVHLENNEL 58
L+ L ++P L + + + ++L N ++ P ++ V L +N +
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
Query: 59 T-GSLPSYM-GSLPNLQELHIENN 80
+ + + + N
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 9/96 (9%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG---- 60
LS ++ + L N L EL L+ N L ++ +++V+L NN ++
Sbjct: 223 LSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSN 281
Query: 61 --SLPSYMGSLPNLQELHIENNSF-VGEIPPALLTG 93
P Y + + + +N EI P+
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 5/90 (5%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS 64
L I + + L L L L +P+++ LI L + L N L+ ++
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS-AIRP 224
Query: 65 YM-GSLPNLQELHIENNSFVGEIPPALLTG 93
L +LQ+L + + I
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 6/91 (6%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
L ++ I K++ L L L N + + L +L + L +N LT ++P
Sbjct: 71 LHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIP 128
Query: 64 SYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
+ L L+EL + NN IP
Sbjct: 129 NGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 24/92 (26%), Positives = 39/92 (42%), Gaps = 7/92 (7%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSL 62
LS +++ I + L L L N LT +P+ L L+ + L NN + S+
Sbjct: 95 LSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SI 151
Query: 63 PSYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
PSY +P+L+ L + + I G
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 17/72 (23%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 15 IPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPN 71
I P + + L +LW+ + + + L L ++L +N LT LP + L +
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHH 280
Query: 72 LQELHIENNSFV 83
L+ +H+ +N +
Sbjct: 281 LERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 20/90 (22%), Positives = 32/90 (35%), Gaps = 7/90 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 64
KNL+ E+P + L L N + + L L I+ L N + ++
Sbjct: 50 CVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEI 105
Query: 65 YM-GSLPNLQELHIENNSFVGEIPPALLTG 93
L NL L + +N + IP
Sbjct: 106 GAFNGLANLNTLELFDNR-LTTIPNGAFVY 134
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 10/82 (12%)
Query: 17 PELKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPN 71
P L + L EL L GN L+ G + L L + +++ + +L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL---WMIQSQIQ-VIERNAFDNLQS 256
Query: 72 LQELHIENNSFVGEIPPALLTG 93
L E+++ +N+ +P L T
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTP 277
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 24/87 (27%), Positives = 36/87 (41%), Gaps = 9/87 (10%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL-ENNELTGS 61
L L IP + L ELWL N + +P +R+ LR + L E L+
Sbjct: 119 LFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLS-Y 175
Query: 62 LPSYM-GSLPNLQELHIENNSFVGEIP 87
+ L NL+ L++ + EIP
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLR-EIP 201
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 27/85 (31%), Positives = 34/85 (40%), Gaps = 4/85 (4%)
Query: 10 NLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGS 68
NL L LT+L LD LT L L L + L +N+L SLP +
Sbjct: 41 NLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQT 98
Query: 69 LPNLQELHIENNSFVGEIPPALLTG 93
LP L L + N +P L G
Sbjct: 99 LPALTVLDVSFNRLT-SLPLGALRG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 5/60 (8%)
Query: 24 ALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 80
L EL+L GN L LP ++ L + L NN LT LP+ + L NL L ++ N
Sbjct: 125 ELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 5e-08
Identities = 21/77 (27%), Positives = 34/77 (44%), Gaps = 5/77 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS- 64
LS L+ +PP L + L L N L + ++ L L+ + L NN L +
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQ-QSAAI 526
Query: 65 -YMGSLPNLQELHIENN 80
+ S P L L+++ N
Sbjct: 527 QPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 22/75 (29%), Positives = 38/75 (50%), Gaps = 4/75 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L+ K+L + L+ + +T L L N L P ++ L L ++ +N L ++
Sbjct: 448 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG- 503
Query: 66 MGSLPNLQELHIENN 80
+ +LP LQEL + NN
Sbjct: 504 VANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 5e-04
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 7/65 (10%)
Query: 17 PELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENNELTGSLPSY----MGSLP 70
+ N+ L EL L N L + + L +++L+ N L LP
Sbjct: 502 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLP 560
Query: 71 NLQEL 75
++ +
Sbjct: 561 SVSSI 565
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 13/84 (15%), Positives = 28/84 (33%), Gaps = 10/84 (11%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIVHLENNEL 58
L L +P L +++ L ++L N +T P+ + + L NN +
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306
Query: 59 T-GSLPSYM-GSLPNLQELHIENN 80
+ + + + N
Sbjct: 307 PYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 7/90 (7%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
L ++ E+ + K ++ L L L N ++ S L L+ +++ N L +P
Sbjct: 61 LQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIP 118
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG 93
+L EL I +N ++P + +G
Sbjct: 119 P--NLPSSLVELRIHDNRIR-KVPKGVFSG 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 64
+S L IP +L E L EL LD N + L D+ R L + L +N++ + +
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIEN 234
Query: 65 YM-GSLPNLQELHIENNSFVGEIPPAL 90
LP L+ELH++NN +P L
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 14/83 (16%), Positives = 30/83 (36%), Gaps = 6/83 (7%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPN 71
+I + + L +L++ N L +P L + + +N + +P + L N
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLVE-IPPNL-PSSLVELRIHDNRIR-KVPKGVFSGLRN 148
Query: 72 LQELHIENNSF-VGEIPPALLTG 93
+ + + N P G
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDG 171
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 20/78 (25%), Positives = 32/78 (41%), Gaps = 5/78 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+S NL L L EL++ N L LPD S L ++ + N+L
Sbjct: 438 VSNNNLD-SFSLFLPR---LQELYISRNKLKT-LPDASLFPVLLVMKISRNQLKSVPDGI 492
Query: 66 MGSLPNLQELHIENNSFV 83
L +LQ++ + N +
Sbjct: 493 FDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 22/147 (14%), Positives = 45/147 (30%), Gaps = 4/147 (2%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLP 63
+ EI + +L EL + L + + D+ + L +E L
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSI 123
+ L +++ L + + + + L + F +L
Sbjct: 190 IFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248
Query: 124 GVLAILLVLFL-CSLIVLRKLRRKISN 149
+L + V F C+L L S+
Sbjct: 249 YILELSEVEFDDCTLNGLGDFNPSESD 275
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 19/91 (20%), Positives = 34/91 (37%), Gaps = 5/91 (5%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSL 62
LS + I L+ L L L + + + L L + L +N L+
Sbjct: 33 LSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLS 90
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
S+ G L +L+ L++ N + +L
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 11/91 (12%), Positives = 27/91 (29%), Gaps = 4/91 (4%)
Query: 6 LSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLENNELTGSL 62
L G + + N+ L L + + D + L L + ++ L
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 63 PSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
+ S+ ++ L + + +
Sbjct: 165 SQSLKSIRDIHHLTLHLSES-AFLLEIFADI 194
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 11/64 (17%), Positives = 24/64 (37%), Gaps = 3/64 (4%)
Query: 19 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78
L ++ LT L + N +R ++L + + + + L+ L +
Sbjct: 383 LLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVS 439
Query: 79 NNSF 82
NN+
Sbjct: 440 NNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 12/87 (13%), Positives = 27/87 (31%), Gaps = 5/87 (5%)
Query: 19 LKNMEALTELWLDGNFLT--GPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 75
+L L L N L ++ L +L + + N +P ++ L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 76 HIENNSFVGEIPPALLTGKVIFKYDNN 102
++ + + + + NN
Sbjct: 416 NLSSTGIR-VVKTCIPQTLEVLDVSNN 441
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 19/101 (18%), Positives = 34/101 (33%), Gaps = 12/101 (11%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
LS ++ + + + L L + N L L L+ +++ N+L +LP
Sbjct: 417 LSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FS--LFLPRLQELYISRNKLK-TLPDA 469
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTGK---VIFKYDNNP 103
P L + I N +P + NP
Sbjct: 470 -SLFPVLLVMKISRNQL-KSVPDGIFDRLTSLQKIWLHTNP 508
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 18/92 (19%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 6 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSL 62
+S + + + +++ L L + N L + S L L + LE LT S+
Sbjct: 111 ISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SI 167
Query: 63 PSYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
P+ L L L + + + I
Sbjct: 168 PTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 4/90 (4%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
L NL IP E L ++ L L L + RL L+++ + + ++
Sbjct: 159 LEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG 93
NL L I + + +P +
Sbjct: 218 PNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 20/84 (23%), Positives = 37/84 (44%), Gaps = 11/84 (13%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTG 60
LS + I L + L E+ L G L ++ L R++++ N+LT
Sbjct: 255 LSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL---RVLNVSGNQLT- 309
Query: 61 SLPSYM-GSLPNLQELHIENNSFV 83
+L + S+ NL+ L +++N
Sbjct: 310 TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 21/92 (22%), Positives = 38/92 (41%), Gaps = 8/92 (8%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSL 62
L +K + + + L EL L+ N ++ + + L +LR + L +N L +
Sbjct: 39 LGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNRLK-LI 95
Query: 63 PSYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
P + L NL +L I N V + +
Sbjct: 96 PLGVFTGLSNLTKLDISENKIV-ILLDYMFQD 126
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 17/90 (18%), Positives = 32/90 (35%), Gaps = 7/90 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 64
K +P + L L N + + + L + L N ++ ++
Sbjct: 18 CHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEP 73
Query: 65 YM-GSLPNLQELHIENNSFVGEIPPALLTG 93
+L NL+ L + +N IP + TG
Sbjct: 74 GAFNNLFNLRTLGLRSNRLK-LIPLGVFTG 102
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 17/91 (18%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
++ NL +P ++++ L L L N ++ M L+ L+ + L +L +
Sbjct: 231 ITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVE 288
Query: 64 SYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
Y L L+ L++ N + ++
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 22/84 (26%), Positives = 34/84 (40%), Gaps = 7/84 (8%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 69
E+ P + + AL L+L N L LPD L +L + L N ++ S+P L
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGL 176
Query: 70 PNLQELHIENNSFVGEIPPALLTG 93
+L L + N + P
Sbjct: 177 HSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 69
+ P + L L LD L L L L+ ++L++N L +LP L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 70 PNLQELHIENNSFVGEIPPALLTG 93
NL L + N +P G
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 7 SGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSY 65
+ L+ +P + A ++L GN ++ P +L I+ L +N L + +
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA 74
Query: 66 M-GSLPNLQELHIENNSFVGEIPPALLTG 93
L L++L + +N+ + + PA G
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHG 103
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 20/82 (24%), Positives = 36/82 (43%), Gaps = 7/82 (8%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSL 62
L G + +P + + +L L L N + + L L ++L N L+ +L
Sbjct: 160 LHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLS-AL 216
Query: 63 PSY-MGSLPNLQELHIENNSFV 83
P+ + L LQ L + +N +V
Sbjct: 217 PTEALAPLRALQYLRLNDNPWV 238
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 14/77 (18%), Positives = 32/77 (41%), Gaps = 4/77 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+S L + + + L L L N L + + L ++L++N + +L
Sbjct: 285 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK-- 340
Query: 66 MGSLPNLQELHIENNSF 82
+ + L+ L + +N +
Sbjct: 341 LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 20/92 (21%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 6 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSL 62
+ ++ +PP + +N+ LT L L+ N L+ LP L + + NN L +
Sbjct: 106 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RI 162
Query: 63 PSYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
+ +LQ L + +N + +L+
Sbjct: 163 EDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 13/91 (14%), Positives = 35/91 (38%), Gaps = 6/91 (6%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
++ ++P L + + L L+ + + ++ +++ N + LP
Sbjct: 58 FKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP 115
Query: 64 SYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
++ ++P L L +E N +P +
Sbjct: 116 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 7/84 (8%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 69
EI + +L++ N + LP + L ++ LE N+L+ SLP + +
Sbjct: 89 EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNT 146
Query: 70 PNLQELHIENNSFVGEIPPALLTG 93
P L L + NN+ I
Sbjct: 147 PKLTTLSMSNNNLE-RIEDDTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 18/57 (31%), Positives = 24/57 (42%), Gaps = 3/57 (5%)
Query: 25 LTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 80
LT L L N LT + L V L NEL + + + L+ L+I NN
Sbjct: 234 LTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNN 288
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 16/72 (22%), Positives = 28/72 (38%), Gaps = 7/72 (9%)
Query: 14 EIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYMGSLP 70
+P + N LT L + N L + D L+ + L +N LT + +P
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIP 192
Query: 71 NLQELHIENNSF 82
+L ++ N
Sbjct: 193 SLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 16/76 (21%), Positives = 29/76 (38%), Gaps = 5/76 (6%)
Query: 18 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
L A+ EL N + + ++L I+ L++N LT + + P L E+ +
Sbjct: 206 TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDL 261
Query: 78 ENNSFVGEIPPALLTG 93
N +I
Sbjct: 262 SYNELE-KIMYHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 10/80 (12%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQ 73
E + + + + LP + + +++L + ++ + +Y +Q
Sbjct: 45 FEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102
Query: 74 ELHIENNSFVGEIPPALLTG 93
+L++ N+ +PP +
Sbjct: 103 KLYMGFNAIR-YLPPHVFQN 121
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 23/110 (20%), Positives = 41/110 (37%), Gaps = 16/110 (14%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSL 62
LS +L + +++AL L L N + + + L+ ++L N+++
Sbjct: 95 LSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS-RF 151
Query: 63 P----SYMGSLPNLQELHIENNSFVGEIPPALLTG-----KVIFKYDNNP 103
P LP L L + +N ++P L K NNP
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKL-KKLPLTDLQKLPAWVKNGLYLHNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 34/166 (20%), Positives = 57/166 (34%), Gaps = 23/166 (13%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
LS +L I E + L L L N L + S L L ++ L NN + +
Sbjct: 71 LSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVD 128
Query: 64 SYM-GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTS 122
+ LQ+L++ N P L+ + PKL + K + T
Sbjct: 129 RNAFEDMAQLQKLYLSQNQIS-RFPVELIKD-----GNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 123 IGVLAILLVLFL----------CSLIVLRK--LRRKISNQKSYEKA 156
+ L + L C L L R++S+ +++
Sbjct: 183 LQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQED 228
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 21/80 (26%), Positives = 33/80 (41%), Gaps = 8/80 (10%)
Query: 6 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGS 61
LS NL + E + L L L N L + + +LR + L +N L +
Sbjct: 46 LSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-T 102
Query: 62 LPSYM-GSLPNLQELHIENN 80
L ++ L L+ L + NN
Sbjct: 103 LDEFLFSDLQALEVLLLYNN 122
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 22/85 (25%), Positives = 31/85 (36%), Gaps = 8/85 (9%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+ L +P L +T L + N LT LP +LR + + N+LT SLP
Sbjct: 47 VGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-SLPVL 99
Query: 66 MGSLPNLQELHIENNSFVGEIPPAL 90
L L +P L
Sbjct: 100 PPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 24/85 (28%), Positives = 31/85 (36%), Gaps = 12/85 (14%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+ G L +P L EL + N L S L L NN+LT SLP
Sbjct: 128 IFGNQLT-SLPVLPPG---LQELSVSDNQLASLPALPSELCKL---WAYNNQLT-SLPM- 178
Query: 66 MGSLPNLQELHIENNSFVGEIPPAL 90
LQEL + +N +P
Sbjct: 179 --LPSGLQELSVSDNQLA-SLPTLP 200
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 21/87 (24%), Positives = 32/87 (36%), Gaps = 23/87 (26%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH-----------------LEN 55
+P L EL + GN LT LP S L +L + +
Sbjct: 215 SLPALPSG---LKELIVSGNRLTS-LPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYR 270
Query: 56 NELTGSLPSYMGSLPNLQELHIENNSF 82
N+LT LP + L + +++E N
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 23/85 (27%), Positives = 33/85 (38%), Gaps = 12/85 (14%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+S L +P L +LW N LT LP + L+ + + N LT SLP
Sbjct: 188 VSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLP--ALPSGLKELIVSGNRLT-SLPV- 238
Query: 66 MGSLPNLQELHIENNSFVGEIPPAL 90
L+EL + N +P
Sbjct: 239 --LPSELKELMVSGNRLT-SLPMLP 260
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 23/95 (24%), Positives = 33/95 (34%), Gaps = 27/95 (28%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSL--- 69
+P L +LW N LT LP S L +L + +N+L SLP+ L
Sbjct: 155 SLPALPSE---LCKLWAYNNQLTS-LPMLPSGLQEL---SVSDNQLA-SLPTLPSELYKL 206
Query: 70 --------------PNLQELHIENNSFVGEIPPAL 90
L+EL + N +P
Sbjct: 207 WAYNNRLTSLPALPSGLKELIVSGNRL-TSLPVLP 240
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 21/77 (27%), Positives = 32/77 (41%), Gaps = 11/77 (14%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
+P L +LW+ GN LT LP L+ + + +N+L SLP+ L
Sbjct: 115 HLPALPSG---LCKLWIFGNQLTS-LPV--LPPGLQELSVSDNQLA-SLPA---LPSELC 164
Query: 74 ELHIENNSFVGEIPPAL 90
+L NN +P
Sbjct: 165 KLWAYNNQLT-SLPMLP 180
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 17/98 (17%), Positives = 38/98 (38%), Gaps = 8/98 (8%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
++ ++ + LT+L N +T D+S+ +L + ++N+LT +L
Sbjct: 49 CHNSSITD--MTGIEKLTGLTKLICTSNNITT--LDLSQNTNLTYLACDSNKLT-NLD-- 101
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 103
+ L L L+ + N ++ + N
Sbjct: 102 VTPLTKLTYLNCDTNKL-TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 15/74 (20%), Positives = 30/74 (40%), Gaps = 5/74 (6%)
Query: 19 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78
+ + LT L + +T + + +L L + +N +T +L + NL L +
Sbjct: 38 EEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACD 93
Query: 79 NNSFVGEIPPALLT 92
+N + LT
Sbjct: 94 SNKLT-NLDVTPLT 106
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 16/75 (21%), Positives = 27/75 (36%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L K ++ LT L N +T D+S+ L ++ + N +T L
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNIT-KLD-- 207
Query: 66 MGSLPNLQELHIENN 80
+ L L +N
Sbjct: 208 LNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 16/75 (21%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+ + ++ + L L +T L D+S+ L ++L N ELT L
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-ELD-- 334
Query: 66 MGSLPNLQELHIENN 80
+ L+ L N
Sbjct: 335 VSHNTKLKSLSCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 23/88 (26%), Positives = 33/88 (37%), Gaps = 6/88 (6%)
Query: 18 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
+L LT L N LT D++ L L N LT L + +L L LH
Sbjct: 207 DLNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261
Query: 78 ENNSFVGEIPPALLTGKVIFKYDNNPKL 105
+ EI T + F+ + K+
Sbjct: 262 IQTDLL-EIDLTHNTQLIYFQAEGCRKI 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 18/75 (24%), Positives = 29/75 (38%), Gaps = 5/75 (6%)
Query: 18 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
+L L L+L+ LT L D+S L+ + N + S +G +P L
Sbjct: 313 DLSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFE 368
Query: 78 ENNSFVGEIPPALLT 92
+ +P LT
Sbjct: 369 AEGQTI-TMPKETLT 382
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 14/75 (18%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 18 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
+L + L +G L D++ L ++ + +T L + P L L++
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYL 325
Query: 78 ENNSFVGEIPPALLT 92
N E+ + T
Sbjct: 326 NNTELT-ELDVSHNT 339
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 7e-07
Identities = 17/80 (21%), Positives = 28/80 (35%), Gaps = 3/80 (3%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
+ + + L+ + L L + + L PD L ++L N L SL
Sbjct: 38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLS 96
Query: 64 SYMGSLPNLQELHIENNSFV 83
+LQEL + N
Sbjct: 97 WKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 7e-06
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 7/95 (7%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGS-LP 70
+ L E LTEL+++ L + L +LR + + + L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 71 NLQELHIENNSFVGEIPPALLTGK--VIFKYDNNP 103
L L++ N+ + + G NP
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 25/107 (23%), Positives = 37/107 (34%), Gaps = 10/107 (9%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
LS + I L+ L L L N + D S L L + L N L+ +L
Sbjct: 59 LSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLS 116
Query: 64 SYM-GSLPNLQELHIENNSFVGEIPPA----LLTGKVIFKYDNNPKL 105
S L +L L++ N + + LT I + N
Sbjct: 117 SSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 2/65 (3%)
Query: 19 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHI 77
L + + L + ++++ L + N+L S+P + L +LQ++ +
Sbjct: 250 LIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
Query: 78 ENNSF 82
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 20/83 (24%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 15 IPPEL-KNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLP 70
+ K + +LT L L GN G S L L+I+ + N + + L
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 71 NLQELHIENNSFVGEIPPALLTG 93
L+EL I+ + P L
Sbjct: 175 FLEELEIDASDLQ-SYEPKSLKS 196
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 17/72 (23%), Positives = 33/72 (45%), Gaps = 1/72 (1%)
Query: 9 KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGS 68
++ +G++ E L L LT + ++ +L L+ + L +N ++G L
Sbjct: 28 RSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLAEK 86
Query: 69 LPNLQELHIENN 80
PNL L++ N
Sbjct: 87 CPNLTHLNLSGN 98
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 65/236 (27%)
Query: 201 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 252
+G+G+FG V + +VA+KI+ + +R + E+ +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFL 83
Query: 253 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 304
V + + C + +E + + L + N +P L ++ +A+
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKEN-NFQPYP-LPHVRHMAYQLC 133
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 345
L +LH + H D+K NIL + +V+DFG +
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 346 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 395
E T +++ R Y PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVAT--R---HYRPPEVILELGWA-----QPCDVWSIGCILFEYYRGF 236
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 64
NL ++P L L L N++ L L+++ L + ++
Sbjct: 11 YRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 65 YM-GSLPNLQELHIENNSFVGEIPPALLTG 93
+LPNL+ L + ++ + P G
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQG 95
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 9/104 (8%)
Query: 6 LSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELT 59
L L+ EL + + L L+L+ N+L P + S L LR + L +N LT
Sbjct: 458 LGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517
Query: 60 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 103
L NL+ L I N + P + + +N
Sbjct: 518 -VLSHND-LPANLEILDISRNQLL-APNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 7/93 (7%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENNELTG- 60
L + + P+ + + L EL L L+ + L L + L N++
Sbjct: 80 LGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138
Query: 61 SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
L G L +L+ + +N + L
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEP 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 16/80 (20%), Positives = 32/80 (40%), Gaps = 5/80 (6%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
LS + + + ++ L L L N + + L +L++++L N L L
Sbjct: 273 LSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELY 330
Query: 64 SYM-GSLPNLQELHIENNSF 82
S LP + + ++ N
Sbjct: 331 SSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 17/96 (17%), Positives = 31/96 (32%), Gaps = 10/96 (10%)
Query: 6 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG------PLPDMSRLIDLRIVHLENNE 57
L+ + +L +L+L N L L L++++L +N
Sbjct: 433 LNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491
Query: 58 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 93
L P L L+ L + +N + L
Sbjct: 492 LNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 18/99 (18%), Positives = 34/99 (34%), Gaps = 6/99 (6%)
Query: 6 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGS 61
L L + + +N++ALT L L N + P +L L+ + +N++
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 62 LPSYMGSL--PNLQELHIENNSFVGEIPPALLTGKVIFK 98
+ L L + NS + F+
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 13/92 (14%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSL 62
++ ++P L + + L L+ + + + ++ +++ N + L
Sbjct: 52 FKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YL 108
Query: 63 PSYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
P ++ ++P L L +E N +P +
Sbjct: 109 PPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 17/66 (25%), Positives = 28/66 (42%), Gaps = 2/66 (3%)
Query: 16 PPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 74
L N L E+ L N L ++ L +++ NN L +L Y +P L+
Sbjct: 241 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 75 LHIENN 80
L + +N
Sbjct: 300 LDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 16/72 (22%), Positives = 28/72 (38%), Gaps = 7/72 (9%)
Query: 14 EIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGSLP 70
+P + N LT L + N L + D L+ + L +N LT + +P
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIP 186
Query: 71 NLQELHIENNSF 82
+L ++ N
Sbjct: 187 SLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 16/76 (21%), Positives = 29/76 (38%), Gaps = 5/76 (6%)
Query: 18 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
L A+ EL N + + ++L I+ L++N LT + + P L E+ +
Sbjct: 200 TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDL 255
Query: 78 ENNSFVGEIPPALLTG 93
N +I
Sbjct: 256 SYNELE-KIMYHPFVK 270
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 4/88 (4%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
L N+ LT L D N ++ + ++ L +L VHL+NN+++ P + + NL +
Sbjct: 167 TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 77 IENNSFVGEIPPALLTGKVIFKYDNNPK 104
+ N + P V+ P
Sbjct: 224 LTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 22/90 (24%), Positives = 40/90 (44%), Gaps = 4/90 (4%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
I P L + L L + ++ L ++ L L + ++N+++ + + SLPNL
Sbjct: 143 NISP-LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKIS-DISP-LASLPNLI 198
Query: 74 ELHIENNSFVGEIPPALLTGKVIFKYDNNP 103
E+H++NN P A + I N
Sbjct: 199 EVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 16/73 (21%), Positives = 35/73 (47%), Gaps = 4/73 (5%)
Query: 8 GKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMG 67
++ P L + L L+LD N +T + ++ L +L+ + + N +++ L +
Sbjct: 115 TSTQITDVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQVS-DLTP-LA 170
Query: 68 SLPNLQELHIENN 80
+L L L ++N
Sbjct: 171 NLSKLTTLKADDN 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 3/64 (4%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
LKN+ +TEL L GN L + ++ L ++ + L + ++T + + L NLQ L+
Sbjct: 79 APLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLY 135
Query: 77 IENN 80
++ N
Sbjct: 136 LDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 14/75 (18%), Positives = 31/75 (41%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
G + I ++ + L L L N +T L + L + + L N L ++ +
Sbjct: 48 AFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLK-NVSA- 102
Query: 66 MGSLPNLQELHIENN 80
+ L +++ L + +
Sbjct: 103 IAGLQSIKTLDLTST 117
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 18/85 (21%), Positives = 35/85 (41%), Gaps = 4/85 (4%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
L ++ L E+ L N ++ + ++ +L IV L N +T + P + NL +
Sbjct: 189 SPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTIT-NQPVFY--NNNLVVPN 244
Query: 77 IENNSFVGEIPPALLTGKVIFKYDN 101
+ I PA ++ + N
Sbjct: 245 VVKGPSGAPIAPATISDNGTYASPN 269
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 50/319 (15%), Positives = 88/319 (27%), Gaps = 101/319 (31%)
Query: 226 IMADSCSHRTQQFVTEVA------LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 279
+ Q+FV EV L+S I P + Y R
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQ-----R 116
Query: 280 DRLHGSVNQKPLDWLTRLQIAHDAAKGLE--------YLH--TGCNPGIIHRDVKSS--- 326
DRL+ ++RLQ + L + G G K+
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--G------KTWVAL 168
Query: 327 NILLDINMRAKVSD------FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 380
++ L ++ K+ E L + + +DP + T +SD
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY----QIDPNW------TSRSD 218
Query: 381 VYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--IVDPVLIGNVKIES 438
S + + AEL R + K ++ NV+
Sbjct: 219 -----------HSSNIKLRIHSIQAELR-----RLLKSKPYENCLLVLL-----NVQNAK 257
Query: 439 IWRIAEVAIQCVEQRGFSRPKMQEIVL----AIQDSIKIEKGGD---QKFSSSSSKGQSS 491
W + C K+ ++ + D + S + + +
Sbjct: 258 AWN--AFNLSC---------KI--LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV- 303
Query: 492 RKTLLTSFLEIESPDLSNE 510
K+LL +L+ DL E
Sbjct: 304 -KSLLLKYLDCRPQDLPRE 321
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 7e-04
Identities = 53/298 (17%), Positives = 91/298 (30%), Gaps = 71/298 (23%)
Query: 15 IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 74
I +++ A + W N ++ +I+ + LE E
Sbjct: 333 IAESIRDGLATWDNWKHVNC-----DKLTTIIESSLNVLEPAEYR----------KMFDR 377
Query: 75 LHI-ENNSFVGEIPPALLTGKVIFKYDNNP--------KLHKES---RRRMRFKLILGTS 122
L + ++ IP LL + +D KLHK S ++ +
Sbjct: 378 LSVFPPSA---HIPTILL---SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES------T 425
Query: 123 IGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEG 182
I + +I L L L L R I + + K P Y + GH +
Sbjct: 426 ISIPSIYLEL-KVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNI 484
Query: 183 VAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEV 242
E E F V+ D + + KI DS + +
Sbjct: 485 --------EHPERMTLFRM---------VFL----DFRFLEQKIRHDSTAWNASGSILN- 522
Query: 243 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 300
L ++ + P I + +++R LV + L + K D L+IA
Sbjct: 523 -TLQQL--KFYKPYICDNDPKYER-LVNAILDF--LPKIEENLICSKYTDL---LRIA 571
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 19/72 (26%), Positives = 30/72 (41%), Gaps = 1/72 (1%)
Query: 9 KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGS 68
K+ G+I L L L L + ++ +L L+ + L N + G L
Sbjct: 35 KSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLDMLAEK 93
Query: 69 LPNLQELHIENN 80
LPNL L++ N
Sbjct: 94 LPNLTHLNLSGN 105
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 18/80 (22%), Positives = 27/80 (33%), Gaps = 5/80 (6%)
Query: 6 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS 64
LS +L+ L L L L + L ++ L N L PS
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLDLSYNRLD-RNPS 291
Query: 65 YMGSLPNLQELHIENNSFVG 84
LP + L ++ N F+
Sbjct: 292 -PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 14/91 (15%), Positives = 28/91 (30%), Gaps = 8/91 (8%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------DMSRLIDLRIVHLENNE 57
++ + +++ AL+ L L N G L L + +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 58 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 88
+G + + LQ L + +NS
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 16/89 (17%), Positives = 27/89 (30%), Gaps = 7/89 (7%)
Query: 6 LSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDMSRLID-----LRIVHLENNEL 58
L + G PP L L L L ++ L L+++ +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 59 TGSLPSYMGSLPNLQELHIENNSFVGEIP 87
+ P L L + +N +GE
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLV 254
+K+G G+FG V + + + K AVK++ + + + E +L +I ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIV 99
Query: 255 PLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKG 306
G C L++E + +L + + + N + ++ + K
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRN-NYNGFH-IEDIKLYCIEILKA 149
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------------KVSDF 341
L YL + H D+K NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 342 GLSRQAEEDL-THISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 394
G + + + I++ R Y PE + SD++SFG VL EL +G
Sbjct: 207 GCATFKSDYHGSIINT--R---QYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
Query: 395 K 395
Sbjct: 256 S 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 6e-06
Identities = 21/75 (28%), Positives = 37/75 (49%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L + +I L ++ L L+L N +T + +SRL L + LE+N+++ +
Sbjct: 116 LEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVPL 171
Query: 66 MGSLPNLQELHIENN 80
G L LQ L++ N
Sbjct: 172 AG-LTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 18/73 (24%), Positives = 37/73 (50%), Gaps = 4/73 (5%)
Query: 8 GKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMG 67
+N ++ LK+++ L L L+ N ++ + + L L ++L NN++T + +
Sbjct: 95 DENKIKDLSS-LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLS 150
Query: 68 SLPNLQELHIENN 80
L L L +E+N
Sbjct: 151 RLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 12/75 (16%), Positives = 34/75 (45%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L K++ + + ++ ++ + + + + + L ++ + L N+LT +
Sbjct: 28 LKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLT-DI-KP 82
Query: 66 MGSLPNLQELHIENN 80
+ +L NL L ++ N
Sbjct: 83 LTNLKNLGWLFLDEN 97
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 16/85 (18%), Positives = 35/85 (41%), Gaps = 5/85 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L + +I L + L L L+ N ++ + ++ L L+ ++L N ++ L
Sbjct: 138 LGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHIS-DL-RA 192
Query: 66 MGSLPNLQELHIENNSFVGEIPPAL 90
+ L NL L + + + +
Sbjct: 193 LAGLKNLDVLELFSQECLNKPINHQ 217
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 24/75 (32%), Positives = 42/75 (56%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L+G L +I P L N++ L L+LD N + L + L L+ + LE+N ++ + +
Sbjct: 72 LNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGIS-DI-NG 126
Query: 66 MGSLPNLQELHIENN 80
+ LP L+ L++ NN
Sbjct: 127 LVHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 9e-04
Identities = 12/66 (18%), Positives = 27/66 (40%), Gaps = 1/66 (1%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
L + L L+L N ++ L ++ L +L ++ L + E ++ +L +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227
Query: 77 IENNSF 82
+ S
Sbjct: 228 NTDGSL 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 20/75 (26%), Positives = 37/75 (49%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L + +I L ++ L L+L N +T + +SRL L + LE+N+++ +
Sbjct: 119 LEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVP- 173
Query: 66 MGSLPNLQELHIENN 80
+ L LQ L++ N
Sbjct: 174 LAGLTKLQNLYLSKN 188
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 17/62 (27%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 19 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78
LK+++ L L L+ N ++ + + L L ++L NN++T + + L L L +E
Sbjct: 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164
Query: 79 NN 80
+N
Sbjct: 165 DN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 13/67 (19%), Positives = 28/67 (41%), Gaps = 1/67 (1%)
Query: 17 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76
L + L L+L N ++ L ++ L +L ++ L + E ++ +L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 230
Query: 77 IENNSFV 83
+ S V
Sbjct: 231 NTDGSLV 237
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 19/71 (26%), Positives = 29/71 (40%), Gaps = 6/71 (8%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 69
IPP + L + L N ++ L L L + L N++T LP + L
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGL 103
Query: 70 PNLQELHIENN 80
+LQ L + N
Sbjct: 104 FSLQLLLLNAN 114
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 20/80 (25%), Positives = 35/80 (43%), Gaps = 5/80 (6%)
Query: 6 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSL 62
L G + E+P L + + +L L L+ N + L L +L ++ L +N+L
Sbjct: 87 LYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIA 144
Query: 63 PSYMGSLPNLQELHIENNSF 82
L +Q +H+ N F
Sbjct: 145 KGTFSPLRAIQTMHLAQNPF 164
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 21/85 (24%), Positives = 36/85 (42%), Gaps = 11/85 (12%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L+ NL +P L +T L + N L LP++ L + +N L+ +LP
Sbjct: 66 LNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPEL--PASLEYLDACDNRLS-TLPE- 117
Query: 66 MGSLPNLQELHIENNSFVGEIPPAL 90
+L+ L ++NN +P
Sbjct: 118 --LPASLKHLDVDNNQLT-MLPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 19/82 (23%), Positives = 30/82 (36%), Gaps = 12/82 (14%)
Query: 14 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73
+P + L L + N LT LP++ L + + N L SLP+ + +
Sbjct: 154 MLPELPTS---LEVLSVRNNQLTF-LPEL--PESLEALDVSTNLLE-SLPAVPVRNHHSE 206
Query: 74 E----LHIENNSFVGEIPPALL 91
E N IP +L
Sbjct: 207 ETEIFFRCRENRIT-HIPENIL 227
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 19/75 (25%), Positives = 30/75 (40%), Gaps = 11/75 (14%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+ L +P L + D N LT LP+ L ++ + NN+LT LP
Sbjct: 127 VDNNQLT-MLPELPAL---LEYINADNNQLTM-LPE--LPTSLEVLSVRNNQLT-FLPE- 177
Query: 66 MGSLPNLQELHIENN 80
+L+ L + N
Sbjct: 178 --LPESLEALDVSTN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 3/59 (5%)
Query: 24 ALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 80
L+ L L GN + S L L+ + L SL ++ G L L+EL++ +N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN 134
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 18/93 (19%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 6 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSL 62
L+G ++ + + +L +L L L + L L+ +++ +N + S
Sbjct: 83 LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQ-SF 139
Query: 63 PS--YMGSLPNLQELHIENNSFVGEIPPALLTG 93
Y +L NL+ L + +N I L
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 14/71 (19%), Positives = 22/71 (30%), Gaps = 6/71 (8%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 69
+ + L L L + + D L L + L N + SL L
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGL 99
Query: 70 PNLQELHIENN 80
+LQ+L
Sbjct: 100 SSLQKLVAVET 110
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 14/79 (17%), Positives = 30/79 (37%), Gaps = 6/79 (7%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLP 63
+S + ++ ++ L L + N + L +L + L +N+L +
Sbjct: 28 ISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHNKLV-KIS 85
Query: 64 SYMGSLPNLQELHIENNSF 82
NL+ L + N+F
Sbjct: 86 C--HPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 15/92 (16%), Positives = 30/92 (32%), Gaps = 6/92 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHLENNELTGS 61
S L + ++ L L L N L L ++ + L+ + + N ++
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYD 389
Query: 62 LPSYM-GSLPNLQELHIENNSFVGEIPPALLT 92
+L L++ +N I L
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 18/88 (20%), Positives = 34/88 (38%), Gaps = 5/88 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 64
S L +P +L + T L + N+++ D+ L LRI+ + +N + S
Sbjct: 7 RSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLT 92
L+ L + +N +I
Sbjct: 64 VFKFNQELEYLDLSHNKL-VKISCHPTV 90
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 21/101 (20%), Positives = 37/101 (36%), Gaps = 27/101 (26%)
Query: 6 LSGKNLKGEIPPE---LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTG 60
L LK E+ M++L +L + N ++ S L +++ +N LT
Sbjct: 355 LQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413
Query: 61 ---------------------SLPSYMGSLPNLQELHIENN 80
S+P + L LQEL++ +N
Sbjct: 414 TIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASN 454
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 13/59 (22%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 25 LTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSF 82
+ L L N + + +L L+ +++ +N+L S+P + L +LQ++ + N +
Sbjct: 423 IKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 10/142 (7%)
Query: 25 LTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81
L L L N LP + L+ + L L S + L + L + +
Sbjct: 92 LKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 82 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 141
+ + P L + N LH F IL S+ +A L + + ++
Sbjct: 151 YGEKEDPEGL------QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 142 KLRRKISNQKSYEKADSLRTST 163
K +S + L T
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLT 226
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 16/89 (17%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 7 SGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSY 65
+ L ++P + + + L N + SRL DL+ + +E + +
Sbjct: 18 INRGLH-QVPELPAH---VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNN 73
Query: 66 M-GSLPNLQELHIENNSFVGEIPPALLTG 93
L +L L ++ N F+ ++ G
Sbjct: 74 TFRGLSSLIILKLDYNQFL-QLETGAFNG 101
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 6/71 (8%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYM-GSL 69
+I + L +L L NFL + L L ++ L N + +L L
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGL 370
Query: 70 PNLQELHIENN 80
PNL+EL ++ N
Sbjct: 371 PNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 22/77 (28%), Positives = 39/77 (50%), Gaps = 6/77 (7%)
Query: 10 NLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYM 66
N G I + +N++ L L L N + L D S L +L+ + L+ N+L S+P +
Sbjct: 333 NFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGI 390
Query: 67 -GSLPNLQELHIENNSF 82
L +LQ++ + N +
Sbjct: 391 FDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 13/72 (18%), Positives = 24/72 (33%), Gaps = 5/72 (6%)
Query: 14 EIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLENNELTGSLPSYM-GS 68
++ + L L L L G L L L ++ L +N + P+ +
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 69 LPNLQELHIENN 80
+ L + N
Sbjct: 153 MRRFHVLDLTFN 164
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 65/236 (27%)
Query: 201 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 252
+G+G+FG V G+ VAVKI+ + + + +E+ +L ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPNSTFR 78
Query: 253 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 304
V ++ + C +V+E + + D + + P L ++ +A+
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKEN-GFLPFR-LDHIRKMAYQIC 128
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 345
K + +LH + + H D+K NIL + KV DFG +
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 346 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 395
+E T +S+ R Y PE + + DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVST--R---HYRAPEVILALGWS-----QPCDVWSIGCILIEYYLGF 231
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 13/76 (17%), Positives = 29/76 (38%), Gaps = 7/76 (9%)
Query: 10 NLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSY 65
N + K + L ++ N +T + + + + L +N L ++
Sbjct: 42 NEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLE-NVQHK 99
Query: 66 M-GSLPNLQELHIENN 80
M L +L+ L + +N
Sbjct: 100 MFKGLESLKTLMLRSN 115
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 9/82 (10%)
Query: 6 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 63
L+ L+ + ++ K +E+L L L N +T D L +R++ L +N++T ++
Sbjct: 88 LTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
Query: 64 SYMG---SLPNLQELHIENNSF 82
G +L +L L++ N F
Sbjct: 146 P--GAFDTLHSLSTLNLLANPF 165
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 17/56 (30%), Positives = 29/56 (51%), Gaps = 2/56 (3%)
Query: 26 TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 80
TEL+LDGN T ++S L ++ L NN ++ +L + ++ L L + N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 19/69 (27%), Positives = 31/69 (44%), Gaps = 5/69 (7%)
Query: 15 IPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPN 71
+P EL N + LT + L N ++ L + S + L + L N L +P L +
Sbjct: 46 VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS 103
Query: 72 LQELHIENN 80
L+ L + N
Sbjct: 104 LRLLSLHGN 112
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 5/60 (8%)
Query: 24 ALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 80
L L+L+ N L LP L +L + + +N+L +LP + L NL EL ++ N
Sbjct: 62 KLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 7/79 (8%)
Query: 6 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSL 62
L+ L+ +P + K ++ L LW+ N L LP +L++L + L+ N+L SL
Sbjct: 68 LNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SL 124
Query: 63 PSYM-GSLPNLQELHIENN 80
P + SL L L + N
Sbjct: 125 PPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 24/86 (27%), Positives = 33/86 (38%), Gaps = 9/86 (10%)
Query: 24 ALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 80
LT L L N L LP +L L+ + L NN+L +P L L+ L ++NN
Sbjct: 134 KLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNN 191
Query: 81 SFVGEIPPALLTGKVIFKY---DNNP 103
+P K NP
Sbjct: 192 QLK-RVPEGAFDSLEKLKMLQLQENP 216
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 6/85 (7%)
Query: 14 EIPPEL-KNMEALTELWLDGN-FLTGPLPDM-SRLIDLRIVHLENNELTGSLP--SYMGS 68
++ N+ +T + + LT PD L L+ + + N L P + + S
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
Query: 69 LPNLQELHIENNSFVGEIPPALLTG 93
L I +N ++ IP G
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQG 153
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 18/97 (18%), Positives = 36/97 (37%), Gaps = 14/97 (14%)
Query: 3 RCALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL-ENNE 57
++ K+++ +PP L L L +P S L ++ +++ +
Sbjct: 15 DFRVTCKDIQRIPSLPPST------QTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVT 67
Query: 58 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 93
L L S+ +L + + I N + I P L
Sbjct: 68 LQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 2/77 (2%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 64
LS + + + T L N T S L L+ + L+ N L +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 65 YMGSLPNLQELHIENNS 81
N+ L + S
Sbjct: 395 VALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 13/60 (21%), Positives = 23/60 (38%), Gaps = 6/60 (10%)
Query: 25 LTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 82
L L L N + L DL + + +N L ++ + +L+ L + N F
Sbjct: 78 LRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 64
S +NL +P +L L L N ++ +PD+S L +LR++ L +N + SL
Sbjct: 38 YSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 65 YMG---SLPNLQELHIENNSFVGEIPPALLT 92
+L+ L + +N I +
Sbjct: 94 --HVFLFNQDLEYLDVSHNRLQ-NISCCPMA 121
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 14/59 (23%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 25 LTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIENNSF 82
+ L L N + D++ L L+ +++ +N+L S+P L +LQ + + +N +
Sbjct: 452 VKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 12/62 (19%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 19 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78
L +++ L L + N L + + L L ++ L NE+T + + L + + +
Sbjct: 124 LIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLT 180
Query: 79 NN 80
Sbjct: 181 GQ 182
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 19/58 (32%), Positives = 28/58 (48%), Gaps = 3/58 (5%)
Query: 25 LTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNS 81
+ L L GN L + + L +L + L N+L SLP+ L NL+EL + N
Sbjct: 65 VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 25 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 79
L EL L N L LPD +L +L ++L +N+L SLP G L NL EL +
Sbjct: 111 LKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSY 166
Query: 80 N 80
N
Sbjct: 167 N 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 9/61 (14%)
Query: 25 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 79
LT L L GN L LP+ +L +L+ + L N+L SLP G L NL L++ +
Sbjct: 87 LTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPD--GVFDKLTNLTYLNLAH 142
Query: 80 N 80
N
Sbjct: 143 N 143
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 22/111 (19%), Positives = 40/111 (36%), Gaps = 15/111 (13%)
Query: 6 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELT 59
L+ I L ++ + N + + ++ +L ++RI + N L
Sbjct: 37 FVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI--EKANNLL 93
Query: 60 GSLPSYM-GSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPKLH 106
+ +LPNLQ L I N +P KV+ +N +H
Sbjct: 94 -YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIH 142
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 4/58 (6%)
Query: 25 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80
LT L L N LT LP RL+ L+ + + N+LT LP + L +L L ++ N
Sbjct: 90 LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 13/61 (21%), Positives = 24/61 (39%), Gaps = 1/61 (1%)
Query: 20 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79
++ + N + L L L+ + + NN + +LP+L EL + N
Sbjct: 39 ATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97
Query: 80 N 80
N
Sbjct: 98 N 98
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 23/62 (37%), Positives = 31/62 (50%), Gaps = 9/62 (14%)
Query: 24 ALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIE 78
L +L+L GN L LP RL L+ + L N+L S+P+ G L NLQ L +
Sbjct: 108 QLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPA--GAFDKLTNLQTLSLS 163
Query: 79 NN 80
N
Sbjct: 164 TN 165
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 22/61 (36%), Positives = 27/61 (44%), Gaps = 9/61 (14%)
Query: 25 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 79
L L L N L LP L L ++L N+L SLPS G L L+EL +
Sbjct: 85 LGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPS--GVFDRLTKLKELRLNT 140
Query: 80 N 80
N
Sbjct: 141 N 141
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 13/111 (11%), Positives = 35/111 (31%), Gaps = 9/111 (8%)
Query: 202 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIGYC 260
K +G + Y + + + + +K+ T E ++ + + VP ++ +
Sbjct: 20 KDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79
Query: 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ L+ + D + +I A+ + H
Sbjct: 80 RHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECIRLFH 122
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 18/58 (31%), Positives = 26/58 (44%), Gaps = 4/58 (6%)
Query: 26 TELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 80
TEL L+ N L D RL L + L+ N+LT + ++QEL + N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGEN 88
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.53 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.51 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.5 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.5 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.44 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.4 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.38 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.38 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.37 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.37 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.36 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.35 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.33 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.3 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.3 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.29 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.27 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.26 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.26 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.25 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.25 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.25 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.24 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.24 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.24 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.23 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.23 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.2 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.19 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.17 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.15 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.15 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.13 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.13 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.13 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.12 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.12 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.12 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.12 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.11 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.11 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.11 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.1 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.1 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.1 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.1 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.09 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.08 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.08 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.08 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.08 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.06 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.06 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.05 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.05 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.05 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.04 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.03 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.03 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.02 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.01 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.01 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.0 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.0 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.99 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.99 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.99 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.98 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.95 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.95 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.95 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.94 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.93 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.93 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.9 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.83 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.83 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.83 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.83 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.82 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.8 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.79 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.78 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.78 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.76 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.74 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.72 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.7 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.66 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.65 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.62 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.61 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.53 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.52 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.52 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.45 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.38 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.36 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.36 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.3 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.18 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.15 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.99 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.95 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.73 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.73 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.64 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.51 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.45 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.39 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.37 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.24 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.23 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.17 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.16 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.12 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.09 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.05 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.83 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.74 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.68 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.29 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.99 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.79 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.49 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 93.81 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.77 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.68 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 93.61 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 93.46 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.22 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.78 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 91.74 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 90.76 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.2 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.58 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.73 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.63 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.24 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.06 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=439.22 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=208.1
Q ss_pred HHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
.+.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3456789999999999999875 4788999999876666678899999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccC------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 270 YEYMHNGTLRDRLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
||||++|+|.++++... ...+++|.+++.|+.|||.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEE
Confidence 99999999999997542 13469999999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCC-cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 010131 338 VSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 338 l~Dfg~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 415 (517)
|+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...+. .+.+ .
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~-~ 271 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAI-D 271 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHHH-H
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHHH-H
Confidence 99999998764432 223344568999999999999999999999999999999999 8999974322 1112 2
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+..+..... +...+..+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 272 ~i~~g~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CITQGRELER---------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHTCCCCC---------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCC---------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2333322111 112334688999999999999999999999999988764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-57 Score=435.21 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=214.8
Q ss_pred HHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..+.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 34556889999999999999874 477899999987666667889999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccC----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 269 VYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
|||||++|+|.++++... ....++|.+++.++.|||+||+|||+ ++|+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 24579999999999999999999999 99999999999999999999999
Q ss_pred ccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 010131 339 SDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...+. .+ +...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~-~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NE-VIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HH-HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HH-HHHH
Confidence 99999987644322 22333468999999999999999999999999999999999 8999974322 12 2223
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
+..+..... +...+..+.+|+.+||+.||++|||++||++.|+++.+.
T Consensus 243 i~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 333332211 122345688999999999999999999999999987764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=435.57 Aligned_cols=263 Identities=24% Similarity=0.400 Sum_probs=215.4
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeec
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE 262 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 262 (517)
.|+..++++|.++||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3445556778899999999999999873 467899999975433 345789999999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeE
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 329 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nil 329 (517)
++..++|||||++|+|.+++..... ...++|.+++.|+.|||+||+|||+ ++|+||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceE
Confidence 9999999999999999999964321 2468999999999999999999999 99999999999999
Q ss_pred eCCCCcEEEccccCccccCCCC-cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccc
Q 010131 330 LDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 407 (517)
Q Consensus 330 l~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~ 407 (517)
|++++.+||+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---- 253 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---- 253 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----
Confidence 9999999999999998764332 223344568999999999999999999999999999999999 8999974332
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
.+ +...+..+..... +...+..+.+|+.+||+.||++||||+||++.|+...
T Consensus 254 --~~-~~~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 254 --QD-VVEMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp --HH-HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --HH-HHHHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 11 2223333332221 2233456889999999999999999999999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=425.42 Aligned_cols=259 Identities=30% Similarity=0.489 Sum_probs=203.7
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..+.+.++||+|+||+||+|++++ .||||+++... ....+.|.+|++++++++|||||+++|+|.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 344578899999999999999863 69999986432 3445789999999999999999999999865 468999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
|++|+|.++++.. ...+++.+++.|+.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999742 4579999999999999999999999 999999999999999999999999999998764322
Q ss_pred cccccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 352 THISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
........||+.|||||++.+ ..++.++|||||||++|||+||+.||...+.. ..+...+..+... |
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~----p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYAS----P 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCC----C
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----C
Confidence 223344579999999999853 46899999999999999999999999743221 1122223222211 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+ .......+..+.+++.+||+.||++||||+||++.|+.+..
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 11122334578899999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-54 Score=420.06 Aligned_cols=261 Identities=24% Similarity=0.272 Sum_probs=209.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.+.++||+|+||+||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+|||||+|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 445678999999999999876 689999999975422 24699999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCCCCcc-
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTH- 353 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~~~- 353 (517)
|+|.++++. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ ++||+|||+|+........
T Consensus 135 g~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 135 GSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999974 4579999999999999999999999 9999999999999999987 6999999999876543211
Q ss_pred ---cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 354 ---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 354 ---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
......||+.|||||++.+..++.++|||||||++|||+||+.||........ .. ..........
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~---~i~~~~~~~~------ 276 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CL---KIASEPPPIR------ 276 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HH---HHHHSCCGGG------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHHcCCCCch------
Confidence 12335699999999999999999999999999999999999999975433221 11 1111111100
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCCCCCcc
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS 482 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~ 482 (517)
..+......+.+++.+||+.||++|||+.|+++.|...+.....-...|-
T Consensus 277 --~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 277 --EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp --GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred --hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 11112234678999999999999999999999999888766554444443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=421.20 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=206.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+|||||+|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 556788999999999999886 6999999999765555566789999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........ .
T Consensus 156 g~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 227 (346)
T 4fih_A 156 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 227 (346)
T ss_dssp EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-B
T ss_pred CcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-c
Confidence 999999973 469999999999999999999999 99999999999999999999999999999887554332 3
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+.. ..+..+....... .
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~-~~i~~~~~~~~~~-------~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAM-KMIRDNLPPRLKN-------L 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH-HHHHHSSCCCCSC-------G
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHH-HHHHcCCCCCCCc-------c
Confidence 446799999999999999999999999999999999999999974322 1111 1222221111111 1
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
......+.+|+.+||+.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112346789999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=422.31 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=202.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4777899999999999999876 69999999997542 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
|+||+|.+++... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999753 34568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......||+.|||||++.+..++.++|||||||++|||+||+.||...+ ..+.+.... .+.... +..
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~-~~~~~~-----~~~ 247 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKII-SGSFPP-----VSL 247 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHH-HTCCCC-----CCT
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHH-cCCCCC-----CCc
Confidence 2234569999999999999999999999999999999999999997432 222222222 232211 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+|+.+||+.||++|||++|+++
T Consensus 248 ----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 ----HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12346889999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=408.03 Aligned_cols=244 Identities=29% Similarity=0.436 Sum_probs=197.5
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeec----CCeeEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 270 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 270 (517)
+|.++||+|+||+||+|.+. +++.||+|++... .....+.|.+|++++++++|||||+++++|.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 35678999999999999876 6899999999653 23345679999999999999999999999865 34579999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--cEecCCCCCCeEeCC-CCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDI-NMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~ 347 (517)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+|||++. ++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999984 4679999999999999999999998 77 999999999999984 799999999999865
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... ......||+.|||||++.+ .++.++|||||||++|||+||+.||..... ... +...+..+......+
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~-~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQ-IYRRVTSGVKPASFD 252 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHH-HHHHHTTTCCCGGGG
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHH-HHHHHHcCCCCCCCC
Confidence 432 2334579999999999876 699999999999999999999999963321 111 222333332211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+. . ...+.+|+.+||+.||++|||++|+++
T Consensus 253 ~~----~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 KV----A----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GC----C----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc----C----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1 225789999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=412.76 Aligned_cols=267 Identities=25% Similarity=0.384 Sum_probs=201.6
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC----eeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~ 272 (517)
+.+.++||+|+||+||+|+++ |+.||||++.... .....+..|+..+.+++|||||+++++|.+++ ..++||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 445789999999999999985 8999999996432 22222344666667889999999999997654 57999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC-----CCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
|++|+|.++++. ..++|..+.+++.|++.||+|||+. ..++|+||||||+|||++.++.+||+|||+|+..
T Consensus 83 ~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999973 4699999999999999999999972 1249999999999999999999999999999876
Q ss_pred CCCCcc---cccccccCCCCcCCCccCCC------CCCccceehhHHHHHHHHHhCCCCCCCCCcc---------ccccH
Q 010131 348 EEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNI 409 (517)
Q Consensus 348 ~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~---------~~~~~ 409 (517)
...... ......||+.|||||++.+. .++.++|||||||++|||+||+.||...... .....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 12335699999999998764 4678999999999999999998887532211 11112
Q ss_pred HHHHHHHHhcCCcccccCccccCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 410 VHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 410 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+ +...+..+. ++|.+... ...+.+..+.+|+.+||+.||++||||+||++.|+++.+.+
T Consensus 239 ~~-~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 239 EE-MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HH-HHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HH-HHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 22 222222211 22222211 13356678899999999999999999999999999887643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-54 Score=422.97 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=216.5
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCC-CCccccceeeec
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH-RNLVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 262 (517)
|+....+++.+.||+|+||+||+|.+.. ++.||||++..... ...+.|.+|+++|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 4455667788999999999999998752 36899999976543 345679999999999965 999999999966
Q ss_pred C-CeeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCe
Q 010131 263 E-HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 328 (517)
Q Consensus 263 ~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Ni 328 (517)
. +..++|||||++|+|.++++... ....+++.+++.++.|||+||+|||+ ++|+||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 4 56899999999999999997532 13468999999999999999999999 9999999999999
Q ss_pred EeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcccc
Q 010131 329 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 406 (517)
Q Consensus 329 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~ 406 (517)
|+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999876544332 2344568999999999999999999999999999999998 999997433221
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+...+..+...... ...+..+.+++.+||+.||++|||++||++.|+++++..
T Consensus 296 -----~~~~~i~~g~~~~~p---------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 -----EFCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp -----HHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----HHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 122334433322211 112346889999999999999999999999999988753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=422.48 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=206.7
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|+|||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 566789999999999999886 6999999999766555567789999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........ .
T Consensus 233 G~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 304 (423)
T 4fie_A 233 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 304 (423)
T ss_dssp EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-B
T ss_pred CcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-c
Confidence 999999963 469999999999999999999999 99999999999999999999999999999877554332 3
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||...+. .+.. ..+..+....... .
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~-~~i~~~~~~~~~~-------~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAM-KMIRDNLPPRLKN-------L 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH-HHHHHSCCCCCSC-------T
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHH-HHHHcCCCCCCcc-------c
Confidence 445799999999999999999999999999999999999999974322 1111 1222221111111 0
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
......+.+|+.+||+.||++|||++|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112236789999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=408.76 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=207.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4778899999999999999876 69999999996431 2345779999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
||+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 113 y~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 113 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred cCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999974 4679999999999999999999999 999999999999999999999999999999865432
Q ss_pred -cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.......+||+.|||||++.+..++.++||||+||++|||+||+.||...+. .+.... +..+... +
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~-i~~~~~~------~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAK-IIKLEYD------F 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHTCCC------C
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHcCCCC------C
Confidence 2234456799999999999999999999999999999999999999974332 122222 2222221 1
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... ...+.+|+.+||+.||++|||++|++.
T Consensus 254 p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 PEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred Cccc----CHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1112 235789999999999999999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=394.80 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=191.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5777899999999999999875 69999999997542 2335679999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+ +|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99 6899999874 5679999999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
......||+.|+|||++.+..+ +.++||||+||++|||+||+.||...+. .... ..+..+... +
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~-~~i~~~~~~------~ 231 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLF-KNISNGVYT------L 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHTCCC------C
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHH-HHHHcCCCC------C
Confidence 2234569999999999988776 5799999999999999999999974322 2222 222222211 1
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ....+.+++.+||+.||++|||++|+++
T Consensus 232 p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 1235789999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=401.27 Aligned_cols=241 Identities=25% Similarity=0.324 Sum_probs=192.4
Q ss_pred HHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
.|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|++++++++|||||++++++.+++..|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4778899999999999999763 47899999997532 22334688899999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
||||+||+|.+++.. .+.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp ECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999984 4679999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
... ......||+.|||||++.+..++.++||||+||++|||+||+.||...+. .+...... .+...
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~-~~~~~------ 244 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMIL-KAKLG------ 244 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCCC------
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHH-cCCCC------
Confidence 322 23345799999999999999999999999999999999999999974332 22222222 22211
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
.... ....+.+++.+||+.||++|||+
T Consensus 245 ~p~~----~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 MPQF----LSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCc----CCHHHHHHHHHHcccCHHHCCCC
Confidence 1111 22357899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=394.75 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=189.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCC---------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--------- 264 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------- 264 (517)
.|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3667899999999999999876 689999999875433 34567999999999999999999999986544
Q ss_pred ---eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccc
Q 010131 265 ---QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 341 (517)
Q Consensus 265 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df 341 (517)
..|+|||||++|+|.+++.........++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 368999999999999999864433456677789999999999999999 99999999999999999999999999
Q ss_pred cCccccCCCCcc-----------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHH
Q 010131 342 GLSRQAEEDLTH-----------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410 (517)
Q Consensus 342 g~a~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 410 (517)
|+|+........ ......||+.|||||++.+..++.++|||||||++|||++ ||.... ...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~ 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERV 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHH
Confidence 999876543221 1223469999999999999999999999999999999996 775211 111
Q ss_pred HHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 411 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 411 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+ ..+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11222222111 1122335678999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=380.15 Aligned_cols=276 Identities=41% Similarity=0.718 Sum_probs=242.9
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
|++.+.||+|+||.||+|.+++++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 44578899999999999998889999999988766666788999999999999999999999999999999999999999
Q ss_pred CHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-ccc
Q 010131 277 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI 354 (517)
Q Consensus 277 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~ 354 (517)
+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++....... ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999997543 23469999999999999999999999 999999999999999999999999999998654322 222
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....||+.|+|||.+.+..++.++||||||+++|||+||+.||.............|.......+.+...+++.+....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 23345899999999998889999999999999999999999999866655666777777777777788888888887788
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
..+.+..+.+++.+||+.||++|||++||++.|+.+++...
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 88999999999999999999999999999999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=387.45 Aligned_cols=259 Identities=19% Similarity=0.315 Sum_probs=198.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeec------CCee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~ 266 (517)
.|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4677899999999999999876 799999999975432 345678899999999999999999998753 3578
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
|+|||||+ |+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 135 ~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999995 68999997 45689999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCC---cccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 347 AEEDL---THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 347 ~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+ ....+.........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTPSP 284 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCCh
Confidence 64322 2223456799999999998775 56899999999999999999999997543221 11111111110000
Q ss_pred ccccCc-----------ccc--CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ISIVDP-----------VLI--GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~~~d~-----------~l~--~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... .+. ...+ ......+.+|+.+||+.||++|||++|+++
T Consensus 285 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 -AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000 0000 011235789999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=378.75 Aligned_cols=286 Identities=40% Similarity=0.704 Sum_probs=241.9
Q ss_pred cccChhHHHHHHHh--hhcccCCCCceEEEEEEecCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeee
Q 010131 185 YFIPLPELEEATNN--FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCE 261 (517)
Q Consensus 185 ~~~~~~~l~~~~~~--~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 261 (517)
..+++.++.....+ +.+.||+|+||.||+|...+|+.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 34556666655544 4789999999999999988899999999875432 22346899999999999999999999999
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcc
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 340 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 340 (517)
+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998654 344699999999999999999999992222999999999999999999999999
Q ss_pred ccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCC--ccccccHHHHHHHHHh
Q 010131 341 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHWARSMIK 418 (517)
Q Consensus 341 fg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~--~~~~~~~~~~~~~~~~ 418 (517)
||++...............||+.|+|||.+.+..++.++||||||+++|+|+||+.||.... .........|+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998776554444555668999999999988889999999999999999999999996322 2234566777777777
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
........+..+...........+.+++.+||+.||.+|||++||++.|++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 7777888888888888889999999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=378.76 Aligned_cols=194 Identities=25% Similarity=0.416 Sum_probs=167.2
Q ss_pred HHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +||||+++++++.+.+..++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 4677899999999999999764 46789999986543 345688999999998 6999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccccCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEE 349 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~~~~ 349 (517)
||+++|+|.+++. .+++.++..++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 100 E~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 100 PYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp ECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred eCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999984 48999999999999999999999 999999999999999877 7999999999986543
Q ss_pred CCcc---------------------------cccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCC
Q 010131 350 DLTH---------------------------ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSV 400 (517)
Q Consensus 350 ~~~~---------------------------~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~ 400 (517)
.... ......||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2111 11234699999999998775 589999999999999999999999963
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=395.03 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=207.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+.+..++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 5677899999999999999876 699999999987666667789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC--CcEEEccccCccccCCCCc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~ 352 (517)
||+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 238 gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 238 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred CCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999864 24579999999999999999999999 999999999999999854 8999999999998755432
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.. +... .+..+... +.+....
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~-~i~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLR-NVKSCDWN--MDDSAFS 381 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHH-HHHTTCCC--CCSGGGT
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHH-HHHhCCCC--CCccccc
Confidence 23456999999999999999999999999999999999999999743321 1122 22222110 0111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ....+.+|+.+||+.||.+|||++|+++
T Consensus 382 ~----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 G----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1235779999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=393.00 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=196.9
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHH---HHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFV---TEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
|++.++||+|+||+||+|+.. +|+.||||++.+.. ......+. .++.+++.++|||||+++++|.+.+..|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 456789999999999999876 69999999996431 12223333 346677788999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
||||+||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.+|++||+|||+|+....
T Consensus 271 mEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp ECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999984 4679999999999999999999999 9999999999999999999999999999987754
Q ss_pred CCcccccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 350 DLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.. ....+||+.|||||++. +..|+.++|+||+||++|||++|+.||......+. .+...... ....
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~-~~~~------ 411 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTL-TMAV------ 411 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHH-HCCC------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhc-CCCC------
Confidence 33 23457999999999996 45799999999999999999999999974333221 12112211 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
.+... ....+.+|+.+||+.||.+|++ ++||++
T Consensus 412 ~~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 01111 1235789999999999999998 677754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=360.07 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=213.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|.+.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 4566789999999999999886 689999999877666677889999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 91 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 91 GGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999753 4679999999999999999999999 999999999999999999999999999998764432211
Q ss_pred -------------ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc---cccHHHHHHHHHh
Q 010131 355 -------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA---ELNIVHWARSMIK 418 (517)
Q Consensus 355 -------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~---~~~~~~~~~~~~~ 418 (517)
.....||+.|+|||++.+..++.++||||||+++|||++|..||....... ...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-- 243 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--
Confidence 114468999999999999999999999999999999999999987432221 11111111110
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
. +...+..+.+++.+||+.||++|||++|+++.|+.+......
T Consensus 244 -----------~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 244 -----------C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp -----------C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -----------C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0 011122578999999999999999999999999998876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=359.63 Aligned_cols=262 Identities=34% Similarity=0.501 Sum_probs=203.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
...|++.+.||+|+||+||+|++. |+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 345677899999999999999875 8899999987543 2344678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--cEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|+++|+|.+++........+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 99999999999853222349999999999999999999999 88 99999999999999999999999999986543
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.............
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~~~----- 259 (309)
T 3p86_A 192 TFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKRLE----- 259 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCCCC-----
T ss_pred ccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCCCC-----
Confidence 322 123345899999999999999999999999999999999999999743221 11111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+......+.+++.+||+.||++|||++|+++.|+.+++...
T Consensus 260 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 260 ----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 111223468899999999999999999999999999887544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=366.39 Aligned_cols=263 Identities=24% Similarity=0.455 Sum_probs=213.8
Q ss_pred HHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecCC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 264 (517)
..|.+.+.||+|+||.||+|.+. ++..||||+++.... ...+.+.+|+.+++++ +||||++++++|.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 45667889999999999999863 356799999976533 3456799999999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 265 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 9999999999999999997542 12458999999999999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccH
Q 010131 332 INMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 409 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 409 (517)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....... .
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999987644322 12233446789999999999999999999999999999999 999997443221 1
Q ss_pred HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 410 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
. ..+..+.... .+......+.+++.+||+.||++|||+.|+++.|++++.....
T Consensus 315 ~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 315 F----KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp H----HHHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred H----HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 1 1222222111 1112334688999999999999999999999999999877543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=354.07 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=205.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++.+.||+|+||+||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 4556789999999999999864 689999999976655667789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999974 368999999999999999999999 99999999999999999999999999999876544332
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....||+.|+|||.+.+..++.++|||||||++|||+||+.||...+.. .........+.. ... .
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~~~-------~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-ELQ-------N 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CCS-------C
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-CCC-------C
Confidence 23456899999999999999999999999999999999999999743221 111111211111 110 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122346789999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=351.10 Aligned_cols=280 Identities=36% Similarity=0.584 Sum_probs=227.5
Q ss_pred cccChhHHHHHHHhhh--------cccCCCCceEEEEEEecCCcEEEEEEecCCC----chhHHHHHHHHHHHhcCCCCC
Q 010131 185 YFIPLPELEEATNNFC--------KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 252 (517)
Q Consensus 185 ~~~~~~~l~~~~~~~~--------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~n 252 (517)
..+++.++..++.+|. +.||+|+||.||+|... ++.||||++.... ....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4567889999998874 56999999999999974 8899999986532 234577999999999999999
Q ss_pred ccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 253 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
|+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||+|||+ .+++||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999999765455679999999999999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 010131 333 NMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 411 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 411 (517)
++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........ ...
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 999999999999876543222 2234568999999998875 588999999999999999999999975443221 112
Q ss_pred HHHHHHh-cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 412 WARSMIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 412 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+...... ...+.+.+++.+ ..........+.+++.+||+.||.+|||+++|++.|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222111 122333444433 34466777889999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=361.45 Aligned_cols=267 Identities=25% Similarity=0.339 Sum_probs=208.5
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC----eeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 270 (517)
..|++.+.||+|+||+||+|++. ++.||||++... ......+..|+.++++++||||+++++++.... ..++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 34567889999999999999887 899999999643 233455667999999999999999999998754 369999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC----------CcEecCCCCCCeEeCCCCcEEEcc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP----------GIIHRDVKSSNILLDINMRAKVSD 340 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~----------~ivH~dlk~~Nill~~~~~~kl~D 340 (517)
||+++|+|.+++.. ..+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999974 459999999999999999999998 7 999999999999999999999999
Q ss_pred ccCccccCCCCcc-cccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccc-------
Q 010131 341 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL------- 407 (517)
Q Consensus 341 fg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~------- 407 (517)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543322 2233568999999999876 35667899999999999999999999754332111
Q ss_pred ---cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 408 ---NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 408 ---~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
....+... .........+.... ........+.+++.+||+.||++|||++||++.|+++.+..
T Consensus 255 ~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEV-VVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHH-HTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhh-hhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111 11111111111111 12245567999999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=362.75 Aligned_cols=264 Identities=27% Similarity=0.486 Sum_probs=212.2
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCe
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 265 (517)
++...+|.+.+.||+|+||.||+|.+. .+..||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 344556778899999999999999885 355699999976533 345679999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999642 4579999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 346 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 346 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... +.. ..+..+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~-~~~~~~~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVI-SSVEEGYR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHH-HHHHTTCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHH-HHHHcCCC
Confidence 76543221 1222345778999999998899999999999999999999 99999633221 111 12222211
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
. ..+...+..+.+++.+||+.||++|||++||++.|+.+.....
T Consensus 273 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 L---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred C---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1 1111233468899999999999999999999999999886543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=351.24 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=212.5
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 3566789999999999999999889999999997543 334679999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999974 24568999999999999999999999 999999999999999999999999999998765443333
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
.....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||...... +... .+..+.. ...+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~-~~~~~~~--~~~~----- 229 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVE-DISTGFR--LYKP----- 229 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH-HHHTTCC--CCCC-----
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHH-HHhcCcc--CCCC-----
Confidence 334456778999999998899999999999999999999 99999743221 1111 1222111 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
......+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 230 --~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 230 --RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11234688999999999999999999999999998763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=352.62 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=212.9
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
...|.+.+.||+|+||.||+|.++++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 44567789999999999999999988899999997543 33567899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999753 3468999999999999999999999 99999999999999999999999999999876554433
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||...... +.... +..+.. ...+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~-~~~~~~--~~~~~--- 228 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLK-VSQGHR--LYRPH--- 228 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH-HHTTCC--CCCCT---
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHH-HHcCCC--CCCCC---
Confidence 3344456778999999998889999999999999999999 99999743321 11111 221111 01111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.....+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 229 ----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 229 ----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp ----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 11236889999999999999999999999999887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=351.56 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=211.2
Q ss_pred cChhHHHHHHHh------------hhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCc
Q 010131 187 IPLPELEEATNN------------FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 253 (517)
Q Consensus 187 ~~~~~l~~~~~~------------~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 253 (517)
++..++..++.. ..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 456676666543 3568999999999999987 799999999987666667889999999999999999
Q ss_pred cccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC
Q 010131 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333 (517)
Q Consensus 254 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~ 333 (517)
+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999986 4569999999999999999999999 999999999999999999
Q ss_pred CcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 010131 334 MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 413 (517)
Q Consensus 334 ~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~ 413 (517)
+.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+..
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~ 250 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAM 250 (321)
T ss_dssp CCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH
T ss_pred CcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH
Confidence 99999999999876543322 2345689999999999999999999999999999999999999974321 1111
Q ss_pred HHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 414 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 414 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .+.......... .......+.+++.+||+.||++|||++|+++
T Consensus 251 ~-~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 K-RLRDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp H-HHHHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-HHhcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 122221111111 1112336789999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.18 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=208.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 35667899999999999999875 68999999985432 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999974 4579999999999999999999999 99999999999999999999999999999876554
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.........||+.|+|||.+.+..++.++||||||+++|+|+||+.||..... .......+... .... ...
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~-~~~- 235 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNV-TTD- 235 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCH-HHH-
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCc-chh-
Confidence 43334445689999999999999999999999999999999999999974322 11122222211 1110 000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhhhcC
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~~~ 476 (517)
.....+..+.+++.+||+.||++|| +++++.+.|+.+......
T Consensus 236 ---~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 236 ---VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp ---SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred ---cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 1112234688999999999999999 999999999987765443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=350.30 Aligned_cols=260 Identities=28% Similarity=0.470 Sum_probs=211.2
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
....|.+.+.||+|+||.||+|.+.++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 344567789999999999999999988899999997543 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999999752 3569999999999999999999999 9999999999999999999999999999987654433
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||...... +.. ..+..+... ..+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~-~~~~~~~~~--~~~--- 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETA-EHIAQGLRL--YRP--- 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHH-HHHHTTCCC--CCC---
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHH-HHHhcccCC--CCC---
Confidence 33333446788999999998889999999999999999998 99999743321 111 122222110 001
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
......+.+++.+||+.||++|||++|+++.|+++.+.+
T Consensus 244 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 244 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 111246889999999999999999999999999988654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=351.29 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=201.8
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhc--CCCCCccccceeeec----CCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEE----EHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~l 268 (517)
..|.+.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 3566789999999999999998 4899999998643 34556677777766 799999999998654 345789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHh--------cCCCCCcEecCCCCCCeEeCCCCcEEEcc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINMRAKVSD 340 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~kl~D 340 (517)
||||+++|+|.++++ ...+++..++.++.|++.||+||| + ++|+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999995 457999999999999999999999 7 9999999999999999999999999
Q ss_pred ccCccccCCCCccc---ccccccCCCCcCCCccCCC------CCCccceehhHHHHHHHHHhC----------CCCCCCC
Q 010131 341 FGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------KKPVSVE 401 (517)
Q Consensus 341 fg~a~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg----------~~p~~~~ 401 (517)
||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||+|| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654433221 2234689999999999876 556799999999999999999 8888633
Q ss_pred CccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 402 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
... ...................... ..........+.+++.+||+.||++|||++||++.|+++
T Consensus 237 ~~~-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPN-DPSFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCS-SCCHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-CcchhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 222 1222222111111111111110 112234667899999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=352.00 Aligned_cols=267 Identities=28% Similarity=0.451 Sum_probs=208.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEe-----cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec--CCe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQ 265 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 265 (517)
....|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 345677789999999999999984 2588999999987666667889999999999999999999999855 356
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999999753 3459999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHH
Q 010131 346 QAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWAR 414 (517)
Q Consensus 346 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~---------~~~~~~~~~~ 414 (517)
....... .......++..|+|||.+.+..++.++||||||+++|||+||..|+...... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7654322 1222334677899999999889999999999999999999999998632211 0011111122
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
..+..+... ..+...+..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 243 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 222222111 11122345788999999999999999999999999998753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=361.55 Aligned_cols=273 Identities=24% Similarity=0.423 Sum_probs=218.5
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 260 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 260 (517)
++....+.+.+.||+|+||+||+|.+. .+..||||++..... ...+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344456777899999999999999863 246799999976543 3457799999999999 899999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence 999999999999999999999975431 2469999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~ 405 (517)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...+.
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999987654322 22233456889999999999999999999999999999999 9999974322
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCCCCCcc
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS 482 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~ 482 (517)
.+ +...+..+..... .......+.+++.+||+.||++|||++||++.|+++.......+....
T Consensus 300 ----~~-~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 300 ----EE-LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp ----HH-HHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred ----HH-HHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 11 2222322221111 111234688999999999999999999999999999988766655543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=352.21 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=203.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 3566789999999999999874 79999999996542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 96 ~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 96 ASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp CTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 999999999974 4569999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCC-ccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.....||+.|+|||++.+..+. .++||||+||++|+|++|+.||...+. .+... .+..+... +
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~-~i~~~~~~------~- 233 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRE-RVLRGKYR------I- 233 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHHCCCC------C-
T ss_pred --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHH-HHHhCCCC------C-
Confidence 3445689999999999887765 799999999999999999999974332 22222 22222211 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.||.+|||++|+++
T Consensus 234 ---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 234 ---PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1112235789999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=366.63 Aligned_cols=261 Identities=26% Similarity=0.472 Sum_probs=200.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
....+.+.+.||+|+||.||+|++. ++..||||+++.... ...+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3445667889999999999999875 577899999976533 34567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999974 24579999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCccc--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 348 EEDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 348 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... + +...+..+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~-~~~~i~~~~~-- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------D-VIKAVDEGYR-- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------H-HHHHHHTTEE--
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCC--
Confidence 5432211 112235678999999998899999999999999999998 99999733221 1 1122222211
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.......+..+.+++.+||+.||++||++.||++.|+.++...
T Consensus 269 -------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 -------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0111123446889999999999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=346.58 Aligned_cols=271 Identities=22% Similarity=0.312 Sum_probs=214.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCC--eeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 271 (517)
.|.+.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 3556789999999999999887 58999999997543 334677889999999999999999999987655 7799999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe----CCCCcEEEccccCcccc
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQA 347 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~~~ 347 (517)
|+++++|.+++........+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999999865545559999999999999999999999 999999999999999 78888999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccC--------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYG--------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
..... .....||+.|+|||++. +..++.++|||||||++|||+||+.||........ ..+.+......
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~ 242 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITG 242 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHHH
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhcC
Confidence 55432 22345899999999875 57889999999999999999999999964333221 12222222222
Q ss_pred CC---ccccc-----------CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 420 GD---VISIV-----------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 420 ~~---~~~~~-----------d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.. ...+. +..............+.+++.+||+.||++|||++|+++..++....
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 11 00000 00111234567778899999999999999999999999998876544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=365.96 Aligned_cols=259 Identities=29% Similarity=0.437 Sum_probs=211.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
...+.+.+.||+|+||.||+|.+. +++.||||+++.... ...+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 345667899999999999999987 789999999875533 334578899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 99999999999742 3468999999999999999999999 999999999999999999999999999998654432
Q ss_pred cccc-cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 352 THIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 352 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.... ....++..|+|||.+.+..++.++|||||||++|||+| |..||...... .+...+..+.....
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~---- 336 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLPC---- 336 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCCC----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC----
Confidence 2111 12235678999999998899999999999999999998 99999743221 12222332221111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
+...+..+.+++.+||+.||++|||+++|++.|+++.+.
T Consensus 337 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 112234688999999999999999999999999988754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=342.66 Aligned_cols=263 Identities=15% Similarity=0.190 Sum_probs=211.5
Q ss_pred HHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|.+.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 456778999999999999986 478999999986432 234578899999999 7999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc-----EEEccccCccccC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAE 348 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~ 348 (517)
+++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++....
T Consensus 89 -~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999999753 4569999999999999999999999 99999999999999987776 9999999998765
Q ss_pred CCCcc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 349 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 349 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 123456899999999999999999999999999999999999999854433222222222211111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
... .. ..+..+.+++.+||+.||++|||+++|++.|+++.+...
T Consensus 243 ~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 REL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 111 01 123468899999999999999999999999999987544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=377.84 Aligned_cols=261 Identities=29% Similarity=0.469 Sum_probs=215.5
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
++....+.+.++||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.++++++||||++++++|.+.+..++|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3445567778999999999999999874 8899999997543 3467899999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 9999999999999754 34568999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
..........++..|+|||.+.+..++.++|||||||++|||+| |+.||...+.. ...+ .+..+...
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~----- 438 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKDYRM----- 438 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTCCC-----
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-----
Confidence 43333333446778999999998899999999999999999999 99999744322 1222 22222111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
..+...+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 439 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ----CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1112233468899999999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=374.18 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=212.5
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
++....+.+.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34445667789999999999999999888999999997643 45678999999999999999999999987 56789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999997431 2368899999999999999999999 99999999999999999999999999999876543
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.........++..|+|||.+.+..++.++|||||||++|||+| |+.||...+.. +.. ..+..+....
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~-~~i~~~~~~~----- 405 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVI-RALERGYRMP----- 405 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHH-HHHHHTCCCC-----
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHHcCCCCC-----
Confidence 2222233346778999999988899999999999999999999 99999743221 111 1222221111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+...+..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 406 ----~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 406 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1112334688999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=347.74 Aligned_cols=261 Identities=19% Similarity=0.232 Sum_probs=209.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|.+.+.||+|+||.||+|... +|+.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 3556789999999999999864 789999999875432 24688999999999 9999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc-----EEEccccCccccC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAE 348 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~Dfg~a~~~~ 348 (517)
+++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 -GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred -CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999999753 4679999999999999999999999 99999999999999999887 9999999998764
Q ss_pred CCCcc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 349 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 349 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 43221 123456899999999999999999999999999999999999999854433222222211111110000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
..+... .+ .+.+++.+|++.||.+||++++|++.|+++....
T Consensus 242 -----~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 -----EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -----HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000000 12 6889999999999999999999999999887654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=344.81 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=199.4
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
...|++.+.||+|+||.||+|.+.. +..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3466778999999999999998753 45799999876433 34567999999999999999999999985 456899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999753 4568999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .... .+..+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~----~i~~~~~~~--- 237 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG----RIENGERLP--- 237 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH----HHHTTCCCC---
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHH----HHHcCCCCC---
Confidence 543333333446788999999988889999999999999999997 99999744322 1111 122221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+...+..+.+++.+||+.||++|||+.|+++.|+++.+.+.
T Consensus 238 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 238 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111223468899999999999999999999999999887643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=347.32 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=203.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||.||+|+.. +|+.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 4566789999999999999876 6899999999753 22345678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 86 YANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999874 4578999999999999999999999 999999999999999999999999999998643322
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ......... +.. .+
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~-~~~------~~- 224 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILM-EEI------RF- 224 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCC------CC-
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHc-CCC------CC-
Confidence 1 23345689999999999999999999999999999999999999974322 111222221 211 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
+......+.+++.+||+.||++|| +++|+++.
T Consensus 225 ---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111223678999999999999999 89998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.26 Aligned_cols=260 Identities=28% Similarity=0.478 Sum_probs=202.8
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.+++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 4566789999999999999986 789999998643 345789999999999999999999998874 47999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc-EEEccccCccccCCCCccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~~~~ 354 (517)
|+|.+++........+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--- 160 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--- 160 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence 999999985433345789999999999999999999854468999999999999998886 7999999997654322
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ....... ...+..... ..
T Consensus 161 -~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~-~~~~~~~~~-----~~-- 227 (307)
T 2eva_A 161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWA-VHNGTRPPL-----IK-- 227 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHH-HHTTCCCCC-----BT--
T ss_pred -ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHH-HhcCCCCCc-----cc--
Confidence 2235899999999999999999999999999999999999999733221 1111111 111211111 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCCC
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD 478 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~ 478 (517)
..+..+.+++.+||+.||++|||++|+++.|+.+.......+
T Consensus 228 --~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 228 --NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred --ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 123468899999999999999999999999999887654433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.55 Aligned_cols=268 Identities=24% Similarity=0.403 Sum_probs=209.6
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEe-----cCCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC-
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE- 263 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 263 (517)
.+....|++.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 33344567789999999999999984 368999999997543 33457899999999999999999999999876
Q ss_pred -CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 264 -HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 264 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccc
Confidence 5689999999999999999643 4569999999999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCc--------cccccHHHH
Q 010131 343 LSRQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--------GAELNIVHW 412 (517)
Q Consensus 343 ~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~--------~~~~~~~~~ 412 (517)
++........ .......+|..|+|||.+.+..++.++||||||+++|+|+||+.|+..... .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654432 223344578889999999988999999999999999999999998752210 011111111
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
....+..+.... .+...+..+.+++.+||+.||.+|||++|+++.|+.+++
T Consensus 252 ~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 252 LVNTLKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHhccCCCC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 222222221111 112233468899999999999999999999999998763
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=348.68 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=217.4
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
++....+.+.+.||+|+||.||+|.+. ++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 334456677899999999999999887 4889999999754 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999754 34669999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+... ..+ .+......
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~~~~~----- 231 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRM----- 231 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC-----
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhccCCC-----
Confidence 54444444557889999999988899999999999999999999 999997443321 111 12111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
......+..+.+++.+||+.||.+|||++|+++.|+.+....
T Consensus 232 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111122346889999999999999999999999999887653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.67 Aligned_cols=260 Identities=22% Similarity=0.274 Sum_probs=200.2
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.++||+|+||+||+|...+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 4567789999999999999998899999999875432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
+ |+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 102 E-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp S-EEHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred C-CCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 7 488888764 34569999999999999999999999 99999999999999999999999999999876543222
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc------
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV------ 426 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 426 (517)
.....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||......+ ....+.............
T Consensus 176 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 176 -YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred -ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhccc
Confidence 233458999999999876 568999999999999999999999997443322 222222222111100000
Q ss_pred ---Cccc--cCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 ---DPVL--IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 ---d~~l--~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+... .... .......+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 0000 0112246789999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=341.71 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=210.8
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
.|.+.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 4567789999999999999998889999999976533 346799999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 88 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 88 GCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 9999999753 4568999999999999999999999 9999999999999999999999999999987654322222
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+... .+..+... ..+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~-~i~~~~~~--~~~------ 227 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVE-DISTGFRL--YKP------ 227 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH-HHHTTCCC--CCC------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHH-HHhcCCcC--CCC------
Confidence 33446778999999988889999999999999999999 8999974322 11111 22222110 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 228 -~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 -RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1123468899999999999999999999999998875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.42 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=207.4
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC-eeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~ 273 (517)
..+.+.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 45566889999999999999987 7899999997643 4578999999999999999999999987655 789999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp TTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 999999999854 23457999999999999999999999 999999999999999999999999999998653321
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ .. ..+..+....
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~~~~~-------- 406 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYKMD-------- 406 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHTTCCCC--------
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC--------
Confidence 12246889999999999999999999999999999998 999997443322 11 1222221111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+...+..+.+++.+||+.||++|||+.++++.|+++...+
T Consensus 407 -~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 407 -APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 11223457889999999999999999999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=343.64 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=204.8
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
...|.+.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356778899999999999999886 689999999875432 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC----cEEEcccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 342 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 342 (517)
++||||+++|+|.+++. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997 35679999999999999999999999 9999999999999999887 89999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +.... +.....
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLAN-VSAVNY 234 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHHTCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHH-HHhcCC
Confidence 9987654322 23346899999999999999999999999999999999999999743221 11111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. . .+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 235 ~-~-~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E-F-EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-C-CHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-c-Cccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0 000001 11235789999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=348.42 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=204.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.|.+.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4667889999999999999886 6899999999754321 35789999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC----cEEEccccCc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLS 344 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a 344 (517)
||||+++|+|.+++. ....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 93 v~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 93 ILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999997 35679999999999999999999999 9999999999999998877 7999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. +... .+..+...
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~-~i~~~~~~- 236 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLA-NITAVSYD- 236 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHH-HHHTTCCC-
T ss_pred eEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHhcCCC-
Confidence 87654322 23456899999999999999999999999999999999999999743221 1111 12222110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.++..... ....+.+++.+||..||++|||+.|+++
T Consensus 237 -~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111111 1235789999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=355.62 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=210.0
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecCC
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 264 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 264 (517)
....|.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 3445667899999999999999742 468899999976543 3456799999999999 7999999999988755
Q ss_pred -eeEEEEEecCCCCHHhHhhccCC--------------------------------------------------------
Q 010131 265 -QRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 287 (517)
Q Consensus 265 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 287 (517)
..++||||+++|+|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 48999999999999999975431
Q ss_pred -------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-ccccccc
Q 010131 288 -------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVAR 359 (517)
Q Consensus 288 -------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~ 359 (517)
...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .......
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 1228999999999999999999999 9999999999999999999999999999987644322 2233455
Q ss_pred cCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHH
Q 010131 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438 (517)
Q Consensus 360 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 438 (517)
||+.|+|||++.+..++.++|||||||++|||+| |+.||....... .+...+..+..... +...
T Consensus 257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~ 321 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA---------PDYT 321 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC---------CTTC
T ss_pred CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC---------CCCC
Confidence 7889999999998899999999999999999998 999997443221 11222222221111 1112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 439 ~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
...+.+++.+||+.||++|||++||++.|+.+++.
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 23688999999999999999999999999998864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.56 Aligned_cols=261 Identities=26% Similarity=0.430 Sum_probs=212.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
...|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 345667889999999999999862 357899999976433 3457799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCC---------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCC
Q 010131 267 ILVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 325 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~ 325 (517)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999975432 2358999999999999999999999 9999999999
Q ss_pred CCeEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCc
Q 010131 326 SNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDF 403 (517)
Q Consensus 326 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~ 403 (517)
+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876443222 2223446788999999988889999999999999999999 9999974432
Q ss_pred cccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 404 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.. .. ..+..+.... ........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 259 ~~---~~----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ER---LF----NLLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG---HH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH---HH----HHhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 11 2222222111 1112234688999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=349.19 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=206.3
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.....|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567888999999999999999876 68999999997543 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEEccccCcc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSR 345 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~ 345 (517)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999987 35679999999999999999999999 999999999999999865 459999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. .. ....+..+....
T Consensus 180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~-~~~~i~~~~~~~- 249 (362)
T 2bdw_A 180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HR-LYAQIKAGAYDY- 249 (362)
T ss_dssp CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCCCC-
T ss_pred EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHHhCCCCC-
Confidence 7654322 2335689999999999999999999999999999999999999974322 11 112222222110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..+. .......+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 01123467899999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=357.42 Aligned_cols=266 Identities=27% Similarity=0.436 Sum_probs=212.3
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
++....+.+.+.||+|+||+||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 344456778899999999999999853 46789999997543 34456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccC----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC---cE
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RA 336 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~---~~ 336 (517)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999997643 22468999999999999999999999 9999999999999999555 59
Q ss_pred EEccccCccccCCCC-cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 010131 337 KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 337 kl~Dfg~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 414 (517)
||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||+| |..||..... .+..
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~- 296 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVL- 296 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHH-
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHH-
Confidence 999999997643221 122233457889999999988899999999999999999998 9999974322 1111
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
..+..+..... ....+..+.+++.+||+.||++|||+.||++.|+.+.....
T Consensus 297 ~~i~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 297 EFVTSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHcCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 22222221111 11223468899999999999999999999999998876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=370.48 Aligned_cols=261 Identities=27% Similarity=0.428 Sum_probs=206.9
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+....+.+.++||+|+||.||+|.++++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3344567789999999999999999988889999997543 345789999999999999999999999876 67899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999743 23468999999999999999999999 999999999999999999999999999998765433
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
........++..|+|||.+.+..++.++||||||+++|||+| |+.||...... + +...+..+...
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~------- 400 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRM------- 400 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCC-------
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCC-------
Confidence 222233446788999999988899999999999999999999 99999743221 1 11222222111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
..+...+..+.+++.+||+.||++|||+++|++.|+++....
T Consensus 401 --~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 401 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 111223446889999999999999999999999999887543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.90 Aligned_cols=261 Identities=27% Similarity=0.434 Sum_probs=210.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 45567889999999999999875 348899999976543 34567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCC---------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCC
Q 010131 268 LVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 326 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~ 326 (517)
+||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+ ++|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcc
Confidence 99999999999999975321 2579999999999999999999999 99999999999
Q ss_pred CeEeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcc
Q 010131 327 NILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 404 (517)
Q Consensus 327 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~ 404 (517)
||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |..||.....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 282 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 282 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-
Confidence 99999999999999999986543221 22233457889999999988889999999999999999999 9999974322
Q ss_pred ccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 405 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+ ....+..+..... +...+..+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 283 -----~~-~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 283 -----EE-VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -----HH-HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -----HH-HHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 11 1222333322111 1122346889999999999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.85 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=200.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 3566789999999999999876 789999999865432 23466889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-c
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-T 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~ 352 (517)
++|+|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 88 SGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 9999999997 45679999999999999999999999 999999999999999999999999999998654322 1
Q ss_pred ccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .....+ ........ +
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~----~~~~~~~~---~--- 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKTYLN---P--- 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHH----HTTCTTST---T---
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHH----hcccccCC---c---
Confidence 22234568999999999977665 789999999999999999999997443221 111111 11111100 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 ---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ---WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123367899999999999999999999763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=337.42 Aligned_cols=252 Identities=31% Similarity=0.526 Sum_probs=201.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchh-------HHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-------TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
..|++.+.||+|+||+||+|++. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 45667889999999999999875 78999999986533221 167899999999999999999999997665
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--cEecCCCCCCeEeCCCCc-----EEEc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMR-----AKVS 339 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~ 339 (517)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999998864 34579999999999999999999999 88 999999999999988776 9999
Q ss_pred cccCccccCCCCcccccccccCCCCcCCCcc--CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 340 DFGLSRQAEEDLTHISSVARGTVGYLDPEYY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 340 Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
|||+++..... .....||+.|+|||.+ ....++.++|||||||++|||++|+.||....... ........
T Consensus 172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~ 243 (287)
T 4f0f_A 172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIR 243 (287)
T ss_dssp CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHH
T ss_pred CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHh
Confidence 99999865432 2335689999999998 45567899999999999999999999997433321 11112222
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..+.. +.+ ....+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 244 ~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLR-----PTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCC-----CCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 21111 111 112234688999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=340.55 Aligned_cols=247 Identities=28% Similarity=0.395 Sum_probs=194.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------------------------hhHHHHHHHHHHHhcC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------------------HRTQQFVTEVALLSRI 248 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l 248 (517)
.|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 4667889999999999999875 688999999865421 1135688999999999
Q ss_pred CCCCccccceeeec--CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCC
Q 010131 249 HHRNLVPLIGYCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 326 (517)
Q Consensus 249 ~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~ 326 (517)
+||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 99999999999986 567899999999999988653 4579999999999999999999999 99999999999
Q ss_pred CeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCC---CCccceehhHHHHHHHHHhCCCCCCCCCc
Q 010131 327 NILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDF 403 (517)
Q Consensus 327 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~ 403 (517)
||+++.++.+||+|||++......... .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999876543222 23346899999999997755 47889999999999999999999974321
Q ss_pred cccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 404 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.... ..+....... .+ .......+.+++.+||+.||++|||++|+++
T Consensus 246 ------~~~~-~~~~~~~~~~-~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 ------MCLH-SKIKSQALEF-PD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------HHHH-HHHHHCCCCC-CS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------HHHH-HHHhcccCCC-CC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111 2222221110 00 0112246889999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=353.05 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=209.1
Q ss_pred hhhcccCCCCceEEEEEEec-----CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV 269 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 269 (517)
++.+.||+|+||+||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67889999999999998653 588999999986543 3456799999999999999999999999874 578999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999973 349999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc--------ccccHHHHHHHHHhc
Q 010131 350 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--------AELNIVHWARSMIKK 419 (517)
Q Consensus 350 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~ 419 (517)
... .......++..|+|||.+.+..++.++||||||+++|+|+||+.||...... ............+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 332 1223345788899999999889999999999999999999999998632211 000001111122222
Q ss_pred CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 010131 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 477 (517)
Q Consensus 420 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 477 (517)
+.. .......+..+.+++.+||+.||++|||++|+++.|+.+.+.-...
T Consensus 267 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 267 GER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 211 1112223357889999999999999999999999999988765433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=346.55 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=199.2
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCC--------
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 264 (517)
..|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 35667899999999999999987 79999999997543 335678999999999999999999999885543
Q ss_pred -------------------------------------------------eeEEEEEecCCCCHHhHhhccCCCCccCHHH
Q 010131 265 -------------------------------------------------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 295 (517)
Q Consensus 265 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 295 (517)
..++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2789999999999999998665555677788
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc-----------ccccccccCCCC
Q 010131 296 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-----------HISSVARGTVGY 364 (517)
Q Consensus 296 ~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~g~~~y 364 (517)
++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999999 9999999999999999999999999999987655321 112334689999
Q ss_pred cCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHH
Q 010131 365 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 444 (517)
Q Consensus 365 ~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 444 (517)
+|||.+.+..++.++|||||||++|||++|..|+. .... ............ ........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~~---------~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFPL---------LFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCCH---------HHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCCc---------ccccCChhHHH
Confidence 99999999999999999999999999999877653 0111 111111111111 11223346789
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 010131 445 VAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 445 li~~cl~~~P~~RPs~~evl~ 465 (517)
++.+||+.||++|||++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=359.86 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=204.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
...|.+.+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456778899999999999999875 689999999875432 34567899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC---CCCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~ 347 (517)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999874 4679999999999999999999999 9999999999999998 4688999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.. + ....+..+... ...
T Consensus 164 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~~~-~~~ 234 (444)
T 3soa_A 164 EGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------R-LYQQIKAGAYD-FPS 234 (444)
T ss_dssp CTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCCC-CCT
T ss_pred cCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------H-HHHHHHhCCCC-CCc
Confidence 543322 23356899999999999999999999999999999999999999743321 1 11222222211 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+. .......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PE-----WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 10 0112346789999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=346.04 Aligned_cols=263 Identities=26% Similarity=0.417 Sum_probs=196.6
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCC----cEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCee-
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR- 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 266 (517)
...|.+.+.||+|+||.||+|.+... ..||||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 44667789999999999999987643 27999998754 334567899999999999999999999999876655
Q ss_pred -----EEEEEecCCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 267 -----ILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 267 -----~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999986533 22368999999999999999999999 99999999999999999999999
Q ss_pred ccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 010131 339 SDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... ... .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~ 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN----Y 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----H
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----H
Confidence 99999987644322 11223346778999999998899999999999999999999 999997433221 111 1
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
+..+.... ........+.+++.+||+.||++|||+.++++.|++++.-..
T Consensus 252 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 252 LIGGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HhcCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111111 111223468899999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=344.09 Aligned_cols=250 Identities=19% Similarity=0.293 Sum_probs=204.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 4567789999999999999876 5889999998744 3445678899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC--CCcEEEccccCccccCCCCc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+|+|.+++.. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++........
T Consensus 85 g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 85 GLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999964 23469999999999999999999999 99999999999999987 78999999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+....... +... .++....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~-~~~~--~~~~~~~ 228 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMN-AEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-TCCC--CCHHHHT
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHc-CCCC--CChhhhc
Confidence 2334589999999999998899999999999999999999999974322 112222222 1111 0000001
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 229 ----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 229 ----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 123467899999999999999999999873
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=343.87 Aligned_cols=256 Identities=22% Similarity=0.375 Sum_probs=204.1
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC-C-------cEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD-G-------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
....|.+.+.||+|+||+||+|.... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 34456778999999999999998763 3 579999997766667788999999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc--------E
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------A 336 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~ 336 (517)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999753 3448999999999999999999999 99999999999999998887 9
Q ss_pred EEccccCccccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 010131 337 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 337 kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 415 (517)
||+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+...... ......
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKLQF 230 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHH
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHHHH
Confidence 99999998765432 22347889999999987 77899999999999999999965554312111 111111
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
........... ...+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 231 ~~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 231 YEDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred hhccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 11111111111 1247799999999999999999999999998876443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=351.24 Aligned_cols=255 Identities=23% Similarity=0.293 Sum_probs=205.0
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
....|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567888999999999999999876 6899999998532 122457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEEcccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFG 342 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg 342 (517)
++||||+++++|.+++.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988876432 34568999999999999999999999 99999999999999987654 9999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .+.. ..+..+..
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~-~~i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLF-EGIIKGKY 249 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHH-HHHHHTCC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHH-HHHHcCCC
Confidence 9987654322 2234468999999999999999999999999999999999999997421 1111 11222211
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ..+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 00100011 1246789999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=336.75 Aligned_cols=249 Identities=30% Similarity=0.419 Sum_probs=193.3
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc----hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 4566789999999999999986 89999999865432 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC---cEecCCCCCCeEeCC--------CCcEEEcc
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG---IIHRDVKSSNILLDI--------NMRAKVSD 340 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~---ivH~dlk~~Nill~~--------~~~~kl~D 340 (517)
|+++++|.+++. ...+++..++.++.|++.||+|||+ .+ ++||||||+||+++. ++.+||+|
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 87 FARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred cCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999985 4579999999999999999999999 77 999999999999986 77899999
Q ss_pred ccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 341 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 341 fg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ..........
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~ 230 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNK 230 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSC
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCC
Confidence 999986644322 2345899999999999889999999999999999999999999743211 1111111111
Q ss_pred CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 421 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 421 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
.. ...+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 231 -~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 -LA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 011112234688999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=353.94 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=198.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.|++.++||+|+||.||+|+.+ +++.||+|++++... ...+.+..|..++.++ +||||+++++++.+.+..++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 4567899999999999999887 578999999975422 2234578899999887 8999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 133 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999974 4579999999999999999999999 99999999999999999999999999999863322
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHHhcCCcccccCc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+.+...+..+...
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----- 280 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----- 280 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-----
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-----
Confidence 2 22344569999999999999999999999999999999999999996433221 111122222333222211
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
+ +......+.+++.+||+.||++||++
T Consensus 281 -~----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 -I----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -C----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 11122367899999999999999996
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=352.25 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=202.4
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
...|++.+.||+|+||+||+|++. +++ .||+|.+.... ....+.+.+|+.++++++||||++++++|.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 345667899999999999999865 344 36888875433 345678999999999999999999999998765 78
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999999753 4679999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
...... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||....... .. ..+..+....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~~~~- 239 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERLP- 239 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCCC-
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH----HHHHcCCCCC-
Confidence 443222 2223346789999999999999999999999999999999 999997443322 11 2222221111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
........+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 240 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 240 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1112234688999999999999999999999999988753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=344.75 Aligned_cols=263 Identities=29% Similarity=0.449 Sum_probs=213.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEe------cCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecCCe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 265 (517)
...|.+.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 34567789999999999999985 2468899999976543 3457799999999999 99999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccCC---------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 266 RILVYEYMHNGTLRDRLHGSVN---------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999975431 2258999999999999999999999 999999999999999
Q ss_pred CCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcccccc
Q 010131 331 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 408 (517)
Q Consensus 331 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~ 408 (517)
+.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 99999999999999876554322 2233446788999999988899999999999999999999 999997433221 1
Q ss_pred HHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 409 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
....+..+... . .....+..+.+++.+||+.||.+|||+.|+++.|++++...
T Consensus 257 ----~~~~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 ----FYKMIKEGFRM-----L----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp ----HHHHHHHTCCC-----C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ----HHHHhccCCCC-----C----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11222221110 0 01112346889999999999999999999999999988653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=346.99 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=181.4
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999886 6899999998643 3467788999999996 99999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC---cEEEccccCccccCCCCcccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++........ .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999984 4679999999999999999999999 9999999999999997765 8999999999865443222 2
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ....+ ....+..+.... . ...
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~~--~----~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFSF--E----GEA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCCC--C----SHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCCC--C----ccc
Confidence 334579999999999999999999999999999999999999975443211 12222 223333332210 0 000
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0112346889999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=351.54 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=202.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 35667899999999999999876 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+.+|+|.+++. ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999998 45679999999999999999999999 99999999999999999999999999999876543
Q ss_pred CcccccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ... +.....
T Consensus 169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~---~~~-~~~~~~----- 237 (384)
T 4fr4_A 169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI---VHT-FETTVV----- 237 (384)
T ss_dssp C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH---HHH-HHHCCC-----
T ss_pred C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH---HHH-Hhhccc-----
Confidence 2 2344569999999999864 4589999999999999999999999974433322221 111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~ 465 (517)
.++......+.+++.+||+.||.+||+ +++|++
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 011112346889999999999999998 666654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=341.05 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=211.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
...|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 34667789999999999999999888899999997543 345789999999999999999999999874 4589999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999999742 12368999999999999999999999 99999999999999999999999999999877654333
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +.. ..+..+... ..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~-~~~~~~~~~-----~~-- 231 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVI-QNLERGYRM-----VR-- 231 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHH-HHHHTTCCC-----CC--
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHH-HHHhcccCC-----CC--
Confidence 3334456789999999988889999999999999999999 99999743221 111 122222110 00
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
....+..+.+++.+||+.||++|||++++++.|+++....
T Consensus 232 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1122346889999999999999999999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=357.45 Aligned_cols=267 Identities=25% Similarity=0.371 Sum_probs=210.8
Q ss_pred HHHhhhcccCCCCceEEEEEEe-----cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeee--cCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 267 (517)
..|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4566789999999999999984 358899999998776666778999999999999999999999886 455688
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999753 3469999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc--------ccccHHHHHHHHH
Q 010131 348 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--------AELNIVHWARSMI 417 (517)
Q Consensus 348 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~--------~~~~~~~~~~~~~ 417 (517)
...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ............+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 543321 223345788899999999888999999999999999999999998632211 0001111112222
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
..+.. ..........+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 258 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 258 EEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 22211 11122234568899999999999999999999999998876544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.98 Aligned_cols=268 Identities=25% Similarity=0.394 Sum_probs=206.0
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC--CCCCccccceeeecC----
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE---- 263 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~---- 263 (517)
.+.....|.+.+.||+|+||.||+|++. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445667888999999999999999987 899999998643 334555666666655 899999999998876
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC--------CcEecCCCCCCeEeCCCCc
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP--------GIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~--------~ivH~dlk~~Nill~~~~~ 335 (517)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCC
Confidence 678999999999999999963 469999999999999999999998 6 9999999999999999999
Q ss_pred EEEccccCccccCCCCccc---ccccccCCCCcCCCccCCCCCCcc------ceehhHHHHHHHHHhC----------CC
Q 010131 336 AKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQQLTEK------SDVYSFGVVLLELISG----------KK 396 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~slG~~l~elltg----------~~ 396 (517)
+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|||+|| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997664432221 123468999999999987766665 9999999999999999 66
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCcccccCccccCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 397 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 397 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
||....... ..... .......... .+..... ........+.+++.+||+.||++|||++||++.|+++.+..
T Consensus 261 p~~~~~~~~-~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 261 PYHDLVPSD-PSYED-MREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTTSCSS-CCHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cHhhhcCCC-Cchhh-hHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 665322211 11111 1222211111 1111111 12356778999999999999999999999999999988754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=338.67 Aligned_cols=259 Identities=19% Similarity=0.278 Sum_probs=197.7
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|.+.+.||+|+||+||+|...+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 556789999999999999998899999999865432 224678899999999999999999999999999999999997
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+ +|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 156 (288)
T 1ob3_A 84 Q-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (288)
T ss_dssp E-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred C-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-
Confidence 5 899888742 4678999999999999999999999 99999999999999999999999999999875432221
Q ss_pred ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--------cc
Q 010131 355 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--------SI 425 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 425 (517)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+ ....+.......... ..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcccc
Confidence 223457999999999876 458999999999999999999999997433211 111111111111000 00
Q ss_pred cCcccc-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 VDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 ~d~~l~-------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.++... ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111110 0001122346789999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.19 Aligned_cols=269 Identities=17% Similarity=0.233 Sum_probs=206.8
Q ss_pred HHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCchhH-----------HHHHHHHHHHhcCCCCCccccc
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRT-----------QQFVTEVALLSRIHHRNLVPLI 257 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~ 257 (517)
..|.+.+.||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 356678999999999999998864 47899999875532111 1244566677788899999999
Q ss_pred eeeecC----CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC--
Q 010131 258 GYCEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-- 331 (517)
Q Consensus 258 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~-- 331 (517)
+++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 998764 4579999999 9999999975 24679999999999999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCccc------ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc
Q 010131 332 INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 405 (517)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 88999999999998764432211 12345899999999999999999999999999999999999999743221
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
............ .....++++.+... ..+..+.+++..|++.+|++||++++|++.|+++.....
T Consensus 268 -~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 -PKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp -HHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -HHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 122222222221 12233333322111 123468899999999999999999999999999887644
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=344.49 Aligned_cols=265 Identities=24% Similarity=0.439 Sum_probs=212.5
Q ss_pred HHHHhhhcccCCCCceEEEEEEec--------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
...|.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 446677899999999999999863 467899999976533 3456789999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999985431 2358999999999999999999999 999999999999999
Q ss_pred CCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCcccccc
Q 010131 331 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 408 (517)
Q Consensus 331 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~ 408 (517)
+.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 99999999999999876543221 1223346788999999988889999999999999999999 9999974322
Q ss_pred HHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 010131 409 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 477 (517)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 477 (517)
.+. ...+..+.... ........+.+++.+||+.||.+|||+.|+++.|+++.......
T Consensus 266 -~~~-~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 266 -EEL-FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp -HHH-HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -HHH-HHHHhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 111 12222222111 11122346889999999999999999999999999999876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=350.40 Aligned_cols=267 Identities=27% Similarity=0.413 Sum_probs=209.7
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeec
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 262 (517)
++....|.+.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 344456777899999999999999862 45689999997543 23446799999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccCC--------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecC
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 322 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~d 322 (517)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence 9999999999999999999975421 1348999999999999999999999 9999999
Q ss_pred CCCCCeEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCC
Q 010131 323 VKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSV 400 (517)
Q Consensus 323 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~ 400 (517)
|||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876443221 2233457889999999988899999999999999999998 9999974
Q ss_pred CCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 401 EDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
..... . ....+..+.... .+......+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 278 ~~~~~--~----~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 278 IPVDA--N----FYKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCCSH--H----HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCcHH--H----HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 43221 1 122222221111 111123468899999999999999999999999998876544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=336.89 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=205.4
Q ss_pred HHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.|.+.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.++ ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 45667899999999999998653 3469999987653 34557899999999999999999999998754 568999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++++|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 92 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 92 ELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp ECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred ecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 999999999999753 4568999999999999999999999 99999999999999999999999999999876554
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.........+++.|+|||.+.+..++.++||||||+++|+|+| |+.||....... ... .+..+.....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~----~~~~~~~~~~---- 235 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG----VLEKGDRLPK---- 235 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH----HHHHTCCCCC----
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH----HHhcCCCCCC----
Confidence 3333344457889999999988889999999999999999998 999997433221 221 1222211111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.......+.+++.+||+.||++|||+.|+++.|+++.+.+.
T Consensus 236 -----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 236 -----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 11123468899999999999999999999999999887653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.98 Aligned_cols=269 Identities=25% Similarity=0.403 Sum_probs=213.2
Q ss_pred hhHHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhc--CCCCCccccceeeecCC--
Q 010131 189 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEEEH-- 264 (517)
Q Consensus 189 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~-- 264 (517)
..+.....|.+.+.||+|+||.||+|++. |+.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 34556678888999999999999999985 899999998643 34677889999887 68999999999998775
Q ss_pred --eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHh--------cCCCCCcEecCCCCCCeEeCCCC
Q 010131 265 --QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINM 334 (517)
Q Consensus 265 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~ivH~dlk~~Nill~~~~ 334 (517)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| + .+|+||||||+||+++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCC
Confidence 78999999999999999973 46999999999999999999999 7 8999999999999999999
Q ss_pred cEEEccccCccccCCCCcc---cccccccCCCCcCCCccCCC------CCCccceehhHHHHHHHHHhC----------C
Q 010131 335 RAKVSDFGLSRQAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------K 395 (517)
Q Consensus 335 ~~kl~Dfg~a~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg----------~ 395 (517)
.+||+|||++......... ......||+.|+|||.+.+. .++.++|||||||++|||+|| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876543322 12344689999999998765 334789999999999999999 7
Q ss_pred CCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 396 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 396 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.||...... ......+... +..... .+.+... ...+....+.+++.+||+.||++|||++||++.|+++.+..
T Consensus 265 ~p~~~~~~~-~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 265 LPYYDLVPS-DPSVEEMRKV-VCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CTTTTTSCS-SCCHHHHHHH-HTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cCccccCcC-cccHHHHHHH-HHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 787633222 1222222222 221111 1111111 12356678999999999999999999999999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.97 Aligned_cols=265 Identities=20% Similarity=0.273 Sum_probs=201.8
Q ss_pred HHhhhcccCCC--CceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.|++.+.||+| +||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 46678999999 99999999987 69999999997543 234567888999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+......
T Consensus 106 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 106 SFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp ECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999754 23569999999999999999999999 99999999999999999999999999988654221
Q ss_pred Cc------ccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc---
Q 010131 351 LT------HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--- 419 (517)
Q Consensus 351 ~~------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 419 (517)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ...........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcccc
Confidence 11 11222358889999999987 6789999999999999999999999974332211 11100000000
Q ss_pred ------CC-------------cccccC---cc------ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 420 ------GD-------------VISIVD---PV------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 420 ------~~-------------~~~~~d---~~------l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.. ..+... +. ............+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 000000 00 0000112233468899999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.65 Aligned_cols=252 Identities=21% Similarity=0.363 Sum_probs=204.3
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC--CeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 270 (517)
..|.+.+.||+|+||.||+|+++ ++.||||++.... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 35667889999999999999986 8999999997543 33456799999999999999999999999876 7789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--cEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999853 23368999999999999999999998 88 9999999999999999999999988876533
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCc---cceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTE---KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
. ....||+.|+|||.+.+...+. ++||||||+++|||++|+.||..... .+........+....
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~- 231 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPT- 231 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCC-
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCC-
Confidence 2 2234789999999998765544 79999999999999999999973322 111222222221111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
. +......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 232 ----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 ----I----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1 11223468899999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.47 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=202.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|..+++.++||||+++++++.+.+..++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4566789999999999999876 68999999997532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 87 YIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999974 4578999999999999999999999 99999999999999999999999999999876432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ......... +.. ..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~-~~~------~~- 222 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN-AEL------RF- 222 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-CCC------CC-
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCC------CC-
Confidence 2345689999999999999999999999999999999999999974321 122222222 211 01
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
+......+.+++.+||+.||++|| +++|+++
T Consensus 223 ---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 ---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111223678999999999999999 8888874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.24 Aligned_cols=250 Identities=21% Similarity=0.341 Sum_probs=205.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4667889999999999999876 689999999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC--CCcEEEccccCccccCCCCc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+|+|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++........
T Consensus 132 gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 132 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999874 23479999999999999999999999 99999999999999974 57799999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+...... ..... .++...
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~-~~~~~--~~~~~~- 274 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVK-RCDWE--FDEDAF- 274 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHH-HCCCC--CCSSTT-
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHH-hCCCC--CCcccc-
Confidence 2234589999999999999999999999999999999999999974322 11122211 11110 111111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
......+.+++.+||+.||++|||+.|+++
T Consensus 275 ---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 ---SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 112346789999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.36 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=199.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch---hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 4667899999999999999876 6889999998754322 34678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 115 LINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred ecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999974 3579999999999999999999999 999999999999999999999999999998765543
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc-ccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV-ISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~l 430 (517)
........|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+..... .....
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~--- 258 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPRPSTVR--- 258 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCCGGGTS---
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCCccccC---
Confidence 3333345689999999999999999999999999999999999999973321 112222222111 11111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhhhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIE 474 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~ 474 (517)
...+..+.+++.+||+.||++|| +++++++.|+......
T Consensus 259 -----~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 259 -----PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -----TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -----CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11223688999999999999999 9999999999876553
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.76 Aligned_cols=260 Identities=21% Similarity=0.278 Sum_probs=198.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 556789999999999999886 68999999997543 233477889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++ ++.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 84 DQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp SE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred CC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 75 55555543 35679999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCcCCCccCCCC-CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc------cc
Q 010131 354 ISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS------IV 426 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 426 (517)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .......+........... ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 223345899999999987765 79999999999999999999888642221 1111111211111110000 00
Q ss_pred C---------ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 D---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d---------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+ ..............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000111223446789999999999999999999976
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=346.10 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=200.3
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999875 6899999999876556677899999999999999999999999999999999999999999
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe--CCCCcEEEccccCccccCCCCccccc
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 998864 23568999999999999999999999 999999999999999 6678999999999987654322 22
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........... ..++ ...
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~--~~~~-~~~---- 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWD--LEDE-EFQ---- 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC--SCSG-GGT----
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCC--CChh-hhc----
Confidence 34589999999999999999999999999999999999999974332 1122222221110 0010 011
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhh
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS 470 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~ 470 (517)
.....+.+++.+||+.||++|||++|+++ .+++.
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12346889999999999999999999987 55544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=338.05 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=202.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 4677899999999999999874 78999999997532 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999986432 35678999999999999999999999 99999999999999999999999999998876443
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....... .+..........
T Consensus 190 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~~~--- 260 (310)
T 2wqm_A 190 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEQCDYPPLPS--- 260 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHH-HHHTTCSCCCCT---
T ss_pred Ccc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHH-HhhcccCCCCcc---
Confidence 221 2234589999999999999999999999999999999999999974322 1222222 222222211111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 477 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 477 (517)
......+.+++.+||+.||++|||+++|++.|+++......+
T Consensus 261 -----~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 261 -----DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred -----cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 112336889999999999999999999999999998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=340.71 Aligned_cols=263 Identities=29% Similarity=0.534 Sum_probs=198.4
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
|+....|.+.++||+|+||+||+|.+. ..||||+++... ....+.+.+|++++++++||||+++++++. .+..++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence 555566778899999999999999875 359999987543 234577999999999999999999999664 456899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999964 34679999999999999999999999 999999999999999999999999999997654
Q ss_pred CCC-cccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 349 EDL-THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 349 ~~~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
... ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||...... +........+....
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCc
Confidence 321 12223345899999999986 667888999999999999999999999743221 11222222222211
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
... ......+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 246 ~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111 1112233578899999999999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.59 Aligned_cols=272 Identities=22% Similarity=0.301 Sum_probs=215.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCC--eeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 271 (517)
.|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4556789999999999999887 58999999997543 234577889999999999999999999987655 6799999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe----CCCCcEEEccccCcccc
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQA 347 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~Dfg~a~~~ 347 (517)
|+++|+|.+++........+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999999865444559999999999999999999999 999999999999999 77888999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCC--------CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.+...+..
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~ 242 (396)
T 4eut_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITG 242 (396)
T ss_dssp CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHS
T ss_pred cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcC
Confidence 54322 233458999999998764 5678899999999999999999999974332211 12222233322
Q ss_pred CCccc---c----------c-CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 420 GDVIS---I----------V-DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 420 ~~~~~---~----------~-d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
..... . . +..............+.+++.+||+.||++||+++|+++.+++++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11100 0 0 001112345677788999999999999999999999999999988653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=347.05 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=199.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 4566789999999999999974 78999999986432 1223578899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+ +|+|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 90 YA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred CC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99 7899998874 4579999999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. .....||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.......... .+..+.
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~~--------- 224 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNSCV--------- 224 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCSSC---------
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHcCC---------
Confidence 2 234468999999999988776 789999999999999999999997443221110 000000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+......+.+++.+||+.||.+|||++|+++.
T Consensus 225 -~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111123467899999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.43 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=199.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 4566789999999999999986 58899999997542 23446688999999988 8999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 90 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999974 3579999999999999999999999 99999999999999999999999999999864322
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccc--ccHHHHHHHHHhcCCcccccCc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........+..+...
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----- 237 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----- 237 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----
Confidence 21 23345689999999999999999999999999999999999999964322111 11112222223222211
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 460 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 460 (517)
+ +......+.+++.+||+.||++||++
T Consensus 238 -~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 -I----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -C----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1 11122367899999999999999996
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=347.45 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=192.9
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeee--------cC
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCE--------EE 263 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~ 263 (517)
..+|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 345677899999999999999875 68999999987666666778999999999996 999999999983 34
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--cEecCCCCCCeEeCCCCcEEEccc
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDF 341 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~Df 341 (517)
...++||||+. |+|.+++........+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 45789999995 7999988765456679999999999999999999999 88 999999999999999999999999
Q ss_pred cCccccCCCCccc-----------ccccccCCCCcCCCcc---CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccc
Q 010131 342 GLSRQAEEDLTHI-----------SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 407 (517)
Q Consensus 342 g~a~~~~~~~~~~-----------~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~ 407 (517)
|++.......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998765432211 1134589999999998 56778999999999999999999999996322110
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
... +.... .........+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 261 ----~~~-----~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 ----IVN-----GKYSI--------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------CCC--------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ----hhc-----CcccC--------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 000 00000 0000111247799999999999999999999999999887544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=349.33 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=199.3
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCee
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 266 (517)
+....|++.+.||+|+||.||+|+.+ +|+.||||++.+.. ....+.+.+|..+++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 33345677899999999999999876 58999999997532 23456688999999988 799999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999974 4579999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+...... .+...
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~-~~~~~--- 242 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAIL-NDEVV--- 242 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCCC---
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHH-cCCCC---
Confidence 43322 123345699999999999988899999999999999999999999974332 12122222 22110
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM------QEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~ 465 (517)
++......+.+++.+||+.||++||++ +|+++
T Consensus 243 -------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 -------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011122357899999999999999998 67765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=333.25 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=207.8
Q ss_pred HHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceee-ecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 272 (517)
..|.+.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..++++ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4577789999999999999987 4789999998754322 23578899999999988887777766 566778999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe---CCCCcEEEccccCccccCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~ 349 (517)
+ +++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 87 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp C-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred c-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9 99999998742 4569999999999999999999999 999999999999999 7889999999999987654
Q ss_pred CCcc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 350 DLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 350 ~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
.... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 3221 1234568999999999999999999999999999999999999998554443333333222211111110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
. +... .+..+.+++.+||+.||++|||+++|++.|+++.....
T Consensus 241 ~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 V-----LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp H-----HTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred h-----hhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 0011 12468899999999999999999999999999987654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=332.09 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=208.8
Q ss_pred HHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceee-ecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~ 273 (517)
.|.+.+.||+|+||.||+|+. .+|+.||||++..... .+.+.+|+.+++.++|++++..+.++ ...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 456678999999999999987 4789999999875432 24688999999999998877777665 5566789999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe---CCCCcEEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~ 350 (517)
+++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++......
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 -GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999999742 4579999999999999999999999 999999999999999 48899999999999876543
Q ss_pred Ccc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 351 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 351 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+..........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence 321 1234568999999999999999999999999999999999999998544433333333222211111110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+... .+..+.+++.+||+.||++|||+++|++.|+++.....
T Consensus 241 ----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 241 ----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----HHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 00111 12468899999999999999999999999999887654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=342.53 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=190.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4667889999999999999876 689999999875432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
+ |+|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 7 69999886432 23468999999999999999999999 99999999999999999999999999999876533
Q ss_pred CcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC--cc-c--
Q 010131 351 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--VI-S-- 424 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~-~-- 424 (517)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+........ .. .
T Consensus 162 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 VNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGG
T ss_pred ccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhh
Confidence 221 233458999999999876 468999999999999999999999997443211 1111111111100 00 0
Q ss_pred ---ccCccccC------------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 ---IVDPVLIG------------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ---~~d~~l~~------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...+.+.. .........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000 000012346889999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=344.67 Aligned_cols=256 Identities=24% Similarity=0.412 Sum_probs=202.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcE----EEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKE----VAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
.|++.+.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 4566789999999999999875 3443 8888875432 233356788999999999999999999986 4568999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 9999999999999742 3578999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.... ......++..|+|||.+.+..++.++|||||||++|+|+| |+.||....... . ...+..+.......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---V----PDLLEKGERLAQPQ 240 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---H----HHHHHTTCBCCCCT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---H----HHHHHcCCCCCCCC
Confidence 3322 2234457889999999998899999999999999999999 999997443221 1 12222222111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.....+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 241 ---------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 241 ---------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ---------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ---------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0112467899999999999999999999999988754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=358.15 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=202.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.++||+|+||+||+|+++ +++.||+|++.+... .....+.+|..++..++||||++++++|.+.+..++|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3456789999999999999987 478999999864211 122348899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 155 y~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 155 YYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 99999999999742 4679999999999999999999999 999999999999999999999999999998766554
Q ss_pred cccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 352 THISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...+.. +.....+.......
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~-- 301 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ-- 301 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCC--
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHHhhhhcccccc--
Confidence 44445567999999999986 567899999999999999999999999743321 11111111100000
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 465 (517)
-|..... ....+.+++.+||+.+|++ ||+++|+++
T Consensus 302 ~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 302 FPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0111011 1235789999999988888 999999976
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=356.46 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=201.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||+||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||++++++|.+.+..++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3556789999999999999887 58899999986421 1123457899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 150 YMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999973 358999999999999999999999 999999999999999999999999999998776544
Q ss_pred cccccccccCCCCcCCCccCCCC----CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 352 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.. ................+
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHCCCCT
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhccccccCCC
Confidence 33344567999999999987654 789999999999999999999999743321 11122211100000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~~ 466 (517)
. . .....+.+++.+||+.+|.+ ||+++||++.
T Consensus 297 ~---~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 D---N----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp T---C----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c---c----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 0 11236789999999999988 9999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=337.55 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=198.0
Q ss_pred hhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC-CCCCccccceeeecCC
Q 010131 189 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 264 (517)
Q Consensus 189 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 264 (517)
..++....|++.++||+|+||+||+|.+. +|+.||||++..... .....+..|+..+.++ +||||++++++|.+.+
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34666778888999999999999999887 799999999865432 2334556666666655 8999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++||||+ +++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceee
Confidence 999999999 77999888753 4569999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
........ .....||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...+..+...
T Consensus 205 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~- 270 (311)
T 3p1a_A 205 VELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLP- 270 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCC-
T ss_pred eecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCC-
Confidence 87654322 233458999999999886 789999999999999999999777652110 1112222111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.+.. .....+.+++.+||+.||++|||++|+++
T Consensus 271 ---~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ---PEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---ccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111 12346889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=341.71 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=196.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCe----eE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ----RI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~ 267 (517)
.|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 5667899999999999999874 789999999976432 234578899999999999999999999876543 39
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 93 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 99999999999999974 4579999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
...... ......||+.|+|||++.+..++.++||||||+++|||+||+.||..... ................
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPS 240 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCCcc
Confidence 443221 22334589999999999999999999999999999999999999974322 1222222222211100
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH-HHHHHhhhhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI-VLAIQDSIKI 473 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev-l~~L~~~~~~ 473 (517)
.. .......+.+++.+||+.||++||++.++ ...+......
T Consensus 241 ---~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 ---AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ---HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ---cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00 00123468899999999999999966554 4556555443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=344.47 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=193.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+|.+.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4667899999999999999887 789999999975432 23668899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc--EEEccccCccccCCCCc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~~~~~~~ 352 (517)
+|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+++......
T Consensus 100 ~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 100 GGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp SCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999873 4569999999999999999999999 99999999999999987765 9999999987543221
Q ss_pred ccccccccCCCCcCCCccCCCCCCcc-ceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEK-SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .............. .. ..+
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~~~-~~-~~~---- 243 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILSVK-YS-IPD---- 243 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHTTC-CC-CCT----
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhcCC-CC-CCC----
Confidence 1233458999999999988777655 89999999999999999999743322 22222222222211 10 000
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ---DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00112367899999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.39 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=204.3
Q ss_pred HHHhhhcccCCCCceEEEEEEe-cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeee----cCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv 269 (517)
..|.+.+.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 4567789999999999999987 478999999987665566778999999999999999999999986 34478899
Q ss_pred EEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 270 YEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999999987532 34679999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCccc--------ccccccCCCCcCCCccCCCC---CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 349 EDLTHI--------SSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 349 ~~~~~~--------~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
...... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ....... .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~----~ 260 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-GDSVALA----V 260 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-TSCHHHH----H
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-cchhhHH----h
Confidence 221110 11234689999999987654 688999999999999999999999621111 1111111 1
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
... . .. .........+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 261 ~~~-~-~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 QNQ-L-SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HCC----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hcc-C-CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 110 0 00 0011123468899999999999999999999999997654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.12 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=208.9
Q ss_pred Hhhhc-ccCCCCceEEEEEEec---CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+.+.+ .||+|+||.||+|.+. ++..||||++..... ...+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 89 (287)
T 1u59_A 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 89 (287)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEE
Confidence 33444 8999999999999864 578899999986533 3567799999999999999999999999 4556899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 90 MAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp CCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred eCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999964 34569999999999999999999999 999999999999999999999999999998765433
Q ss_pred ccc--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 352 THI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 352 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... .. ...+..+....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~----~~~i~~~~~~~---- 233 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV----MAFIEQGKRME---- 233 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH----HHHHHTTCCCC----
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHhcCCcCC----
Confidence 221 223346789999999988889999999999999999999 99999743321 11 12222222111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
.+...+..+.+++.+||+.||++||++.|+++.|+.+......
T Consensus 234 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 234 -----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1112334788999999999999999999999999999876553
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.83 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=205.3
Q ss_pred hhcccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee-EEEEEe
Q 010131 199 FCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR-ILVYEY 272 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~ 272 (517)
..++||+|+||+||+|.+.+ +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 45889999999999998642 23799999976443 3457899999999999999999999999776655 999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+.+|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 105 MCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999975 35678999999999999999999999 9999999999999999999999999999986543221
Q ss_pred ---ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 353 ---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 353 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ...... .+..+....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~----~~~~~~~~~----- 248 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTH----FLAQGRRLP----- 248 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHH----HHHTTCCCC-----
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHH----HhhcCCCCC-----
Confidence 122334578899999999999999999999999999999996666542221 112222 122221111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 477 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 477 (517)
........+.+++.+||+.||.+|||++|+++.|++++......
T Consensus 249 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 249 ----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 01112346889999999999999999999999999998765433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=346.38 Aligned_cols=257 Identities=23% Similarity=0.407 Sum_probs=200.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCC-CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..|++.+.||+|+||.||+|.+. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 35667899999999999999875 444 3577777543 3345678999999999999999999999998765 789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999753 4569999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 349 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 349 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
..... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .. ..+..+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~~~~~~~~~~-- 239 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERLP-- 239 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCCC--
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCCC--
Confidence 43221 1223346778999999999999999999999999999999 999997443322 11 1222221111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
........+.+++.+||+.||.+|||++|+++.|+++...
T Consensus 240 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 240 -------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111233688999999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.16 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=211.8
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+....+.+.++||+|+||.||+|.+.++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3445567789999999999999999988889999997643 345789999999999999999999999876 67899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999999743 13468999999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
........++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .+ +...+..+....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~-~~~~i~~~~~~~------ 484 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------RE-VLDQVERGYRMP------ 484 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HH-HHHHHHTTCCCC------
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCCCC------
Confidence 222233346788999999988899999999999999999999 9999974322 11 112222221111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
........+.+++.+||+.||++|||+++|++.|+++...
T Consensus 485 ---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1112334688999999999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.59 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=207.8
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec------
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------ 262 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------ 262 (517)
+......|.+.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3455667788899999999999999986 79999999997543 356789999999999999999998854
Q ss_pred ----------CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 263 ----------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 263 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVD 157 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcC
Confidence 44579999999999999999754 24578999999999999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHH
Q 010131 333 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 412 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~ 412 (517)
++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..|+... ..
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~- 226 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK- 226 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH-
T ss_pred CCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH-
Confidence 99999999999987654322 22345899999999999989999999999999999999999887411 11
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
....+..+..... ....+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus 227 ~~~~~~~~~~~~~------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 227 FFTDLRDGIISDI------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHTTCCCTT------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHHhhccccccc------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1112222222111 12357899999999999999999999999998765433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.33 Aligned_cols=273 Identities=23% Similarity=0.374 Sum_probs=198.3
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHH--HhcCCCCCccccceeee-----cCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL--LSRIHHRNLVPLIGYCE-----EEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~-----~~~~~~l 268 (517)
.|.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.++ +..++||||+++++.+. .....++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEEC-CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 4566789999999999999874 899999998643 23444455555 44589999999998543 2335689
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC---------CcEecCCCCCCeEeCCCCcEEEc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP---------GIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~---------~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
||||+++|+|.+++.. ...++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+
T Consensus 90 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEe
Confidence 9999999999999973 345899999999999999999998 7 99999999999999999999999
Q ss_pred cccCccccCCCCc-------ccccccccCCCCcCCCccCC-------CCCCccceehhHHHHHHHHHhCCCCCCCCCcc-
Q 010131 340 DFGLSRQAEEDLT-------HISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG- 404 (517)
Q Consensus 340 Dfg~a~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~- 404 (517)
|||++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987643221 11223458999999999987 45677999999999999999997776532221
Q ss_pred ccccH----------HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 405 AELNI----------VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 405 ~~~~~----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
..... ................+.... .........+.+++.+||+.||++|||++|+++.|++++..-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11100 001111111111111111110 112345667999999999999999999999999999999765
Q ss_pred cCCCCCc
Q 010131 475 KGGDQKF 481 (517)
Q Consensus 475 ~~~~~~~ 481 (517)
.....+.
T Consensus 321 ~~~~~~~ 327 (336)
T 3g2f_A 321 ERNKSVS 327 (336)
T ss_dssp CC-----
T ss_pred HhcccCC
Confidence 5444443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=329.29 Aligned_cols=249 Identities=20% Similarity=0.271 Sum_probs=204.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
..|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45777899999999999999876 57799999998766666788999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe---CCCCcEEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~ 350 (517)
++++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||++ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999998874 4568999999999999999999999 999999999999999 78899999999999876543
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. .....||+.|+|||.+.+. ++.++||||||+++|+|++|+.||...... +.. ..+..+..... .. .
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~-~~-~ 230 (277)
T 3f3z_A 163 KM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVM-LKIREGTFTFP-EK-D 230 (277)
T ss_dssp SC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCCCCC-HH-H
T ss_pred cc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHH-HHHHhCCCCCC-ch-h
Confidence 32 2334589999999998764 899999999999999999999999743321 111 12222211100 00 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. .....+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 12346889999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.98 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=200.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.|.+.+.||+|+||.||+|+.+ +|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4566789999999999999986 68999999997532 23456788899999887 8999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 98 EYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999974 3578999999999999999999999 99999999999999999999999999999864332
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+... .+..+.. ..
T Consensus 172 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~-~i~~~~~------~~ 237 (345)
T 1xjd_A 172 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFH-SIRMDNP------FY 237 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHHCCC------CC
T ss_pred CC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHH-HHHhCCC------CC
Confidence 21 23445689999999999999999999999999999999999999974332 11111 2222211 11
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 464 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl 464 (517)
.. .....+.+++.+||+.||++||++. |++
T Consensus 238 p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred Cc----ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 1223678999999999999999997 664
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=345.47 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=196.7
Q ss_pred HhhhcccCCCCceEEEEEEec--CC--cEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK--DG--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 270 (517)
+.+.+.||+|+||+||+|.+. ++ ..||||.+.... ....+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 445688999999999999864 22 468999987543 3456789999999999999999999998754 55789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999974 24568899999999999999999999 99999999999999999999999999999865432
Q ss_pred Ccc---cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 351 LTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 351 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
... ......+++.|+|||.+.+..++.++|||||||++|||+| |.+||...... .... .+..+... .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~----~~~~~~~~--~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITV----YLLQGRRL--L 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHH----HHHTTCCC--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHH----HHHcCCCC--C
Confidence 211 1223346788999999998899999999999999999999 67777633322 2222 12222111 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
. +...+..+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 317 ~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1 11123468899999999999999999999999999887544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=339.26 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=192.7
Q ss_pred HHHhhhcccCCCCceEEEEEEe----cCCcEEEEEEecCCC----chhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
..|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4567789999999999999987 468999999997642 22345678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999974 4568999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+. ......... ...
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~-~~~---- 238 (327)
T 3a62_A 171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILK-CKL---- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCC----
T ss_pred cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCC----
Confidence 433222 22344689999999999998999999999999999999999999974332 111222222 111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.+ +......+.+++.+||+.||++|| ++.|+++
T Consensus 239 --~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 --NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 01 111234678999999999999999 6777765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=342.44 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=194.8
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCC--CCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++.+++| |||+++++++.+.+..++|||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 356678999999999999999889999999987543 2344778999999999976 999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+.+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 90 -~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 -CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp -CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred -CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 568899999984 5679999999999999999999999 9999999999999997 6789999999998765433
Q ss_pred cc-cccccccCCCCcCCCccCC-----------CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 010131 352 TH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 352 ~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .........+..
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~ 236 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDP 236 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCT
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcC
Confidence 22 2234568999999999854 678899999999999999999999996321 111222222221
Q ss_pred CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 420 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... ...+......+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~---------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 NHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Ccc---------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111 11111112367899999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=340.54 Aligned_cols=262 Identities=29% Similarity=0.474 Sum_probs=204.5
Q ss_pred HHHHHhhhcccCCCCceEEEEEEecC-----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
....+.+.+.||+|+||.||+|.+.. +..||||++..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 33455567899999999999998753 24699999976533 3456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999975 24679999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 347 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 347 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+ +...+..+...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~-~~~~~~~~~~~ 269 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HE-VMKAINDGFRL 269 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH-HHHHHHTTCCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HH-HHHHHHCCCcC
Confidence 6543221 1122335778999999998899999999999999999999 9999963322 11 11222222111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
. .....+..+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 270 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 270 P---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp C---------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred C---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1 111223468899999999999999999999999999886533
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=336.50 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=202.4
Q ss_pred HhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeee-cCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~ 270 (517)
|++.+.||+|+||+||+|.+.+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4567899999999999998653 23689999876433 34577999999999999999999999864 556789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 107 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp ECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999974 34568999999999999999999999 99999999999999999999999999999876443
Q ss_pred Cc---ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 351 LT---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 351 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
.. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...... .... ....+....
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~----~~~~~~~~~-- 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITV----YLLQGRRLL-- 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHH----HHHTTCCCC--
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHH----HHhcCCCCC--
Confidence 21 11223446788999999998899999999999999999999 55555432221 1111 111111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
. +...+..+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 253 ~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 253 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred C-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 11123468899999999999999999999999999887543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=341.52 Aligned_cols=256 Identities=25% Similarity=0.295 Sum_probs=199.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
...|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 456777899999999999999875 6889999998643 2344578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccC-------------------------------------CCCccCHHHHHHHHHHHHHHHHHH
Q 010131 268 LVYEYMHNGTLRDRLHGSV-------------------------------------NQKPLDWLTRLQIAHDAAKGLEYL 310 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~aL~~L 310 (517)
+||||+++|+|.+++.... ....+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985211 022346778889999999999999
Q ss_pred hcCCCCCcEecCCCCCCeEeCCCC--cEEEccccCccccCCCCc---ccccccccCCCCcCCCccCC--CCCCccceehh
Q 010131 311 HTGCNPGIIHRDVKSSNILLDINM--RAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPEYYGN--QQLTEKSDVYS 383 (517)
Q Consensus 311 H~~~~~~ivH~dlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s 383 (517)
|+ .+|+||||||+||+++.++ .+||+|||++........ .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 99 9999999999999998776 899999999986533211 12234568999999999865 67889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 010131 384 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 463 (517)
Q Consensus 384 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev 463 (517)
|||++|||++|+.||..... .+............. .+. .......+.+++.+||+.||.+|||+.|+
T Consensus 262 lG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~--~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVND------ADTISQVLNKKLCFE--NPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCTT--SGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcccccC--Ccc-----cccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99999999999999974332 122222222211110 111 01123468899999999999999999999
Q ss_pred HH
Q 010131 464 VL 465 (517)
Q Consensus 464 l~ 465 (517)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=339.93 Aligned_cols=266 Identities=28% Similarity=0.445 Sum_probs=211.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEe-----cCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC--ee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 266 (517)
...+++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34566789999999999999984 368899999998766666788999999999999999999999986644 68
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999753 3569999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHHH
Q 010131 347 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWARS 415 (517)
Q Consensus 347 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~---------~~~~~~~~~~~ 415 (517)
....... ......++..|+|||.+.+..++.++||||||+++|||+||..||...... ........+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 6544321 122334677899999998888999999999999999999999998632100 00011111122
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+..+.... .....+..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 275 ~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 275 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 222221111 1112334688999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=344.59 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=187.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 4666789999999999999987 57899999997543 34678899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCccccCCCC
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~ 351 (517)
+|+|.+++. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 132 ~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 132 GGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp SCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999999997 35679999999999999999999999 99999999999999975 8899999999998764432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.....+...... ...+
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~-~~~~--- 273 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYY-FISP--- 273 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCC-CCTT---
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCc-cCCc---
Confidence 123345899999999999999999999999999999999999999633221 1111122222111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+||+.||++|||+.|+++
T Consensus 274 --~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 --WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122346889999999999999999999976
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=341.55 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=202.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 4556789999999999999886 68999999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999974 3568999999999999999999999 99999999999999999999999999999876543
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+... .+..+... +
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~-~i~~~~~~------~- 257 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYE-KIVSGKVR------F- 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHHCCCC------C-
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHH-HHHcCCCC------C-
Confidence 2334689999999999999999999999999999999999999974321 12222 22222211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
+......+.+++.+||+.||.+||+ ++||++
T Consensus 258 ---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1112346889999999999999998 888765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=339.19 Aligned_cols=264 Identities=27% Similarity=0.423 Sum_probs=210.9
Q ss_pred HHHHhhhcccCCCCceEEEEEEe------cCCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecCC-
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH- 264 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~- 264 (517)
...|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 34567789999999999999975 2468899999976543 3456789999999999 7999999999987654
Q ss_pred eeEEEEEecCCCCHHhHhhccCC-------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 58999999999999999985432 1238999999999999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccH
Q 010131 332 INMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 409 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 409 (517)
.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||....... .
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~- 259 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E- 259 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--H-
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--H-
Confidence 999999999999987644322 22233457889999999988899999999999999999998 999997433221 1
Q ss_pred HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 410 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
....+..+..... .......+.+++.+||+.||.+|||+.|+++.|+.+++...
T Consensus 260 ---~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 260 ---FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp ---HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---HHHHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1122222221111 11122368899999999999999999999999999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.67 Aligned_cols=266 Identities=23% Similarity=0.270 Sum_probs=197.8
Q ss_pred hHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-----chhHHHHHHHHHHHhcC---CCCCccccceee
Q 010131 190 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRI---HHRNLVPLIGYC 260 (517)
Q Consensus 190 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~~~~~~ 260 (517)
.++...+|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.+++++ +||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 3445567788899999999999999874 68999999986322 11234566788877776 499999999999
Q ss_pred ecCC-----eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc
Q 010131 261 EEEH-----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 335 (517)
Q Consensus 261 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~ 335 (517)
.... ..++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 7654 4789999996 69999997542 3449999999999999999999999 99999999999999999999
Q ss_pred EEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 010131 336 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 336 ~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 415 (517)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..
T Consensus 159 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~ 233 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFD 233 (308)
T ss_dssp EEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHH
T ss_pred EEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 99999999987654322 234568999999999998899999999999999999999999997433211 1111111
Q ss_pred HHhcCCccccc------CccccC--C-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 416 MIKKGDVISIV------DPVLIG--N-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 416 ~~~~~~~~~~~------d~~l~~--~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.........+. ...... . ...+....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11111000000 000000 0 00122346789999999999999999999976
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=330.67 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=197.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46778899999999999999875 68999999987543 33567899999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe---CCCCcEEEccccCccccC
Q 010131 273 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 273 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~ 348 (517)
+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999886432 34679999999999999999999999 999999999999999 456889999999998765
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... +.... ............
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~-~~~~~~~~~~~~ 248 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQK-ATYKEPNYAVEC 248 (285)
T ss_dssp ----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCCCCCC--
T ss_pred Cccc--CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhh-hccCCccccccc
Confidence 4322 233458999999999864 6889999999999999999999999743321 11111 111111000000
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 249 ---~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 ---RP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---Cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1236789999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=340.93 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=197.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|++.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3556789999999999999886 5899999998654332 346788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 84 CDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999887 35679999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH-----------hcC
Q 010131 353 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-----------KKG 420 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 420 (517)
. .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ...+.... ...
T Consensus 158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 158 Y-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHHTC
T ss_pred c-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhcccccccccccccc
Confidence 2 233458999999999865 6789999999999999999999999974433211 11111111 000
Q ss_pred Ccc---cccCccccCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 421 DVI---SIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 421 ~~~---~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... ...++.-.... .......+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00010000000 01223458899999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=353.58 Aligned_cols=252 Identities=24% Similarity=0.263 Sum_probs=200.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||.||+|+.+ +|+.||+|++.+... ...+.+.+|..++..++||||+++++++.+.+..++|||
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 3556789999999999999986 699999999964321 223458899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++... +..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++......
T Consensus 142 ~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 142 YYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp CCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999743 3479999999999999999999999 999999999999999999999999999998776544
Q ss_pred cccccccccCCCCcCCCccC-------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 352 THISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
........||+.|+|||++. +..++.++|||||||++|||++|+.||...+.. +...........
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~-- 288 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYGKIVHYKEH-- 288 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHH--
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhcccC--
Confidence 43344567999999999986 467899999999999999999999999743321 111111110000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~evl~ 465 (517)
..-|.. .......+.+++.+||+ +|++| |+++|+++
T Consensus 289 ~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 289 LSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000111 11122367899999999 99998 58888865
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.39 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=205.4
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch------hHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
...|.+.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456778899999999999999876 6899999998754321 357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC----cEEEcccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 342 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 342 (517)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997 35679999999999999999999999 9999999999999999888 79999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .+.... +.....
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~-i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLAN-ITSVSY 235 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHH-HHTTCC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHH-HHhccc
Confidence 9987654322 2334589999999999999999999999999999999999999974322 111111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001111111 1235789999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=364.00 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=203.5
Q ss_pred ccCCCCceEEEEEEec---CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCC
Q 010131 202 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
.||+|+||.||+|.+. ++..||||+++... ....+.|.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 46679999997643 3456889999999999999999999999976 56899999999999
Q ss_pred HHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc--c
Q 010131 278 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--S 355 (517)
Q Consensus 278 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~ 355 (517)
|.+++.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......... .
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999974 24569999999999999999999999 999999999999999999999999999998765432211 1
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+..+.... .
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~---------~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME---------C 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCC---------C
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCC---------C
Confidence 22335689999999998899999999999999999998 999997433211 122333332211 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhcC
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 476 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 476 (517)
+...+..+.+++.+||+.||++||++.+|++.|+.+......
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 122345788999999999999999999999999998765443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.45 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=200.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------hhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
...|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 356777899999999999999865 689999999975421 12345778999999999999999999999999
Q ss_pred eeEEEEEecCCC-CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 265 QRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 265 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
..++||||+.+| +|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 9999997 45679999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
+........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ..
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~---- 238 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VE---- 238 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TT----
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hh----
Confidence 987654332 223458999999999988776 88999999999999999999999631110 00
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....+ +......+.+++.+||+.||++|||++|+++.
T Consensus 239 -~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 -AAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -hccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00122368899999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=341.38 Aligned_cols=262 Identities=24% Similarity=0.411 Sum_probs=211.1
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCe
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 265 (517)
....|.+.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 3446677899999999999999765 367899999975433 344678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccC-------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEE
Q 010131 266 RILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl 338 (517)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEE
Confidence 999999999999999987532 12467999999999999999999999 99999999999999999999999
Q ss_pred ccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 010131 339 SDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||..... .+. ...
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~-~~~ 252 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQV-LRF 252 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHH-HHH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------HHH-HHH
Confidence 99999986544322 12223346889999999988889999999999999999999 8999874322 111 122
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
+..+..... ....+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 253 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 222222111 112234688999999999999999999999999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=328.50 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=203.1
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45677899999999999999886 68999999986443 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.+++. ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.+........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999987 35679999999999999999999999 9999999999999999999999999999986543221
Q ss_pred -ccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 353 -HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 353 -~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... .....+ ....... .+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~~~~~~---~~-- 230 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKTYL---NP-- 230 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHH----HTTCTTS---TT--
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHh----hhccccc---Cc--
Confidence 12234568999999999987665 789999999999999999999997433221 111111 1111100 00
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.||++|||++|+++
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112336789999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=343.75 Aligned_cols=267 Identities=19% Similarity=0.203 Sum_probs=199.7
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCCchh-----------HHHHHHHHHHHhcCCCCCccccc
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHR-----------TQQFVTEVALLSRIHHRNLVPLI 257 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~ 257 (517)
....|.+.+.||+|+||.||+|... ++..||||+........ ...+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3345677899999999999999886 57889999987653221 13466788999999999999999
Q ss_pred eeeec----CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC
Q 010131 258 GYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 333 (517)
Q Consensus 258 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~ 333 (517)
+++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence 99887 67889999999 9999999974 3389999999999999999999999 999999999999999888
Q ss_pred C--cEEEccccCccccCCCCcc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccc
Q 010131 334 M--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405 (517)
Q Consensus 334 ~--~~kl~Dfg~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 405 (517)
+ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~ 266 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK-D 266 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT-C
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-c
Confidence 7 9999999999876432211 11344689999999999999999999999999999999999999963221 1
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.... .......... ....+..... ....+..+.+++.+||+.||++|||+++|++.|+++..
T Consensus 267 ~~~~-~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 PVAV-QTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHH-HHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cHHH-HHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1111 1111111111 1111100000 00123368899999999999999999999999987543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=334.95 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=199.1
Q ss_pred HHHHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC---
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--- 264 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 264 (517)
...|.+.+.||+|+||.||+|.+. .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 345667889999999999999765 24589999987542 234567999999999999999999999997755
Q ss_pred --eeEEEEEecCCCCHHhHhhccC---CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc
Q 010131 265 --QRILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 265 --~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEe
Confidence 3499999999999999985322 34679999999999999999999999 999999999999999999999999
Q ss_pred cccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH
Q 010131 340 DFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 340 Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .+
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----~~ 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD----YL 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH----HH
Confidence 9999987644322 12223446789999999999999999999999999999999 889987433221 111 11
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
..+..... ....+..+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 263 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 LHGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HTTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HcCCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 12211111 1122346889999999999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=342.00 Aligned_cols=247 Identities=25% Similarity=0.333 Sum_probs=201.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
..|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 34667899999999999999987 47899999997532 23456788999999988 899999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999974 3569999999999999999999999 9999999999999999999999999999986432
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +...
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-~~~~------ 239 (353)
T 2i0e_A 174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-HNVA------ 239 (353)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCCC------
T ss_pred CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-CCCC------
Confidence 221 23345689999999999999999999999999999999999999974322 122222222 2110
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
+ +......+.+++.+||+.||++||+ ++|+++
T Consensus 240 ~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 1112346789999999999999995 466654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=344.84 Aligned_cols=264 Identities=30% Similarity=0.496 Sum_probs=208.3
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcE--EEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCe
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE--VAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 265 (517)
.+....|.+.+.||+|+||.||+|+.. ++.. ||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 333456777899999999999999875 4654 4999887533 23456789999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 266 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcC
Confidence 999999999999999997532 23479999999999999999999999 99999999999999999
Q ss_pred CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHH
Q 010131 333 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 411 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~ 411 (517)
++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~ 249 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE 249 (327)
T ss_dssp GGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH
T ss_pred CCeEEEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HH
Confidence 99999999999875432211 122346789999999988889999999999999999998 9999974322 11
Q ss_pred HHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 412 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 412 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
. ...+..+... .........+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 250 ~-~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 L-YEKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp H-HHHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred H-HHHhhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 1222222111 1111223468899999999999999999999999999887644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=344.75 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=195.9
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCC--CCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++ ||||+++++++...+..++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 366788999999999999998889999999986543 334577999999999996 5999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+.+++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 137 -~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 -CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp -CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred -cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 668899999984 4578999999999999999999999 9999999999999996 5899999999998765433
Q ss_pred cc-cccccccCCCCcCCCccCC-----------CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 010131 352 TH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 352 ~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .........+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~ 283 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDP 283 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCT
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCc
Confidence 22 2334569999999999864 468899999999999999999999996322 111222222221
Q ss_pred CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 420 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..... .+......+.+++.+||+.||++|||+.|+++.
T Consensus 284 ~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCC---------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111 111112367899999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=332.64 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=205.0
Q ss_pred HHhhhc-ccCCCCceEEEEEEec---CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 196 TNNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 196 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
.|.+.+ .||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 445555 8999999999999653 468899999975432 2357799999999999999999999999 55678999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999984 4569999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCccc--ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 350 DLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 350 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
..... .....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||...... + +...+..+....
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~~-- 240 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGERMG-- 240 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCCC--
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCCC--
Confidence 33221 122345688999999988889999999999999999999 99999743221 1 122222222111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.+...+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 241 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 241 -------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111223468899999999999999999999999999886543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=331.29 Aligned_cols=247 Identities=27% Similarity=0.416 Sum_probs=181.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 3566789999999999999874 78999999986432 1234678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 92 MCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred cCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999742 3678999999999999999999999 999999999999999999999999999998764332
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .. .... +...
T Consensus 167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~----~~~~---~~~~- 231 (278)
T 3cok_A 167 EK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NK----VVLA---DYEM- 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSS---CCCC-
T ss_pred Cc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HH----Hhhc---ccCC-
Confidence 21 22345899999999999989999999999999999999999999744322110 00 0000 0011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.||++|||++|+++
T Consensus 232 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 ---PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1112346789999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=339.14 Aligned_cols=246 Identities=28% Similarity=0.398 Sum_probs=199.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|...+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45666789999999999999864 789999999975432 23467899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+. |+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 6888877542 4679999999999999999999999 99999999999999999999999999999876432
Q ss_pred CcccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ........... ......
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~-~~~~~~ 275 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SPALQS 275 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCCCCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-CCCCCC
Confidence 2345899999999873 56789999999999999999999999973321 12222222221 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
......+.+++.+||+.||++|||++|+++.
T Consensus 276 --------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 --------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1122357899999999999999999999763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.39 Aligned_cols=245 Identities=25% Similarity=0.380 Sum_probs=202.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4566789999999999999886 79999999996432 1234678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++. ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 97 YVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999997 35679999999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... ... ..+..+... .+
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~-~~i~~~~~~---~p-- 236 (476)
T 2y94_A 171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLF-KKICDGIFY---TP-- 236 (476)
T ss_dssp C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHH-HHHHTTCCC---CC--
T ss_pred c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHH-HHHhcCCcC---CC--
Confidence 2 234568999999999988765 78999999999999999999999743321 111 122222110 01
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
......+.+++.+||+.||++|||++|+++
T Consensus 237 -----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 -----QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111235789999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=332.74 Aligned_cols=245 Identities=26% Similarity=0.413 Sum_probs=198.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 4556789999999999999876 57799999986432 1234678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 90 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999874 3568999999999999999999999 999999999999999999999999999986554322
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... +... .+..... .
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~------~-- 225 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYK-RISRVEF------T-- 225 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-HHHHTCC------C--
T ss_pred ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHH-HHHhCCC------C--
Confidence 23345899999999999999999999999999999999999999743321 1111 1111111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+......+.+++.+||+.||++|||++|+++.
T Consensus 226 --~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111122367899999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=341.68 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=200.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 271 (517)
...|.+.+.||+|+||.||+|..+ +|+.||||++..... ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 346777899999999999999886 688999999976432 235688888888 79999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC----CcEEEccccCcccc
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 347 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~~ 347 (517)
|+++|+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+||++..+ +.+||+|||++...
T Consensus 97 ~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999997 35679999999999999999999999 999999999999998543 35999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+ +...+..+....
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~-~~~~i~~~~~~~--- 242 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEE-ILARIGSGKFSL--- 242 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHH-HHHHHHHCCCCC---
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHH-HHHHHccCCccc---
Confidence 54322 2234468999999999988888999999999999999999999997432222 112 222233332211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...........+.+++.+||+.||++|||+.|+++
T Consensus 243 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 ---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111122346789999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.96 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=202.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
...|.+.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456778899999999999999876 6899999999865544556789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe---CCCCcEEEccccCccccCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~ 349 (517)
+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999874 3568999999999999999999999 999999999999999 7889999999999876543
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ...+..+... . ...
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~-~~~i~~~~~~-~-~~~ 229 (304)
T 2jam_A 162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKL-FEKIKEGYYE-F-ESP 229 (304)
T ss_dssp BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHH-HHHHHHCCCC-C-CTT
T ss_pred Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHH-HHHHHcCCCC-C-Ccc
Confidence 21 2234589999999999999999999999999999999999999974321 111 1222222211 0 011
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .......+.+++.+||+.||++|||++|+++
T Consensus 230 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 F----WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp T----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1122346889999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=342.89 Aligned_cols=264 Identities=16% Similarity=0.198 Sum_probs=206.0
Q ss_pred HHhhhcccCCCCceEEEEEEecC---------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccc-----------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP----------- 255 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 255 (517)
.|.+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 45678899999999999998763 789999998754 45789999999999999987
Q ss_pred ----cceeeec-CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe
Q 010131 256 ----LIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 330 (517)
Q Consensus 256 ----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill 330 (517)
+++++.. ++..++||||+ +++|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 5666665 67889999999 99999999853 13679999999999999999999999 999999999999999
Q ss_pred CCCC--cEEEccccCccccCCCCcc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCC
Q 010131 331 DINM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402 (517)
Q Consensus 331 ~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 402 (517)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999876543221 1133468999999999999999999999999999999999999997433
Q ss_pred ccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 403 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.. ...+......... ....+.+.... .......+.+++.+||+.||++|||+++|++.|+++.+...
T Consensus 273 ~~-~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PN-TEDIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TC-HHHHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cC-HHHHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 11 1122222221111 11111111110 00112468899999999999999999999999999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.30 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=199.4
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecC-CeeEEEEEec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-HQRILVYEYM 273 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~ 273 (517)
..|++.+.||+|+||+||+|... |+.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 45667899999999999999886 8999999987542 457789999999999999999999987544 4789999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 9999999997431 2347899999999999999999999 999999999999999999999999999988654322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||....... .. ..+..+...
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~--------- 233 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYKM--------- 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCCC---------
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCCC---------
Confidence 22346889999999988899999999999999999998 999997433221 11 122222111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
......+..+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 111122346889999999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=346.93 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=210.5
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecCCe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 265 (517)
...|.+.+.||+|+||.||+|.... ...||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3456678999999999999998752 24799999976543 3456799999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccC-----------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC
Q 010131 266 RILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 334 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~ 334 (517)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 999999999999999987532 13468999999999999999999999 9999999999999999999
Q ss_pred cEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 010131 335 RAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 412 (517)
Q Consensus 335 ~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~ 412 (517)
.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||+| |..||....... ..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~--- 276 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KF--- 276 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HH---
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HH---
Confidence 9999999999876443221 2233446789999999988889999999999999999999 999997433221 11
Q ss_pred HHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 413 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 413 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
......+.... .+...+..+.+++.+||+.||.+|||++||++.|+++....
T Consensus 277 -~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 -YKLVKDGYQMA---------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -HHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHhcCCCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 12222221100 01112346889999999999999999999999999887653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=348.66 Aligned_cols=201 Identities=26% Similarity=0.326 Sum_probs=175.4
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-----CCCccccceeeecCC
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----HRNLVPLIGYCEEEH 264 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~ 264 (517)
++....|.+.++||+|+||+||+|+.. +++.||||++... ....+.+..|+.+++.++ ||||+++++++...+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 344456778899999999999999885 6899999999743 344566788999999986 999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC------------
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------------ 332 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~------------ 332 (517)
..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhc
Confidence 999999999 99999999754 23469999999999999999999999 99999999999999975
Q ss_pred -------------CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 333 -------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 333 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|+||+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 7899999999998654322 33468999999999999999999999999999999999999997
Q ss_pred CC
Q 010131 400 VE 401 (517)
Q Consensus 400 ~~ 401 (517)
..
T Consensus 261 ~~ 262 (360)
T 3llt_A 261 TH 262 (360)
T ss_dssp CS
T ss_pred CC
Confidence 43
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.72 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=197.0
Q ss_pred Hhh-hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNF-CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+ .+.||+|+||+||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 344 367999999999999865 6899999999876556678899999999985 7999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~~ 350 (517)
++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++......
T Consensus 94 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 94 RGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred CCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999974 3578999999999999999999999 99999999999999998776 999999998765322
Q ss_pred Cc------ccccccccCCCCcCCCccCC-----CCCCccceehhHHHHHHHHHhCCCCCCCCCccccc--------cHHH
Q 010131 351 LT------HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVH 411 (517)
Q Consensus 351 ~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~--------~~~~ 411 (517)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11123458999999999864 56789999999999999999999999754322100 0011
Q ss_pred HHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 412 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 412 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+..+... ..++. .. .....+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~i~~~~~~-~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYE-FPDKD-WA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCC-CCHHH-HT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcc-cCchh-cc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 112222222210 00000 00 12346889999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=345.41 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=202.5
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
...|.+.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 345667889999999999999886 689999999976533 345679999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999974 3568999999999999999999998 6 8999999999999999999999999998765332
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccH---------------------
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI--------------------- 409 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~--------------------- 409 (517)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 186 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp C-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1 2234689999999999999999999999999999999999999974332110000
Q ss_pred ---------------HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 410 ---------------VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 410 ---------------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.+...... .+.... . ........+.+++.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIV-NEPPPK-----L---PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHH-HSCCCC-----C---CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHh-ccCCCC-----C---CcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000 000000 0 001123468899999999999999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=326.60 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=202.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 4566789999999999999876 58999999986543 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEEccccCccccCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEE 349 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~a~~~~~ 349 (517)
+++++|.+.+.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++. +||+|||++.....
T Consensus 87 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 87 VTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999988874 4568999999999999999999999 99999999999999987655 99999999987654
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ..+..+... ...+.
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~-~~~~~~~~~-~~~~~ 230 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLY-AQIKAGAYD-YPSPE 230 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHTCCC-CCTTT
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHH-HHHHhcccc-CCchh
Confidence 332 23345899999999999999999999999999999999999999743221 111 122222111 00110
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.||++|||++|+++
T Consensus 231 -----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 -----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp -----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112236789999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=327.19 Aligned_cols=245 Identities=29% Similarity=0.430 Sum_probs=196.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec----CCeeEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 269 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 269 (517)
+.+.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 345678999999999999875 68899999987542 3345778999999999999999999998865 3568999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--cEecCCCCCCeEeC-CCCcEEEccccCccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQ 346 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~ 346 (517)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++||||||+||+++ .++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999974 3578999999999999999999999 77 99999999999998 789999999999976
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
..... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ..... ..+..+......
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~-~~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIY-RRVTSGVKPASF 251 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHH-HHHTTTCCCGGG
T ss_pred ccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHH-HHHhccCCcccc
Confidence 54432 223458999999998875 589999999999999999999999973322 11111 222222111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+.. ....+.+++.+||+.||.+|||++|+++
T Consensus 252 ~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 DKV--------AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGC--------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC--------CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111 1236889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=326.54 Aligned_cols=259 Identities=24% Similarity=0.298 Sum_probs=205.8
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
...|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 346778899999999999999887 689999999865422 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC----cEEEcccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 342 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg 342 (517)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999974 4578999999999999999999999 9999999999999998877 89999999
Q ss_pred CccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 343 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 343 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... +... .+.....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLT-NISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-HHHTTCC
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHH-HhHhccc
Confidence 9987654322 22345899999999999999999999999999999999999999743221 1111 1111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhhhhh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIKI 473 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~~~ 473 (517)
. .++.... .....+.+++.+||+.||++|||+.|+++ .++.+...
T Consensus 229 ~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 229 D--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp C--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred C--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 0 0000001 12236789999999999999999999997 45655433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=341.93 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=193.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHH-HhcCCCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..|++.+.||+|+||.||+|+.+ +++.||+|++.+... .....+..|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 35677899999999999999886 588999999975432 233456777776 5678999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999974 4578999999999999999999999 9999999999999999999999999999986433
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... +...
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-~~~~------ 257 (373)
T 2r5t_A 192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN-KPLQ------ 257 (373)
T ss_dssp CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHH-SCCC------
T ss_pred CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-cccC------
Confidence 22 123445699999999999999999999999999999999999999974322 122222222 1110
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 467 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 467 (517)
+.. .....+.+++.+||+.||.+||++.+.++.+
T Consensus 258 ~~~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 258 LKP----NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp CCS----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred CCC----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 111 1223678999999999999999986544433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=365.04 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=200.6
Q ss_pred cccCCCCceEEEEEEec---CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
++||+|+||.||+|.+. .++.||||+++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999664 467899999975432 346789999999999999999999999965 458899999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc--c
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT--H 353 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~--~ 353 (517)
|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999973 5679999999999999999999999 9999999999999999999999999999987654322 1
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... + +...+..+.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~-~~~~i~~~~~~~~------- 593 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGERMGC------- 593 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCCCC-------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCCC-------
Confidence 2223346788999999999899999999999999999998 99999743321 1 2223333322111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+...+..+.+++.+||+.||++||++++|++.|+++..
T Consensus 594 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 594 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11233578899999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=341.23 Aligned_cols=259 Identities=19% Similarity=0.254 Sum_probs=190.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|.+.+.||+|+||+||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 5677899999999999999865 6899999999754322 245678999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe-----CCCCcEEEccccCcccc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA 347 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill-----~~~~~~kl~Dfg~a~~~ 347 (517)
++ |+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++...
T Consensus 115 ~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 115 AE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp CS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred CC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 97 599999874 4569999999999999999999999 999999999999999 45556999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc-
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI- 425 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 425 (517)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.. +............
T Consensus 188 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFK-IFEVLGLPDDTTWP 263 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTTTST
T ss_pred CCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHH-HHHHhCCCchhhhh
Confidence 433222 2334579999999998774 58999999999999999999999997433211 1111 1111110000000
Q ss_pred --------c--CccccCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 --------V--DPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 --------~--d~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .+...... .......+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 00000000 0012346789999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=338.65 Aligned_cols=266 Identities=27% Similarity=0.443 Sum_probs=208.0
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
++....|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 444556778899999999999999842 47789999997543 34456789999999999999999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCC----CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcE
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRA 336 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~ 336 (517)
+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999986431 2458999999999999999999999 99999999999999984 4569
Q ss_pred EEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 010131 337 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 337 kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 414 (517)
||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||..... .+ ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~-~~ 255 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QE-VL 255 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HH-HH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HH-HH
Confidence 9999999876433221 12233457889999999988889999999999999999998 9999973321 11 11
Q ss_pred HHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 415 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
..+..+..... .......+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 256 ~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 256 EFVTSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHhcCCCCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 22222211111 11123468899999999999999999999999998876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=329.08 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=196.8
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCCCHH
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 279 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 279 (517)
..||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999875 68899999998766666678999999999999999999999999999999999999999999
Q ss_pred hHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCccccCCCCccccccc
Q 010131 280 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVA 358 (517)
Q Consensus 280 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 358 (517)
+++........+++..+..++.|++.||+|||+ .+++|+||||+||+++. ++.+||+|||++........ .....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence 999865445567899999999999999999999 99999999999999987 89999999999987644221 12334
Q ss_pred ccCCCCcCCCccCCCC--CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCH
Q 010131 359 RGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436 (517)
Q Consensus 359 ~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 436 (517)
.|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ......... .. .+.+ +.
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~-~~-----~~~~----~~ 249 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGMF-KV-----HPEI----PE 249 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHHH-CC-----CCCC----CT
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhccc-cc-----cccc----cc
Confidence 5899999999986643 7899999999999999999999996322111 011111111 10 1111 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 437 ~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22346789999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.88 Aligned_cols=263 Identities=25% Similarity=0.337 Sum_probs=190.0
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCC-CCCccccceeeecCC--ee
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH--QR 266 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~ 266 (517)
....|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3446777899999999999999875 68999999986532 344567889999999997 999999999997544 68
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 689998873 468999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCC--------------------cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccc
Q 010131 347 AEEDL--------------------THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 405 (517)
Q Consensus 347 ~~~~~--------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~ 405 (517)
..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 53211 111233468999999999876 678999999999999999999999997543221
Q ss_pred cccHHHHHHHHHhcCCcccc---cC-----------------ccccCCC-------------CHHHHHHHHHHHHHhhcc
Q 010131 406 ELNIVHWARSMIKKGDVISI---VD-----------------PVLIGNV-------------KIESIWRIAEVAIQCVEQ 452 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~---~d-----------------~~l~~~~-------------~~~~~~~l~~li~~cl~~ 452 (517)
....+...+.......+ .. +...... .......+.+++.+||+.
T Consensus 239 ---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 ---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp ---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred ---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 11111111110000000 00 0000000 001134678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 010131 453 RGFSRPKMQEIVLA 466 (517)
Q Consensus 453 ~P~~RPs~~evl~~ 466 (517)
||++|||++|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=328.78 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=202.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 3556789999999999999887 57899999986542 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 96 LCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999998873 4578999999999999999999999 999999999999999999999999999998764332
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... +.... +..+.. .+.
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~~------~~~ 235 (294)
T 2rku_A 170 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLR-IKKNEY------SIP 235 (294)
T ss_dssp CC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHTTCC------CCC
T ss_pred cc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhhccC------CCc
Confidence 21 23345899999999999989999999999999999999999999743321 11111 111111 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
. .....+.+++.+||+.||++|||++|+++.
T Consensus 236 ~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 K----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred c----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 122367899999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=341.31 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=188.6
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhc-CCCCCccccceeeec----CCeeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSR-IHHRNLVPLIGYCEE----EHQRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~lv~e~~~ 274 (517)
+.||+|+||+||+|... +|+.||||++... ..+.+|+.++.+ .+||||+++++++.. .+..++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999876 6899999998642 456788888754 489999999998865 567899999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCccccCCCC
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~ 351 (517)
+|+|.+++... ....+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 143 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 99999999853 23469999999999999999999999 99999999999999997 7899999999998764332
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+..+... ...+.
T Consensus 219 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~~-~~~~~- 290 (400)
T 1nxk_A 219 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYE-FPNPE- 290 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCCC-CCTTT-
T ss_pred c--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCccc-CCCcc-
Confidence 2 2345689999999999999999999999999999999999999974432211 11111 12222211 00000
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 291 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 ----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01123468899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=340.99 Aligned_cols=261 Identities=23% Similarity=0.343 Sum_probs=198.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|++.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4667889999999999999886 589999999865433 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++++|.++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 106 VDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999988876 35679999999999999999999999 9999999999999999999999999999987544322
Q ss_pred ccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH----------HHHhcCC
Q 010131 353 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR----------SMIKKGD 421 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~~ 421 (517)
......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ...... .......
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhcc
Confidence 12334589999999998775 789999999999999999999999974432211 111100 0001000
Q ss_pred -cccccCccccCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 -VISIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 -~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
......+.+..... ......+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00111111111111 123456889999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.79 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=192.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecC------Cee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 266 (517)
.|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 4667889999999999999876 6899999999754 233456788999999999999999999998654 356
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999976 4666664 248999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH----------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM---------- 416 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 416 (517)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+. ...+...
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHHHT
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHH
Confidence 65432 22345689999999999999999999999999999999999999975442211 1111111
Q ss_pred ---------HhcCC------cccccCccccCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 417 ---------IKKGD------VISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 417 ---------~~~~~------~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
..... ........+.... .......+.+|+.+||+.||++|||++|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 11224578899999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=352.72 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=193.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 34667899999999999999876 6899999999753 2233456788999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999974 4578999999999999999999995 278999999999999999999999999999864332
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+....... .... +
T Consensus 303 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~-~~~~------~ 368 (446)
T 4ejn_A 303 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILM-EEIR------F 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCCC------C
T ss_pred Cc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHh-CCCC------C
Confidence 22 22345689999999999999999999999999999999999999974332 111122221 1110 1
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
+......+.+++.+||+.||.+|| +++|+++
T Consensus 369 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 ----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111224678999999999999999 9999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=343.24 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=202.6
Q ss_pred HHHhhhcccCCCCceEEEEEEe----cCCcEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCCccccceeeecCCe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 265 (517)
..|.+.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 3567789999999999999987 368999999986432 12345677899999999 69999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999974 3568999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE--- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC---
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccC---
Confidence 765444433444568999999999975 357899999999999999999999997433221 2222222222211
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 466 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~~ 466 (517)
+. .+......+.+++.+||+.||++|| +++|+++.
T Consensus 283 ----~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 ----PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11 1112234678999999999999999 89998764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=344.07 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=193.1
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------hhHHHHHHHHHHHhcCCCCCccccceeee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCE 261 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 261 (517)
......|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 444556778899999999999999876 689999999864321 11234889999999999999999999986
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEE
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKV 338 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl 338 (517)
. +..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.+ ..+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 4 45799999999999999887 45679999999999999999999999 999999999999999754 45999
Q ss_pred ccccCccccCCCCcccccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 010131 339 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 415 (517)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~---- 355 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKD---- 355 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHH----
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHH----
Confidence 9999998765432 2234568999999999853 67788999999999999999999999743322 12221
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+..+..... +.... .....+.+++.+||+.||++|||++|+++
T Consensus 356 ~i~~~~~~~~--~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCC--chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2222221110 00001 12346889999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.05 Aligned_cols=250 Identities=25% Similarity=0.316 Sum_probs=203.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+.+.+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 455688999999999999886 69999999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++||+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 266 ~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 266 MNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 9999999998753 23459999999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... +...+.....
T Consensus 342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~-i~~~i~~~~~---------- 406 (576)
T 2acx_A 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REE-VERLVKEVPE---------- 406 (576)
T ss_dssp --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHH-HHHHHHHCCC----------
T ss_pred --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHH-HHHHhhcccc----------
Confidence 2334699999999999999999999999999999999999999975432211 111 1122221111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
.++......+.+++.+||+.||++|| +++||++
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01111223678999999999999999 7788875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=328.23 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=204.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 3556789999999999999875 68999999997543 345678999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++++|.+++. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 103 ~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 103 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp TTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 9999999986 4579999999999999999999999 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .... ..+..+... .+...
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~-----~~~~~ 242 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVL-FLIPKNNPP-----TLEGN 242 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH-HHHHHSCCC-----CCCSS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHH-HHhhcCCCC-----CCccc
Confidence 12334589999999999999999999999999999999999999973321 1111 112222111 11111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
....+.+++.+||+.||++|||+.|+++.
T Consensus 243 ----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 ----YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 22358899999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=344.81 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=206.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC-CCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|.+.++||+|+||.||+|.+. +++.||||++..... ..++..|+++++.++| +++..+..++.+.+..++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4566789999999999999874 689999998865432 2357889999999977 55555656667788889999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe---CCCCcEEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a~~~~~~ 350 (517)
+++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999999742 4579999999999999999999999 999999999999999 68899999999999876543
Q ss_pred Ccc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 351 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 351 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+...........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 321 12245689999999999999999999999999999999999999985443322222222221111111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+. .. .+..+.+++.+||+.+|++||++++|++.|+++....
T Consensus 240 l~-----~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 LC-----RG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HH-----TT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred Hh-----cC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 10 11 1346889999999999999999999999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=334.92 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=202.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 4566789999999999999886 57899999986542 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 122 ~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 122 LCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999998874 4578999999999999999999999 999999999999999999999999999998764332
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... +.... +..+.. .+.
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-~~~~~~------~~~ 261 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLR-IKKNEY------SIP 261 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHHTCC------CCC
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHH-HhcCCC------CCC
Confidence 2 123345899999999999888999999999999999999999999743221 11111 111111 011
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .....+.+++.+||+.||++|||++|+++
T Consensus 262 ~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 K----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred c----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11235789999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.18 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=203.8
Q ss_pred cChhHHHHHHHhhh-cccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcC-CCCCccccceeee
Q 010131 187 IPLPELEEATNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCE 261 (517)
Q Consensus 187 ~~~~~l~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 261 (517)
+...+.....|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33345555666665 88999999999999876 68999999987543 23467899999999999 5799999999999
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEE
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKV 338 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl 338 (517)
+.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999998643 34679999999999999999999999 99999999999999998 789999
Q ss_pred ccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 339 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+... .... +.
T Consensus 176 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~-i~ 246 (327)
T 3lm5_A 176 VDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLN-IS 246 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HH
T ss_pred eeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHH-HH
Confidence 99999987654322 233458999999999999999999999999999999999999997433211 1111 11
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... . ...........+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 QVNVD-Y-----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HTCCC-C-----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccc-c-----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 11100 0 00111122346889999999999999999999876
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=339.57 Aligned_cols=259 Identities=21% Similarity=0.318 Sum_probs=193.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchh-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|.+.+.||+|+||+||+|... +++.||||++....... ...+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 556789999999999999886 78999999986543221 1245679999999999999999999999999999999997
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 84 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 156 (324)
T 3mtl_A 84 -KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 156 (324)
T ss_dssp -EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred -cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence 5898888753 4568999999999999999999999 99999999999999999999999999999865433221
Q ss_pred ccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC---cccccC---
Q 010131 355 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VISIVD--- 427 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--- 427 (517)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+ ....+........ ......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchh
Confidence 223457999999999876 568999999999999999999999997443221 1222222211110 000000
Q ss_pred ------ccccCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 ------PVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ------~~l~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+...... .......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 0112346789999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.21 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=201.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeee--cCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~ 270 (517)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 4566789999999999999886 68999999997543 334567999999999999999999999874 466889999
Q ss_pred EecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCC-----cEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 271 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999997543 34559999999999999999999999 77 999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
......... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+. .+ ....+..+....
T Consensus 164 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~~~~ 235 (279)
T 2w5a_A 164 RILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KE-LAGKIREGKFRR 235 (279)
T ss_dssp HHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHTCCCC
T ss_pred eeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HH-HHHHHhhccccc
Confidence 876543221 2234589999999999988999999999999999999999999974321 11 122233333211
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
+ +......+.+++.+||+.||++|||++||++.+.
T Consensus 236 ~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 I---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp C---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred C---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1 1112346889999999999999999999988543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.69 Aligned_cols=250 Identities=20% Similarity=0.360 Sum_probs=197.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 4567889999999999999987 589999999976666667889999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+++|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 100 ~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 173 (302)
T 2j7t_A 100 GGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-K 173 (302)
T ss_dssp TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-C
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-c
Confidence 99999988642 4568999999999999999999999 9999999999999999999999999998764322111 1
Q ss_pred ccccccCCCCcCCCcc-----CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 355 SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
.....|++.|+|||.+ .+..++.++||||||+++|+|++|+.||...+. ......... +.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~-- 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK-SDPPTLLT-- 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCCCCSS--
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhc-cCCcccCC--
Confidence 1234588999999988 467789999999999999999999999974322 111222222 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.||++|||+.|+++
T Consensus 245 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 -----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112346889999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=337.07 Aligned_cols=253 Identities=16% Similarity=0.164 Sum_probs=204.6
Q ss_pred HHHhhhcccCCCCceEEEEEE------ecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCCccccceeeecCCe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~ 265 (517)
..|.+.+.||+|+||+||+|. ..+++.||||++... ....+..|++++++++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 456667899999999999994 346889999999754 3456778888888886 9999999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-----------
Q 010131 266 RILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----------- 332 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~----------- 332 (517)
.++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccc
Confidence 999999999999999997432 35679999999999999999999999 99999999999999998
Q ss_pred CCcEEEccccCccccCCC-CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHH
Q 010131 333 NMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 411 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~ 411 (517)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 899999999999765321 12233445699999999999999999999999999999999999999963221110
Q ss_pred HHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHhhhhhh
Q 010131 412 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR-PKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 412 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R-Ps~~evl~~L~~~~~~~ 474 (517)
.++..+.... ....+.+++..|++.+|.+| |+++++.+.|++.....
T Consensus 294 -------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 -------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0111111111 13356789999999999998 68999999999887653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=328.64 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=201.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4667889999999999999876 57899999986432 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 95 FAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999974 3568999999999999999999999 999999999999999999999999999987654322
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... +..... .+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-~~~~~~------~~- 231 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRR-IVNVDL------KF- 231 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHTTCC------CC-
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHH-Hhcccc------CC-
Confidence 23345899999999999999999999999999999999999999743221 11111 111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.||.+|||++|+++
T Consensus 232 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 ---PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1112346789999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=328.15 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=199.5
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
....|.+.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3455667899999999999999886 58999999997542 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999863 24678999999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... ...........
T Consensus 180 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~---- 247 (314)
T 3com_A 180 AK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFM-IPTNPPPTFRK---- 247 (314)
T ss_dssp SC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHSCCCCCSS----
T ss_pred cc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHH-HhcCCCcccCC----
Confidence 22 23345899999999999989999999999999999999999999733211 11111 11111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.||.+|||+.|+++
T Consensus 248 ---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ---PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112346889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=328.97 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=197.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec--CCc--EEEEEEecCC---CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK--DGK--EVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
..|++.+.||+|+||+||+|++. +++ .||||++... .....+.+.+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45677899999999999999864 233 6899998754 2344578999999999999999999999998765 88
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+|+||+++++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999999753 3568999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 348 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 348 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .+........+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCCC
Confidence 543322 1223446778999999988889999999999999999999 9999974322 122222222211110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.....+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 246 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 246 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1112234688999999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=348.17 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=202.5
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
...|++.+.||+|+||+||+|... +++.||||++... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457888999999999999999886 7899999998642 2234678899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC---CCCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~ 347 (517)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999998874 4579999999999999999999999 9999999999999995 4567999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
..... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .+... .+..+......
T Consensus 175 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~-~i~~~~~~~~~- 243 (486)
T 3mwu_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILK-RVETGKYAFDL- 243 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHHTCCCSCS-
T ss_pred CCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH-HHHhCCCCCCC-
Confidence 54322 233468999999999976 589999999999999999999999974322 11122 22222211100
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+. .......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 01122367899999999999999999999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=338.13 Aligned_cols=261 Identities=19% Similarity=0.244 Sum_probs=197.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeec--------CC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 264 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~ 264 (517)
.|.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 5677899999999999999885 789999999865432 234578899999999999999999999876 34
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 68999999975 777777642 3569999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCC---cccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 010131 345 RQAEEDL---THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420 (517)
Q Consensus 345 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 420 (517)
+...... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ....+.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~ 248 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSI 248 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC
Confidence 8764321 122234468999999998876 567999999999999999999999997443221 111111111110
Q ss_pred C---cccccCccc--------cCCCCH-H------HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 D---VISIVDPVL--------IGNVKI-E------SIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~---~~~~~d~~l--------~~~~~~-~------~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ....-.... ...... + ....+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 000000000 000000 1 1235789999999999999999999887
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=348.01 Aligned_cols=191 Identities=26% Similarity=0.392 Sum_probs=153.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec-----CCeeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 267 (517)
.|.+.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 5677899999999999999876 68999999987542 2345678999999999999999999999843 35689
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+ +++|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 134 lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 999998 579999987 45679999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCc--------------------------ccccccccCCCCcCCCcc-CCCCCCccceehhHHHHHHHHHh
Q 010131 348 EEDLT--------------------------HISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELIS 393 (517)
Q Consensus 348 ~~~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~ellt 393 (517)
..... .......||+.|+|||++ .+..++.++|||||||++|||+|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 43211 112334689999999975 56779999999999999999999
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=328.63 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=198.9
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
...|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 456777899999999999999886 79999999987542 33456788999999999 999999999999999999999
Q ss_pred EEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---------------
Q 010131 270 YEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--------------- 333 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~--------------- 333 (517)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997532 12568999999999999999999999 999999999999999844
Q ss_pred ----CcEEEccccCccccCCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCcccccc
Q 010131 334 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 408 (517)
Q Consensus 334 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~ 408 (517)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|+|++|.+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998765432 23489999999998765 66789999999999999999998765211
Q ss_pred HHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 409 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ...+..+..... .. .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~----~~~~~~~~~~~~-----~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 Q----WHEIRQGRLPRI-----PQ----VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H----HHHHHTTCCCCC-----SS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----HHHHHcCCCCCC-----Cc----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 112222222111 11 12246889999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=348.55 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=202.4
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.+.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~ 267 (543)
T 3c4z_A 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM 267 (543)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence 34577999999999999986 69999999996532 233467889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 274 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 274 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+||+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 9999999987543 24579999999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....+....... +..
T Consensus 345 ~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~~~~i~~-~~~---------- 410 (543)
T 3c4z_A 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRVLE-QAV---------- 410 (543)
T ss_dssp C-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHHHHHHHH-CCC----------
T ss_pred c-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHHHHHHhh-ccc----------
Confidence 2 23346999999999999999999999999999999999999999744321 112222222222 111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 465 (517)
.++......+.+++.+||+.||++||++ ++|++
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0111123467899999999999999975 55553
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.45 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=202.0
Q ss_pred HHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 193 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 193 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
....|.+.+.||+|+||+||+|+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457888999999999999999886 68899999987543 23356789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEEccccCccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQ 346 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a~~ 346 (517)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.. +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999998874 4568999999999999999999999 999999999999999764 5599999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
...... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... +.. ..+..+.... .
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~-~~i~~~~~~~-~ 257 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EIL-RKVEKGKYTF-D 257 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHTCCCC-C
T ss_pred CCCCcc--ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCCCC-C
Confidence 654322 234568999999999874 6899999999999999999999999743321 111 2222222110 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 471 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~ 471 (517)
.+. ... ....+.+++.+||+.||.+|||+.|+++. +++..
T Consensus 258 ~~~-~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 258 SPE-WKN----VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp SGG-GTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred chh-ccc----CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 111 111 22367899999999999999999999863 55443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=335.26 Aligned_cols=262 Identities=21% Similarity=0.215 Sum_probs=196.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchh-----HHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-----TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
..|.+.+.||+|+||.||+|... +|+.||||++....... .+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 46777899999999999999886 58999999986432211 2467899999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++ +|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 90 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 9999975 88888864 24568889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc-
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV- 426 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 426 (517)
.... ......||+.|+|||.+.+. .++.++|||||||++|||++|..||...+... ....+...........+.
T Consensus 164 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSS
T ss_pred CCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhhhhh
Confidence 4322 22334589999999998654 58899999999999999999999997433211 111111111110000000
Q ss_pred -----Cccc---cCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 427 -----DPVL---IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 427 -----d~~l---~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+... ....+ ......+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00001 1223578899999999999999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=349.51 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=205.9
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
.....|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34567888999999999999999886 78999999986532 345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe---CCCCcEEEccccCc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLS 344 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~Dfg~a 344 (517)
+||||+.+|+|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 103 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 103 LVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999987 45679999999999999999999999 999999999999999 56789999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
........ .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+. .+.. ..+..+....
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~-~~i~~~~~~~ 246 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDIL-KKVEKGKYTF 246 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHCCCCC
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHH-HHHHcCCCCC
Confidence 87654332 223458999999999876 689999999999999999999999974332 1111 2222222211
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. +. .......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~-~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 EL-PQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CS-GG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-cc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 00 0112346789999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.14 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=191.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------ee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 266 (517)
.|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 4566789999999999999875 69999999986532 233567899999999999999999999987653 45
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 8899999873 468999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC----
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---- 421 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 421 (517)
.... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+. ...+........
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHH
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHH
Confidence 6543 233458999999999876 6899999999999999999999999975432211 111111000000
Q ss_pred --------------cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 422 --------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 422 --------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+ ..........+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000 0011122346889999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=321.72 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=194.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4566789999999999999986 79999999986432 2235678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999974 3568999999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
. .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... .. ....+..+... +
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~------~ 230 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PT-LFKKIRGGVFY------I 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHHCCCC------C
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HH-HHHHhhcCccc------C
Confidence 2 223458899999999987765 6899999999999999999999974321 11 11222222110 0
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122367899999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=348.77 Aligned_cols=247 Identities=16% Similarity=0.145 Sum_probs=189.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHH---HHhcCCCCCccccc-------eeee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVA---LLSRIHHRNLVPLI-------GYCE 261 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~~~ 261 (517)
.|.+.+.||+|+||.||+|++. +|+.||||++... .....+.+.+|+. .+++++||||++++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 3456789999999999999974 6999999999742 3345678999995 55555899999998 5555
Q ss_pred cCC-----------------eeEEEEEecCCCCHHhHhhccC----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEe
Q 010131 262 EEH-----------------QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 320 (517)
Q Consensus 262 ~~~-----------------~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH 320 (517)
+.+ ..++||||+ +|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 443 278999999 689999997532 12345568889999999999999999 99999
Q ss_pred cCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCC-----------CCCccceehhHHHHHH
Q 010131 321 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLL 389 (517)
Q Consensus 321 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l~ 389 (517)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999986443 2233457 999999999877 8999999999999999
Q ss_pred HHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HH
Q 010131 390 ELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AI 467 (517)
Q Consensus 390 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L 467 (517)
||++|+.||......... ..+.. . ... .+..+.+++.+||+.||++|||+.|+++ .+
T Consensus 305 elltg~~Pf~~~~~~~~~---------------~~~~~-~-~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 305 WIWCADLPITKDAALGGS---------------EWIFR-S-CKN----IPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHSSCCC------CCS---------------GGGGS-S-CCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHCCCCCcccccccch---------------hhhhh-h-ccC----CCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 999999999743321110 00000 0 011 1246889999999999999999999986 45
Q ss_pred Hhhhh
Q 010131 468 QDSIK 472 (517)
Q Consensus 468 ~~~~~ 472 (517)
+++..
T Consensus 364 ~~~~~ 368 (377)
T 3byv_A 364 EQLRT 368 (377)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.54 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=200.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------hhHHHHHHHHHHHhcC-CCCCccccceeeecCC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 264 (517)
..|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 34556789999999999999986 799999999875431 1135688999999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.+||+|||++
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 99999999999999999974 4579999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccC------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
........ .....||+.|+|||++. ...++.++|||||||++|+|++|+.||..... .... ..+.
T Consensus 248 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~-~~i~ 318 (365)
T 2y7j_A 248 CHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILML-RMIM 318 (365)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHH
T ss_pred cccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHH-HHHH
Confidence 87654322 23356899999999875 33688899999999999999999999973321 1111 1122
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.... ..+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 319 ~~~~~~-~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQF-SSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCC-CHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCC-CCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221110 00000 0 11235889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=327.16 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=186.0
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch-h-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-R-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
..|++.+.||+|+||+||+|... +|+.||||++...... . .+.+.++...++.++||||+++++++.+.+..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 45667899999999999999875 7899999999754322 2 2334555556888899999999999999999999999
Q ss_pred ecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 272 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|++ |+|.+++.... ....+++..++.++.|++.||+|||+ . +++||||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 997 58877775422 35679999999999999999999999 7 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCCcCCCcc----CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 350 DLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
... .....||+.|+|||.+ .+..++.++||||||+++|+|+||+.||...... ............. ..
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-~~ 234 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSP-QL 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCC-CC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCC-Cc
Confidence 322 2233589999999995 5667899999999999999999999999732211 1112222222211 11
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .......+.+++.+||+.||++|||++|+++
T Consensus 235 ~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 P--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 0112346889999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=342.54 Aligned_cols=197 Identities=25% Similarity=0.354 Sum_probs=165.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 267 (517)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4667899999999999999876 58899999997542 23456789999999999999999999998765 5689
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||++ |+|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 107 lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999986 69999997 45679999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc---------------------cccccccCCCCcCCCcc-CCCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 348 EEDLTH---------------------ISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 348 ~~~~~~---------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
...... ......||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 443211 12445689999999985 56679999999999999999998655554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=329.09 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=197.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeec--CCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 270 (517)
..|.+.+.||+|+||+||+|... +++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 45667899999999999999864 7899999998743 3567899999999997 9999999999987 66789999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 349 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 349 (517)
||+++++|.+++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999885 38899999999999999999999 9999999999999999776 899999999987654
Q ss_pred CCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHHhcC
Q 010131 350 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKG 420 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 420 (517)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ...+..... ..+...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHh
Confidence 332 233458899999999877 67899999999999999999999999532211 111111110 001100
Q ss_pred Cc--------------ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DV--------------ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~--------------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ....+..............+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000000111111123457889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=330.16 Aligned_cols=254 Identities=26% Similarity=0.351 Sum_probs=198.4
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--------hhHHHHHHHHHHHhcCCCCCccccceeee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCE 261 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 261 (517)
......|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 344567888999999999999999876 588999999865321 12245889999999999999999999987
Q ss_pred cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEE
Q 010131 262 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKV 338 (517)
Q Consensus 262 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl 338 (517)
..+ .++||||+++++|.+++. ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++. +||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred CCc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 665 899999999999999987 45679999999999999999999999 99999999999999987654 999
Q ss_pred ccccCccccCCCCcccccccccCCCCcCCCcc---CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 010131 339 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 339 ~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 415 (517)
+|||++........ .....||+.|+|||++ ....++.++|||||||++|+|++|+.||....... .+..
T Consensus 159 ~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---- 230 (322)
T 2ycf_A 159 TDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD---- 230 (322)
T ss_dssp CCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHH----
T ss_pred ccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHH----
Confidence 99999987654321 2234589999999986 35678999999999999999999999997433221 2222
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+..+.... .+.... .....+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 122222110 000001 12346889999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=340.14 Aligned_cols=269 Identities=21% Similarity=0.262 Sum_probs=205.9
Q ss_pred cChhHHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC--------CCCccccc
Q 010131 187 IPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HRNLVPLI 257 (517)
Q Consensus 187 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~ 257 (517)
+...++....|.+.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||++++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 3344444567888899999999999999865 6889999999743 344577889999999985 78899999
Q ss_pred eeee----cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCC
Q 010131 258 GYCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDI 332 (517)
Q Consensus 258 ~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~ 332 (517)
+++. .....++||||+ +++|.+++... ....+++..++.++.||+.||+|||+ + +|+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECC
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEec
Confidence 9987 556789999999 66666666543 23569999999999999999999999 8 9999999999999997
Q ss_pred CC-------------------------------------------------cEEEccccCccccCCCCcccccccccCCC
Q 010131 333 NM-------------------------------------------------RAKVSDFGLSRQAEEDLTHISSVARGTVG 363 (517)
Q Consensus 333 ~~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~ 363 (517)
++ .+||+|||++....... ....||+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~ 258 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQ 258 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCc
Confidence 75 79999999998765432 23458999
Q ss_pred CcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHH---HHHHhc--------CCcc-cccCc---
Q 010131 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA---RSMIKK--------GDVI-SIVDP--- 428 (517)
Q Consensus 364 y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~--------~~~~-~~~d~--- 428 (517)
|+|||++.+..++.++|||||||++|||+||+.||...+........... ...... +... .....
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999999989999999999999999999999999754433222111111 111110 0000 00000
Q ss_pred -------cc---------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 429 -------VL---------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 429 -------~l---------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ...........+.+|+.+||+.||++|||++|+++
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 01234566778999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.98 Aligned_cols=249 Identities=27% Similarity=0.359 Sum_probs=199.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-------------hhHHHHHHHHHHHhcCCCCCccccceee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 260 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~~ 260 (517)
..|.+.++||+|+||+||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35677899999999999999876 588999999875421 2346789999999999999999999999
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC---cEE
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAK 337 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k 337 (517)
.+.+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999874 4569999999999999999999999 9999999999999998776 699
Q ss_pred EccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 417 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 417 (517)
|+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... +.. ..+
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~-~~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DII-KKV 259 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHH
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHH
Confidence 999999987654322 234468999999999875 6899999999999999999999999743321 111 222
Q ss_pred hcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 418 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 418 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..+...... ..... ....+.+++.+||+.||.+|||++|+++
T Consensus 260 ~~~~~~~~~--~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 EKGKYYFDF--NDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHCCCCCCH--HHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCCCc--cccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222211000 00011 1236889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=332.00 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=183.9
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 34566789999999999999865 68999999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccC-----CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 273 MHNGTLRDRLHGSV-----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 273 ~~~gsL~~~l~~~~-----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+++++|.+++.... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 99999999986421 24568999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc----ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 348 EEDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 348 ~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
..... .......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .. ..... +..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~-~~~ 244 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL---MLTLQ-NDP 244 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHHT-SSC
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH---HHHhc-cCC
Confidence 43211 11233458999999999865 468899999999999999999999997433221 11 11111 111
Q ss_pred cc----ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 IS----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~----~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ..++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 111111112 2346789999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=358.91 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=207.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCee
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 266 (517)
+....+.+.+.||+|+||.||+|.+.. +..||||.+..... ...+.+.+|+.++++++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 334567778999999999999998752 46799999875433 344679999999999999999999999854 568
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999753 4568999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +.. ..+..+....
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~-~~i~~~~~~~- 612 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVI-GRIENGERLP- 612 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHHTCCCC-
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHH-HHHHcCCCCC-
Confidence 75543333334456789999999988899999999999999999997 99999743221 111 1222222111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+...+..+.+++.+||+.||++|||+.|+++.|+++.+.+
T Consensus 613 --------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 --------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 11122346889999999999999999999999999988654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=321.14 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=196.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC----chhHHHHHHHHHHHhcCCCCCccccceee--ecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYC--EEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~--~~~~~~~l 268 (517)
.|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .+.+..++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 3566789999999999999875 68899999986532 23457799999999999999999999998 44567899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||++++ |.+++... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 99999876 77777643 35679999999999999999999999 999999999999999999999999999998764
Q ss_pred CCC-cccccccccCCCCcCCCccCCCC--CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 349 EDL-THISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 349 ~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
... ........|++.|+|||++.+.. .+.++||||||+++|||++|+.||..... .+.. ..+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~i~~~~~~-- 231 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLF-ENIGKGSYA-- 231 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH-HHHHHCCCC--
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHH-HHHhcCCCC--
Confidence 322 22223445899999999987644 47899999999999999999999974321 1111 222222211
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+.. .....+.+++.+||+.||++|||++|+++.
T Consensus 232 ----~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 ----IPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 123467899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=340.98 Aligned_cols=259 Identities=23% Similarity=0.276 Sum_probs=192.4
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCC------eeEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILV 269 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv 269 (517)
+|.+.+.||+|+||+||+|++..+..||+|++..... ...+|+++++.++||||+++++++...+ ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 4667899999999999999998777799998864322 1236999999999999999999985543 37899
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC-CCCcEEEccccCccccC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAE 348 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~ 348 (517)
|||++++.+............+++..+..++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999875444333222245679999999999999999999999 9999999999999999 79999999999998764
Q ss_pred CCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc--------
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-------- 419 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 419 (517)
.... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+ .+...+. .+..
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~-~~g~p~~~~~~~ 268 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK-VLGTPSREQIKT 268 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCHHHHHH
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCCHHHHHh
Confidence 4332 2234579999999998664 58999999999999999999999997543221 1111111 1000
Q ss_pred --CCcccccCccccC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 420 --GDVISIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 420 --~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
.......-+.... .........+.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000000 0011133468899999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.11 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=198.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 268 (517)
+|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4667889999999999999876 688999999975433 3347789999999999999999999998654 36899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||++ |+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 108 v~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999996 599998863 469999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCccc--ccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--
Q 010131 349 EDLTHI--SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 423 (517)
Q Consensus 349 ~~~~~~--~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 423 (517)
...... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||......+ ....+..........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHHH
Confidence 432221 23446899999999864 4558999999999999999999999997544322 111111111110000
Q ss_pred -------------cccCcccc--CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 -------------SIVDPVLI--GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 -------------~~~d~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+... ..........+.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0000112346789999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=337.79 Aligned_cols=263 Identities=21% Similarity=0.238 Sum_probs=195.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec------------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------------ 262 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------------ 262 (517)
.|.+.+.||+|+||+||+|... +|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4667899999999999999874 789999999865432 23479999999999999999999843
Q ss_pred --------------------------CCeeEEEEEecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCCC
Q 010131 263 --------------------------EHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315 (517)
Q Consensus 263 --------------------------~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ 315 (517)
....++||||++ |+|.+.+.... ....+++..+..++.|++.||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--- 159 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--- 159 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence 334789999997 58777765422 45679999999999999999999999
Q ss_pred CCcEecCCCCCCeEeC-CCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHh
Q 010131 316 PGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS 393 (517)
Q Consensus 316 ~~ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~ellt 393 (517)
.+|+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999997 689999999999987644332 2334579999999998764 58999999999999999999
Q ss_pred CCCCCCCCCccccccHHHHHHHHHhc----------CCcccccCccccCC-----CCHHHHHHHHHHHHHhhccCCCCCC
Q 010131 394 GKKPVSVEDFGAELNIVHWARSMIKK----------GDVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRP 458 (517)
Q Consensus 394 g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RP 458 (517)
|+.||...+..+ .+...+ ..... .......-+..... .+......+.+++.+||+.||++||
T Consensus 238 g~~pf~~~~~~~--~~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 238 GKPLFSGETSID--QLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp SSCSSCCSSHHH--HHHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCCCChHH--HHHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 999997443221 111111 11100 00001000111000 1112334688999999999999999
Q ss_pred CHHHHHH--HHHhhh
Q 010131 459 KMQEIVL--AIQDSI 471 (517)
Q Consensus 459 s~~evl~--~L~~~~ 471 (517)
|+.|+++ .++++.
T Consensus 315 t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 315 NPYEAMAHPFFDHLR 329 (383)
T ss_dssp CHHHHHTSGGGHHHH
T ss_pred CHHHHhcCHHHHHHH
Confidence 9999985 355443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=331.86 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=190.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCC------ee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 266 (517)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 4667789999999999999875 68999999997542 234567889999999999999999999987654 67
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999997 57888875 348899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccH----------------H
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI----------------V 410 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~----------------~ 410 (517)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....... .
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 64432 12334689999999999999999999999999999999999999974432110000 0
Q ss_pred HHHHHHHhcCCc------ccccCccccCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 411 HWARSMIKKGDV------ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 411 ~~~~~~~~~~~~------~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
............ ............ .......+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 000000000000 12235678999999999999999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.08 Aligned_cols=251 Identities=10% Similarity=0.035 Sum_probs=178.2
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcC--CCCCccccc-------eeeecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI--HHRNLVPLI-------GYCEEE 263 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~~~ 263 (517)
|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 556789999999999999976 789999999986543 3345677885544444 699988755 344322
Q ss_pred -----------------CeeEEEEEecCCCCHHhHhhccCCCCccCHHHH------HHHHHHHHHHHHHHhcCCCCCcEe
Q 010131 264 -----------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGLEYLHTGCNPGIIH 320 (517)
Q Consensus 264 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~aL~~LH~~~~~~ivH 320 (517)
...++||||++ |+|.+++... ...+++..+ +.++.||+.||+|||+ ++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 33799999998 8999999753 223344455 6788999999999999 99999
Q ss_pred cCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCC
Q 010131 321 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPV 398 (517)
Q Consensus 321 ~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~ 398 (517)
|||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998765322 13346799999999987 68999999999999999999999999
Q ss_pred CCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 399 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......... .........................+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 7543221100 0000000000001100111123457889999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.67 Aligned_cols=247 Identities=25% Similarity=0.330 Sum_probs=202.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 269 (517)
..|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..++|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 34667889999999999999876 5889999999753 123446788899999988 799999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 421 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999984 3579999999999999999999999 9999999999999999999999999999986433
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+...... .+..
T Consensus 495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~-~~~~------- 559 (674)
T 3pfq_A 495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM-EHNV------- 559 (674)
T ss_dssp TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-SSCC-------
T ss_pred CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHH-hCCC-------
Confidence 222 23445699999999999999999999999999999999999999974332 12222222 2211
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 465 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 465 (517)
.++......+.+|+.+||+.||++||++ +||++
T Consensus 560 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0111223468899999999999999998 66654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.13 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=181.5
Q ss_pred Hhh-hcccCCCCceEEEEEEec---CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeee--cCCeeEEEE
Q 010131 197 NNF-CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVY 270 (517)
Q Consensus 197 ~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~ 270 (517)
|++ .++||+|+||+||+|++. +++.||||++.... ....+.+|+.++++++||||+++++++. .....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 468999999999999976 57899999997542 2346889999999999999999999994 467889999
Q ss_pred EecCCCCHHhHhhccC------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe----CCCCcEEEcc
Q 010131 271 EYMHNGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSD 340 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D 340 (517)
||++ |+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 58877775321 22359999999999999999999999 999999999999999 6789999999
Q ss_pred ccCccccCCCCc--ccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccc------cccHHH
Q 010131 341 FGLSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA------ELNIVH 411 (517)
Q Consensus 341 fg~a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~------~~~~~~ 411 (517)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ......
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987654321 12234568999999999877 458999999999999999999999997443210 011111
Q ss_pred HHHHHHhcCCcccccC---------------ccccCCCCH---------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 412 WARSMIKKGDVISIVD---------------PVLIGNVKI---------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 412 ~~~~~~~~~~~~~~~d---------------~~l~~~~~~---------~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+...+.......+.+ ......... .....+.+|+.+||+.||++|||++|+++
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111000000000 000000000 00236789999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=320.76 Aligned_cols=249 Identities=26% Similarity=0.322 Sum_probs=200.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---------hhHHHHHHHHHHHhcCC-CCCccccceeeecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---------HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 264 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 264 (517)
.|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+++++++. ||||+++++++...+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4556789999999999999886 689999999865421 22456889999999995 999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999974 4578999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccC------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
........ .....+++.|+|||.+. ...++.++||||||+++|+|++|+.||..... ..... .+.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~ 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLR-MIM 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHH-HHh
Confidence 87654322 23345899999999874 45688999999999999999999999974321 11111 222
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.... ..+ ........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 221110 000 01122346889999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.07 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=180.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecC------Cee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 266 (517)
.|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 4667789999999999999865 68999999986542 23456788999999999999999999998654 567
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++|+|++ +++|.+++. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 110 ~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 9999999 789998886 3579999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+... ....+...+.... .+.
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~-~~~ 253 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPG-AEL 253 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCC-HHH
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC-HHH
Confidence 5432 223468999999999876 688999999999999999999999997543211 1111111111000 000
Q ss_pred cCc-----------ccc--CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 426 VDP-----------VLI--GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 426 ~d~-----------~l~--~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
+.. .+. .... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 000 0000 0112457899999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.71 Aligned_cols=257 Identities=22% Similarity=0.306 Sum_probs=202.0
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCch-----------------hHHHHHHHHHHHhcCCCCCccccce
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------------RTQQFVTEVALLSRIHHRNLVPLIG 258 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~~~~ 258 (517)
.|.+.+.||+|+||.||+|.. +|+.||||++...... ..+.+.+|+.++++++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 566788999999999999999 7999999998643211 1178999999999999999999999
Q ss_pred eeecCCeeEEEEEecCCCCHHhH------hhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC
Q 010131 259 YCEEEHQRILVYEYMHNGTLRDR------LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 332 (517)
Q Consensus 259 ~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~ 332 (517)
++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||.|||+ ..+++||||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 99999999999999999999998 5422 25779999999999999999999996 379999999999999999
Q ss_pred CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCC-CCCc-cceehhHHHHHHHHHhCCCCCCCCCccccccHH
Q 010131 333 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410 (517)
Q Consensus 333 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 410 (517)
++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||...... .
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~--- 259 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--V--- 259 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--H---
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--H---
Confidence 999999999999876443 22345589999999999877 6666 999999999999999999999743321 1
Q ss_pred HHHHHHHhcCCcccccC------cccc---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 411 HWARSMIKKGDVISIVD------PVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 411 ~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+ ....+..+......+ +... ..........+.+++.+||+.||++|||+.|+++
T Consensus 260 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 E-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 112222221111000 0000 0001223446889999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=327.06 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=192.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeec------CCeeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~ 267 (517)
.|++.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.+++++ +||||+++++++.. .+..+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 3556789999999999999885 68999999987543 3456788999999999 79999999999876 46789
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 104 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 9999999999999997542 3578999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
..... ......|++.|+|||.+. +..++.++|||||||++|+|++|+.||..... ...... +.....
T Consensus 180 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~ 251 (326)
T 2x7f_A 180 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFL-IPRNPA 251 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCC
T ss_pred CcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHH-hhcCcc
Confidence 43322 122345899999999986 56788999999999999999999999963321 111111 111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...... .....+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLKSK--------KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCSCS--------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCcc--------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 11246889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=328.81 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=197.4
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|.+.+.||+|+||.||+|.+.. .||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 345678899999999999998863 49999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~- 351 (517)
+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++ ++.+||+|||++.......
T Consensus 111 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 111 CKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999742 3468999999999999999999999 9999999999999998 6799999999987643211
Q ss_pred ---cccccccccCCCCcCCCccCC---------CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 010131 352 ---THISSVARGTVGYLDPEYYGN---------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 352 ---~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ... ..+..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~-~~~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AII-WQMGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------HHH-HHHHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHhcc
Confidence 111223458899999999864 45788999999999999999999999733221 111 12222
Q ss_pred CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 420 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+......... ....+.+++.+||+.||++|||++++++.|+++....
T Consensus 258 ~~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GMKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TCCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 2221111111 1225789999999999999999999999999887654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=337.44 Aligned_cols=198 Identities=26% Similarity=0.328 Sum_probs=171.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC------CCCCccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI------HHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~ 267 (517)
.+|++.+.||+|+||+||+|... +++.||||++... ....+.+.+|+.+++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 35777899999999999999876 5899999999753 33446778888888877 5779999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc--EEEccccCcc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSR 345 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~ 345 (517)
+||||+. ++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++.
T Consensus 176 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999995 6999988754 23459999999999999999999999 99999999999999999887 9999999997
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCC
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 402 (517)
..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 65432 223468999999999999999999999999999999999999997543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.36 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=190.4
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCch-----------hHHHHHHHHHHHhcCCCCCccccceeeec--
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNLVPLIGYCEE-- 262 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 262 (517)
.|.+.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 45567899999999999999888999999998643221 23779999999999999999999999843
Q ss_pred ---CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEc
Q 010131 263 ---EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 339 (517)
Q Consensus 263 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~ 339 (517)
....++||||++ |+|.+++.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEE
Confidence 346799999997 688888874 34579999999999999999999999 999999999999999999999999
Q ss_pred cccCccccCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 340 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 340 Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
|||++........ .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+.....
T Consensus 177 Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~ 251 (362)
T 3pg1_A 177 DFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---QLNKIVEVVG 251 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred ecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcC
Confidence 9999976443322 233457899999999876 678999999999999999999999997443211 1111111111
Q ss_pred cCCcc-----------cccCcccc---C----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 KGDVI-----------SIVDPVLI---G----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 ~~~~~-----------~~~d~~l~---~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
..... +.+..... . .........+.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 10000 00000000 0 001112346889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=320.25 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=191.9
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec-----------
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 262 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------- 262 (517)
..|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45667899999999999999875 7899999998643 3445778999999999999999999998754
Q ss_pred --CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcc
Q 010131 263 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 340 (517)
Q Consensus 263 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 340 (517)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 45679999999999999999752 4568889999999999999999999 9999999999999999999999999
Q ss_pred ccCccccCCCC-------------cccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCcccc
Q 010131 341 FGLSRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406 (517)
Q Consensus 341 fg~a~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 406 (517)
||++....... ........|++.|+|||.+.+. .++.++|||||||++|+|++ ||...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~----- 231 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG----- 231 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----
Confidence 99998764321 1112234588999999998764 78999999999999999998 55411
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
....+.. ..+.... ..+........+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 MERVNIL-KKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHH-HHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHH-Hhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111 1122111 11111222333456789999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=331.23 Aligned_cols=259 Identities=22% Similarity=0.292 Sum_probs=201.9
Q ss_pred HHHHhhhcccCCCCceEEEEEEe-c-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCC------CccccceeeecCCe
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKM-K-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQ 265 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~ 265 (517)
...|++.+.||+|+||.||+|.. . +++.||||++... ....+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 34677889999999999999987 3 6889999999753 34456788999999988655 49999999999999
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-------------
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------------- 332 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~------------- 332 (517)
.++||||+ +++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999998754 23468999999999999999999999 99999999999999987
Q ss_pred ------CCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCcccc
Q 010131 333 ------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 406 (517)
Q Consensus 333 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~ 406 (517)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999875432 2234589999999999999999999999999999999999999974432211
Q ss_pred ccHHHHHHHHHhc--------CCccccc---------------------Ccc-ccCCCCHHHHHHHHHHHHHhhccCCCC
Q 010131 407 LNIVHWARSMIKK--------GDVISIV---------------------DPV-LIGNVKIESIWRIAEVAIQCVEQRGFS 456 (517)
Q Consensus 407 ~~~~~~~~~~~~~--------~~~~~~~---------------------d~~-l~~~~~~~~~~~l~~li~~cl~~~P~~ 456 (517)
...+...... ....... .+. -...........+.+++.+||+.||++
T Consensus 243 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 243 ---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp ---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 1111111110 0000000 000 000112345678899999999999999
Q ss_pred CCCHHHHHH
Q 010131 457 RPKMQEIVL 465 (517)
Q Consensus 457 RPs~~evl~ 465 (517)
|||++|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.50 Aligned_cols=258 Identities=24% Similarity=0.268 Sum_probs=191.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecC------CeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 268 (517)
.|.+.+.||+|+||.||+|++. +|+.||||++..... .+.+|++++++++||||++++++|... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3566789999999999999986 589999999865422 234799999999999999999988532 23679
Q ss_pred EEEecCCCCHHhHhhcc-CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-CcEEEccccCccc
Q 010131 269 VYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQ 346 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Dfg~a~~ 346 (517)
||||+++ ++.+.+... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 666555422 245679999999999999999999999 999999999999999965 6689999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH-------HHh
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS-------MIK 418 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~ 418 (517)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+ .+.+.+.. .+.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 644322 2334589999999998764 78999999999999999999999997443211 11111110 000
Q ss_pred --cCCcccccCccccCC-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 --KGDVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 --~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.....+...+.+... +.......+.+|+.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 011111111111110 11122356889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=316.38 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=203.3
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeE
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 267 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 267 (517)
......|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 444567888999999999999999886 68999999986532 235678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC---CcEEEccccCc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLS 344 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~Dfg~a 344 (517)
+|+||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999998874 3568999999999999999999999 999999999999999764 46999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .+.. ..+..+....
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDIL-KRVETGKYAF 241 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHCCCCC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHcCCCCC
Confidence 87654322 122347889999999876 489999999999999999999999974321 1111 2222222111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. +. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~-~~-~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL-PQ-WR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS-GG-GT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-hh-hh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 00 01 12246889999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=321.71 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=194.5
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--chhHHHHHHHHHHHhcCC--CCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++.+++ ||||+++++++.+.+..++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 3466788999999999999999889999999986542 334577899999999996 599999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
| +.+++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++ ++.+||+|||++......
T Consensus 108 e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 108 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp C-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred e-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9 668899999984 4578999999999999999999999 9999999999999996 489999999999876543
Q ss_pred Ccc-cccccccCCCCcCCCccCC-----------CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 351 LTH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 351 ~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ..........
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~ 254 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID 254 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHh
Confidence 221 1233458999999999865 4788899999999999999999999963221 1112222222
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...... .+......+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccC---------CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 111112468899999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=321.69 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=190.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeee-------------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE------------- 261 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------------- 261 (517)
.|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 4566789999999999999887 48999999998665566778999999999999999999998873
Q ss_pred -cCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC-CCCcEEEc
Q 010131 262 -EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVS 339 (517)
Q Consensus 262 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~ 339 (517)
+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++ .++.+||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 69999986 4568999999999999999999999 9999999999999997 56799999
Q ss_pred cccCccccCCCCcc--cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 010131 340 DFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 340 Dfg~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
|||++......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~ 237 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE------QMQLI 237 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 99999876432211 1223447889999998755 678999999999999999999999997443211 11111
Q ss_pred HhcCCc-------------ccccCcccc-CCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 417 IKKGDV-------------ISIVDPVLI-GNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 417 ~~~~~~-------------~~~~d~~l~-~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...... ...+..... ... .......+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111000 000000000 000 0112346889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=328.99 Aligned_cols=270 Identities=20% Similarity=0.306 Sum_probs=203.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-----------CCCccccceeee
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCE 261 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 261 (517)
...|.+.+.||+|+||+||+|... +++.||||++... ....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 346777899999999999999874 6899999999743 334567889999999886 899999999987
Q ss_pred cCC----eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeC-----
Q 010131 262 EEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLD----- 331 (517)
Q Consensus 262 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~----- 331 (517)
..+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+ + +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 654 789999999 899999997542 4569999999999999999999999 8 999999999999994
Q ss_pred -CCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHH
Q 010131 332 -INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410 (517)
Q Consensus 332 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~ 410 (517)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 44589999999998765432 2345899999999999999999999999999999999999999754322111111
Q ss_pred HHHHHHHh-cCCccc--------------------ccCc-c---------ccCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 010131 411 HWARSMIK-KGDVIS--------------------IVDP-V---------LIGNVKIESIWRIAEVAIQCVEQRGFSRPK 459 (517)
Q Consensus 411 ~~~~~~~~-~~~~~~--------------------~~d~-~---------l~~~~~~~~~~~l~~li~~cl~~~P~~RPs 459 (517)
........ .+.... .+.. . -....+......+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11111110 010000 0000 0 011234567778999999999999999999
Q ss_pred HHHHHH--HHHhhhhh
Q 010131 460 MQEIVL--AIQDSIKI 473 (517)
Q Consensus 460 ~~evl~--~L~~~~~~ 473 (517)
++|+++ .+++....
T Consensus 328 ~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHHHTCGGGTTCTTC
T ss_pred HHHHhhChhhhcccCc
Confidence 999987 35544433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.75 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=192.9
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCee------
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR------ 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------ 266 (517)
+|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 5566789999999999999876 689999999976432 3356788999999999999999999999877654
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 123 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 68888774 348999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+ ....+...... ...+.
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~-~~~~~ 265 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGV-PGTEF 265 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC-CCHHH
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC-CcHHH
Confidence 5433 223457999999999877 788999999999999999999999997443211 11111110000 00000
Q ss_pred c---------------CccccCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 426 V---------------DPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 426 ~---------------d~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
. ....... ........+.+++.+||+.||++|||++|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0000000 001123468899999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.52 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=196.8
Q ss_pred HHhhhcccCCCCceEEEEEEe--cCCcEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCCccccceeee-----cC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKM--KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 263 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~ 263 (517)
.|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 456788999999999999987 3688999999864322 1223566777777766 8999999999987 55
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
...++||||++ |+|.+++... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 67899999997 6999998754 24458999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
+....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+..........
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGG
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCcc
Confidence 98765332 223455899999999999999999999999999999999999999743321 1111111111110000
Q ss_pred ccc------Cccc-------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIV------DPVL-------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~------d~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+. .... ...........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000 00011123346789999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=334.35 Aligned_cols=262 Identities=19% Similarity=0.239 Sum_probs=185.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCe-------
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------- 265 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 265 (517)
...|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+|++.++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 345667899999999999999886 68999999986542 223456778888899999999999999865433
Q ss_pred eEEEEEecCCCCHHhHhhc-cCCCCccCHHHHHHHHHHHHHHHHHHh--cCCCCCcEecCCCCCCeEeCC-CCcEEEccc
Q 010131 266 RILVYEYMHNGTLRDRLHG-SVNQKPLDWLTRLQIAHDAAKGLEYLH--TGCNPGIIHRDVKSSNILLDI-NMRAKVSDF 341 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~~LH--~~~~~~ivH~dlk~~Nill~~-~~~~kl~Df 341 (517)
.++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.+||+||
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 7899999976 44444332 224667899999999999999999999 7 99999999999999997 899999999
Q ss_pred cCccccCCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-
Q 010131 342 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK- 419 (517)
Q Consensus 342 g~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 419 (517)
|++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+... .+.. +......
T Consensus 177 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~-~~~~~~~~ 251 (360)
T 3e3p_A 177 GSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHE-IVRVLGCP 251 (360)
T ss_dssp TTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCC
T ss_pred CCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHH-HHHHcCCC
Confidence 99987654332 2334579999999998654 48999999999999999999999997443221 1111 1111100
Q ss_pred -----------CCcccccCc------cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 420 -----------GDVISIVDP------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 420 -----------~~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+. .............+.+++.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000 0001111224567899999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.47 Aligned_cols=200 Identities=28% Similarity=0.314 Sum_probs=169.6
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CC-----CccccceeeecCCeeE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HR-----NLVPLIGYCEEEHQRI 267 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~ 267 (517)
..|.+.+.||+|+||+||+|... +++.||||++... ......+..|+.+++.++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 45677899999999999999876 6889999999743 334567788999988884 55 4999999999999999
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC--CCCcEEEccccCcc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSR 345 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~ 345 (517)
+||||++ |+|.+++... ....+++..+..++.|++.||.|||+ ...+|+||||||+|||++ .++.+||+|||+++
T Consensus 133 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 9999995 5999998754 23568999999999999999999994 127999999999999995 47889999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCC
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 402 (517)
...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 210 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765432 23458999999999999999999999999999999999999997443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=327.75 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=192.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCe------e
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~ 266 (517)
+|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3556789999999999999876 689999999975432 235678899999999999999999999987654 4
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 105 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 99999997 68888764 348999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC-----
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG----- 420 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 420 (517)
.... .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..+ ....+.......
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHHHH
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence 5432 223457999999999876 678999999999999999999999997443211 111111110000
Q ss_pred -------------CcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 -------------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 -------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+ ..........+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 0111223457889999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=327.70 Aligned_cols=259 Identities=21% Similarity=0.248 Sum_probs=195.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecC-----CeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 268 (517)
.|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 4556789999999999999876 689999999975433 3456788999999999999999999987654 67899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+. ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999996 689998863 468999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCcc---------cccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 349 EDLTH---------ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 349 ~~~~~---------~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+... ....+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhC
Confidence 32211 112345899999999865 4788999999999999999999999997543211 1111111111
Q ss_pred cCCccc----ccCc-------cc--cCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 KGDVIS----IVDP-------VL--IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 ~~~~~~----~~d~-------~l--~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
...... ...+ .+ .... .......+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 0000 00 0000 0122346789999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=322.57 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=177.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHH-HHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|.+.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 3456788999999999999886 689999999976533 33445666666 67778999999999999999999999999
Q ss_pred cCCCCHHhHhhccC--CCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 273 MHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 273 ~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
+++ +|.+++.... ....+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 975 8877765311 25678999999999999999999999 7 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCCcCCCcc----CCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 350 DLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||....... +.... ...+.
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~---- 246 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQ-VVKGD---- 246 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSC----
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHH-HhcCC----
Confidence 322 2223589999999998 46678999999999999999999999997322110 00000 00011
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.+...........+.+++.+||+.||++|||+.|+++
T Consensus 247 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 -PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111123346889999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=327.83 Aligned_cols=262 Identities=19% Similarity=0.251 Sum_probs=200.4
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CC-cEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC------ccccceeeec
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DG-KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCEE 262 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~ 262 (517)
+.....|++.+.||+|+||+||+|... ++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 333456778899999999999999875 34 68999999743 344567889999999997655 8899999999
Q ss_pred CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEe------------
Q 010131 263 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL------------ 330 (517)
Q Consensus 263 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill------------ 330 (517)
.+..++||||+ ++++.+++... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 66777777643 23579999999999999999999999 999999999999999
Q ss_pred -------CCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCc
Q 010131 331 -------DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 403 (517)
Q Consensus 331 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~ 403 (517)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 567899999999998654332 234589999999999999999999999999999999999999974332
Q ss_pred cccccHHHHHHHHHhc--------CCcccc-cCccc---------------------cCCCCHHHHHHHHHHHHHhhccC
Q 010131 404 GAELNIVHWARSMIKK--------GDVISI-VDPVL---------------------IGNVKIESIWRIAEVAIQCVEQR 453 (517)
Q Consensus 404 ~~~~~~~~~~~~~~~~--------~~~~~~-~d~~l---------------------~~~~~~~~~~~l~~li~~cl~~~ 453 (517)
.. ....+...... ...... ..... ...........+.+++.+||+.|
T Consensus 245 ~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 245 RE---HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp HH---HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred HH---HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 21 11111111100 000000 00000 00112234557889999999999
Q ss_pred CCCCCCHHHHHH
Q 010131 454 GFSRPKMQEIVL 465 (517)
Q Consensus 454 P~~RPs~~evl~ 465 (517)
|++|||+.|+++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=346.38 Aligned_cols=270 Identities=22% Similarity=0.319 Sum_probs=206.7
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeec------CCee
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 266 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~ 266 (517)
..|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 56888999999999999999875 68999999987643 3445679999999999999999999998765 6678
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc---EEEccccC
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGL 343 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~Dfg~ 343 (517)
++||||+++|+|.+++........+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999999865555579999999999999999999999 99999999999999997765 99999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC--
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD-- 421 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 421 (517)
+........ .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..|.........
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchh
Confidence 987654332 23456899999999999999999999999999999999999999732111 111100000000
Q ss_pred --cccccCc--------cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHhhhhhh
Q 010131 422 --VISIVDP--------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-----IVLAIQDSIKIE 474 (517)
Q Consensus 422 --~~~~~d~--------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e-----vl~~L~~~~~~~ 474 (517)
..+.... .............+.+++.+||+.||++|||++| ..+.++++....
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0000000 0011233446678999999999999999999988 556677666543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=320.20 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=170.1
Q ss_pred HHhhh-cccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec----CCeeEEE
Q 010131 196 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 269 (517)
Q Consensus 196 ~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 269 (517)
.|.+. +.||+|+||+||+|... +|+.||||++.... ....+....++.++||||+++++++.. ....++|
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 34553 46999999999999887 68999999986531 122223334566799999999999876 4458999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCccc
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 346 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~ 346 (517)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++..
T Consensus 105 ~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 105 MECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999999999999853 23579999999999999999999999 99999999999999976 45599999999986
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
..... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||......... ......+..+.. ...
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~-~~~ 253 (336)
T 3fhr_A 181 TTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQY-GFP 253 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CCC
T ss_pred ccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhcccc-ccC
Confidence 54322 22345799999999999989999999999999999999999999743322110 000111111100 000
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .........+.+++.+||+.||++|||++|+++
T Consensus 254 ~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 254 N-----PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp T-----TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c-----hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 001122346889999999999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.63 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=185.2
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4789999999998776667999999998643 345678999999886 89999999999999999999999995 699
Q ss_pred HhHhhccCCCC----ccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC-------------CcEEEccc
Q 010131 279 RDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------MRAKVSDF 341 (517)
Q Consensus 279 ~~~l~~~~~~~----~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~kl~Df 341 (517)
.+++....... ..++..++.++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99997532111 11334567899999999999999 999999999999999754 48999999
Q ss_pred cCccccCCCCcc---cccccccCCCCcCCCccCC-------CCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHH
Q 010131 342 GLSRQAEEDLTH---ISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 410 (517)
Q Consensus 342 g~a~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~ 410 (517)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....... .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~ 248 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----S 248 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----H
Confidence 999876543321 1223468999999999865 678999999999999999999 999996322111 1
Q ss_pred HHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 411 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 411 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ... +... . +.............+.+++.+||+.||++|||+.||++
T Consensus 249 ~----i~~-~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 N----IIR-GIFS-L--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H----HHH-TCCC-C--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----Hhc-CCCC-c--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 111 1110 0 11111123455678899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.69 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=190.0
Q ss_pred HHHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch------hHHHHHHHHHHHhcC----CCCCcccccee
Q 010131 191 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRI----HHRNLVPLIGY 259 (517)
Q Consensus 191 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~~~ 259 (517)
+.....|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 445567888999999999999999875 6889999999654321 223466799999988 89999999999
Q ss_pred eecCCeeEEEEEe-cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC-CCCcEE
Q 010131 260 CEEEHQRILVYEY-MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 337 (517)
Q Consensus 260 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k 337 (517)
+...+..++|+|+ +.+++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999974 4568999999999999999999999 9999999999999999 889999
Q ss_pred EccccCccccCCCCcccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 416 (517)
|+|||++....... .....|+..|+|||++.+..+ +.++||||||+++|+|++|+.||.... + .
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----~ 245 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----I 245 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----H
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H----H
Confidence 99999998765432 233458999999999876655 458999999999999999999996211 0 1
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ... .+ .......+.+++.+||+.||++|||++|+++
T Consensus 246 ~~-~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LE-AEL------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HH-TCC------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hh-hcc------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 110 01 1112336789999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.18 Aligned_cols=239 Identities=24% Similarity=0.381 Sum_probs=195.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch------hHHHHHHHHHHHhcCC--CCCccccceeeecCCe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQ 265 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 265 (517)
..|.+.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++ ||||+++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 45667899999999999999865 6899999998654221 2245678999999996 5999999999999999
Q ss_pred eEEEEEecCC-CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC-CCCcEEEccccC
Q 010131 266 RILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGL 343 (517)
Q Consensus 266 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~Dfg~ 343 (517)
.++|+|++.+ ++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++ .++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999976 899999874 4578999999999999999999999 9999999999999999 789999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
+....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .... +..
T Consensus 197 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~-~~~ 260 (320)
T 3a99_A 197 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR-GQV 260 (320)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH-CCC
T ss_pred cccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhc-ccc
Confidence 98765432 223458999999999876655 688999999999999999999996221 0111 111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .... ....+.+++.+||+.||++|||++|+++
T Consensus 261 ~------~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 F------FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C------CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------cccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111 1236789999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.54 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=178.4
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch-h-HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-R-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
.|.+.+.||+|+||.||+|.+. +|+.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 4566789999999999999886 6899999999765332 2 23344555678888999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCC-CcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~-~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
+ ++.+..+... ....+++..++.++.|++.||.|||+ + +++|+||||+||+++.++.+||+|||++.......
T Consensus 106 ~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 106 M-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp C-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred c-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9 5555555442 24678999999999999999999998 6 99999999999999999999999999997654432
Q ss_pred cccccccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 352 THISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
. .....+++.|+|||.+. ...++.++||||||+++|+|++|+.||..... ..+........ ......
T Consensus 180 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~-~~~~~~ 251 (318)
T 2dyl_A 180 A--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQE-EPPLLP 251 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHS-CCCCCC
T ss_pred c--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhcc-CCCCCC
Confidence 2 22345899999999984 55788999999999999999999999973221 11222222222 111110
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .......+.+++.+||+.||.+|||++|+++
T Consensus 252 ~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 G-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp S-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 0012236889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.21 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=183.3
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.+.+.||+|+||+||.....+|+.||||++...... .+.+|+++++++ +||||+++++++.+.+..++||||+.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 4456889999999976555567999999999754322 356799999999 79999999999999999999999996
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-----CCcEEEccccCccccCCC
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~~~ 350 (517)
|+|.+++... .....+..++.++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 102 g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 102 ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6999999753 2334555677899999999999999 99999999999999953 346889999999876543
Q ss_pred Cc--ccccccccCCCCcCCCccC---CCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 351 LT--HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 351 ~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
.. .......||+.|+|||++. ...++.++|||||||++|||+| |..||...... . ...... .....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~---~~~~~~-~~~~~ 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----Q---ANILLG-ACSLD 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----H---HHHHTT-CCCCT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----H---HHHHhc-cCCcc
Confidence 21 1223456899999999997 4567889999999999999999 99998522111 0 111111 11111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ........+.+++.+||+.||++|||++||++
T Consensus 249 ~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 11233445789999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=302.19 Aligned_cols=235 Identities=14% Similarity=0.190 Sum_probs=183.4
Q ss_pred HHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
..+|.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 345777899999999999999886 489999999976533 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++++|.+++.. . ....++..++.|++.||+|||+ ++|+||||||+||+++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999852 2 3556788999999999999999 999999999999999999999998543
Q ss_pred CCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcc
Q 010131 350 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 429 (517)
|++ .++.++|||||||++|||+||+.||...+........ .... .+.. ..+
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~~---~~~- 225 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQP---IEP- 225 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSCB---CCH-
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccCC---CCh-
Confidence 333 3688999999999999999999999854332110000 0000 0000 000
Q ss_pred ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 430 l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
.......+..+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 226 --~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 --ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp --HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred --hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00011223468899999999999999 99999999999876544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.94 Aligned_cols=240 Identities=18% Similarity=0.281 Sum_probs=194.2
Q ss_pred HHHHhhhcccCCCCceEEEEEEec--CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCe-----
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ----- 265 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 265 (517)
...|.+.+.||+|+||+||+|.+. +|+.||||++..... .....+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 346778899999999999999876 589999999865433 345678999999999999999999999987665
Q ss_pred eEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 266 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 266 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
.++||||+++++|.+++. ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999988775 269999999999999999999999 999999999999999985 89999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.........
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------ 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------ 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence 76543 3345899999999987654 88999999999999999999988632111000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 471 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~ 471 (517)
...........+.+++.+||+.||++|| +++++.+.|..+.
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000112234688999999999999999 5777777777665
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=310.85 Aligned_cols=243 Identities=18% Similarity=0.220 Sum_probs=184.1
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCC--------chhHHHHHHHHHHHhcCC---------C----
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--------SHRTQQFVTEVALLSRIH---------H---- 250 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h---- 250 (517)
+....|.+.+.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+++.++ |
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456788899999999999999998 58999999997542 223477889999998886 4
Q ss_pred -------------CCccccceeeec-------------CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHH
Q 010131 251 -------------RNLVPLIGYCEE-------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 304 (517)
Q Consensus 251 -------------~niv~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia 304 (517)
|||+++++++.+ .+..++||||+++|++.+.+. ...+++..+..++.||+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHH
Confidence 455555555443 678999999999997766664 35689999999999999
Q ss_pred HHHHHHh-cCCCCCcEecCCCCCCeEeCCCC--------------------cEEEccccCccccCCCCcccccccccCCC
Q 010131 305 KGLEYLH-TGCNPGIIHRDVKSSNILLDINM--------------------RAKVSDFGLSRQAEEDLTHISSVARGTVG 363 (517)
Q Consensus 305 ~aL~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~ 363 (517)
.||+||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 8 9999999999999999887 8999999999876542 2358999
Q ss_pred CcCCCccCCCCCCccceehhHHHH-HHHHHhCCCCCCCCCccccccHHHHHHHHHh-cCCcccccCccccCCCCHHHHHH
Q 010131 364 YLDPEYYGNQQLTEKSDVYSFGVV-LLELISGKKPVSVEDFGAELNIVHWARSMIK-KGDVISIVDPVLIGNVKIESIWR 441 (517)
Q Consensus 364 y~aPE~~~~~~~~~~~Dv~slG~~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~ 441 (517)
|+|||++.+.. +.++||||+|++ .+++++|..||... .........+. ..... ..............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence 99999998766 899999998777 77888999998511 00011111111 11110 00011112346678
Q ss_pred HHHHHHHhhccCCCCCCCHHHHH
Q 010131 442 IAEVAIQCVEQRGFSRPKMQEIV 464 (517)
Q Consensus 442 l~~li~~cl~~~P~~RPs~~evl 464 (517)
+.+|+.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 898887
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=297.38 Aligned_cols=220 Identities=22% Similarity=0.312 Sum_probs=174.0
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHH-hcCCCCCccccceeeec----CCeeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALL-SRIHHRNLVPLIGYCEE----EHQRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~lv~e~~~ 274 (517)
+.||+|+||.||+|... +++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 67999999999999875 6899999998642 4567888888 55589999999999876 677899999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCccccCCCC
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~~ 351 (517)
+|+|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 99 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp SCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 99999999854 24579999999999999999999999 99999999999999998 7889999999886532
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
+..++.++|||||||++|||+||+.||........ .......+.....
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~~~- 219 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMGQY- 219 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCC-
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhccc-
Confidence 23567899999999999999999999963321110 0000000000000
Q ss_pred CCCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVK----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ......+.+++.+||+.||++|||+.|+++
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 220 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011 112346889999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.28 Aligned_cols=237 Identities=16% Similarity=0.112 Sum_probs=177.6
Q ss_pred hhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCC-CCccccce---------------
Q 010131 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHH-RNLVPLIG--------------- 258 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~~--------------- 258 (517)
..+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.+++.++| +|......
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 4678999999999999865 799999999874322 235779999999999977 33221111
Q ss_pred ------eeec-----CCeeEEEEEecCCCCHHhHhhcc----CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCC
Q 010131 259 ------YCEE-----EHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 323 (517)
Q Consensus 259 ------~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dl 323 (517)
++.. ....+++|+++ +++|.+++... .....+++..++.++.|++.||+|||+ ++|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCc
Confidence 1111 12345666655 78999888421 134568899999999999999999999 99999999
Q ss_pred CCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCcc----------CCCCCCccceehhHHHHHHHHHh
Q 010131 324 KSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY----------GNQQLTEKSDVYSFGVVLLELIS 393 (517)
Q Consensus 324 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~slG~~l~ellt 393 (517)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998875543 233457 999999998 66678899999999999999999
Q ss_pred CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 394 GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 394 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
|+.||......... ...+... .. .+..+.+++.+||+.||++||++.|+++
T Consensus 313 g~~Pf~~~~~~~~~---------------~~~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGGS---------------EWIFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSCS---------------GGGGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhhH---------------HHHHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999743322110 0011100 11 1246889999999999999999888754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-31 Score=280.49 Aligned_cols=186 Identities=17% Similarity=0.143 Sum_probs=131.1
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCC----------chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEE
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----------SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 268 (517)
...+.|++|.+..++.. -|+.+++|++.... ....++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34677777777766432 58899999996532 12235699999999999 79999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||++|++|.+++.. .++++.. +|+.||+.||+|+|+ +|||||||||+|||++.++.+||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999983 4566654 478999999999999 999999999999999999999999999998765
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 397 (517)
..... .....||++|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 54332 233569999999999976 467789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=250.00 Aligned_cols=183 Identities=17% Similarity=0.209 Sum_probs=147.4
Q ss_pred hcccCCCCceEEEEEEecCCcEEEEEEecCCCch--------hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 200 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.+.||+|+||.||+|... ++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999655 788999986543211 13458999999999999999977777777778899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999973 56899999999999999 99999999999999998 99999999999876532
Q ss_pred ccc------ccccccCCCCcCCCccCC--CCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 352 THI------SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 352 ~~~------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
... .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221 234568999999999976 567888999999999888888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-24 Score=207.74 Aligned_cols=141 Identities=15% Similarity=0.113 Sum_probs=116.3
Q ss_pred hhcccCCCCceEEEEEEecCCcEEEEEEecCCCc------------------hhHHHHHHHHHHHhcCCCCCccccceee
Q 010131 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 260 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~~~ 260 (517)
+.+.||+|+||.||+|.+.+|+.||||+++.... .....+.+|+.++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 3588999999999999997799999999864321 13456899999999999 5 7777766
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcc
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 340 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 340 (517)
.. +..++||||+++++|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred ec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 44 55699999999999988 431 1345799999999999999 9999999999999999 99999999
Q ss_pred ccCccccCCCCcccccccccCCCCcCCCccC
Q 010131 341 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371 (517)
Q Consensus 341 fg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~ 371 (517)
||+++. +..+.|||++.
T Consensus 236 FG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHH
Confidence 999863 34578888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=175.62 Aligned_cols=135 Identities=23% Similarity=0.246 Sum_probs=105.2
Q ss_pred hhhcccCCCCceEEEEEEe-cCCcE--EEEEEecCCCch------------------------hHHHHHHHHHHHhcCCC
Q 010131 198 NFCKKIGKGSFGSVYYGKM-KDGKE--VAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 250 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h 250 (517)
.+.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+.++.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999998 67989 999987543111 11367899999999988
Q ss_pred CCc--cccceeeecCCeeEEEEEecCC-C----CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHh-cCCCCCcEecC
Q 010131 251 RNL--VPLIGYCEEEHQRILVYEYMHN-G----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRD 322 (517)
Q Consensus 251 ~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~d 322 (517)
+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| + .+|+|||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 764 333332 356899999942 4 66665432 234567889999999999999 8 9999999
Q ss_pred CCCCCeEeCCCCcEEEccccCcccc
Q 010131 323 VKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 323 lk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
|||+|||++. .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999765
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-17 Score=164.82 Aligned_cols=138 Identities=16% Similarity=0.153 Sum_probs=98.9
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc--------------hhHHH--------HHHHHHHHhcCCCCCcc
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------------HRTQQ--------FVTEVALLSRIHHRNLV 254 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~niv 254 (517)
|.+.+.||+|++|.||+|...+|+.||||+++.... ..... ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 456788999999999999999999999999753210 00111 23456666666444332
Q ss_pred ccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC
Q 010131 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 334 (517)
Q Consensus 255 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~ 334 (517)
-..-+.. ...++||||++|++|..+... .....++.|++.+|.|||+ .|||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 1111111 234799999999888765421 1245678999999999999 9999999999999998776
Q ss_pred ----------cEEEccccCccccC
Q 010131 335 ----------RAKVSDFGLSRQAE 348 (517)
Q Consensus 335 ----------~~kl~Dfg~a~~~~ 348 (517)
.+.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=7.1e-16 Score=168.95 Aligned_cols=108 Identities=34% Similarity=0.454 Sum_probs=100.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+++|.+|..|+++++|+.|+|++|+|+|.+|+ |+++++|+.|+|++|+++|.+|..++.+++|+.|++++
T Consensus 634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~ 713 (768)
T 3rgz_A 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713 (768)
T ss_dssp CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence 57899999999999999999999999999999999999998 99999999999999999999999999999999999999
Q ss_pred ccccCCCCccc-cccceeeeccCCCccccc
Q 010131 80 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 108 (517)
Q Consensus 80 N~l~~~~P~~~-~~~~~~~~~~~n~~~~~~ 108 (517)
|+++|.+|... +......++.|||++|+.
T Consensus 714 N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp SEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred CcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 99999999753 344556779999999974
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-14 Score=129.93 Aligned_cols=106 Identities=22% Similarity=0.281 Sum_probs=95.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|+|+ .+|..|.++++|+.|+|++|.|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|++++
T Consensus 33 l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~ 111 (193)
T 2wfh_A 33 VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHG 111 (193)
T ss_dssp CCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCC
Confidence 678999999999 8999999999999999999999999887 99999999999999999977777899999999999999
Q ss_pred ccccCCCCccccc---cceeeeccCCCccccc
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n~~~~~~ 108 (517)
|+|+ .+|+..+. .+..+.+.+||+.|..
T Consensus 112 N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 112 NDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SCCC-BCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCC-eeChhhhhcCccccEEEeCCCCeecCC
Confidence 9999 67776433 5667889999999863
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.51 E-value=3e-14 Score=128.37 Aligned_cols=107 Identities=18% Similarity=0.204 Sum_probs=94.7
Q ss_pred CceecCCCCcccccCCc-cccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|++|+|++|+|++..|. .|..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..+..+++|+.|+++
T Consensus 31 l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 110 (192)
T 1w8a_A 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110 (192)
T ss_dssp CSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECC
T ss_pred CCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECC
Confidence 57899999999966554 388999999999999999999887 9999999999999999998888889999999999999
Q ss_pred cccccCCCCccccc--cceeeeccCCCcccc
Q 010131 79 NNSFVGEIPPALLT--GKVIFKYDNNPKLHK 107 (517)
Q Consensus 79 ~N~l~~~~P~~~~~--~~~~~~~~~n~~~~~ 107 (517)
+|++++..|..+.. .+..+.+.+|++.|.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 111 DNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 99999777766543 567788999999876
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-14 Score=130.81 Aligned_cols=107 Identities=17% Similarity=0.175 Sum_probs=90.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|.|++.+|. |..+++|+.|+|++|+|++..|..+..+++|+.|++++
T Consensus 59 L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 138 (220)
T 2v70_A 59 LRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYD 138 (220)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTT
T ss_pred CCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCC
Confidence 57888999999877777888899999999999999988887 88899999999999999977788899999999999999
Q ss_pred ccccCCCCccccc--cceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALLT--GKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~~--~~~~~~~~~n~~~~~ 107 (517)
|++++..|..+.. .+..+.+.+|++.|.
T Consensus 139 N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 139 NQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 9999655655533 456778899998886
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.50 E-value=4.9e-14 Score=129.91 Aligned_cols=107 Identities=21% Similarity=0.281 Sum_probs=85.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|.|+..++. |..+++|+.|+|++|++++..|..|..+++|+.|++++
T Consensus 58 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 137 (220)
T 2v9t_B 58 LRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137 (220)
T ss_dssp CCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCC
Confidence 57788888888877788888888888888888888877776 78888888888888888877777888888888889999
Q ss_pred ccccCCCCcccc---ccceeeeccCCCccccc
Q 010131 80 NSFVGEIPPALL---TGKVIFKYDNNPKLHKE 108 (517)
Q Consensus 80 N~l~~~~P~~~~---~~~~~~~~~~n~~~~~~ 108 (517)
|+|+ .+|+..+ ..+..+.+.+||+.|..
T Consensus 138 N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 138 NKLQ-TIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp SCCS-CCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CcCC-EECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 9888 4555432 24566778899988863
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-13 Score=126.25 Aligned_cols=87 Identities=24% Similarity=0.304 Sum_probs=42.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.|++++
T Consensus 42 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~ 121 (229)
T 3e6j_A 42 AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121 (229)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccC
Confidence 34555555555544454555555555555555555444443 44555555555555555533233344444444444444
Q ss_pred ccccCCCCc
Q 010131 80 NSFVGEIPP 88 (517)
Q Consensus 80 N~l~~~~P~ 88 (517)
|+|+ .+|.
T Consensus 122 N~l~-~lp~ 129 (229)
T 3e6j_A 122 NKLT-ELPR 129 (229)
T ss_dssp SCCC-SCCT
T ss_pred Cccc-ccCc
Confidence 4444 4443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.8e-13 Score=119.38 Aligned_cols=106 Identities=22% Similarity=0.284 Sum_probs=91.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++..+..|..+++|+.|+|++|.|++.++. |..+++|+.|+|++|++++..+..+..+++|+.|++++
T Consensus 30 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 109 (177)
T 2o6r_A 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDT 109 (177)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcC
Confidence 67899999999966566788999999999999999998887 89999999999999999966666688999999999999
Q ss_pred ccccCCCCcccc---ccceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALL---TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~---~~~~~~~~~~n~~~~~ 107 (517)
|+++ .+|+..+ ..+..+.+.+|++.|.
T Consensus 110 N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 110 NQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCS-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred Ccce-EeCHHHhcCCcccCEEEecCCCeecc
Confidence 9999 6777653 3556788899998875
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=3.6e-13 Score=118.69 Aligned_cols=102 Identities=26% Similarity=0.346 Sum_probs=88.8
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.|++++|+++ .+|..+. ++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..|..+++|+.|++++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 67999999999 6898774 8999999999999999887 999999999999999999555556789999999999999
Q ss_pred cccCCCCcccc---ccceeeeccCCCcccc
Q 010131 81 SFVGEIPPALL---TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 81 ~l~~~~P~~~~---~~~~~~~~~~n~~~~~ 107 (517)
+|+ .+|+..+ ..+..+.+.+|++.|.
T Consensus 89 ~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 89 QLK-SIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ccC-EeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999 5776533 3567788999999886
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.41 E-value=9.3e-14 Score=135.37 Aligned_cols=108 Identities=27% Similarity=0.305 Sum_probs=95.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++.+|..|..+++|+.|+|++|.+++.+|.+..+++|+.|+|++|+++|.+|..+..+++|+.|++++|
T Consensus 199 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 278 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence 57888999999988888899999999999999999998888889999999999999999999999999999999999999
Q ss_pred cccCCCCccc-cccceeeeccCCCccccc
Q 010131 81 SFVGEIPPAL-LTGKVIFKYDNNPKLHKE 108 (517)
Q Consensus 81 ~l~~~~P~~~-~~~~~~~~~~~n~~~~~~ 108 (517)
+++|.+|... ......+.+.+|+++|+.
T Consensus 279 ~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred cccccCCCCccccccChHHhcCCCCccCC
Confidence 9999999762 234566788999999974
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=6.3e-13 Score=117.56 Aligned_cols=102 Identities=22% Similarity=0.352 Sum_probs=87.9
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..+..|..+++|+.|++++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 47899999997 8998775 8999999999999999887 999999999999999999544445789999999999999
Q ss_pred cccCCCCcccc---ccceeeeccCCCcccc
Q 010131 81 SFVGEIPPALL---TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 81 ~l~~~~P~~~~---~~~~~~~~~~n~~~~~ 107 (517)
+|+ .+|+..+ ..+..+.+.+|++.|.
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCcccc
Confidence 999 6777633 3566788999999876
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.40 E-value=5.7e-13 Score=128.18 Aligned_cols=105 Identities=29% Similarity=0.370 Sum_probs=66.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCC-CCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|. .+..+++|+.|+++
T Consensus 102 L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~L~ 180 (290)
T 1p9a_G 102 LTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180 (290)
T ss_dssp CCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEEECC
Confidence 45566666666644445566666666666666666666555 566666666666666666 3343 34566677777777
Q ss_pred cccccCCCCccccc--cceeeeccCCCcccc
Q 010131 79 NNSFVGEIPPALLT--GKVIFKYDNNPKLHK 107 (517)
Q Consensus 79 ~N~l~~~~P~~~~~--~~~~~~~~~n~~~~~ 107 (517)
+|+++ .+|..++. .+..+.+.+|||.|.
T Consensus 181 ~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp SSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence 77776 56665544 245566788888876
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=6.7e-13 Score=117.39 Aligned_cols=89 Identities=19% Similarity=0.250 Sum_probs=80.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.|++++
T Consensus 35 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~ 114 (174)
T 2r9u_A 35 KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYN 114 (174)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCS
T ss_pred CcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCC
Confidence 68899999999988888999999999999999999998887 89999999999999999954444599999999999999
Q ss_pred ccccCCCCccc
Q 010131 80 NSFVGEIPPAL 90 (517)
Q Consensus 80 N~l~~~~P~~~ 90 (517)
|.+. ..|..+
T Consensus 115 N~~~-c~~~~~ 124 (174)
T 2r9u_A 115 NPWD-CECRDI 124 (174)
T ss_dssp SCBC-TTBGGG
T ss_pred CCcc-cccccH
Confidence 9999 666543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.38 E-value=7.4e-13 Score=116.68 Aligned_cols=87 Identities=22% Similarity=0.218 Sum_probs=79.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..|..+..+++|+.|++++
T Consensus 32 l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 111 (170)
T 3g39_A 32 TQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLN 111 (170)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCC
Confidence 57899999999988788999999999999999999999888 89999999999999999965555699999999999999
Q ss_pred ccccCCCCc
Q 010131 80 NSFVGEIPP 88 (517)
Q Consensus 80 N~l~~~~P~ 88 (517)
|+++ ..++
T Consensus 112 N~~~-c~c~ 119 (170)
T 3g39_A 112 NPWD-CACS 119 (170)
T ss_dssp SCBC-TTBG
T ss_pred CCCC-CCch
Confidence 9999 4554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=4.8e-13 Score=120.44 Aligned_cols=87 Identities=21% Similarity=0.325 Sum_probs=82.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..+..+++|+.|++++
T Consensus 56 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 135 (192)
T 1w8a_A 56 LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS 135 (192)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTT
T ss_pred CCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCC
Confidence 68999999999998899999999999999999999999998 99999999999999999999999999999999999999
Q ss_pred ccccCCCC
Q 010131 80 NSFVGEIP 87 (517)
Q Consensus 80 N~l~~~~P 87 (517)
|++++..+
T Consensus 136 N~l~c~c~ 143 (192)
T 1w8a_A 136 NPFNCNCH 143 (192)
T ss_dssp CCBCCSGG
T ss_pred CCccCcCc
Confidence 99997655
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=122.88 Aligned_cols=105 Identities=21% Similarity=0.255 Sum_probs=50.6
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.|+|++|++++..|..|..+++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..|..+..+++|+.|++++|
T Consensus 86 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 165 (251)
T 3m19_A 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165 (251)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence 4444444444433333344455555555555555544444 455555555555555555333334555555555555555
Q ss_pred cccCCCCcc-cc--ccceeeeccCCCcccc
Q 010131 81 SFVGEIPPA-LL--TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 81 ~l~~~~P~~-~~--~~~~~~~~~~n~~~~~ 107 (517)
+++ .+|+. +. ..+..+.+.+|++.|.
T Consensus 166 ~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 166 QLQ-SVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCS-CCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCC-ccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 555 23332 21 1334455566665553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-13 Score=143.32 Aligned_cols=29 Identities=10% Similarity=0.015 Sum_probs=25.3
Q ss_pred HHHHHHHHHHHhcCCCCCccccceeeecC
Q 010131 235 TQQFVTEVALLSRIHHRNLVPLIGYCEEE 263 (517)
Q Consensus 235 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 263 (517)
.++|..|++.+.+++|+|+|+++|||...
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 46799999999999999999999999764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.8e-12 Score=120.14 Aligned_cols=106 Identities=24% Similarity=0.235 Sum_probs=92.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|++++
T Consensus 66 L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~ 144 (229)
T 3e6j_A 66 LKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144 (229)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCS
T ss_pred CcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCC
Confidence 68999999999854445678999999999999999998887 899999999999999999 9999999999999999999
Q ss_pred ccccCCCCcccc---ccceeeeccCCCccccc
Q 010131 80 NSFVGEIPPALL---TGKVIFKYDNNPKLHKE 108 (517)
Q Consensus 80 N~l~~~~P~~~~---~~~~~~~~~~n~~~~~~ 108 (517)
|+|+ .+|+..+ ..+..+.+.+||+.|..
T Consensus 145 N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 145 NQLK-SIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CcCC-ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 9999 6776543 35567889999998863
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.3e-12 Score=117.52 Aligned_cols=83 Identities=24% Similarity=0.339 Sum_probs=44.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..+..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|++++..+..+..+++|+.|++++
T Consensus 30 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 109 (208)
T 2o6s_A 30 TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT 109 (208)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCC
Confidence 34555566655543333445555555555555555555444 45555555555555555533333345555555555555
Q ss_pred cccc
Q 010131 80 NSFV 83 (517)
Q Consensus 80 N~l~ 83 (517)
|+++
T Consensus 110 N~l~ 113 (208)
T 2o6s_A 110 NQLQ 113 (208)
T ss_dssp SCCC
T ss_pred CcCc
Confidence 5555
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.6e-12 Score=128.43 Aligned_cols=102 Identities=20% Similarity=0.223 Sum_probs=91.7
Q ss_pred eecCCCC-cccccCCccccCCCCCcEEEcCC-CCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 3 RCALSGK-NLKGEIPPELKNMEALTELWLDG-NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 3 ~L~l~~n-~~~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
.++++++ +++ .+|. |..+++|+.|+|++ |.|++.+|. |.+|++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 5788998 899 6998 99999999999996 999999987 99999999999999999988888899999999999999
Q ss_pred ccccCCCCcccccc--ceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALLTG--KVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~~~--~~~~~~~~n~~~~~ 107 (517)
|+|+ .+|+..+.. +..+.+.+|++.|.
T Consensus 90 N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred Cccc-eeCHHHcccCCceEEEeeCCCccCC
Confidence 9999 688776543 56778899999886
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.33 E-value=3.7e-12 Score=121.38 Aligned_cols=105 Identities=21% Similarity=0.239 Sum_probs=48.4
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++|+|++|++++..|..|.++++|+.|+|++|.+++.++. |..+++|+.|++++|++++..|..+..+++|+.|++++|
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 4444444444433333344445555555555555544444 444555555555555555333333444555555555555
Q ss_pred cccCCCCccc---cccceeeeccCCCcccc
Q 010131 81 SFVGEIPPAL---LTGKVIFKYDNNPKLHK 107 (517)
Q Consensus 81 ~l~~~~P~~~---~~~~~~~~~~~n~~~~~ 107 (517)
++++ +|+.. ...+..+.+.+|++.|.
T Consensus 192 ~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 192 QLKS-VPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CCSC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cCCc-cCHHHHhCCcCCCEEEccCCCcccc
Confidence 5553 22221 12334445555555543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.32 E-value=4e-12 Score=120.94 Aligned_cols=106 Identities=24% Similarity=0.303 Sum_probs=71.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++..|..|..+++|+.|+|++|.|++.++. |..+++|+.|+|++|++++..+..+..+++|+.|++++
T Consensus 111 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 190 (270)
T 2o6q_A 111 LAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190 (270)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCC
Confidence 45666666666655555566677777777777777766665 67777777777777777744444566777777777777
Q ss_pred ccccCCCCcccc---ccceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALL---TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~---~~~~~~~~~~n~~~~~ 107 (517)
|+++ .+|+..+ ..+..+.+.+||+.|.
T Consensus 191 N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 191 NQLK-RVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp SCCS-CCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred CcCC-cCCHHHhccccCCCEEEecCCCeeCC
Confidence 7777 4555432 2445667788888776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.9e-12 Score=120.45 Aligned_cols=140 Identities=14% Similarity=0.072 Sum_probs=108.9
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
+.+...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 334566788888999999865 7899999986532223346889999999884 67788999999888899999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------ 313 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------------------------------------------ 313 (517)
.+|.+.+.. ......++.+++++|+.||+.
T Consensus 95 ~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 95 VLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred eehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999876421 112347789999999999971
Q ss_pred --------------CCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 314 --------------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 314 --------------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
....++|||+++.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876666799999764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.30 E-value=7.9e-13 Score=128.75 Aligned_cols=103 Identities=29% Similarity=0.605 Sum_probs=81.7
Q ss_pred CceecCCCCcccc--cCCccccCCCCCcEEEcCC-CCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccc
Q 010131 1 MARCALSGKNLKG--EIPPELKNMEALTELWLDG-NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76 (517)
Q Consensus 1 l~~L~l~~n~~~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~ 76 (517)
|+.|+|++|+++| .+|..|+++++|+.|+|++ |.+++.+|. |..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 52 l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 131 (313)
T 1ogq_A 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEe
Confidence 3578888888888 7888888888888888884 888888886 88888888888888888888888888888888888
Q ss_pred cccccccCCCCccccc--cceeeeccCCC
Q 010131 77 IENNSFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 77 l~~N~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
+++|++++.+|..+.. .+..+.+.+|.
T Consensus 132 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 132 FSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 8888888778776543 44556666664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.30 E-value=4.5e-12 Score=116.66 Aligned_cols=103 Identities=21% Similarity=0.221 Sum_probs=85.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCC-CCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|+ |.++++|+.|+|++|+|+ .+|.. +..+++|+.|+++
T Consensus 34 l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp CCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECC
Confidence 57899999999977677899999999999999999999887 999999999999999999 55554 7889999999999
Q ss_pred cccccCCCCcccc--ccceeeeccCCCc
Q 010131 79 NNSFVGEIPPALL--TGKVIFKYDNNPK 104 (517)
Q Consensus 79 ~N~l~~~~P~~~~--~~~~~~~~~~n~~ 104 (517)
+|++++..|..+. ..+..+.+.+|.-
T Consensus 113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l 140 (220)
T 2v9t_B 113 ANKINCLRVDAFQDLHNLNLLSLYDNKL 140 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCEeCHHHcCCCCCCCEEECCCCcC
Confidence 9999954454443 2455667777753
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=3e-12 Score=136.90 Aligned_cols=108 Identities=17% Similarity=0.173 Sum_probs=94.3
Q ss_pred CceecCCCCcccc-cCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|++.+ .+|..|..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..+..+++|+.|+++
T Consensus 471 L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls 550 (635)
T 4g8a_A 471 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 550 (635)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECT
T ss_pred hhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECC
Confidence 5789999998554 5678899999999999999999999997 9999999999999999997777789999999999999
Q ss_pred cccccCCCCcccc---ccceeeeccCCCccccc
Q 010131 79 NNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 108 (517)
Q Consensus 79 ~N~l~~~~P~~~~---~~~~~~~~~~n~~~~~~ 108 (517)
+|+|++..|..+. ..+..+.+.+||+.|..
T Consensus 551 ~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 551 LNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp TSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 9999976665553 34667889999999974
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=3.1e-12 Score=140.05 Aligned_cols=102 Identities=26% Similarity=0.467 Sum_probs=93.6
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
..++++.|.++|.+|..++++++|+.|||++|+++|.+|. |++++.|+.|+|++|+++|.+|..++++++|+.||+++|
T Consensus 611 ~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N 690 (768)
T 3rgz_A 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690 (768)
T ss_dssp CCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCC
Confidence 3467888999999999999999999999999999999998 999999999999999999999999999999999999999
Q ss_pred cccCCCCccccc--cceeeeccCCC
Q 010131 81 SFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
+++|.+|..+.. .+..+.+++|+
T Consensus 691 ~l~g~ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 691 KLDGRIPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp CCEECCCGGGGGCCCCSEEECCSSE
T ss_pred cccCcCChHHhCCCCCCEEECcCCc
Confidence 999999988754 45667777775
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.26 E-value=2.8e-12 Score=110.21 Aligned_cols=101 Identities=20% Similarity=0.241 Sum_probs=87.1
Q ss_pred CceecCCCCccc-ccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|++++|+++ +.+|..+..+++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++.+|..+..+++|+.|++++
T Consensus 19 l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~ 97 (149)
T 2je0_A 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97 (149)
T ss_dssp CSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTT
T ss_pred CeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCC
Confidence 688999999999 88999999999999999999999998 6699999999999999999977888888899999999999
Q ss_pred ccccCCCC--ccccc--cceeeeccCCC
Q 010131 80 NSFVGEIP--PALLT--GKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P--~~~~~--~~~~~~~~~n~ 103 (517)
|++++ +| ..+.. ....+.+.+|+
T Consensus 98 N~i~~-~~~~~~~~~l~~L~~L~l~~N~ 124 (149)
T 2je0_A 98 NKIKD-LSTIEPLKKLENLKSLDLFNCE 124 (149)
T ss_dssp SCCCS-HHHHGGGGGCTTCCEEECTTCG
T ss_pred CcCCC-hHHHHHHhhCCCCCEEeCcCCc
Confidence 99994 44 44432 45566677775
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-11 Score=116.15 Aligned_cols=88 Identities=23% Similarity=0.273 Sum_probs=51.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++..|..|.++++|+.|+|++|.|++.+|. |..+++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 37 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 116 (251)
T 3m19_A 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGG 116 (251)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCC
Confidence 35566666666655555566666666666666666665555 56666666666666666644444455566666666666
Q ss_pred ccccCCCCcc
Q 010131 80 NSFVGEIPPA 89 (517)
Q Consensus 80 N~l~~~~P~~ 89 (517)
|+++ .+|+.
T Consensus 117 N~l~-~~~~~ 125 (251)
T 3m19_A 117 NQLK-SLPSG 125 (251)
T ss_dssp SCCC-CCCTT
T ss_pred CcCC-CcChh
Confidence 6665 34443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=7.9e-12 Score=128.23 Aligned_cols=106 Identities=21% Similarity=0.262 Sum_probs=84.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..|..|.++++|+.|+|++|.+++.+|. |..+++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 301 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 380 (455)
T 3v47_A 301 LEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT 380 (455)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCC
Confidence 56788888888877777788888888888888888877776 78888888888888888877788888888888888888
Q ss_pred ccccCCCCcccc---ccceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALL---TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~---~~~~~~~~~~n~~~~~ 107 (517)
|+++ .+|+..+ ..+..+.+.+|+..|.
T Consensus 381 N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 381 NQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp SCCS-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred Cccc-cCCHhHhccCCcccEEEccCCCcccC
Confidence 8888 5666443 2456677888888775
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.25 E-value=4e-12 Score=111.69 Aligned_cols=101 Identities=22% Similarity=0.236 Sum_probs=86.5
Q ss_pred CceecCCCCccc-ccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+++ +.+|..+..+++|+.|+|++|.+++. +.+..+++|+.|+|++|++++.+|..+..+++|+.|++++
T Consensus 26 L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 104 (168)
T 2ell_A 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG 104 (168)
T ss_dssp CSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBS
T ss_pred CCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccC
Confidence 688999999998 88999899999999999999999988 6699999999999999999977888787899999999999
Q ss_pred ccccCCCC--ccccc--cceeeeccCCC
Q 010131 80 NSFVGEIP--PALLT--GKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P--~~~~~--~~~~~~~~~n~ 103 (517)
|+++ .+| ..+.. .+..+.+.+|+
T Consensus 105 N~l~-~~~~~~~l~~l~~L~~L~l~~N~ 131 (168)
T 2ell_A 105 NKLK-DISTLEPLKKLECLKSLDLFNCE 131 (168)
T ss_dssp SSCC-SSGGGGGGSSCSCCCEEECCSSG
T ss_pred CccC-cchhHHHHhcCCCCCEEEeeCCc
Confidence 9999 565 33322 44556667775
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=7e-12 Score=115.40 Aligned_cols=87 Identities=24% Similarity=0.305 Sum_probs=80.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..|..|.++++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..+..+++|+.|++++
T Consensus 83 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 162 (220)
T 2v70_A 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLA 162 (220)
T ss_dssp CCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecC
Confidence 68999999999977777799999999999999999999887 99999999999999999988899999999999999999
Q ss_pred ccccCCCC
Q 010131 80 NSFVGEIP 87 (517)
Q Consensus 80 N~l~~~~P 87 (517)
|.+++..+
T Consensus 163 N~l~c~c~ 170 (220)
T 2v70_A 163 NPFNCNCY 170 (220)
T ss_dssp CCEECSGG
T ss_pred cCCcCCCc
Confidence 99996544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.25 E-value=3.7e-12 Score=126.63 Aligned_cols=89 Identities=22% Similarity=0.185 Sum_probs=75.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 66 L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 145 (361)
T 2xot_A 66 LHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145 (361)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred cCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCC
Confidence 67889999999976677788899999999999999888886 88889999999999998877778888888888888888
Q ss_pred ccccCCCCccc
Q 010131 80 NSFVGEIPPAL 90 (517)
Q Consensus 80 N~l~~~~P~~~ 90 (517)
|+|+ .+|...
T Consensus 146 N~l~-~l~~~~ 155 (361)
T 2xot_A 146 NQIS-RFPVEL 155 (361)
T ss_dssp SCCC-SCCGGG
T ss_pred CcCC-eeCHHH
Confidence 8888 577654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.25 E-value=5.3e-12 Score=123.69 Aligned_cols=102 Identities=16% Similarity=0.232 Sum_probs=66.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+++ .+|..++++++|+.|+|++|.+++.++.+..+++|+.|+|++|.+.+.+|..++.+++|+.|++++|
T Consensus 185 L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n 263 (328)
T 4fcg_A 185 LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263 (328)
T ss_dssp CCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTC
T ss_pred CCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCC
Confidence 456666666666 6666666667777777777777765555666677777777776666667766667777777777776
Q ss_pred cccCCCCccccc--cceeeeccCCC
Q 010131 81 SFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
++.+.+|..+.. .+..+.+.+|+
T Consensus 264 ~~~~~~p~~~~~l~~L~~L~L~~n~ 288 (328)
T 4fcg_A 264 SNLLTLPLDIHRLTQLEKLDLRGCV 288 (328)
T ss_dssp TTCCBCCTTGGGCTTCCEEECTTCT
T ss_pred CchhhcchhhhcCCCCCEEeCCCCC
Confidence 666666665432 33445555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=8.4e-12 Score=119.70 Aligned_cols=105 Identities=20% Similarity=0.287 Sum_probs=50.4
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++|+|++|++++..+..|.++++|+.|+|++|.+++.++. |..+++|+.|+|++|.+++..|..+..+++|+.|++++|
T Consensus 132 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 4444444444433333344444555555555555444443 444555555555555555444555555555555555555
Q ss_pred cccCCCCcc-cc--ccceeeeccCCCcccc
Q 010131 81 SFVGEIPPA-LL--TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 81 ~l~~~~P~~-~~--~~~~~~~~~~n~~~~~ 107 (517)
++++ +|+. +. ..+..+.+.+|++.|.
T Consensus 212 ~l~~-~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 212 NLSA-LPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp CCSC-CCHHHHTTCTTCCEEECCSSCEECS
T ss_pred cCCc-CCHHHcccCcccCEEeccCCCccCC
Confidence 5552 3332 11 1334455566665554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.1e-11 Score=111.14 Aligned_cols=106 Identities=21% Similarity=0.282 Sum_probs=89.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..+..|.++++|+.|+|++|.|++.++. |..+++|+.|+|++|++++..+..+..+++|+.|++++
T Consensus 54 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 133 (208)
T 2o6s_A 54 LTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQ 133 (208)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCC
Confidence 68999999999965555678999999999999999998887 89999999999999999966556688999999999999
Q ss_pred ccccCCCCcccc---ccceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALL---TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~---~~~~~~~~~~n~~~~~ 107 (517)
|+++ .+|+..+ ..+..+.+.+|++.|.
T Consensus 134 N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 134 NQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp SCCS-CCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred Cccc-eeCHHHhccCCCccEEEecCCCeecC
Confidence 9999 5666533 3566778899988764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.24 E-value=7.7e-12 Score=122.52 Aligned_cols=91 Identities=18% Similarity=0.265 Sum_probs=86.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+++ .+|+.++.+++|+.|+|++|.+.+.+|. +..+++|+.|+|++|.+.+.+|..+..+++|+.|++++
T Consensus 208 L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~ 286 (328)
T 4fcg_A 208 LKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286 (328)
T ss_dssp CCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTT
T ss_pred CCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCC
Confidence 689999999999 5888899999999999999999999998 99999999999999999999999999999999999999
Q ss_pred ccccCCCCccccc
Q 010131 80 NSFVGEIPPALLT 92 (517)
Q Consensus 80 N~l~~~~P~~~~~ 92 (517)
|++.+.+|..+..
T Consensus 287 n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 287 CVNLSRLPSLIAQ 299 (328)
T ss_dssp CTTCCCCCGGGGG
T ss_pred CCchhhccHHHhh
Confidence 9999999988765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=1.2e-11 Score=126.37 Aligned_cols=105 Identities=25% Similarity=0.334 Sum_probs=91.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+++ .+| .+..+++|+.|+|++|.|++..|. |.++++|+.|+|++|++++..|..|..+++|+.|+|++
T Consensus 187 L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 264 (440)
T 3zyj_A 187 LRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAH 264 (440)
T ss_dssp CCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTT
T ss_pred cCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCC
Confidence 678899999988 667 488899999999999999998887 99999999999999999988888899999999999999
Q ss_pred ccccCCCCccccc---cceeeeccCCCccccc
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n~~~~~~ 108 (517)
|+++ .+|...+. .+..+.+.+||+.|..
T Consensus 265 N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 265 NNLT-LLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp SCCC-CCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred CCCC-ccChhHhccccCCCEEEcCCCCccCCC
Confidence 9999 67766543 5567889999999974
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.4e-11 Score=122.47 Aligned_cols=103 Identities=22% Similarity=0.132 Sum_probs=77.4
Q ss_pred CceecCCCCcccccCCcccc-CCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
++.|+|++|+|++..+..|. ++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 46788888888866666666 788888888888888888876 8888888888888888886666668888888888888
Q ss_pred cccccCCCCcccc--ccceeeeccCCC
Q 010131 79 NNSFVGEIPPALL--TGKVIFKYDNNP 103 (517)
Q Consensus 79 ~N~l~~~~P~~~~--~~~~~~~~~~n~ 103 (517)
+|++++..|..+. ..+..+.+.+|.
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~ 147 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQ 147 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCc
Confidence 8888844344432 234455566653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.23 E-value=9.9e-12 Score=120.49 Aligned_cols=107 Identities=17% Similarity=0.178 Sum_probs=63.0
Q ss_pred CceecCCCCcccc-cCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|++|+|++|.+++ .+|..+..+++|+.|+|++|.+++.+|. |..+++|+.|+|++|.+++..+..+..+++|+.|+++
T Consensus 152 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 231 (306)
T 2z66_A 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS 231 (306)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECT
T ss_pred CCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECC
Confidence 4556666666654 3555566666666666666666666554 6666666666666666664444455666666666666
Q ss_pred cccccCCCCccccc---cceeeeccCCCcccc
Q 010131 79 NNSFVGEIPPALLT---GKVIFKYDNNPKLHK 107 (517)
Q Consensus 79 ~N~l~~~~P~~~~~---~~~~~~~~~n~~~~~ 107 (517)
+|++++..|..+.. ....+.+.+|++.|.
T Consensus 232 ~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 232 LNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp TSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 66666555544332 344556666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.2e-11 Score=111.21 Aligned_cols=84 Identities=24% Similarity=0.270 Sum_probs=76.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..+..+..+++|+.|++++
T Consensus 56 L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 135 (193)
T 2wfh_A 56 LTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGA 135 (193)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCC
Confidence 68999999999977778899999999999999999999997 99999999999999999954445688999999999999
Q ss_pred ccccC
Q 010131 80 NSFVG 84 (517)
Q Consensus 80 N~l~~ 84 (517)
|.+..
T Consensus 136 N~~~C 140 (193)
T 2wfh_A 136 NPLYC 140 (193)
T ss_dssp SCEEC
T ss_pred CCeec
Confidence 99983
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.23 E-value=2.2e-11 Score=117.03 Aligned_cols=102 Identities=27% Similarity=0.338 Sum_probs=84.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++.+|. |..+++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence 578888888888 7888888899999999999999988887 89999999999999999955555678899999999999
Q ss_pred ccccCCCCccccc---cceeeeccCCCc
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNNPK 104 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n~~ 104 (517)
|+|+ .+|+..+. .+..+.+.+|.-
T Consensus 158 N~l~-~l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 158 NNLT-ELPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp SCCS-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CcCC-ccCHHHhcCcCCCCEEECCCCcC
Confidence 9999 68876543 455666777753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.4e-11 Score=109.28 Aligned_cols=87 Identities=21% Similarity=0.326 Sum_probs=76.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++..+..|.++++|+.|+|++|.|++.++. |..+++|+.|+|++|++++..+..+..+++|+.|++++
T Consensus 54 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 133 (177)
T 2o6r_A 54 LTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 133 (177)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred ccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecC
Confidence 68999999999965556688999999999999999999887 89999999999999999954444568899999999999
Q ss_pred ccccCCCC
Q 010131 80 NSFVGEIP 87 (517)
Q Consensus 80 N~l~~~~P 87 (517)
|++++..|
T Consensus 134 N~~~~~~~ 141 (177)
T 2o6r_A 134 NPWDCSCP 141 (177)
T ss_dssp SCBCCCHH
T ss_pred CCeeccCc
Confidence 99996554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.8e-11 Score=114.28 Aligned_cols=131 Identities=17% Similarity=0.093 Sum_probs=98.3
Q ss_pred ccC-CCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC--ccccceeeecCCeeEEEEEecCCCCH
Q 010131 202 KIG-KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 202 ~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
.++ .|..+.||++...+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++....+..++||||++|.++
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 354 55569999998877888999997653 2245778999999885444 55688888877788999999999888
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------- 314 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------- 314 (517)
. .. . .. ...++.++++.|..||+..
T Consensus 103 ~--~~----~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SS----H--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TS----C--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cC----c--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 22 1 11 2357788888888888721
Q ss_pred -----------CCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 315 -----------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 315 -----------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
...++|||++|.||++++++.+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999997653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.1e-11 Score=125.02 Aligned_cols=105 Identities=24% Similarity=0.320 Sum_probs=91.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++ +| .+..+++|+.|+|++|.|++.+|. |.++++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 198 L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 275 (452)
T 3zyi_A 198 LKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275 (452)
T ss_dssp CCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCC
Confidence 6788999999984 55 588899999999999999999887 99999999999999999988888999999999999999
Q ss_pred ccccCCCCccccc---cceeeeccCCCccccc
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n~~~~~~ 108 (517)
|+|+ .+|...+. .+..+.+.+||+.|..
T Consensus 276 N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 276 NNLS-SLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp SCCS-CCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CcCC-ccChHHhccccCCCEEEccCCCcCCCC
Confidence 9999 67765543 4567889999999874
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.19 E-value=4.6e-11 Score=113.71 Aligned_cols=83 Identities=24% Similarity=0.316 Sum_probs=48.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..|..|.++++|+.|+|++|++++.++. |..+++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 87 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 166 (272)
T 3rfs_A 87 LTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSY 166 (272)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCC
Confidence 45566666666644444455566666666666666655555 55666666666666666644444455666666666666
Q ss_pred cccc
Q 010131 80 NSFV 83 (517)
Q Consensus 80 N~l~ 83 (517)
|+++
T Consensus 167 n~l~ 170 (272)
T 3rfs_A 167 NQLQ 170 (272)
T ss_dssp SCCC
T ss_pred CCcC
Confidence 6666
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=1.2e-11 Score=131.76 Aligned_cols=107 Identities=20% Similarity=0.143 Sum_probs=82.1
Q ss_pred CceecCCCCccccc-CCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGE-IPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|++++. +|..|..+++|+.|+|++|++++.+|. |..+++|+.|+|++|++++.+|..+..+++|+.|+++
T Consensus 450 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 529 (606)
T 3vq2_A 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529 (606)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECT
T ss_pred CCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECC
Confidence 56777777777763 677777788888888888888887776 7888888888888888887777778888888888888
Q ss_pred cccccCCCCccccc---cceeeeccCCCccccc
Q 010131 79 NNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 79 ~N~l~~~~P~~~~~---~~~~~~~~~n~~~~~~ 108 (517)
+|+++ .+|..+.. ....+.+.+||+.|..
T Consensus 530 ~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 530 FNRIE-TSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp TSCCC-CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred CCcCc-ccCHhHhhhcccCcEEEccCCCcccCC
Confidence 88888 67776433 3566778888888763
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=2.3e-11 Score=129.98 Aligned_cols=102 Identities=15% Similarity=0.046 Sum_probs=79.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
+++|||++|+|++..|..|.++++|+.|+|++|+|++.+|+ |.+|++|++|+|++|+|++..|..|.++++|++|++++
T Consensus 54 ~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~ 133 (635)
T 4g8a_A 54 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 133 (635)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTT
T ss_pred CCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCC
Confidence 57889999999866667888899999999999999988886 88899999999999998855555688888899999999
Q ss_pred ccccCCCCcccc---ccceeeeccCCC
Q 010131 80 NSFVGEIPPALL---TGKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P~~~~---~~~~~~~~~~n~ 103 (517)
|+++ .+|+..+ ..+..+.+.+|.
T Consensus 134 N~l~-~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 134 TNLA-SLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp SCCC-CSTTCCCTTCTTCCEEECCSSC
T ss_pred CcCC-CCChhhhhcCcccCeeccccCc
Confidence 9888 4665432 234455555553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=4.2e-11 Score=117.36 Aligned_cols=104 Identities=21% Similarity=0.241 Sum_probs=87.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..|..|..+++|+.|+|++|.+++.++. +..+++|+.|+|++|+++ .+|..+..+++|+.|++++
T Consensus 194 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~ 272 (330)
T 1xku_A 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272 (330)
T ss_dssp CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCS
T ss_pred CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCC
Confidence 57889999999987788899999999999999999998886 889999999999999999 8899999999999999999
Q ss_pred ccccCCCCccccc---------cceeeeccCCCccc
Q 010131 80 NSFVGEIPPALLT---------GKVIFKYDNNPKLH 106 (517)
Q Consensus 80 N~l~~~~P~~~~~---------~~~~~~~~~n~~~~ 106 (517)
|+++ .+|...+. ....+.+.+||..+
T Consensus 273 N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp SCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CcCC-ccChhhcCCcccccccccccceEeecCcccc
Confidence 9999 57665442 22346678888654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.7e-11 Score=127.78 Aligned_cols=105 Identities=14% Similarity=0.212 Sum_probs=94.1
Q ss_pred CceecCCCCcccccCCcccc--CCCCCcEEEcCCCCCCCCCCcccCccccceeEe------cCceeeecCCCCCCCcccc
Q 010131 1 MARCALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL------ENNELTGSLPSYMGSLPNL 72 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l------~~n~l~~~~p~~~~~l~~L 72 (517)
|+.|+|++|+++ .+|..++ .+++|+.|+|++|+|++.++.+..+++|+.|+| ++|++.+.+|..++.+++|
T Consensus 490 L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L 568 (636)
T 4eco_A 490 LTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSL 568 (636)
T ss_dssp CCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred ccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCC
Confidence 678999999999 7999887 999999999999999994344999999999999 5688899999999999999
Q ss_pred cccccccccccCCCCccccccceeeeccCCCcccc
Q 010131 73 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHK 107 (517)
Q Consensus 73 ~~l~l~~N~l~~~~P~~~~~~~~~~~~~~n~~~~~ 107 (517)
+.|++++|++ +.+|..+...+..+.+.+|+..|-
T Consensus 569 ~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 569 TQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISI 602 (636)
T ss_dssp CEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEE
T ss_pred CEEECCCCcC-CccCHhHhCcCCEEECcCCCCccc
Confidence 9999999999 499998888888889999998764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=4e-11 Score=125.93 Aligned_cols=100 Identities=25% Similarity=0.302 Sum_probs=85.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+|++ +|. |+++++|+.|+|++|.|+..++.|+.+++|+.|+|++|+|++ +| .++.+++|+.|++++|
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N 518 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 518 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCC
Confidence 5789999999995 786 999999999999999999443349999999999999999995 78 8999999999999999
Q ss_pred cccCCC-Cccccc--cceeeeccCCCc
Q 010131 81 SFVGEI-PPALLT--GKVIFKYDNNPK 104 (517)
Q Consensus 81 ~l~~~~-P~~~~~--~~~~~~~~~n~~ 104 (517)
+|++.. |..+.. .+..+.+.+|+.
T Consensus 519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 519 RLQQSAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence 999654 777643 556777888864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.15 E-value=3.4e-11 Score=130.44 Aligned_cols=100 Identities=30% Similarity=0.428 Sum_probs=76.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++. .+|..++++++|+.|+|++|.|+ .+|. |++|++|+.|+|++|+|+ .+|..|++|++|+.|+|++
T Consensus 226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~ 302 (727)
T 4b8c_D 226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFD 302 (727)
T ss_dssp CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCS
T ss_pred CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCC
Confidence 567888888887 67777778888888888888888 4454 888888888888888888 7788888888888888888
Q ss_pred ccccCCCCccccc--cceeeeccCCCc
Q 010131 80 NSFVGEIPPALLT--GKVIFKYDNNPK 104 (517)
Q Consensus 80 N~l~~~~P~~~~~--~~~~~~~~~n~~ 104 (517)
|.|+ .+|..+.. .+..+.+.+|+.
T Consensus 303 N~l~-~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 303 NMVT-TLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp SCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred CCCC-ccChhhhcCCCccEEeCCCCcc
Confidence 8887 77776543 455566677754
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.14 E-value=5.7e-11 Score=116.55 Aligned_cols=104 Identities=22% Similarity=0.184 Sum_probs=87.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..|..|..+++|+.|+|++|.+++.++. +..+++|+.|+|++|+++ .+|..+..+++|+.|++++
T Consensus 195 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~ 273 (332)
T 2ft3_A 195 LNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273 (332)
T ss_dssp CSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCS
T ss_pred CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCC
Confidence 57889999999977778899999999999999999998886 999999999999999999 8999999999999999999
Q ss_pred ccccCCCCccccc---------cceeeeccCCCccc
Q 010131 80 NSFVGEIPPALLT---------GKVIFKYDNNPKLH 106 (517)
Q Consensus 80 N~l~~~~P~~~~~---------~~~~~~~~~n~~~~ 106 (517)
|+++ .+|...+. ....+.+.+||..+
T Consensus 274 N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 274 NNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp SCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred CCCC-ccChhHccccccccccccccceEeecCcccc
Confidence 9999 56654332 23456788888764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=3.6e-11 Score=126.30 Aligned_cols=86 Identities=27% Similarity=0.319 Sum_probs=79.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecC-CCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~-p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|+ .+|..|++|++|+.|+|++|.|++ +|.++.+++|+.|+|++|+|++.. |..++.+++|+.|++++
T Consensus 465 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~ 542 (567)
T 1dce_A 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542 (567)
T ss_dssp CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTT
T ss_pred CcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecC
Confidence 689999999999 899999999999999999999998 568999999999999999999766 99999999999999999
Q ss_pred ccccCCCCcc
Q 010131 80 NSFVGEIPPA 89 (517)
Q Consensus 80 N~l~~~~P~~ 89 (517)
|++++ +|+.
T Consensus 543 N~l~~-~~~~ 551 (567)
T 1dce_A 543 NSLCQ-EEGI 551 (567)
T ss_dssp SGGGG-SSSC
T ss_pred CcCCC-CccH
Confidence 99995 4543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.13 E-value=3.2e-11 Score=108.87 Aligned_cols=84 Identities=14% Similarity=0.262 Sum_probs=52.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|.++ .++.+..+++|+.|+|++|.+++..|. +..+++|+.|+|++|.+++..|..+..+++|+.|++++
T Consensus 68 L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~ 145 (197)
T 4ezg_A 68 IKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSY 145 (197)
T ss_dssp CSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCS
T ss_pred CCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccC
Confidence 456666666554 233566666666666666666664443 66666666666666666655566666666666666666
Q ss_pred cc-ccCCCC
Q 010131 80 NS-FVGEIP 87 (517)
Q Consensus 80 N~-l~~~~P 87 (517)
|. ++ .+|
T Consensus 146 n~~i~-~~~ 153 (197)
T 4ezg_A 146 NGAIT-DIM 153 (197)
T ss_dssp CTBCC-CCG
T ss_pred CCCcc-ccH
Confidence 66 44 455
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=111.97 Aligned_cols=102 Identities=22% Similarity=0.266 Sum_probs=65.7
Q ss_pred CceecCCCCc-ccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~-~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|++|+|++|. +....|..|..+++|+.|+|++|.+++.+|. |..+++|+.|+|++|++++..+..+..+++|+.|+++
T Consensus 82 L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 161 (285)
T 1ozn_A 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161 (285)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECC
Confidence 5667777776 5544466677777777777777777776665 6777777777777777774444456677777777777
Q ss_pred cccccCCCCcc-cc--ccceeeeccCCC
Q 010131 79 NNSFVGEIPPA-LL--TGKVIFKYDNNP 103 (517)
Q Consensus 79 ~N~l~~~~P~~-~~--~~~~~~~~~~n~ 103 (517)
+|+++ .+|.. +. ..+..+.+.+|.
T Consensus 162 ~n~l~-~~~~~~~~~l~~L~~L~l~~n~ 188 (285)
T 1ozn_A 162 GNRIS-SVPERAFRGLHSLDRLLLHQNR 188 (285)
T ss_dssp SSCCC-EECTTTTTTCTTCCEEECCSSC
T ss_pred CCccc-ccCHHHhcCccccCEEECCCCc
Confidence 77777 44443 21 233444455553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.13 E-value=2.7e-11 Score=129.58 Aligned_cols=102 Identities=19% Similarity=0.280 Sum_probs=87.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCC-----------------------------------------------
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGN----------------------------------------------- 33 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N----------------------------------------------- 33 (517)
++.|+|++|+++|.+|+.|++|++|+.|+|++|
T Consensus 83 V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~ 162 (636)
T 4eco_A 83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI 162 (636)
T ss_dssp EEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHH
T ss_pred EEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHH
Confidence 467999999999999999999999999999988
Q ss_pred -------------------------------CCCCCCCc-ccCccccceeEecCceeeec-----------------CCC
Q 010131 34 -------------------------------FLTGPLPD-MSRLIDLRIVHLENNELTGS-----------------LPS 64 (517)
Q Consensus 34 -------------------------------~l~~~~p~-~~~l~~L~~l~l~~n~l~~~-----------------~p~ 64 (517)
+|+| +|+ |+++++|+.|+|++|.|+|. +|.
T Consensus 163 ~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~ 241 (636)
T 4eco_A 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE 241 (636)
T ss_dssp HHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch
Confidence 3445 665 99999999999999999975 999
Q ss_pred CCC--CcccccccccccccccCCCCccccc--cceeeeccCCC
Q 010131 65 YMG--SLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 65 ~~~--~l~~L~~l~l~~N~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
.++ ++++|++|++++|++.|.+|..+.. .+..+.+.+|.
T Consensus 242 ~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 999 9999999999999999999987754 45566677775
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.7e-11 Score=121.71 Aligned_cols=103 Identities=17% Similarity=0.173 Sum_probs=48.3
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
++|+|++|.+++..|..|..+++|+.|+|++|++++.++.+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~ 329 (390)
T 3o6n_A 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329 (390)
T ss_dssp SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSC
T ss_pred cEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCc
Confidence 3444444444444444444444444444444444443333444444445555555444 344444444455555555555
Q ss_pred ccCCCCccccccceeeeccCCCccc
Q 010131 82 FVGEIPPALLTGKVIFKYDNNPKLH 106 (517)
Q Consensus 82 l~~~~P~~~~~~~~~~~~~~n~~~~ 106 (517)
++ .+|.........+.+.+|++.|
T Consensus 330 i~-~~~~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 330 IV-TLKLSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp CC-CCCCCTTCCCSEEECCSSCEEH
T ss_pred cc-eeCchhhccCCEEEcCCCCccc
Confidence 44 3343333344445555555554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.7e-11 Score=131.17 Aligned_cols=89 Identities=33% Similarity=0.427 Sum_probs=81.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+|+ .+|..|++|++|+.|+|++|.|+..++.|+.|++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|
T Consensus 249 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N 326 (727)
T 4b8c_D 249 LTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326 (727)
T ss_dssp CSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred CCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence 689999999999 8999999999999999999999954334999999999999999998 99999999999999999999
Q ss_pred cccCCCCcccc
Q 010131 81 SFVGEIPPALL 91 (517)
Q Consensus 81 ~l~~~~P~~~~ 91 (517)
.|+|.+|..+.
T Consensus 327 ~l~~~~p~~~~ 337 (727)
T 4b8c_D 327 PLEKQFLKILT 337 (727)
T ss_dssp CCCSHHHHHHH
T ss_pred ccCCCChHHHh
Confidence 99987776653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.6e-10 Score=109.85 Aligned_cols=88 Identities=23% Similarity=0.357 Sum_probs=59.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|+++...+..|.++++|+.|+|++|.+++.++. |..+++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 63 L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 142 (270)
T 2o6q_A 63 LRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGY 142 (270)
T ss_dssp CCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCC
Confidence 56677777777743333446677777777777777776665 66777777777777777755555566777777777777
Q ss_pred ccccCCCCcc
Q 010131 80 NSFVGEIPPA 89 (517)
Q Consensus 80 N~l~~~~P~~ 89 (517)
|.++ .+|..
T Consensus 143 n~l~-~~~~~ 151 (270)
T 2o6q_A 143 NELQ-SLPKG 151 (270)
T ss_dssp SCCC-CCCTT
T ss_pred CcCC-ccCHh
Confidence 7776 45544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.12 E-value=2.6e-11 Score=128.87 Aligned_cols=104 Identities=17% Similarity=0.174 Sum_probs=48.6
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
+.|+|++|.+++.+|..|+++++|+.|+|++|.|++.++.+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|+
T Consensus 257 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~ 335 (597)
T 3oja_B 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335 (597)
T ss_dssp SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSC
T ss_pred CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCC
Confidence 3444444444444444444444444444444444443333444444444444444444 444444444444455555554
Q ss_pred ccCCCCccccccceeeeccCCCcccc
Q 010131 82 FVGEIPPALLTGKVIFKYDNNPKLHK 107 (517)
Q Consensus 82 l~~~~P~~~~~~~~~~~~~~n~~~~~ 107 (517)
++ .+|......+..+.+.+||+.|.
T Consensus 336 l~-~~~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 336 IV-TLKLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CC-CcChhhcCCCCEEEeeCCCCCCh
Confidence 44 23333333444455556655543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.12 E-value=5.3e-11 Score=117.52 Aligned_cols=84 Identities=23% Similarity=0.188 Sum_probs=74.1
Q ss_pred CceecCCC-CcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCC-CCCccccccccc
Q 010131 1 MARCALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l 77 (517)
|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++.+|. |.+|++|+.|+|++|+|+ .+|.. +..++ |+.|+|
T Consensus 33 L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~-L~~l~l 110 (347)
T 2ifg_A 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVL 110 (347)
T ss_dssp CSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCC-CCEEEC
T ss_pred eeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccc-eeCHHHcccCC-ceEEEe
Confidence 68999996 999987778899999999999999999999997 999999999999999999 55554 44454 999999
Q ss_pred ccccccCCCC
Q 010131 78 ENNSFVGEIP 87 (517)
Q Consensus 78 ~~N~l~~~~P 87 (517)
.+|.+. +.+
T Consensus 111 ~~N~~~-c~c 119 (347)
T 2ifg_A 111 SGNPLH-CSC 119 (347)
T ss_dssp CSSCCC-CCG
T ss_pred eCCCcc-CCC
Confidence 999998 444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.11 E-value=3.4e-11 Score=106.64 Aligned_cols=100 Identities=22% Similarity=0.254 Sum_probs=82.2
Q ss_pred CceecCCCCcccccCCccccCC-CCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCC-CCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNM-EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
|+.|+|++|+++ .+|. +..+ ++|+.|+|++|.|++. +.|..+++|+.|+|++|+++ .+|.. +..+++|+.|+++
T Consensus 21 L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~ 96 (176)
T 1a9n_A 21 DRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILT 96 (176)
T ss_dssp CEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECC
T ss_pred ceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECC
Confidence 578999999999 5664 5555 4999999999999987 67999999999999999999 45554 4899999999999
Q ss_pred cccccCCCCc--ccc--ccceeeeccCCCcc
Q 010131 79 NNSFVGEIPP--ALL--TGKVIFKYDNNPKL 105 (517)
Q Consensus 79 ~N~l~~~~P~--~~~--~~~~~~~~~~n~~~ 105 (517)
+|+++ .+|. .+. ..+..+.+.+|+..
T Consensus 97 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 97 NNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 99997 7886 443 24566778888754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=127.81 Aligned_cols=104 Identities=15% Similarity=0.268 Sum_probs=91.0
Q ss_pred CceecCCCCcccccCCcccc--CCCCCcEEEcCCCCCCCCCCcccCccccceeEecC------ceeeecCCCCCCCcccc
Q 010131 1 MARCALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN------NELTGSLPSYMGSLPNL 72 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~------n~l~~~~p~~~~~l~~L 72 (517)
|+.|+|++|+++ .+|..++ .+++|+.|+|++|.|++.++.+..+++|+.|+|++ |++.+.+|..+..+++|
T Consensus 730 L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L 808 (876)
T 4ecn_A 730 LTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSL 808 (876)
T ss_dssp CCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSC
T ss_pred ccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCC
Confidence 578999999999 7898887 89999999999999999544588999999999976 88888999999999999
Q ss_pred cccccccccccCCCCccccccceeeeccCCCccc
Q 010131 73 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 106 (517)
Q Consensus 73 ~~l~l~~N~l~~~~P~~~~~~~~~~~~~~n~~~~ 106 (517)
+.|++++|++ +.+|..+...+..+.+.+|+...
T Consensus 809 ~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 809 IQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp CEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred CEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 9999999999 59999888777888888998653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.11 E-value=3.7e-11 Score=105.47 Aligned_cols=84 Identities=21% Similarity=0.261 Sum_probs=75.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCC--CCCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p--~~~~~l~~L~~l~l 77 (517)
|+.|+|++|.+++. ..+..+++|+.|+|++|.+++.+|. +..+++|+.|+|++|.++ .+| ..+..+++|+.|++
T Consensus 51 L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~l~~l~~L~~L~l 127 (168)
T 2ell_A 51 LEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDL 127 (168)
T ss_dssp CCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC-SSGGGGGGSSCSCCCEEEC
T ss_pred CCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC-cchhHHHHhcCCCCCEEEe
Confidence 68999999999965 7899999999999999999998887 777999999999999999 544 67999999999999
Q ss_pred ccccccCCCCc
Q 010131 78 ENNSFVGEIPP 88 (517)
Q Consensus 78 ~~N~l~~~~P~ 88 (517)
++|+++ .+|.
T Consensus 128 ~~N~l~-~~~~ 137 (168)
T 2ell_A 128 FNCEVT-NLND 137 (168)
T ss_dssp CSSGGG-TSTT
T ss_pred eCCcCc-chHH
Confidence 999999 5665
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=5.7e-11 Score=122.67 Aligned_cols=106 Identities=18% Similarity=0.242 Sum_probs=93.0
Q ss_pred CceecCCCCcccccCC-ccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|+++ .+| ..|.++++|+.|+|++|.+++.++. |..+++|+.|+|++|++++..|..+..+++|+.|+++
T Consensus 226 L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 226 LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred ccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 578889999999 455 5788999999999999999998887 9999999999999999998889999999999999999
Q ss_pred cccccCCCCccccc---cceeeeccCCCccccc
Q 010131 79 NNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 79 ~N~l~~~~P~~~~~---~~~~~~~~~n~~~~~~ 108 (517)
+|+++ .+|+..+. .+..+.+.+||+.|..
T Consensus 305 ~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 305 GNQLT-TLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp SSCCS-CCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CCcCc-eeCHhHcCCCcccCEEEccCCCccCcc
Confidence 99999 57765543 4567889999998873
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.10 E-value=6e-11 Score=104.97 Aligned_cols=84 Identities=21% Similarity=0.194 Sum_probs=59.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCC--CCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~--~~~~l~~L~~l~l 77 (517)
|+.|+|++|++++. +.|..+++|+.|+|++|.|++.+|. |..+++|+.|+|++|+++ .+|. .+..+++|+.|++
T Consensus 44 L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l 120 (176)
T 1a9n_A 44 FDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCI 120 (176)
T ss_dssp CSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEEC
T ss_pred CCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEe
Confidence 46677777777753 4677777777777777777776666 477777777777777775 5665 5677777777777
Q ss_pred ccccccCCCCc
Q 010131 78 ENNSFVGEIPP 88 (517)
Q Consensus 78 ~~N~l~~~~P~ 88 (517)
++|+++ .+|.
T Consensus 121 ~~N~i~-~~~~ 130 (176)
T 1a9n_A 121 LRNPVT-NKKH 130 (176)
T ss_dssp CSSGGG-GSTT
T ss_pred cCCCCC-CcHh
Confidence 777776 5554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.7e-10 Score=109.95 Aligned_cols=102 Identities=15% Similarity=0.048 Sum_probs=80.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++..+..|.++++|+.|+|++|.+++.++. |..+++|+.|+|++|.+++..|..+..+++|+.|++++
T Consensus 30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 109 (276)
T 2z62_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence 57889999999876666888899999999999999888875 88899999999999999877777888888999999999
Q ss_pred ccccCCCCc-ccc--ccceeeeccCCC
Q 010131 80 NSFVGEIPP-ALL--TGKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P~-~~~--~~~~~~~~~~n~ 103 (517)
|++++ ++. .+. ..+..+.+.+|.
T Consensus 110 n~l~~-~~~~~~~~l~~L~~L~l~~n~ 135 (276)
T 2z62_A 110 TNLAS-LENFPIGHLKTLKELNVAHNL 135 (276)
T ss_dssp SCCCC-STTCCCTTCTTCCEEECCSSC
T ss_pred CCccc-cCchhcccCCCCCEEECcCCc
Confidence 98884 444 332 244555666664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.10 E-value=3.7e-11 Score=131.68 Aligned_cols=103 Identities=18% Similarity=0.273 Sum_probs=88.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEc-CCCCCCCC-----------------------------------------
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWL-DGNFLTGP----------------------------------------- 38 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l-~~N~l~~~----------------------------------------- 38 (517)
++.|+|++|+++|.+|+.|++|++|+.|+| ++|.++|.
T Consensus 325 V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~ 404 (876)
T 4ecn_A 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404 (876)
T ss_dssp EEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHH
T ss_pred EEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHH
Confidence 467999999999999999999999999999 77765544
Q ss_pred -----------------------------------CCc-ccCccccceeEecCceeee-----------------cCCCC
Q 010131 39 -----------------------------------LPD-MSRLIDLRIVHLENNELTG-----------------SLPSY 65 (517)
Q Consensus 39 -----------------------------------~p~-~~~l~~L~~l~l~~n~l~~-----------------~~p~~ 65 (517)
+|. |++|++|+.|+|++|+|+| .+|..
T Consensus 405 ~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~ 484 (876)
T 4ecn_A 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE 484 (876)
T ss_dssp HHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC
T ss_pred HHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChh
Confidence 665 8999999999999999998 49999
Q ss_pred CC--CcccccccccccccccCCCCccccc--cceeeeccCCC
Q 010131 66 MG--SLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 66 ~~--~l~~L~~l~l~~N~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
++ ++++|+.|++++|++.|.+|..+.. .+..+.+.+|.
T Consensus 485 l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred hhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 88 9999999999999999999987654 55667777775
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.10 E-value=3.3e-11 Score=103.50 Aligned_cols=85 Identities=19% Similarity=0.219 Sum_probs=75.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeec-CCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~-~p~~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|++++. ..++++++|+.|+|++|.+++.+|. +..+++|+.|++++|.+++. .|..+..+++|+.|+++
T Consensus 44 L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~ 121 (149)
T 2je0_A 44 LEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121 (149)
T ss_dssp CCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECT
T ss_pred CcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCc
Confidence 68999999999965 7799999999999999999998887 77799999999999999953 34789999999999999
Q ss_pred cccccCCCCc
Q 010131 79 NNSFVGEIPP 88 (517)
Q Consensus 79 ~N~l~~~~P~ 88 (517)
+|++++ +|+
T Consensus 122 ~N~l~~-~~~ 130 (149)
T 2je0_A 122 NCEVTN-LND 130 (149)
T ss_dssp TCGGGG-STT
T ss_pred CCcccc-hHH
Confidence 999994 554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=1.1e-10 Score=123.29 Aligned_cols=107 Identities=21% Similarity=0.229 Sum_probs=78.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCC-CCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|.+++..|..|.++++|+.|+|++|.++ +.+|. +..+++|+.|+|++|++++..|..+..+++|+.|+++
T Consensus 423 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 502 (570)
T 2z63_A 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502 (570)
T ss_dssp CCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCC
Confidence 567777777777777777777888888888888877 45665 7788888888888888887777788888888888888
Q ss_pred cccccCCCCcccc--ccceeeeccCCCcccc
Q 010131 79 NNSFVGEIPPALL--TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 79 ~N~l~~~~P~~~~--~~~~~~~~~~n~~~~~ 107 (517)
+|++++..|..+. ..+..+.+.+|++.|.
T Consensus 503 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 8888843333332 2455677888887765
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.2e-10 Score=109.18 Aligned_cols=103 Identities=18% Similarity=0.205 Sum_probs=76.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..+..|.++++|+.|+|++|.+++.++. |.++++|+.|++++|++++..+..++.+++|+.|++++
T Consensus 54 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 133 (276)
T 2z62_A 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133 (276)
T ss_dssp CSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCS
T ss_pred CcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcC
Confidence 57788888888866666778888888888888888887776 88888888888888888855555678888888888888
Q ss_pred ccccC-CCCccccc--cceeeeccCCC
Q 010131 80 NSFVG-EIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~-~~P~~~~~--~~~~~~~~~n~ 103 (517)
|++++ .+|..+.. .+..+.+.+|.
T Consensus 134 n~l~~~~l~~~~~~l~~L~~L~Ls~N~ 160 (276)
T 2z62_A 134 NLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (276)
T ss_dssp SCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred CccceecCchhhccCCCCCEEECCCCC
Confidence 88874 25655542 44455556553
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=1.2e-10 Score=119.44 Aligned_cols=104 Identities=18% Similarity=0.166 Sum_probs=91.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++.+|..|.++++|+.|+|++|.+++.+|. |..+++|+.|+|++|.+++..|..+..+++|+.|++++
T Consensus 277 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 356 (455)
T 3v47_A 277 VKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSY 356 (455)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCS
T ss_pred ceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCC
Confidence 57899999999999999999999999999999999999886 99999999999999999988888899999999999999
Q ss_pred ccccCCCCccccc--cceeeeccCCCc
Q 010131 80 NSFVGEIPPALLT--GKVIFKYDNNPK 104 (517)
Q Consensus 80 N~l~~~~P~~~~~--~~~~~~~~~n~~ 104 (517)
|++++..|..+.. .+..+.+.+|.-
T Consensus 357 N~l~~~~~~~~~~l~~L~~L~L~~N~l 383 (455)
T 3v47_A 357 NHIRALGDQSFLGLPNLKELALDTNQL 383 (455)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcccccChhhccccccccEEECCCCcc
Confidence 9999666665543 456667777753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.08 E-value=5.6e-11 Score=131.47 Aligned_cols=104 Identities=22% Similarity=0.290 Sum_probs=74.1
Q ss_pred CceecCCCCccc-----ccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccc
Q 010131 1 MARCALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 74 (517)
Q Consensus 1 l~~L~l~~n~~~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~ 74 (517)
|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..+. ++|+.
T Consensus 453 L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~ 530 (844)
T 3j0a_A 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEI 530 (844)
T ss_dssp CCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCE
T ss_pred cccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccE
Confidence 345555555554 22334566778888888888888888777 78888888888888888854444444 78888
Q ss_pred cccccccccCCCCccccccceeeeccCCCcccc
Q 010131 75 LHIENNSFVGEIPPALLTGKVIFKYDNNPKLHK 107 (517)
Q Consensus 75 l~l~~N~l~~~~P~~~~~~~~~~~~~~n~~~~~ 107 (517)
|++++|++++..|.. +.....+.+.+||+.|.
T Consensus 531 L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 531 LDISRNQLLAPNPDV-FVSLSVLDITHNKFICE 562 (844)
T ss_dssp EEEEEECCCCCCSCC-CSSCCEEEEEEECCCCS
T ss_pred EECCCCcCCCCChhH-hCCcCEEEecCCCcccc
Confidence 888888888655544 34566778899998883
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.08 E-value=2.2e-10 Score=121.67 Aligned_cols=102 Identities=19% Similarity=0.220 Sum_probs=80.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCC-CCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
|+.|+|++|.+++..|..|+++++|+.|+|++|.|++.+|. |+++++|+.|+|++|.|+ .+|.. |+.+++|+.|+++
T Consensus 77 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls 155 (597)
T 3oja_B 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS 155 (597)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEee
Confidence 67889999999977777888899999999999999998887 788999999999999988 45544 6888899999999
Q ss_pred cccccCCCCcccc--ccceeeeccCCC
Q 010131 79 NNSFVGEIPPALL--TGKVIFKYDNNP 103 (517)
Q Consensus 79 ~N~l~~~~P~~~~--~~~~~~~~~~n~ 103 (517)
+|.+++..|..+. ..+..+.+.+|.
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~L~~N~ 182 (597)
T 3oja_B 156 NNNLERIEDDTFQATTSLQNLQLSSNR 182 (597)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECTTSC
T ss_pred CCcCCCCChhhhhcCCcCcEEECcCCC
Confidence 9999865554443 244556666664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.7e-10 Score=118.23 Aligned_cols=102 Identities=20% Similarity=0.177 Sum_probs=85.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|+|++..|..|.++++|+.|+|++|.|++.+|. |.++++|+.|+|++|++++..+..+..+++|+.|++++
T Consensus 77 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 156 (452)
T 3zyi_A 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRN 156 (452)
T ss_dssp CSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCS
T ss_pred ccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCC
Confidence 57899999999988888999999999999999999999887 99999999999999999955555688999999999999
Q ss_pred ccccCCCCccccc---cceeeeccCCC
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n~ 103 (517)
|+++ .+|...+. .+..+.+.+|.
T Consensus 157 N~l~-~~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 157 NPIE-SIPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp CCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CCcc-eeCHhHHhcCCcccEEeCCCCC
Confidence 9999 67764432 34445555543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=3.7e-10 Score=111.99 Aligned_cols=141 Identities=16% Similarity=0.232 Sum_probs=106.5
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEec--CCC-chhHHHHHHHHHHHhcCC--CCCccccceeeecC---CeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMA--DSC-SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEE---HQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e~ 272 (517)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56899999999999876 4678888765 322 122456888999999996 45678888888766 458999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------- 314 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------- 314 (517)
++|..+.+.. -..++..+...++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9998775421 234678888899999999999999720
Q ss_pred -----------------CCCcEecCCCCCCeEeCCCCc--EEEccccCcccc
Q 010131 315 -----------------NPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQA 347 (517)
Q Consensus 315 -----------------~~~ivH~dlk~~Nill~~~~~--~kl~Dfg~a~~~ 347 (517)
...++|||+++.||+++.++. +.|.||+.+...
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999988653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.06 E-value=5.1e-11 Score=115.86 Aligned_cols=85 Identities=19% Similarity=0.241 Sum_probs=63.6
Q ss_pred CceecCCCCcccccCCccc--cCCCCCcEEEcCCCCCCCCCCcccCc-----cccceeEecCceeeecCCCCCCCccccc
Q 010131 1 MARCALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPDMSRL-----IDLRIVHLENNELTGSLPSYMGSLPNLQ 73 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~--~~l~~L~~L~l~~N~l~~~~p~~~~l-----~~L~~l~l~~n~l~~~~p~~~~~l~~L~ 73 (517)
|++|+|++|++++.+|..+ ..+++|+.|+|++|++++.++.+..+ ++|+.|+|++|++++..|..++.+++|+
T Consensus 97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 176 (312)
T 1wwl_A 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS 176 (312)
T ss_dssp CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCC
T ss_pred ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCC
Confidence 5677888888887777765 67788888888888888773236666 7788888888888766667777888888
Q ss_pred ccccccccccCC
Q 010131 74 ELHIENNSFVGE 85 (517)
Q Consensus 74 ~l~l~~N~l~~~ 85 (517)
.|++++|++.|.
T Consensus 177 ~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 177 TLDLSDNPELGE 188 (312)
T ss_dssp EEECCSCTTCHH
T ss_pred EEECCCCCcCcc
Confidence 888888877654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=2.7e-10 Score=121.27 Aligned_cols=82 Identities=20% Similarity=0.101 Sum_probs=39.7
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++|+|++|++++..|..|.++++|+.|+|++|.+++.+|. |.++++|+.|+|++|.+++..|..|+++++|++|++++|
T Consensus 35 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 114 (606)
T 3vq2_A 35 KNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114 (606)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTS
T ss_pred CEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCC
Confidence 4445555555444444444455555555555555544443 444455555555555544333444444444444444444
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
.++
T Consensus 115 ~l~ 117 (606)
T 3vq2_A 115 KLA 117 (606)
T ss_dssp CCC
T ss_pred ccc
Confidence 444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=1.2e-10 Score=123.86 Aligned_cols=87 Identities=20% Similarity=0.187 Sum_probs=47.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCC---CCc-ccCccccceeEecCceeeecCCCCCCCcccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~---~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~ 76 (517)
|+.|+|++|.+++..|..|..+++|+.|+|++|.+++. .+. +..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 427 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 506 (606)
T 3t6q_A 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506 (606)
T ss_dssp CCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEE
Confidence 45566666666655555555566666666666665542 112 55555555555555555555555555555555555
Q ss_pred cccccccCCCC
Q 010131 77 IENNSFVGEIP 87 (517)
Q Consensus 77 l~~N~l~~~~P 87 (517)
+++|++++..|
T Consensus 507 Ls~N~l~~~~~ 517 (606)
T 3t6q_A 507 LSHNRLTSSSI 517 (606)
T ss_dssp CCSSCCCGGGG
T ss_pred CCCCccCcCCh
Confidence 55555554333
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.7e-10 Score=120.20 Aligned_cols=102 Identities=24% Similarity=0.327 Sum_probs=65.0
Q ss_pred ceecCCCCcccccCCcc-ccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
+.|+|++|++++.+|.. +..+++|+.|+|++|.+++.+|. +. ++|+.|+|++|+++ .+|..+..+++|+.|++++
T Consensus 406 ~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~ 482 (562)
T 3a79_B 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVAS 482 (562)
T ss_dssp CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCS
T ss_pred CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCC
Confidence 34444444444433332 33444444444444444443333 22 57777777788777 7888777888899999999
Q ss_pred ccccCCCCcccc---ccceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALL---TGKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~---~~~~~~~~~~n~~~~~ 107 (517)
|+++ .+|...+ .....+.+.+||+.|.
T Consensus 483 N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 512 (562)
T 3a79_B 483 NQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT 512 (562)
T ss_dssp SCCC-CCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred CCCC-CCCHHHHhcCCCCCEEEecCCCcCCC
Confidence 9998 7887632 2455677889998886
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.3e-10 Score=110.78 Aligned_cols=83 Identities=17% Similarity=0.220 Sum_probs=40.5
Q ss_pred CceecCCCCcccccCC-ccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeee-cCCCCCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~-~~p~~~~~l~~L~~l~l 77 (517)
|+.|+|++|++++..+ ..+..+++|+.|+|++|.+++.+|. +..+++|+.|+|++|.+++ .+|..+..+++|+.|++
T Consensus 103 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L 182 (306)
T 2z66_A 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182 (306)
T ss_dssp CCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEEC
Confidence 3445555555553322 2444455555555555555554444 4445555555555555543 34444445555555555
Q ss_pred cccccc
Q 010131 78 ENNSFV 83 (517)
Q Consensus 78 ~~N~l~ 83 (517)
++|+++
T Consensus 183 s~n~l~ 188 (306)
T 2z66_A 183 SQCQLE 188 (306)
T ss_dssp TTSCCC
T ss_pred CCCCcC
Confidence 555554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.04 E-value=4.8e-10 Score=112.51 Aligned_cols=103 Identities=18% Similarity=0.211 Sum_probs=82.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCC-CCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
|++|+|++|++++..|..|..+++|+.|+|++|.+++.+|. |..+++|+.|+|++|.++ .+|.. +..+++|++|+++
T Consensus 71 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~ 149 (390)
T 3o6n_A 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS 149 (390)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECC
Confidence 67899999999977777889999999999999999998887 889999999999999999 66665 5889999999999
Q ss_pred cccccCCCCcccc--ccceeeeccCCCc
Q 010131 79 NNSFVGEIPPALL--TGKVIFKYDNNPK 104 (517)
Q Consensus 79 ~N~l~~~~P~~~~--~~~~~~~~~~n~~ 104 (517)
+|++++..|..+. ..+..+.+.+|..
T Consensus 150 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l 177 (390)
T 3o6n_A 150 NNNLERIEDDTFQATTSLQNLQLSSNRL 177 (390)
T ss_dssp SSCCCBCCTTTTSSCTTCCEEECCSSCC
T ss_pred CCccCccChhhccCCCCCCEEECCCCcC
Confidence 9999854444333 2445566666643
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=3.5e-10 Score=116.70 Aligned_cols=103 Identities=22% Similarity=0.243 Sum_probs=78.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++..|..|.++++|+.|+|++|.+++..|. |.++++|+.|+|++|++++..+..|..+++|+.|++++
T Consensus 34 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 113 (477)
T 2id5_A 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISE 113 (477)
T ss_dssp CSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTT
T ss_pred CcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCC
Confidence 56788888888877777888888888888888888888776 88888888888888888844334577888888888888
Q ss_pred ccccCCCCccccc--cceeeeccCCC
Q 010131 80 NSFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
|++++..|..+.. .+..+.+.+|.
T Consensus 114 n~i~~~~~~~~~~l~~L~~L~l~~n~ 139 (477)
T 2id5_A 114 NKIVILLDYMFQDLYNLKSLEVGDND 139 (477)
T ss_dssp SCCCEECTTTTTTCTTCCEEEECCTT
T ss_pred CccccCChhHccccccCCEEECCCCc
Confidence 8888554544432 34455566654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.03 E-value=1.1e-10 Score=113.86 Aligned_cols=103 Identities=20% Similarity=0.166 Sum_probs=52.7
Q ss_pred ceecCCCCcccccCCcccc-CCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.|+|++|++++..|..+. .+++|+.|+|++|.|++. |....+++|+.|+|++|+++ .+|..+..+++|+.|++++|
T Consensus 147 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N 224 (317)
T 3o53_A 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224 (317)
T ss_dssp EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTS
T ss_pred CEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCC
Confidence 3444444444443343332 344555555555555443 22223555666666666665 34444556666666666666
Q ss_pred cccCCCCccccc--cceeeeccCCCcccc
Q 010131 81 SFVGEIPPALLT--GKVIFKYDNNPKLHK 107 (517)
Q Consensus 81 ~l~~~~P~~~~~--~~~~~~~~~n~~~~~ 107 (517)
+++ .+|..+.. ....+.+.+|++.|.
T Consensus 225 ~l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred ccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 666 45554322 344555666665543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=3.7e-10 Score=120.16 Aligned_cols=103 Identities=15% Similarity=-0.038 Sum_probs=80.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
++.|+|++|++++..|..|+++++|++|+|++|.+++..|. |.++++|+.|+|++|++++..|..++.+++|++|++++
T Consensus 35 l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 114 (606)
T 3t6q_A 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114 (606)
T ss_dssp CCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTT
T ss_pred CcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccc
Confidence 57888999999877788888899999999999998888786 88889999999999988877788888888888888888
Q ss_pred ccccCCCCcccc--ccceeeeccCCC
Q 010131 80 NSFVGEIPPALL--TGKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P~~~~--~~~~~~~~~~n~ 103 (517)
|++++..|..+. ..+..+.+.+|.
T Consensus 115 n~i~~l~~~~~~~l~~L~~L~L~~n~ 140 (606)
T 3t6q_A 115 TGISSIDFIPLHNQKTLESLYLGSNH 140 (606)
T ss_dssp SCCSCGGGSCCTTCTTCCEEECCSSC
T ss_pred cCcccCCcchhccCCcccEEECCCCc
Confidence 888842233332 234455555553
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=1.8e-10 Score=121.05 Aligned_cols=103 Identities=19% Similarity=0.209 Sum_probs=73.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..|..|.++++|++|+|++|++++.+|+ |..+++|++|+|++|++++..|..++.+++|++|++++
T Consensus 28 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 107 (549)
T 2z81_A 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMG 107 (549)
T ss_dssp CCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTT
T ss_pred ccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCC
Confidence 56788888888877777788888888888888888887776 88888888888888888855555577888888888888
Q ss_pred ccccC-CCCccccc--cceeeeccCCC
Q 010131 80 NSFVG-EIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~-~~P~~~~~--~~~~~~~~~n~ 103 (517)
|++++ .+|..+.. .+..+.+.+|.
T Consensus 108 n~l~~~~~~~~~~~l~~L~~L~L~~n~ 134 (549)
T 2z81_A 108 NPYQTLGVTSLFPNLTNLQTLRIGNVE 134 (549)
T ss_dssp CCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred CcccccchhhhhhccCCccEEECCCCc
Confidence 88774 23443322 33444444443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=4.9e-10 Score=120.95 Aligned_cols=89 Identities=20% Similarity=0.235 Sum_probs=52.5
Q ss_pred ccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccccccCCCCcc-c---ccc
Q 010131 19 LKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA-L---LTG 93 (517)
Q Consensus 19 ~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~P~~-~---~~~ 93 (517)
|.++++|+.|+|++|+|+..++. |.++++|+.|+|++|++++..+..+..+++|+.|++++|++++ +|+. + ...
T Consensus 532 ~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~~ 610 (680)
T 1ziw_A 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRN 610 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCB-CCHHHHHHHHTT
T ss_pred hcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCc-cChhHhcccccc
Confidence 34445555555555555544443 6666666666666666663333335566666666666666663 3332 1 234
Q ss_pred ceeeeccCCCccccc
Q 010131 94 KVIFKYDNNPKLHKE 108 (517)
Q Consensus 94 ~~~~~~~~n~~~~~~ 108 (517)
...+.+.+||+.|..
T Consensus 611 L~~l~l~~N~~~c~c 625 (680)
T 1ziw_A 611 LTELDMRFNPFDCTC 625 (680)
T ss_dssp CSEEECTTCCCCBCC
T ss_pred cCEEEccCCCcccCC
Confidence 556778899999874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.00 E-value=4e-10 Score=118.84 Aligned_cols=80 Identities=19% Similarity=0.226 Sum_probs=50.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|+ |.++++|++|+|++|+++ .+|.. .+++|++|++++
T Consensus 54 L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~ 130 (562)
T 3a79_B 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSF 130 (562)
T ss_dssp CCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCS
T ss_pred cCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCC
Confidence 45566666666654445666666666666666666666555 666666666666666666 55554 566666666666
Q ss_pred cccc
Q 010131 80 NSFV 83 (517)
Q Consensus 80 N~l~ 83 (517)
|+++
T Consensus 131 N~l~ 134 (562)
T 3a79_B 131 NDFD 134 (562)
T ss_dssp SCCS
T ss_pred CCcc
Confidence 6666
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.00 E-value=2.5e-10 Score=106.28 Aligned_cols=101 Identities=20% Similarity=0.267 Sum_probs=84.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCC-CCCCCCc-ccCccccceeEecC-ceeeecCCCCCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPLPD-MSRLIDLRIVHLEN-NELTGSLPSYMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~-~~~l~~L~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l 77 (517)
|+.|+|++|++++..+..|.++++|+.|+|++|. +++..+. |.++++|+.|+|++ |++++..|..+..+++|+.|++
T Consensus 33 l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l 112 (239)
T 2xwt_C 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112 (239)
T ss_dssp CCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEE
T ss_pred ccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeC
Confidence 5789999999997666689999999999999997 8888885 99999999999999 9999666677889999999999
Q ss_pred ccccccCCCCccccc--cce---eeeccCCC
Q 010131 78 ENNSFVGEIPPALLT--GKV---IFKYDNNP 103 (517)
Q Consensus 78 ~~N~l~~~~P~~~~~--~~~---~~~~~~n~ 103 (517)
++|+++ .+|. +.. ... .+.+.+|+
T Consensus 113 ~~n~l~-~lp~-~~~l~~L~~L~~L~l~~N~ 141 (239)
T 2xwt_C 113 FNTGLK-MFPD-LTKVYSTDIFFILEITDNP 141 (239)
T ss_dssp EEECCC-SCCC-CTTCCBCCSEEEEEEESCT
T ss_pred CCCCCc-cccc-cccccccccccEEECCCCc
Confidence 999999 4886 221 223 56667763
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.3e-10 Score=119.41 Aligned_cols=103 Identities=15% Similarity=0.167 Sum_probs=76.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCC--CCCc-ccCccccceeEecCceeeecCCCC-CCCcccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPD-MSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELH 76 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~-~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~ 76 (517)
|+.|+|++|++++.+|..++++++|+.|+|++|++++ .+|. +..+++|+.|+|++|.+++.+|.. +..+++|+.|+
T Consensus 326 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~ 405 (520)
T 2z7x_B 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405 (520)
T ss_dssp CCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEE
T ss_pred ccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEE
Confidence 5678888888887778788888888888888888886 3444 778888888888888888656654 66777888888
Q ss_pred cccccccCCCCccccccceeeeccCCC
Q 010131 77 IENNSFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 77 l~~N~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
+++|++++.+|..+......+.+.+|.
T Consensus 406 Ls~N~l~~~~~~~l~~~L~~L~Ls~N~ 432 (520)
T 2z7x_B 406 MSSNILTDTIFRCLPPRIKVLDLHSNK 432 (520)
T ss_dssp CCSSCCCGGGGGSCCTTCCEEECCSSC
T ss_pred CcCCCCCcchhhhhcccCCEEECCCCc
Confidence 888888777766655455555566653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=5e-10 Score=114.29 Aligned_cols=102 Identities=20% Similarity=0.169 Sum_probs=82.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
++.|+|++|++++..+..|.++++|+.|+|++|.|++..+. |.++++|+.|+|++|++++..+..+..+++|+.|++++
T Consensus 66 l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 145 (440)
T 3zyj_A 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRN 145 (440)
T ss_dssp CSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCS
T ss_pred CcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCC
Confidence 57899999999987788899999999999999999988876 99999999999999999944445688999999999999
Q ss_pred ccccCCCCccccc---cceeeeccCCC
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n~ 103 (517)
|+++ .+|+..+. .+..+.+.+|.
T Consensus 146 N~i~-~~~~~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 146 NPIE-SIPSYAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp CCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred Cccc-ccCHHHhhhCcccCEeCCCCCC
Confidence 9998 56654332 34445555543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=2e-10 Score=119.85 Aligned_cols=81 Identities=16% Similarity=0.162 Sum_probs=43.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++..|..|.++++|+.|+|++|++++.+|+ |.++++|++|+|++|+++ .+|.. .+++|++|++++
T Consensus 23 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~ 99 (520)
T 2z7x_B 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSF 99 (520)
T ss_dssp CSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCS
T ss_pred ccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccC
Confidence 34555555555544444555555555555555555555443 555555555555555555 44444 455555555555
Q ss_pred ccccC
Q 010131 80 NSFVG 84 (517)
Q Consensus 80 N~l~~ 84 (517)
|++++
T Consensus 100 N~l~~ 104 (520)
T 2z7x_B 100 NAFDA 104 (520)
T ss_dssp SCCSS
T ss_pred Ccccc
Confidence 55553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.99 E-value=3.4e-10 Score=102.11 Aligned_cols=100 Identities=15% Similarity=0.205 Sum_probs=85.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+++ .+| .+..+++|+.|++++|.++. ++.+..+++|+.|++++|.+++..|..++.+++|+.|++++|
T Consensus 46 L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n 122 (197)
T 4ezg_A 46 LTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122 (197)
T ss_dssp CCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSS
T ss_pred ccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCC
Confidence 678999999999 778 69999999999999997764 456999999999999999999888999999999999999999
Q ss_pred cccCCCCccccc--cceeeeccCCC
Q 010131 81 SFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
++++..|..+.. .+..+.+.+|.
T Consensus 123 ~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 123 AHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp BCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred ccCcHhHHHHhhCCCCCEEEccCCC
Confidence 999766765543 45556666665
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.98 E-value=8.1e-10 Score=108.28 Aligned_cols=97 Identities=30% Similarity=0.350 Sum_probs=52.9
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.+++++|+++ .+|..+. ++|+.|+|++|.+++.+|. |.++++|+.|+|++|++++..|..++.+++|++|++++|
T Consensus 36 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred CEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 44555555555 4554442 4555555555555555553 555555555555555555444555555555555555555
Q ss_pred cccCCCCccccccceeeeccCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNN 102 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n 102 (517)
+++ .+|..+...+..+.+.+|
T Consensus 113 ~l~-~l~~~~~~~L~~L~l~~n 133 (332)
T 2ft3_A 113 HLV-EIPPNLPSSLVELRIHDN 133 (332)
T ss_dssp CCC-SCCSSCCTTCCEEECCSS
T ss_pred cCC-ccCccccccCCEEECCCC
Confidence 555 455554444444444444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=3.1e-10 Score=112.25 Aligned_cols=100 Identities=24% Similarity=0.245 Sum_probs=71.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCC-CCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~ 78 (517)
|++|+|++|++++..+..|.++++|+.|+|++|.+++.+|. |.++++|+.|+|++|+++ .+|.. +..+++|++|+++
T Consensus 54 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECT
T ss_pred CcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECC
Confidence 56788888888865555777888888888888888887776 788888888888888887 45544 7778888888888
Q ss_pred cccccCCCCc-ccc---ccceeeeccCC
Q 010131 79 NNSFVGEIPP-ALL---TGKVIFKYDNN 102 (517)
Q Consensus 79 ~N~l~~~~P~-~~~---~~~~~~~~~~n 102 (517)
+|+++ .+|. ..+ ..+..+.+.+|
T Consensus 133 ~n~l~-~l~~~~~~~~l~~L~~L~l~~n 159 (353)
T 2z80_A 133 GNPYK-TLGETSLFSHLTKLQILRVGNM 159 (353)
T ss_dssp TCCCS-SSCSSCSCTTCTTCCEEEEEES
T ss_pred CCCCc-ccCchhhhccCCCCcEEECCCC
Confidence 88887 5665 222 23344455555
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.95 E-value=3.7e-10 Score=116.73 Aligned_cols=59 Identities=29% Similarity=0.336 Sum_probs=51.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeee
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~ 60 (517)
|+.|+|++|++++..|..|..+++|+.|+|++|.+++.+| |..+++|+.|+|++|.|++
T Consensus 36 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~ 94 (487)
T 3oja_A 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQE 94 (487)
T ss_dssp CCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEE
T ss_pred ccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCC
Confidence 6789999999998777889999999999999999998776 8888888888888888774
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.5e-10 Score=110.92 Aligned_cols=86 Identities=17% Similarity=0.202 Sum_probs=48.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCC---CCcc--cCccccceeEecCceeee--cCCC-CCCCcccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---LPDM--SRLIDLRIVHLENNELTG--SLPS-YMGSLPNL 72 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~---~p~~--~~l~~L~~l~l~~n~l~~--~~p~-~~~~l~~L 72 (517)
|++|+|++|++++..|..|+++++|+.|+|++|++++. ++.+ ..+++|+.|+|++|++++ .++. .+..+++|
T Consensus 151 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L 230 (312)
T 1wwl_A 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230 (312)
T ss_dssp CCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCC
T ss_pred CcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCC
Confidence 56777777777766666777777777777777776654 1122 555555555555555551 1111 12234455
Q ss_pred cccccccccccCCC
Q 010131 73 QELHIENNSFVGEI 86 (517)
Q Consensus 73 ~~l~l~~N~l~~~~ 86 (517)
+.|++++|++++..
T Consensus 231 ~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 231 QGLDLSHNSLRDAA 244 (312)
T ss_dssp SEEECTTSCCCSSC
T ss_pred CEEECCCCcCCccc
Confidence 55555555555433
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=5.2e-10 Score=108.51 Aligned_cols=102 Identities=16% Similarity=0.188 Sum_probs=60.1
Q ss_pred CceecCCCCccccc--CC--ccccCCCCCcEEEcCCCCCCCCCC---c-ccCccccceeEecCceeeecCCCCCCCc---
Q 010131 1 MARCALSGKNLKGE--IP--PELKNMEALTELWLDGNFLTGPLP---D-MSRLIDLRIVHLENNELTGSLPSYMGSL--- 69 (517)
Q Consensus 1 l~~L~l~~n~~~~~--~p--~~~~~l~~L~~L~l~~N~l~~~~p---~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l--- 69 (517)
|+.|+|++|++.+. ++ ..+..+++|+.|+|++|+++...+ . +..+++|+.|+|++|++++.+|..++.+
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 56677777776542 21 223456666667777766654322 1 3456666666666666665556655555
Q ss_pred ccccccccccccccCCCCccccccceeeeccCCC
Q 010131 70 PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 70 ~~L~~l~l~~N~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
++|+.|++++|+++ .+|..+...+..+.+++|.
T Consensus 251 ~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~ 283 (310)
T 4glp_A 251 SALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNR 283 (310)
T ss_dssp TTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCC
T ss_pred CcCCEEECCCCCCC-chhhhhcCCCCEEECCCCc
Confidence 46666666666666 5666655545555555553
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.95 E-value=8.1e-10 Score=122.16 Aligned_cols=89 Identities=19% Similarity=0.198 Sum_probs=66.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCC-Cc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL-PD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|.|++..|..|.++++|+.|+|++|.+.+.+ |. |.++++|++|+|++|.+++..|..|+++++|++|+++
T Consensus 26 l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 105 (844)
T 3j0a_A 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105 (844)
T ss_dssp CCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECT
T ss_pred cCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCc
Confidence 567888888888777777777777777777777665555 44 7777777777777777776677777777777777777
Q ss_pred cccccCCCCcc
Q 010131 79 NNSFVGEIPPA 89 (517)
Q Consensus 79 ~N~l~~~~P~~ 89 (517)
+|.+++.+|..
T Consensus 106 ~n~l~~~~~~~ 116 (844)
T 3j0a_A 106 FCGLSDAVLKD 116 (844)
T ss_dssp TCCCSSCCSTT
T ss_pred CCCCCcccccC
Confidence 77777655553
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=9.9e-10 Score=118.59 Aligned_cols=83 Identities=17% Similarity=0.131 Sum_probs=37.7
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.|+|++|++++..|..|+++++|+.|+|++|.+++.++. |.++++|+.|+|++|++++..|..++++++|++|++++|
T Consensus 52 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 131 (680)
T 1ziw_A 52 TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN 131 (680)
T ss_dssp SEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSS
T ss_pred cEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCC
Confidence 3444444444444444444444444444444444444433 444444444444444444333334444444444444444
Q ss_pred cccC
Q 010131 81 SFVG 84 (517)
Q Consensus 81 ~l~~ 84 (517)
.+++
T Consensus 132 ~l~~ 135 (680)
T 1ziw_A 132 GLSS 135 (680)
T ss_dssp CCSC
T ss_pred cccc
Confidence 4443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.3e-09 Score=114.88 Aligned_cols=87 Identities=16% Similarity=0.073 Sum_probs=59.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|. |.++++|+.|+|++|.+++..|..|..+++|++|++++
T Consensus 30 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 109 (570)
T 2z63_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (570)
T ss_dssp CCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccc
Confidence 45677777777766666677777777777777777776665 77777777777777777755556666677777777777
Q ss_pred ccccCCCCc
Q 010131 80 NSFVGEIPP 88 (517)
Q Consensus 80 N~l~~~~P~ 88 (517)
|+++ .+|.
T Consensus 110 n~l~-~l~~ 117 (570)
T 2z63_A 110 TNLA-SLEN 117 (570)
T ss_dssp SCCC-CSTT
T ss_pred cccc-cCCC
Confidence 7666 3443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.6e-10 Score=111.88 Aligned_cols=183 Identities=22% Similarity=0.246 Sum_probs=120.5
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCC--ccccceeeecCC---eeEEEEEecC
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRN--LVPLIGYCEEEH---QRILVYEYMH 274 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~ 274 (517)
+.++.|.+..||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..++||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999874 46889986432 34567889999998883 332 334444433333 3478999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 313 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~----------------------------------------- 313 (517)
|.++.+... ..++..++..++.++++.++.||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988765332 2356677778888888888888851
Q ss_pred --------------CCCCcEecCCCCCCeEeCC--CCcEEEccccCccccCCCCcccccccccCCCC---cCCCccC---
Q 010131 314 --------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGY---LDPEYYG--- 371 (517)
Q Consensus 314 --------------~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y---~aPE~~~--- 371 (517)
....++|||++|.||++++ +..+.|.||+.+........-. . ...+ ..|+...
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-~----~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-S----LMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-T----TCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-H----HHhhccccCHHHHHHHH
Confidence 1145799999999999998 5568899999886532211100 0 0000 1222110
Q ss_pred ---CC--------CCCccceehhHHHHHHHHHhCCCCCC
Q 010131 372 ---NQ--------QLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 372 ---~~--------~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
+. ......+.|+++.++|.+.+|..+|.
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 01123689999999999999987763
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=7.7e-10 Score=116.21 Aligned_cols=103 Identities=19% Similarity=0.190 Sum_probs=85.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeee-cCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~-~~p~~~~~l~~L~~l~l~ 78 (517)
|++|+|++|++++..|..|+++++|+.|+|++|.+++.+|. |+++++|+.|+|++|.+++ .+|..++++++|+.|+++
T Consensus 52 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~ 131 (549)
T 2z81_A 52 LQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131 (549)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEE
T ss_pred ccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECC
Confidence 68899999999988888999999999999999999999988 9999999999999999986 467789999999999999
Q ss_pred cccccCCCCccccc---cceeeeccCCC
Q 010131 79 NNSFVGEIPPALLT---GKVIFKYDNNP 103 (517)
Q Consensus 79 ~N~l~~~~P~~~~~---~~~~~~~~~n~ 103 (517)
+|++.+.+|+..+. ....+.+.+|.
T Consensus 132 ~n~~~~~~~~~~~~~l~~L~~L~L~~n~ 159 (549)
T 2z81_A 132 NVETFSEIRRIDFAGLTSLNELEIKALS 159 (549)
T ss_dssp ESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred CCccccccCHhhhhcccccCeeeccCCc
Confidence 99966578754332 33445555554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=2.2e-09 Score=105.01 Aligned_cols=99 Identities=21% Similarity=0.278 Sum_probs=81.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.+++++++++ .+|..+. ++|+.|+|++|.+++.++. |.++++|+.|+|++|.+++..|..+..+++|++|++++
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 467888888888 6787664 6888999999999988885 88899999999999999877788888899999999999
Q ss_pred ccccCCCCccccccceeeeccCCC
Q 010131 80 NSFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
|+++ .+|..+...+..+.+.+|.
T Consensus 110 n~l~-~l~~~~~~~L~~L~l~~n~ 132 (330)
T 1xku_A 110 NQLK-ELPEKMPKTLQELRVHENE 132 (330)
T ss_dssp SCCS-BCCSSCCTTCCEEECCSSC
T ss_pred CcCC-ccChhhcccccEEECCCCc
Confidence 9988 7888777666677777664
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.92 E-value=1e-09 Score=108.59 Aligned_cols=101 Identities=19% Similarity=0.234 Sum_probs=83.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCC--CCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~--~~~~l~~L~~l~l 77 (517)
|+.|+|++|++++..|..|.++++|+.|+|++|++++.++. |..+++|+.|+|++|+++ .+|. .+..+++|+.|++
T Consensus 78 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l 156 (353)
T 2z80_A 78 LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRV 156 (353)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEE
T ss_pred CCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEEC
Confidence 68899999999987788899999999999999999988877 899999999999999999 6776 6889999999999
Q ss_pred cccc-ccCCCCcc-ccc--cceeeeccCCC
Q 010131 78 ENNS-FVGEIPPA-LLT--GKVIFKYDNNP 103 (517)
Q Consensus 78 ~~N~-l~~~~P~~-~~~--~~~~~~~~~n~ 103 (517)
++|+ +. .+|+. +.. ....+.+.+|.
T Consensus 157 ~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 157 GNMDTFT-KIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp EESSSCC-EECTTTTTTCCEEEEEEEEETT
T ss_pred CCCcccc-ccCHHHccCCCCCCEEECCCCC
Confidence 9995 66 55543 322 34445556654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.3e-09 Score=105.82 Aligned_cols=103 Identities=17% Similarity=0.185 Sum_probs=84.2
Q ss_pred CceecCCCCcccccCCccc--cCCCCCcEEEcCCCCCCCCCCc-----ccCccccceeEecCceeeecCCCCCCCccccc
Q 010131 1 MARCALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPD-----MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 73 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~--~~l~~L~~L~l~~N~l~~~~p~-----~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~ 73 (517)
|++|+|++|++++..|..+ ..+++|+.|+|++|.+++..+. +..+++|+.|+|++|++++..|..++.+++|+
T Consensus 93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 172 (310)
T 4glp_A 93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT 172 (310)
T ss_dssp CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence 6889999999999999988 8899999999999999997762 45799999999999999977788899999999
Q ss_pred ccccccccccCC--CCccc----cccceeeeccCCC
Q 010131 74 ELHIENNSFVGE--IPPAL----LTGKVIFKYDNNP 103 (517)
Q Consensus 74 ~l~l~~N~l~~~--~P~~~----~~~~~~~~~~~n~ 103 (517)
+|++++|++.+. +|... ...+..+.+.+|.
T Consensus 173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 208 (310)
T 4glp_A 173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTG 208 (310)
T ss_dssp EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSC
T ss_pred EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCC
Confidence 999999998742 22221 2234455566653
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.3e-09 Score=101.37 Aligned_cols=99 Identities=18% Similarity=0.251 Sum_probs=62.5
Q ss_pred CceecCCCCcccccCCccccCCCCCc---EEEcCCC-CCCCCCCc-ccCccccc-eeEecCceeeecCCCCCCCcccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALT---ELWLDGN-FLTGPLPD-MSRLIDLR-IVHLENNELTGSLPSYMGSLPNLQE 74 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~-~~~l~~L~-~l~l~~n~l~~~~p~~~~~l~~L~~ 74 (517)
|+.|+|++|++++ +|. |..+++|+ .|++++| .+++.++. |..+++|+ .|++++|+++ .+|......++|+.
T Consensus 107 L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~ 183 (239)
T 2xwt_C 107 LKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183 (239)
T ss_dssp CCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEE
T ss_pred CCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCE
Confidence 4667777777774 665 66666666 7777777 77766665 77777777 7777777777 66655444467777
Q ss_pred ccccccc-ccCCCCcccc----ccceeeeccCCC
Q 010131 75 LHIENNS-FVGEIPPALL----TGKVIFKYDNNP 103 (517)
Q Consensus 75 l~l~~N~-l~~~~P~~~~----~~~~~~~~~~n~ 103 (517)
|++++|+ ++ .+|+..+ .....+.+.+|+
T Consensus 184 L~L~~n~~l~-~i~~~~~~~l~~~L~~L~l~~N~ 216 (239)
T 2xwt_C 184 VYLNKNKYLT-VIDKDAFGGVYSGPSLLDVSQTS 216 (239)
T ss_dssp EECTTCTTCC-EECTTTTTTCSBCCSEEECTTCC
T ss_pred EEcCCCCCcc-cCCHHHhhccccCCcEEECCCCc
Confidence 7777774 66 4554432 223344455554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.1e-09 Score=106.49 Aligned_cols=96 Identities=28% Similarity=0.322 Sum_probs=77.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|++++..|..|.++++|+.|+|++|.+++.+| +..+++|+.|+|++|++++ +| ..++|+.|++++|
T Consensus 36 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~l~~n 109 (317)
T 3o53_A 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHAANN 109 (317)
T ss_dssp CSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEECCSS
T ss_pred CCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCcccc-cc----CCCCcCEEECCCC
Confidence 6789999999997767789999999999999999998766 8899999999999999984 44 2378888888888
Q ss_pred cccCCCCccccccceeeeccCCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
+++ .+|...+.....+.+.+|.
T Consensus 110 ~l~-~~~~~~~~~L~~L~l~~N~ 131 (317)
T 3o53_A 110 NIS-RVSCSRGQGKKNIYLANNK 131 (317)
T ss_dssp CCS-EEEECCCSSCEEEECCSSC
T ss_pred ccC-CcCccccCCCCEEECCCCC
Confidence 888 4555545556667777765
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.83 E-value=4.1e-09 Score=102.09 Aligned_cols=82 Identities=26% Similarity=0.465 Sum_probs=53.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ +| .+..+++|+.|+|++|.+++. +.+..+++|+.|++++|.++ .+|. +..+++|+.|++++|
T Consensus 87 L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n 161 (308)
T 1h6u_A 87 ITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNA 161 (308)
T ss_dssp CCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECCSS
T ss_pred CCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-hhhcCCCCCCEEECCCCccC-cCcc-ccCCCCccEEEccCC
Confidence 5667777777774 33 566777777777777777663 33666777777777777776 3333 666666777777777
Q ss_pred cccCCCCc
Q 010131 81 SFVGEIPP 88 (517)
Q Consensus 81 ~l~~~~P~ 88 (517)
+++ .+|+
T Consensus 162 ~l~-~~~~ 168 (308)
T 1h6u_A 162 QVS-DLTP 168 (308)
T ss_dssp CCC-CCGG
T ss_pred cCC-CChh
Confidence 666 3443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.83 E-value=5.8e-09 Score=98.53 Aligned_cols=77 Identities=21% Similarity=0.331 Sum_probs=44.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|++++|+++ .+| .+..+++|+.|+|++|+|++.+| +..+++|+.|+|++|+++ .+|.... ++|+.|++++|
T Consensus 43 L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L~~N 116 (263)
T 1xeu_A 43 VQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFLDNN 116 (263)
T ss_dssp CSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEECCSS
T ss_pred CcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEEccCC
Confidence 455666666666 444 45566666666666666666544 666666666666666665 3443222 55555555555
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
+++
T Consensus 117 ~l~ 119 (263)
T 1xeu_A 117 ELR 119 (263)
T ss_dssp CCS
T ss_pred ccC
Confidence 555
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.83 E-value=1.9e-09 Score=104.37 Aligned_cols=97 Identities=25% Similarity=0.462 Sum_probs=71.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ +|. +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|+++ .+|. +..+++|+.|++++|
T Consensus 109 L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l~~n 183 (308)
T 1h6u_A 109 IKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDN 183 (308)
T ss_dssp CCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSS
T ss_pred CCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCC-CChh-hcCCCCCCEEECCCC
Confidence 5788888888885 453 8888888888888888887655 888888888888888888 4554 778888888888888
Q ss_pred cccCCCCc-cccccceeeeccCCC
Q 010131 81 SFVGEIPP-ALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~-~~~~~~~~~~~~~n~ 103 (517)
+++ .+|+ .-...+..+.+.+|.
T Consensus 184 ~l~-~~~~l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 184 KIS-DISPLASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CCC-CCGGGGGCTTCCEEECTTSC
T ss_pred ccC-cChhhcCCCCCCEEEccCCc
Confidence 888 4554 112244555566664
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.82 E-value=5.5e-09 Score=98.67 Aligned_cols=97 Identities=27% Similarity=0.334 Sum_probs=74.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ +|. +.++++|+.|+|++|++++.. .+.. ++|+.|+|++|+++ .+| .+..+++|+.|++++|
T Consensus 65 L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~-~~~~-~~L~~L~L~~N~l~-~~~-~l~~l~~L~~L~Ls~N 138 (263)
T 1xeu_A 65 LKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLN-GIPS-ACLSRLFLDNNELR-DTD-SLIHLKNLEILSIRNN 138 (263)
T ss_dssp CCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCT-TCCC-SSCCEEECCSSCCS-BSG-GGTTCTTCCEEECTTS
T ss_pred CCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcC-cccc-CcccEEEccCCccC-CCh-hhcCcccccEEECCCC
Confidence 6789999999995 554 889999999999999999854 4333 88999999999988 454 4888899999999999
Q ss_pred cccCCCCcc-ccccceeeeccCCCc
Q 010131 81 SFVGEIPPA-LLTGKVIFKYDNNPK 104 (517)
Q Consensus 81 ~l~~~~P~~-~~~~~~~~~~~~n~~ 104 (517)
+++ .+|.- -...+..+.+.+|..
T Consensus 139 ~i~-~~~~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 139 KLK-SIVMLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp CCC-BCGGGGGCTTCCEEECTTSCC
T ss_pred cCC-CChHHccCCCCCEEECCCCcC
Confidence 988 45531 123445566666653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.82 E-value=2.2e-09 Score=105.82 Aligned_cols=100 Identities=18% Similarity=0.303 Sum_probs=65.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ +|. +..+++|+.|++++|.+++. +.+..+++|+.|++++|.++ .+| .+..+++|+.|++++|
T Consensus 223 L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~-~~~-~~~~l~~L~~L~L~~n 297 (347)
T 4fmz_A 223 LNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNN 297 (347)
T ss_dssp CCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSS
T ss_pred CCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccC-CCh-hhcCCCCCCEEECcCC
Confidence 5677778887774 443 77777777777777777763 55777777777777777777 343 4667777777777777
Q ss_pred cccCCCCcccc--ccceeeeccCCCcc
Q 010131 81 SFVGEIPPALL--TGKVIFKYDNNPKL 105 (517)
Q Consensus 81 ~l~~~~P~~~~--~~~~~~~~~~n~~~ 105 (517)
++++..|..+. .....+.+.+|+..
T Consensus 298 ~l~~~~~~~l~~l~~L~~L~L~~n~l~ 324 (347)
T 4fmz_A 298 QLGNEDMEVIGGLTNLTTLFLSQNHIT 324 (347)
T ss_dssp CCCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred cCCCcChhHhhccccCCEEEccCCccc
Confidence 77754444332 23445566666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.81 E-value=4.4e-09 Score=100.97 Aligned_cols=78 Identities=31% Similarity=0.513 Sum_probs=53.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ ++. +.++++|+.|+|++|.+++ +|.+..+++|+.|+|++|+++ .+ +.+..+++|+.|++++|
T Consensus 70 L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~i~-~~-~~l~~l~~L~~L~l~~n 144 (291)
T 1h6t_A 70 VTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNN 144 (291)
T ss_dssp CCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSS
T ss_pred CCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCCcCC-CC-hhhcCCCCCCEEEccCC
Confidence 5677777777774 343 7777777777777777776 344777777777777777776 33 34666677777777777
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
+++
T Consensus 145 ~l~ 147 (291)
T 1h6t_A 145 KIT 147 (291)
T ss_dssp CCC
T ss_pred cCC
Confidence 776
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.80 E-value=3.5e-09 Score=101.67 Aligned_cols=97 Identities=26% Similarity=0.352 Sum_probs=63.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ +| .+..+++|+.|+|++|++++. +.+..+++|+.|++++|++++ + ..+..+++|+.|++++|
T Consensus 92 L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N 166 (291)
T 1h6t_A 92 LGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDN 166 (291)
T ss_dssp CCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred CCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEccCC
Confidence 5677788887774 33 377777777777777777764 557777777777777777773 3 45677777777777777
Q ss_pred cccCCCCc-cccccceeeeccCCC
Q 010131 81 SFVGEIPP-ALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~-~~~~~~~~~~~~~n~ 103 (517)
++++ +++ .-...+..+.+.+|.
T Consensus 167 ~l~~-~~~l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 167 QISD-IVPLAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CCCC-CGGGTTCTTCCEEECCSSC
T ss_pred cccc-chhhcCCCccCEEECCCCc
Confidence 7774 433 112234445555553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.79 E-value=8.7e-09 Score=107.76 Aligned_cols=75 Identities=27% Similarity=0.386 Sum_probs=37.1
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
+.|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. +. ++|+.|++++|+
T Consensus 123 ~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~ 191 (571)
T 3cvr_A 123 KHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNL 191 (571)
T ss_dssp CEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSC
T ss_pred CEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCC
Confidence 444444444443 443 34455555555555554 222 34455555555555552 444 33 455555555555
Q ss_pred ccCCCCc
Q 010131 82 FVGEIPP 88 (517)
Q Consensus 82 l~~~~P~ 88 (517)
|+ .+|.
T Consensus 192 L~-~lp~ 197 (571)
T 3cvr_A 192 LE-SLPA 197 (571)
T ss_dssp CS-SCCC
T ss_pred CC-chhh
Confidence 55 4555
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.78 E-value=1e-10 Score=105.56 Aligned_cols=99 Identities=23% Similarity=0.342 Sum_probs=79.2
Q ss_pred CceecCCCCcccccCCc------cccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccc
Q 010131 1 MARCALSGKNLKGEIPP------ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 74 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~------~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~ 74 (517)
++.+++++|.++|.+|. .|..+++|+.|+|++|.+++ +|.+..+++|+.|++++|.++ .+|..+..+++|+.
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~ 97 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSE
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcCCE
Confidence 46788888899888887 88889999999999999998 558888999999999999998 78887777889999
Q ss_pred cccccccccCCCCcccc--ccceeeeccCCC
Q 010131 75 LHIENNSFVGEIPPALL--TGKVIFKYDNNP 103 (517)
Q Consensus 75 l~l~~N~l~~~~P~~~~--~~~~~~~~~~n~ 103 (517)
|++++|++++ +|. +. ..+..+.+.+|.
T Consensus 98 L~L~~N~l~~-l~~-~~~l~~L~~L~l~~N~ 126 (198)
T 1ds9_A 98 LWISYNQIAS-LSG-IEKLVNLRVLYMSNNK 126 (198)
T ss_dssp EEEEEEECCC-HHH-HHHHHHSSEEEESEEE
T ss_pred EECcCCcCCc-CCc-cccCCCCCEEECCCCc
Confidence 9999999984 663 22 234455555554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.1e-08 Score=107.11 Aligned_cols=94 Identities=20% Similarity=0.229 Sum_probs=77.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccc-------c
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL-------Q 73 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L-------~ 73 (517)
|+.|+|++|+|++ +|. .+++|+.|+|++|.|++.++ |. ++|+.|+|++|+|+ .+|. +.. +| +
T Consensus 142 L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~ 210 (571)
T 3cvr_A 142 LEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEI 210 (571)
T ss_dssp CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCE
T ss_pred ccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccce
Confidence 6889999999995 786 67899999999999999444 65 89999999999999 8888 665 77 9
Q ss_pred ccccccccccCCCCccccc--cceeeeccCCCccc
Q 010131 74 ELHIENNSFVGEIPPALLT--GKVIFKYDNNPKLH 106 (517)
Q Consensus 74 ~l~l~~N~l~~~~P~~~~~--~~~~~~~~~n~~~~ 106 (517)
.|++++|+|+ .+|..+.. .+..+.+.+|+..+
T Consensus 211 ~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp EEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCH
T ss_pred EEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCC
Confidence 9999999999 79987754 55667788887553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.78 E-value=7.5e-09 Score=109.38 Aligned_cols=78 Identities=29% Similarity=0.483 Sum_probs=43.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+|++. |+ +..|++|+.|+|++|.|++ +|.+..+++|+.|+|++|+|+ .+| .+..+++|+.|+|++|
T Consensus 67 L~~L~Ls~N~l~~~-~~-l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N 141 (605)
T 1m9s_A 67 VTKLFLNGNKLTDI-KP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNN 141 (605)
T ss_dssp CCEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CTTSTTCTTCCEEECTTSCCC-CCG-GGGGCTTCSEEECCSS
T ss_pred CCEEEeeCCCCCCC-hh-hccCCCCCEEECcCCCCCC-ChhhccCCCCCEEEecCCCCC-CCc-cccCCCccCEEECCCC
Confidence 45666666666643 32 5566666666666666654 334555566666666666655 232 3555555555555555
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
+++
T Consensus 142 ~l~ 144 (605)
T 1m9s_A 142 KIT 144 (605)
T ss_dssp CCC
T ss_pred ccC
Confidence 555
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.77 E-value=4.3e-10 Score=101.47 Aligned_cols=99 Identities=25% Similarity=0.275 Sum_probs=81.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|++++ +| .+.++++|+.|+|++|.++. +|. +..+++|+.|+|++|++++ +| .+..+++|+.|++++
T Consensus 50 L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~ 124 (198)
T 1ds9_A 50 CKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSN 124 (198)
T ss_dssp CSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESE
T ss_pred CCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCC
Confidence 6889999999995 78 89999999999999999995 555 7788999999999999994 66 588999999999999
Q ss_pred ccccCCCCc--cc--cccceeeeccCCCcc
Q 010131 80 NSFVGEIPP--AL--LTGKVIFKYDNNPKL 105 (517)
Q Consensus 80 N~l~~~~P~--~~--~~~~~~~~~~~n~~~ 105 (517)
|+++ .+|. .+ ...+..+.+.+|+..
T Consensus 125 N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 125 NKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp EECC-CHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred CcCC-chhHHHHHhcCCCCCEEEecCCccc
Confidence 9999 4554 22 224556667777643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.76 E-value=6.4e-09 Score=109.87 Aligned_cols=98 Identities=24% Similarity=0.356 Sum_probs=64.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|.|++ +| .+..|++|+.|+|++|.|++ ++.+..|++|+.|+|++|+|++ + ..+..+++|+.|+|++|
T Consensus 89 L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N 163 (605)
T 1m9s_A 89 LGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDN 163 (605)
T ss_dssp CCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCSS
T ss_pred CCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcCC
Confidence 5677788887774 44 57777777777777777776 3557777777777777777773 3 45677777777777777
Q ss_pred cccCCCCccccccceeeeccCCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
+|++..|-.-...+..+.+.+|.
T Consensus 164 ~l~~~~~l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 164 QISDIVPLAGLTKLQNLYLSKNH 186 (605)
T ss_dssp CCCCCGGGTTCTTCCEEECCSSC
T ss_pred cCCCchhhccCCCCCEEECcCCC
Confidence 77743331112234445555553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.74 E-value=8.6e-09 Score=101.73 Aligned_cols=88 Identities=20% Similarity=0.178 Sum_probs=70.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc--ccCccccce-eEecCceeeecCCCCCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRI-VHLENNELTGSLPSYMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~l~~L~~-l~l~~n~l~~~~p~~~~~l~~L~~l~l 77 (517)
|++|+|++|+|+...+..|.++++|+.|+|++|++.+.+|. |.++++|.. +.++.|++++..|..|..+++|+.|++
T Consensus 32 l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l 111 (350)
T 4ay9_X 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111 (350)
T ss_dssp CSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEE
T ss_pred CCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccc
Confidence 57899999999843335688899999999999998876663 888888765 666778888666777889999999999
Q ss_pred ccccccCCCCcc
Q 010131 78 ENNSFVGEIPPA 89 (517)
Q Consensus 78 ~~N~l~~~~P~~ 89 (517)
++|+++ .+|+.
T Consensus 112 ~~n~l~-~~~~~ 122 (350)
T 4ay9_X 112 SNTGIK-HLPDV 122 (350)
T ss_dssp EEECCS-SCCCC
T ss_pred cccccc-cCCch
Confidence 999998 56654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.72 E-value=8.5e-09 Score=105.96 Aligned_cols=78 Identities=32% Similarity=0.442 Sum_probs=45.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ +|. +..+++|+.|+|++|++++.+| +..+++|+.|+|++|++++..| +..+++|+.|++++|
T Consensus 267 L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 267 LTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341 (466)
T ss_dssp CSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSS
T ss_pred CCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCC
Confidence 4566666666664 332 5566666666666666665433 5556666666666666664433 445555555555555
Q ss_pred ccc
Q 010131 81 SFV 83 (517)
Q Consensus 81 ~l~ 83 (517)
+++
T Consensus 342 ~l~ 344 (466)
T 1o6v_A 342 KVS 344 (466)
T ss_dssp CCC
T ss_pred ccC
Confidence 555
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.70 E-value=2.9e-08 Score=101.56 Aligned_cols=95 Identities=17% Similarity=0.234 Sum_probs=70.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ +| .++.+++|+.|+|++|+|++. | ++.+++|+.|++++|.+++ +| ++.+++|++|++++|
T Consensus 44 L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N 116 (457)
T 3bz5_A 44 LTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTN 116 (457)
T ss_dssp CCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSS
T ss_pred CCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCC
Confidence 5788888888885 46 688888888888888888885 3 7788888888888888884 44 778888888888888
Q ss_pred cccCCCCccccccceeeeccCCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
++++ +|-.-...+..+.+.+|.
T Consensus 117 ~l~~-l~~~~l~~L~~L~l~~N~ 138 (457)
T 3bz5_A 117 KLTK-LDVSQNPLLTYLNCARNT 138 (457)
T ss_dssp CCSC-CCCTTCTTCCEEECTTSC
T ss_pred cCCe-ecCCCCCcCCEEECCCCc
Confidence 8884 653223344455555553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.69 E-value=1.6e-08 Score=103.89 Aligned_cols=96 Identities=26% Similarity=0.325 Sum_probs=46.7
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
+.|+|++|.+++..| +..+++|+.|+|++|.+++.++ +..+++|+.|++++|++++. +. +..+++|+.|++++|+
T Consensus 246 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~L~~n~ 320 (466)
T 1o6v_A 246 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDI-SP-ISNLKNLTYLTLYFNN 320 (466)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC-GG-GGGCTTCSEEECCSSC
T ss_pred CEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCc-hh-hcCCCCCCEEECcCCc
Confidence 445555555553222 4455555555555555554433 55555555555555555532 22 4555555556666665
Q ss_pred ccCCCCccccccceeeeccCC
Q 010131 82 FVGEIPPALLTGKVIFKYDNN 102 (517)
Q Consensus 82 l~~~~P~~~~~~~~~~~~~~n 102 (517)
+++..|-.....+..+.+.+|
T Consensus 321 l~~~~~~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 321 ISDISPVSSLTKLQRLFFYNN 341 (466)
T ss_dssp CSCCGGGGGCTTCCEEECCSS
T ss_pred CCCchhhccCccCCEeECCCC
Confidence 554333222223334444444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.66 E-value=3.5e-08 Score=101.00 Aligned_cols=81 Identities=19% Similarity=0.233 Sum_probs=69.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|++++ +| ++.+++|+.|++++|.+++. ++..+++|+.|++++|++++ +| ++.+++|+.|++++|
T Consensus 172 L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N 243 (457)
T 3bz5_A 172 LTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN 243 (457)
T ss_dssp CCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS
T ss_pred CCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCC
Confidence 6789999999996 66 88899999999999999986 48889999999999999995 77 888999999999999
Q ss_pred cccCCCCccc
Q 010131 81 SFVGEIPPAL 90 (517)
Q Consensus 81 ~l~~~~P~~~ 90 (517)
++++ +|...
T Consensus 244 ~l~~-~~~~~ 252 (457)
T 3bz5_A 244 PLTE-LDVST 252 (457)
T ss_dssp CCSC-CCCTT
T ss_pred cCCC-cCHHH
Confidence 9995 55433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.65 E-value=2.1e-08 Score=102.52 Aligned_cols=61 Identities=31% Similarity=0.444 Sum_probs=45.8
Q ss_pred CCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccccccC--CCCccc
Q 010131 23 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPAL 90 (517)
Q Consensus 23 ~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~P~~~ 90 (517)
++|+.|+|++|++++ +|.. +++|+.|++++|+++ .+|. .+++|+.|++++|++++ .+|..+
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~--~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l 379 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL--PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESV 379 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred CcCCEEECCCCcccc-cccc--CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHH
Confidence 578888888888887 4432 477888888888888 6776 36788888888888886 666655
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.3e-07 Score=87.74 Aligned_cols=135 Identities=17% Similarity=0.111 Sum_probs=98.6
Q ss_pred ccCCCCce-EEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 202 KIGKGSFG-SVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 202 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556655 68988765 467899998653 34556888999998884 33477888899888999999999999888
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG--------------------------------------------- 313 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~--------------------------------------------- 313 (517)
.+..... ......+..+++..|..||+.
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654321 123345667777777777751
Q ss_pred ----------CCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 314 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 314 ----------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
....++|||+++.||++++++.+-|.||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012378999999999999877778999997753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.62 E-value=1.4e-08 Score=99.99 Aligned_cols=100 Identities=21% Similarity=0.284 Sum_probs=84.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|.+++ + +.+..+++|+.|++++|.+++. |.+..+++|+.|++++|.+++..|..+..+++|+.|++++|
T Consensus 245 L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 321 (347)
T 4fmz_A 245 LTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321 (347)
T ss_dssp CCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSS
T ss_pred CCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCC
Confidence 6899999999995 4 4688999999999999999986 66999999999999999999888888999999999999999
Q ss_pred cccCCCCccccccceeeeccCCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
++++..|-........+.+.+|+
T Consensus 322 ~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 322 HITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp SCCCCGGGGGCTTCSEESSSCC-
T ss_pred ccccccChhhhhccceeehhhhc
Confidence 99965452334455667777775
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.61 E-value=7.7e-08 Score=98.33 Aligned_cols=80 Identities=33% Similarity=0.492 Sum_probs=43.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|++++ +| .|+++++|+.|++++|++++ +|.. ..+|+.|++++|++++ +| .++.+++|+.|++++|
T Consensus 133 L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N 205 (454)
T 1jl5_A 133 LEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNN 205 (454)
T ss_dssp CCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred CCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCC
Confidence 3455555555553 55 35555666666666666555 2321 1355666666666553 44 3566666666666666
Q ss_pred cccCCCCc
Q 010131 81 SFVGEIPP 88 (517)
Q Consensus 81 ~l~~~~P~ 88 (517)
++++ +|.
T Consensus 206 ~l~~-l~~ 212 (454)
T 1jl5_A 206 SLKK-LPD 212 (454)
T ss_dssp CCSS-CCC
T ss_pred cCCc-CCC
Confidence 6663 443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.60 E-value=1.9e-08 Score=106.47 Aligned_cols=75 Identities=28% Similarity=0.390 Sum_probs=59.3
Q ss_pred CCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccccccCCCCccccc--cceeeecc
Q 010131 23 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYD 100 (517)
Q Consensus 23 ~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~P~~~~~--~~~~~~~~ 100 (517)
++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|. .+++|+.|++++|+|+ .+|..+.. .+..+.+.
T Consensus 221 ~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 67888888888888744 45678999999999998 7777 5678999999999999 88877643 45667788
Q ss_pred CCCcc
Q 010131 101 NNPKL 105 (517)
Q Consensus 101 ~n~~~ 105 (517)
+|+..
T Consensus 293 ~N~l~ 297 (622)
T 3g06_A 293 GNPLS 297 (622)
T ss_dssp SCCCC
T ss_pred CCCCC
Confidence 88754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.55 E-value=3.6e-09 Score=105.91 Aligned_cols=104 Identities=19% Similarity=0.301 Sum_probs=73.3
Q ss_pred CceecCCCCccc-ccCC---ccccCCCCCcEEEcCCCCCC--C---CCC-cccCccccceeEecCceee----ecCCCCC
Q 010131 1 MARCALSGKNLK-GEIP---PELKNMEALTELWLDGNFLT--G---PLP-DMSRLIDLRIVHLENNELT----GSLPSYM 66 (517)
Q Consensus 1 l~~L~l~~n~~~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p-~~~~l~~L~~l~l~~n~l~----~~~p~~~ 66 (517)
|+.|+|++|+++ +.+| ..+..+++|+.|+|++|.|+ | ..| .+..+++|+.|+|++|.++ +.+|..+
T Consensus 161 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l 240 (386)
T 2ca6_A 161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240 (386)
T ss_dssp CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred CcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH
Confidence 577888888887 4455 45667788888888888887 3 345 4777888888888888885 5677777
Q ss_pred CCcccccccccccccccCC----CCccc----cccceeeeccCCCc
Q 010131 67 GSLPNLQELHIENNSFVGE----IPPAL----LTGKVIFKYDNNPK 104 (517)
Q Consensus 67 ~~l~~L~~l~l~~N~l~~~----~P~~~----~~~~~~~~~~~n~~ 104 (517)
..+++|+.|++++|.+++. +|..+ ...+..+.+.+|.-
T Consensus 241 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i 286 (386)
T 2ca6_A 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286 (386)
T ss_dssp GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCC
T ss_pred ccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcC
Confidence 7888888888888888754 34433 23445566666653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=4.2e-07 Score=87.69 Aligned_cols=135 Identities=15% Similarity=0.187 Sum_probs=93.1
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCC---Cccccceeee-cCCeeEEEEEecCCC
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCE-EEHQRILVYEYMHNG 276 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g 276 (517)
+.++.|....||+. |..+++|+-.. ......+.+|.++|+.+.+. .+.+++.++. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899988 56788888532 23456788999999999642 3556666664 455678999999998
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------- 313 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------------------------------------------- 313 (517)
++.+... ..++..+...++.++++.|+.||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8765321 1234444455555555555555541
Q ss_pred --------------CCCCcEecCCCCCCeEeCC---CCc-EEEccccCccc
Q 010131 314 --------------CNPGIIHRDVKSSNILLDI---NMR-AKVSDFGLSRQ 346 (517)
Q Consensus 314 --------------~~~~ivH~dlk~~Nill~~---~~~-~kl~Dfg~a~~ 346 (517)
....++|+|+++.||+++. ++. +.|.||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1245699999999999987 455 48999997754
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.53 E-value=1.4e-07 Score=99.78 Aligned_cols=90 Identities=30% Similarity=0.341 Sum_probs=61.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++.|++++|+++ .+|..+. ++|+.|+|++|.|+..++ .+++|+.|+|++|+|+ .+|. .+++|++|++++|
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N 111 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSN 111 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSC
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCC
Confidence 457788888887 7777665 678888888888775444 4677778888888777 5666 5567777777777
Q ss_pred cccCCCCccccccceeeeccCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNN 102 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n 102 (517)
+++ .+|. ....+..+.+.+|
T Consensus 112 ~l~-~l~~-~l~~L~~L~L~~N 131 (622)
T 3g06_A 112 PLT-HLPA-LPSGLCKLWIFGN 131 (622)
T ss_dssp CCC-CCCC-CCTTCCEEECCSS
T ss_pred cCC-CCCC-CCCCcCEEECCCC
Confidence 777 4665 3333444445544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.52 E-value=1e-08 Score=101.73 Aligned_cols=83 Identities=22% Similarity=0.209 Sum_probs=43.8
Q ss_pred CceecCCCCcccccCC----ccccCCC-CCcEEEcCCCCCCCCCCc-ccCc-----cccceeEecCceeeecCCCCCCC-
Q 010131 1 MARCALSGKNLKGEIP----PELKNME-ALTELWLDGNFLTGPLPD-MSRL-----IDLRIVHLENNELTGSLPSYMGS- 68 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~p~-~~~l-----~~L~~l~l~~n~l~~~~p~~~~~- 68 (517)
|++|+|++|++++..+ ..|.+++ +|+.|+|++|.|++..+. +..+ ++|+.|+|++|.+++..+..+..
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 3455666666554433 4445555 566666666666555443 4443 55666666666655433332222
Q ss_pred ---c-cccccccccccccc
Q 010131 69 ---L-PNLQELHIENNSFV 83 (517)
Q Consensus 69 ---l-~~L~~l~l~~N~l~ 83 (517)
+ ++|+.|++++|+++
T Consensus 104 l~~~~~~L~~L~Ls~N~l~ 122 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFS 122 (362)
T ss_dssp HHTSCTTCCEEECCSSCGG
T ss_pred HHhCCCCccEEECcCCcCC
Confidence 2 45666666666655
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.52 E-value=5.1e-09 Score=104.85 Aligned_cols=104 Identities=18% Similarity=0.241 Sum_probs=74.8
Q ss_pred CceecCCCCcccc----cCCccccCC---------CCCcEEEcCCCCCC-CCCC---c-ccCccccceeEecCceee--e
Q 010131 1 MARCALSGKNLKG----EIPPELKNM---------EALTELWLDGNFLT-GPLP---D-MSRLIDLRIVHLENNELT--G 60 (517)
Q Consensus 1 l~~L~l~~n~~~~----~~p~~~~~l---------~~L~~L~l~~N~l~-~~~p---~-~~~l~~L~~l~l~~n~l~--~ 60 (517)
|+.|+|++|.+++ .++..+..+ ++|+.|+|++|.++ +.+| . +..+++|+.|+|++|+++ |
T Consensus 124 L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g 203 (386)
T 2ca6_A 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203 (386)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHH
T ss_pred CCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhH
Confidence 6788888888863 355666666 88888888888887 4455 2 667888888888888887 3
Q ss_pred ---cCCCCCCCccccccccccccccc----CCCCccccc--cceeeeccCCCc
Q 010131 61 ---SLPSYMGSLPNLQELHIENNSFV----GEIPPALLT--GKVIFKYDNNPK 104 (517)
Q Consensus 61 ---~~p~~~~~l~~L~~l~l~~N~l~----~~~P~~~~~--~~~~~~~~~n~~ 104 (517)
.+|..+..+++|+.|++++|.++ +.+|..+.. .+..+.+.+|.-
T Consensus 204 ~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i 256 (386)
T 2ca6_A 204 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256 (386)
T ss_dssp HHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred HHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence 45557788888888888888885 456654432 445566677653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.45 E-value=4.8e-08 Score=91.48 Aligned_cols=82 Identities=21% Similarity=0.289 Sum_probs=64.6
Q ss_pred ecCCCCcccccCCc----cccCCCCCcEEEcCCCCCCC--CCCc-ccCccccceeEecCceeeecCCCCCCCcc--cccc
Q 010131 4 CALSGKNLKGEIPP----ELKNMEALTELWLDGNFLTG--PLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLP--NLQE 74 (517)
Q Consensus 4 L~l~~n~~~~~~p~----~~~~l~~L~~L~l~~N~l~~--~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~--~L~~ 74 (517)
++++.|... .++. ...++++|+.|+|++|+|++ .+|+ +..+++|+.|+|++|+|++. ..+..+. +|+.
T Consensus 148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~ 224 (267)
T 3rw6_A 148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE 224 (267)
T ss_dssp CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE
T ss_pred ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce
Confidence 677888543 3332 22468999999999999999 4556 78899999999999999954 3355555 8999
Q ss_pred cccccccccCCCCc
Q 010131 75 LHIENNSFVGEIPP 88 (517)
Q Consensus 75 l~l~~N~l~~~~P~ 88 (517)
|+|++|.+++.+|.
T Consensus 225 L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 225 LWLDGNSLCDTFRD 238 (267)
T ss_dssp EECTTSTTGGGCSS
T ss_pred EEccCCcCccccCc
Confidence 99999999988874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.38 E-value=5.2e-08 Score=91.24 Aligned_cols=62 Identities=21% Similarity=0.324 Sum_probs=30.0
Q ss_pred CceecCCCCcccc--cCCccccCCCCCcEEEcCCCCCCCCCCcccCcc--ccceeEecCceeeecCC
Q 010131 1 MARCALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENNELTGSLP 63 (517)
Q Consensus 1 l~~L~l~~n~~~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~--~L~~l~l~~n~l~~~~p 63 (517)
|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. .++..+. +|+.|+|++|.+++.+|
T Consensus 172 L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 172 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccC
Confidence 3455555555554 2334444555555555555555543 2122222 55555555555554444
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=8.7e-07 Score=87.45 Aligned_cols=80 Identities=5% Similarity=0.037 Sum_probs=55.9
Q ss_pred ccc-CCCCceEEEEEEec-------CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCC-C--CCccccceeeecC---
Q 010131 201 KKI-GKGSFGSVYYGKMK-------DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEE--- 263 (517)
Q Consensus 201 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~--- 263 (517)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998764 26788999865422 101245678888888884 3 3567788877655
Q ss_pred CeeEEEEEecCCCCHHh
Q 010131 264 HQRILVYEYMHNGTLRD 280 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~ 280 (517)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.36 E-value=1.9e-08 Score=98.45 Aligned_cols=104 Identities=12% Similarity=0.080 Sum_probs=84.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCC-CCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP-LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
++.|++++|.+.+..|. ++.+++|+.|+|++|.+++. +|. +..+++|+.|+|++|.+++..|..++.+++|+.|+++
T Consensus 72 l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~ 150 (336)
T 2ast_B 72 VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150 (336)
T ss_dssp CSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECC
Confidence 57899999999976554 77899999999999999876 776 8899999999999999998888889999999999999
Q ss_pred cc-cccCC-CCccc--cccceeeeccCCCcc
Q 010131 79 NN-SFVGE-IPPAL--LTGKVIFKYDNNPKL 105 (517)
Q Consensus 79 ~N-~l~~~-~P~~~--~~~~~~~~~~~n~~~ 105 (517)
+| .+++. +|..+ ...+..+.+.+|+..
T Consensus 151 ~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l 181 (336)
T 2ast_B 151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDF 181 (336)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTC
T ss_pred CCCCCCHHHHHHHHhcCCCCCEEcCCCCCCc
Confidence 99 67752 44433 234566677777433
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.36 E-value=5.4e-08 Score=95.21 Aligned_cols=102 Identities=20% Similarity=0.281 Sum_probs=84.9
Q ss_pred CceecCCCCcccccCCccccCC--CCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeec-CCCCCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNM--EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l--~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~-~p~~~~~l~~L~~l~l 77 (517)
++.|++++|++. |..+..+ ++|+.|++++|.+++.++.+..+++|+.|+|++|.+++. +|..+..+++|+.|++
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L 125 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 125 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeC
Confidence 367899999887 5667777 899999999999999999888899999999999999866 8888999999999999
Q ss_pred ccccccCCCCccccc--cceeeeccCCCcc
Q 010131 78 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 105 (517)
Q Consensus 78 ~~N~l~~~~P~~~~~--~~~~~~~~~n~~~ 105 (517)
++|.+++..|..+.. .+..+.+.+|...
T Consensus 126 ~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l 155 (336)
T 2ast_B 126 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155 (336)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSC
T ss_pred cCcccCHHHHHHHhcCCCCCEEECCCCCCC
Confidence 999998777765533 4556677777433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.30 E-value=5.1e-07 Score=88.92 Aligned_cols=100 Identities=15% Similarity=0.144 Sum_probs=74.4
Q ss_pred ceecCCC-CcccccCCccccCCC-CCcEEEcCCCCCCCCCCcccCccccceeEecC-ceeeecCCC-CCCCccccccccc
Q 010131 2 ARCALSG-KNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN-NELTGSLPS-YMGSLPNLQELHI 77 (517)
Q Consensus 2 ~~L~l~~-n~~~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~-n~l~~~~p~-~~~~l~~L~~l~l 77 (517)
..|++++ |++....+..|..+. .|+.|+|++|+|+..++......+|+.|++++ |.++ .+|. .|..+++|+.|++
T Consensus 131 ~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdL 209 (350)
T 4ay9_X 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDI 209 (350)
T ss_dssp EEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEEC
T ss_pred hhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhc
Confidence 3566654 566644445666664 68899999999998777755667899999975 5566 7775 4788999999999
Q ss_pred ccccccCCCCccccccceeeeccCCC
Q 010131 78 ENNSFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 78 ~~N~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
++|+|+ .+|...+.+...+...++.
T Consensus 210 s~N~l~-~lp~~~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 210 SRTRIH-SLPSYGLENLKKLRARSTY 234 (350)
T ss_dssp TTSCCC-CCCSSSCTTCCEEECTTCT
T ss_pred CCCCcC-ccChhhhccchHhhhccCC
Confidence 999999 7998777666655555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.29 E-value=5.7e-08 Score=96.28 Aligned_cols=101 Identities=14% Similarity=0.053 Sum_probs=82.5
Q ss_pred eecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCC----c-ccCcc-ccceeEecCceeeecCCCCCCCc-----cc
Q 010131 3 RCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP----D-MSRLI-DLRIVHLENNELTGSLPSYMGSL-----PN 71 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p----~-~~~l~-~L~~l~l~~n~l~~~~p~~~~~l-----~~ 71 (517)
.++|++|+++|.+|..+...++|+.|+|++|.|++..+ + |..++ +|+.|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999988877777789999999999999887 5 77888 89999999999997767767765 89
Q ss_pred ccccccccccccCCCCcccc-------ccceeeeccCCC
Q 010131 72 LQELHIENNSFVGEIPPALL-------TGKVIFKYDNNP 103 (517)
Q Consensus 72 L~~l~l~~N~l~~~~P~~~~-------~~~~~~~~~~n~ 103 (517)
|+.|++++|++++..+..+. .....+.+.+|.
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 120 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSC
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCc
Confidence 99999999999965554332 244556666665
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=8.1e-06 Score=79.80 Aligned_cols=140 Identities=16% Similarity=0.228 Sum_probs=79.9
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC--CCCccccce------eeecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--HRNLVPLIG------YCEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~------~~~~~~~~~lv~e~ 272 (517)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.+. .-.+.+++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999987655 5899988752 233445556555552 112333332 12345678999999
Q ss_pred cCCCCHH--------------hHhhccCC----C-------CccCHHHH-------------------------------
Q 010131 273 MHNGTLR--------------DRLHGSVN----Q-------KPLDWLTR------------------------------- 296 (517)
Q Consensus 273 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~------------------------------- 296 (517)
++|..+. ..+|.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11121100 0 01122211
Q ss_pred HHHHHHHHHHHHHHhc----------CCCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 297 LQIAHDAAKGLEYLHT----------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 297 ~~i~~~ia~aL~~LH~----------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
..+..++..++.+|+. .....++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666652 023789999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=6.5e-06 Score=82.42 Aligned_cols=74 Identities=16% Similarity=0.171 Sum_probs=49.0
Q ss_pred cccCCCCceEEEEEEec-CCcEEEEEEecCCCc-------hhHHHHHHHHHHHhcCCC--CCcc-ccceeeecCCeeEEE
Q 010131 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------HRTQQFVTEVALLSRIHH--RNLV-PLIGYCEEEHQRILV 269 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~~~~~~~~~~~~~lv 269 (517)
+.+|.|.++.||++... +++.++||....... ...+.+..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57999999999999764 468899998653221 123456779999888732 3333 44443 34456899
Q ss_pred EEecCCC
Q 010131 270 YEYMHNG 276 (517)
Q Consensus 270 ~e~~~~g 276 (517)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.14 E-value=2.7e-06 Score=82.88 Aligned_cols=89 Identities=15% Similarity=0.050 Sum_probs=74.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccc-eeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLR-IVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~-~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|+++..-+..|.++++|+.|+|++| ++...+. |.++.+|+ .+++++ .++..-+..|.++++|+.++++
T Consensus 228 L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~ 305 (329)
T 3sb4_A 228 LVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLAT 305 (329)
T ss_dssp CCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEEC
T ss_pred CeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeC
Confidence 678999999999444457889999999999998 7776666 99999999 999999 6773445679999999999999
Q ss_pred cccccCCCCccccc
Q 010131 79 NNSFVGEIPPALLT 92 (517)
Q Consensus 79 ~N~l~~~~P~~~~~ 92 (517)
+|+++ .+++..+.
T Consensus 306 ~n~i~-~I~~~aF~ 318 (329)
T 3sb4_A 306 GDKIT-TLGDELFG 318 (329)
T ss_dssp SSCCC-EECTTTTC
T ss_pred CCccC-ccchhhhc
Confidence 99999 78876654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.07 E-value=1.4e-07 Score=96.44 Aligned_cols=103 Identities=18% Similarity=0.198 Sum_probs=75.5
Q ss_pred CceecCCCCcccccCCccccC-----CCCCcEEEcCCCCCCCC----CCc-ccCccccceeEecCceeeecCCCCCCC--
Q 010131 1 MARCALSGKNLKGEIPPELKN-----MEALTELWLDGNFLTGP----LPD-MSRLIDLRIVHLENNELTGSLPSYMGS-- 68 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~-----l~~L~~L~l~~N~l~~~----~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~-- 68 (517)
|+.|+|++|.+++..+..+.. .++|+.|+|++|.+++. ++. +..+++|+.|+|++|.+++..+..+..
T Consensus 286 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 365 (461)
T 1z7x_W 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGL 365 (461)
T ss_dssp CCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHH
T ss_pred cceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHH
Confidence 678999999988654444433 36899999999999876 344 677899999999999988654444432
Q ss_pred ---cccccccccccccccC----CCCcccc--ccceeeeccCCC
Q 010131 69 ---LPNLQELHIENNSFVG----EIPPALL--TGKVIFKYDNNP 103 (517)
Q Consensus 69 ---l~~L~~l~l~~N~l~~----~~P~~~~--~~~~~~~~~~n~ 103 (517)
.++|+.|++++|++++ .+|..+. ..+..+.+.+|+
T Consensus 366 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 366 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred cCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 6789999999999885 5665543 345566777775
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.04 E-value=7.9e-08 Score=98.42 Aligned_cols=84 Identities=23% Similarity=0.238 Sum_probs=49.4
Q ss_pred CceecCCCCcccccC-----CccccCCCCCcEEEcCCCCCCCC----CCc-ccCccccceeEecCceeeecCCCCCCC--
Q 010131 1 MARCALSGKNLKGEI-----PPELKNMEALTELWLDGNFLTGP----LPD-MSRLIDLRIVHLENNELTGSLPSYMGS-- 68 (517)
Q Consensus 1 l~~L~l~~n~~~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~-- 68 (517)
|+.|+|++|.+++.. +..+..+++|+.|+|++|.+++. ++. +..+++|+.|+|++|.+++..+..+..
T Consensus 229 L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l 308 (461)
T 1z7x_W 229 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETL 308 (461)
T ss_dssp CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHH
T ss_pred ccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHh
Confidence 566777777766432 11222467777777777777763 343 556677777777777765432222222
Q ss_pred ---cccccccccccccccC
Q 010131 69 ---LPNLQELHIENNSFVG 84 (517)
Q Consensus 69 ---l~~L~~l~l~~N~l~~ 84 (517)
.++|+.|++++|.+++
T Consensus 309 ~~~~~~L~~L~L~~n~l~~ 327 (461)
T 1z7x_W 309 LEPGCQLESLWVKSCSFTA 327 (461)
T ss_dssp TSTTCCCCEEECTTSCCBG
T ss_pred ccCCccceeeEcCCCCCch
Confidence 2466666666666664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.7e-05 Score=73.87 Aligned_cols=137 Identities=18% Similarity=0.215 Sum_probs=92.1
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCCccccceeeecCCeeEEEEEecCCCC
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
+.|+.|....+|+.... +..+++|+.... ....+..|...|+.|. ...+.+++.++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46899999999999874 678899987532 3567889999998883 3568888888887888999999999876
Q ss_pred HHh-----------HhhccCC-------------------CCccCHHHHH---HHH----------------HHHHHHH-
Q 010131 278 LRD-----------RLHGSVN-------------------QKPLDWLTRL---QIA----------------HDAAKGL- 307 (517)
Q Consensus 278 L~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~----------------~~ia~aL- 307 (517)
+.. .++.... .-.-+|.... ++. ..++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 421 2222111 0012454332 111 1122222
Q ss_pred HHHhc-CCCCCcEecCCCCCCeEeCCCCcEEEcccc
Q 010131 308 EYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFG 342 (517)
Q Consensus 308 ~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg 342 (517)
..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 1247899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.95 E-value=3e-05 Score=73.82 Aligned_cols=74 Identities=19% Similarity=0.265 Sum_probs=54.6
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCC---CccccceeeecCCeeEEEEEecCCCC
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
+.+|.|..+.||+.+..||+.|++|+...........|..|+..|+.|.-. -+.+++++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 568999999999999999999999987654444445688899999888421 234444432 3478999998765
Q ss_pred H
Q 010131 278 L 278 (517)
Q Consensus 278 L 278 (517)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.94 E-value=4.6e-07 Score=89.89 Aligned_cols=104 Identities=21% Similarity=0.173 Sum_probs=72.4
Q ss_pred CceecCCCCcccccCCccc-----cCCCCCcEEEcCCCCCCCC----CCc-ccCccccceeEecCceeee----cCCCCC
Q 010131 1 MARCALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGP----LPD-MSRLIDLRIVHLENNELTG----SLPSYM 66 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~-----~~l~~L~~L~l~~N~l~~~----~p~-~~~l~~L~~l~l~~n~l~~----~~p~~~ 66 (517)
|+.|+|++|+|+..-...+ ...++|+.|+|++|.|+.. ++. +..+++|+.|+|++|.|+. .++..+
T Consensus 128 L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L 207 (372)
T 3un9_A 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQL 207 (372)
T ss_dssp EEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHG
T ss_pred ccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHH
Confidence 4689999999875544444 2467899999999998763 233 5678889999999999874 235556
Q ss_pred CCcccccccccccccccCCCCccc------cccceeeeccCCCc
Q 010131 67 GSLPNLQELHIENNSFVGEIPPAL------LTGKVIFKYDNNPK 104 (517)
Q Consensus 67 ~~l~~L~~l~l~~N~l~~~~P~~~------~~~~~~~~~~~n~~ 104 (517)
...++|+.|++++|.|+..-...+ ...+..+.+++|+-
T Consensus 208 ~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 208 DRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp GGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred hcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 777889999999999873211111 12455667777763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00013 Score=73.46 Aligned_cols=78 Identities=12% Similarity=0.098 Sum_probs=47.5
Q ss_pred CCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCC---CCCccceehhHHHHHHHHH
Q 010131 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELI 392 (517)
Q Consensus 316 ~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~ell 392 (517)
..++|||+++.||+++.++ +++.||+.+..-.....-......-...|.+|+..... ......++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 8899999999999999876 99999998875432211100000001235555544311 1122455567777888777
Q ss_pred hC
Q 010131 393 SG 394 (517)
Q Consensus 393 tg 394 (517)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.73 E-value=1.6e-06 Score=85.88 Aligned_cols=103 Identities=17% Similarity=0.067 Sum_probs=71.8
Q ss_pred CceecCCCCcccccCCcccc-CCCCCcEEEcCCCCCCCCCCc-c-----cCccccceeEecCceeee----cCCCCCCCc
Q 010131 1 MARCALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-M-----SRLIDLRIVHLENNELTG----SLPSYMGSL 69 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~-~-----~~l~~L~~l~l~~n~l~~----~~p~~~~~l 69 (517)
|++|+|++|.++..-...+. .+++|+.|+|++|.|+..... + ...++|+.|+|++|.|+. .++..+..+
T Consensus 103 L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~ 182 (372)
T 3un9_A 103 LDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGN 182 (372)
T ss_dssp EEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTC
T ss_pred ceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcC
Confidence 57899999998754444444 467899999999999875443 3 346789999999999873 244555678
Q ss_pred ccccccccccccccCCC----Ccccc--ccceeeeccCCC
Q 010131 70 PNLQELHIENNSFVGEI----PPALL--TGKVIFKYDNNP 103 (517)
Q Consensus 70 ~~L~~l~l~~N~l~~~~----P~~~~--~~~~~~~~~~n~ 103 (517)
++|++|+|++|.|+..- +..+. ..+..+.+.+|.
T Consensus 183 ~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~ 222 (372)
T 3un9_A 183 TSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNG 222 (372)
T ss_dssp SSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSC
T ss_pred CCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCC
Confidence 89999999999987321 22221 234555666664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.64 E-value=4.1e-06 Score=74.20 Aligned_cols=84 Identities=21% Similarity=0.281 Sum_probs=59.5
Q ss_pred CceecCCCC-ccccc----CCccccCCCCCcEEEcCCCCCCCC----CCc-ccCccccceeEecCceeeec----CCCCC
Q 010131 1 MARCALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGP----LPD-MSRLIDLRIVHLENNELTGS----LPSYM 66 (517)
Q Consensus 1 l~~L~l~~n-~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~-~~~l~~L~~l~l~~n~l~~~----~p~~~ 66 (517)
|++|+|++| .|... +...+...++|+.|+|++|.|+.. +.. +...+.|+.|+|++|.|+.. +...+
T Consensus 38 L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L 117 (185)
T 1io0_A 38 LEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEAL 117 (185)
T ss_dssp CCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGG
T ss_pred CCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHH
Confidence 577888888 77643 344556678888888888888753 222 45567788888888888732 45566
Q ss_pred CCccccccccc--ccccccC
Q 010131 67 GSLPNLQELHI--ENNSFVG 84 (517)
Q Consensus 67 ~~l~~L~~l~l--~~N~l~~ 84 (517)
...++|+.|++ ++|.+..
T Consensus 118 ~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 118 QSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp GGCSSCCEEECCCCSSCCCH
T ss_pred HhCCCceEEEecCCCCCCCH
Confidence 77778888888 7788773
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.51 E-value=5.7e-06 Score=87.40 Aligned_cols=84 Identities=17% Similarity=0.133 Sum_probs=44.8
Q ss_pred CceecCC----CCccccc-----CCccccCCCCCcEEEcCCC--CCCCCCCc-cc-CccccceeEecCceeee-cCCCCC
Q 010131 1 MARCALS----GKNLKGE-----IPPELKNMEALTELWLDGN--FLTGPLPD-MS-RLIDLRIVHLENNELTG-SLPSYM 66 (517)
Q Consensus 1 l~~L~l~----~n~~~~~-----~p~~~~~l~~L~~L~l~~N--~l~~~~p~-~~-~l~~L~~l~l~~n~l~~-~~p~~~ 66 (517)
|+.|+|+ .|.+++. ++..+.++++|+.|+|+.| .+++..+. +. .+++|+.|+|++|.+++ .++..+
T Consensus 405 L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~ 484 (592)
T 3ogk_B 405 LCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFS 484 (592)
T ss_dssp CCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHH
T ss_pred CcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHH
Confidence 4566664 5566642 2222445666666666532 24443332 22 35666666666666654 233344
Q ss_pred CCcccccccccccccccC
Q 010131 67 GSLPNLQELHIENNSFVG 84 (517)
Q Consensus 67 ~~l~~L~~l~l~~N~l~~ 84 (517)
..+++|+.|++++|.+++
T Consensus 485 ~~~~~L~~L~l~~n~l~~ 502 (592)
T 3ogk_B 485 RGCPNLQKLEMRGCCFSE 502 (592)
T ss_dssp TCCTTCCEEEEESCCCBH
T ss_pred hcCcccCeeeccCCCCcH
Confidence 555666666666666553
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.50 E-value=4.2e-06 Score=74.16 Aligned_cols=83 Identities=14% Similarity=0.254 Sum_probs=65.7
Q ss_pred CceecCCCCccccc----CCccccCCCCCcEEEcCCCCCCCC----CCc-ccCccccceeEe--cCceeeec----CCCC
Q 010131 1 MARCALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGP----LPD-MSRLIDLRIVHL--ENNELTGS----LPSY 65 (517)
Q Consensus 1 l~~L~l~~n~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~-~~~l~~L~~l~l--~~n~l~~~----~p~~ 65 (517)
|++|+|++|+|... +...+...++|+.|+|++|.|+.. +.. +...+.|+.|+| ++|.++.. +...
T Consensus 67 L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~ 146 (185)
T 1io0_A 67 VKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANM 146 (185)
T ss_dssp CCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHH
T ss_pred cCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHH
Confidence 68999999999753 344456668999999999999874 233 677889999999 88999843 3444
Q ss_pred CCCccccccccccccccc
Q 010131 66 MGSLPNLQELHIENNSFV 83 (517)
Q Consensus 66 ~~~l~~L~~l~l~~N~l~ 83 (517)
+...++|+.|++++|.+.
T Consensus 147 L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 147 LEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHCSSCCEEECCCSSHH
T ss_pred HHhCCCcCEEeccCCCCC
Confidence 556689999999999886
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00062 Score=66.05 Aligned_cols=142 Identities=12% Similarity=0.060 Sum_probs=73.6
Q ss_pred cccCCCCceE-EEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-C-CCccccceeeecCCeeEEEEEecCCCC
Q 010131 201 KKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-RNLVPLIGYCEEEHQRILVYEYMHNGT 277 (517)
Q Consensus 201 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~~gs 277 (517)
+.|+.|+... +|+....+|..+++|....... ..+..|+.+++.+. + -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465565554 6677664477788886543221 23445667666663 2 23555666543333 78999997766
Q ss_pred HHhHhhcc---------------------CC--CCccCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 010131 278 LRDRLHGS---------------------VN--QKPLDWLTRL-------Q-------------IAHDAAKGLEYLH--- 311 (517)
Q Consensus 278 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~~ia~aL~~LH--- 311 (517)
+.+++... .. ...++..... . ....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65443211 00 0111111100 0 0011111222221
Q ss_pred cCCCCCcEecCCCCCCeEeCCC----CcEEEccccCcccc
Q 010131 312 TGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 347 (517)
Q Consensus 312 ~~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~~ 347 (517)
......++|||+.+.||+++.+ +.+.|.||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123689999999999999875 67999999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0014 Score=63.39 Aligned_cols=141 Identities=13% Similarity=0.169 Sum_probs=81.8
Q ss_pred ccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC--CCcccccee-----eecCCeeEEEEEecC
Q 010131 202 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGY-----CEEEHQRILVYEYMH 274 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~-----~~~~~~~~lv~e~~~ 274 (517)
.++ |....||+....+|+.+++|+..... .....+..|..+++.+.. -.+++++.. ....+..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77889999887778789999986431 234566778888877732 123444443 122456688999998
Q ss_pred CCCHH-----h---------HhhccC------CCCccCHHHH----------------------HHHHHHHHHHHHHHhc
Q 010131 275 NGTLR-----D---------RLHGSV------NQKPLDWLTR----------------------LQIAHDAAKGLEYLHT 312 (517)
Q Consensus 275 ~gsL~-----~---------~l~~~~------~~~~l~~~~~----------------------~~i~~~ia~aL~~LH~ 312 (517)
|..+. . .++... .....++... ...+..++..+.-+-.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75431 0 011100 0111222111 1112222222222211
Q ss_pred -CCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 313 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 313 -~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
.....++|||+++.||+++ + .+.+.||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1236789999999999999 4 899999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0003 Score=67.27 Aligned_cols=70 Identities=10% Similarity=0.107 Sum_probs=43.2
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCc-cccceeeecCCeeEEEEEec-CCCCH
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYM-HNGTL 278 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gsL 278 (517)
+.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .++++++ .+..++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 67888999999999 458889876432111 122457877777742222 4555543 33357899999 55444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00023 Score=58.77 Aligned_cols=54 Identities=26% Similarity=0.345 Sum_probs=25.9
Q ss_pred EEEcCCCCCC--CCCCcccCccccceeEecCceeeecCCC-CCCCccccccccccccccc
Q 010131 27 ELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFV 83 (517)
Q Consensus 27 ~L~l~~N~l~--~~~p~~~~l~~L~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~~N~l~ 83 (517)
.++.+++.|+ ..+..+. ++|+.|+|++|+|+ .+|. .|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 4555555554 2222222 23555555555555 3333 2444555555555555554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00045 Score=69.63 Aligned_cols=72 Identities=17% Similarity=0.316 Sum_probs=49.6
Q ss_pred cccCCCCceEEEEEEecC--------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCc-cccceeeecCCeeEEEEE
Q 010131 201 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 271 (517)
+.|+.|....||+....+ ++.+++|+..... ..+.+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567888889999998753 5789999885421 12455679999988843333 566665542 38999
Q ss_pred ecCCCCH
Q 010131 272 YMHNGTL 278 (517)
Q Consensus 272 ~~~~gsL 278 (517)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0015 Score=62.85 Aligned_cols=143 Identities=14% Similarity=0.206 Sum_probs=79.6
Q ss_pred cccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC--cccccee------eecCCeeEEEEEe
Q 010131 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGY------CEEEHQRILVYEY 272 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~ 272 (517)
+.|+.|....+|+....+| .+++|+..... ..+.+..|+.+++.+.... +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999987755 68899886521 1234556777777663211 3333321 1224567899999
Q ss_pred cCCCCHHh--------------HhhccC---CCC------ccCHHHHHH------------HHHHHHHHHHHHhc----C
Q 010131 273 MHNGTLRD--------------RLHGSV---NQK------PLDWLTRLQ------------IAHDAAKGLEYLHT----G 313 (517)
Q Consensus 273 ~~~gsL~~--------------~l~~~~---~~~------~l~~~~~~~------------i~~~ia~aL~~LH~----~ 313 (517)
++|..+.. .++... ... ...|...+. +...+...+++++. .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865321 112110 000 011222110 01123444555542 1
Q ss_pred CCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 314 ~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
...+++|+|+++.||+++.+..+.+.||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 236799999999999999876668999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0026 Score=61.86 Aligned_cols=68 Identities=13% Similarity=0.244 Sum_probs=44.1
Q ss_pred CCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCCcccccee------eecCCeeEEEEEecC
Q 010131 204 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGY------CEEEHQRILVYEYMH 274 (517)
Q Consensus 204 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~ 274 (517)
|.|....||+....+| .+++|+...... ..|+.+++.|. -|.+.+++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444679999988777 899998765432 34555555552 2324444432 234567899999999
Q ss_pred CCCH
Q 010131 275 NGTL 278 (517)
Q Consensus 275 ~gsL 278 (517)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8755
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00082 Score=66.26 Aligned_cols=141 Identities=17% Similarity=0.189 Sum_probs=83.7
Q ss_pred cccCCCCceEEEEEEec--------CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 201 KKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
+.|..|....+|+.... +++.+++|+.... ......+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888899999875 2578999986432 223456678999998884 3333566666643 29999
Q ss_pred ecCCCCHHhH-----------------hhccC--CCCcc--CHHHHHHHHHHHHH-------------------HHHHHh
Q 010131 272 YMHNGTLRDR-----------------LHGSV--NQKPL--DWLTRLQIAHDAAK-------------------GLEYLH 311 (517)
Q Consensus 272 ~~~~gsL~~~-----------------l~~~~--~~~~l--~~~~~~~i~~~ia~-------------------aL~~LH 311 (517)
|++|..|..- +|... -.... -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998654310 11110 01112 24455555544322 223332
Q ss_pred ----c-CCCCCcEecCCCCCCeEeCCC----CcEEEccccCccc
Q 010131 312 ----T-GCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQ 346 (517)
Q Consensus 312 ----~-~~~~~ivH~dlk~~Nill~~~----~~~kl~Dfg~a~~ 346 (517)
. .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123578999999999999876 7899999997753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00043 Score=67.13 Aligned_cols=75 Identities=17% Similarity=0.044 Sum_probs=63.3
Q ss_pred CceecCCCCcccccCCccccCCCCCc-EEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALT-ELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l 77 (517)
|+.|+|++| ++..-+..|.++++|+ .|+|++ .++...+. |.+|++|+.|++++|+++..-+..|.++++|+.++.
T Consensus 252 L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 252 LLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 688999998 7744456788999999 999998 88877776 999999999999999999444457899999998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0031 Score=56.08 Aligned_cols=103 Identities=12% Similarity=0.054 Sum_probs=68.1
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
-+|.++|... +.++++.++|.++.|.+.+|.-+-.. ..-..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 3788888764 68899999999999999998876210 1111233456889999999988764 1110
Q ss_pred cccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCC
Q 010131 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p 397 (517)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0133577888764 3557888999999999999875444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0021 Score=65.06 Aligned_cols=73 Identities=11% Similarity=0.087 Sum_probs=47.5
Q ss_pred cccCCCCceEEEEEEecC-CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCc-cccceeeecCCeeEEEEEecCCCCH
Q 010131 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
+.|+.|....+|+....+ +..+++|+......... ....|..+++.|...++ .++++++. + .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 568888899999998875 47899998754322111 12478889988864444 46666663 2 359999987544
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.09 E-value=2.7e-05 Score=82.10 Aligned_cols=102 Identities=16% Similarity=0.132 Sum_probs=69.7
Q ss_pred CceecCC--C----CcccccCC------ccccCCCCCcEEEcCCCCCCCCCCc-ccC-ccccceeEecCceeeecCCCCC
Q 010131 1 MARCALS--G----KNLKGEIP------PELKNMEALTELWLDGNFLTGPLPD-MSR-LIDLRIVHLENNELTGSLPSYM 66 (517)
Q Consensus 1 l~~L~l~--~----n~~~~~~p------~~~~~l~~L~~L~l~~N~l~~~~p~-~~~-l~~L~~l~l~~n~l~~~~p~~~ 66 (517)
|+.|+|+ + |+++ ..| .-+.++++|+.|+|++ .+++..+. +.. +++|+.|+|++|.+++..+..+
T Consensus 399 L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l 476 (594)
T 2p1m_B 399 MTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHV 476 (594)
T ss_dssp CCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHH
T ss_pred cceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHH
Confidence 5778888 4 5666 223 2256789999999977 66665443 554 8899999999999876544444
Q ss_pred -CCcccccccccccccccCCCCcccc---ccceeeeccCCCc
Q 010131 67 -GSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 104 (517)
Q Consensus 67 -~~l~~L~~l~l~~N~l~~~~P~~~~---~~~~~~~~~~n~~ 104 (517)
..+++|+.|++++|.+++..+..+. ..+..+.+.+|+.
T Consensus 477 ~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 477 LSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 5688999999999998643333222 2445566667653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.05 E-value=3.9e-05 Score=66.54 Aligned_cols=57 Identities=11% Similarity=0.128 Sum_probs=28.1
Q ss_pred CCcEEEcCCCCCCCC-CCcccCccccceeEecCce-eeecCCCCCCCc----ccccccccccc
Q 010131 24 ALTELWLDGNFLTGP-LPDMSRLIDLRIVHLENNE-LTGSLPSYMGSL----PNLQELHIENN 80 (517)
Q Consensus 24 ~L~~L~l~~N~l~~~-~p~~~~l~~L~~l~l~~n~-l~~~~p~~~~~l----~~L~~l~l~~N 80 (517)
+|+.|||+++.++.. +..+..+++|+.|+|++|. ++..-=..++.+ ++|++|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C 124 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISC 124 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCC
Confidence 466666666665543 2225556666666666653 442111112222 24666666655
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00024 Score=74.83 Aligned_cols=78 Identities=13% Similarity=0.105 Sum_probs=60.3
Q ss_pred CceecCCCCccccc----CCccccCCCCCcEEEcCCCCCCCC----CCc-ccCccccceeEecCceeeecCCCCCCCccc
Q 010131 1 MARCALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGP----LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPN 71 (517)
Q Consensus 1 l~~L~l~~n~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~ 71 (517)
|++|+|++|.+++. ++..+.++++|+.|+|++|.+++. ++. +.++++|+.|+|++|.+. .+|..+..+++
T Consensus 166 L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~~~~~~ 244 (592)
T 3ogk_B 166 IKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAAAN 244 (592)
T ss_dssp CSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHHHHCTT
T ss_pred CCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHHhhhhH
Confidence 68899999998765 333456788999999999999843 334 567899999999999888 46666777777
Q ss_pred cccccccc
Q 010131 72 LQELHIEN 79 (517)
Q Consensus 72 L~~l~l~~ 79 (517)
|+.|+++.
T Consensus 245 L~~L~l~~ 252 (592)
T 3ogk_B 245 LEEFCGGS 252 (592)
T ss_dssp CCEEEECB
T ss_pred HHhhcccc
Confidence 77777765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0013 Score=64.75 Aligned_cols=73 Identities=14% Similarity=0.189 Sum_probs=44.1
Q ss_pred cccCCCCceEEEEEEecC---------CcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC-ccccceeeecCCeeEEEE
Q 010131 201 KKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 270 (517)
+.++.|....+|+....+ ++.+++|+....... ......|..+++.+...+ +.++++.+ . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467888888999998764 268999987543221 112356888888774333 34565544 2 36899
Q ss_pred EecCCCCH
Q 010131 271 EYMHNGTL 278 (517)
Q Consensus 271 e~~~~gsL 278 (517)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.83 E-value=8.5e-05 Score=78.31 Aligned_cols=64 Identities=16% Similarity=0.272 Sum_probs=36.3
Q ss_pred CCCCCcEEEcCCCCCCCCCCc-cc-CccccceeEecCc-eeeec-CCCCCCCcccccccccccccccC
Q 010131 21 NMEALTELWLDGNFLTGPLPD-MS-RLIDLRIVHLENN-ELTGS-LPSYMGSLPNLQELHIENNSFVG 84 (517)
Q Consensus 21 ~l~~L~~L~l~~N~l~~~~p~-~~-~l~~L~~l~l~~n-~l~~~-~p~~~~~l~~L~~l~l~~N~l~~ 84 (517)
.+++|+.|+|++|.+++..+. +. .+++|+.|+|++| .++.. ++..+.++++|++|++++|.+++
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~ 170 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDD 170 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEEC
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCC
Confidence 456666666666666655443 43 4666666666666 34321 33333356666666666666554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00019 Score=70.48 Aligned_cols=85 Identities=15% Similarity=0.239 Sum_probs=58.6
Q ss_pred CceecCCCCcccccCCcccc--CCCCCcEEEcCC--CCCCCC--C----Ccc--cCccccceeEecCceeeecCCCCC--
Q 010131 1 MARCALSGKNLKGEIPPELK--NMEALTELWLDG--NFLTGP--L----PDM--SRLIDLRIVHLENNELTGSLPSYM-- 66 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~--~l~~L~~L~l~~--N~l~~~--~----p~~--~~l~~L~~l~l~~n~l~~~~p~~~-- 66 (517)
|+.|+|+.|.++......+. .+++|+.|+|+. |...+. + +.+ ..+++|+.|+|.+|.+++..+..+
T Consensus 195 L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~ 274 (362)
T 2ra8_A 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE 274 (362)
T ss_dssp CSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHH
T ss_pred CcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHh
Confidence 67899988887654444454 689999999863 222221 1 122 357899999999999875433322
Q ss_pred -CCcccccccccccccccCC
Q 010131 67 -GSLPNLQELHIENNSFVGE 85 (517)
Q Consensus 67 -~~l~~L~~l~l~~N~l~~~ 85 (517)
..+++|+.|+|+.|.+.+.
T Consensus 275 a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 275 SDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp CSSGGGCSEEECCSSCCBHH
T ss_pred CccCCCCCEEECCCCCCChH
Confidence 3578999999999998853
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.002 Score=53.04 Aligned_cols=55 Identities=27% Similarity=0.389 Sum_probs=28.4
Q ss_pred eeEecCceee-ecCCCCCCCcccccccccccccccCCCCccccc---cceeeeccCCCcccc
Q 010131 50 IVHLENNELT-GSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHK 107 (517)
Q Consensus 50 ~l~l~~n~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~P~~~~~---~~~~~~~~~n~~~~~ 107 (517)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+ .+|...+. .+..+.+.+|||.|+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~Cd 70 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWRCD 70 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCeecc
Confidence 4555555554 34444322 24556666666666 55555433 233445566666654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.59 E-value=0.003 Score=62.96 Aligned_cols=97 Identities=14% Similarity=0.159 Sum_probs=63.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCC-----CCCCc-ccCccccceeEecCceeeecCC-CCCCCccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLT-----GPLPD-MSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQ 73 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~-----~~~p~-~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~ 73 (517)
|+.+.| .|+++..-+..|.++++|+.|+|.+|.+. ...+. |.+|++|+.+.|.+ .++ .|+ ..|.++.+|+
T Consensus 250 L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 250 ITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKVT 326 (401)
T ss_dssp CSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSCC
T ss_pred ccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCcc
Confidence 456666 45566444567788888888888888776 23333 88888888888884 466 444 4577788888
Q ss_pred ccccccccccCCCCccccc--cceeeeccCC
Q 010131 74 ELHIENNSFVGEIPPALLT--GKVIFKYDNN 102 (517)
Q Consensus 74 ~l~l~~N~l~~~~P~~~~~--~~~~~~~~~n 102 (517)
.++|.+| ++ .++...+. .+..+.+.+|
T Consensus 327 ~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n 355 (401)
T 4fdw_A 327 QLTIPAN-VT-QINFSAFNNTGIKEVKVEGT 355 (401)
T ss_dssp EEEECTT-CC-EECTTSSSSSCCCEEEECCS
T ss_pred EEEECcc-cc-EEcHHhCCCCCCCEEEEcCC
Confidence 8888554 55 56554433 3344455555
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0042 Score=61.83 Aligned_cols=87 Identities=15% Similarity=0.133 Sum_probs=54.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceee-----ecCCCCCCCcccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT-----GSLPSYMGSLPNLQE 74 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~-----~~~p~~~~~l~~L~~ 74 (517)
|+.|+|.+| ++..-...|.+ .+|+.++| .|.++...+. |.++++|+.+.+.+|.+. ..-+..|.++++|+.
T Consensus 228 L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~ 304 (401)
T 4fdw_A 228 LKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLAR 304 (401)
T ss_dssp CCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCE
T ss_pred CCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCe
Confidence 456666654 44222334545 67888888 3556655554 778888888888777654 233345777778888
Q ss_pred cccccccccCCCCccccc
Q 010131 75 LHIENNSFVGEIPPALLT 92 (517)
Q Consensus 75 l~l~~N~l~~~~P~~~~~ 92 (517)
+++. |.++ .++...+.
T Consensus 305 l~l~-~~i~-~I~~~aF~ 320 (401)
T 4fdw_A 305 FEIP-ESIR-ILGQGLLG 320 (401)
T ss_dssp ECCC-TTCC-EECTTTTT
T ss_pred EEeC-CceE-EEhhhhhc
Confidence 8877 4466 56665443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0006 Score=66.92 Aligned_cols=83 Identities=17% Similarity=0.143 Sum_probs=56.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-cc--CccccceeEecC--ceeeec-----CCCCC--CC
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MS--RLIDLRIVHLEN--NELTGS-----LPSYM--GS 68 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~--~l~~L~~l~l~~--n~l~~~-----~p~~~--~~ 68 (517)
|++|+|++|.-. .+|. +. +++|+.|+|..|.++...-. +. .+++|+.|+|+. |...|. +...+ ..
T Consensus 174 L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~ 250 (362)
T 2ra8_A 174 LNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250 (362)
T ss_dssp CCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTT
T ss_pred CcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCC
Confidence 688999888322 3444 43 89999999999887654332 33 789999999964 222111 11122 35
Q ss_pred cccccccccccccccCCC
Q 010131 69 LPNLQELHIENNSFVGEI 86 (517)
Q Consensus 69 l~~L~~l~l~~N~l~~~~ 86 (517)
+++|+.|++.+|.+....
T Consensus 251 ~p~Lr~L~L~~~~i~~~~ 268 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVV 268 (362)
T ss_dssp CTTCCEEEEESCTTHHHH
T ss_pred CCCcCEEeCCCCCCchHH
Confidence 789999999999987443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.79 E-value=0.001 Score=58.71 Aligned_cols=80 Identities=15% Similarity=0.196 Sum_probs=44.5
Q ss_pred CceecCCCC-ccccc----CCccccCCCCCcEEEcCCCCCCCCC----Cc-ccCccccceeEecCceeeec----CCCCC
Q 010131 1 MARCALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPL----PD-MSRLIDLRIVHLENNELTGS----LPSYM 66 (517)
Q Consensus 1 l~~L~l~~n-~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----p~-~~~l~~L~~l~l~~n~l~~~----~p~~~ 66 (517)
|++|+|++| +|... +.+.+..-+.|+.|+|++|+|...- .+ +..-+.|+.|+|++|+|+.. +-..+
T Consensus 43 L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL 122 (197)
T 1pgv_A 43 LKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRST 122 (197)
T ss_dssp CCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHT
T ss_pred ccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHH
Confidence 456677664 54421 3334454566777777777776421 22 33455677777777776621 22334
Q ss_pred CCcccccccccccc
Q 010131 67 GSLPNLQELHIENN 80 (517)
Q Consensus 67 ~~l~~L~~l~l~~N 80 (517)
..-+.|+.|+|++|
T Consensus 123 ~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 123 LVTQSIVEFKADNQ 136 (197)
T ss_dssp TTTCCCSEEECCCC
T ss_pred hhCCceeEEECCCC
Confidence 44456777777654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.042 Score=54.80 Aligned_cols=140 Identities=14% Similarity=0.183 Sum_probs=83.2
Q ss_pred cccCCCCceEEEEEEecC--------CcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 201 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
+.+..|....+|+....+ ++.+++|+....... .-...+|..+++.+. +.-..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 467778888999998763 578999986543211 112346888888774 322345555332 378999
Q ss_pred ecCCCCHHh--H---------------hhcc-------C---CCCccCHHHHHHHHHHH-------------------HH
Q 010131 272 YMHNGTLRD--R---------------LHGS-------V---NQKPLDWLTRLQIAHDA-------------------AK 305 (517)
Q Consensus 272 ~~~~gsL~~--~---------------l~~~-------~---~~~~l~~~~~~~i~~~i-------------------a~ 305 (517)
|++|..|.. . +|.. . ...+..+.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865321 0 1110 0 11111244444443322 12
Q ss_pred HHHHHhc---------------------CCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 306 GLEYLHT---------------------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 306 aL~~LH~---------------------~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
.+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 11356899999999999 7788999999998754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=93.81 E-value=0.0095 Score=51.46 Aligned_cols=81 Identities=9% Similarity=0.056 Sum_probs=60.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCC-CCCCC-CcccCc----cccceeEecCce-eeecCCCCCCCccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPL-PDMSRL----IDLRIVHLENNE-LTGSLPSYMGSLPNLQ 73 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~-l~~~~-p~~~~l----~~L~~l~l~~n~-l~~~~p~~~~~l~~L~ 73 (517)
|+.||||++.++..--..+.++++|+.|+|+++. ++..- ..++.+ ++|+.|+|++|. +|..--..+..+++|+
T Consensus 63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~ 142 (176)
T 3e4g_A 63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLK 142 (176)
T ss_dssp EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCC
T ss_pred EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCC
Confidence 5789999999875544567889999999999985 66532 225543 479999999985 7632223467889999
Q ss_pred cccccccc
Q 010131 74 ELHIENNS 81 (517)
Q Consensus 74 ~l~l~~N~ 81 (517)
.|+++++.
T Consensus 143 ~L~L~~c~ 150 (176)
T 3e4g_A 143 YLFLSDLP 150 (176)
T ss_dssp EEEEESCT
T ss_pred EEECCCCC
Confidence 99999875
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.77 E-value=0.0034 Score=55.39 Aligned_cols=82 Identities=16% Similarity=0.176 Sum_probs=55.9
Q ss_pred CceecCCCCcccccCCcc----ccCCCCCcEEEcCCCCCCCCC----Cc-ccCccccceeEecCce---eee----cCCC
Q 010131 1 MARCALSGKNLKGEIPPE----LKNMEALTELWLDGNFLTGPL----PD-MSRLIDLRIVHLENNE---LTG----SLPS 64 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~----~~~l~~L~~L~l~~N~l~~~~----p~-~~~l~~L~~l~l~~n~---l~~----~~p~ 64 (517)
|+.|+|++|+|...-... +..-++|+.|+|++|+|+..- -+ +..-+.|+.|+|++|. +.. .+..
T Consensus 72 L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~ 151 (197)
T 1pgv_A 72 IEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMM 151 (197)
T ss_dssp CCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHH
T ss_pred cCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHH
Confidence 689999999998543333 445589999999999998742 23 5556779999999763 331 1333
Q ss_pred CCCCcccccccccccccc
Q 010131 65 YMGSLPNLQELHIENNSF 82 (517)
Q Consensus 65 ~~~~l~~L~~l~l~~N~l 82 (517)
.+..-+.|+.|+++.|.+
T Consensus 152 aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 152 AIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHCSSCCEEECCCCCH
T ss_pred HHHhCCCcCeEeccCCCc
Confidence 344456677777765544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.68 E-value=0.21 Score=49.48 Aligned_cols=30 Identities=30% Similarity=0.383 Sum_probs=25.2
Q ss_pred CcEecCCCCCCeEe------CCCCcEEEccccCccc
Q 010131 317 GIIHRDVKSSNILL------DINMRAKVSDFGLSRQ 346 (517)
Q Consensus 317 ~ivH~dlk~~Nill------~~~~~~kl~Dfg~a~~ 346 (517)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=93.61 E-value=0.072 Score=52.66 Aligned_cols=68 Identities=12% Similarity=0.081 Sum_probs=38.2
Q ss_pred cccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCC-CCCCCcccccccccccccccCCCCccc
Q 010131 18 ELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPAL 90 (517)
Q Consensus 18 ~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~P~~~ 90 (517)
.|..+.+|+.+.+.++ ++..... |.++.+|+.++|.++ ++ .|+ ..|.++.+|+.+++..| ++ .|+...
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~a 361 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANA 361 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTT
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHH
Confidence 3556666777766544 4443333 666667777666544 44 333 34666666666666554 44 444433
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=93.46 E-value=0.12 Score=50.72 Aligned_cols=59 Identities=19% Similarity=0.147 Sum_probs=27.6
Q ss_pred cccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCC-CCCCCcccccccccc
Q 010131 18 ELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIE 78 (517)
Q Consensus 18 ~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~l~l~ 78 (517)
.|.++.+|+.+.+..+ ++..... |.++.+|+.+.+.+|.++ .|+ ..|.++.+|+.+.|.
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECC
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcC
Confidence 3444555555555432 3322222 555555555555555544 332 234455555555553
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.22 E-value=0.11 Score=51.23 Aligned_cols=95 Identities=14% Similarity=0.225 Sum_probs=61.6
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCC-CCCCCccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIEN 79 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~l~l~~ 79 (517)
+.+.+.++..+ .-...|.++++|+.+.+. +.++..... |.++.+|+.+.|..| ++ .|. ..|.++.+|+.+.+..
T Consensus 268 ~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip~ 343 (394)
T 4gt6_A 268 ASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIPS 343 (394)
T ss_dssp CEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEECT
T ss_pred cEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEECc
Confidence 44555444332 334467788889999886 456655555 888889999998765 55 444 4577888898888864
Q ss_pred ccccCCCCccccc---cceeeeccCC
Q 010131 80 NSFVGEIPPALLT---GKVIFKYDNN 102 (517)
Q Consensus 80 N~l~~~~P~~~~~---~~~~~~~~~n 102 (517)
+ ++ .|+...+. .+..+.+.++
T Consensus 344 s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 344 S-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp T-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred c-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 4 66 67665443 3444555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.78 E-value=0.28 Score=48.26 Aligned_cols=72 Identities=11% Similarity=0.177 Sum_probs=49.0
Q ss_pred CccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCC-CCCCcccccccccccccccCCCCcccc
Q 010131 16 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPALL 91 (517)
Q Consensus 16 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~P~~~~ 91 (517)
...|.+++.|+.+.+.++..+-.--.|.++..|+.+.+. +.++ .++. .|.++.+|+.++|..| ++ .|....+
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF 330 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAF 330 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTT
T ss_pred cceeeecccccEEecccccceecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHh
Confidence 345778888999998876554222238888899999886 4455 4444 4778888998888754 55 4555443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=91.74 E-value=0.3 Score=47.75 Aligned_cols=71 Identities=17% Similarity=0.297 Sum_probs=44.3
Q ss_pred ccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCC-CCCCCcccccccccccccccCCCCcccc
Q 010131 17 PELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPALL 91 (517)
Q Consensus 17 ~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~P~~~~ 91 (517)
..|.++..|+.+.+..+ ++..-.. |.++.+|+.+.+..+ ++ .++ ..|..+.+|+.+.+.+|.++ .|+...+
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF 306 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVF 306 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCC-EECTTTT
T ss_pred ccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccccccccc-eehhhhh
Confidence 44566777777777665 4444343 677777777777554 44 333 34666777777777777766 5655443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=90.76 E-value=0.21 Score=49.26 Aligned_cols=76 Identities=11% Similarity=0.058 Sum_probs=57.4
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCC-CCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~l~l~ 78 (517)
|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-.. |.++.+|+.+.|..| ++ .|+ ..|.++++|+.+++.
T Consensus 299 L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 299 LTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVELP 374 (394)
T ss_dssp CCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEEEE
T ss_pred ccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEEEC
Confidence 455666544 55333456889999999999855 6665555 999999999999887 66 444 468899999999987
Q ss_pred cc
Q 010131 79 NN 80 (517)
Q Consensus 79 ~N 80 (517)
.|
T Consensus 375 ~~ 376 (394)
T 4fs7_A 375 KR 376 (394)
T ss_dssp GG
T ss_pred CC
Confidence 55
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.20 E-value=0.12 Score=52.13 Aligned_cols=59 Identities=8% Similarity=0.086 Sum_probs=17.1
Q ss_pred hcccCCCCceEEEEEEecC-CcEEEE------EEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeee
Q 010131 200 CKKIGKGSFGSVYYGKMKD-GKEVAV------KIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCE 261 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 261 (517)
.+.|| ||.||+|.+.. ..+||| |..+... ......|.+|..+++.++|||+++.+++..
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 46676 99999998874 367888 7655422 223356888999999999999999988653
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.58 E-value=0.6 Score=29.59 Aligned_cols=25 Identities=32% Similarity=0.460 Sum_probs=10.3
Q ss_pred eeeehhhHHHHHHHHHHHHHhhhhh
Q 010131 118 ILGTSIGVLAILLVLFLCSLIVLRK 142 (517)
Q Consensus 118 i~~~~~~~~~~~lvl~l~~~~~~~~ 142 (517)
|.+.+++.+++++++.++.++++|+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhh
Confidence 3344444344433444444444443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.73 E-value=3.4 Score=36.65 Aligned_cols=115 Identities=11% Similarity=0.096 Sum_probs=75.8
Q ss_pred CCCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHH-HHhcCCCCCcEecCCCCCC
Q 010131 249 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE-YLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 249 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~-~LH~~~~~~ivH~dlk~~N 327 (517)
.||++ -...-.+++...+.|+.-+++.=...+ ...+...+++++.+|+.... ++++ -+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 334445666666667654333222233 24678889999999988776 5543 5788899999
Q ss_pred eEeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
+++|.++.+++.-.|.- +-++|..+ +..-=.-.+=+++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~------------------~~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK------------------ESLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEET------------------TTBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCc------------------ccCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999876643 23344322 111112356678888888888775
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.63 E-value=0.61 Score=29.50 Aligned_cols=26 Identities=31% Similarity=0.364 Sum_probs=10.9
Q ss_pred eeeehhhHHHHHHHHHHHHHhhhhhh
Q 010131 118 ILGTSIGVLAILLVLFLCSLIVLRKL 143 (517)
Q Consensus 118 i~~~~~~~~~~~lvl~l~~~~~~~~~ 143 (517)
|.+.+++.+++++++.++.++++|++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 33444443444444444444444443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.24 E-value=2.3 Score=37.62 Aligned_cols=116 Identities=11% Similarity=0.071 Sum_probs=77.4
Q ss_pred CCCCccccceeeecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCe
Q 010131 249 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 328 (517)
Q Consensus 249 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Ni 328 (517)
.||++++. .+-.+++...+.|+.-+ +..++-. -...+...+++++.+|+....++++ -+|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57888866 45555665555555433 2222221 2357888999999999998866664 47889999999
Q ss_pred EeCCCCcEEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCC
Q 010131 329 LLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 399 (517)
Q Consensus 329 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~ 399 (517)
+++.++.+++.=.|+... ++|.. .+...=.-.+=+++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNV------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTT------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccC------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999986664322 22321 1222223356788999999998885
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.06 E-value=0.63 Score=29.37 Aligned_cols=7 Identities=29% Similarity=0.786 Sum_probs=3.4
Q ss_pred eeeehhh
Q 010131 118 ILGTSIG 124 (517)
Q Consensus 118 i~~~~~~ 124 (517)
+.+.++|
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 4444555
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 517 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.004 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-04 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-67
Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 25/276 (9%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPL 256
++IG GSFG+VY GK +VAVK++ + + Q F EV +L + H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+GY +V ++ +L LH + + + + IA A+G++YLH
Sbjct: 70 MGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---AK 123
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQ- 374
IIHRD+KS+NI L ++ K+ DFGL+ + +H G++ ++ PE Q
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 375 --LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432
+ +SDVY+FG+VL EL++G+ P S +N M+ +G + P L
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDL-S 232
Query: 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468
V+ + + +C++++ RP +I+ +I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-65
Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 21/271 (7%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+++G G FG V+ G +VAVK + S F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+E ++ EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 379 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438
SDV+SFG++L E+++ + E+ +++G + D
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCP-------- 236
Query: 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469
+ ++ C ++R RP + ++D
Sbjct: 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 3e-64
Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 66
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G C E+ LV+E+M +G L D + + T L + D +G+ YL
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 378 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437
KSDV+SFGV++ E+ S K +E+ I G + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLAST---- 229
Query: 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469
+ ++ C ++R RP ++ + +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 7e-64
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ + H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
G C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 378 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437
KSD+++FGV++ E+ S K +E I +G + + P L
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASE---- 228
Query: 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469
++ + C ++ RP + ++ I D
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 2e-63
Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 34/301 (11%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 260
+ IGKG FG V+ GK + G+EVAVKI S R+ E+ + H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 261 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-- 314
+++ Q LV +Y +G+L D L+ + + +++A A GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 315 ---NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 368
P I HRD+KS NIL+ N ++D GL+ + + I GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 369 YY------GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHWARSMIK 418
+ + +++D+Y+ G+V E+ + + +L + ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 419 KGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIV-----LAIQDSIK 472
K + P + + E++ +A++ +C G +R I L+ Q+ IK
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
Query: 473 I 473
+
Sbjct: 303 M 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-63
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 12/215 (5%)
Query: 192 LEEATNNF--CKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSR 247
+E ++F ++G G+ G V+ K G +A K++ + Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 248 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 307
+ +V G + + + E+M G+L L + +++ KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 367
YL I+HRDVK SNIL++ K+ DFG+S Q + + + GT Y+ P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172
Query: 368 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402
E + +SD++S G+ L+E+ G+ P+ D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-60
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 67
Query: 259 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179
Query: 378 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 437
KSDV+SFG++L E+ S + ++ ++KG + D
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCP------- 226
Query: 438 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469
+ EV C RP ++ ++
Sbjct: 227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-60
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
EE +V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 134
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 379 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 438
SDV+SFG++L EL + + E+ +++G +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPE------- 241
Query: 439 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
+ ++ QC + RP + + ++D
Sbjct: 242 --SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 4e-59
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 49/311 (15%)
Query: 189 LPELEEATNNF--CKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQ-QFV 239
L LE NN + IG+G+FG V+ + VAVK++ + S Q F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 240 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------- 284
E AL++ + N+V L+G C L++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 285 ------SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 338
S PL +L IA A G+ YL +HRD+ + N L+ NM K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 339 SDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
+DFGLSR D + ++ PE + T +SDV+++GVVL E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 398 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 457
E+ ++ G++++ + + + + C + R
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADR 286
Query: 458 PKMQEIVLAIQ 468
P I +Q
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 9e-59
Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 199 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 255
F +IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 256 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
E + +LV E M +GTL+ L K + KGL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 312 TGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
T P IIHRD+K NI + K+ D GL+ GT ++ PE Y
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 185
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430
++ E DVY+FG+ +LE+ + + P S E + G + D V
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
I VK E+ C+ Q R +++++
Sbjct: 239 IPEVK--------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 1e-58
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 198 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
K+G G +G VY G K VAVK + + + ++F+ E A++ I H NLV L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 377 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436
KSDV++FGV+L E+ + I V +++
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPE 239
Query: 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
++ E+ C + RP EI A + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-58
Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 201 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 255
K++G G+FG+V G + K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
+IG CE E +LV E G L L + + +++ H + G++YL
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQ 373
+HRD+ + N+LL AK+SDFGLS+ D + + + V + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433
+ + KSDV+SFGV++ E S + G+E+ +M++KG+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPAGCP--- 236
Query: 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469
+ ++ C +RP + L +++
Sbjct: 237 ------REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 3e-58
Identities = 72/303 (23%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 191 ELEEATNNFC-----------KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT 235
+ EA F + IG G FG V G +K + VA+K + + +
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 70
Query: 236 -QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 294
+ F++E +++ + H N++ L G + +++ E+M NG+L L N +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVI 128
Query: 295 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354
+ + A G++YL + +HRD+ + NIL++ N+ KVSDFGLSR E+D +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 355 SSVA----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 409
+ + + + + PE ++ T SDV+S+G+V+ E++S G++P +N
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469
+ + D S + ++ + C ++ RPK +IV +
Sbjct: 246 IEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 470 SIK 472
I+
Sbjct: 290 MIR 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-57
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 25/275 (9%)
Query: 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV 254
IG GS+G + K DGK + K + Q V+EV LL + H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 255 PLIGYCEEEHQRIL--VYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 312 --TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
+ ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPEQ 185
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429
EKSD++S G +L EL + P + I++G I
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKFRRIPYRY 238
Query: 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
+ E+ + + + + RP ++EI+
Sbjct: 239 SD---------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-57
Identities = 63/288 (21%), Positives = 123/288 (42%), Gaps = 30/288 (10%)
Query: 191 ELEEATNNFC---KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVA 243
+L +N ++G G+FGSV G + +VA+K++ + T++ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 244 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 303
++ ++ + +V LIG C+ +LV E G L L G ++ + ++ H
Sbjct: 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 304 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 361
+ G++YL +HRD+ + N+LL AK+SDFGLS+ D S +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 362 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421
+ + PE ++ + +SDV+S+GV + E +S + + G E+ + I++G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGK 229
Query: 422 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469
+ + + C + RP + ++
Sbjct: 230 RMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 4e-57
Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 33/271 (12%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 256
++IG GSFG+VY+ + + + VA+K M + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
G EH LV EY ++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQ 373
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433
Q K DV+S G+ +EL K P+ + + L I + + ++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPALQSGHWSEY 242
Query: 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
+ C+++ RP + ++
Sbjct: 243 FR--------NFVDSCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-57
Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 193 EEATNNFCKKIGKGSFGSVYYGKMKDGK----EVAVKIM-ADSCSHRTQQFVTEVALLSR 247
+F + IG+G FG VY+G + D AVK + + QF+TE ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 248 IHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
H N++ L+G C E ++V YM +G LR+ + AKG
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG 142
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVG 363
+ + +HRD+ + N +LD KV+DFGL+R E D H + A+ V
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423
++ E Q+ T KSDV+SFGV+L EL++ P ++N + +G +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV-YLLQGRRL 253
Query: 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 469
+ + EV ++C + RP E+V I
Sbjct: 254 LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-57
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 201 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
++G G+FG VY + K+ A K++ + ++ E+ +L+ H N+V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
E+ ++ E+ G + + ++PL + L YLH + II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-----YGNQQ 374
HRD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRP 191
Query: 375 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434
K+DV+S G+ L+E+ + P + L I K + ++ P +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEPPTLAQPSRWSS- 243
Query: 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEI 463
+ +C+E+ +R ++
Sbjct: 244 ------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-56
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 254
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L G + +++ EYM NG L L L + + A G++YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGN 372
N +HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 373 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432
++ T SDV+SFG+V+ E+++ + E +V+ ++
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNHEVMKAINDGFRL 232
Query: 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
++ I ++ +QC +Q RPK +IV + I+
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-56
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPL 256
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SK 125
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRMHD 182
Query: 377 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 436
EK D++S GV+ E + GK P F A + R + V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGAR----- 232
Query: 437 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
++ + ++ RP ++E++
Sbjct: 233 -------DLISRLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 2e-55
Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+ +V EY+ G+L D + + +D + + + LE+LH + +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 320 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 379
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 380 DVYSFGVVLLELISGKKP 397
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-55
Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 199 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 250
F K +G G+FG V VAVK++ + + ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG---------------SVNQKPLDWLT 295
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 296 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 354
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + D + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414
AR V ++ PE N T +SDV+S+G+ L EL S + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFY 258
Query: 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
MIK+G + + + ++ C + RP ++IV I+ I
Sbjct: 259 KMIKEGFRMLSPEHAP---------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 8e-55
Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 198 NFCKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHR-TQQFVTEVALLSRI-HHRN 252
F IG+G+FG V ++K + A+K M + S + F E+ +L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 253 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRLQI 299
++ L+G CE L EY +G L D L + L L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 300 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 359
A D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E + ++ R
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 360 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419
V ++ E T SDV+S+GV+L E++S AEL + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ 241
Query: 420 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475
G + + ++ QC ++ + RP +I++++ ++ K
Sbjct: 242 GYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-53
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 46/295 (15%)
Query: 199 FCKKIGKGSFGSVYYGKMKD------GKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 250
F K +G G+FG V +VAVK++ + S + ++E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 251 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------------SVNQKP 290
N+V L+G C L++EY G L + L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 291 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350
L + L A+ AKG+E+L +HRD+ + N+L+ K+ DFGL+R D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 351 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 409
+ + AR V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
+ + ++ + + I + C RP +
Sbjct: 266 --PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-53
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 189 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLS 246
+P +E+ + +G+G++G V + + VAVKI+ + E+ +
Sbjct: 1 VPFVEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 247 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
++H N+V G+ E + + L EY G L DR+ + + H G
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAG 115
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 365
+ YLH GI HRD+K N+LLD K+SDFGL+ + + + GT+ Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 366 DPEYYGNQQL-TEKSDVYSFGVVLLELISGK 395
PE ++ E DV+S G+VL +++G+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-53
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 199 FCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHR 251
+K+G GSFG V G+ VAVK + + + F+ EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
NL+ L G ++ V E G+L DRL +Q T + A A+G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEY 369
+ IHRD+ + N+LL K+ DFGL R ++ H + + + PE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429
+ + SD + FGV L E+ + + LN + K+G+ + +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470
I V +QC + RP + + ++
Sbjct: 241 ---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-52
Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 26/282 (9%)
Query: 199 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNL 253
+ IG+G FG V+ G + VA+K + S ++F+ E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
V LIG E ++ E G LR V + LD + + A+ + L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+ +HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433
+ T SDV+ FGV + E++ ++ I+ G+ + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCPP-- 236
Query: 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475
+ + +C RP+ E+ + ++ EK
Sbjct: 237 -------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-51
Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 33/289 (11%)
Query: 199 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHR 251
+++G+GSFG VY G K VA+K + ++ S R +F+ E +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------GSVNQKPLDWLTRLQIAHDAA 304
++V L+G + +++ E M G L+ L + P +Q+A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 305 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 363
G+ YL +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 364 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423
++ PE + T SDV+SFGVVL E+ + + ++ + +G ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGGLL 254
Query: 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
D + E+ C + RP EI+ +I++ ++
Sbjct: 255 DKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (445), Expect = 5e-51
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
E++++ +++YE+M G L +++ + ++ KGL ++H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 320 HRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
H D+K NI+ + K+ DFGL+ + + + GT + PE + +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204
Query: 378 KSDVYSFGVVLLELISGKKP 397
+D++S GV+ L+SG P
Sbjct: 205 YTDMWSVGVLSYILLSGLSP 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (445), Expect = 6e-51
Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+++G G+FG V+ G+ K + E+++++++HH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
E++++ +L+ E++ G L DR+ + + A +GL+++H I+
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 320 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
H D+K NI+ + K+ DFGL+ + D + T + PE + +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 378 KSDVYSFGVVLLELISGKKP 397
+D+++ GV+ L+SG P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP 227
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-50
Identities = 60/271 (22%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 201 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 254
K +G G+FG+VY G E VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L+G C + L+ + M G L D + ++ + L AKG+ YL
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 128
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQ 373
+ ++HRD+ + N+L+ K++DFGL++ E+ + + + + ++ E ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433
T +SDV+S+GV + EL++ +E+ S+++KG+ + I
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPICTI-- 240
Query: 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 464
+ + ++C SRPK +E++
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-49
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 199 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLV 254
F K +G+GSF +V + + +E A+KI+ ++ E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L +++ + Y NG L + D + LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQ 373
GIIHRD+K NILL+ +M +++DFG ++ + E ++ GT Y+ PE +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 374 QLTEKSDVYSFGVVLLELISGKKP 397
+ SD+++ G ++ +L++G P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-48
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 40/297 (13%)
Query: 199 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 250
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 251 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTR 296
N+V L+G C + + ++ E+ G L L + + L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 297 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-S 355
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R +D ++
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 356 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 415
AR + ++ PE ++ T +SDV+SFGV+L E+ S + I
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 248
Query: 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
+K+G + D + + + C RP E+V + + ++
Sbjct: 249 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-47
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 42/294 (14%)
Query: 199 FCKKIGKGSFGSVYYGKMK--------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI- 248
K +G+G+FG V + +VAVK++ +D+ ++E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 249 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVNQKPLDWLT 295
H+N++ L+G C ++ ++ EY G LR+ L ++ L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 296 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355
+ A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 356 S-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414
+ R V ++ PE ++ T +SDV+SFGV+L E+ + V
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVEELF 247
Query: 415 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468
++K+G + + + C RP +++V +
Sbjct: 248 KLLKEGHRMDKPSNCT---------NELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-47
Identities = 41/200 (20%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+ +G+G FG V+ K K + + + E+++L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES 69
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
E + ++++E++ + +R++ + L+ + H + L++LH + I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 320 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
H D++ NI+ + K+ +FG +RQ + Y PE + + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 378 KSDVYSFGVVLLELISGKKP 397
+D++S G ++ L+SG P
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (408), Expect = 2e-46
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 256
+ +G G V+ + ++ ++VAVK++ + +F E + ++H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 257 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
E E +V EY+ TLRD +H + P+ +++ DA + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFS-- 127
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYY 370
GIIHRDVK +NI++ KV DFG++R + ++ A GT YL PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKP 397
+ +SDVYS G VL E+++G+ P
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (410), Expect = 9e-46
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 19/230 (8%)
Query: 197 NNF--CKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSR 247
N+F + IG+G FG VY + D GK A+K + ++L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 248 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 307
+V + + + + M+ G L L A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 308 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 367
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 368 EYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 416
E +D +S G +L +L+ G P + I +M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 1e-45
Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 7/202 (3%)
Query: 198 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 255
+F +G G+F V + + K VA+K +A + + E+A+L +I H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 256 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 315
L E L+ + + G L DR+ + ++ ++YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 316 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 375
+ LD + + +SDFGLS+ + ++ GT GY+ PE +
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQKPY 186
Query: 376 TEKSDVYSFGVVLLELISGKKP 397
++ D +S GV+ L+ G P
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPP 208
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 1e-45
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH- 249
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 250 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
H N++ L E LV++ M G L D L + L +I + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICA 125
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
LH I+HRD+K NILLD +M K++DFG S Q + GT YL PE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 180
Query: 370 Y------GNQQLTEKSDVYSFGVVLLELISGKKP 397
+ ++ D++S GV++ L++G P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-45
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 12/227 (5%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSR-IHHRNL 253
K +GKGSFG V+ + K + A+K + + + E +LS H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+ + + V EY++ G L + + D A + GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL--- 119
Query: 314 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 373
+ GI++RD+K NILLD + K++DFG+ ++ ++ GT Y+ PE Q
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 374 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 420
+ D +SFGV+L E++ G+ P +D + + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (404), Expect = 2e-45
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 256
+ +G GSFG V+ + + +G+ A+K++ R +Q E +LS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
G ++ Q ++ +Y+ G L L + A + LEYLH +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SK 123
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
II+RD+K NILLD N K++DFG ++ + + GT Y+ PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPEVVSTKPYN 179
Query: 377 EKSDVYSFGVVLLELISGKKP 397
+ D +SFG+++ E+++G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 3e-44
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 28/283 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P I +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 260 C-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
C E ++V E + + T L +A +EY+H +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNF 124
Query: 319 IHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEY 369
IHRDVK N L + DFGL+++ + TH + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 429
+ + + + D+ S G VL+ G P + +S V
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEV 239
Query: 430 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
L E A C R +P + ++
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (391), Expect = 5e-44
Identities = 42/199 (21%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIG 258
+KIG+G++G VY + G+ A+K + + E+++L + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+ + +LV+E++ + + L+ +T G+ Y H + +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 378
+HRD+K N+L++ K++DFGL+R + + G+++ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 379 SDVYSFGVVLLELISGKKP 397
D++S G + E+++G
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-43
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 193 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 251
+E + K IG GSFG VY K+ D G+ VA+K + + E+ ++ ++ H
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 252 NLVPLIGYCEEEHQR------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 305
N+V L + ++ LV +Y+ R H S ++ L + + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 306 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 364
L Y+H + GI HRD+K N+LLD + K+ DFG ++Q ++S + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YY 188
Query: 365 LDP-EYYGNQQLTEKSDVYSFGVVLLELISGKKP 397
P +G T DV+S G VL EL+ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 7e-43
Identities = 42/284 (14%), Positives = 91/284 (32%), Gaps = 28/284 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
++IG+GSFG ++ G + + ++VA+K Q E + +P + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 260 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 319
+E ++ + +L D L + + T A ++ +H ++
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 320 HRDVKSSNILLD-----INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPE 368
+RD+K N L+ V DFG+ + + +T GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 369 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428
+ ++ + + D+ + G V + + G P + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----R 238
Query: 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472
L E + + P + ++
Sbjct: 239 ELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-42
Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 8/200 (4%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
+KIG+G++G VY + K G+ VA+K + + E++LL ++H N+V L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
E++ LV+E++H + + +GL + +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
++HRD+K N+L++ K++DFGL+R + + G + +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 378 KSDVYSFGVVLLELISGKKP 397
D++S G + E+++ +
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-42
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 254
+G+G F +VY + K + VA+K + +++ + + E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L+ + LV+++M N L +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH--- 117
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQ 373
I+HRD+K +N+LLD N K++DFGL++ + T Y PE G +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 374 QLTEKSDVYSFGVVLLELISGKKP 397
D+++ G +L EL+
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-41
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 15/231 (6%)
Query: 201 KKIGKGSFGSVYYGKMK--DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNL 253
+IG+G++G V+ + G+ VA+K + + T + V + L H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 310
V L C + + V + + T + +GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 311 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
H + ++HRD+K NIL+ + + K++DFGL+R + S V T+ Y PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 371 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 421
D++S G + E+ K +L + + + D
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-41
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 8/232 (3%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 258
IG+G++G V + VA+K + Q+ + E+ +L R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 259 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 318
+ Y+ + L+ + + L + +GL+Y+H + +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 319 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQL- 375
+HRD+K SN+LL+ K+ DFGL+R A+ D H + T Y PE N +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 376 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427
T+ D++S G +L E++S + + + +LN + + D+ I++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 7e-41
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 23/231 (9%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 258
+ +G G G V K ++ A+K++ D + EV L R ++V ++
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72
Query: 259 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
E ++V E + G L R+ + +I + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 315 NPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE G
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422
++ + D++S GV++ L+ G P L I ++ I+ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKTRIRMGQY 234
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 8e-41
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 11/216 (5%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLV 254
+ K +GKG+FG V + K G+ A+KI+ VTE +L H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 255 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
L + + V EY + G L L T + A+ + L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH 122
Query: 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 374
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 375 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410
D + GVV+ E++ G+ P +D ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-40
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT------QQFVTEVALLSRIHHRNL 253
+++G G F V + K G + A K + + + + EV++L I H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 254 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 313
+ L E + IL+ E + G L D L ++ L + G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 314 CNPGIIHRDVKSSNILLD----INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 369
+ I H D+K NI+L R K+ DFGL+ + + + GT ++ PE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKP 397
+ L ++D++S GV+ L+SG P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-40
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
+KIG+G++G+V+ K + + VA+K + D + E+ LL + H+N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 317
+ + LV+E+ + LD KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 318 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 377
++HRD+K N+L++ N K+++FGL+R + S+ +G + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 378 KSDVYSFGVVLLELISGKKP 397
D++S G + EL + +P
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 3e-39
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 14/218 (6%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 256
K +G GSFG V K K G A+KI+ + +Q + E +L ++ LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 257 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
++ +V EY+ G + L A EYLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
+I+RD+K N+L+D +V+DFG +++ + + GT L PE ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYN 216
Query: 377 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414
+ D ++ GV++ E+ +G P + + +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-39
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 24/223 (10%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIH--HR 251
+G G FGSVY G + D VA+K + + EV LL ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
++ L+ + E +L+ E + L + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC- 126
Query: 312 TGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 370
N G++HRD+K NIL+D+N K+ DFG ++ + GT Y PE+
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWI 181
Query: 371 -GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 412
++ + V+S G++L +++ G P F + I+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRG 219
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 257
KIG+G+FG V+ + K G++VA+K + + + E+ +L + H N+V LI
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 258 GYCEE--------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 309
C + LV+++ + + L T +I L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNG 129
Query: 310 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLD 366
L+ I+HRD+K++N+L+ + K++DFGL+R A+ + + T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 367 PEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 410
PE G + D++ G ++ E+ + + +L ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 258 GYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 316
+ ++ G + + L + + KGL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AA 140
Query: 317 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 376
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T + T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYT 197
Query: 377 EKSDVYSFGVVLLELISGKKP 397
+ D++S G ++ E+I+GK
Sbjct: 198 QTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (334), Expect = 2e-35
Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 199 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 256
+K+G+G + V+ + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITL 95
Query: 257 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 314
++ R LV+E+++N + + L ++ K L+Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH--- 146
Query: 315 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 372
+ GI+HRDVK N+++D + + ++ D+GL+ + V + + PE
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
Q D++S G +L +I K+P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-35
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 201 KKIGKGSFGSVYYGK----MKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRI-HHR 251
K +G G++G V+ + GK A+K++ + T+ TE +L I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 252 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
LV L + E + L+ +Y++ G L L + T ++ + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALE 143
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--Y 369
GII+RD+K NILLD N ++DFGLS++ D T + GT+ Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 370 YGNQQLTEKSDVYSFGVVLLELISGKKP 397
G+ + D +S GV++ EL++G P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-31
Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 258 GYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 312
E + + ++ L + + + L + + +GL+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 313 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 372
+ IIHRD+K SN+ ++ + K+ DFGL+R + ++
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 193
Query: 373 QQLTEKSDVYSFGVVLLELISGKKP 397
+ D++S G ++ EL++G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 201 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 257
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 258 GYC------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 311
EE LV E M + Q LD + + G+++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 136
Query: 312 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 371
+ IHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPEVIL 191
Query: 372 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 408
E D++S G ++ E++ K D+ + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (301), Expect = 1e-30
Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 27/238 (11%)
Query: 201 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 259
+K+G G F +V+ K M + VA+KI+ T+ E+ LL R++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 260 CEEEHQRILVY-------------EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
++L + + G L + + + QI+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQAEEDLTHISSVARG 360
L+Y+H GIIH D+K N+L++I ++ K++D G + +E T+
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQ 191
Query: 361 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418
T Y PE +D++S ++ ELI+G ++ + +I+
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 5e-21
Identities = 24/163 (14%), Positives = 49/163 (30%), Gaps = 28/163 (17%)
Query: 201 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHH 250
K +G+G +V+ + E VK + + F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 251 RNLVPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 306
R L L G + ++ E + + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 307 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349
+ + + GI+H D+ N+L+ + DF S + E
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.5 bits (153), Expect = 2e-11
Identities = 11/75 (14%), Positives = 33/75 (44%), Gaps = 5/75 (6%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
L N+ P + ++ L L+ N ++ ++ L ++ + +N+++ P
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQISDLTP-- 368
Query: 66 MGSLPNLQELHIENN 80
+ +L + +L + +
Sbjct: 369 LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 8e-09
Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 3/72 (4%)
Query: 21 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80
N++ LT L L N ++ P +S L L+ + NN+++ S + +L N+ L +N
Sbjct: 305 NLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 81 SFVGEIPPALLT 92
P A LT
Sbjct: 362 QISDLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 5e-05
Identities = 14/72 (19%), Positives = 31/72 (43%), Gaps = 5/72 (6%)
Query: 5 ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS 64
L N+ + +++ +T L D + + + L +L ++ NN+LT P
Sbjct: 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP- 83
Query: 65 YMGSLPNLQELH 76
+ +L L ++
Sbjct: 84 -LKNLTKLVDIL 94
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 12/73 (16%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 20 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79
+ + L +T + + L + + + + S+ + L NL +++ N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 80 NSFVGEIPPALLT 92
N P LT
Sbjct: 76 NQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 21 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80
+ L L N ++ P +L + L N+L + SL NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 81 SFVGEIP 87
P
Sbjct: 252 QISNLAP 258
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 28/117 (23%), Positives = 45/117 (38%), Gaps = 23/117 (19%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-- 63
L+G LK L ++ LT+L L N ++ L +S L L + L N+++ P
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLA 282
Query: 64 ------------------SYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 102
S + +L NL L + N+ P + LT + NN
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANN 339
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 2e-10
Identities = 18/66 (27%), Positives = 27/66 (40%), Gaps = 2/66 (3%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN-ELT 59
+ L + G +P L ++ L L + N L G +P L + NN L
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
Query: 60 GS-LPS 64
GS LP+
Sbjct: 306 GSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 2e-09
Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 1/55 (1%)
Query: 52 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALLTGKVIFKYDNNPKL 105
L NN + G+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 2e-09
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 29 WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 87
L N + G LP +++L L +++ N L G +P G+L NN + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 22/97 (22%), Positives = 38/97 (39%), Gaps = 5/97 (5%)
Query: 7 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSY 65
S L+ ++P +L L L N +T D L +L + L NN+++ P
Sbjct: 18 SDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 66 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 102
L L+ L++ N E+P + + N
Sbjct: 75 FAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.3 bits (90), Expect = 7e-04
Identities = 20/101 (19%), Positives = 35/101 (34%), Gaps = 1/101 (0%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 64
L + + KN++ L L L N ++ P + L+ L ++L N+L
Sbjct: 38 LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK 97
Query: 65 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 105
+L L+ E + L V+ N K
Sbjct: 98 MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 37.7 bits (86), Expect = 0.002
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 7 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG------ 60
S ++ L N L EL L+ N L ++ +++V+L NN ++
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDF 262
Query: 61 SLPSYMGSLPNLQELHIENNSF-VGEIPPA 89
P Y + + + +N EI P+
Sbjct: 263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 9e-07
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 25/103 (24%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL----------------- 48
L+ K+L + L+ + +T L L N L P ++ L L
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 49 -----RIVHLENNELTG-SLPSYMGSLPNLQELHIENNSFVGE 85
+ + L NN L + + S P L L+++ NS E
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 2e-06
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 8/68 (11%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 65
+S L E+P L L N L +P++ + +L+ +H+E N L P
Sbjct: 291 VSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ--NLKQLHVEYNPLR-EFPDI 342
Query: 66 MGSLPNLQ 73
S+ +L+
Sbjct: 343 PESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 21/92 (22%), Positives = 33/92 (35%), Gaps = 9/92 (9%)
Query: 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 60
+ EI +L EL + N L LP + L + N L
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL--PPRLERLIASFNHLA- 317
Query: 61 SLPSYMGSLPNLQELHIENNSF--VGEIPPAL 90
+P NL++LH+E N +IP ++
Sbjct: 318 EVPE---LPQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 16 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 75
L N+ LT L D N ++ + ++ L +L VHL+NN+++ P + + NL +
Sbjct: 166 LTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 76 HIEN 79
+ N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 40 PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 92
++ L L + ++N+++ P + SLPNL E+H++NN P A +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTS 217
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 6/75 (8%)
Query: 25 LTELWLDGNFLT-GPLPDM-SRLIDLRIVHLENNELTG----SLPSYMGSLPNLQELHIE 78
+ L + L+ ++ L ++V L++ LT + S + P L EL++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 79 NNSFVGEIPPALLTG 93
+N +L G
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 4e-04
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 4/94 (4%)
Query: 13 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 72
+I + L +T + + L + + N+++ + LPN+
Sbjct: 15 KQIFS-DDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNV 70
Query: 73 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 106
+L + N P A L D N
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD 104
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 4e-04
Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 18 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 77
E+ + + E+ D LT PD+ + D I+HL N L + + L +L++
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 78 ENNSFVGEIPPALLT 92
+ L
Sbjct: 63 DRAELTKLQVDGTLP 77
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 38.8 bits (89), Expect = 0.001
Identities = 17/135 (12%), Positives = 45/135 (33%), Gaps = 10/135 (7%)
Query: 190 PELEEATNNF-CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 248
PEL++ + C K +G + Y + + + + +K+ T E ++ +
Sbjct: 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 249 HHRNLVP-LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 307
+ VP ++ + + L+ + D + +I A+ +
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECI 118
Query: 308 EYLHTGCNPGIIHRD 322
H+ + +
Sbjct: 119 RLFHSIDISDCPYTN 133
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.001
Identities = 15/90 (16%), Positives = 28/90 (31%), Gaps = 28/90 (31%)
Query: 2 ARCALSGKNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 52
AR ++ GK+LK + L +++ E+ L GN +
Sbjct: 1 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG---------------- 44
Query: 53 LENNELTGSLPSYMGSLPNLQELHIENNSF 82
E L + S +L+ +
Sbjct: 45 ---TEAARWLSENIASKKDLEIAEFSDIFT 71
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.002
Identities = 19/102 (18%), Positives = 34/102 (33%), Gaps = 6/102 (5%)
Query: 6 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLP 63
+ + L E LTEL+++ L + L +LR + + + L P
Sbjct: 15 CTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 64 SYMGSLPNLQELHIENNSFVGEIPPALLTG--KVIFKYDNNP 103
P L L++ N+ + + G NP
Sbjct: 74 DAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 517 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.36 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.28 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.27 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.23 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.22 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.22 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.21 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.15 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.11 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.01 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.83 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.77 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.66 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.63 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.6 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.57 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.56 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.51 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.47 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.46 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.42 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.22 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.15 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.02 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.99 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.77 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.48 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.31 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.9 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.84 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.77 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.71 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.66 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.33 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.46 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-54 Score=407.17 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=200.1
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+++.+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 4567899999999999999998899999999754 344578999999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++.. ....+++..++.++.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+++...........
T Consensus 86 ~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 86 CLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp BHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred cHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999874 34678999999999999999999999 99999999999999999999999999999877655444444
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
...||+.|+|||++.+..++.++|||||||++|||+|+ ++||.... ..+.. ..+..+... ..|.
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~-~~i~~~~~~--~~p~------ 225 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVV-EDISTGFRL--YKPR------ 225 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHH-HHHHHTCCC--CCCT------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHH-HHHHhcCCC--CCcc------
Confidence 45689999999999999999999999999999999995 54444211 11112 222222111 1111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
..+..+.+++.+||+.||++||||+||++.|+++.+
T Consensus 226 -~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 -LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 123468899999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-54 Score=416.05 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=215.9
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
+....+++.++||+|+||+||+|++. +|+.||||+++.. ....++|.+|++++++++|||||+++++|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 44445677899999999999999986 5889999998754 344678999999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999998754 35679999999999999999999999 99999999999999999999999999999987665
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.........|++.|+|||++.+..++.++|||||||++|||++|..||..... ..+ +...+..+....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~-~~~~i~~~~~~~------ 236 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ-VYELLEKDYRME------ 236 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHH-HHHHHHTTCCCC------
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHH-HHHHHhcCCCCC------
Confidence 54444455688999999999999999999999999999999998777642211 111 222333322111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+...+..+.+|+.+||+.||++||||+||++.|+.+.+
T Consensus 237 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111223468899999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=406.57 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=211.5
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+....+++.+.||+|+||+||+|.+++++.||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 334466778999999999999999998899999999754 3445789999999999999999999998865 46799999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++... ....+++..++.++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999987643 23458999999999999999999999 999999999999999999999999999999876654
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
........||+.|+|||++.+..++.++|||||||++|||+||..|+..... ..+ +...+..+.....
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~-~~~~i~~~~~~~~------ 231 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPE-VIQNLERGYRMVR------ 231 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHH-HHHHHHTTCCCCC------
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHH-HHHHHHhcCCCCC------
Confidence 4444556689999999999988999999999999999999997665542211 111 1222322221111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+...+..+.+++.+||+.||++||||+||++.|++...
T Consensus 232 ---p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11223468899999999999999999999999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=402.22 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=207.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|.+.++||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4566789999999999999875 699999999976555566789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++.. ..+++.++..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++....... .
T Consensus 101 gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 9999998863 469999999999999999999999 9999999999999999999999999999987654332 2
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||...+. .+........+.. ....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~-~~~~------- 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-ELQN------- 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-CCSS-------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC-CCCC-------
Confidence 3345699999999999999999999999999999999999999974322 1222222222211 1111
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112346889999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=405.20 Aligned_cols=259 Identities=29% Similarity=0.495 Sum_probs=202.9
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..+.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 34566789999999999999876 36999998643 23456789999999999999999999998865 468999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++... ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999742 4569999999999999999999999 9999999999999999999999999999987654322
Q ss_pred -ccccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 353 -HISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 353 -~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...+..+.......
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~~~- 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDLS- 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCCGG-
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCcch-
Confidence 22344568999999999864 357899999999999999999999997432211 1222222222111110
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
......+..+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 ----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112233578899999999999999999999999998765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-53 Score=408.04 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=198.6
Q ss_pred HhhhcccCCCCceEEEEEEecC-C---cEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
+++.+.||+|+||+||+|+++. + ..||||.+..... ...+.|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 3345789999999999998752 3 3589998876433 345679999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ....+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 108 y~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 108 FMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp CCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred ecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999998874 34579999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccc----ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 352 THI----SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 352 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+.. ..+..+....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------~~~~-~~i~~~~~~~-- 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------QDVI-NAIEQDYRLP-- 253 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHH-HHHHTTCCCC--
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------HHHH-HHHHcCCCCC--
Confidence 211 112347889999999999999999999999999999998 8999974322 1111 2222221111
Q ss_pred CccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 427 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 427 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+...+..+.+++.+||+.||++||||+||++.|+++++-
T Consensus 254 -------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 254 -------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1122345688999999999999999999999999988763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=395.21 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=211.5
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 276 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 276 (517)
+++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|+|.+++..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 35678999999999999999988899999998653 34578999999999999999999999999999999999999999
Q ss_pred CHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccccc
Q 010131 277 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 356 (517)
Q Consensus 277 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 356 (517)
+|.+++... ...+++..+++++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++...........
T Consensus 85 ~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 85 CLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp EHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred cHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999997643 4568999999999999999999999 99999999999999999999999999999876554444444
Q ss_pred ccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCCC
Q 010131 357 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 435 (517)
Q Consensus 357 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 435 (517)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... + +...+..+... ..|.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~~--~~p~------ 224 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------E-TAEHIAQGLRL--YRPH------ 224 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HHHHHHTTCCC--CCCT------
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------H-HHHHHHhCCCC--CCcc------
Confidence 4568999999999999999999999999999999998 89999743321 1 22233333211 1111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 436 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 436 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
..+..+.+++.+||+.||++|||++||++.|.++
T Consensus 225 -~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 -LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1224688999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=399.08 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=200.6
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 567899999999999999886 689999999875432 334678999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC-cc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 353 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~-~~ 353 (517)
+|+|.+++. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 87 gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 87 GGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp TEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999997 45689999999999999999999999 999999999999999999999999999998764432 22
Q ss_pred cccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....... ... ............
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~----~~~~~~~~~~~~------- 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEY----SDWKEKKTYLNP------- 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHH----HHHHTTCTTSTT-------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHH----HHHhcCCCCCCc-------
Confidence 2345679999999999988776 678999999999999999999997433221 111 111111111000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.||++|||++|+++
T Consensus 229 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111236779999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=396.78 Aligned_cols=244 Identities=26% Similarity=0.417 Sum_probs=204.7
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||+||+|+.+ +++.||+|++.+.. ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 3667899999999999999986 68999999986432 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 87 y~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred ecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999973 4579999999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||...+. .+.. ..+..+... +
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~-~~i~~~~~~------~- 223 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETY-KRISRVEFT------F- 223 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH-HHHHTTCCC------C-
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHH-HHHHcCCCC------C-
Confidence 2345699999999999999999999999999999999999999974332 1111 222222211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.||++|||++|+++
T Consensus 224 ---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 ---PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112246789999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=399.04 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=205.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 566789999999999999876 6899999999876666678899999999999999999999999999999999999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcccc
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 355 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 355 (517)
|+|.+++... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 94 g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 94 GAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 9999987642 4579999999999999999999999 9999999999999999999999999999976543221 22
Q ss_pred cccccCCCCcCCCccC-----CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 356 SVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 356 ~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
....||+.|+|||++. +..++.++|||||||++|||+||+.||......+ . +.... .+.......
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~~~i~-~~~~~~~~~--- 237 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---LLKIA-KSEPPTLAQ--- 237 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHH-HSCCCCCSS---
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---HHHHH-cCCCCCCCc---
Confidence 3456999999999973 4568899999999999999999999997443221 1 11122 222111111
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+......+.+++.+||+.||++|||++|+++
T Consensus 238 ----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 ----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122346889999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=396.20 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=193.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec--CCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 270 (517)
.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ ++..++||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 3667899999999999999875 68999999987543 2345678999999999999999999999864 45679999
Q ss_pred EecCCCCHHhHhhccC-CCCccCHHHHHHHHHHHHHHHHHHhcCC--CCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9999999999986432 3567999999999999999999999811 124999999999999999999999999999887
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+. .+ +...+..+....+
T Consensus 165 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~-~~~~i~~~~~~~~-- 234 (269)
T d2java1 165 NHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KE-LAGKIREGKFRRI-- 234 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHTCCCCC--
T ss_pred ccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HH-HHHHHHcCCCCCC--
Confidence 543322 2345689999999999999999999999999999999999999974322 11 2223333333221
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ....+.+++.+||+.||++|||++|+++
T Consensus 235 ---~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ---PYR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---Ccc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 2236889999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=390.02 Aligned_cols=244 Identities=29% Similarity=0.431 Sum_probs=196.5
Q ss_pred hhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec----CCeeEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 270 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 270 (517)
+|.++||+|+||+||+|++. +++.||+|++.... ....+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999876 68899999986542 3345679999999999999999999999864 34578999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCC--cEecCCCCCCeEeC-CCCcEEEccccCcccc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 347 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~Dfg~a~~~ 347 (517)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999974 4579999999999999999999998 77 99999999999996 5789999999999865
Q ss_pred CCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
.... .....||+.|+|||++.+ .++.++|||||||++|||+||+.||..... ..+ +...+..+.....++
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~-~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQ-IYRRVTSGVKPASFD 235 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHH-HHHHHTTTCCCGGGG
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHH-HHHHHHcCCCCcccC
Confidence 4332 234569999999999876 599999999999999999999999963321 111 222233222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. . ....+.+++.+||+.||++|||++|+++
T Consensus 236 ~----~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 K----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----c----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 1 1225789999999999999999999975
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=401.93 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=202.3
Q ss_pred HHhhhcccCCCCceEEEEEEecCC-----cEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDG-----KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
.+.+.+.||+|+||+||+|.+++. ..||||++..... .....|.+|++++++++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 345578899999999999987642 4799999975443 3446799999999999999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+.+|++.+++.. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 88 TEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998764 34679999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 350 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 350 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
... .......||+.|+|||++.+..++.++|||||||++|||+||..|+..... ..+ +...+..+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----~~~-~~~~i~~~~~~---- 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHE-VMKAINDGFRL---- 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHH-HHHHHHTTCCC----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-----HHH-HHHHHhccCCC----
Confidence 322 222334588999999999999999999999999999999997666642221 111 12223332211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
..+...+..+.+|+.+||+.||++||||+||++.|+++++.
T Consensus 233 -----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 -----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11122335688999999999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=391.79 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=206.4
Q ss_pred hhc-ccCCCCceEEEEEEec---CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 199 FCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 199 ~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+.+ +||+|+||+||+|.++ ++..||||+++.... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 4999999999999765 355799999976543 345789999999999999999999999975 4579999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
++|+|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 91 ~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 91 GGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp TTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999999864 34679999999999999999999999 99999999999999999999999999999876543322
Q ss_pred --cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 354 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 354 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... . +...+..+.....
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~----~~~~i~~~~~~~~----- 233 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---E----VMAFIEQGKRMEC----- 233 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---H----HHHHHHTTCCCCC-----
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCCCCC-----
Confidence 2233458899999999998999999999999999999998 99999743321 1 2223333432221
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 234 ----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 234 ----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11233468899999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=391.83 Aligned_cols=248 Identities=27% Similarity=0.465 Sum_probs=201.1
Q ss_pred cccCCCCceEEEEEEecC---CcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecCC
Q 010131 201 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 275 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 275 (517)
++||+|+||+||+|.+++ ++.||||+++... ....+.|.+|++++++++|||||+++|+|.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 469999999999998753 4689999996543 23456899999999999999999999999654 57899999999
Q ss_pred CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc--
Q 010131 276 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 353 (517)
Q Consensus 276 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 353 (517)
|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999983 5679999999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 354 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+.. + +...+..+.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~-~~~~i~~~~~~~~------- 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGERMGC------- 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCCCC-------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------H-HHHHHHcCCCCCC-------
Confidence 2233468999999999999999999999999999999998 89999743221 1 2233333332211
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhh
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 471 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 471 (517)
+...+..+.+|+.+||+.||++|||++||++.|+...
T Consensus 232 --p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1122346889999999999999999999999988753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=404.70 Aligned_cols=200 Identities=27% Similarity=0.394 Sum_probs=176.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
..|++.++||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|.+.+..++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45667899999999999999875 68999999997543 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 86 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp CTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999974 4579999999999999999999997 1489999999999999999999999999998764322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 402 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~ 402 (517)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=396.39 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=204.1
Q ss_pred HHHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
..+++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 457788999999999999999998889999999754 3445789999999999999999999999865 56789999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++... ....+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999988753 24569999999999999999999999 999999999999999999999999999998775544444
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 434 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 434 (517)
.....||+.|+|||++.+..++.++|||||||++|||+||..|+..... ..+.. ..+..+.... .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~-~~i~~~~~~~---------~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVL-DQVERGYRMP---------C 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHH-HHHHTTCCCC---------C
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHH-HHHHhcCCCC---------C
Confidence 4445689999999999999999999999999999999997766642221 11112 2222221111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 435 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 435 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
+...+..+.+++.+||+.||++||||++|+++|++....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 112234688999999999999999999999999986643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=399.04 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=206.5
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEecC-C-----cEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMKD-G-----KEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+++.++||+|+||+||+|++.. + ..||||.+.... ......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 334456788999999999999998753 2 369999986543 33446789999999998 899999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccCC--------------------CCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 323 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dl 323 (517)
+..++||||+++|+|.++++.... ...+++..++.++.||+.||+|||+ ++|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccC
Confidence 999999999999999999975421 2458999999999999999999999 99999999
Q ss_pred CCCCeEeCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCC
Q 010131 324 KSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVE 401 (517)
Q Consensus 324 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~ 401 (517)
||+||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 2234557999999999999999999999999999999998 89999743
Q ss_pred CccccccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 010131 402 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 468 (517)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 468 (517)
+... . +...+..+...+ .+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus 271 ~~~~--~----~~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDA--N----FYKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSH--H----HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHH--H----HHHHHhcCCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3221 1 222333322111 11122346889999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-50 Score=392.15 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=189.3
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.+.||+|+||+||+|+.+ +|+.||||++..... .....+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4678899999999999999876 689999999975432 33456889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC---CCCcEEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~Dfg~a~~~~~~ 350 (517)
+||+|.+++. ....+++..+..++.||+.||+|||+ ++|+||||||+||++. +++.+||+|||+++.....
T Consensus 90 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 90 SGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999997 45679999999999999999999999 9999999999999994 5789999999999876543
Q ss_pred CcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+.... +..+... ....
T Consensus 164 ~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~-i~~~~~~--~~~~- 231 (307)
T d1a06a_ 164 SV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQ-ILKAEYE--FDSP- 231 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-HHTTCCC--CCTT-
T ss_pred Ce--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHH-HhccCCC--CCCc-
Confidence 22 2345699999999999999999999999999999999999999974322 111112 2222111 0011
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
........+.+++.+||+.||++|||++|+++
T Consensus 232 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 ---YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11122346889999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-50 Score=391.74 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=201.5
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
..|+..+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45677899999999999999875 688999999875432 23457899999999999999999999999999999999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
|||++|+|..++. ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999987765 35679999999999999999999999 99999999999999999999999999999876442
Q ss_pred CcccccccccCCCCcCCCccCC---CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 351 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....... +.......
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~-~~~~~~~~ 236 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESPALQS 236 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCCCCSC
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCCCCCCC
Confidence 23469999999999854 4689999999999999999999999973321 122222222 22211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~--------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 G--------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C--------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 11236889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=388.48 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=201.0
Q ss_pred HHHHhhhcccCCCCceEEEEEEecC----CcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 194 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 194 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
...|++.+.||+|+||.||+|++.. +..||||.++.... ...+.|.+|++++++++|||||++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3457778999999999999998753 35689999865433 345679999999999999999999999964 57899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998764 35679999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccC
Q 010131 349 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 427 (517)
Q Consensus 349 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 427 (517)
...........||+.|+|||.+.+..++.++|||||||++|||+| |.+||...... .+. ..+..+.....
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~----~~i~~~~~~~~-- 230 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI----GRIENGERLPM-- 230 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH----HHHHTTCCCCC--
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCCCCC--
Confidence 544444445568999999999999999999999999999999998 89998744332 122 22233322211
Q ss_pred ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 428 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 428 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
+...+..+.+++.+||+.||++|||++||++.|+.+++.+.
T Consensus 231 -------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 231 -------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 11223468899999999999999999999999999887653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=390.96 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=202.5
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 3677899999999999999885 68999999986431 2345679999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. .+.+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 89 y~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 89 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999873 4679999999999999999999999 999999999999999999999999999998765432
Q ss_pred -cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccc
Q 010131 352 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 430 (517)
Q Consensus 352 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 430 (517)
........||+.|+|||++.+..++.++||||+||++|||+||+.||...+. .+.. ..+..+.. . +
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~-~~i~~~~~-~-----~ 229 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIF-QKIIKLEY-D-----F 229 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHTTCC-C-----C
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHH-HHHHcCCC-C-----C
Confidence 2223345699999999999999999999999999999999999999974321 1111 22222221 1 1
Q ss_pred cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 431 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 431 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
... ....+.+|+.+||+.||++|||++|+++
T Consensus 230 p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 230 PEK----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111 2235789999999999999999999755
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=385.40 Aligned_cols=251 Identities=29% Similarity=0.479 Sum_probs=198.7
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~ 274 (517)
.+++.+.||+|+||.||+|+++ |+.||||+++.. ...+.|.+|++++++++||||++++|+|.+ .+..++||||++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 3567889999999999999996 789999999753 345779999999999999999999999855 456899999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCccc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 354 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 354 (517)
+|+|.+++... ....+++..+++++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 99999999743 23458999999999999999999999 999999999999999999999999999998754432
Q ss_pred ccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccCC
Q 010131 355 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 433 (517)
Q Consensus 355 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 433 (517)
....++..|+|||++.+..++.++|||||||++|||+| |+.||...+. .++..+ +..+...+.
T Consensus 158 -~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~----i~~~~~~~~-------- 221 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKMDA-------- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHH----HTTTCCCCC--------
T ss_pred -ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHH----HHcCCCCCC--------
Confidence 23347889999999998999999999999999999998 6777763322 222222 222222221
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 434 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 434 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
+...+..+.+++.+||+.||++||||.||+++|+++..-
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 112234688999999999999999999999999988643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.9e-50 Score=393.59 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=207.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 5777899999999999999875 689999999987666667789999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC--CCcEEEccccCccccCCCCc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+|+|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++.......
T Consensus 107 gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 107 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp SCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999864 24579999999999999999999999 99999999999999964 67899999999987755432
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+. .+....... +... .++..
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~-~~~~--~~~~~-- 248 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKS-CDWN--MDDSA-- 248 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-TCCC--SCCGG--
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCCC--CCccc--
Confidence 2345689999999999999999999999999999999999999974332 122222222 2110 00100
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+++.+||+.||++|||++|+++
T Consensus 249 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 --FSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112236789999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.9e-50 Score=393.94 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=207.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
.|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..++|||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4677899999999999999875 799999999987655666788999999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC--CCCcEEEccccCccccCCCCc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+|+|.+++.. ....+++.+++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|........
T Consensus 110 gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 110 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999988763 24579999999999999999999999 9999999999999998 578999999999988765432
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+.. +.... +..+... ..+..
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~-i~~~~~~--~~~~~-- 251 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQN-VKRCDWE--FDEDA-- 251 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHHCCCC--CCSST--
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC--CCccc--
Confidence 23456899999999999999999999999999999999999999743321 11222 2222211 01111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.......+.+|+.+||+.||.+|||++|+++
T Consensus 252 --~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 --FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp --TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112346789999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-50 Score=390.95 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=208.7
Q ss_pred HHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.+++.+.||+|+||+||+|+++ +++.||||++...... ..++|.+|++++++++||||++++++|.+.+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4567899999999999999875 3578999999765433 35679999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccC---------------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCC
Q 010131 269 VYEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 327 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~N 327 (517)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 999999999999986432 12358999999999999999999999 999999999999
Q ss_pred eEeCCCCcEEEccccCccccCCCC-cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCC-CCCCCCCccc
Q 010131 328 ILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGA 405 (517)
Q Consensus 328 ill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~ 405 (517)
||++.++.+||+|||+++...... ........|++.|+|||.+.+..++.++|||||||++|||++|. +||...+.
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-- 248 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 248 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH--
Confidence 999999999999999998654432 22233456889999999999999999999999999999999986 56653221
Q ss_pred cccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 406 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+. ...+..+...... ...+..+.+|+.+||+.||++||||.||+++|+++.+
T Consensus 249 ----~e~-~~~v~~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 ----EEV-IYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ----HHH-HHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----HHH-HHHHHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 121 2233444332221 1223468899999999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=382.25 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=203.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.|++.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 5677899999999999999985 789999999864321 235789999999999999999999999999999999
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC----cEEEccccCc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLS 344 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~Dfg~a 344 (517)
|||||++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++ .+|++|||++
T Consensus 91 v~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999974 4579999999999999999999999 9999999999999998776 4999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
........ .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+.. +... .+..+....
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~-~i~~~~~~~ 235 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLA-NVSAVNYEF 235 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHTTCCCC
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHH-HHHhcCCCC
Confidence 87654322 23446899999999999999999999999999999999999999743321 1111 122221100
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+.... .....+.+++.+||+.||++|||++|+++
T Consensus 236 --~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 --EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001 12236789999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=385.83 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=204.9
Q ss_pred hhhcccCCCCceEEEEEEecCC----cEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCCccccceeeec-CCeeEEEEE
Q 010131 198 NFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 271 (517)
Q Consensus 198 ~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 271 (517)
+|.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||++++|++.+ ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999987532 36899999754 33455789999999999999999999999865 457899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ....+++..+++++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999875 34567888999999999999999999 999999999999999999999999999998765432
Q ss_pred cc---cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 352 TH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 352 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .+.. ..+..+.... .|
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~----~~i~~g~~~~--~p 256 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDIT----VYLLQGRRLL--QP 256 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTCCCC--CC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHH----HHHHcCCCCC--Cc
Confidence 22 223346899999999999999999999999999999999988887632211 1111 1222232211 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
...+..+.+++.+||+.||++||||+||++.|+++...
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11234688999999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=386.01 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=204.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|+||.||+|+.+ +|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 667899999999999999875 79999999997532 23457789999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+.......
T Consensus 87 ~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 87 ANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999884 5678999999999999999999999 9999999999999999999999999999987644322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. +.. ..+..+.. .+..
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~-~~i~~~~~------~~p~ 226 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLF-ELILMEEI------RFPR 226 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCC------CCCT
T ss_pred -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHH-HHHhcCCC------CCCc
Confidence 233456999999999999999999999999999999999999999854321 112 22222221 1111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
.. ...+.+|+.+||++||.+||+ ++|+++
T Consensus 227 ~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 TL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 12 235789999999999999995 788876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=377.81 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=197.1
Q ss_pred HHhhhcccCCCCceEEEEEEecC--C--cEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 268 (517)
.+++.+.||+|+||+||+|++.. + ..||||++.... ....+.|.+|+.++++++||||++++|+|.+ +..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 45678899999999999998642 2 378999986532 3345689999999999999999999999976 46789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccC
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 348 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~ 348 (517)
||||+++|++.+++... ...+++..++.++.|+|.||.|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999987753 4569999999999999999999999 999999999999999999999999999999875
Q ss_pred CCCcc--cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 349 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 349 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
..... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+. .+......+.+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~~~~ 236 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLPR 236 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCCCCC
Confidence 54332 2233457889999999999999999999999999999998 8999973322 2223333333222111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 470 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 470 (517)
....+..+.+++.+||+.||++|||++||++.|++.
T Consensus 237 ---------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 237 ---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112234688999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=383.65 Aligned_cols=254 Identities=24% Similarity=0.425 Sum_probs=202.5
Q ss_pred HhhhcccCCCCceEEEEEEec-CCc----EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 270 (517)
|++.++||+|+||+||+|.+. +|+ .||+|.++... ....+.|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 667899999999999999875 343 68999886543 34567899999999999999999999999875 567889
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCC
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 350 (517)
||+.+|+|.+++.. ....+++..++.++.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999998875 35679999999999999999999999 99999999999999999999999999999876543
Q ss_pred Ccc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 351 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 351 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+... +. ..+..+....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~----~~i~~~~~~~---- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERLP---- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH----HHHHHTCCCC----
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCCC----
Confidence 322 2233458999999999999999999999999999999999 788887443222 22 2222232111
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+...+..+.+++.+||+.||++|||++||++.|+.+..
T Consensus 234 -----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 -----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111223468899999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=385.46 Aligned_cols=264 Identities=26% Similarity=0.402 Sum_probs=201.2
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....|++.++||+|+||.||+|++. +++.||||+++.... ...+.+.+|...+.++ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 33446778899999999999999864 246899999975433 3456788888888887 689999999987654
Q ss_pred -CeeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeE
Q 010131 264 -HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 329 (517)
Q Consensus 264 -~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nil 329 (517)
...++|||||++|+|.++++... ....+++.++..++.||++||+|||+ ++|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcccee
Confidence 46899999999999999997532 13458999999999999999999999 99999999999999
Q ss_pred eCCCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCC-CCCCCCCccccc
Q 010131 330 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAEL 407 (517)
Q Consensus 330 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~~~ 407 (517)
++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||.......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-- 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999876543322 233456899999999999999999999999999999999975 5675332211
Q ss_pred cHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 408 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.+...+..+......+ ..+..+.+++.+||+.||++|||++||++.|+++++.
T Consensus 245 ----~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 ----EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp ----HHHHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHhcCCCCCCCc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1223333333222211 1233688999999999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.1e-49 Score=375.37 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=202.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCCccccceeeecCC----eeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 267 (517)
+|++.+.||+|+||+||+|+.. +|+.||||+++.... ...+.|.+|++++++++||||+++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4667899999999999999875 799999999975432 23457999999999999999999999987644 378
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
+||||++|++|.+++.. .+.+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++..+++|||.+...
T Consensus 88 lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999999998873 4679999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 348 EEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 348 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...+ ..+.....+..+.....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIPPS 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCCGG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCCCc
Confidence 43222 22344569999999999999999999999999999999999999997432 22233333433322110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHhhh
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 471 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~ 471 (517)
.. ....+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus 236 ---~~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 ---AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GT----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---hh----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00 111224688999999999999999 8999999888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=381.35 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=208.3
Q ss_pred HHHhhhcccCCCCceEEEEEEecC--------CcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecCC
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 264 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 264 (517)
..|++.+.||+|+||.||+|+... +..||||+++.... .....+.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 456778999999999999998642 34799999976544 3457789999999888 8999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccC-------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeC
Q 010131 265 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 331 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~ 331 (517)
..++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999997543 13468999999999999999999999 9999999999999999
Q ss_pred CCCcEEEccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHh-CCCCCCCCCccccccH
Q 010131 332 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 409 (517)
Q Consensus 332 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~p~~~~~~~~~~~~ 409 (517)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------ 243 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 243 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH------
Confidence 9999999999999876543322 2344568899999999999999999999999999999998 6888863322
Q ss_pred HHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 410 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 410 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
+.+...+..+...... ...+..+.+++.+||+.||++|||+.||++.|+++++.
T Consensus 244 -~~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 -EELFKLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -HHHHHHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCC---------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1123334433322211 11234688999999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-48 Score=378.00 Aligned_cols=242 Identities=22% Similarity=0.365 Sum_probs=203.4
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 667899999999999999975 69999999986432 23457799999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
++||+|..++. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 86 IEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred cCCcccccccc---ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 99999999887 45678899999999999999999999 999999999999999999999999999998865432
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
....||+.|+|||++.+..++.++||||+||++|||+||+.||...+. .+...... .+... .
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~-~~~~~------~-- 220 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKIL-NAELR------F-- 220 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-HCCCC------C--
T ss_pred ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHH-cCCCC------C--
Confidence 345699999999999999999999999999999999999999974322 22222222 22210 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
+......+.+++.+||+.||.+|| |++|+++
T Consensus 221 --p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 --PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111123578999999999999996 8999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=378.21 Aligned_cols=267 Identities=25% Similarity=0.382 Sum_probs=201.7
Q ss_pred HhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHH--HHHHHhcCCCCCccccceeeecCC----eeEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGYCEEEH----QRILVY 270 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 270 (517)
+.+.+.||+|+||+||+|+++ |+.||||+++.. ..+.+.. |+..+.+++||||++++++|.+.+ ..++||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 345688999999999999975 899999998643 2334444 445556789999999999997654 578999
Q ss_pred EecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC-----CCCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 271 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 271 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
||+++|+|.++++. ..++|..+++++.|+|.||+|||+. ..++|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999974 4699999999999999999999962 13699999999999999999999999999998
Q ss_pred ccCCCCcc---cccccccCCCCcCCCccCCC------CCCccceehhHHHHHHHHHhCCCCCCCCCccc--------ccc
Q 010131 346 QAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELN 408 (517)
Q Consensus 346 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~--------~~~ 408 (517)
........ ......||+.|+|||++.+. .++.++|||||||++|||+||..||....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76543322 22345699999999998764 35779999999999999999998875322110 001
Q ss_pred HHHHHHHHHhcCCcccccCccccCCC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhhc
Q 010131 409 IVHWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 475 (517)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 475 (517)
..+........+. .+|.+.... ..+....+.+++.+||+.||++|||+.||++.|+++.+.+.
T Consensus 237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 1122222222211 122221111 23456678999999999999999999999999998886554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=381.02 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=205.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCc--EEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCCccccceeeecCCeeEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 270 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 270 (517)
.+++.++||+|+||+||+|+++ +|. .||||++.... ....+.|.+|+++|+++ +|||||+++|+|.+.+..++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 4556789999999999999886 344 57888876543 33456799999999999 7999999999999999999999
Q ss_pred EecCCCCHHhHhhcc-------------CCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 271 EYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 271 e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
||+++|+|.++++.. .....+++..+..++.|||.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceE
Confidence 999999999999743 134679999999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCC-CCCCCCccccccHHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK-PVSVEDFGAELNIVHWARSM 416 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~-p~~~~~~~~~~~~~~~~~~~ 416 (517)
|+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||...+ ..+ +...
T Consensus 168 l~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~-~~~~ 238 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAE-LYEK 238 (309)
T ss_dssp ECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHH-HHHH
T ss_pred Eccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHH-HHHH
Confidence 9999999865443222 23458999999999999999999999999999999999765 565222 112 1222
Q ss_pred HhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 417 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 417 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
+..+.... .+...+..+.+|+.+||+.||++||||+||++.|+++++..
T Consensus 239 i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 239 LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 33332111 11122346889999999999999999999999999998643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=380.81 Aligned_cols=264 Identities=29% Similarity=0.423 Sum_probs=212.6
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCCccccceeeecC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 263 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 263 (517)
+....+++.++||+|+||.||+|++. +++.||||+++.... .....|.+|+.+++++ +|||||+++++|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44456778899999999999999863 457899999976443 3456799999999999 699999999999999
Q ss_pred CeeEEEEEecCCCCHHhHhhccC---------------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCe
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSV---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 328 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Ni 328 (517)
+..++||||+++|+|.++++... ....+++..+..++.||+.||+|||+ ++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 99999999999999999997543 23368999999999999999999999 9999999999999
Q ss_pred EeCCCCcEEEccccCccccCCCCc-ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhC-CCCCCCCCcccc
Q 010131 329 LLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAE 406 (517)
Q Consensus 329 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg-~~p~~~~~~~~~ 406 (517)
+++.++.+|++|||.++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+ .+||......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999997755433 233445689999999999999999999999999999999995 5555422221
Q ss_pred ccHHHHHHHHHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhh
Q 010131 407 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 473 (517)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 473 (517)
.. +...+..+.... .+...+..+.+|+.+||+.||++||||+||+++|++++..
T Consensus 255 ~~----~~~~i~~~~~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SK----FYKMIKEGFRML---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HH----HHHHHHHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHHHhcCCCCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11 222233222111 1112234688999999999999999999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.9e-48 Score=367.30 Aligned_cols=249 Identities=25% Similarity=0.305 Sum_probs=202.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCch---------hHHHHHHHHHHHhcCC-CCCccccceeeecCC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 264 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 264 (517)
.|++.+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 3567889999999999999875 7899999998654211 2346889999999997 999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCc
Q 010131 265 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 344 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a 344 (517)
..++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999974 4579999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccC------CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 418 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 418 (517)
+....... .....||+.|+|||.+. ...++.++||||+||++|||+||+.||...+. .. ....+.
T Consensus 158 ~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~-~~~~i~ 228 (277)
T d1phka_ 158 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ML-MLRMIM 228 (277)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHH
T ss_pred eEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HH-HHHHHH
Confidence 88765332 23456899999999874 34578899999999999999999999974332 11 112222
Q ss_pred cCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 419 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 419 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+... .. ..........+.+++.+||+.||++|||++||++
T Consensus 229 ~~~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hCCCC-CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22221 00 0011122346889999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=378.61 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=211.6
Q ss_pred HHHHHHhhhcccCCCCceEEEEEEec------CCcEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCCccccceeeecCC
Q 010131 192 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 264 (517)
Q Consensus 192 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 264 (517)
+....+++.+.||+|+||+||+|.++ +++.||||+++.... .....|.+|++++++++||||++++++|...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 33445677899999999999999874 257899999975433 34457899999999999999999999999999
Q ss_pred eeEEEEEecCCCCHHhHhhccC-------CCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEE
Q 010131 265 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 337 (517)
Q Consensus 265 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~k 337 (517)
..++||||+++|+|.+++.... ....+++..+..++.|+|+||.|||+ ++|+||||||+|||++.++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEE
Confidence 9999999999999999886432 23457999999999999999999999 9999999999999999999999
Q ss_pred EccccCccccCCCCcc-cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCC-CCCCCCCccccccHHHHHHH
Q 010131 338 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARS 415 (517)
Q Consensus 338 l~Dfg~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~ 415 (517)
|+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||... +..+...
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~- 246 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLR- 246 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHH-
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHH-
Confidence 9999999876543332 233345899999999999999999999999999999999985 666532 2222222
Q ss_pred HHhcCCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhh
Q 010131 416 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 472 (517)
Q Consensus 416 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 472 (517)
.+..+...... ...+..+.+++.+||+.+|++||||+||++.|++.++
T Consensus 247 ~i~~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 247 FVMEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHhCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 23333322211 1123468899999999999999999999999987754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=375.78 Aligned_cols=256 Identities=21% Similarity=0.213 Sum_probs=195.2
Q ss_pred hcccCCCCceEEEEEEec-CCcEEEEEEecCCCchh-----HHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 200 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-----TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.++||+|+||+||+|+.. +|+.||||+++...... .+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999975 68999999986532221 246889999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
.++++..+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9888777665 45678999999999999999999999 99999999999999999999999999999876554322
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc----
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP---- 428 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~---- 428 (517)
.....||+.|+|||++.+ ..++.++||||+||++|||+||+.||......+ ....+.............+.
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccc
Confidence 233468999999998865 467999999999999999999999997433211 11111111111100000000
Q ss_pred --c---ccCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 429 --V---LIGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 429 --~---l~~~~~~-----~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. .....+. .....+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 0000111 12346889999999999999999999976
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=373.70 Aligned_cols=249 Identities=19% Similarity=0.292 Sum_probs=203.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEecC
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 274 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 274 (517)
+|.+.+.||+|+||+||+|.+. +|+.||||+++.. ......+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3667899999999999999886 6889999999754 3345678899999999999999999999999999999999999
Q ss_pred CCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCC--CcEEEccccCccccCCCCc
Q 010131 275 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 275 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~Dfg~a~~~~~~~~ 352 (517)
||+|.+++... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 85 gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 85 GLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999742 3469999999999999999999999 999999999999999854 5799999999987654322
Q ss_pred ccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCccccC
Q 010131 353 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 432 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 432 (517)
.....+|+.|+|||.+.+..++.++||||+||++|+|++|+.||...+. .+....... +... ++.....
T Consensus 160 --~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~-~~~~--~~~~~~~ 228 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMN-AEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-TCCC--CCHHHHT
T ss_pred --ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCCC--CChhhcc
Confidence 2334589999999999999999999999999999999999999974332 111222222 2110 0000001
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 433 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 433 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
. ....+.+++.+||+.||++|||++|+++
T Consensus 229 ~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 E----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1235789999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-47 Score=377.89 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=203.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
.|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4667899999999999999886 79999999986431 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+.+|+|.+++.. .+.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 122 ~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999874 4579999999999999999999999 999999999999999999999999999998775432
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
....||+.|+|||++.+..++.++|||||||++|||+||+.||...+. ...... +..+... ..
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~-i~~~~~~------~p 258 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEK-IVSGKVR------FP 258 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHCCCC------CC
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHH-HhcCCCC------CC
Confidence 345699999999999999999999999999999999999999974321 122222 2222211 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 465 (517)
. .....+.+++.+||+.||.+|+ |++|+++
T Consensus 259 ~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 S----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp T----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred c----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 1223678999999999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.5e-48 Score=380.97 Aligned_cols=246 Identities=22% Similarity=0.265 Sum_probs=196.3
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHH---HHHHHhcCCCCCccccceeeecCCeeEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 269 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~lv 269 (517)
|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 567889999999999999876 69999999986421 112233344 46777788999999999999999999999
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp ECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999974 4678999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCcccccccccCCCCcCCCccC-CCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc
Q 010131 350 DLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 428 (517)
Q Consensus 350 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 428 (517)
.. .....||+.|+|||++. +..++.++|||||||++|||+||+.||........ .... ....... .
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~-~~~~~~~------~ 226 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEID-RMTLTMA------V 226 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHH-HHSSSCC------C
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHH-HhcccCC------C
Confidence 32 23456999999999986 45689999999999999999999999975433221 1111 1111110 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 429 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 429 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
..... ....+.+++.+||+.||++||| ++|+++
T Consensus 227 ~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11111 2235789999999999999999 688865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=376.18 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=195.7
Q ss_pred HHhhh-cccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCCccccceeeec----CCeeEE
Q 010131 196 TNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRIL 268 (517)
Q Consensus 196 ~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~l 268 (517)
.|.+. +.||+|+||+||+|++. +++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ +...++
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 34554 46999999999999874 6899999998642 4577899987655 89999999999865 456899
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCcc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSR 345 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~ 345 (517)
|||||+||+|.+++... ....+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 87 vmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 99999999999999743 24579999999999999999999999 99999999999999985 5679999999998
Q ss_pred ccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 010131 346 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 425 (517)
Q Consensus 346 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (517)
....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...+...+..+..
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~--- 234 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY--- 234 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS---
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC---
Confidence 7654332 2345699999999999999999999999999999999999999974332211 1111111111110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+...........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000111223456889999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=375.28 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=200.8
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC---chhHHHHHHHHHHHh-cCCCCCccccceeeecCCeeEEEEE
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e 271 (517)
|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 567899999999999999886 68999999996432 234456677777765 6899999999999999999999999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 351 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 351 (517)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 84 YLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred ecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999984 4578999999999999999999999 999999999999999999999999999998765433
Q ss_pred cccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCcccc
Q 010131 352 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 431 (517)
Q Consensus 352 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 431 (517)
.. .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+.. + +...+..+.. ...
T Consensus 158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~-~~~~i~~~~~------~~p 223 (320)
T d1xjda_ 158 AK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------E-LFHSIRMDNP------FYP 223 (320)
T ss_dssp CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC------CCC
T ss_pred cc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCC------CCC
Confidence 22 33456999999999999999999999999999999999999999743321 1 1222222221 111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 010131 432 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 465 (517)
Q Consensus 432 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl~ 465 (517)
.. ....+.+|+.+||+.||++|||+. |+++
T Consensus 224 ~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cc----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 123578999999999999999996 6754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-47 Score=367.21 Aligned_cols=260 Identities=18% Similarity=0.249 Sum_probs=198.6
Q ss_pred HHhhhcccCCCCceEEEEEEecCCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
+|++.++||+|+||+||+|++++|+.||||++..... ...+.+.+|+.+|++++||||+++++++.+++..++++|++
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 3556789999999999999999999999999965432 23578999999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
.++.+..+.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||.+.........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 83 DQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp SEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred hhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 8877777665 46789999999999999999999999 99999999999999999999999999999876543322
Q ss_pred cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc------
Q 010131 354 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV------ 426 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 426 (517)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+ ....+.............
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhhhh
Confidence 233458899999999865 456899999999999999999999997433211 111111111110000000
Q ss_pred --Cccc-------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 427 --DPVL-------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 427 --d~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
+... ...........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00001112346789999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=362.51 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=196.0
Q ss_pred HhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEec
Q 010131 197 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 197 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
|.+.+.||+|+||+||+|.+. +|+.||||+++.... ...+++.+|++++++++|||||++++++.+.+..++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 556789999999999999875 799999999964432 23467899999999999999999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCcc
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 353 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 353 (517)
.++ +.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 84 ~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 84 HQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp SEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred CCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 754 44444322 35679999999999999999999999 9999999999999999999999999999987654332
Q ss_pred cccccccCCCCcCCCccCCCC-CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccCc----
Q 010131 354 ISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP---- 428 (517)
Q Consensus 354 ~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~---- 428 (517)
......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+..+ ....+.... +...+..-+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~--~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTL--GTPDEVVWPGVTS 232 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHH--CCCCTTTSTTGGG
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhc--CCCchhhcccccc
Confidence 233446899999999876654 5789999999999999999999997433211 111111111 110000000
Q ss_pred --ccc------CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 429 --VLI------GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 429 --~l~------~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
... .... ......+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 0000 1122467899999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=365.20 Aligned_cols=238 Identities=24% Similarity=0.394 Sum_probs=193.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc------hhHHHHHHHHHHHhcCC--CCCccccceeeecCCee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 266 (517)
+|++.+.||+|+||+||+|+.. +|+.||||++..... ....++.+|+.++++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4667899999999999999875 789999999864321 11234678999999996 89999999999999999
Q ss_pred EEEEEecCC-CCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-CCcEEEccccCc
Q 010131 267 ILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 344 (517)
Q Consensus 267 ~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~Dfg~a 344 (517)
++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999976 678888763 4679999999999999999999999 99999999999999985 479999999999
Q ss_pred cccCCCCcccccccccCCCCcCCCccCCCCC-CccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 345 RQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 345 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
+...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||...+ ... .+..
T Consensus 159 ~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~-~~~~- 221 (273)
T d1xwsa_ 159 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII-RGQV- 221 (273)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH-HCCC-
T ss_pred eeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHh-hccc-
Confidence 8754432 234569999999999876655 677999999999999999999997321 111 1111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+. ... ...+.+++.+||+.||++|||++|+++
T Consensus 222 -~~~----~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -FFR----QRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCS----SCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCC----CCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011 111 236789999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=359.41 Aligned_cols=260 Identities=20% Similarity=0.254 Sum_probs=193.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-C-CcEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCCccccceeeec-----C
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----E 263 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~ 263 (517)
.|++.++||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 5677899999999999999874 4 66799999864322 2233466777777665 79999999999853 3
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
...+++|||+.++.+...... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 467899999988877554432 45678999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 010131 344 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 423 (517)
Q Consensus 344 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (517)
++...... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+..+ ....+..........
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGG
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCchh
Confidence 88654332 2344569999999999999999999999999999999999999997443211 111111111100000
Q ss_pred ccc------Cccc-------cCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 424 SIV------DPVL-------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 424 ~~~------d~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+. .... ...........+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000 00011112335779999999999999999999876
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=363.78 Aligned_cols=265 Identities=24% Similarity=0.246 Sum_probs=194.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccceeeec------CCeeEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRIL 268 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~l 268 (517)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|+++|++++||||++++++|.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4556788999999999999986 699999999975432 23479999999999999999999853 234789
Q ss_pred EEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCcccc
Q 010131 269 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQA 347 (517)
Q Consensus 269 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~ 347 (517)
||||++++.+............+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876544443333356789999999999999999999999 9999999999999999775 8999999999876
Q ss_pred CCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH----------H
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS----------M 416 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~----------~ 416 (517)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+ .+...... .
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhhh
Confidence 54332 233468999999998764 578999999999999999999999997443211 11111100 0
Q ss_pred Hhc----CCcccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 010131 417 IKK----GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 471 (517)
Q Consensus 417 ~~~----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~ 471 (517)
... ......................+.+|+.+||+.||++|||++|+++. ++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 00000000000000111223467899999999999999999999863 55443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-44 Score=347.91 Aligned_cols=262 Identities=16% Similarity=0.190 Sum_probs=208.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC-CCccccceeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 273 (517)
.|++.++||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4667899999999999999976 68999999986532 23457789999999965 89999999999999999999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC-----CCcEEEccccCccccC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAE 348 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~Dfg~a~~~~ 348 (517)
+++|.+++.. ....+++.++..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 -~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 7899998864 34579999999999999999999999 99999999999999974 5789999999998764
Q ss_pred CCCcc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 010131 349 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 422 (517)
Q Consensus 349 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (517)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43211 223456999999999999999999999999999999999999999755444332222222211111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 423 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 423 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+ +... .+..+.+++..|++.+|++||+++.+.+.|+++.+..
T Consensus 238 ~~-----l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 RE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH-----hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 11 1111 1246889999999999999999999999999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=358.20 Aligned_cols=262 Identities=18% Similarity=0.219 Sum_probs=194.3
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCCccccceeeec--------C
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------E 263 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~ 263 (517)
.+|++.++||+|+||+||+|++. +|+.||||++... .....+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 35667899999999999999975 7999999998543 22345678899999999999999999998754 3
Q ss_pred CeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccC
Q 010131 264 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 343 (517)
Q Consensus 264 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~ 343 (517)
+..++||||+.++.+..... ....++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence 46789999998877765554 45678999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCc---ccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 010131 344 SRQAEEDLT---HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 419 (517)
Q Consensus 344 a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 419 (517)
+........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...+... ....+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcCC
Confidence 986653221 122334689999999998765 68999999999999999999999997433211 11111111111
Q ss_pred CC---cccccCc--------cccCCCCHH-------HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 420 GD---VISIVDP--------VLIGNVKIE-------SIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 420 ~~---~~~~~d~--------~l~~~~~~~-------~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
-. ....... ......... ....+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0000000 000001111 1235678999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=348.94 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=199.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCCccccc-eeeecCCeeEEEEEec
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GYCEEEHQRILVYEYM 273 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~-~~~~~~~~~~lv~e~~ 273 (517)
+|++.+.||+|+||+||+|++. +|+.||||++..... .+++..|+++++.++|+|++..+ +++.+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4677899999999999999875 689999999875432 24578899999999877765555 4556777889999999
Q ss_pred CCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCC---CCcEEEccccCccccCCC
Q 010131 274 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 350 (517)
Q Consensus 274 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~Dfg~a~~~~~~ 350 (517)
++++.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++. +..+||+|||+|+.....
T Consensus 86 -~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 86 -GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 5666666543 35679999999999999999999999 99999999999999864 567999999999986543
Q ss_pred Ccc------cccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHH-HHHHHHHhcCCcc
Q 010131 351 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWARSMIKKGDVI 423 (517)
Q Consensus 351 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 423 (517)
... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||............ .+...... ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CChh
Confidence 321 223456999999999999999999999999999999999999999754433222211 11111111 1110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHhhhhhh
Q 010131 424 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 474 (517)
Q Consensus 424 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 474 (517)
.+... .+..+.+++.+|++.+|++||+++++.+.|+++....
T Consensus 239 -----~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 239 -----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -----HHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----HhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 11111 2246889999999999999999999999999886544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=354.44 Aligned_cols=260 Identities=21% Similarity=0.297 Sum_probs=193.6
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCCccccceeeecCC----eeEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILV 269 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv 269 (517)
+|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 3567799999999999999865 79999999997543 334568899999999999999999999986543 34566
Q ss_pred EEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCC
Q 010131 270 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 349 (517)
Q Consensus 270 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 349 (517)
++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 677789999999963 469999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCcc--cccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc--
Q 010131 350 DLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS-- 424 (517)
Q Consensus 350 ~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 424 (517)
.... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...+..+.. ..............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLN 238 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhhhh
Confidence 3221 2344568999999999854 56788999999999999999999999744322111 10100000000000
Q ss_pred -----------ccCccccCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 425 -----------IVDPVLIGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 425 -----------~~d~~l~~~~~~-----~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
...+.. ...+. .....+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000 111357899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=356.39 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=193.2
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeecCC------ee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 266 (517)
+|++.++||+|+||+||+|... +|+.||||+++.... ...+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 5667889999999999999875 699999999975432 34567899999999999999999999997654 46
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+ +.+|..+.+ ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+++.
T Consensus 99 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 9999999 667887775 3569999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCC-CCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 419 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 419 (517)
..... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.... +.. .......
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKE-IMKVTGTPPAEFV 243 (346)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCHHHH
T ss_pred cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHH-HHhccCCCcHHHH
Confidence 65432 33568999999999865 4578999999999999999999999974432111 000 0000000
Q ss_pred --CC----------cccccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--HHhhh
Q 010131 420 --GD----------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 471 (517)
Q Consensus 420 --~~----------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~ 471 (517)
.. ........+. .........+.+|+.+||+.||++|||++|+++. |+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 0000000000 0001112356799999999999999999999874 55544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=344.30 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=201.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeecCCeeEEEEEe
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 272 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 272 (517)
+|++.++||+|+||+||+|++. +|+.||||+++... .....++.+|+.+++.++||||+++++++.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 3566789999999999999875 78999999986543 23467899999999999999999999999999999999999
Q ss_pred cCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccccCCCCc
Q 010131 273 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 352 (517)
Q Consensus 273 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 352 (517)
+.++++..++. ..+.+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 83 ~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 83 CDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ccccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 99999988876 46788999999999999999999999 9999999999999999999999999999987654433
Q ss_pred ccccccccCCCCcCCCccCCCC-CCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc------ccc
Q 010131 353 HISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV------ISI 425 (517)
Q Consensus 353 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 425 (517)
. .....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||..... ..+....+......... ...
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp C-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2 22334678899999887654 68999999999999999999999752221 11111111111111000 000
Q ss_pred cCc---------cccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 426 VDP---------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 426 ~d~---------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.+. .-...........+.+|+.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000111122345789999999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=352.92 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=201.2
Q ss_pred HHhhhcccCCCCceEEEEEEec----CCcEEEEEEecCCC----chhHHHHHHHHHHHhcCCC-CCccccceeeecCCee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 266 (517)
.|++.++||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 3778899999999999999752 48899999986432 2234668899999999966 8999999999999999
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999974 4567889999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCcCCCccCCC--CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 424 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (517)
.............|++.|+|||.+.+. .++.++||||+||++|||+||+.||....... ............ ..
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~~~~~~~-~~-- 253 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS-EP-- 253 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC-CC--
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcccC-CC--
Confidence 755544444556789999999998654 46789999999999999999999997544332 222222222211 11
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 010131 425 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 465 (517)
Q Consensus 425 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 465 (517)
. .+......+.+++.+||++||++||| ++|+++
T Consensus 254 ----~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----P----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----C----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----C----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 11122346889999999999999994 788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-43 Score=347.33 Aligned_cols=254 Identities=19% Similarity=0.286 Sum_probs=194.0
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeec--CCeeEEEEE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVYE 271 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~e 271 (517)
.|++.++||+|+||+||+|+.. +|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5778899999999999999875 6899999998743 3467889999999995 9999999999874 456899999
Q ss_pred ecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCC-cEEEccccCccccCCC
Q 010131 272 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEED 350 (517)
Q Consensus 272 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 350 (517)
|+.+++|..+. +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 ~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 113 HVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999997754 358999999999999999999999 9999999999999998655 6999999999876543
Q ss_pred CcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHH---------HHhcC
Q 010131 351 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS---------MIKKG 420 (517)
Q Consensus 351 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~~ 420 (517)
.. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ....+.. .....
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHT
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhhc
Confidence 32 2344589999999997765 579999999999999999999999974332111 0000100 00000
Q ss_pred Cc------ccccC--------ccccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 010131 421 DV------ISIVD--------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 465 (517)
Q Consensus 421 ~~------~~~~d--------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 465 (517)
.. ..... ..............+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 00000111122345789999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=344.49 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=188.1
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCCccccceeeec------CCee
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 266 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~ 266 (517)
.|++.++||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.++++++||||++++++|.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 3666789999999999999876 69999999997543 2344578899999999999999999999853 3678
Q ss_pred EEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 267 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 267 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
|+||||+.++.+ +.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||+++.
T Consensus 98 ~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 98 YLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence 999999976554 4443 358999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHH----------------
Q 010131 347 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV---------------- 410 (517)
Q Consensus 347 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~---------------- 410 (517)
...... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+........
T Consensus 169 ~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccccc--cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 654322 23445899999999999999999999999999999999999999744321100000
Q ss_pred HHHHHHHhcCC-c-----ccccCccccCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 010131 411 HWARSMIKKGD-V-----ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 466 (517)
Q Consensus 411 ~~~~~~~~~~~-~-----~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 466 (517)
........... . ............ .......+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000111100 0 000001111111 22345578899999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=343.66 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=193.8
Q ss_pred HHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCCccccceeeec-----CCeeE
Q 010131 196 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRI 267 (517)
Q Consensus 196 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 267 (517)
+|++.++||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||+|++++++.. +...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4677899999999999999875 799999999975432 344678899999999999999999999853 33456
Q ss_pred EEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEccccCcccc
Q 010131 268 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 347 (517)
Q Consensus 268 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~~ 347 (517)
++++|+.+|+|.+++. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++...
T Consensus 99 ~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 7788888999999986 4569999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCCcCCCccCCC-CCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 010131 348 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 426 (517)
Q Consensus 348 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (517)
... .....|++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+.... ...+....... ..+..
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~-~~~~~ 243 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTP-GAELL 243 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC-CHHHH
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCC-ChHHh
Confidence 432 2334588999999986654 568899999999999999999999974432211 11111111000 00000
Q ss_pred ------------Cccc-cCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH--HHHhh
Q 010131 427 ------------DPVL-IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS 470 (517)
Q Consensus 427 ------------d~~l-~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~ 470 (517)
.... ..... ......+.+|+.+||+.||++|||++|+++ .+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000 00000 011235789999999999999999999987 34443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-39 Score=317.91 Aligned_cols=274 Identities=20% Similarity=0.274 Sum_probs=197.4
Q ss_pred HHHhhhcccCCCCceEEEEEEec-CCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-----------CCCccccceeeec
Q 010131 195 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE 262 (517)
Q Consensus 195 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 262 (517)
.+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 34788899999999999999875 79999999997542 33467788999988875 5789999998754
Q ss_pred --CCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCc-----
Q 010131 263 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR----- 335 (517)
Q Consensus 263 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~----- 335 (517)
....+++++++..+..............+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 34567777777665544333333356788999999999999999999996 378999999999999986653
Q ss_pred -EEEccccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 010131 336 -AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 414 (517)
Q Consensus 336 -~kl~Dfg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~p~~~~~~~~~~~~~~~~~ 414 (517)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||...+............
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 999999999865432 234568999999999999999999999999999999999999997544322211111111
Q ss_pred HHHh-cCCc-----------c---------cccCcc----------ccCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 010131 415 SMIK-KGDV-----------I---------SIVDPV----------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 463 (517)
Q Consensus 415 ~~~~-~~~~-----------~---------~~~d~~----------l~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev 463 (517)
..+. -+.. . ..+... ............+.+|+.+||+.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1110 0000 0 000000 0112345667789999999999999999999999
Q ss_pred HHH--HHhhhhhhc
Q 010131 464 VLA--IQDSIKIEK 475 (517)
Q Consensus 464 l~~--L~~~~~~~~ 475 (517)
++. +++....+.
T Consensus 326 L~Hp~f~~~~~~~~ 339 (362)
T d1q8ya_ 326 VNHPWLKDTLGMEE 339 (362)
T ss_dssp HTCGGGTTCTTCTT
T ss_pred hcCcccCCCCCccc
Confidence 873 555544433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=3.1e-24 Score=191.88 Aligned_cols=168 Identities=15% Similarity=0.121 Sum_probs=119.6
Q ss_pred hhcccCCCCceEEEEEEecCCcEEEEEEecCCCc------------------hhHHHHHHHHHHHhcCCCCCccccceee
Q 010131 199 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 260 (517)
Q Consensus 199 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~~~ 260 (517)
+.++||+|+||+||+|+..+|+.||||+++.... ........|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4688999999999999988899999998753211 0113355688899999999998887653
Q ss_pred ecCCeeEEEEEecCCCCHHhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcCCCCCcEecCCCCCCeEeCCCCcEEEcc
Q 010131 261 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 340 (517)
Q Consensus 261 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D 340 (517)
..+++|||+++..+.+ ++......++.|++.+++|||+ .+|+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 2379999998765533 2334456789999999999999 999999999999999965 589999
Q ss_pred ccCccccCCCCcccccccccCCCCcCCCccCCCCCCccceehhHHHHH
Q 010131 341 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 388 (517)
Q Consensus 341 fg~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l 388 (517)
||.|...........-. .+...+ .+. ....++.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~l~--rd~~~~-~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREILE--RDVRNI-ITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHHH--HHHHHH-HHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHH--HHHHHH-HHH-HcCCCCCcccHHHHHHHH
Confidence 99997764332110000 000000 011 124678899999976443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.47 E-value=4.1e-14 Score=125.33 Aligned_cols=106 Identities=18% Similarity=0.206 Sum_probs=92.9
Q ss_pred CceecCCCCcccccCC-ccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
+++|+|++|+|++.++ ..|.++++|+.|+|++|.+++.++. |..+++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 31 l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~ 110 (192)
T d1w8aa_ 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110 (192)
T ss_dssp CSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECC
T ss_pred CCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccC
Confidence 5789999999987564 5678899999999999999999997 9999999999999999997767779999999999999
Q ss_pred cccccCCCCccccc---cceeeeccCCCcccc
Q 010131 79 NNSFVGEIPPALLT---GKVIFKYDNNPKLHK 107 (517)
Q Consensus 79 ~N~l~~~~P~~~~~---~~~~~~~~~n~~~~~ 107 (517)
+|+|+ .+|+..+. ....+.+.+|++.|.
T Consensus 111 ~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 111 DNQIS-CVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SSCCC-EECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred Ccccc-ccCHHHhcCCcccccccccccccccc
Confidence 99999 67776543 456778899999876
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.36 E-value=5.2e-13 Score=108.76 Aligned_cols=99 Identities=25% Similarity=0.333 Sum_probs=83.2
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
+.|+|++|+++ .+| .+..+++|+.|+|++|.|+..++.++.+++|+.|++++|.|+ .+|. +..+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCc
Confidence 57999999999 666 589999999999999999976656999999999999999999 6764 8999999999999999
Q ss_pred ccCCCCc--ccc--ccceeeeccCCCcc
Q 010131 82 FVGEIPP--ALL--TGKVIFKYDNNPKL 105 (517)
Q Consensus 82 l~~~~P~--~~~--~~~~~~~~~~n~~~ 105 (517)
++ .+|. .+. .....+.+.+|+..
T Consensus 77 i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 99 5664 232 24556778888743
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.32 E-value=3.4e-13 Score=129.00 Aligned_cols=107 Identities=27% Similarity=0.299 Sum_probs=96.4
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
..+++++|.+.|.+|..+..+++|+.|++++|.+++.+|.+..+++|+.|+|++|+|+|.+|.+++++++|++|+|++|+
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~ 279 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence 46788889999999988999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccc-cccceeeeccCCCccccc
Q 010131 82 FVGEIPPAL-LTGKVIFKYDNNPKLHKE 108 (517)
Q Consensus 82 l~~~~P~~~-~~~~~~~~~~~n~~~~~~ 108 (517)
|+|.+|... ...+..+.+.+|+.+|+.
T Consensus 280 l~g~iP~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 280 LCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred ccccCCCcccCCCCCHHHhCCCccccCC
Confidence 999999642 335567788999988874
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=1.7e-12 Score=110.32 Aligned_cols=105 Identities=17% Similarity=0.159 Sum_probs=91.7
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCC-CCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGN-FLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
+.++.+++++. .+|..+..+++|+.|++++| .|+...++ |.++++|+.|+|++|+|+...|..|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 46888999998 78999999999999999876 58887776 99999999999999999966677799999999999999
Q ss_pred ccccCCCCccccc--cceeeeccCCCccccc
Q 010131 80 NSFVGEIPPALLT--GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 80 N~l~~~~P~~~~~--~~~~~~~~~n~~~~~~ 108 (517)
|+|+ .+|...+. ....+.+.+||+.|..
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCc-ccChhhhccccccccccCCCcccCCc
Confidence 9999 89988765 4457789999999863
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=3.9e-12 Score=118.49 Aligned_cols=106 Identities=26% Similarity=0.294 Sum_probs=77.8
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.|++++|.+.+..+..+..+.+|+.|++++|.++..++. +..+++|+.|++++|+|++..|..+..+++|++|+|++|
T Consensus 103 ~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 182 (266)
T d1p9ag_ 103 TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182 (266)
T ss_dssp CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred ccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccC
Confidence 3344444444433333344445555555556666666666 677899999999999999766677899999999999999
Q ss_pred cccCCCCccccc--cceeeeccCCCccccc
Q 010131 81 SFVGEIPPALLT--GKVIFKYDNNPKLHKE 108 (517)
Q Consensus 81 ~l~~~~P~~~~~--~~~~~~~~~n~~~~~~ 108 (517)
+|+ .+|+.++. .+..+.+.+|||.|..
T Consensus 183 ~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 183 SLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 999 89998765 4567889999999973
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.27 E-value=2.1e-12 Score=105.04 Aligned_cols=80 Identities=28% Similarity=0.359 Sum_probs=73.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCC--CCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p--~~~~~l~~L~~l~l~ 78 (517)
|++|+|++|+|+ .+|+.|+.+++|+.|++++|.|++. |++..+++|+.|++++|+++ .+| ..++.+++|+.|+++
T Consensus 22 L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~l~ 98 (124)
T d1dcea3 22 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQ 98 (124)
T ss_dssp CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEECT
T ss_pred CCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEECC
Confidence 689999999999 7898999999999999999999975 67999999999999999999 555 358889999999999
Q ss_pred ccccc
Q 010131 79 NNSFV 83 (517)
Q Consensus 79 ~N~l~ 83 (517)
+|+++
T Consensus 99 ~N~i~ 103 (124)
T d1dcea3 99 GNSLC 103 (124)
T ss_dssp TSGGG
T ss_pred CCcCC
Confidence 99998
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.23 E-value=5.2e-12 Score=111.44 Aligned_cols=84 Identities=21% Similarity=0.341 Sum_probs=79.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|+|++|++.+..+..|..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|..+++|++|++++
T Consensus 56 L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~ 135 (192)
T d1w8aa_ 56 LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLAS 135 (192)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTT
T ss_pred EeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccc
Confidence 68999999999988888999999999999999999999998 99999999999999999977777899999999999999
Q ss_pred ccccC
Q 010131 80 NSFVG 84 (517)
Q Consensus 80 N~l~~ 84 (517)
|.+..
T Consensus 136 N~~~~ 140 (192)
T d1w8aa_ 136 NPFNC 140 (192)
T ss_dssp CCBCC
T ss_pred ccccc
Confidence 99984
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=6.1e-12 Score=118.32 Aligned_cols=106 Identities=20% Similarity=0.294 Sum_probs=91.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.+++++|++++..+..|..+++|+.|+|++|+|++.++. |.++++|+.+++++|++++..|..|..+++|++|++++
T Consensus 131 L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~ 210 (284)
T d1ozna_ 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210 (284)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred cchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccc
Confidence 57899999999965566788899999999999999998887 99999999999999999988899999999999999999
Q ss_pred ccccCCCCcccc-c--cceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALL-T--GKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~-~--~~~~~~~~~n~~~~~ 107 (517)
|++.+ +|+..+ . .+..+.+.+||+.|.
T Consensus 211 N~i~~-~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 211 NNLSA-LPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp SCCSC-CCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ccccc-ccccccccccccCEEEecCCCCCCC
Confidence 99994 555432 2 456778999999986
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.22 E-value=2.4e-12 Score=122.94 Aligned_cols=103 Identities=29% Similarity=0.605 Sum_probs=90.1
Q ss_pred CceecCCCCcccc--cCCccccCCCCCcEEEcCC-CCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccc
Q 010131 1 MARCALSGKNLKG--EIPPELKNMEALTELWLDG-NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 76 (517)
Q Consensus 1 l~~L~l~~n~~~~--~~p~~~~~l~~L~~L~l~~-N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~ 76 (517)
++.|+|++|+++| .+|++|++|++|+.|+|++ |+++|.+|+ |++|++|++|+|++|++++..|..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4689999999998 4899999999999999987 899999987 99999999999999999998888899999999999
Q ss_pred cccccccCCCCccccc--cceeeeccCCC
Q 010131 77 IENNSFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 77 l~~N~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
+++|++.+.+|..+.. ....+.+.+|.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccCchhhccCcccceeeccccc
Confidence 9999999899987754 33455566664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=4.6e-12 Score=108.28 Aligned_cols=100 Identities=22% Similarity=0.255 Sum_probs=83.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCC-CCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~-~~~l~~L~~l~l~~ 79 (517)
|++|+|++|+|+ .+|..+..+++|+.|||++|.|+.. +.|..+++|+.|++++|+++ .+|.. +..+++|+.|++++
T Consensus 20 lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 20 DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp CEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCS
T ss_pred CcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCccccccccccccceecc
Confidence 578999999999 6787677899999999999999965 67999999999999999999 55554 56799999999999
Q ss_pred ccccCCCCc--cc--cccceeeeccCCCc
Q 010131 80 NSFVGEIPP--AL--LTGKVIFKYDNNPK 104 (517)
Q Consensus 80 N~l~~~~P~--~~--~~~~~~~~~~~n~~ 104 (517)
|+++ .++. .+ ...+..+.+.+||.
T Consensus 97 N~i~-~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 97 NSLV-ELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccc-ccccccccccccccchhhcCCCcc
Confidence 9998 5664 22 23456777888874
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.15 E-value=3.4e-11 Score=114.34 Aligned_cols=105 Identities=21% Similarity=0.227 Sum_probs=93.6
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|+.|++++|.+++..+..|.+++.++.|++++|.+++..+. +.++++|+.|+|++|.|+ .+|.++.++++|+.|++++
T Consensus 173 L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~ 251 (305)
T d1xkua_ 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 251 (305)
T ss_dssp CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCS
T ss_pred cCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCC
Confidence 57899999999999999999999999999999999999887 999999999999999999 8899999999999999999
Q ss_pred ccccCCCCccccc---------cceeeeccCCCcccc
Q 010131 80 NSFVGEIPPALLT---------GKVIFKYDNNPKLHK 107 (517)
Q Consensus 80 N~l~~~~P~~~~~---------~~~~~~~~~n~~~~~ 107 (517)
|+|+ .++...+. ....+.+.+||+.+.
T Consensus 252 N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 252 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp SCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred CccC-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 9999 78765432 344567899998764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.11 E-value=3.9e-11 Score=101.65 Aligned_cols=82 Identities=22% Similarity=0.162 Sum_probs=72.8
Q ss_pred CceecCCCCc-ccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccc
Q 010131 1 MARCALSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~-~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~ 78 (517)
|++|+|++|+ ++..-+..|.++++|+.|+|++|+|+...|. |..+++|++|+|++|+|+ .+|..+.....|+.|+|+
T Consensus 33 l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~ 111 (156)
T d2ifga3 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS 111 (156)
T ss_dssp CSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECC
T ss_pred cCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccC
Confidence 5789998775 8855556799999999999999999999887 999999999999999999 888876666689999999
Q ss_pred ccccc
Q 010131 79 NNSFV 83 (517)
Q Consensus 79 ~N~l~ 83 (517)
+|.+.
T Consensus 112 ~Np~~ 116 (156)
T d2ifga3 112 GNPLH 116 (156)
T ss_dssp SSCCC
T ss_pred CCccc
Confidence 99986
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=6.7e-11 Score=100.84 Aligned_cols=84 Identities=21% Similarity=0.225 Sum_probs=74.3
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCC--CCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~--~~~~l~~L~~l~l 77 (517)
|+.|+|++|+|+ .++ .|..+++|+.|+|++|+++..++. +..+++|+.|++++|+++ .+++ .+..+++|++|++
T Consensus 43 L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l 119 (162)
T d1a9na_ 43 FDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCI 119 (162)
T ss_dssp CSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEEC
T ss_pred CCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccchhhc
Confidence 688999999999 565 588999999999999999998887 778999999999999998 5553 5788999999999
Q ss_pred ccccccCCCCc
Q 010131 78 ENNSFVGEIPP 88 (517)
Q Consensus 78 ~~N~l~~~~P~ 88 (517)
++|+++ ..|.
T Consensus 120 ~~N~i~-~~~~ 129 (162)
T d1a9na_ 120 LRNPVT-NKKH 129 (162)
T ss_dssp CSSGGG-GSTT
T ss_pred CCCccc-cccc
Confidence 999998 5663
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=8.6e-10 Score=102.20 Aligned_cols=82 Identities=24% Similarity=0.252 Sum_probs=75.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
++.|++++|.++...+..+..+++|+.|++++|+|++.+++ |..+++|+.|+|++|+|+ .+|.++..+++|+.|+|++
T Consensus 126 l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~ 204 (266)
T d1p9ag_ 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204 (266)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCS
T ss_pred cccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecC
Confidence 57899999999965556677899999999999999999988 999999999999999999 9999999999999999999
Q ss_pred cccc
Q 010131 80 NSFV 83 (517)
Q Consensus 80 N~l~ 83 (517)
|.+.
T Consensus 205 Np~~ 208 (266)
T d1p9ag_ 205 NPWL 208 (266)
T ss_dssp CCBC
T ss_pred CCCC
Confidence 9987
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.83 E-value=3.7e-09 Score=98.81 Aligned_cols=103 Identities=20% Similarity=0.209 Sum_probs=81.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 79 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 79 (517)
|++|+|++|.+.+..+..+..+++|+.+++++|+|++.++. |..+++|+.|++++|++++..|..+..+++|+.+++++
T Consensus 107 L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~ 186 (284)
T d1ozna_ 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186 (284)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhh
Confidence 57888999988866666777788899999999999887776 88888999999999999876677788889999999999
Q ss_pred ccccCCCCccccc--cceeeeccCCC
Q 010131 80 NSFVGEIPPALLT--GKVIFKYDNNP 103 (517)
Q Consensus 80 N~l~~~~P~~~~~--~~~~~~~~~n~ 103 (517)
|++++..|..+.. ....+.+.+|.
T Consensus 187 N~l~~i~~~~f~~l~~L~~L~l~~N~ 212 (284)
T d1ozna_ 187 NRVAHVHPHAFRDLGRLMTLYLFANN 212 (284)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred ccccccChhHhhhhhhcccccccccc
Confidence 9998655655442 34455566654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.77 E-value=7.9e-09 Score=97.52 Aligned_cols=98 Identities=21% Similarity=0.271 Sum_probs=84.0
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
+.++-++++++ .+|..+. ++|+.|+|++|+|+..++. |.++++|+.|++++|.++...|..|.+++.|+.|++++|
T Consensus 13 ~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 56788888999 8898774 7899999999999999886 999999999999999999666788999999999999999
Q ss_pred cccCCCCccccccceeeeccCCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
+++ .+|.........+....|.
T Consensus 90 ~l~-~l~~~~~~~l~~L~~~~n~ 111 (305)
T d1xkua_ 90 QLK-ELPEKMPKTLQELRVHENE 111 (305)
T ss_dssp CCS-BCCSSCCTTCCEEECCSSC
T ss_pred ccC-cCccchhhhhhhhhccccc
Confidence 999 7998776655555555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.70 E-value=1.4e-10 Score=102.32 Aligned_cols=98 Identities=27% Similarity=0.249 Sum_probs=61.2
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|+|++|+|+ .++ .|.+|++|+.|+|++|.|+...+-+..+++|+.|++++|+++ .++ .+..+++|+.|++++|
T Consensus 50 L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N 125 (198)
T d1m9la_ 50 CKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNN 125 (198)
T ss_dssp CCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEE
T ss_pred cceeECcccCCC-Ccc-cccCCccccChhhccccccccccccccccccccccccccccc-ccc-cccccccccccccccc
Confidence 466777777777 454 466777777777777777653322445566777777777776 443 3666777777777777
Q ss_pred cccCCCCc--cc--cccceeeeccCCC
Q 010131 81 SFVGEIPP--AL--LTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~--~~--~~~~~~~~~~~n~ 103 (517)
+++ .++. .+ ...+..+.+.+||
T Consensus 126 ~i~-~~~~~~~l~~l~~L~~L~L~~N~ 151 (198)
T d1m9la_ 126 KIT-NWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp ECC-CHHHHHHHTTTTTCSEEEECSSH
T ss_pred hhc-cccccccccCCCccceeecCCCc
Confidence 776 4442 12 1234555666665
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.66 E-value=1.6e-08 Score=88.98 Aligned_cols=97 Identities=24% Similarity=0.352 Sum_probs=72.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|++++|+++ .++ .+..+++|+.|+|++|++++..| +.++++|+.|++++|.+. .+|. +.+++.|+.|++++|
T Consensus 42 l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~ 116 (199)
T d2omxa2 42 VTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNN 116 (199)
T ss_dssp CCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSS
T ss_pred CCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-cccc-ccccccccccccccc
Confidence 577899999888 454 47888999999999999987554 888899999999999887 5653 788888999999888
Q ss_pred cccCCCCc-cccccceeeeccCCC
Q 010131 81 SFVGEIPP-ALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~-~~~~~~~~~~~~~n~ 103 (517)
.+.. ++. .-......+.+++|.
T Consensus 117 ~~~~-~~~~~~l~~L~~L~l~~n~ 139 (199)
T d2omxa2 117 QITD-IDPLKNLTNLNRLELSSNT 139 (199)
T ss_dssp CCCC-CGGGTTCTTCSEEECCSSC
T ss_pred cccc-ccccchhhhhHHhhhhhhh
Confidence 8873 332 222344555566653
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.63 E-value=9.2e-09 Score=100.14 Aligned_cols=96 Identities=22% Similarity=0.294 Sum_probs=73.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
++.+++++|++++ +..+..+++++.|+|++|++++.. .+..+++|+.|++++|+++ .+| .+.++++|++|++++|
T Consensus 287 l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 287 LTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHN 361 (384)
T ss_dssp CSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSS
T ss_pred ccccccccccccc--ccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCC
Confidence 3567888888885 345788899999999999998854 4888999999999999998 565 5888999999999999
Q ss_pred cccCCCCc-cccccceeeeccCC
Q 010131 81 SFVGEIPP-ALLTGKVIFKYDNN 102 (517)
Q Consensus 81 ~l~~~~P~-~~~~~~~~~~~~~n 102 (517)
++++ +|+ .-.+.+..+.+++|
T Consensus 362 ~l~~-l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 362 QISD-LTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CCCB-CGGGTTCTTCSEEECCCE
T ss_pred cCCC-ChhhccCCCCCEeeCCCC
Confidence 9994 543 22234445555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.60 E-value=3.2e-08 Score=87.76 Aligned_cols=81 Identities=23% Similarity=0.449 Sum_probs=68.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|++++|+++. ++ .+..+++|+.|+|++|+|++. +.++.+++|+.|++++|+++ .+| .+..+++|+.|++++|
T Consensus 48 L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~ 122 (210)
T d1h6ta2 48 IDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHN 122 (210)
T ss_dssp CCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTS
T ss_pred ccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-cccccCcccccccccccccc-ccc-cccccccccccccccc
Confidence 5789999999984 44 478899999999999999974 45788999999999999998 566 4888999999999999
Q ss_pred cccCCCC
Q 010131 81 SFVGEIP 87 (517)
Q Consensus 81 ~l~~~~P 87 (517)
.+. .++
T Consensus 123 ~~~-~~~ 128 (210)
T d1h6ta2 123 GIS-DIN 128 (210)
T ss_dssp CCC-CCG
T ss_pred ccc-ccc
Confidence 887 554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.57 E-value=3.8e-08 Score=87.28 Aligned_cols=98 Identities=27% Similarity=0.382 Sum_probs=75.5
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|+|++ ++ .++++++|+.|++++|+|++ +|.+..+++|+.|++++|.+. .++ .+..++.|+.+++++|
T Consensus 70 L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n 144 (210)
T d1h6ta2 70 VTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNN 144 (210)
T ss_dssp CCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSS
T ss_pred CCEEeCCCccccC-cc-ccccCccccccccccccccc-ccccccccccccccccccccc-ccc-cccccccccccccccc
Confidence 6899999999995 55 47899999999999999997 557889999999999999987 554 4778888888888888
Q ss_pred cccCCCCccccccceeeeccCCC
Q 010131 81 SFVGEIPPALLTGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~~~~~n~ 103 (517)
.++...+.........+.+.+|.
T Consensus 145 ~l~~~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 145 KITDITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp CCCCCGGGGGCTTCSEEECCSSC
T ss_pred ccccccccccccccccccccccc
Confidence 88742222223344555555553
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.56 E-value=2.3e-08 Score=89.97 Aligned_cols=81 Identities=21% Similarity=0.393 Sum_probs=64.7
Q ss_pred ceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCccccccccccccc
Q 010131 2 ARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 81 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 81 (517)
..++++.+.+... ..+.++++|+.|++++|.++.. +.+.++++|+.|+|++|+++ .+|. +..+++|++|++++|+
T Consensus 132 ~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 132 QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSC
T ss_pred hhhhchhhhhchh--hhhccccccccccccccccccc-hhhcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCc
Confidence 5677888887743 3477888999999999988754 34888999999999999998 5654 7888999999999999
Q ss_pred ccCCCCc
Q 010131 82 FVGEIPP 88 (517)
Q Consensus 82 l~~~~P~ 88 (517)
++ .+|+
T Consensus 207 lt-~i~~ 212 (227)
T d1h6ua2 207 IS-DVSP 212 (227)
T ss_dssp CC-BCGG
T ss_pred CC-CCcc
Confidence 98 5664
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.51 E-value=4.5e-08 Score=95.10 Aligned_cols=96 Identities=26% Similarity=0.368 Sum_probs=66.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|++++|++++ ++ .+..++.++.++++.|.+++ ++.+..+++++.|++++|++++ ++ .+..+++|+.|++++|
T Consensus 265 L~~L~l~~~~l~~-~~-~~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n 339 (384)
T d2omza2 265 LTELKLGANQISN-IS-PLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANN 339 (384)
T ss_dssp CSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSS
T ss_pred CCEeeccCcccCC-CC-cccccccccccccccccccc-ccccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCC
Confidence 5677888888874 33 36677788888888888876 4457777788888888888874 33 2677788888888888
Q ss_pred cccCCCCcccc--ccceeeeccCCC
Q 010131 81 SFVGEIPPALL--TGKVIFKYDNNP 103 (517)
Q Consensus 81 ~l~~~~P~~~~--~~~~~~~~~~n~ 103 (517)
+++ .+| .+. ..+..+.+.+|.
T Consensus 340 ~l~-~l~-~l~~l~~L~~L~l~~N~ 362 (384)
T d2omza2 340 KVS-DVS-SLANLTNINWLSAGHNQ 362 (384)
T ss_dssp CCC-CCG-GGGGCTTCCEEECCSSC
T ss_pred CCC-CCh-hHcCCCCCCEEECCCCc
Confidence 887 455 232 234555566664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=1.6e-07 Score=86.21 Aligned_cols=132 Identities=14% Similarity=0.092 Sum_probs=93.0
Q ss_pred CCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEEecCCCCHHhHhhc
Q 010131 206 GSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 284 (517)
Q Consensus 206 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 284 (517)
++.+.||+...+ ++.+++|+...........+.+|...+..+. +--+.+++.++.+++..++||++++|.++.+....
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 334689998754 6678888876554444455778888888774 43467778888888889999999999888654431
Q ss_pred cCCCCccCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------------
Q 010131 285 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------------- 314 (517)
Q Consensus 285 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------------- 314 (517)
. .....++.++++.++.||+..
T Consensus 104 ~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 104 E--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp C--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred c--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 1 112334566666667776410
Q ss_pred ------CCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 315 ------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 315 ------~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
...++|+|+.|.||++++++..-|.||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12478999999999999877677999997653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.47 E-value=1.1e-09 Score=96.42 Aligned_cols=81 Identities=22% Similarity=0.411 Sum_probs=70.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCC--CCCCCcccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELHIE 78 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p--~~~~~l~~L~~l~l~ 78 (517)
|+.|+|++|.|+ .+|..+..+++|+.|++++|+|+.. +.+..+++|+.|+|++|+++ .++ ..+..+++|+.|+++
T Consensus 72 L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~ 148 (198)
T d1m9la_ 72 LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLA 148 (198)
T ss_dssp CCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEEC
T ss_pred ccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceeecC
Confidence 689999999998 6786666678999999999999974 55889999999999999998 555 358899999999999
Q ss_pred cccccC
Q 010131 79 NNSFVG 84 (517)
Q Consensus 79 ~N~l~~ 84 (517)
+|++..
T Consensus 149 ~N~l~~ 154 (198)
T d1m9la_ 149 GNPLYN 154 (198)
T ss_dssp SSHHHH
T ss_pred CCcccc
Confidence 999883
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.46 E-value=1e-07 Score=83.57 Aligned_cols=96 Identities=25% Similarity=0.442 Sum_probs=74.1
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|++++ +++ ++++++|+.|++++|.+... +.+.+++.|+.|++++|.+. .++ .+..+++|+.|++++|
T Consensus 64 L~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~~~~~-~~~-~~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 64 LTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQIT-DID-PLKNLTNLNRLELSSN 138 (199)
T ss_dssp CCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSS
T ss_pred cCcCccccccccC-ccc-ccCCcccccccccccccccc-cccccccccccccccccccc-ccc-ccchhhhhHHhhhhhh
Confidence 6889999999995 443 89999999999999998864 45889999999999999987 333 4778999999999999
Q ss_pred cccCCCCccc-cccceeeeccCC
Q 010131 81 SFVGEIPPAL-LTGKVIFKYDNN 102 (517)
Q Consensus 81 ~l~~~~P~~~-~~~~~~~~~~~n 102 (517)
++. .+|.-. ......+.+.+|
T Consensus 139 ~l~-~~~~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 139 TIS-DISALSGLTSLQQLNFSSN 160 (199)
T ss_dssp CCC-CCGGGTTCTTCSEEECCSS
T ss_pred hhc-ccccccccccccccccccc
Confidence 988 565311 223344444444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=1e-07 Score=86.37 Aligned_cols=83 Identities=22% Similarity=0.215 Sum_probs=58.9
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc--ccCccccceeEecC-ceeeecCCCCCCCccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN-NELTGSLPSYMGSLPNLQELHI 77 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~l~~L~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l 77 (517)
+++|+|++|+|+...+..|.++++|++|+|++|.+...+|. |.++++++.+.+.. |++....+..+.++++|+.+++
T Consensus 31 l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l 110 (242)
T d1xwdc1 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 110 (242)
T ss_dssp CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEE
T ss_pred CCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccccc
Confidence 46778888887743334577778888888888877765543 67777777777654 5666566666777788888888
Q ss_pred cccccc
Q 010131 78 ENNSFV 83 (517)
Q Consensus 78 ~~N~l~ 83 (517)
++|.+.
T Consensus 111 ~~~~l~ 116 (242)
T d1xwdc1 111 SNTGIK 116 (242)
T ss_dssp ESCCCC
T ss_pred chhhhc
Confidence 888776
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.26 E-value=6.8e-07 Score=79.91 Aligned_cols=79 Identities=18% Similarity=0.327 Sum_probs=60.0
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|+.|++++|+|+ .++ .+..|++|+.|+|++|++++..| +..+++|+.+++++|.++ .++ .+..+++|+.+++++|
T Consensus 43 L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~ 117 (227)
T d1h6ua2 43 ITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTST 117 (227)
T ss_dssp CCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTS
T ss_pred cCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc-cccccccccccccccccc-ccc-cccccccccccccccc
Confidence 567888888887 454 57788888888888888876543 777888888888888877 554 3677888888888888
Q ss_pred cccC
Q 010131 81 SFVG 84 (517)
Q Consensus 81 ~l~~ 84 (517)
...+
T Consensus 118 ~~~~ 121 (227)
T d1h6ua2 118 QITD 121 (227)
T ss_dssp CCCC
T ss_pred cccc
Confidence 7773
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.22 E-value=3.6e-06 Score=76.34 Aligned_cols=131 Identities=17% Similarity=0.090 Sum_probs=87.4
Q ss_pred ccCCCCc-eEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCC--CCCccccceeeecCCeeEEEEEecCCCCH
Q 010131 202 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVYEYMHNGTL 278 (517)
Q Consensus 202 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL 278 (517)
.+..|.. +.||+...+++..+++|....... ..+..|...++.+. .-.+.+++.++.+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 679999988888899998654432 34667888877763 23366778888888889999999988665
Q ss_pred HhHhhccCCCCccCHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 010131 279 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG--------------------------------------------- 313 (517)
Q Consensus 279 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~--------------------------------------------- 313 (517)
.+.. ... ...+.++++.|+-||+.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3211 111 11223344444444420
Q ss_pred ----------CCCCcEecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 314 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 314 ----------~~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 123479999999999999877778999997643
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.15 E-value=2.4e-06 Score=81.25 Aligned_cols=90 Identities=27% Similarity=0.326 Sum_probs=66.7
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|+++ .+|+. +++|+.|+|++|+|+.. |+. +.+|+.|++++|+++ .++.- .+.|++|++++|
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~--~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n 108 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PEL--PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNN 108 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSS
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccc--hhhhhhhhhhhcccc-hhhhh---cccccccccccc
Confidence 578999999998 68863 57899999999999954 542 357889999999988 66642 136899999999
Q ss_pred cccCCCCccc-cccceeeeccCC
Q 010131 81 SFVGEIPPAL-LTGKVIFKYDNN 102 (517)
Q Consensus 81 ~l~~~~P~~~-~~~~~~~~~~~n 102 (517)
.++ .+|... ......+.+.+|
T Consensus 109 ~l~-~lp~~~~l~~L~~L~l~~~ 130 (353)
T d1jl5a_ 109 QLE-KLPELQNSSFLKIIDVDNN 130 (353)
T ss_dssp CCS-SCCCCTTCTTCCEEECCSS
T ss_pred ccc-cccchhhhccceeeccccc
Confidence 998 687532 223444444444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.02 E-value=2.7e-07 Score=77.94 Aligned_cols=72 Identities=25% Similarity=0.218 Sum_probs=55.2
Q ss_pred CCccccCCCCCcEEEcCCCCCCCCCC--c-ccCccccceeEecCceeeecCCC-CCCCcccccccccccccccCCCC
Q 010131 15 IPPELKNMEALTELWLDGNFLTGPLP--D-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIP 87 (517)
Q Consensus 15 ~p~~~~~l~~L~~L~l~~N~l~~~~p--~-~~~l~~L~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~P 87 (517)
++..+..+++|++|+|++|+|+...+ . +..+++|+.|+|++|.++ .++. .......|+.|++++|+++....
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 33334578999999999999998643 4 678999999999999999 6654 22234578999999999985443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.99 E-value=3.3e-06 Score=75.97 Aligned_cols=92 Identities=16% Similarity=0.110 Sum_probs=61.9
Q ss_pred ecCCCCcccccCCccccCCC-CCcEEEcCCCCCCCCCCcccCcccccee-EecCceeeecCCCC-CCCcccccccccccc
Q 010131 4 CALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIV-HLENNELTGSLPSY-MGSLPNLQELHIENN 80 (517)
Q Consensus 4 L~l~~n~~~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~l~~L~~l-~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N 80 (517)
+..+++++...-+..|..++ .++.|++++|+++...+......++..+ ++++|+++ .+|.. |.++++|+.|++++|
T Consensus 133 ~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp EEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTS
T ss_pred ccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCC
Confidence 34456666644455566654 7888888888888766664444555444 56777787 66654 677888888888888
Q ss_pred cccCCCCccccccceee
Q 010131 81 SFVGEIPPALLTGKVIF 97 (517)
Q Consensus 81 ~l~~~~P~~~~~~~~~~ 97 (517)
+|+ .+|...+.....+
T Consensus 212 ~l~-~l~~~~~~~l~~L 227 (242)
T d1xwdc1 212 RIH-SLPSYGLENLKKL 227 (242)
T ss_dssp CCC-CCCSSSCTTCCEE
T ss_pred cCC-ccCHHHHcCCccc
Confidence 888 7877655544333
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.90 E-value=9.7e-06 Score=76.81 Aligned_cols=79 Identities=27% Similarity=0.411 Sum_probs=65.8
Q ss_pred CceecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCcccCccccceeEecCceeeecCCCCCCCcccccccccccc
Q 010131 1 MARCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 80 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 80 (517)
|++|+|++|+|+ .+|..+ .+|+.|++++|+++.. +++. +.|++|++++|.++ .+|. ++.+++|+.|++++|
T Consensus 60 L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~ 130 (353)
T d1jl5a_ 60 LESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDLP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNN 130 (353)
T ss_dssp CSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSCC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSS
T ss_pred CCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhhc--cccccccccccccc-cccc-hhhhccceeeccccc
Confidence 689999999999 889654 5899999999999854 4432 46999999999999 8885 688999999999999
Q ss_pred cccCCCCcc
Q 010131 81 SFVGEIPPA 89 (517)
Q Consensus 81 ~l~~~~P~~ 89 (517)
.++ ..|..
T Consensus 131 ~~~-~~~~~ 138 (353)
T d1jl5a_ 131 SLK-KLPDL 138 (353)
T ss_dssp CCS-CCCCC
T ss_pred ccc-ccccc
Confidence 998 45543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=3.7e-05 Score=74.28 Aligned_cols=76 Identities=16% Similarity=0.196 Sum_probs=48.7
Q ss_pred hcccCCCCceEEEEEEecC-CcEEEEEEecCC-------CchhHHHHHHHHHHHhcCC-C-C-CccccceeeecCCeeEE
Q 010131 200 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-------CSHRTQQFVTEVALLSRIH-H-R-NLVPLIGYCEEEHQRIL 268 (517)
Q Consensus 200 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-niv~~~~~~~~~~~~~l 268 (517)
.+.||.|....||+....+ ++.|+||.-... .....++...|.+.|+.+. + | .+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3578999999999998764 678999975431 1112344566888887762 2 2 34455544 4455689
Q ss_pred EEEecCCCC
Q 010131 269 VYEYMHNGT 277 (517)
Q Consensus 269 v~e~~~~gs 277 (517)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.77 E-value=2.9e-07 Score=77.66 Aligned_cols=97 Identities=21% Similarity=0.169 Sum_probs=63.6
Q ss_pred eecCCCCcccccCCccccCCCCCcEEEcCCCCCCCCCCc-ccCccccceeEecCceeeecCC---CCCCCcccccccccc
Q 010131 3 RCALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP---SYMGSLPNLQELHIE 78 (517)
Q Consensus 3 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~l~~L~~l~l~~n~l~~~~p---~~~~~l~~L~~l~l~ 78 (517)
.|+++++... + .+..+..+..|++.+|... .++. +..++.|+.|+|++|+|+ .++ ..+..+++|+.|+++
T Consensus 26 ~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls 99 (162)
T d1koha1 26 ALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLS 99 (162)
T ss_dssp CBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCT
T ss_pred eeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccc
Confidence 4566554322 2 3444555555655555433 3344 567899999999999998 443 446678999999999
Q ss_pred cccccCCCCccc-c--ccceeeeccCCCccc
Q 010131 79 NNSFVGEIPPAL-L--TGKVIFKYDNNPKLH 106 (517)
Q Consensus 79 ~N~l~~~~P~~~-~--~~~~~~~~~~n~~~~ 106 (517)
+|.++ .+++-. . .....+.+.+||-.+
T Consensus 100 ~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 100 GNELK-SERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp TSCCC-CGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred cCccc-cchhhhhhhccccceeecCCCCcCc
Confidence 99999 676521 1 134556788998653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.48 E-value=0.00036 Score=65.21 Aligned_cols=135 Identities=13% Similarity=0.184 Sum_probs=79.3
Q ss_pred eEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCCCC--ccccce-----eeecCCeeEEEEEecCCCCHH--
Q 010131 209 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIG-----YCEEEHQRILVYEYMHNGTLR-- 279 (517)
Q Consensus 209 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~-----~~~~~~~~~lv~e~~~~gsL~-- 279 (517)
-.||+++.++|+.|++|+.+.. ....+++..|...+..|.... ++..+. .+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999998654 334567888998888874221 121111 234466778999999764321
Q ss_pred ---h---------Hhhc----cC--CCCccCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCCc
Q 010131 280 ---D---------RLHG----SV--NQKPLDWL----------------------TRLQIAHDAAKGLEYL-HTGCNPGI 318 (517)
Q Consensus 280 ---~---------~l~~----~~--~~~~l~~~----------------------~~~~i~~~ia~aL~~L-H~~~~~~i 318 (517)
. .++. .. .....++. .....+.++...+.-. .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0110 00 01111111 1222333333333322 12234679
Q ss_pred EecCCCCCCeEeCCCCcEEEccccCccc
Q 010131 319 IHRDVKSSNILLDINMRAKVSDFGLSRQ 346 (517)
Q Consensus 319 vH~dlk~~Nill~~~~~~kl~Dfg~a~~ 346 (517)
+|+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899997653
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.31 E-value=6.5e-06 Score=81.06 Aligned_cols=83 Identities=17% Similarity=0.171 Sum_probs=45.9
Q ss_pred CceecCCCCcccccC-CccccCCCCCcEEEcCCCCCCC----CCCc-ccCccccceeEecCceeee----cCCCCCCC-c
Q 010131 1 MARCALSGKNLKGEI-PPELKNMEALTELWLDGNFLTG----PLPD-MSRLIDLRIVHLENNELTG----SLPSYMGS-L 69 (517)
Q Consensus 1 l~~L~l~~n~~~~~~-p~~~~~l~~L~~L~l~~N~l~~----~~p~-~~~l~~L~~l~l~~n~l~~----~~p~~~~~-l 69 (517)
|+.|||++|++++.. ..-+..+++|++|+|++|.|+. .++. +..+++|+.|+|++|.|+. .+...+.. .
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~ 83 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 83 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCC
Confidence 456777777776421 2223445666777777776653 1223 4556667777777776641 12222222 2
Q ss_pred cccccccccccccc
Q 010131 70 PNLQELHIENNSFV 83 (517)
Q Consensus 70 ~~L~~l~l~~N~l~ 83 (517)
.+|+.|++++|+++
T Consensus 84 ~~L~~L~L~~n~it 97 (460)
T d1z7xw1 84 CKIQKLSLQNCCLT 97 (460)
T ss_dssp CCCCEEECTTSCCB
T ss_pred CCCCEEECCCCCcc
Confidence 35666777777665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.09 E-value=1.3e-05 Score=73.89 Aligned_cols=65 Identities=17% Similarity=0.194 Sum_probs=43.1
Q ss_pred ccCCCCCcEEEcCCCCCCCC-CCc-ccCccccceeEecCceeeecCCCCCCCcccccccccccc-ccc
Q 010131 19 LKNMEALTELWLDGNFLTGP-LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN-SFV 83 (517)
Q Consensus 19 ~~~l~~L~~L~l~~N~l~~~-~p~-~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N-~l~ 83 (517)
.....+|+.|||+++.++.. ++. +..+++|+.|+|++|.+++..+..++.+++|+.|+++++ .++
T Consensus 42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it 109 (284)
T d2astb2 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109 (284)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence 33456777777777776654 234 666777777777777776666666667777777777773 444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.96 E-value=3.8e-05 Score=72.74 Aligned_cols=84 Identities=18% Similarity=0.257 Sum_probs=62.4
Q ss_pred CceecCCCCccccc----CCccccCCCCCcEEEcCCCCCCCC-----CCc-ccCccccceeEecCceeeec----CCCCC
Q 010131 1 MARCALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGP-----LPD-MSRLIDLRIVHLENNELTGS----LPSYM 66 (517)
Q Consensus 1 l~~L~l~~n~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~-~~~l~~L~~l~l~~n~l~~~----~p~~~ 66 (517)
|+.|++++|.++.. +...+..+++|+.|+|++|.++.. +.. +..+++|+.|+|++|.++.. +...+
T Consensus 160 L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l 239 (344)
T d2ca6a1 160 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239 (344)
T ss_dssp CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred cceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc
Confidence 46788888887632 333455678899999999998752 223 67788899999999988632 44557
Q ss_pred CCcccccccccccccccC
Q 010131 67 GSLPNLQELHIENNSFVG 84 (517)
Q Consensus 67 ~~l~~L~~l~l~~N~l~~ 84 (517)
..+++|++|++++|++++
T Consensus 240 ~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 240 KSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp GGCTTCCEEECTTCCCCH
T ss_pred cccccchhhhhhcCccCc
Confidence 778889999999998874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.90 E-value=2.6e-05 Score=76.49 Aligned_cols=82 Identities=21% Similarity=0.208 Sum_probs=39.8
Q ss_pred ceecCCCCcccccCCcc----cc-CCCCCcEEEcCCCCCCCCCCc-----ccCccccceeEecCceeee----cCCCCCC
Q 010131 2 ARCALSGKNLKGEIPPE----LK-NMEALTELWLDGNFLTGPLPD-----MSRLIDLRIVHLENNELTG----SLPSYMG 67 (517)
Q Consensus 2 ~~L~l~~n~~~~~~p~~----~~-~l~~L~~L~l~~N~l~~~~p~-----~~~l~~L~~l~l~~n~l~~----~~p~~~~ 67 (517)
..+++++|.++...... +. ...+|+.+++++|.++..... +...++|+.|+|++|.++. .++..+.
T Consensus 286 ~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~ 365 (460)
T d1z7xw1 286 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLG 365 (460)
T ss_dssp CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred cccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhh
Confidence 45566666654321111 11 234566666666666543221 2233456666666666542 1222222
Q ss_pred -Cccccccccccccccc
Q 010131 68 -SLPNLQELHIENNSFV 83 (517)
Q Consensus 68 -~l~~L~~l~l~~N~l~ 83 (517)
..+.|+.|++++|+|+
T Consensus 366 ~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 366 QPGSVLRVLWLADCDVS 382 (460)
T ss_dssp STTCCCCEEECTTSCCC
T ss_pred cccCCCCEEECCCCCCC
Confidence 2345666666666665
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.84 E-value=0.0017 Score=62.21 Aligned_cols=72 Identities=14% Similarity=0.254 Sum_probs=49.1
Q ss_pred cccCCCCceEEEEEEecC--------CcEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCCccccceeeecCCeeEEEEE
Q 010131 201 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 271 (517)
Q Consensus 201 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 271 (517)
+.|+.|-.=.+|++...+ .+.|.+++.... .. .....+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 568888888999998754 356777776532 22 334567899988884 4334567776643 68999
Q ss_pred ecCCCCH
Q 010131 272 YMHNGTL 278 (517)
Q Consensus 272 ~~~~gsL 278 (517)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.77 E-value=0.00036 Score=63.85 Aligned_cols=80 Identities=20% Similarity=0.270 Sum_probs=59.7
Q ss_pred CceecCCCC--ccccc-CCccccCCCCCcEEEcCCC-CCCCCCCc-ccCccccceeEecCc-eeeecCCCCCCCcccccc
Q 010131 1 MARCALSGK--NLKGE-IPPELKNMEALTELWLDGN-FLTGPLPD-MSRLIDLRIVHLENN-ELTGSLPSYMGSLPNLQE 74 (517)
Q Consensus 1 l~~L~l~~n--~~~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~p~-~~~l~~L~~l~l~~n-~l~~~~p~~~~~l~~L~~ 74 (517)
|+.|+++++ +++.. +..-+.++++|+.|+|++| .+++.... +..+++|+.|+|++| .+++.....++++++|+.
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~ 229 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence 577888864 34322 2222356899999999986 57765554 889999999999995 677666667888999999
Q ss_pred cccccc
Q 010131 75 LHIENN 80 (517)
Q Consensus 75 l~l~~N 80 (517)
|+++++
T Consensus 230 L~l~~~ 235 (284)
T d2astb2 230 LQVFGI 235 (284)
T ss_dssp EECTTS
T ss_pred EeeeCC
Confidence 999877
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.71 E-value=0.00011 Score=61.66 Aligned_cols=83 Identities=14% Similarity=0.174 Sum_probs=56.0
Q ss_pred CceecCCCC-ccccc----CCccccCCCCCcEEEcCCCCCCCCC----Cc-ccCccccceeEecCceeeec----CCCCC
Q 010131 1 MARCALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPL----PD-MSRLIDLRIVHLENNELTGS----LPSYM 66 (517)
Q Consensus 1 l~~L~l~~n-~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----p~-~~~l~~L~~l~l~~n~l~~~----~p~~~ 66 (517)
|++|+|+++ .++.. +-..+...++|+.|+|++|.++..- .. +...+.|+.|+|++|.++.. +-..+
T Consensus 17 L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL 96 (167)
T d1pgva_ 17 LKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRST 96 (167)
T ss_dssp CCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHT
T ss_pred CcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHH
Confidence 578888874 45432 2234556678888888888887421 12 44567788888888888732 22346
Q ss_pred CCccccccccccccccc
Q 010131 67 GSLPNLQELHIENNSFV 83 (517)
Q Consensus 67 ~~l~~L~~l~l~~N~l~ 83 (517)
...++|++|++++|.+.
T Consensus 97 ~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 97 LVTQSIVEFKADNQRQS 113 (167)
T ss_dssp TTTCCCSEEECCCCSSC
T ss_pred HhCCcCCEEECCCCcCC
Confidence 66778888888888766
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.62 E-value=0.0001 Score=69.72 Aligned_cols=83 Identities=19% Similarity=0.215 Sum_probs=59.2
Q ss_pred CceecCCCCccc--------c---c--CCccccCCCCCcEEEcCCCCCCCCC----Cc-ccCccccceeEecCceeee--
Q 010131 1 MARCALSGKNLK--------G---E--IPPELKNMEALTELWLDGNFLTGPL----PD-MSRLIDLRIVHLENNELTG-- 60 (517)
Q Consensus 1 l~~L~l~~n~~~--------~---~--~p~~~~~l~~L~~L~l~~N~l~~~~----p~-~~~l~~L~~l~l~~n~l~~-- 60 (517)
|+.|+|++|.+. . . ........+.|+.|++++|.++..- .. +..++.|+.|+|++|+++.
T Consensus 123 L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g 202 (344)
T d2ca6a1 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202 (344)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHH
T ss_pred chheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccc
Confidence 578889888741 0 0 1112235678999999999887432 22 5567889999999999863
Q ss_pred ---cCCCCCCCccccccccccccccc
Q 010131 61 ---SLPSYMGSLPNLQELHIENNSFV 83 (517)
Q Consensus 61 ---~~p~~~~~l~~L~~l~l~~N~l~ 83 (517)
.+...+..+++|+.|++++|.++
T Consensus 203 ~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 203 IEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp HHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cccchhhhhcchhhhccccccccccc
Confidence 14456778889999999999886
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.83 E-value=0.025 Score=51.71 Aligned_cols=141 Identities=13% Similarity=0.107 Sum_probs=73.9
Q ss_pred ccCCCCceEEEEEEecCCcEEEEEEecCCCchhHHHHHHHHHHHhcCCC-----CCccccc-e--eeecCCeeEEEEEec
Q 010131 202 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-----RNLVPLI-G--YCEEEHQRILVYEYM 273 (517)
Q Consensus 202 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~~~-~--~~~~~~~~~lv~e~~ 273 (517)
.|..|.--+.|+.+.++|+ +++|+...... .+.+..|++++..|.. |..+... | +.........++.+.
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 3566777889999887664 89998864322 2344456666666632 2222211 1 122344566777777
Q ss_pred CCCCHHh--------------Hhhcc----CCCC--c------------------cCHHHHHHHHHHHHHHHHHHhc-CC
Q 010131 274 HNGTLRD--------------RLHGS----VNQK--P------------------LDWLTRLQIAHDAAKGLEYLHT-GC 314 (517)
Q Consensus 274 ~~gsL~~--------------~l~~~----~~~~--~------------------l~~~~~~~i~~~ia~aL~~LH~-~~ 314 (517)
.+..... .++.. .... . .........+......+...+. ..
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6643211 00000 0000 0 0001112222233333333322 23
Q ss_pred CCCcEecCCCCCCeEeCCCCcEEEccccCcc
Q 010131 315 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 345 (517)
Q Consensus 315 ~~~ivH~dlk~~Nill~~~~~~kl~Dfg~a~ 345 (517)
..++||+|+.++||+++.+...-+.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5789999999999999988777899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.66 E-value=0.0004 Score=57.97 Aligned_cols=81 Identities=15% Similarity=0.141 Sum_probs=56.9
Q ss_pred CceecCCCCcccccCC----ccccCCCCCcEEEcCCCCCCCCCC-----cccCccccceeEecCceeee-------cCCC
Q 010131 1 MARCALSGKNLKGEIP----PELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTG-------SLPS 64 (517)
Q Consensus 1 l~~L~l~~n~~~~~~p----~~~~~l~~L~~L~l~~N~l~~~~p-----~~~~l~~L~~l~l~~n~l~~-------~~p~ 64 (517)
|++|+|++|.+...-. ..+...++|+.|+|++|.|+..-. .+...+.|+.|+|++|.+.. .+..
T Consensus 46 L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~ 125 (167)
T d1pgva_ 46 IEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMM 125 (167)
T ss_dssp CCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHH
T ss_pred cceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHH
Confidence 6789999999874322 334556899999999999987422 26667889999999997651 1233
Q ss_pred CCCCccccccccccccc
Q 010131 65 YMGSLPNLQELHIENNS 81 (517)
Q Consensus 65 ~~~~l~~L~~l~l~~N~ 81 (517)
.+...++|+.|+++.+.
T Consensus 126 ~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 126 AIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHCSSCCEEECCCCC
T ss_pred HHHhCCCccEeeCcCCC
Confidence 34445667777665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.33 E-value=0.0041 Score=51.37 Aligned_cols=40 Identities=13% Similarity=0.151 Sum_probs=17.2
Q ss_pred CccccceeEecCceeeec----CCCCCCCccccccccccccccc
Q 010131 44 RLIDLRIVHLENNELTGS----LPSYMGSLPNLQELHIENNSFV 83 (517)
Q Consensus 44 ~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~ 83 (517)
..++|+.|+|++|.++.. +-..+...++|+.+++++|.+.
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 344555555555544321 1112223344555555555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.46 E-value=0.0046 Score=51.04 Aligned_cols=83 Identities=20% Similarity=0.277 Sum_probs=59.1
Q ss_pred CceecCCC-Cccccc----CCccccCCCCCcEEEcCCCCCCCCCC----c-ccCccccceeEecCceeeec----CCCCC
Q 010131 1 MARCALSG-KNLKGE----IPPELKNMEALTELWLDGNFLTGPLP----D-MSRLIDLRIVHLENNELTGS----LPSYM 66 (517)
Q Consensus 1 l~~L~l~~-n~~~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~-~~~l~~L~~l~l~~n~l~~~----~p~~~ 66 (517)
|++|+|++ |.++.. +...+...++|+.|+|++|.++..-- . +...+.|+.+++++|.++.. +-..+
T Consensus 19 L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l 98 (166)
T d1io0a_ 19 LEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEAL 98 (166)
T ss_dssp CCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGG
T ss_pred CcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHH
Confidence 67899997 456532 23345678999999999999877422 3 55678999999999998632 33456
Q ss_pred CCccccccccc--cccccc
Q 010131 67 GSLPNLQELHI--ENNSFV 83 (517)
Q Consensus 67 ~~l~~L~~l~l--~~N~l~ 83 (517)
...++|+.++| ++|.+.
T Consensus 99 ~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 99 QSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGCSSCCEEECCCCSSCCC
T ss_pred HhCccccEEeeccCCCcCc
Confidence 67788886544 566665
|